Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,establishment of endothelial barrier (GO:0061028),-0.7320511268179406,-2.3852752765799528,0.0,0.0,0.0,21/29,20.44%,TJP1;RAPGEF2;PECAM1;AFDN;RAPGEF6;EZR;F11R;RDX;RAP1A;RAPGEF1;TJP2;PPP1R16B;ICAM1;ROBO4;RAPGEF3;RAP2C;RAB1A;SOX18;RAP2B;MSN;RAB1B
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.570812966537509,-2.367447836699433,0.0,0.0,0.0,48/91,18.25%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;SSR2;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;ARL6IP1;RPL31;RPS23;RPL23A;RPL19;RPL36
prerank,protein targeting to ER (GO:0045047),-0.5601221758686059,-2.338092291045428,0.0,0.0,0.0,51/99,18.43%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;SPCS2;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;RPL31;RPS23;RPL23A;SGTB;CHMP4B;CHMP4A;RPL19;RPL36;EDEM1
prerank,cytoplasmic translation (GO:0002181),-0.5732519142124135,-2.3371072035935665,0.0,0.0,0.0,59/91,28.30%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;DRG2;RPL36A;FTSJ1;RPL22L1;RPL34;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;RPL31;RPS23;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;UBA52;RPS11;GSPT1;RPL15;RPL38;RPL13A;RPS25;RPS12;RPL24;RPL18A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5677697030308843,-2.3189245644645005,0.0,0.0,0.0,50/87,22.69%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;RPL31;RPS23;RPL23A;RPL19;RPL36;RPL17;RPL23;UBA52;ZFAND2B;RPS11
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5189276972657589,-2.188567743794892,0.0,0.001029966064340008,0.005,61/110,24.79%,RPS14;RPS9;SMG6;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;PPP2R1A;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;HELZ2;RPL36A;PYM1;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;SMG5;RPS8;RPL31;RPS23;PABPC1;EIF3E;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;RBM8A;NCBP2;UBA52;RPS11;GSPT1;MAGOH;RPL15;RPL38
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.65733175288769,-2.181908943108602,0.0,0.0010593936661782936,0.006,18/34,15.33%,FLT1;FOXC1;GAS1;NRP1;KDR;NOTCH1;VEGFD;ANXA1;VEGFC;SEMA6A;GAB1;MAPK14;ITGB1BP1;NR4A1;HSPB1;FLT4;RAMP2;ERN1
prerank,collagen fibril organization (GO:0030199),0.6551470083014108,2.180756167375353,0.0,0.00783687578444888,0.009,25/88,6.84%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;LOXL4;COL23A1;LUM;PLOD1;COL10A1;ADAMTS14;COL22A1;COL7A1;COLGALT1;DPT;LOXL3;LOXL2;COLGALT2;COL12A1;COL26A1;NF1;COL1A2;COL16A1
prerank,regulation of cell junction assembly (GO:1901888),-0.6840773101091437,-2.1347275101367185,0.0,0.0018539389158120138,0.012,12/27,6.08%,TJP1;RAPGEF2;ROCK2;PRKCH;MEF2C;PDLIM5;OCLN;F11R;CLDN5;RAP1A;RUNX1;RAPGEF1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.8077292298536851,-2.085007067546917,0.002403846153846154,0.0064544540031973826,0.043,6/12,7.73%,CYP26B1;MBNL1;TGFB2;SKI;MEGF8;LRP6
prerank,vascular process in circulatory system (GO:0003018),-0.786860156590335,-2.072833788197747,0.0,0.006516876188914958,0.053,10/13,18.40%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.786860156590335,-2.072833788197747,0.0,0.006516876188914958,0.053,10/13,18.40%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,dopamine metabolic process (GO:0042417),-0.7192968026005157,-2.0523509764259837,0.002570694087403599,0.009269694579060071,0.081,6/18,8.47%,SNCAIP;MOXD1;TGFB2;MAOB;GCH1;MAOA
prerank,external encapsulating structure organization (GO:0045229),0.5512846624115589,2.029649330939428,0.0,0.1362745622518055,0.198,46/205,7.01%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP28;MMP24;MMP25;TNR;VCAN;ST7;RECK;APLP1;SPP1;NF1;ADAM19;COLQ;COL1A2;COL16A1;ADAMTS12
prerank,extracellular structure organization (GO:0043062),0.5520723364972249,2.0287424211260863,0.0,0.0917204721439202,0.201,47/204,7.01%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP28;MMP24;MMP25;TNR;VCAN;ST7;RECK;APLP1;SPP1;NF1;ADAM19;COLQ;COL1A2;COL16A1;TEX14;ADAMTS12
prerank,extracellular matrix organization (GO:0030198),0.5381123740037316,2.02864292340808,0.0,0.06900804510195263,0.201,59/276,7.01%,LAMA1;COL15A1;SCUBE1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;FLRT2;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;LOXL4;GPM6B;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;PLOD1;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP28;MMP24;MMP25;TNR;COLGALT1;DPT;VCAN;ST7;LOXL3;LOXL2;COLGALT2;RECK;KLKB1;APLP1;SPP1;COL12A1;COL26A1;NF1;ADAM19;COLQ;COL1A2;COL16A1;ADAMTS12
prerank,muscle cell development (GO:0055001),-0.6359493429363499,-2.021486592713262,0.0,0.015021658907605035,0.138,11/30,17.04%,NEBL;MYOF;IGF1;CXADR;ANK2;MYH11;DMD;HEY2;RAMP2;DYSF;SDC1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.7175028579465514,-2.017845375243088,0.0,0.01536120815958526,0.149,10/17,11.42%,DOCK5;IGF1;DOCK4;ADAMTS1;IGFBP5;NRP1;VTN;S100A11;CCN4;MDK
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7846080125591846,-1.9996343472955624,0.0,0.018374594587825737,0.189,10/11,20.44%,TJP1;RAPGEF2;AFDN;RAPGEF6;F11R;TJP2;RAP2C;RAB1A;RAP2B;RAB1B
prerank,epithelial cell morphogenesis (GO:0003382),0.7960639110160318,1.9911601959570253,0.0017543859649122807,0.11076117775354417,0.347,4/17,6.13%,COL15A1;COL18A1;COL22A1;SIPA1L3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.7627385339518682,-1.9822687591307453,0.002352941176470588,0.023483226266952175,0.246,9/14,13.36%,FOXC1;NRP1;KDR;VEGFD;VEGFC;GAB1;PIK3CD;MYO1C;FLT4
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.7272660241527344,1.9629668404633125,0.0,0.14498220201230427,0.484,5/25,6.54%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,positive regulation of wound healing (GO:0090303),-0.5700091212503955,-1.9463472233083317,0.0,0.03976880733134006,0.39,11/36,5.01%,OCLN;PLPP3;MYLK;ITGB1;THBS1;FOXC2;ST3GAL4;ACTG1;VTN;KANK1;ANXA1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.5760070242722999,-1.9431600106659865,0.0,0.03900138163634163,0.401,21/36,22.05%,CAV1;NPR3;EGFR;NOS3;ZDHHC21;NOSTRIN;SCARB1;CALM1;APOE;GCH1;PIK3CB;TERT;DDAH1;NOS1AP;DHFR;AKT1;WASL;NOSIP;NUS1;LYPLA1;DDAH2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.772542563806288,-1.9414721692595378,0.0,0.037729283198981334,0.408,6/12,2.44%,DOCK5;MEF2C;DOCK4;ADAMTS1;IGFBP5;TPM1
prerank,cell junction organization (GO:0034330),-0.4925200407827608,-1.928822865045582,0.0,0.04412374619632594,0.466,17/71,9.04%,SDK1;TJP1;APBB2;LIMS2;OCLN;CXADR;SLC8A3;ACTB;APP;TGFB2;ACTG1;DVL1;CDC42;TJP2;MAPT;SMAD3;PPFIBP1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5605911793618585,-1.916601408719229,0.0,0.05049776475449867,0.529,17/35,18.21%,PLXNA2;SEMA3D;SEMA3C;PLXNA4;SEMA7A;NRP2;NRP1;RAC1;SEMA6A;SEMA4B;PLXNB1;SEMA5B;FLNA;MET;SEMA6C;SEMA3G;SEMA6B
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6628019170864298,-1.9130498037476833,0.0,0.050393430529799284,0.544,9/20,15.79%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.5376973998318555,-1.9121403112519362,0.0,0.048686048050019845,0.551,17/44,11.40%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A
prerank,icosanoid secretion (GO:0032309),-0.7564940589082438,-1.8976387525368532,0.0,0.05767809960304044,0.626,4/12,6.29%,ABCC4;ANXA1;ACE;BDKRB2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6670139475527238,1.8930931472395311,0.003115264797507788,0.3811458318024027,0.859,5/32,6.54%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,carbohydrate biosynthetic process (GO:0016051),-0.638979652826922,-1.868599457349131,0.0026595744680851063,0.08305646342837822,0.766,9/21,15.79%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.5080937314765095,-1.859997708021006,0.0,0.08865630969203606,0.795,19/51,14.88%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A;RAPGEF3;CX3CL1
prerank,lipid catabolic process (GO:0016042),0.7348389569305794,1.859654506188803,0.004754358161648178,0.5188664842287196,0.947,5/18,5.09%,HSD11B1;CEL;ACADL;LIPC;LIPH
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.597814711629828,-1.859089643892819,0.0028653295128939827,0.08665447821313932,0.8,13/27,19.39%,HMBOX1;BMPR2;SMG6;DACH1;PDGFA;ACVRL1;NIBAN2;SMG5;ATM;CDKN1A;PARP4;HGF;RGCC
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6616236679680132,-1.858116815493206,0.0,0.08466321048874864,0.802,5/17,3.73%,ROCK2;VCL;F11R;CLDN5;ZDHHC21
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4166649084942139,-1.854418266523844,0.0,0.08506809370024782,0.813,56/168,13.28%,DDX5;CSDE1;RPS14;RPS9;SMG6;RPS16;TUT7;RPLP1;RPL13;SAMD4A;CNOT10;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;PPP2R1A;RPL41;RPS18;RPS20;PARN;RPS19;PAN3;RPS24;NBAS;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;ERI1;CNOT8;RPL10A;RPS5;RPL11;HELZ2;RPL36A;RC3H1;PYM1;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;SMG5;POLR2G;ATM;RPS8
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6523211873476038,-1.8503281606765885,0.0,0.08676434126000225,0.821,7/19,4.27%,TJP1;ROCK2;PRKCH;OCLN;F11R;CLDN5;RUNX1
prerank,organophosphate ester transport (GO:0015748),-0.6008353659175991,-1.8455925338880343,0.0,0.08926815553770107,0.833,11/24,17.78%,PITPNC1;OSBPL8;EPG5;PLTP;SCARB1;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1;PCTP
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.6473064898251656,1.8452716073060944,0.0031007751937984496,0.5504195844164158,0.969,9/32,14.70%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;TRPC3;P2RX4;AKAP6;F2R
prerank,anterograde trans-synaptic signaling (GO:0098916),0.49373515070775587,1.8368885035751097,0.0,0.5479717701281867,0.979,72/224,18.15%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;SLC18A3;CHRNB4;NRXN2;CEL;GRIN2B;NRXN1;NOVA1;GABRA1;ASIC2;GRIK2;KCNQ3;GRIA4;GRIA1;GABRD;SLC12A6;SCN2B;PCDHB16;PDYN;HTR2B;DLG2;GRIK4;CAMKK2;KCNIP2;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;PRKACB;HTR5A;LPAR3;GABRG3;HTR1A;GPR176;PRKACA;NPY;CACNB4;HTR2C;MBP;CAMK4;GLRA3;PLP1;GABRG2;KCND2;GRM5;GLRA1;DLG4;SYT5;CBLN1;HTR4;GLRA2;GABRB1;ATXN3;PRKAR1A;SYN2;APBA2;GLRB;GABBR2;GRM7;HTR6;CDK5;UNC13C;AMPH;GRM1;GRIA2
prerank,genitalia development (GO:0048806),0.796661793667521,1.8320475950052817,0.01060070671378092,0.5268122055101747,0.98,4/12,4.31%,CHD7;WNT5A;DNAJC19;TBX3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7307302151788035,-1.8318802434136379,0.0,0.10258462000826478,0.888,5/12,9.74%,CAV1;CAMK2D;SRI;CALM1;GJD3
prerank,negative regulation of vascular permeability (GO:0043116),-0.7266791073564551,-1.828080484389091,0.002304147465437788,0.10337113954830622,0.894,7/12,14.58%,PTPRJ;SLIT2;CLDN5;PDE3A;CEACAM1;DDAH1;RAMP2
prerank,cellular response to sterol (GO:0036315),0.7561790828863718,1.8260197649115433,0.007042253521126761,0.5191930207197383,0.983,3/13,2.27%,RORA;GRAMD1B;GPLD1
prerank,regulation of tissue remodeling (GO:0034103),-0.6402316196902162,-1.8034513565610062,0.012165450121654502,0.1354465960846189,0.946,7/18,13.36%,LEPR;IL18;CST3;RUNX1;MDK;CEACAM1;FLT4
prerank,myotube cell development (GO:0014904),-0.7536801282047252,-1.8025123243804884,0.002207505518763797,0.1332364100830234,0.947,4/10,5.87%,IGF1;SKI;CAV2;SIX1
prerank,muscle contraction (GO:0006936),-0.42357637207002025,-1.8019835204164525,0.0,0.130187710532577,0.947,29/126,13.05%,SORBS1;MYOF;TMOD3;ROCK2;SNTB1;SORBS3;ACTN2;VIM;CALD1;VCL;MYLK;EDNRA;TPM1;SNTA1;MYL6;CRYAB;BDKRB2;CALM1;ITGA1;MYL9;MYH11;DMD;GJC1;LMOD1;KCNJ12;ACTA2;DTNA;NOS1;TMOD1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.7090935038985657,1.8008916963052077,0.009448818897637795,0.6332463561211941,0.995,5/19,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,organic anion transport (GO:0015711),-0.45421143523480306,-1.798745999064945,0.0,0.13208062113730995,0.953,29/76,26.05%,ABCG2;ABCC4;SLC4A10;LRRC8C;SLC16A2;SLC26A7;SLCO2A1;SLCO1C1;SLC22A6;SLC39A8;SLC4A3;ABCC6;LRRC8D;CA4;SLC4A8;CYB5R1;SLC35A2;SLC26A6;SLC52A3;SLCO5A1;SLC35C2;SLC35B2;CFTR;SLC4A7;SLC17A9;CYB5R4;SLCO4A1;SLC25A4;SLC52A2
prerank,myelin maintenance (GO:0043217),0.8206840749810094,1.7958626933747088,0.010948905109489052,0.6174338564462225,0.997,7/10,15.09%,EPB41L3;PTEN;ABCD2;PRX;DEGS1;MYRF;CLU
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.7992399518257961,1.795715237726558,0.0,0.5773745670528041,0.997,5/12,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,negative regulation of hemostasis (GO:1900047),-0.7203021690086386,-1.7950107333745615,0.009345794392523364,0.13387390486810963,0.958,7/12,15.37%,THBD;VTN;CD34;APOE;SERPINE1;SERPINE2;EDN1
prerank,atrial septum morphogenesis (GO:0060413),-0.762168989420746,-1.7949767091706752,0.0,0.13047293190424036,0.958,6/10,12.73%,NOTCH2;BMPR2;TGFB2;SOX4;ACVR1;HEY2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.520810411749018,-1.7910885391347477,0.0,0.1328347233179308,0.96,15/39,12.98%,SNCAIP;TJP1;RAPGEF2;ROCK2;EZR;TIE1;RDX;RAP1A;HSPA8;NOTCH1;RAPGEF1;APOE;PARP10;NCLN;VPS11
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7429336675400432,1.7881111101281826,0.0066555740432612314,0.5870581881031254,0.998,7/16,12.41%,APOD;PPARA;ABCD2;ADCY7;APPL2;PYCARD;PDCD4
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4365924022579933,-1.7876516582899216,0.0,0.13438796238520256,0.964,33/92,13.99%,ANXA3;DOCK5;ROCK2;FOXP1;TEK;DOCK1;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;KDR;TGFB2;RAC1;SCARB1;PPM1F;AAMP;FGF1;ITGB1BP1;ATOH8;HYAL1;PIK3CB;ENPP2;PIK3CD;ETS1;MAPRE2;CTSH;ITGB3;PLCG2;FLT4;PTK2B;RRAS
prerank,translation (GO:0006412),-0.3863886244413726,-1.7839357232631987,0.0,0.1364263621222936,0.965,102/208,29.75%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;EEF1G;RPL35A;RPS15A;RPL10A;RPS5;RPL11;ABCF1;DRG2;RPL36A;FTSJ1;EEF1A1;RPL22L1;RPL34;KARS1;RPLP2;RPS29;RPL32;RPL4;RPLP0;EEF2K;IARS2;RPL30;RPL26;RPS4X;RPS21;GARS1;RPL29;RPS8;EEFSEC;EEF1D;MRPS7;RPL31;APEH;RPS23;NOA1;RPL23A;GTPBP1;SRBD1;MRPS17;AGO2;RPL19;RPL36;MRPL16;EEF1E1;GSPT2;MRPS18A;MRPL2;RARS1;MRPS18B;RPL17;RPL23;GATC;UBA52;MRPL24;RPS11;MRPL57;MRPL55;QARS1;PTCD3;LARS2;GSPT1;RPL15;MRPS34;RPL38;HARS2;TRMT112;MRPL36;MRPL35;RPL13A;RPS25;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A;FASTKD2;MRPS2;MRPL18;GTPBP2;EIF4EBP2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7242955007856762,-1.7796204735469012,0.0022675736961451248,0.1395484253684857,0.97,6/11,18.69%,NOS3;CALM1;GCH1;DHFR;AKT1;PRKG2
prerank,chemical synaptic transmission (GO:0007268),0.4686949767673704,1.779565990739816,0.0,0.6024150071954462,0.999,82/284,16.25%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;PTEN;SLC18A3;CHRNB4;NRXN2;GRID2;CEL;PTPRN2;GRIN2B;NRXN1;NOVA1;GRID1;GABRA1;ASIC2;GRIK2;GRIK5;KCNQ3;GRIA4;GRIA1;GABRD;SLC12A6;SCN2B;PCDHB16;PDYN;VAMP2;HTR2B;CHAT;DLG2;GRIK4;CAMKK2;FCHSD2;KCNIP2;NAPB;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;PRKACB;SNPH;HTR5A;LPAR3;GABRG3;HTR1A;GPR176;PRKACA;NPY;CACNB4;HTR2C;MBP;CAMK4;GLRA3;ERC2;PLP1;GABRG2;KCND2;GRM5;SHISA6;GLRA1;RIMS1;DLG4;SYT5;DNAJC5;CBLN1;HTR4;GLRA2;UNC13A;GABRB1;ATXN3;PRKAR1A;SYN2;APBA2;GLRB;GABBR2;PDZD11;GRM7
prerank,regulation of stress fiber assembly (GO:0051492),-0.4430362431469435,-1.7731124089594812,0.0,0.1458431947105451,0.977,27/74,11.67%,PHLDB2;TJP1;ROCK2;ARHGEF18;PPM1E;SORBS3;WASF2;CCN2;TPM1;F11R;NRP1;LIMCH1;S100A10;ACTG1;RAC1;CGNL1;CDC42;PPM1F;ARHGEF15;TMEFF2;RHOC;RHPN2;ITGB1BP1;SFRP1;FHOD1;CCDC88A;ARHGAP28
prerank,lymphocyte chemotaxis (GO:0048247),0.6075164679827854,1.7696762122173495,0.007633587786259542,0.6311587553068182,1.0,7/34,10.57%,CYP7B1;XCL1;CXCL10;MSMP;CCL15;GPR183;CCL25
prerank,regulation of steroid metabolic process (GO:0019218),0.6528542849677913,1.7647509035209783,0.010903426791277258,0.6288290797568601,1.0,4/23,7.56%,RORA;NR1H4;ACADL;DGKQ
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6371175293857982,1.7593906623822466,0.009554140127388535,0.6300848130696899,1.0,8/26,10.45%,PPARA;SLC30A10;ABCD2;TLR6;ADGRB1;TLR4;CYBA;SLC25A33
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7429154332854461,-1.7570578991233854,0.006787330316742082,0.16949121554779167,0.988,5/10,6.68%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.536445886812492,-1.7542114011750107,0.0028328611898017,0.17075046101428043,0.99,6/31,5.70%,RANBP3L;CRIM1;SMAD6;NOTCH1;SKI;CDK6
prerank,camera-type eye development (GO:0043010),0.6428228526656938,1.753975033090803,0.007961783439490446,0.6319258569047669,1.0,2/25,1.20%,LAMA1;TENM3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5983134698756895,1.7517789738879674,0.0,0.6166987959469595,1.0,17/37,18.03%,DYNLL1;TRAF3IP1;WDR35;DYNC2LI1;IFT81;KIFAP3;TTC21B;IFT74;SSX2IP;TNPO1;IFT88;DYNLL2;TRIP11;KIF3C;IFT43;CLUAP1;PCM1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5564782460501153,1.7492958069983406,0.004160887656033287,0.6049916668381309,1.0,11/55,6.01%,CEMIP;DCN;LUM;HSPG2;BGN;GPC4;VCAN;GPC5;HMMR;CEMIP2;SLC9A1
prerank,peptide biosynthetic process (GO:0043043),-0.3900372139102202,-1.7489789251796277,0.0,0.17642661256996883,0.995,76/153,28.65%,RPS14;RPS9;GGTA1;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;ABCF1;RPL36A;EEF1A1;DMD;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;FURIN;MRPS7;RPL31;PCSK5;RPS23;RPL23A;SRBD1;MRPS17;AGO2;RPL19;RPL36;GSPT2;MRPS18A;MRPS18B;RPL17;RPL23;MRPL24;RPS11;MRPL55;GSPT1;RPL15;RPL38;HARS2;MRPL36;MRPL35;RPL13A;RPS25;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A;GGT1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5302515137100986,-1.7476700524996367,0.0029585798816568047,0.17488823772493334,0.995,19/30,35.70%,CAV1;INPP5F;PPP2R1A;MVP;SFRP1;PTPN2;PRKCZ;PRKCD;DMTN;SOCS3;HYAL2;PTPN6;NTF3;SOCS1;SAMSN1;SH3BP5L;PPP2CA;NF2;SH3BP5
prerank,blood circulation (GO:0008015),-0.4726243591833545,-1.7470834252807013,0.0,0.17232803636500243,0.995,19/49,14.82%,MYOF;ROCK2;NOS3;TBC1D8;GUCY1A1;GCLC;COL4A3;ACE;CYB5R3;BDKRB2;ELN;ACVRL1;ITGB1BP1;NPR1;GPX1;ADCY6;SCPEP1;AGTR1;F5
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5857448209847627,-1.7464821146017635,0.005494505494505495,0.16670909544929208,0.996,5/21,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5857448209847627,-1.7464821146017635,0.005494505494505495,0.16670909544929208,0.996,5/21,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5874751212437714,-1.7453989499728415,0.005405405405405406,0.16533332177420984,0.996,6/20,10.64%,PICALM;BCL2L1;RHOQ;DAB2;PKDCC;TMEM59
prerank,steroid catabolic process (GO:0006706),0.7865025673143639,1.7441411822882356,0.013888888888888888,0.608047228109161,1.0,2/10,5.26%,HSD11B1;SPP1
prerank,embryonic digit morphogenesis (GO:0042733),0.6937339603945126,1.7420568903616094,0.009900990099009901,0.5952194234686529,1.0,8/18,11.48%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3;MSX1
prerank,platelet degranulation (GO:0002576),-0.41767416606315866,-1.7410697382445017,0.0,0.1690465811411483,0.996,37/118,18.27%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;LHFPL2;ANXA5;APP;PCDH7;SPARC;ECM1;SRGN;TGFB2;VEGFD;VEGFC;CD109;PDGFA;CALM1;ENDOD1;SERPINE1;TAGLN2;CD63;LGALS3BP;ITGB3;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;ALDOA;LAMP2;EGF
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6276569709839924,-1.7395336545913975,0.010101010101010102,0.16811334983505238,0.996,7/16,16.72%,ROCK2;GSN;RUFY3;KANK1;PTK2B;CDH5;BCAS3
prerank,hyaluronan catabolic process (GO:0030214),0.6806515512007555,1.7348681012303222,0.011475409836065573,0.6110083838097665,1.0,4/18,6.01%,CEMIP;HMMR;CEMIP2;SLC9A1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7577644243988751,1.7348477498505066,0.010221465076660987,0.588442944703927,1.0,2/12,2.01%,APOD;CBLB
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7436537249024618,1.7335857585067225,0.005357142857142857,0.573833460216868,1.0,7/13,15.77%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81;BRSK2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5073980416313164,-1.7335829957235482,0.0,0.17586576915327057,0.997,15/38,15.37%,ROCK2;CAV1;KLF4;SIRPA;INSR;RAC1;CD34;KLF2;SMAD3;CX3CR1;ASS1;DDAH1;NOS1AP;PTGS2;EDN1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6714484502539041,1.7327194590538337,0.009852216748768473,0.5585500511199926,1.0,9/21,12.86%,EPHA7;GRIN2B;NGFR;SOX2;DELE1;BIRC2;PYCARD;FYN;PSMB9
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7885321998279263,1.731372670668462,0.01340033500837521,0.5467236750958485,1.0,2/10,0.48%,APOD;LRP1
prerank,phospholipid transport (GO:0015914),-0.46014402654961045,-1.7308257701149556,0.0,0.17751465118900034,0.997,18/52,18.60%,PITPNC1;ATP10A;OSBPL8;ATP8A1;PLTP;ATP11B;SCARB1;PITPNA;APOE;ABCA3;ATP8B1;TNFAIP8L3;MFSD2A;ABCB4;PRELID2;PRELID1;PCTP;ATP8A2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5024366638326018,-1.7308101794786452,0.002898550724637681,0.1744220425589689,0.997,12/38,10.45%,BCL2L1;NOS3;THBS1;TNFSF10;FAS;GSK3B;CASP8;MADD;GPX1;SFRP1;SERPINE1;ICAM1
prerank,actin filament bundle organization (GO:0061572),-0.5048450663665937,-1.7306109545386021,0.002857142857142857,0.17169179131836088,0.997,16/33,23.71%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;LIMA1;SHROOM1;BAIAP2;RFLNA;RFLNB;DMTN;ADD2;CORO1B
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5736905847027485,-1.7300033154176526,0.002551020408163265,0.16982918407331068,0.997,11/24,26.02%,PECAM1;ITGB1;EZR;F11R;ICAM1;NT5E;VCAM1;MSN;GFUS;CERCAM;ITGB2
prerank,positive regulation of angiogenesis (GO:0045766),-0.4120446421113823,-1.7298816012878133,0.0,0.16722529020624366,0.997,40/108,15.24%,FLT1;ANXA3;TJP1;TEK;ITGB8;BMPER;ITGB1;NOS3;THBS1;KLF4;FOXC2;TIE1;ECM1;KDR;RUNX1;CYP1B1;VEGFD;VEGFC;CD34;GAB1;HIPK1;HK2;FGF1;HYAL1;GATA2;SERPINE1;PIK3CD;ETS1;CTSH;MDK;HSPB1;PKM;HIPK2;SMAD1;GATA6;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6
prerank,response to ketone (GO:1901654),-0.5482226356743852,-1.7260643600253467,0.013774104683195593,0.17068395001967654,0.997,9/24,19.16%,CAV1;SLIT2;THBS1;TGFB2;WBP2;ABHD2;ABCB4;CATSPER2;TGFBR3
prerank,neuron cell-cell adhesion (GO:0007158),0.7308133623736317,1.7188490021660257,0.005319148936170213,0.5940014774686039,1.0,7/14,8.56%,ASTN2;NRXN2;CEL;NRXN1;CNTN4;ASTN1;NRXN3
prerank,triglyceride catabolic process (GO:0019433),0.6709249932558339,1.7160349094839125,0.00974025974025974,0.5896160572827719,1.0,5/19,12.17%,LIPC;LIPH;FABP5;FABP4;FABP3
prerank,positive regulation of leukocyte migration (GO:0002687),0.6310344755899338,1.7145279223866485,0.01155115511551155,0.579902421262064,1.0,3/27,1.27%,PTN;XCL1;EDN3
prerank,oogenesis (GO:0048477),0.697172169322255,1.7109602061721318,0.013605442176870748,0.5814142289495375,1.0,2/15,2.60%,PTN;NANOS3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.37947893827641926,-1.7103042676180435,0.0,0.19673680817364267,1.0,49/182,12.73%,IGF1;PICALM;SLC24A3;ROCK2;FOXP1;ITGB8;MEF2C;OCLN;ROBO1;NOTCH2;APP;KLF4;NFKB1;KDM4A;CLDN5;KDR;RIN3;WWP2;NOTCH1;RUNX1;TGFB2;WNT4;SMO;CD34;PRKAA2;ADAM10;DICER1;APOE;XDH;CELF1;ACVRL1;MAPT;ATOH8;CITED2;SFRP1;GATA2;TNRC6A;PARP10;OPTN;VHL;PARP9;SLC7A5;TARDBP;MAP2K2;TLE5;TERT;TNRC6C;PTRH2;HEY2
prerank,basement membrane organization (GO:0071711),0.7113643639576707,1.7070762638722405,0.0156794425087108,0.5845065386661651,1.0,4/14,0.96%,FLRT2;LAMB1;COL4A1;NID1
prerank,regulation of glucose metabolic process (GO:0010906),0.5963121894318566,1.7059656462834183,0.009077155824508321,0.5727450052468056,1.0,7/34,7.56%,RORA;OGT;GPLD1;PDK1;IRS1;IRS2;DGKQ
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7270122637833709,1.705740567139558,0.008818342151675485,0.5582773794555446,1.0,6/13,12.94%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81
prerank,hyaluronan metabolic process (GO:0030212),0.6398401906350746,1.7053970288642124,0.008025682182985553,0.545602375519672,1.0,4/23,6.01%,CEMIP;HMMR;CEMIP2;SLC9A1
prerank,actomyosin structure organization (GO:0031032),-0.42778860697295945,-1.7019742513155205,0.004016064257028112,0.2102307875327147,1.0,32/75,24.89%,SORBS1;TJP1;TMOD3;FAM171A1;ROCK2;EPB41L5;ACTN2;PGM5;ITGB1;TPM1;F11R;PHACTR1;CDC42BPB;FRMD5;ZYX;LMOD1;CSRP2;TMOD1;MYH10;CDC42BPG;EPB41L1;CUL3;FHDC1;TNNT3;TNFAIP1;MYO18A;SIX4;MYH9;EPB41;EPB41L4A;SRC;MYOM2
prerank,cardiac conduction system development (GO:0003161),0.6350417669367296,1.6959092993642209,0.022222222222222223,0.576869970492324,1.0,5/24,6.12%,TBX18;MSC;SMAD5;GJA1;CACNA1G
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5354127927026824,-1.6954774490938491,0.005479452054794521,0.22007799879785114,1.0,10/24,26.31%,PICALM;BCL2L1;RHOQ;DAB2;ITGB1BP1;TMEM59;PID1;DMTN;MRAP2;NUMB
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6092965340791491,-1.694972876569244,0.007042253521126761,0.21768095085349676,1.0,12/17,31.74%,ATP5F1B;ATP5F1C;ATP5MG;VPS9D1;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5307076849597429,-1.6916081475081373,0.0055248618784530384,0.22084345085021295,1.0,15/30,26.33%,BCL2L1;NOS3;TNFSF10;FAS;GSK3B;CASP8;GPX1;SERPINE1;ICAM1;TRADD;TNFAIP3;CFLAR;RFFL;BRCA1;PARK7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5642318726860016,-1.6906570583060985,0.002652519893899204,0.21953957250824654,1.0,5/20,10.64%,PICALM;BCL2L1;RHOQ;DAB2;TMEM59
prerank,arachidonic acid secretion (GO:0050482),-0.7139657868021804,-1.6888097937414484,0.00847457627118644,0.2168302471101877,1.0,3/10,6.29%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.7139657868021804,-1.6888097937414484,0.00847457627118644,0.2168302471101877,1.0,3/10,6.29%,ANXA1;ACE;BDKRB2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7087544174990543,1.687761319794968,0.01981981981981982,0.6046802740684348,1.0,2/13,3.16%,ENPP1;TPST1
prerank,diol metabolic process (GO:0034311),-0.5870246264466502,-1.6869849676273092,0.015267175572519083,0.21740523686088883,1.0,8/19,21.50%,PLPP3;NOS3;DEGS2;CALM1;GCH1;AKT1;PRKG2;SPHK2
prerank,inner ear morphogenesis (GO:0042472),0.6577761491550078,1.6866538943561202,0.012965964343598054,0.5957724647841733,1.0,4/22,7.24%,TBX18;CHD7;ZIC1;MYO6
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7476603044275134,1.6857196966347936,0.005681818181818182,0.5865010028208316,1.0,5/11,14.94%,PPARA;SLC30A10;ABCD2;FYN;ABCB7
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.6257171068110927,-1.6821843386646083,0.023696682464454975,0.22398715520895007,1.0,9/15,23.08%,LEMD3;MAGI2;SKI;ACVR1;ACVR2B;CSNK2B;SMAD7;ACVR2A;FSTL3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5878331762671076,1.6762558067320148,0.020249221183800622,0.6198016980222917,1.0,6/34,7.17%,RORA;ENPP1;WNT5A;LRP3;RUNX1T1;ZFP36L2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.667982829084178,1.674240111043716,0.018272425249169437,0.6154124400732495,1.0,7/17,13.23%,KCNS2;ANK3;VAMP2;KCNG1;KCNAB1;KCNE4;AKAP6
prerank,phagosome-lysosome fusion (GO:0090385),0.7372765418198963,1.6735380352598257,0.014336917562724014,0.6055486192556624,1.0,4/10,10.42%,RAB34;RAB20;SYT7;ARL8B
prerank,actin filament bundle assembly (GO:0051017),-0.49497368997245106,-1.6722825307799836,0.006153846153846154,0.2413038827737915,1.0,11/33,14.18%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;LIMA1;SHROOM1;BAIAP2
prerank,response to laminar fluid shear stress (GO:0034616),-0.7012998777166947,-1.671844346701078,0.015384615384615385,0.23884489758319707,1.0,6/10,15.15%,SMAD6;KLF4;SREBF2;KLF2;ASS1;MAP2K5
prerank,cAMP biosynthetic process (GO:0006171),0.764426493263667,1.671026230416159,0.02120141342756184,0.6051241743997037,1.0,6/10,8.89%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,positive regulation of cell migration (GO:0030335),-0.35822842998005816,-1.6698680821451322,0.0,0.2393752481208809,1.0,67/253,11.42%,FLT1;PDGFD;FN1;DOCK5;IGF1;TJP1;RAPGEF2;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PECAM1;PODXL;EGFR;MYLK;DOCK1;IGF1R;ITGB1;FER;THBS1;SEMA7A;ITGA6;NRP1;BMPR2;RDX;KDR;INSR;SOD2;NOTCH1;RUFY3;TGFB2;ACTG1;VTN;S100A11;APC;SMO;DAB2;NEDD9;ADAM10;SEMA6A;GAB1;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;RHOC;FGF1;SMURF2;PDGFC;HYAL1;ENPP2;PIK3CD;CCN4;FAM107A;SPAG9;EPHB2;ELP5;SEMA5B;CTSH;MYO1C;CD151;MDK
prerank,central nervous system development (GO:0007417),0.44503623131345915,1.6687045289021365,0.001091703056768559,0.6033282740439191,1.0,70/250,17.25%,APOD;CHST8;ROBO2;CHD7;ADGRL3;EPHA7;COL4A1;ZFHX3;MEIS1;HSPG2;MARCKS;PTEN;SH3GL3;CNTNAP2;ADGRA2;GRIN2B;ZIC4;ASIC2;MEIS2;VCAN;AFF2;POU3F3;LOXL3;TBX3;SOX6;ZIC1;ZBTB16;ADORA2A;NF1;CNTN4;GRIN2A;GRIK1;IER3IP1;SZT2;HAPLN2;RPS6KA6;NPAS2;C1QA;DSCAML1;RELN;DHX30;MBP;ABCB6;CNTN6;AMIGO3;AHI1;SOX10;ALDH5A1;SMARCA1;PLXNB2;SOX9;ANKLE2;ATN1;EML1;ADAM22;MYRF;ARNT2;BPTF;HAPLN3;BAG6;CHD8;PBX2;HAPLN1;TBC1D23;NRCAM;NDUFS4;SMG9;NHEJ1;ZIC5;CDK5
prerank,regulation of small molecule metabolic process (GO:0062012),0.6036490318194074,1.6652972961100065,0.007849293563579277,0.608228637270838,1.0,6/28,7.56%,RORA;PPARA;NR1H4;PDK1;ACADL;DGKQ
prerank,actin crosslink formation (GO:0051764),-0.6574641632695495,-1.661447290791396,0.011547344110854504,0.2559918854953229,1.0,6/12,19.59%,BAIAP2L1;DPYSL3;FLNA;BAIAP2;GAS2L3;GAS2
prerank,polyol metabolic process (GO:0019751),-0.4650140883140746,-1.6592640552077298,0.00949367088607595,0.25763245880959584,1.0,17/46,15.70%,PLCE1;PLCB1;ITPKB;INPP4B;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;PLCH1;ITPK1;INPP5B
prerank,positive regulation of signaling (GO:0023056),0.5585280950181142,1.6591420433148352,0.012012012012012012,0.6265768781947462,1.0,9/37,11.37%,ECE1;HCRT;EDN3;GRIK2;SCRIB;RIMS2;RAB29;RIMS1;DLG4
prerank,negative regulation of viral life cycle (GO:1903901),-0.6141821436422017,-1.6584546467836747,0.014251781472684086,0.25614854734656384,1.0,9/15,20.87%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;PPIA;SNX3;IFITM2
prerank,apical junction assembly (GO:0043297),-0.4524155908146731,-1.6577981193737727,0.0,0.2542748528379093,1.0,20/53,19.75%,VCL;OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RHOC;RAB13;ARL2;RAMP2;CDH5;CTNNA1;PAK2;PKN2;DLG1;CLDN11;PDCD6IP
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5564250589889574,1.6570874909295685,0.019345238095238096,0.6251214584062056,1.0,8/40,4.84%,PDGFRA;NTRK3;NTRK2;TXK;C5AR1;FGFR1;ARHGAP6;HTR2B
prerank,macrophage activation involved in immune response (GO:0002281),-0.6370237794104798,-1.6520675193510928,0.0117096018735363,0.2638381930485553,1.0,8/13,26.76%,LBP;NMI;IFI35;CX3CR1;PLCG2;DYSF;TYROBP;SBNO2
prerank,muscle cell differentiation (GO:0042692),0.5826216698135764,1.651869214554877,0.01726844583987441,0.6397212677379752,1.0,4/32,2.78%,TBX18;RORA;TMEM204;GLMN
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6864887720501124,1.65142167221727,0.02936096718480138,0.6300144821331628,1.0,7/14,15.02%,ENPP1;AK1;ENPP3;ITPA;AK4;AK8;AK3
prerank,actin filament depolymerization (GO:0030042),-0.6619754618675322,-1.651286328961165,0.017429193899782137,0.2622860081145047,1.0,6/11,21.46%,MICAL2;GSN;CFL1;DSTN;MICAL3;TWF2
prerank,cochlea morphogenesis (GO:0090103),0.7615463154885154,1.650828366021869,0.021739130434782608,0.6211011575582924,1.0,1/10,0.03%,TBX18
prerank,cranial nerve development (GO:0021545),0.736069771953971,1.6494091725662106,0.011864406779661017,0.6159203857259452,1.0,3/11,7.28%,CHD7;SALL1;TMEM126A
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.5415349570914448,-1.6492604664297728,0.022900763358778626,0.26353398366246333,1.0,12/22,30.41%,PDGFD;ACE;PDGFA;CALM1;PDGFC;NBN;RAP2C;NEK10;TAOK2;GREM1;RAD50;RASSF2
prerank,DNA damage checkpoint signaling (GO:0000077),-0.5153103773376754,-1.6491129926879604,0.008849557522123894,0.2607421894685531,1.0,15/28,27.52%,ATR;ATM;CDC5L;NBN;CLOCK;DONSON;HUS1;E2F1;PRPF19;ATRIP;HINFP;CHEK2;BRIP1;CHEK1;RHNO1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6033629662131511,-1.6485982009393136,0.01643192488262911,0.2587473301297153,1.0,12/16,35.07%,ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3;STOML2
prerank,response to sterol (GO:0036314),0.7178878492990023,1.6472956768693903,0.023465703971119134,0.615471810344344,1.0,1/11,0.04%,RORA
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6822453617910931,1.644199880110984,0.02772963604852686,0.6201394445146632,1.0,5/15,6.26%,PPARA;GPLD1;PPARD;IRS1;IRS2
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4083220225164155,-1.6432867916683755,0.0,0.2673497627008278,1.0,37/84,18.27%,ANXA3;ROCK2;FOXP1;TEK;PLPP3;NOS3;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;ATP5F1B;KDR;RAC1;MAPK14;SCARB1;AAMP;FGF1;ITGB1BP1;ATOH8;PIK3CB;GATA2;PIK3CD;ETS1;HSPB1;ITGB3;FLT4;PTK2B;RRAS;TMSB4X;EDN1;MET;SIRT1;BCAS3;AKT1;EGF
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.691770846542984,-1.6427080973974255,0.008948545861297539,0.26545497134952256,1.0,6/10,17.06%,ATP5F1C;ATP5MG;VPS9D1;ATP5MC2;ATP5F1D;ATP5MC1
prerank,positive regulation of vasculature development (GO:1904018),-0.4014207373522013,-1.641885835724079,0.0,0.2638054475863979,1.0,34/94,15.99%,FLT1;ANXA3;TEK;ITGB8;ITGB1;NOS3;THBS1;TIE1;ECM1;KDR;RUNX1;CYP1B1;VEGFD;VEGFC;CD34;GAB1;HIPK1;HK2;FGF1;HYAL1;GATA2;SERPINE1;PIK3CD;ETS1;CTSH;HSPB1;HIPK2;GATA6;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6;SIRT1
prerank,regulation of receptor recycling (GO:0001919),0.6605263110364592,1.6415514782134029,0.030927835051546393,0.6228559444123777,1.0,4/16,8.89%,ECE1;TBC1D16;SCRIB;RAB29
prerank,histone H3-K9 demethylation (GO:0033169),-0.6768072685729514,-1.6398104692222393,0.017467248908296942,0.26529084531703867,1.0,7/11,25.65%,KDM4A;KDM4C;PHF8;HR;KDM4B;KDM3B;KDM1A
prerank,inositol phosphate metabolic process (GO:0043647),-0.4618818650995981,-1.6388045108509828,0.012658227848101266,0.2644812403307275,1.0,17/46,15.70%,PLCE1;PLCB1;ITPKB;INPP4B;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;PLCH1;ITPK1;INPP5B
prerank,integrated stress response signaling (GO:0140467),0.6899104161514691,1.6375768513780204,0.020134228187919462,0.6319044095161941,1.0,10/14,23.90%,OMA1;HERPUD1;EIF2AK1;EIF2S1;HSPA5;IMPACT;EIF2AK3;CCL2;DDIT3;ATF4
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6404756986748305,-1.6336023307392897,0.014925373134328358,0.27371637476145916,1.0,7/13,23.18%,ACTN2;CAV1;CAB39;NOS1;PTK2B;STK39;CASQ2
prerank,cellular response to fluid shear stress (GO:0071498),-0.6453727470049178,-1.6334689095839967,0.01674641148325359,0.27094973932571137,1.0,7/12,15.15%,MEF2C;KLF4;SREBF2;KLF2;HDAC3;ASS1;MAP2K5
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5629967614332521,-1.632994655486078,0.020689655172413793,0.2691539010596827,1.0,11/18,33.53%,ITGB1;JAM2;SLC39A8;CX3CR1;GCNT1;VCAM1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6080782778497982,1.6296549200880517,0.018487394957983194,0.6621053134499919,1.0,3/24,4.82%,CEMIP;ANK3;MTCL1
prerank,triglyceride homeostasis (GO:0070328),0.6055112167651371,1.629255095570452,0.022435897435897436,0.6531165202362091,1.0,3/26,5.08%,RORA;NR1H4;LIPC
prerank,tight junction assembly (GO:0120192),-0.45048510982618034,-1.6292284881377674,0.00303951367781155,0.2747994240792373,1.0,19/49,19.75%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;ACTG1;APC;LSR;RAB13;ARL2;CLDN12;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP
prerank,catecholamine biosynthetic process (GO:0042423),-0.6725727356329563,-1.6270264430931343,0.02088167053364269,0.27702764659570916,1.0,3/11,8.26%,MOXD1;TGFB2;GCH1
prerank,regulation of phospholipase activity (GO:0010517),0.7317581478314508,1.6219600705300397,0.03185840707964602,0.6797811689093627,1.0,3/10,3.87%,LRP1;FGFR1;PDPK1
prerank,negative regulation of coagulation (GO:0050819),-0.6193392015764584,-1.6213601755520695,0.012376237623762377,0.2876892445245877,1.0,9/14,24.60%,THBD;VTN;CD34;APOE;SERPINE1;SERPINE2;EDN1;TFPI;PROCR
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.5835878675209923,1.620665628355547,0.018808777429467086,0.6748842151794302,1.0,7/30,4.67%,VAMP5;GGA2;RAB34;SEC16A;SPTBN1;ANK3;VAMP2
prerank,regulation of GTPase activity (GO:0043087),-0.36065570723606005,-1.6198628208961134,0.0,0.2879394812965017,1.0,57/177,15.41%,PKP4;PLXNA2;EPHA4;PICALM;RAPGEF2;LRCH1;FGD5;PLXNA4;CHN2;SIPA1L1;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;RASGRF1;RDX;S100A10;RAP1A;NDEL1;RASIP1;SH3BP4;CAV2;WNK1;SRGAP2;RAPGEF1;EFNA5;GSK3B;RSU1;RALBP1;ITGB1BP1;PLXNB1;NGEF;SGSM2;CPEB2;SFRP1;MAPRE2;ARL2;ARHGAP12;GMIP;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;PRKG1;TBC1D10B;ARHGAP15;RAPGEF3;CX3CL1;EZH2;PLXNA1;RAP1GDS1;RGS10
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6136441759523875,-1.6178027732451539,0.0330188679245283,0.2896908301714315,1.0,8/13,25.59%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,T cell differentiation in thymus (GO:0033077),0.6671663580027553,1.6160114123132265,0.02622950819672131,0.6875303565182375,1.0,4/14,9.85%,MR1;RABL3;ZFP36L2;GLI3
prerank,anion transport (GO:0006820),-0.48333243392387615,-1.6109402627329459,0.021341463414634148,0.3039822729520771,1.0,7/33,7.78%,ABCG2;SLC13A4;SLC13A3;LRRC8C;SLC26A7;SLC22A6;LRRC8D
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5652892024181149,-1.6107607328501459,0.02072538860103627,0.30128399156349117,1.0,8/18,16.72%,ROCK2;TEK;RUFY3;KANK1;PTK2B;CDH5;LLGL2;BCAS3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6955840271666618,1.6100876714422592,0.0379746835443038,0.7086658196333409,1.0,4/12,3.66%,DCN;BGN;DSE;VCAN
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.4065702574831067,-1.6093755801564074,0.003703703703703704,0.3019610811902032,1.0,15/75,9.79%,PLCE1;PLCB1;ROCK2;RGS3;RGS6;RGS5;NMT2;MGRN1;RGS12;MGLL;YWHAB;CALM1;FRMPD1;RGS4;GIT1
prerank,phagolysosome assembly (GO:0001845),0.6845409011864604,1.6090849161921041,0.03125,0.7035906890171618,1.0,4/12,10.42%,RAB34;RAB20;SYT7;ARL8B
prerank,neural tube development (GO:0021915),-0.580285181699055,-1.6057835355050205,0.019704433497536946,0.3074201510199482,1.0,5/15,18.84%,ALDH1A2;DVL1;SOX4;SOX11;ARL13B
prerank,acylglycerol homeostasis (GO:0055090),0.6321430548093849,1.6052970154591844,0.02671118530884808,0.7136570453407555,1.0,2/20,5.08%,RORA;LIPC
prerank,cAMP metabolic process (GO:0046058),0.6765975196522293,1.604182689321059,0.036303630363036306,0.7090358130951793,1.0,6/13,8.89%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,glycogen metabolic process (GO:0005977),-0.5068382237407811,-1.6020660556550588,0.016172506738544475,0.31359101423497476,1.0,11/27,13.49%,PRKAG2;PYGB;PGM2L1;GBE1;CALM1;GSK3B;GYG1;UGP2;GAA;PGM2;PPP1R3C
prerank,regulation of lamellipodium organization (GO:1902743),-0.5827847699219746,-1.6017567254467404,0.0351288056206089,0.31111033766976115,1.0,9/14,21.82%,FER;RAC1;CAPZB;CDC42;CD44;PDPN;EPHA2;TWF2;DMTN
prerank,regulation of protein targeting to membrane (GO:0090313),0.5796226424496037,1.6017439197189283,0.0208,0.711567832663816,1.0,3/28,4.82%,CEMIP;ANK3;MTCL1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6439134647586686,-1.6010379211782253,0.025404157043879907,0.3101177821375125,1.0,6/11,9.80%,MLLT3;RSPO3;WNT5B;CSNK1D;DAB2;SFRP1
prerank,nitric oxide metabolic process (GO:0046209),-0.603150121495464,-1.600634908666283,0.034229828850855744,0.30801531294881906,1.0,8/14,25.59%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,regulation of cell migration (GO:0030334),-0.3237437518438801,-1.5988545662960496,0.0,0.3090486745056789,1.0,119/382,15.37%,FLT1;PDGFD;PLXNA2;CLIC4;EPHA4;IGF1;TJP1;LMO4;SYNE2;ROCK2;DPYSL3;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PLXNA4;VCL;PTPRJ;SLIT2;PECAM1;ROBO1;PODXL;EGFR;AFDN;MYLK;IGF1R;ITGB1;FER;PTPRK;THBS1;IGFBP5;SEMA7A;ARID2;TPM1;CDH1;ITGA6;CLDN5;RDX;DACH1;MAGI2;LIMCH1;MCTP1;KDR;INSR;SOD2;NOTCH1;RUFY3;CYP1B1;ACTG1;PHACTR1;AMOT;KANK1;MINK1;ANXA1;APC;RAC1;SMO;DAB2;NEDD9;ACE;ADAM10;SRGAP3;SRGAP2;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;PRR5L;TMEFF2;RHOC;FGF1;ACVRL1;PDGFC;PLXNB1;FRMD5;CITED2;IFITM1;ENPP2;SFRP1;SERPINE1;PIK3CD;FAM107A;CAMK2B;SPAG9;SPATA13;EPHB2;ELP5;ROBO4;SEMA5B;RNF41;CTSH;MYO1C;LMNA;CD151;MDK;DAG1;ARPIN;DLG5;RET;CEACAM1;TRIP6;AMOTL2;ATM;FLNA;MACF1;PTK2B;SERPINE2;CPNE3;TMSB4X;CDH5;CX3CL1;RAP2C;PLXNA1;ARSB;EDN1
prerank,phosphate ion homeostasis (GO:0055062),0.7312056137141991,1.5987852300233534,0.03076923076923077,0.7175095162650974,1.0,1/10,0.11%,ENPP1
prerank,Rap protein signal transduction (GO:0032486),-0.672805902792404,-1.5987626813262414,0.0200445434298441,0.3063080208703246,1.0,7/10,23.30%,RAPGEF2;RAP1A;RAPGEF1;RAPGEF3;RAP2C;RAP2B;RAP1B
prerank,positive regulation of cell motility (GO:2000147),-0.3496044927388399,-1.5964883473650011,0.0,0.3091630846212371,1.0,56/205,11.42%,FLT1;PDGFD;IGF1;TJP1;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAVIN1;CAV1;PECAM1;PODXL;EGFR;SPOCK2;MYLK;IGF1R;ITGB1;FER;NTN1;THBS1;SEMA7A;ITGA6;RDX;KDR;INSR;SOD2;NOTCH1;RUFY3;ACTG1;APC;SMO;DAB2;NEDD9;ADAM10;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;RHOC;FGF1;PDGFC;PIK3CD;FAM107A;SPAG9;EPHB2;ELP5;SEMA5B;CTSH;MYO1C;CD151;MDK
prerank,regulation of nervous system development (GO:0051960),0.537940957755763,1.595879070017811,0.016516516516516516,0.7229828898288395,1.0,8/37,9.92%,PTN;GBX1;NPHP3;TENM4;DOCK7;PER2;LGI4;WNT3
prerank,ribosomal small subunit assembly (GO:0000028),-0.5949849045113882,-1.5957618028070404,0.0397196261682243,0.3078683006986098,1.0,7/16,14.65%,RPS14;PRKDC;RPS19;RPS27;RPS15;RPS5;MRPS7
prerank,ethanol metabolic process (GO:0006067),0.7046512160459155,1.5953727682641892,0.03577817531305903,0.7154000598724132,1.0,2/12,1.50%,ADH1A;ALDH1A1
prerank,epidermis development (GO:0008544),0.500899029743191,1.5941330467609116,0.016689847009735744,0.7125751870674815,1.0,11/56,9.47%,EMP1;EDA2R;PLOD1;HDAC1;COL7A1;SVEP1;FABP5;ATP2A2;FLOT2;GLI1;EVPL
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5644879560338143,1.5913244514297393,0.0343213728549142,0.7168534612146489,1.0,13/33,11.54%,GRID2;CEL;GRID1;GRIK2;GRIK5;ABR;GRIK4;FABP5;GRIK1;RELN;LRRC4C;NRG3;PSMC5
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.6186976573442186,-1.589314085027228,0.026905829596412557,0.320635050290008,1.0,6/13,20.42%,GOPC;YWHAB;NFKBIA;FLNA;SUFU;GET4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.6284856789544935,1.5893082266345318,0.03430531732418525,0.7176977895572163,1.0,4/18,5.65%,PTN;IL34;TENM4;NF1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6003236323517771,-1.5889447941572814,0.02564102564102564,0.3184842337496457,1.0,4/15,5.61%,PRKCH;IL18;NFKB1;MAPK9
prerank,sensory perception of sound (GO:0007605),0.4731112758003536,1.5884450149265723,0.009079118028534372,0.7124242546449662,1.0,6/88,1.84%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,regulation of keratinocyte migration (GO:0051547),0.6814695876532728,1.5871299428909538,0.029668411867364748,0.7103257134626859,1.0,4/12,9.11%,PTEN;MAP4K4;IQSEC1;MTOR
prerank,presynapse organization (GO:0099172),0.7115315529980827,1.5851223981041305,0.025547445255474453,0.7113915511866171,1.0,3/10,4.15%,WNT5A;C5AR1;LRRTM3
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6171244283050498,1.5842080947641513,0.032,0.70681474845669,1.0,4/20,2.93%,SULF1;SPRY4;SPRY1;FGFBP3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6601592235413919,-1.5821933306499558,0.024070021881838075,0.3301556219241895,1.0,7/10,28.28%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6601592235413919,-1.5821933306499558,0.024070021881838075,0.3301556219241895,1.0,7/10,28.28%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2;NSMAF
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6187242279909674,1.5808233833681034,0.028333333333333332,0.7154152737910534,1.0,3/22,8.09%,APOD;CIDEA;BSCL2
prerank,receptor clustering (GO:0043113),0.5710786087262927,1.5807751204385934,0.0452418096723869,0.706624966564474,1.0,6/27,5.11%,PTN;NRXN2;NRXN1;SCRIB;DLG3;DLG2
prerank,cilium movement (GO:0003341),0.5287517920263292,1.5804923092169383,0.020378457059679767,0.6994169758738389,1.0,13/47,15.25%,CFAP251;CCDC63;ODAD4;ADCY10;DNAAF4;RSPH9;DNAI4;DNAH9;SPA17;CABYR;GAS8;ZBBX;CCDC39
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4292068946207183,-1.580096758656994,0.009316770186335404,0.332298042485456,1.0,17/51,15.60%,CRIM1;SMAD6;BMPER;LEMD3;NBL1;FSTL1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SMURF2;HIPK2;SMAD1;GREM2;CHRDL1;RBPMS2
prerank,neurotransmitter uptake (GO:0001504),0.6881981580166874,1.579258615798548,0.03429602888086643,0.6970359437550466,1.0,2/12,1.47%,SLC1A3;ATP1A2
prerank,brain development (GO:0007420),0.44715895856796783,1.5772000358572948,0.006031363088057901,0.6995067333385723,1.0,36/136,16.35%,APOD;ROBO2;ADGRL3;EPHA7;COL4A1;ZFHX3;MEIS1;CTNNA2;HSPG2;PTEN;CNTNAP2;GRIN2B;MEIS2;AFF2;SOX6;ZIC1;NF1;CNTN4;GRIN2A;IER3IP1;DSCAML1;RELN;ABCB6;AMIGO3;SMARCA1;PLXNB2;EML1;ARNT2;BPTF;BAG6;CHD8;PBX2;CENPF;TBC1D23;NDUFS4;SMG9
prerank,negative regulation of cell motility (GO:2000146),-0.3773419154358395,-1.5769934190999773,0.0,0.33715668072469007,1.0,33/108,11.77%,CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;TPM1;CDH1;CLDN5;DACH1;MAGI2;LIMCH1;MCTP1;CYP1B1;KANK1;SRGAP3;SRGAP2;TMEFF2;ACVRL1;FRMD5;CITED2;IFITM1;SFRP1;SERPINE1;RNF41;DAG1;ARPIN;DLG5
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5223513462118718,1.5769053312724417,0.02674591381872214,0.6925683480939546,1.0,9/46,2.28%,LAMC3;LAMC1;PIK3R1;LAMB1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4676211829054625,-1.5767203127884604,0.017391304347826087,0.33493421665139483,1.0,20/36,29.02%,SGMS1;DEPTOR;TPD52L1;TMBIM6;FAS;CRADD;MADD;NR4A2;CX3CR1;CYLD;PPIA;CX3CL1;ING5;TRAF1;QARS1;TRIM39;RB1;ASAH2;BDNF;MAPK8IP2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6211841113241214,-1.5732054745404251,0.03333333333333333,0.3413911310432916,1.0,8/12,20.87%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;SNX3;IFITM2
prerank,sprouting angiogenesis (GO:0002040),-0.43119092814267607,-1.5731064283394538,0.0030959752321981426,0.3386634057095006,1.0,23/51,17.86%,TEK;RSPO3;BMPER;SLIT2;ROBO1;THBS1;NRP1;EFNB2;KDR;OTULIN;VEGFD;EPHB4;VEGFC;CCBE1;ACVRL1;ITGB1BP1;NR4A1;FLT4;PTK2B;RAMP2;ESM1;NAXE;AKT1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6942331839285741,1.571938175861869,0.03333333333333333,0.7097750833013602,1.0,3/11,1.70%,XCL1;CXCL10;WNT5A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5739033439559317,1.5691375609545415,0.04643962848297214,0.715443983112607,1.0,2/24,0.66%,RORA;SULF1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5076342570517212,-1.5653730534345103,0.03389830508474576,0.3560295914540461,1.0,5/24,7.46%,LPGAT1;PLA2G4A;CDS2;PGS1;ABCA3
prerank,endoderm development (GO:0007492),0.6603917018765779,1.5653188496244719,0.049723756906077346,0.7266375248416204,1.0,2/13,3.91%,LAMC1;DUSP1
prerank,sulfate transport (GO:0008272),-0.5892014747352413,-1.5640609168500483,0.034722222222222224,0.3566833067048526,1.0,4/14,4.04%,SLC13A4;SLC26A7;SLC26A2;SLC26A11
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5688519825002117,1.5639196837765408,0.03484848484848485,0.72544534250137,1.0,7/32,3.78%,APOD;DLC1;CASK;PTEN;CDKN2A;MAP4K4;ARHGAP6
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5288456380016477,-1.5633551858367347,0.02518891687657431,0.3554412888037367,1.0,11/20,10.22%,IGF1;SLIT2;IGFBP5;NRP1;IGFBP3;VTN;S100A11;ACE;PDGFA;SERPINE1;CCN4
prerank,leukocyte tethering or rolling (GO:0050901),-0.5492313345365957,-1.562475265227132,0.027777777777777776,0.3548837451903956,1.0,10/17,33.53%,ITGB1;JAM2;CX3CR1;GCNT1;VCAM1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,dermatan sulfate metabolic process (GO:0030205),0.6607927767776218,1.56193826507179,0.04727272727272727,0.7279195485180981,1.0,4/13,3.66%,DCN;BGN;DSE;VCAN
prerank,lamellipodium assembly (GO:0030032),-0.5076234324886708,-1.5618812131519848,0.02956989247311828,0.3535350073502287,1.0,9/26,11.40%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SRGAP2;SPATA13;CCDC88A
prerank,protein autoprocessing (GO:0016540),0.6400648508764608,1.560381399366322,0.030664395229982964,0.7281908877046427,1.0,6/17,13.88%,CASP4;OMA1;FXN;HTRA2;SPRTN;MYRF
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6274501113747848,-1.559557261449757,0.04555808656036447,0.3563883551604591,1.0,5/11,23.18%,ACTN2;CAV1;CAB39;STK39;CASQ2
prerank,modified amino acid transport (GO:0072337),0.6462890473845995,1.5593156972793674,0.04230118443316413,0.7255473375824809,1.0,3/15,1.44%,SLC6A13;SLC6A8;SLC16A12
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5296347584767882,1.558689906841934,0.029717682020802376,0.7209357832143372,1.0,7/38,11.90%,RORA;CCDC22;NR1H4;CARD19;TLE1;PYCARD;TRIM59
prerank,positive regulation of neuron projection development (GO:0010976),0.47223491856592054,1.5586553261963603,0.01593625498007968,0.71338040966899,1.0,22/85,14.07%,ROR1;PTN;NTRK3;ROR2;TENM3;WNT5A;NTRK2;CAPRIN1;PRKCI;PRKD1;RELN;STMN2;P3H1;BMP7;EPHA3;DHX36;PLXNB2;RETREG3;ARHGAP35;LRRC7;CUX2;LYN
prerank,regulation of actin filament depolymerization (GO:0030834),0.6715828481835213,1.5584917682954598,0.03664921465968586,0.7064860148661682,1.0,3/12,5.18%,PLEKHH2;SEMA5A;MTPN
prerank,sensory perception of mechanical stimulus (GO:0050954),0.46437880544201915,1.5578428269020084,0.018396846254927726,0.7022665637159297,1.0,6/85,1.84%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.693801205682182,1.5577554917112746,0.044642857142857144,0.6954410917470834,1.0,5/11,6.91%,LIG3;TIPIN;FBXO5;MSH3;GMNN
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5467229129377633,1.55673996770333,0.032448377581120944,0.6931640327285278,1.0,9/37,12.41%,APOD;PPARA;ABCD2;TLR6;ADCY7;APPL2;TLR4;PYCARD;PDCD4
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5799867394425937,-1.5560954488565617,0.02619047619047619,0.3626643411388179,1.0,6/16,6.48%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;MAPK14
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5029363993089312,-1.5556014369322577,0.02857142857142857,0.3609890980126977,1.0,14/26,24.35%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TIFA;ALPK1;TNFAIP3;UBA52;IKBKG;NOD2
prerank,negative regulation of developmental process (GO:0051093),-0.4028403092654705,-1.554385746548084,0.0,0.3611649573612833,1.0,25/69,20.89%,NFIB;ROCK2;FOXC1;NOS3;CST3;KLF7;NOTCH1;KANK1;TFRC;CDK6;TBX1;ARHGEF15;MAPT;RC3H1;SFRP1;TBX2;ARPIN;HEY2;ADCK1;RAPGEF3;FGFR3;WNT11;VASH1;HOPX;MIF
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6022681508025368,1.5540427127128424,0.044142614601018676,0.6995788866358256,1.0,4/19,7.79%,ENPP1;TPST1;SLC35B3;PAPSS2
prerank,smooth muscle cell differentiation (GO:0051145),0.6837399248580592,1.5538224272409888,0.04448398576512456,0.6936822474659144,1.0,2/12,0.68%,TBX18;TMEM204
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6500576049279516,1.550644559951629,0.05807622504537205,0.7023843460011111,1.0,5/12,12.48%,MYCBP2;PTEN;EPHB1;EPHB6;ARHGAP35
prerank,peptide catabolic process (GO:0043171),0.5779649560654875,1.5504155254091119,0.0347682119205298,0.6966629093929331,1.0,4/23,4.90%,ECE1;GGT5;GGT7;CPQ
prerank,regulation of stem cell population maintenance (GO:2000036),0.6249076872115622,1.5502275740864575,0.042328042328042326,0.6905755913196331,1.0,8/18,17.61%,PTN;LOXL2;REST;NCOA3;KAT2A;CNOT1;MYC;CNOT3
prerank,microvillus organization (GO:0032528),-0.583788945255601,-1.5493923404431964,0.046511627906976744,0.37173178355523095,1.0,6/13,5.01%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,glucose metabolic process (GO:0006006),0.49233047880479675,1.5490561437182266,0.021917808219178082,0.6892477301298087,1.0,10/58,7.98%,APOD;MDH1;PFKFB1;GDPGP1;PPARD;IRS2;CRTC2;OMA1;ALDOB;PER2
prerank,macrophage differentiation (GO:0030225),-0.6017335030106977,-1.5489851312716405,0.026905829596412557,0.36995737302302867,1.0,6/13,24.09%,IL31RA;CDC42;CASP8;SIRT1;CSF1R;PARP1
prerank,stress fiber assembly (GO:0043149),-0.589036166390953,-1.5485727337463637,0.029484029484029485,0.3653020254474103,1.0,4/15,4.52%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.589036166390953,-1.5485727337463637,0.029484029484029485,0.3653020254474103,1.0,4/15,4.52%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,regulation of histone deacetylation (GO:0031063),-0.6115215068236002,-1.5481139693942347,0.0334075723830735,0.36357959317929656,1.0,6/13,22.66%,CAMK2D;SAP30BP;AKAP8;ZBTB7B;SPHK2;APLNR
prerank,dendrite morphogenesis (GO:0048813),0.5302773489367546,1.5479340786215348,0.03490136570561457,0.6879872683847911,1.0,7/35,2.41%,PTN;DOCK10;CTNNA2;PTEN;EPHB1;FARP1;ABITRAM
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6181925157455993,1.547180451381594,0.04513888888888889,0.6849927015023206,1.0,3/17,4.49%,PTN;IL34;TENM4
prerank,muscle filament sliding (GO:0030049),-0.4548245431705506,-1.5465765102968363,0.015432098765432098,0.36210818944125783,1.0,20/38,40.32%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,actin-myosin filament sliding (GO:0033275),-0.4548245431705506,-1.5465765102968363,0.015432098765432098,0.36210818944125783,1.0,20/38,40.32%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5518662547587467,1.54501971022136,0.049079754601226995,0.6889303853907812,1.0,2/26,0.66%,RORA;SULF1
prerank,sodium-independent organic anion transport (GO:0043252),-0.6476692170126561,-1.5448730789747334,0.04157549234135667,0.36378708845045593,1.0,3/10,1.96%,SLC16A2;SLCO2A1;SLCO1C1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5692142885382694,-1.544826879383711,0.04906542056074766,0.3611839218158013,1.0,5/16,12.73%,NOTCH2;BMPR2;NOTCH1;TGFB2;HEY2
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3705513814577942,-1.5445972180192609,0.0049504950495049506,0.3592188408103013,1.0,30/103,15.59%,PLCE1;IGF1;RAPGEF2;RAPGEF5;ARHGEF18;TIAM2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAC1;PLD2;RASGRP3;MAPK14;NUCB1;RALBP1;ARHGAP18;RRAGC;RGL2;CCDC88A;RALB;CCDC88C;BCR;RAB38;RRAS;GRB2;CDKN1A;GRAP
prerank,circulatory system development (GO:0072359),-0.35742554027663653,-1.5442247642236777,0.0,0.35759820313847496,1.0,41/118,15.84%,HEG1;PLCE1;FN1;TEK;CACNA1C;MEF2C;MICAL2;PDLIM5;CXADR;FOXC1;OSR1;MEF2A;FOXC2;NXN;RBP4;NOTCH1;TGFB2;GLI2;SOX4;TCF25;TBX1;SH3PXD2B;ACVR1;ACVRL1;SOX17;POU6F1;CRIP1;CASP8;FOXL1;CITED2;ZDHHC16;HEY2;TAB2;FLT4;RAMP2;CDH5;STRA6;CACYBP;CDKN1A;PCSK5;MKKS
prerank,negative regulation of nervous system development (GO:0051961),0.6184167282515223,1.5441267865847046,0.03833333333333333,0.686951397292506,1.0,4/17,9.09%,ROBO2;REST;SORL1;APPL2
prerank,regulation of T cell migration (GO:2000404),0.620456563887614,1.543770088327835,0.05555555555555555,0.6821951994586303,1.0,3/18,1.10%,APOD;CXCL10;TMEM102
prerank,regulation of organelle organization (GO:0033043),-0.3944470904341101,-1.5437058260348975,0.0,0.356457820528107,1.0,23/80,19.08%,CLIC4;TJP1;EZR;DIAPH1;MTM1;ARMH3;F11R;STX18;RDX;VPS35;SQSTM1;MAVS;MAPT;PLXNB1;CLEC16A;SURF4;VPS11;ARL6IP1;LMAN1;PAK2;CAMSAP2;MSN;MARK2
prerank,microvillus assembly (GO:0030033),-0.5684141297775529,-1.543195478447912,0.043373493975903614,0.35524492836701,1.0,6/14,5.01%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6476438599225239,1.5427708950289587,0.04639175257731959,0.6807536900833957,1.0,6/14,15.42%,AUTS2;KMT2E;KMT2A;WDR5;SNW1;PAXIP1
prerank,response to estrogen (GO:0043627),-0.4776458430154672,-1.542752208750722,0.03287671232876712,0.35396990871182243,1.0,11/31,16.99%,CAV1;NCOA4;TRIM24;TRIM25;WBP2;CITED2;SFRP1;ARID5A;SFR1;BCAS3;ESR1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.45183518224098884,-1.5424030920111185,0.026785714285714284,0.35233605069060947,1.0,15/35,26.88%,PICALM;HIP1R;VTN;RAC1;B2M;RAB21;PIK3CB;SERPINE1;HIP1;HFE;HNRNPK;CCL19;FLOT1;BICD1;ARF1
prerank,fatty acid metabolic process (GO:0006631),0.4479612617645828,1.5423227849511505,0.003865979381443299,0.6766231895714828,1.0,25/115,15.44%,LPIN3;GGT5;PPARA;ACOX2;ACSF2;ABCD2;CEL;PEX2;PPARD;CRAT;LIPC;LIPH;ACADSB;ECHDC3;PER2;HSD17B8;FA2H;ACOT7;ACSL6;ACLY;SGPL1;NDUFAB1;NUDT19;ACOT2;LPIN2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.49787915015207745,1.5422311311999208,0.03566333808844508,0.6709589447887013,1.0,8/51,9.07%,PTN;IL34;XCL1;CXCL10;EDN3;PTK2;PLA2G7;LGMN
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6612014256624189,1.5421766417795402,0.055944055944055944,0.6652559030237474,1.0,4/12,14.07%,IL34;PTK2;IL12A;LYN
prerank,negative regulation of cell migration (GO:0030336),-0.3530310794474886,-1.5417377205170226,0.0,0.351604302549963,1.0,38/137,11.77%,PHLDB2;CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;TPM1;CDH1;CLDN5;DACH1;MAGI2;LIMCH1;MCTP1;IGFBP3;PTPRG;CYP1B1;KANK1;RAC1;SRGAP3;SRGAP2;ARHGDIB;TMEFF2;ACVRL1;ITGB1BP1;CITED2;IFITM1;SFRP1;SERPINE1;RNF41;DAG1;ARPIN;DLG5
prerank,renal system development (GO:0072001),0.5051356540685181,1.541270343462272,0.022889842632331903,0.6635375615017935,1.0,7/52,3.14%,TBX18;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3
prerank,supramolecular fiber organization (GO:0097435),0.40063768200233246,1.5404205067241614,0.0,0.6614445374562722,1.0,66/333,12.95%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;RND3;LOXL4;COL23A1;GGA2;LUM;TGFBI;PLOD1;COL10A1;ERMN;ADAMTS14;HSPG2;MYO7A;MARCKS;COL22A1;COL7A1;NCKAP5L;COLGALT1;DPT;TNXB;TCHH;ELMO1;LOXL3;LOXL2;COLGALT2;PPP1R9A;RAC3;MFAP4;MYO1B;SORL1;COL12A1;COL26A1;NF1;CLIP3;ACTN1;CAPN3;CALCA;COL1A2;COL16A1;RHOBTB3;MYO6;CALB1;STMN2;CLRN1;COL4A2;P3H1;WDR73;ADAMTS2;STMN4;ZBED3;KATNA1;SLK;TGFBR1;IAPP;MYO1G;TUBGCP4;FIGNL1;CEP126;TRIOBP;CLIP2
prerank,ganglioside biosynthetic process (GO:0001574),-0.5770804171563105,-1.5399576278189973,0.04522613065326633,0.35366585779073095,1.0,7/15,15.79%,ST8SIA4;B4GALT5;ST3GAL1;ST6GALNAC3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6617584002229938,1.5387752947986872,0.0492091388400703,0.6631662722989239,1.0,5/13,8.63%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA
prerank,cellular glucan metabolic process (GO:0006073),-0.6183342141244342,-1.5380897174244277,0.0449438202247191,0.3553812074499835,1.0,5/11,13.49%,PRKAG2;GBE1;GSK3B;UGP2;PPP1R3C
prerank,melanocyte differentiation (GO:0030318),0.6508137257796613,1.537999430125086,0.06390328151986183,0.6610074434398611,1.0,2/11,1.49%,ENPP1;SLC24A5
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6334286185954687,1.5379352634500145,0.03945111492281304,0.6556555042569733,1.0,2/16,3.88%,RORA;PDK1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4889587355601948,-1.5368259270161129,0.026954177897574125,0.35587103326506475,1.0,14/28,24.35%,IRAK2;OTULIN;UBB;AAMP;CASP8;LACC1;TAB2;CYLD;UBE2N;UBC;TNFAIP3;UBA52;IKBKG;NOD2
prerank,protein oxidation (GO:0018158),0.6870357816948649,1.536774431857893,0.05263157894736842,0.6555155487837838,1.0,3/11,4.22%,LOXL4;LOXL3;LOXL2
prerank,positive regulation of T cell migration (GO:2000406),0.5964972023571773,1.5366558497696854,0.04404567699836868,0.6504680074535935,1.0,4/20,1.70%,XCL1;CXCL10;TMEM102;WNT5A
prerank,cristae formation (GO:0042407),-0.49057099055369846,-1.5364087404560738,0.028645833333333332,0.3545171411706645,1.0,16/27,31.74%,APOOL;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;CHCHD3;LETM1;APOO;UQCC3;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4584351680190389,-1.534139226973232,0.03333333333333333,0.3581759538031373,1.0,8/34,5.90%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;RAC1;NEDD9;CDC42
prerank,axonogenesis (GO:0007409),0.406131091043106,1.534106861892472,0.002254791431792559,0.6562295014505873,1.0,67/237,16.74%,LAMA1;ROBO2;LAMA2;PIK3R1;ISL2;EPHA7;AUTS2;CTNNA2;WNT5A;PTEN;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;ANK3;EPHA6;UNC5A;ADGRB1;NEFH;DSCAM;RAB8A;CNTN4;IRS2;LLGL1;DAB1;DOCK7;DSCAML1;PTPRO;UNC5C;PTK2;RELN;PALLD;EPHB6;DCC;NRXN3;PRKCA;NEXN;CNTN6;OPHN1;LYPLA2;EPHA3;PPP3CB;PTPRA;DOK5;FYN;USP33;UNC5D;GFRA1;ARHGAP35;SH3KBP1;KIF5C;GFRA2;EPHA5;EVL;GDNF;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;ULK2;TUBB3;EFNA1;CYFIP1;SLITRK1
prerank,bile acid biosynthetic process (GO:0006699),0.571837204323336,1.5330087286216363,0.04777070063694268,0.6558723802744596,1.0,4/24,3.45%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,positive regulation of chemotaxis (GO:0050921),0.510873373048005,1.5322574364434822,0.028400597907324365,0.6536796618567856,1.0,9/43,11.18%,PTN;NTRK3;XCL1;EDN3;SEMA5A;DSCAM;PRKD1;LGMN;P2RX4
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6249781715716958,1.5305027083577343,0.048903878583473864,0.6560180049157542,1.0,3/18,1.27%,PTN;XCL1;EDN3
prerank,apical protein localization (GO:0045176),-0.6316422943045065,-1.5285150290884428,0.04025423728813559,0.37068757024803456,1.0,6/10,12.33%,ACTB;SHROOM3;GOPC;MAL;ATP8B1;SHROOM2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.6423734234974074,1.5281322166810445,0.05676126878130217,0.6608396349205612,1.0,5/14,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6753006864315358,1.5272424439570584,0.043333333333333335,0.6594121437830497,1.0,1/12,0.10%,IL33
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5788588414061975,1.526966025173427,0.044274809160305344,0.6554364842581135,1.0,8/22,16.91%,DYNLL1;CDKN2A;CDKN2D;BMP7;TP53;ANKLE2;CDKN2C;PRKRIP1
prerank,cellular response to alcohol (GO:0097306),0.5073561774238998,1.5268659646829337,0.04011887072808321,0.6507280900704062,1.0,14/42,14.54%,PTGFR;GRAMD1B;ADCY5;GPLD1;JUP;ADCY8;ADCY3;ADCY2;ADCY7;GLRA1;SPIDR;GLRA2;MAP4K1;GNG2
prerank,retina homeostasis (GO:0001895),-0.5109256499603461,-1.525191798182576,0.031413612565445025,0.3769261044049124,1.0,7/23,12.23%,ACTB;POTEF;ACTG1;WHRN;B2M;HSPB1;PRDX1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5146437208564252,-1.5246886527633505,0.042821158690176324,0.3757728189138084,1.0,14/22,36.55%,AEBP1;HSPA8;APOE;MAPT;GPX1;ARL2;CAMSAP2;PARK7;CAMSAP3;MAP1S;EFEMP2;PIK3CA;AKAP13;PRUNE1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5626119314033435,-1.5240685800476934,0.03747072599531616,0.37514228869534755,1.0,9/15,28.48%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;ORMDL2;SPHK2;NSMAF;SAMD8
prerank,negative regulation of chemokine production (GO:0032682),0.6642049968213024,1.5240334909760058,0.04569420035149385,0.6582159317709512,1.0,1/14,0.04%,APOD
prerank,regulation of BMP signaling pathway (GO:0030510),-0.38554452046053433,-1.523660829250205,0.012244897959183673,0.373698792512669,1.0,17/73,8.18%,CRIM1;SMAD6;RBPJ;BMPER;LEMD3;NBL1;XIAP;FSTL1;BMPR2;FOXD1;SKIL;NOTCH1;SKI;UBE2D3;CCN1;ACVRL1;SMURF2
prerank,lipoprotein transport (GO:0042953),0.6842601778834939,1.5229520897208757,0.08029197080291971,0.6576900561429735,1.0,7/10,24.91%,LRP1;UNC119;PRKCB;MIA3;UNC119B;ZDHHC17;VMP1
prerank,muscle cell migration (GO:0014812),-0.6322907319701794,-1.5216345284171389,0.05656108597285068,0.3772260808351792,1.0,5/10,11.86%,CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,positive regulation of vascular permeability (GO:0043117),-0.5941282407006648,-1.5215311391197772,0.041379310344827586,0.3750735120846695,1.0,5/12,13.30%,TJP1;OCLN;PDE3A;TJP2;TRPV4
prerank,regulation of protein kinase A signaling (GO:0010738),0.5833691400479484,1.5181558665129014,0.05194805194805195,0.6740717902290709,1.0,7/20,14.45%,AKAP5;ADGRV1;AKAP7;LRRK2;IAPP;AKAP6;PRKAR1A
prerank,response to purine-containing compound (GO:0014074),0.6105600084618328,1.5164405214431418,0.06209150326797386,0.6764639624322121,1.0,10/17,23.94%,P2RY1;RYR2;DGKQ;TRPC3;P2RX4;TRPM2;NDUFS4;ABCC9;STAT1;P2RY6
prerank,intestinal lipid absorption (GO:0098856),0.6692498414606708,1.515200303335186,0.055846422338568937,0.676603399481118,1.0,3/11,10.31%,NPC1L1;CEL;SOAT2
prerank,cellular response to interleukin-12 (GO:0071349),-0.414227742652144,-1.5145147446419718,0.019867549668874173,0.39114522854764183,1.0,20/48,23.30%,PLCB1;SIRPA;SOD2;CDC42;TALDO1;PITPNA;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3712560868538289,-1.5140698120011566,0.00796812749003984,0.3898659238003316,1.0,18/82,10.62%,RANBP3L;CRIM1;SMOC1;IGF1;SMAD6;DDX5;MEF2C;BMPR2;NOTCH1;WNT4;SKI;IL6ST;CDK6;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,regulation of neuroblast proliferation (GO:1902692),0.6346455814293772,1.5117910747250785,0.06397306397306397,0.6871047951765589,1.0,4/15,5.91%,PTN;LRRK2;NF1;DISC1
prerank,Notch signaling involved in heart development (GO:0061314),-0.6242763328801532,-1.511412383081272,0.06167400881057269,0.39423164766893426,1.0,7/11,16.71%,RBPJ;NOTCH2;NOTCH1;GALNT11;HEYL;HEY2;SNAI1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.45771427682432825,-1.5113158102991024,0.029850746268656716,0.39197900899757054,1.0,13/31,14.08%,PPP1R13B;HIP1R;YWHAB;GSK3B;YWHAG;CASP8;BAD;BAX;PPP3CC;PPP3R1;BID;BOK;ZNF205
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.48645538549106254,1.5101947000003804,0.029288702928870293,0.689086220509559,1.0,19/57,24.27%,ADCY5;AKAP5;GPR37L1;ADCY8;ADCY3;ADCY2;HTR5A;HTR1A;ADCY7;LPAR1;HTR4;GPR37;GRM7;ADRA2A;CHRM2;GNAI3;ADCY1;P2RY12;GRM8
prerank,negative regulation of cell junction assembly (GO:1901889),0.5645092347624087,1.5095281989731764,0.05030487804878049,0.6869360255504574,1.0,5/25,3.78%,APOD;ROBO2;DLC1;PTEN;ARHGAP6
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6058693672343411,1.5086902383003071,0.05178571428571429,0.6856497990237431,1.0,7/18,6.20%,GRID2;GRID1;GRIK2;GRIK5;GRIK4;NAPB;GRIK1
prerank,nucleotide catabolic process (GO:0009166),-0.5572532969152153,-1.5067672664642464,0.03855421686746988,0.4018500049971399,1.0,9/16,19.98%,SAMHD1;DERA;NUDT3;XDH;VCP;GPX1;NT5E;GDA;NT5C1A
prerank,bile acid metabolic process (GO:0008206),0.5533352100642186,1.5067236136270152,0.05246422893481717,0.6895560858514672,1.0,4/27,3.45%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,regulation of fat cell differentiation (GO:0045598),0.45502858516789096,1.5045882418036869,0.035278154681139755,0.6940115086795196,1.0,19/74,18.50%,RORA;ENPP1;WNT5A;LRP3;PTPRQ;PPARD;RUNX1T1;ZBTB16;ZFP36L2;WDFY2;ZFPM2;FTO;CARM1;ASXL1;FERMT2;TAF8;FRZB;BMP2;ALOX5
prerank,positive regulation of immune system process (GO:0002684),-0.5517359807553625,-1.5035990820726504,0.0593607305936073,0.4081832760434276,1.0,4/16,9.97%,TGFB2;ANXA1;PIK3CB;PIK3CD
prerank,activation of protein kinase A activity (GO:0034199),0.6078639063843734,1.5032872863278237,0.056910569105691054,0.6950074716465999,1.0,7/16,8.89%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5605513984020182,-1.5028019436881621,0.050119331742243436,0.4079356523699155,1.0,2/14,0.41%,IGF1;CD200
prerank,response to progesterone (GO:0032570),-0.5234323461061414,-1.5024100497089776,0.05789473684210526,0.4064246089885671,1.0,5/18,9.86%,CAV1;THBS1;TGFB2;WBP2;ABHD2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5659841702487625,1.5019718075120005,0.03864734299516908,0.6959083499163745,1.0,9/24,16.57%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.48901523975092925,1.5018517088644439,0.042735042735042736,0.6915656902836398,1.0,6/48,8.67%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;PRKACA
prerank,interstrand cross-link repair (GO:0036297),0.4813996540883019,1.5008249244492022,0.024390243902439025,0.6912210291853381,1.0,13/53,11.96%,FANCI;ERCC6L2;ERCC1;FAN1;USP1;FANCA;NEIL3;RPA1;ERCC4;RNF168;FAAP100;FAAP20;POLN
prerank,regulation of vasculogenesis (GO:2001212),-0.5710948990568028,-1.4994360946330805,0.06018518518518518,0.4118474119113683,1.0,8/14,13.99%,RAPGEF2;KDR;RAP1A;CD34;XDH;CEACAM1;HEY2;RRAS
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.49830674361547744,-1.4993685492494042,0.049738219895287955,0.4095471646421638,1.0,8/22,15.54%,SLIT2;KANK3;HIP1R;GSN;KANK1;SSH1;TMSB4X;PRKCD
prerank,endothelial cell development (GO:0001885),0.5618210501142311,1.498815663076502,0.0457516339869281,0.6953567935737026,1.0,3/25,2.43%,COL15A1;COL18A1;COL22A1
prerank,positive regulation of leukocyte activation (GO:0002696),0.6021817474765461,1.4982603754980535,0.06896551724137931,0.6930192794386947,1.0,5/18,9.41%,IL33;WNT5A;TSLP;TLR6;TLR4
prerank,protein hydroxylation (GO:0018126),0.6175855625808611,1.4970636835715956,0.05460750853242321,0.6937346570845356,1.0,8/15,17.95%,PLOD1;HIF1AN;VIPAS39;P3H1;P3H3;ASPH;VPS33B;PLOD2
prerank,pore complex assembly (GO:0046931),-0.5203114174602649,-1.49517824287894,0.04177545691906005,0.41883289106550686,1.0,9/19,15.32%,ANO6;AFDN;ADAM10;BAD;NUP98;NUP153;TMEM170A;P2RX7;NUP205
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6326313615388117,-1.4943893041292722,0.0468384074941452,0.4182977599567661,1.0,2/10,4.88%,NFKB1;SREBF2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6141074442573174,1.4932155556776776,0.054365733113673806,0.7060881942504706,1.0,4/17,2.66%,CASK;SULF1;TMEM204;ITGA3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.509940457645827,1.4920224291569741,0.045722713864306784,0.706823405973982,1.0,13/41,16.57%,XCL1;ITPR1;GRIN2B;RYR2;HTR2B;GRIN2A;TRPV3;HTR2C;TRPM2;RYR3;F2R;CACNA2D1;CHERP
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3421834576873365,-1.4916603041782093,0.005128205128205128,0.4233715595969112,1.0,40/137,15.41%,PKP4;CD200;PICALM;RAPGEF2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;RASGRF1;S100A10;RAP1A;NDEL1;CAV2;SRGAP2;RAPGEF1;CALM1;GSK3B;MTMR9;RHOC;RSU1;RALBP1;PLXNB1;SGSM2;SFRP1;MAPRE2;CTSH;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;RAPGEF3;CX3CL1;EZH2;RAP1GDS1;RGS10
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6268964048655612,-1.4905858559938994,0.06407322654462243,0.4238016078740749,1.0,5/10,22.66%,MGRN1;PDE3A;PDE11A;CDC34;APLNR
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4839546862250226,-1.49050048882226,0.042666666666666665,0.42153524721297303,1.0,11/24,18.21%,SEMA3D;SEMA3C;SEMA7A;NRP1;MEGF8;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,regulation of protein import into nucleus (GO:0042306),0.5220905274347027,1.4895517969871457,0.043154761904761904,0.7133086684346946,1.0,6/36,4.80%,APOD;PIK3R1;JUP;PIK3R2;ZIC1;MDFIC
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6737945788266289,1.4879154341059255,0.09022556390977443,0.7156920156171006,1.0,1/10,0.10%,IL33
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.48802743998048004,-1.4876683328147382,0.0379746835443038,0.42704574132143563,1.0,12/24,24.35%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TNFAIP3;UBA52;IKBKG;NOD2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6642065950299623,1.485974488795854,0.07282415630550622,0.7195064683168385,1.0,8/10,27.97%,HERPUD1;EIF2S1;HSPA5;EIF2AK3;CCL2;DDIT3;ATF4;QRICH1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5548462294166385,-1.4856453560146539,0.052109181141439205,0.43022947378087456,1.0,8/15,8.03%,TJP1;ARHGEF18;ACTB;F11R;ACTG1;CGNL1;TJP2;LSR
prerank,positive regulation of embryonic development (GO:0040019),-0.5121687835735982,-1.484706002282534,0.06419753086419754,0.4303365885706747,1.0,6/19,10.18%,PLCB1;OSR1;WNT4;B4GALT5;CFL1;NIBAN2
prerank,cellular response to glucagon stimulus (GO:0071377),0.5974871283704507,1.483877019333429,0.06788079470198675,0.7243545284476881,1.0,7/17,8.89%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,sensory perception (GO:0007600),0.4842346475382537,1.4832927520648798,0.045925925925925926,0.7221211281119405,1.0,10/45,11.18%,TRPA1;ADGRV1;MYO7A;NIPSNAP1;C5AR1;PDYN;ADORA2A;PTGES;CLRN1;P2RX4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.45280179089358596,-1.4830534486149918,0.044444444444444446,0.43252144856329533,1.0,11/32,14.25%,HMBOX1;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;ATM;MAP3K4
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.38050117672842254,-1.4826545310961214,0.014234875444839857,0.43107986560459577,1.0,17/72,8.74%,HEG1;ARHGEF18;ROBO1;ARHGEF28;NET1;KANK2;F11R;NRP1;GPR4;KANK1;RASIP1;RAC1;PRAG1;APOE;ARHGDIB;RALBP1;EPS8L2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4705668916088852,-1.4823563184224013,0.0440771349862259,0.429393440775386,1.0,12/26,21.22%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;TRPV4;MET;CDK5RAP2;NUMA1;FES;KATNB1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.46474883325182403,1.4822142916509304,0.03477051460361613,0.7223812415167229,1.0,18/59,15.59%,RUNX2;PTEN;TCF7L2;AGO4;CDKN2A;THRA;CDK8;MED12;MED6;TWIST1;TP53;MED10;AGO3;MED8;SOX9;MED1;MED25;TNRC6B
prerank,nervous system development (GO:0007399),0.38083651776411737,1.4821118372443112,0.0,0.7181258362221717,1.0,110/429,17.45%,CHST8;ROBO2;CHD7;PTN;ADGRL3;RBFOX1;NRG1;GPM6B;MERTK;TEAD1;ADGRV1;CXCL1;UNC119;MARCKS;PTEN;SEMA5A;ERBB4;EPHB1;SH3GL3;FARP1;ADGRA2;NRXN2;BTBD2;NRXN1;ZIC4;ASIC2;WDPCP;PCDHA5;VCAN;POU3F3;TBX3;DPYSL2;PCDHB16;SOX6;ZIC1;DCHS1;PRX;ZBTB16;APLP1;ADGRB2;ADGRB1;DSCAM;ADORA2A;NF1;CNTN4;ADORA1;GRIK1;LIMK1;PCDHB4;SZT2;HAPLN2;PCDHB11;RPS6KA6;NPAS2;DSCAML1;UTP11;NAV2;RELN;DHX30;AXL;NAV3;RAB29;TENM1;LSAMP;MBP;CNTN6;AHI1;LPAR1;OPHN1;SOX10;ALDH5A1;PRPS1;FGF12;RBFOX3;NDUFV2;FKTN;DLG4;TGFBR1;GFRA1;CBLN1;MYT1L;DPF2;ANKLE2;ATN1;SDCBP2;SCN2A;ADAM22;ATXN3;ARNT2;GFRA2;HAPLN3;FGF5;EVL;APBA2;NRSN2;KIRREL3;GDNF;TRIM3;HAPLN1;GLRB;NRCAM;IGF2BP3;CHERP;JAG1;SLITRK1;NHEJ1;ZIC5;CDK5;LDB2;LDB1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3105659677995372,-1.4812128363135166,0.0,0.43005764850124145,1.0,133/306,28.30%,MEF2A;RPS14;RPS9;RPS16;PTMA;ST3GAL4;RPLP1;RPL13;DRG1;TOP1;B4GALT5;RPL27A;RPS2;RPL37A;ALAS1;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;EXT1;RPS19;RPS24;RPS27;RPS15;APOE;RPL21;TBRG1;RPL10;EEF1G;RPL35A;LARGE1;RPS15A;RPL10A;RPS5;RPL11;ABCF1;RPL36A;PTMS;EEF1A1;RRAGC;RBBP8;ORC6;NR4A2;RECQL5;RPL34;POLR2B;ATR;RPLP2;RPS29;RPL32;RPL4;RPLP0;POLR2H;EEF2K;RPL30;RPL26;RPS4X;TERT;RPS21;RPL29;POLR2G;ATM;RPS8;EEFSEC;FUT9;EEF1D;POLR2C;POLE2;NBN;ING4;MRPS7;KAT5;RPL31;ST3GAL2;GCNT1;RPS23;ING5;RPL23A;GTPBP1;DONSON;SRBD1;MRPS17;AGO2;RPL19;HUS1;RPL36;HOXD3;ORC1;GSPT2;CREBL2;MCM6;MRPS18A;GAL3ST2;TYMS;MRPS18B;RPL17;RPL23;E2F1;MCM9;TOP1MT;MRPL24;RPS11;MRPL55;POLD2;MCM8;GSPT1;RPA2;RPL15;ATRIP;RPL38;RMI2;HARS2;CDC45;NT5M;BRCA1;PCLAF;BRIP1;MRPL36;MRPL35;RPL13A;POLR2I;RPS25;CHEK1;POLR2K;RHNO1;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A
prerank,maintenance of blood-brain barrier (GO:0035633),-0.45226346556643104,-1.4810382110813956,0.03651685393258427,0.4280399306981569,1.0,19/30,14.67%,TJP1;VCL;OCLN;PECAM1;ACTB;ITGB1;ESAM;F11R;CLDN5;JAM2;ACTG1;TJP2;LSR;DMD;SLC1A1;CLDN12;GJB6;MFSD2A;CDH5
prerank,presynapse assembly (GO:0099054),0.6073266864430118,1.479750275452696,0.05872193436960276,0.7242340612930438,1.0,4/16,4.15%,WNT5A;PTEN;CEL;LRRTM3
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.45790111070101275,-1.4791591523757952,0.05747126436781609,0.43094705944178596,1.0,11/29,15.54%,TJP1;SLIT2;SHANK3;KANK3;HIP1R;KANK1;SHANK1;SSH1;ARPIN;LIMA1;PRKCD
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6356624508353311,1.4786436842622428,0.0702054794520548,0.7246040099417602,1.0,4/12,11.75%,PPARA;ITGAV;NR1H2;ABCA5
prerank,bicellular tight junction assembly (GO:0070830),-0.41683867472960784,-1.4784769888572182,0.018018018018018018,0.430610974099443,1.0,21/46,27.35%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RAB13;ARL2;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP;PATJ;CLDN10;MARVELD2;ECT2;CLDN1
prerank,negative regulation of GTPase activity (GO:0034260),-0.5049331194136302,-1.4777880987175742,0.04935064935064935,0.4303266881216842,1.0,8/22,11.17%,LRCH1;F11R;RDX;SH3BP4;WNK1;CPEB2;ARL2;GMIP
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6287431310958567,1.4767437257868283,0.06837606837606838,0.7286075972592109,1.0,3/14,1.52%,SULF1;SPRY4;SPRY1
prerank,embryonic eye morphogenesis (GO:0048048),-0.5907465643069667,-1.4759877287351173,0.08520179372197309,0.43277694514303433,1.0,6/11,22.73%,MFAP5;LRP6;TBX2;EFEMP1;MFAP2;KDM2B
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5539686536786401,-1.4757163271085376,0.06532663316582915,0.4313090418353577,1.0,8/15,21.98%,RBPJ;EGFR;FER;CEACAM1;RHBDF2;ERBB2;EGF;MVB12B
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.610119432010683,1.4754567251690827,0.07512520868113523,0.7296451002857418,1.0,6/16,9.37%,SEC16B;SEC16A;RYR2;GBF1;LRRK2;TAPT1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.36561686200531995,-1.4754240041984525,0.008264462809917356,0.4297626269251369,1.0,28/85,14.56%,PLCE1;IGF1;ARHGEF18;DENND4A;ARHGEF28;KANK2;NOTCH2;RASGRF1;RDX;SHOC2;SQSTM1;NOTCH1;TGFB2;KANK1;DENND3;GABARAP;ARHGAP17;RAPGEF1;NGF;ARHGDIB;EPS8L2;MADD;EPHB2;MAPKAP1;BCR;DENND1A;DENND4C;GRB2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6380743215917867,1.4745005342412538,0.07155963302752294,0.729530440336981,1.0,3/12,8.15%,CDC14B;PTEN;GOLGA2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6088000748016679,1.4738539693596744,0.075,0.7279532417028456,1.0,3/15,4.06%,PPARA;PPARD;NR1H2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6713355239119818,1.4737327810284067,0.08648648648648649,0.7239996825462145,1.0,4/10,12.54%,ENPP1;APPL2;PRKCB;GSK3A
prerank,regulation of monooxygenase activity (GO:0032768),-0.47836615093144363,-1.4736298826995493,0.04619565217391304,0.4324917066430157,1.0,13/23,22.05%,CAV1;EGFR;NOS3;ZDHHC21;NOSTRIN;CALM1;DDAH1;NOS1AP;AKT1;WASL;NOSIP;LYPLA1;DDAH2
prerank,inflammatory response (GO:0006954),0.4039531794862753,1.47304711553752,0.011737089201877934,0.7225029714117045,1.0,22/195,6.49%,SCUBE1;GGT5;IL1RN;IL2RA;XCL1;CXCL10;PTGFR;CXCL1;HSPG2;CD40;C5AR1;TPST1;MMP25;NFATC3;LOXL3;FOS;TLR6;CCL15;ADORA2A;ADORA1;PRDX5;ADCY8
prerank,neuron migration (GO:0001764),0.48336839453854247,1.4725931296112886,0.04685212298682284,0.7199989396567492,1.0,12/48,8.44%,SH3RF1;ADGRL3;AUTS2;NTRK2;ASTN2;FGFR1;DNAAF4;LRP12;CDKL5;DISC1;ASTN1;RELN
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5292386129762945,-1.4718791023298174,0.05952380952380952,0.4348639206094407,1.0,5/17,4.26%,PBX1;RBPJ;MAML2;NOTCH3;NOTCH1
prerank,motile cilium assembly (GO:0044458),0.6367195767287197,1.4715067483126336,0.07216494845360824,0.7203235705779415,1.0,4/12,15.25%,RSPH9;E2F4;DNAAF3;CCDC39
prerank,regulation of phospholipase C activity (GO:1900274),0.6115236721547475,1.4702692364126995,0.07652173913043478,0.7213408777597169,1.0,3/15,3.03%,PDGFRA;NTRK3;FGFR1
prerank,lipoprotein localization (GO:0044872),0.6382819229989177,1.4696410259962203,0.09584086799276673,0.7197336363003092,1.0,3/11,9.17%,LRP1;UNC119;PRKCB
prerank,regulation of plasminogen activation (GO:0010755),-0.5924986546550054,-1.4695503842961153,0.05829596412556054,0.43900476133346417,1.0,6/12,14.38%,THBS1;RUNX1;SERPINE1;ENO1;SERPINE2;CTSZ
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5194745703252373,-1.4693059040534389,0.053164556962025315,0.43728503603935354,1.0,5/19,6.17%,SLCO1C1;APP;KLF4;NFKB1;KLF2
prerank,regulation of kinase activity (GO:0043549),0.4341603637806617,1.4684275028570186,0.030379746835443037,0.7211020694357463,1.0,19/89,10.41%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;NPRL2;EPHA6;ANKRD54;CAMKK2;IRS2;EPHB6;AXL;FGR;EPHA3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5594299343990646,-1.466827518393115,0.04672897196261682,0.4421315601637928,1.0,8/14,28.15%,THBS1;KLF4;NOTCH1;ITGB1BP1;MAP2K5;CARD10;DLL4;HDAC5
prerank,ERBB2 signaling pathway (GO:0038128),0.5212883626084446,1.4666518467142058,0.0514820592823713,0.7244859943113066,1.0,7/31,8.66%,PIK3R1;NRG1;ERBB4;PTPRR;NRG2;NRG4;PRKCA
prerank,neurotransmitter transport (GO:0006836),0.4472781512824917,1.465921605172033,0.02459016393442623,0.7233214793715131,1.0,17/73,14.58%,SLC1A3;CASK;ATP1A2;SLC18A3;NRXN2;PTPRN2;NRXN1;VAMP2;CHAT;PPFIA2;SNPH;RIMS1;SLC29A1;DNAJC5;UNC13A;PPFIA4;SYN2
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5603823976255482,-1.4657554913113469,0.053488372093023255,0.44270884205517363,1.0,7/14,16.72%,NCOA4;TRIM24;WBP2;SFRP1;ARID5A;SFR1;BCAS3
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.45354279419362614,-1.4656308827341709,0.05420054200542006,0.44074958330120356,1.0,11/28,20.97%,OCLN;DRG1;RAC1;MAPT;GIT1;ARL2;SLAIN2;MET;CDK5RAP2;NUMA1;FES
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5307991223812383,-1.4651277476607878,0.057736720554272515,0.4398785538574285,1.0,8/17,16.71%,RBPJ;NOTCH2;NOTCH1;ACVR1;GALNT11;HEYL;HEY2;SNAI1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5768019136728582,1.4649075867583077,0.0592,0.7233180241994536,1.0,7/21,8.89%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;AMPD2;ADCY7
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5808452754548974,1.4643774975309505,0.07508532423208192,0.7216189111696135,1.0,4/18,4.96%,PPARA;PAG1;TNFAIP8L2;PTPN22
prerank,negative regulation of biosynthetic process (GO:0009890),0.5906578725548853,1.4615566291267696,0.07665505226480836,0.7302621584492233,1.0,3/16,2.33%,PPARA;SLC30A10;ABCD2
prerank,regulation of secretion (GO:0051046),0.6117191497469413,1.4613385587276435,0.08419243986254296,0.7270426201416204,1.0,5/13,15.57%,NRG1;GPLD1;MYO6;POFUT2;SGK1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6163973286568598,-1.4609153520911242,0.06136363636363636,0.4495930616602177,1.0,7/10,22.29%,TUT7;UBB;NEDD8;ISG15;UBC;CHFR;UBA52
prerank,regulation of telomere capping (GO:1904353),-0.48614707182869754,-1.4606543917825705,0.05080213903743316,0.4479167652074456,1.0,8/23,14.36%,SMG6;TNKS2;NEK7;MAP2K7;RTEL1;ATM;MAP3K4;NBN
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5915093848461325,1.460065973388275,0.07525083612040134,0.7286793162337373,1.0,6/16,15.42%,AUTS2;KMT2A;BCOR;WDR5;SNW1;PAXIP1
prerank,diacylglycerol metabolic process (GO:0046339),-0.48008949706275816,-1.4595819274854,0.05817174515235457,0.44860862115774214,1.0,6/23,12.53%,PLCE1;DGKH;PGS1;DGKG;LIPE;DGKZ
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.4032164870285891,-1.4576900196011213,0.033003300330033,0.45172727018776837,1.0,19/46,23.30%,PLCB1;SOD2;CDC42;TALDO1;PITPNA;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.44155380256167864,-1.4576336738559599,0.027247956403269755,0.44961802257249117,1.0,12/30,23.43%,FLT1;MLLT3;KDR;ACE;SFRP1;FLT4;FLT3;ARMC6;CSF1R;BATF;FSTL3;SP7
prerank,carboxylic acid metabolic process (GO:0019752),-0.44242760911195345,-1.4571773738372673,0.022922636103151862,0.44854656124217984,1.0,8/33,6.17%,DDO;CSGALNACT1;ST6GAL1;SLC2A1;PLA2G4A;PON3;ST3GAL1;CYB5R3
prerank,cardiac muscle tissue development (GO:0048738),0.47168357927398186,1.4570978582614607,0.04264705882352941,0.7379948607759393,1.0,9/50,11.48%,TBX18;MSC;NRG1;SMAD5;GJA1;CACNA1G;BMP7;NDUFV2;MSX1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.47948951075571844,-1.456027859058722,0.03287671232876712,0.44970191034656265,1.0,8/24,22.66%,RAPGEF2;MGRN1;PDE3A;PDE11A;PRKAR2A;PRKAR2B;CDC34;APLNR
prerank,axonemal dynein complex assembly (GO:0070286),0.5345879445185064,1.454131798600959,0.0717557251908397,0.7469225380697366,1.0,7/27,9.67%,CCDC63;ODAD4;DNAAF4;DNAAF3;TTC12;DNAI4;CCDC65
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5912837180251088,-1.4530704891108486,0.08068459657701711,0.45560937034245197,1.0,7/11,24.44%,FOXO1;CAV1;FAS;ATP6V0A2;ATP6V1G1;CCDC115;TMEM199
prerank,bicarbonate transport (GO:0015701),-0.4677510109455113,-1.4530580241402948,0.05785123966942149,0.4533684022690559,1.0,11/25,24.81%,SLC4A10;SLC26A7;SLC39A8;SLC4A3;CA4;SLC4A8;CYB5R1;SLC26A6;CFTR;SLC4A7;CYB5R4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5245648583487637,-1.452861669978547,0.06989247311827956,0.451641656475876,1.0,5/16,10.60%,CAV1;INPP5F;PPP2R1A;PTPN2;VHL
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5894543894928591,1.4525208387719895,0.08053691275167785,0.7497818986542906,1.0,3/18,7.46%,APOD;MDFIC;POLR1A
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.539454178396186,1.4512768388464121,0.06050955414012739,0.7508969552344255,1.0,9/26,16.57%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5442715874427752,1.4512576330773952,0.06700167504187604,0.7467555108126497,1.0,9/23,22.28%,XCL1;NR1H4;PDCD1LG2;AXL;TLR4;LGALS9;INHBA;DDIT3;HMGB1
prerank,negative regulation of viral transcription (GO:0032897),-0.557168144406052,-1.4500936827500208,0.09131403118040089,0.45741506755206124,1.0,6/13,19.19%,TRIM11;IFITM3;TRIM14;TRIM27;UBP1;HEXIM1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6481290594553812,1.4496983910960426,0.07599309153713299,0.7495391178507989,1.0,5/12,12.29%,BOD1;CENPE;RMDN1;CENPC;CDT1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5989801735028168,-1.4487909142601902,0.07256235827664399,0.45902796939183965,1.0,5/11,16.48%,MEF2C;EFNB2;TGFB2;GPER1;MYOCD
prerank,intermediate filament organization (GO:0045109),-0.5225427628151116,-1.447654804216366,0.07341772151898734,0.4598798477278135,1.0,3/17,3.27%,VIM;MTM1;KLHL24
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4332734976136355,-1.44738136247325,0.055384615384615386,0.4583781069637587,1.0,8/36,5.90%,RHOBTB1;GULP1;DOCK1;THBS1;GSN;RHOBTB2;RAC1;CDC42
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4846715703806283,-1.4468747181567203,0.0582010582010582,0.45763492169437336,1.0,11/22,17.86%,SLIT2;ROBO1;ID1;NRP1;EFNB2;KDR;EPHB4;NR4A1;CDH5;SOX18;AKT1
prerank,hexose metabolic process (GO:0019318),0.4960927465586351,1.4466097587392763,0.05343511450381679,0.7592580786085273,1.0,6/39,6.92%,APOD;GDPGP1;PPARD;IRS2;OMA1;ALDOB
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4467494454506295,1.4457229102368898,0.0438957475994513,0.7588612362925649,1.0,15/69,8.22%,PDGFRA;PLCL1;PIK3R1;OGT;PTEN;FGFR1;GAB2;PIK3R2;HTR2B;IRS1;NF1;IRS2;PI4KA;RPS6KB1;PLEKHA1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5980848328479731,1.4445782102526836,0.08084358523725835,0.7598248388826468,1.0,3/14,7.71%,GHR;PIK3R1;PTK2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.3751131586462806,-1.4442443185280058,0.02464788732394366,0.46297720944303883,1.0,23/67,14.88%,FN1;DOCK5;LIMS2;DOCK1;VIT;NRP1;S100A10;RAC1;NEDD9;CDK6;CDC42;PPM1F;GSK3B;RSU1;ECM2;SFRP1;NPNT;ARL2;MDK;PLEKHA2;FLNA;PTK2B;CX3CL1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.572559195154446,1.4424445411789915,0.09090909090909091,0.7655198452706734,1.0,7/18,15.25%,ODAD4;ADCY10;NPHP3;DNAAF4;SPA17;CABYR;CCDC39
prerank,regulation of hippo signaling (GO:0035330),-0.5061646698645033,-1.44186537406885,0.052109181141439205,0.46750753871583917,1.0,8/17,18.24%,MAPK14;MOB3B;SCHIP1;DLG5;AJUBA;MARK3;VGLL4;SOX11
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.6007415096229627,-1.4416722965716064,0.09263657957244656,0.46587385597688885,1.0,4/10,15.35%,ST6GAL1;ST3GAL1;RENBP;NPL
prerank,positive regulation of macrophage activation (GO:0043032),0.5808920414268637,1.4414449308766295,0.09863945578231292,0.7658628045135318,1.0,4/17,9.41%,IL33;WNT5A;TLR6;TLR4
prerank,neutrophil chemotaxis (GO:0030593),0.4685486023183774,1.4404520610700364,0.05738880918220947,0.7661973944958431,1.0,7/53,5.34%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,protein ADP-ribosylation (GO:0006471),-0.4457872258533323,-1.4400923638312004,0.057803468208092484,0.46819314524712924,1.0,13/28,27.96%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;PARP4;SIRT1;SIRT5;PARP1;PARP2;PARP12;ARF4
prerank,oligosaccharide metabolic process (GO:0009311),-0.40317881760167523,-1.439024516888251,0.038338658146964855,0.46891474909505004,1.0,14/46,13.55%,B4GALT1;ST3GAL6;FUT8;ST8SIA4;B3GALT1;ST3GAL4;ST6GALNAC3;ST3GAL3;MANBA;MAN2C1;MPDU1;ST8SIA2;NAGA;FUT9
prerank,cholesterol homeostasis (GO:0042632),0.44462528830412357,1.438104715165114,0.05313351498637602,0.772553906430261,1.0,5/64,5.08%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,positive regulation of cell projection organization (GO:0031346),0.41736064558084024,1.4370095879583276,0.03258145363408521,0.7732291472857358,1.0,28/115,14.07%,ROR1;ROBO2;PTN;NTRK3;PLXNC1;ROR2;TENM3;WNT5A;NTRK2;GRIP1;NGFR;CDKL5;CAPRIN1;PRKCI;CDKL3;CARMIL2;PRKD1;RELN;STMN2;P3H1;EPHA3;DLG4;PLXNB2;RETREG3;ARHGAP35;LRRC7;CUX2;LYN
prerank,positive regulation of cell communication (GO:0010647),0.5158704236326931,1.4369232691460376,0.07332293291731669,0.7694420640853842,1.0,10/28,18.62%,HCRT;EDN3;GRIK2;ANK3;RIMS2;RIMS1;DLG4;NMU;CLSTN1;SYT1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5706111993431111,-1.4366821362032398,0.08863636363636364,0.4732849532218085,1.0,3/12,7.21%,PICALM;ROCK2;APOE
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5257135123465494,-1.436175920184444,0.07192575406032482,0.47264127233062897,1.0,8/16,25.48%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;DTX3L;KMT5C
prerank,heart trabecula morphogenesis (GO:0061384),-0.508155163857636,-1.4360361407705409,0.06361323155216285,0.47081962746727535,1.0,7/18,4.36%,TEK;RBPJ;ADGRG6;S1PR1;RBP4;NOTCH1;TGFB2
prerank,response to growth factor (GO:0070848),-0.4042203689421557,-1.4349405423884611,0.03164556962025317,0.4719467385160277,1.0,21/41,23.68%,KLF4;BMPR2;ACVR1;ACVRL1;SFRP1;TBC1D7;NOS1;GATA6;CPNE3;PLK5;MAP2K5;EPHA2;ACVR2B;ERBB2;AKT1;CIB1;HDAC6;TGFBR2;TWF2;ACVR2A;EMD
prerank,heart morphogenesis (GO:0003007),0.46586917257291915,1.434632598832881,0.056818181818181816,0.7755298948797892,1.0,11/50,12.88%,CHD7;FLRT2;DLC1;RYR2;TBX3;HTR2B;PTK2;MDM4;TGFBR1;SOX9;OLFM1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6461565897527852,1.434310602412068,0.10131332082551595,0.7729785492315834,1.0,3/10,15.09%,C5AR1;SORL1;CLU
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4520837606840863,1.4341977410106652,0.05070422535211268,0.769501382001742,1.0,19/60,15.59%,RUNX2;PTEN;TCF7L2;AGO4;CDKN2A;CDK8;MED12;SRF;MED6;TP53;DHX36;MED10;AGO3;MED8;SOX9;MED1;MED25;PAXIP1;TNRC6B
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.4159976708058964,-1.433938727741381,0.034782608695652174,0.4726056506561033,1.0,14/41,22.48%,MEF2C;RBPJ;TPM1;CPE;NOTCH1;TGFB2;SOX4;HEYL;HEY2;SOX11;TGFBR3;PKP2;TGFBR2;SMAD7
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4718198148473813,-1.4337960515252723,0.05614973262032086,0.47080935397830076,1.0,6/24,10.10%,ROCK2;PRKCH;FOXC1;RUNX1;ERRFI1;TRIM16
prerank,sulfur compound catabolic process (GO:0044273),0.4867726550009238,1.4333333804111354,0.06764705882352941,0.7694711158100012,1.0,9/38,10.08%,DCN;GGT5;LUM;BGN;GGT7;VCAN;ADO;GNS;TXN2
prerank,aorta development (GO:0035904),0.5989573988745377,1.4333270766963682,0.059422750424448216,0.7655317006968376,1.0,2/14,0.48%,ROBO2;LRP1
prerank,positive regulation of synapse assembly (GO:0051965),0.524674708237321,1.432432581781986,0.06913183279742766,0.7654863786173017,1.0,10/27,17.98%,SRPX2;EPHB1;GRID2;NRXN1;SYNDIG1;IL1RAP;VSTM5;CUX2;IL1RAPL1;CLSTN1
prerank,regulation of nervous system process (GO:0031644),-0.5175125204888049,-1.4317947339041652,0.08068459657701711,0.4744212676949037,1.0,4/18,2.48%,ROCK2;SLC8A3;NOS3;APP
prerank,modulation by symbiont of host process (GO:0044003),-0.5983170868299781,-1.4315961320910586,0.0835117773019272,0.4726782342615507,1.0,7/10,22.29%,UBB;B2M;PGK1;ENO1;UBC;MRC1;UBA52
prerank,epithelium development (GO:0060429),-0.34234412391362473,-1.4313748522497007,0.008620689655172414,0.47119823844212444,1.0,25/107,13.88%,ALDH1A2;VCL;OSR1;KANK2;KDR;WNT4;SMO;DVL1;CD34;SIX1;ERRFI1;TOLLIP;PGK1;TBX1;SOX17;BDH2;PTER;TBX2;TAGLN2;TAGLN;DAG1;PCNA;ALDOC;GATA6;MFSD2A
prerank,negative regulation of response to external stimulus (GO:0032102),0.4111964311962295,1.431297793476955,0.029449423815621,0.7667298942786515,1.0,14/105,7.85%,RORA;CASK;PPARA;CTNNA2;PTEN;TRAF3IP1;GRID2;NR1H4;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5761566315034778,-1.4309880766550074,0.0824524312896406,0.47007837595675117,1.0,7/11,18.83%,ARL6IP5;MAP3K5;CYP1B1;PRODH;STK25;PRKCD;GSKIP
prerank,cellular response to purine-containing compound (GO:0071415),0.6508877411137759,1.4308243993520597,0.08787346221441125,0.7650214044811386,1.0,4/10,13.69%,P2RY1;RYR2;TRPM2;RYR3
prerank,regulation of synapse assembly (GO:0051963),0.46914014984967256,1.4304216661949787,0.07004470938897168,0.762951961540468,1.0,16/46,18.74%,ROBO2;SRPX2;EPHB1;GRID2;NRXN1;GPC4;SETD5;SYNDIG1;LRFN5;IL1RAP;CUX2;LHFPL4;IL1RAPL1;SLITRK1;CLSTN1;GPC6
prerank,sterol homeostasis (GO:0055092),0.4430114747870384,1.4300978751448594,0.052054794520547946,0.7604657471841005,1.0,5/65,5.08%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,cGMP-mediated signaling (GO:0019934),0.6248871409425203,1.4299365955360042,0.08551483420593368,0.757447106026625,1.0,4/13,9.09%,PDE9A;HTR2B;KCNC2;HTR2C
prerank,morphogenesis of an epithelium (GO:0002009),0.5253375923865571,1.4297861655153385,0.0966183574879227,0.7543025433725183,1.0,7/25,12.02%,TBX18;KDF1;TRAF3IP1;PRKX;AHI1;SOX10;SOX9
prerank,negative regulation of macrophage activation (GO:0043031),-0.5139917984959889,-1.429249918861424,0.07673267326732673,0.4728657712146949,1.0,2/16,0.90%,CD200;IL31RA
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5066372765576274,-1.4283911004831396,0.07616707616707617,0.473128536766196,1.0,8/19,12.73%,SMAD6;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;HEYL;HEY2
prerank,smooth muscle contraction (GO:0006939),-0.5541661211501011,-1.4280263054713564,0.0815347721822542,0.472180585296217,1.0,6/14,12.34%,ROCK2;MYLK;EDNRA;BDKRB2;MYH11;ACTA2
prerank,cellular protein metabolic process (GO:0044267),-0.29042842381406164,-1.4279502705133467,0.0,0.47027426524913285,1.0,113/396,18.25%,FN1;ST3GAL6;IGF1;ST8SIA4;IGFBP6;RPS14;RPS9;IGFBP5;MSRB3;APP;FSTL1;PAPPA;CPE;CST3;UBE2G1;RPS16;IGFBP3;PRKDC;RPLP1;RPL13;WWP2;FDX1;DENND3;RPL27A;IGFBP2;RPS2;UBE2D3;GPC3;ST3GAL1;RPL37A;RPL5;RPL8;ADAM10;SERPIND1;RPS7;RPL41;RPS18;PRSS23;RPS20;FBXL2;RPS19;RPS24;LMCD1;RPS27;NUCB1;RPS15;APOE;CCN1;ABCA3;RPL21;RPL10;TNC;RPL35A;MSLN;LAMB2;RPS15A;MANBA;RPL10A;RPS5;RPL11;SPCS2;ABCF1;RPL36A;EEF1A1;SHISA5;RPL34;ST8SIA2;CTSH;RPLP2;RPS29;SEC11C;GALNT11;RPL32;RPL4;RPLP0;APH1A;RPL30;RPL26;RPS4X;RPS21;RPL29;CLN5;APH1B;MMP15;CSNK1G3;RPS8;GOLM1;GATA6;FURIN;MRPS7;USP25;F5;MMP1;RPL31;CHRDL1;FDXR;PARP4;PCSK5;RPS23;UBE2L6;RPL23A;NEDD8;SIAH2;YME1L1;TTF1;SRBD1;MRPS17;AGO2;YES1;RPL19;MFGE8;QPCT;RPL36
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4084320787484871,-1.4275139521972233,0.038461538461538464,0.46936920763563983,1.0,19/40,26.57%,MAGI2;INSR;VTN;DAB2;B2M;RAB21;SERPINE1;CD63;HIP1;HFE;HNRNPK;WASL;EGF;TBC1D5;CCL19;NTF3;GREM1;ARRB2;BICD1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.49439306270880456,-1.4265018237584453,0.05912596401028278,0.4702634483368095,1.0,9/20,18.21%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,regulation of feeding behavior (GO:0060259),-0.579425479436436,-1.426287353826944,0.07801418439716312,0.46889476122779994,1.0,1/11,0.93%,LEPR
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5801937963904149,-1.42550933053761,0.08695652173913043,0.4690546415035653,1.0,7/10,34.23%,INPP5F;PPP2R1A;PTPN2;SOCS3;SOCS1;PPP2CA;NF2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4284706316827046,-1.4254420189405377,0.04610951008645533,0.46716573810468826,1.0,20/39,28.61%,RPS14;RPS16;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RIOK1;RPS5;RIOK3;MRPS7;NPM1;NOL11;TSR3;PWP2;LTV1;RPS25;RRP36
prerank,cellular response to ionizing radiation (GO:0071479),-0.4020138930743505,-1.4241563909593538,0.03715170278637771,0.46875494491858744,1.0,22/47,27.76%,NET1;CRYAB;MAPK14;TLK2;INO80;ATR;RPL26;ATM;EEF1D;GRB2;CDKN1A;SIRT1;TMEM109;CLOCK;HUS1;RAD51;KDM1A;LIG4;ECT2;RHOB;RHNO1;GADD45A
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3944269702075695,-1.4239962377817852,0.04304635761589404,0.46714466008852895,1.0,6/43,2.31%,IGF1;FOXP1;IL18;ADAMTS1;THBS1;IGFBP5
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5711883338955495,-1.4236933492639936,0.08796296296296297,0.4660415202474853,1.0,5/11,9.63%,THBS1;SEMA6A;KLF2;EPN2;PIK3CB
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5077124332230226,1.4230935268616336,0.07465007776049767,0.7801700368386668,1.0,11/31,15.81%,PDGFRA;EIF4A3;HOXC9;DSCAML1;TWIST1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,regulation of platelet activation (GO:0010543),0.5464283299076245,1.4226936405512707,0.08333333333333333,0.7781670206262861,1.0,6/21,9.41%,PDGFRA;HRG;TXK;C1QTNF1;PRKCA;TLR4
prerank,mesenchyme morphogenesis (GO:0072132),-0.506167508905778,-1.4226435948889984,0.07838479809976247,0.4672295799253987,1.0,7/17,11.63%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,limb morphogenesis (GO:0035108),-0.4919480004909029,-1.4222585796258334,0.07588075880758807,0.4663090273864533,1.0,6/20,7.73%,CYP26B1;MBNL1;TGFB2;SKI;MEGF8;LRP6
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5169979074840365,-1.4221852439107714,0.08333333333333333,0.4645478634160256,1.0,5/16,4.82%,IGF1;IGFBP6;IGFBP5;IGFBP3;IGFBP2
prerank,limb development (GO:0060173),0.5100694714067548,1.4221397973002026,0.08566978193146417,0.7767812249485707,1.0,7/28,12.49%,CHD7;KDF1;SALL1;KREMEN1;KAT2A;GLI3;LNPK
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4478592383445253,-1.4220601099182302,0.05982905982905983,0.4629267220219434,1.0,5/26,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5032789347335381,-1.4219568998230703,0.08433734939759036,0.46133478298340647,1.0,3/18,3.83%,PRKAG2;OCLN;SLC2A1
prerank,motor neuron axon guidance (GO:0008045),-0.5246359033200496,-1.4218825008664326,0.0875,0.4596010242785967,1.0,5/15,5.15%,EPHA4;SLIT2;NTN1;TMEFF1;RAC1
prerank,epithelial structure maintenance (GO:0010669),-0.5816770168295718,-1.420698423443613,0.09050772626931568,0.46094586260440534,1.0,2/11,4.20%,CXADR;RBP4
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4590721796794593,-1.4195573196731213,0.056,0.4622641550609889,1.0,8/26,10.77%,ROCK2;SHANK3;RDX;ACTG1;RAC1;CDC42;SHANK1;FHOD1
prerank,negative regulation of gene expression (GO:0010629),-0.3012747852926324,-1.4186647363102503,0.0,0.46282078388673475,1.0,84/302,17.86%,DAPK1;IGF1;PICALM;SLC24A3;ROCK2;FOXP1;ITGB8;MEF2C;OCLN;ROBO1;PPHLN1;NOTCH2;IGFBP5;APP;KLF4;NFKB1;KDM4A;CLDN5;SRGN;KDR;TMBIM6;WWP2;SAMD4A;NOTCH1;RUNX1;TGFB2;WNT4;CNOT10;SMO;LGR4;CD34;PRKAA2;ADAM10;ATP2B1;DICER1;APOE;LSM6;XDH;CELF1;ACVRL1;MAPT;CNOT8;BTG2;PTBP3;ATOH8;RPS6KA5;CITED2;SFRP1;GATA2;PPM1D;TNRC6A;PARP10;CPEB3;VHL;PARP9;SLC7A5;TARDBP;PAIP2;GAPDH;MAP2K2;RBM4;TLE5;TERT;TNRC6C;PTRH2;HEY2;YBX1;LSM2;JARID2;TOB1;DHFR;EZH2;ERN1;TRIM27;SIRT1;GPER1;PRKAA1;HAVCR2;ESR1;RBBP7;TWSG1;AGO2;PPP1R11;DNMT3B
prerank,response to glucagon (GO:0033762),0.5535428338283844,1.4184747019702746,0.08681672025723473,0.7896512497735417,1.0,7/19,8.89%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,renal water homeostasis (GO:0003091),0.5314669866992108,1.4184685733444704,0.08957654723127036,0.7858264452986804,1.0,7/23,8.89%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,respiratory system development (GO:0060541),0.4927324375833296,1.4175923925212597,0.0791476407914764,0.7859254839292287,1.0,5/32,4.20%,CHD7;BASP1;ITGA3;NPHP3;LOXL3
prerank,endocardial cushion development (GO:0003197),-0.48244811773868856,-1.4173066742079135,0.07124681933842239,0.46470542947370275,1.0,8/21,11.63%,NOS3;BMPR2;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6026078585387813,1.4171823738914144,0.09269162210338681,0.7841020286065655,1.0,5/15,11.51%,PDGFRA;EIF4A3;MTHFD1L;TWIST1;TGFBR1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.40686964810327164,-1.4170175231742772,0.04804804804804805,0.46356577546298433,1.0,11/39,8.29%,TSPAN5;RBPJ;ROBO1;MAML2;NOS3;NOTCH1;TGFB2;CCN3;IL6ST;EPN2;ITGB1BP1
prerank,synapse assembly (GO:0007416),0.4366988000087579,1.4170058879183398,0.058029689608636977,0.7811044508604338,1.0,16/67,11.42%,ADGRL3;WNT5A;PTEN;FARP1;NRXN2;GRID2;NRXN1;GABRA1;LRRTM3;PCDHB16;DSCAM;PCDHB4;PCDHB11;RAB29;GABRG2;PLXNB2
prerank,fatty acid transmembrane transport (GO:1902001),-0.5051821559697607,-1.4169111511768953,0.0625,0.4620015778203539,1.0,5/19,5.48%,PRKAG2;ABCD3;SLC2A1;ABCD4;PRKAA2
prerank,regulation of hydrolase activity (GO:0051336),-0.35976707085091064,-1.4168791784902754,0.04198473282442748,0.46021898289534,1.0,23/71,16.04%,PLXNA2;EPHA4;FGD5;CAV1;PLXNA4;CHN2;SIPA1L1;RAPGEF6;RDX;RASIP1;EFNA5;RALBP1;ITGB1BP1;PLXNB1;NGEF;ARHGAP12;ARHGAP27;NOS1;PRKG1;TBC1D10B;ARHGAP15;PLXNA1;ARHGAP44
prerank,regulated exocytosis (GO:0045055),-0.32093564547052345,-1.416754795100274,0.0,0.4586709928207197,1.0,44/173,18.27%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;LHFPL2;ANXA5;APP;PCDH7;SPARC;ECM1;SRGN;SYT9;TGFB2;VEGFD;VEGFC;CD109;ARHGAP17;PDGFA;STX1A;CALM1;ENDOD1;RAB31;SERPINE1;TAGLN2;CD63;LGALS3BP;ITGB3;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;SYNGR2;ALDOA;CPLX2;LAMP2;CPLX1;EGF
prerank,sulfur amino acid catabolic process (GO:0000098),0.6329183968130099,1.4165955173924756,0.10265486725663717,0.7791513127791805,1.0,4/10,10.08%,MTRR;BLMH;ADO;TXN2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5710516974769386,-1.4162531698645082,0.09047619047619047,0.4581820649572401,1.0,4/12,15.35%,ACOT8;PON3;RENBP;NPL
prerank,regulation of multicellular organismal development (GO:2000026),0.5362406326518643,1.4162485334276103,0.0877742946708464,0.7768659061585825,1.0,5/25,10.90%,PTN;GBX1;CCSAP;KAT2A;DHX36
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5038729662082703,1.4160357801618941,0.09375,0.7741214968400758,1.0,3/32,1.71%,CXCL10;HRG;CXCL1
prerank,striated muscle cell development (GO:0055002),-0.5281841245682156,-1.4159286056889864,0.07598039215686274,0.45723544088069473,1.0,5/14,17.04%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6323192693040156,1.4148231937530291,0.09090909090909091,0.7758629669417919,1.0,5/11,11.85%,DLC1;FAP;CIDEA;TP53;PTGIS
prerank,vitamin transport (GO:0051180),-0.4311367804864039,-1.4143252963450414,0.05637982195845697,0.4595741537999174,1.0,21/29,47.78%,ABCG2;SLC25A32;PDPN;CUBN;SLC52A3;AFM;SLC52A2;CD320;TCN2;SLC5A6;TTPA;SLC2A2;SLC23A1;TCN1;SLC27A1;SLC46A1;AMN;SLC2A6;SLC2A10;FOLR2;FOLR1
prerank,regulation of interleukin-1 production (GO:0032652),-0.5180114808301035,-1.4135240165683565,0.08843537414965986,0.4599442718999654,1.0,4/15,12.31%,FOXP1;SIRPA;ANXA1;CEACAM1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5773267448679997,1.4133851771359547,0.10296684118673648,0.7785118224750962,1.0,4/15,3.66%,DCN;BGN;DSE;VCAN
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.6395060953672927,1.413106768506685,0.0946969696969697,0.7761787579258347,1.0,5/10,21.42%,CD40;FGR;LYN;BAG6;BTLA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6324524607809872,1.412842731062498,0.09773123909249563,0.7737745755879127,1.0,2/11,0.79%,TARM1;XCL1
prerank,regulation of establishment of protein localization (GO:0070201),0.6077324973387801,1.412602383608324,0.11,0.7712200039122292,1.0,5/13,11.64%,CORO2B;CEP295;CEP135;SCFD1;SPIDR
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3875610818236314,-1.4117657574790745,0.029411764705882353,0.46287165391470586,1.0,9/47,7.09%,RAPGEF2;ROCK2;CAV1;NFKB1;ERLIN1;SIRPA;WNT4;CD34;SIK1
prerank,regulation of anoikis (GO:2000209),-0.4798072910601459,-1.4115353367200727,0.079155672823219,0.4617407073642159,1.0,8/19,12.66%,CAV1;ITGB1;MCL1;NOTCH1;SIK1;MYBBP1A;TLE5;PTRH2
prerank,cellular response to interleukin-2 (GO:0071352),0.6227496213652948,1.410856621613077,0.10927152317880795,0.7722006509252163,1.0,2/11,3.37%,IL2RA;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6227496213652948,1.410856621613077,0.10927152317880795,0.7722006509252163,1.0,2/11,3.37%,IL2RA;JAK1
prerank,response to ethanol (GO:0045471),0.5917534554364975,1.410830142231738,0.10998307952622674,0.7687618922917785,1.0,6/14,17.62%,GRIN2B;GRIN2A;ADCY7;GLRA1;GLRA2;GRIN3A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6065445405824837,1.410499455992468,0.10664335664335664,0.7668948360651388,1.0,2/14,1.27%,ECE1;EDN3
prerank,organelle fission (GO:0048285),0.5296188307487835,1.4104760777796708,0.08634222919937205,0.763522724386904,1.0,8/24,15.43%,SEC16B;MTFR2;OPA1;DNM1;WASHC5;PEX11A;MTFP1;PEX19
prerank,positive regulation of chemokine production (GO:0032722),0.4783076082498497,1.4100013937026805,0.07092198581560284,0.7621371462304518,1.0,8/44,10.91%,IL33;WNT5A;TSLP;TWIST1;MBP;TLR4;EIF2AK2;PYCARD
prerank,cellular sodium ion homeostasis (GO:0006883),0.5864250438483289,1.4096330052773152,0.08747855917667238,0.7604762762083084,1.0,3/15,6.01%,ATP1A2;ATP1A3;SLC9A1
prerank,negative regulation of protein processing (GO:0010955),-0.5602406319171095,-1.40916074956834,0.08,0.4661074929310157,1.0,6/12,14.38%,THBS1;GAS1;SERPINE1;TMEM59;SERPINE2;CTSZ
prerank,ameboidal-type cell migration (GO:0001667),-0.3899058205669049,-1.408672720743375,0.029900332225913623,0.465471957594789,1.0,22/51,20.74%,SEMA3D;SEMA3C;SEMA7A;AMOT;CCN3;GPC3;MEGF8;SRGAP2;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B;AMOTL2;SEMA6C;PKN2;AKT1;SEMA3G;SEMA6B;FAT2;AMOTL1;PKN3
prerank,positive regulation of phospholipase activity (GO:0010518),0.5385364518051127,1.4083632490774045,0.08013355592654424,0.7625763896033232,1.0,4/22,3.87%,PDGFRA;NTRK3;FGFR1;PDPK1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.41370046365849983,-1.407731923688789,0.06744868035190615,0.4661352822467035,1.0,15/39,14.24%,FN1;VCL;PLPP3;ACTB;GNAS;MEGF11;ACTG1;TJP2;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,acylglycerol catabolic process (GO:0046464),0.5102321984138442,1.4069338915271918,0.06471494607087827,0.7652127409884315,1.0,8/30,12.17%,LIPC;LIPH;FABP5;FABP4;ABHD16A;LYPLA2;ABHD12;FABP3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4100959363760207,1.4066536333370643,0.047073791348600506,0.7630769403686062,1.0,25/102,11.16%,ENPP1;LPIN3;PIK3R1;ADCY5;CPEB1;SLC30A10;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;ADCY8;ADCY3;ADCY2;PRKACB;RPS6KB1;PRKACA;ADCY7;GCK;SLC25A33;RAB15
prerank,potassium ion transport (GO:0006813),0.4026895940065627,1.4062881053423066,0.038318912237330034,0.7613570654275037,1.0,24/120,13.15%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNQ3;SLC9A9;KCNMA1;KCNIP2;SLC9A1;KCNG1;KCNH4;KCNAB1;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNK1;KCNN2;KCNH7;KCNJ8;KCNAB3
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5956421315841115,-1.4059367355650723,0.10513447432762836,0.4692124624127496,1.0,2/10,1.30%,CD200;SLIT2
prerank,regulation of cation transmembrane transport (GO:1904062),0.49887123029564256,1.4054976991623842,0.07611940298507462,0.7614926032125598,1.0,10/29,13.15%,DPP6;DPP10;SLC30A5;KCNIP1;KCNIP2;KCNAB1;KCNIP4;FGF12;KCNN2;KCNAB3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.44030578884756433,1.4044199515773361,0.06315789473684211,0.7629633958149009,1.0,16/68,17.68%,IL33;WNT5A;IL16;TSLP;TLR6;TLR8;TWIST1;MBP;TLR4;CYBA;PYCARD;F2R;DHX9;TIRAP;LGALS9;MYD88
prerank,positive regulation of kinase activity (GO:0033674),0.4081374360005476,1.4042578686574099,0.04584882280049566,0.7603428108965031,1.0,22/107,10.41%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;TRAF4;ERBB4;EPHB1;FGFR1;EPHA6;CENPE;MRNIP;PTK2;RELN;EPHB6;AXL;JTB;DAXX;CACUL1;EPHA3
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5326537711673056,1.403687797298593,0.0985691573926868,0.759475085300501,1.0,6/23,8.67%,PDE4B;RYR2;APLP1;LRRK2;SLC9A1;PRKACA
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41833053391337627,-1.4035216523514098,0.06606606606606606,0.47384666661424746,1.0,10/37,13.64%,CAV1;BCL2L1;BECN1;RPS7;NCK1;UBB;BAD;BAX;BID;BOK
prerank,bone morphogenesis (GO:0060349),-0.5344877872685615,-1.4026279718701284,0.1108433734939759,0.47443179683684583,1.0,4/14,7.73%,CYP26B1;BMPR2;SKI;LRP6
prerank,protein localization to cell junction (GO:1902414),-0.4765092963015239,-1.4004896026645504,0.06451612903225806,0.4785539247558858,1.0,6/22,7.61%,HEG1;TJP1;ARHGEF18;CGNL1;TJP2;SHANK1
prerank,retinol metabolic process (GO:0042572),0.592271905688321,1.4000201829937864,0.11033274956217162,0.771934133360438,1.0,3/14,2.38%,ADH1A;RDH10;RDH11
prerank,steroid biosynthetic process (GO:0006694),0.4451111531086743,1.3996603543770776,0.06741573033707865,0.7700716579817832,1.0,6/56,6.25%,HSD11B1;CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D
prerank,negative regulation of transferase activity (GO:0051348),0.5087208898380549,1.3990080869114878,0.10634920634920635,0.7696627203625528,1.0,10/28,12.54%,NPRL2;FBXO5;IRS2;LIMK1;ERCC4;TERF1;EIF4A2;PIF1;TP53;GSK3A
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4664145722530023,-1.3988461753161625,0.07446808510638298,0.48147006740065107,1.0,6/23,20.49%,IGF1;GIT1;CX3CR1;CEACAM1;CX3CL1;TNFAIP3
prerank,cardiolipin metabolic process (GO:0032048),-0.5533176263139925,-1.3985601727893526,0.10173697270471464,0.4804296362954889,1.0,6/13,17.31%,PLA2G4A;PGS1;LCLAT1;PLA2G6;HADHA;PLSCR3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5381850657999142,1.3979758324613363,0.09618573797678276,0.7707294297843491,1.0,4/21,8.27%,PPARA;SLC30A10;ABCD2;PINK1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5710650014328176,-1.3973897049368498,0.10779816513761468,0.48200062078646194,1.0,7/11,24.78%,KANK1;CD44;ENPP2;ARPIN;PDPN;CORO1B;SRC
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4427832503168202,-1.3963263002377646,0.06232294617563739,0.4830400391836772,1.0,14/26,26.54%,SPTLC2;NOS3;ACER2;CYP1B1;ACER3;CYB5R3;GCH1;NOS1;AKT1;SPHK2;DDAH2;ASAH1;NQO1;ASAH2
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5219912411975614,1.396081288597027,0.09870550161812297,0.7752040593702079,1.0,4/25,4.74%,ZFYVE28;PPARA;CBLB;CNRIP1
prerank,odontogenesis (GO:0042476),0.47930183821971134,1.3953968488038109,0.08011869436201781,0.7747713943707975,1.0,8/35,6.89%,LAMB1;EDA;HDAC1;ANKRD11;TUFT1;BCOR;COL1A2;AMELX
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5225136265409602,-1.3942836390174698,0.0851063829787234,0.48683736329632615,1.0,10/16,20.26%,NPR3;SCARB1;APOE;GCH1;PIK3CB;TERT;NOS1AP;DHFR;AKT1;NUS1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.5511881655578548,1.394178887544666,0.09882747068676717,0.7765575152602453,1.0,11/18,22.93%,LIG3;MCM7;GINS3;POLA1;RFC3;MCM4;POLE3;MCMDC2;POLE;RFC4;GINS1
prerank,sulfur compound transport (GO:0072348),-0.4361351087740392,-1.3937646048887833,0.06060606060606061,0.48643825838686655,1.0,6/27,7.78%,ABCG2;SLC13A4;SLC26A7;SLC6A6;SLC26A11;LRRC8D
prerank,activation of phospholipase C activity (GO:0007202),0.49608249529724197,1.3934698155777052,0.102803738317757,0.7764856347263087,1.0,7/29,12.37%,NTRK2;TXK;C5AR1;ARHGAP6;HTR2B;LPAR1;CD86
prerank,potassium ion transmembrane transport (GO:0071805),0.39360698291877294,1.3931536642313163,0.03427172582619339,0.774647530859507,1.0,27/135,13.15%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNT2;KCNQ3;SLC12A6;SLC9A9;ATP1A3;KCNIP2;SLC9A1;KCNG1;KCNH4;KCNAB1;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNE4;KCNK1;KCNN2;KCNH7;KCNJ8;KCNAB3
prerank,B cell differentiation (GO:0030183),-0.38814487203998976,-1.3929223230094248,0.050314465408805034,0.4868661158787625,1.0,20/46,28.15%,PTPRJ;FNIP1;TPD52;ITGB1;HDAC4;DNAJB9;PTPN2;IRF2BP2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK;KLF6;CLCF1;JAK3;ADGRG3;MSH2;HDAC5
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4478328859385977,-1.3929157262992997,0.06842105263157895,0.4850678984206658,1.0,5/26,5.48%,PRKAG2;ADIPOR2;ERLIN1;LPGAT1;PRKAA2
prerank,O-glycan processing (GO:0016266),-0.3788767314426823,-1.3925219344749733,0.04075235109717868,0.48429387232279925,1.0,17/54,20.92%,ST6GAL1;GXYLT2;ST3GAL4;B4GALT5;ST3GAL1;ST6GALNAC2;C1GALT1C1;ST3GAL3;GALNT11;GALNT1;ST3GAL2;GCNT1;B3GNT2;GALNT6;GXYLT1;GALNT3;GALNT12
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.44812657519005045,-1.391596739565198,0.09020618556701031,0.48506366240766485,1.0,8/25,11.74%,ACTN2;ATP1B3;WNK4;WNK1;ANK2;STAC;DMD;TRPC6
prerank,lamellipodium organization (GO:0097581),-0.43809010889852396,-1.3915828365781369,0.06424581005586592,0.4833148062124146,1.0,8/29,11.40%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SPATA13;CCDC88A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6046253809248608,1.3914742635045336,0.11029411764705882,0.7786177171132587,1.0,1/13,0.10%,IL33
prerank,positive regulation of glucose import (GO:0046326),-0.48318269892603427,-1.391450117781102,0.08870967741935484,0.48191506288078173,1.0,6/21,4.57%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,diterpenoid metabolic process (GO:0016101),0.4506556273559189,1.3911376236387976,0.0684931506849315,0.7767823842809041,1.0,7/55,4.65%,LRP1;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,regulation of synapse organization (GO:0050807),0.5097790546669568,1.3911309277869104,0.09250398724082935,0.773627399557656,1.0,9/26,8.05%,ARHGAP22;CTNNA2;WNT5A;YWHAZ;CDKL5;NEDD4;SETD5;ABHD17C;ABHD17B
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.42470979764793104,1.3905649932183872,0.06276150627615062,0.7728865510031918,1.0,9/70,2.28%,LAMC3;LAMC1;PIK3R1;LAMB1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5677146882471837,1.39041396734934,0.11072664359861592,0.7704562136380814,1.0,5/16,13.17%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,response to organonitrogen compound (GO:0010243),0.4812278069953041,1.3902497240355336,0.07239819004524888,0.7680067761555363,1.0,16/38,19.56%,NR1H4;KYNU;SEL1L;MTOR;DNAJB12;GLRA3;GLRA1;RCN3;TRPM2;GLRA2;MEAK7;GLRB;BRSK2;UBXN6;KAT7;RHBDD1
prerank,DNA packaging (GO:0006323),0.5698251899974937,1.3898486725335157,0.1040268456375839,0.7665461682389384,1.0,4/16,10.61%,NAA10;CHAF1B;NOC2L;TP53
prerank,positive regulation of positive chemotaxis (GO:0050927),0.571264413701916,1.389634788798466,0.11784511784511785,0.7643803980763283,1.0,2/15,2.18%,NTRK3;IL16
prerank,histone H3-K36 demethylation (GO:0070544),-0.590177338047111,-1.3895156023982118,0.09803921568627451,0.485297372900213,1.0,6/10,22.73%,KDM4A;KDM4C;RIOX2;PHF8;KDM4B;KDM2B
prerank,Wnt signaling pathway (GO:0016055),-0.3362004372138342,-1.388719451482339,0.028688524590163935,0.4856643339385209,1.0,33/92,18.81%,LEF1;WNT5B;PLPP3;CPE;NXN;WNT9A;VPS35;WNT4;APC;DVL1;CUL1;WLS;FZD4;UBB;FZD7;ARL6;GSK3B;LRP6;WNT6;SFRP1;NR4A2;BCL9L;PLCG2;FZD3;CSNK1G3;CCDC88C;VPS29;WNT16;FZD8;UBC;CSNK1A1;WNT11;SNX3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4412215290071842,-1.387968639866495,0.06299212598425197,0.48592974942710093,1.0,12/26,19.39%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;MTBP;ANXA1;HYAL1;CCND1;ANKRD17;AKT1;RGCC
prerank,amide transport (GO:0042886),-0.4411658198533647,-1.3877260636292204,0.07754010695187166,0.4848766762980131,1.0,13/26,31.25%,ABCG2;SLC25A32;CERT1;PLTP;SLC38A5;TAP2;PDPN;ABCB9;GLTP;DISP1;AQP11;SLC5A6;ABCA13
prerank,regulation of muscle contraction (GO:0006937),-0.45002192172359345,-1.387583421772581,0.06201550387596899,0.4835054844650336,1.0,7/26,13.26%,PLCE1;CAV1;TPM1;SRI;MYL9;PPP1R12B;ENO1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5981563647724794,1.3867167168510854,0.1141396933560477,0.7734822246455834,1.0,3/13,9.31%,APOD;MDFIC;SP100
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4951278167186206,-1.3858500204766573,0.08168316831683169,0.48632330020126807,1.0,7/17,9.90%,SLIT2;ROBO1;NRP1;EFNB2;KDR;EPHB4;NR4A1
prerank,rRNA processing (GO:0006364),-0.31130935363364576,-1.3857479904300078,0.0,0.48495675266851324,1.0,84/172,30.70%,NSA2;RPS14;RPS9;RPS16;PRKDC;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RPL21;PDCD11;RIOK1;RPL10;RPL35A;ERI1;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPLP2;ESF1;UTP3;RIOK3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RPL31;IMP3;EXOSC3;RPL23A;SART1;RPL19;RPL36;WDR12;PES1;RRP15;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52;TSR3;WDR74;PWP2;RPL15;RPL38;MRM2;NOP2;RSL1D1;RPL13A;EXOSC4;RPS25;NHP2;RPL24;RPL18A;WDR75;RRP36;BMS1;PIH1D2;NOP53;RRP9;WDR46;RPL22
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3636986512580712,-1.385714302078416,0.03793103448275862,0.4833130470716405,1.0,36/65,34.76%,FOXP1;PIR;IL31RA;LEF1;RUNX1;CDC42;RXRA;MAPK14;OSTM1;GLO1;CASP8;PIK3CD;CDKN1A;SIRT1;PDE1B;EPHA2;E2F1;TGFBR2;CSF1R;BATF;TYROBP;MYH9;CCL19;PARP1;SPI1;SBNO2;SNX10;CEBPA;PPARG;CSF1;MT1G;EFNA2;TREM2;BATF2;PML;DEK
prerank,vacuolar acidification (GO:0007035),-0.4601465152883041,-1.3850861106121704,0.08020050125313283,0.4831809056196848,1.0,12/21,27.74%,ATP6V0A4;CLN5;ATP6AP2;ATP6V0E2;TMEM9;ATP6V0A2;ATP6V0D2;ATP6V0A1;CLN6;CCDC115;TMEM199;SLC11A1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4850596043473572,-1.384429658664584,0.10256410256410256,0.4833959452521382,1.0,5/19,20.49%,IGF1;GIT1;CX3CR1;CX3CL1;TNFAIP3
prerank,purine ribonucleotide transport (GO:0015868),-0.5015558444386723,-1.3843704724369583,0.10138248847926268,0.48191056708212227,1.0,4/16,7.78%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,epiboly involved in wound healing (GO:0090505),-0.5039295466302725,-1.3843393855547346,0.09535452322738386,0.48030509024317586,1.0,9/16,16.26%,CCN1;CD44;TMEFF2;RHOC;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,negative regulation of lipid storage (GO:0010888),0.5341240447589681,1.384329689934456,0.10586319218241043,0.7806416391183072,1.0,4/19,4.06%,PPARA;ITGAV;PPARD;NR1H2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.42153624974279075,1.384202793495357,0.06802721088435375,0.7780656221392008,1.0,20/76,16.08%,FANCI;PRICKLE1;MYCBP2;GNL3;LRRK2;PSMD10;PINK1;TSPYL5;COMMD1;BIRC2;SAE1;NDFIP2;SPRTN;GSK3A;PTTG1IP;DCUN1D5;AXIN1;UBE2D1;PAXIP1;NDFIP1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4783954534041896,-1.3840044636408724,0.08585858585858586,0.47960423994732687,1.0,8/20,15.67%,ANO6;ENTPD1;IL18;APP;TXNIP;NT5E;P2RX7;PSTPIP1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5346276490112326,1.3821792769688468,0.1206896551724138,0.7835774422898145,1.0,7/21,15.44%,LPIN3;CEL;PPARD;FAH;HOGA1;NUDT19;LPIN2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5117458371959018,1.3815651073675501,0.10743801652892562,0.7830807862253572,1.0,1/23,0.02%,CEMIP
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.48418255380463393,-1.3815496493242023,0.07673267326732673,0.4846127181357655,1.0,11/18,25.06%,EZR;RDX;DAB2;RAB21;MAP2K2;VPS11;MSN;SNX3;MTMR2;SRC;DNAJC13
prerank,iron ion homeostasis (GO:0055072),-0.37188527871802535,-1.3814231022792092,0.03571428571428571,0.4832643838666495,1.0,25/58,24.44%,ABCG2;PICALM;NEO1;HMOX2;CUL1;TFRC;SCARA5;B2M;BDH2;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;TMEM199
prerank,granulocyte chemotaxis (GO:0071621),0.44471493591220196,1.3813263715145208,0.07571428571428572,0.7810206503456921,1.0,7/55,5.34%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.546457462208671,-1.3809542771203092,0.1141552511415525,0.48277942655830636,1.0,4/12,4.87%,PLCB1;SLIT2;NBL1;CCN3
prerank,sodium ion export across plasma membrane (GO:0036376),0.5928030395426975,1.3809012464609356,0.1267361111111111,0.7797453306001934,1.0,3/13,6.01%,ATP1A2;ATP1A3;SLC9A1
prerank,pyruvate metabolic process (GO:0006090),-0.381299069247364,-1.3807187989884127,0.058823529411764705,0.48173758083924495,1.0,21/52,20.82%,BSG;ME2;DLAT;HK1;LDHA;PGK1;PFKFB2;SLC16A1;HK2;GLO1;TPI1;ME1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;LDHB;GAPDHS;PGM1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3567150482697516,-1.3806997998455537,0.05138339920948617,0.48012755990989064,1.0,27/70,20.38%,BCL2L1;CASP8AP2;MCL1;FAS;TGFB2;GABARAP;CRADD;NGF;CASP2;GSK3B;HIPK1;IFI27;CASP3;SMAD3;CASP8;BAD;BAX;RNF41;BAG3;BID;BOK;P2RX7;TNFRSF1A;FGFR3;ERBB3;CIB1;TRADD
prerank,response to insulin (GO:0032868),0.4187181074397606,1.3802533813522604,0.0773405698778833,0.7792931003245117,1.0,21/80,13.02%,ENPP1;LPIN3;PIK3R1;OGT;CPEB1;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;ZBED3;RAB15;GSK3A;MEAK7
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.44681629275834656,-1.3797849294027724,0.08579088471849866,0.4811236941703398,1.0,8/26,9.23%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3699000864249998,-1.3796620471646883,0.034722222222222224,0.4798146292662518,1.0,20/63,15.14%,CXADR;SIPA1L1;FER;EZR;NRP1;RICTOR;PARVB;S1PR1;GSN;PHACTR1;MINK1;ANXA1;NEDD9;GAB1;CDC42BPB;PTPN1;TRPV4;FLNA;GRB2;CDC42BPG
prerank,carbohydrate catabolic process (GO:0016052),-0.4035221062751757,-1.3792353614600372,0.07430340557275542,0.47937081304162255,1.0,19/38,20.82%,DERA;HK1;LDHA;PGK1;PFKFB2;HK2;TPI1;MANBA;MAN2C1;GAPDH;NAGA;PKM;ALDOC;ENO1;PFKL;ALDOA;MAN2B2;GAPDHS;PGM1
prerank,regulation of myoblast differentiation (GO:0045661),-0.4170227094955624,-1.3785330243209106,0.07336956521739131,0.47966570602094094,1.0,7/32,6.48%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;NOTCH1;MAPK14
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5493400181419381,1.3783118442102784,0.11564625850340136,0.784261337653913,1.0,7/19,5.53%,SCRIB;DLG3;FSCN1;MTCL1;PARD3B;DLG2;PRKCI
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.480764155552175,-1.3782540132137264,0.112,0.47876453737326663,1.0,8/18,18.37%,CTSC;EZR;RDX;VPS35;APOE;VPS11;VGLL4;MSN
prerank,cell-cell junction organization (GO:0045216),-0.34470689334524407,-1.3778193333961892,0.0326530612244898,0.47833294243189434,1.0,16/79,9.73%,SDK1;PKP4;TJP1;LIMS2;OCLN;CXADR;AFDN;CDH1;CLDN5;CDH8;TGFB2;CTNND1;TJP2;SMAD3;PVR;GJC1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6350171845028009,1.3778076865894577,0.13157894736842105,0.7832337053299585,1.0,7/10,21.52%,GPR37L1;LRRK2;PYCR1;RIPK1;GPR37;STK26;PDE8A
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4627388048904863,-1.3776002694561273,0.08333333333333333,0.4772883549546835,1.0,4/20,10.61%,RAPGEF2;ADRA1B;ZDHHC21;LMBRD2
prerank,central nervous system myelination (GO:0022010),0.6103097133162587,1.3773434606663462,0.10805860805860806,0.7820867123658425,1.0,7/11,19.41%,PTEN;TENM4;SOX10;PLP1;MYRF;CLU;ABCA2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4877403648736496,-1.3773296117681735,0.10052910052910052,0.4764415637919224,1.0,7/18,19.11%,EZR;RDX;VPS35;VPS11;VGLL4;MSN;WDR91
prerank,positive regulation of neuron migration (GO:2001224),-0.5765659470010212,-1.3758879191287043,0.09975669099756691,0.47880814380454223,1.0,3/11,11.42%,RAPGEF2;SEMA6A;MDK
prerank,telomere maintenance via recombination (GO:0000722),0.6016878629255338,1.375421709321155,0.1206896551724138,0.7872173419953123,1.0,3/11,7.73%,TEP1;ERCC1;ERCC4
prerank,negative regulation of immune effector process (GO:0002698),-0.5250566658537951,-1.3745713878437613,0.1038374717832957,0.4809076348973791,1.0,5/13,16.77%,FER;CD55;RPS19;RC3H1;HAVCR2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3652863775883643,-1.374533026895352,0.03409090909090909,0.4794084833616835,1.0,22/55,24.27%,CAV1;BCL2L1;TPD52L1;BECN1;TNFSF10;FAS;WWOX;CRADD;BAD;BAX;BID;CYLD;BOK;GPER1;ING5;PAK2;AGT;NUPR1;BCL10;TRIM39;HYAL2;BCL2L11
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4295949735826995,-1.374309908622697,0.07458563535911603,0.4783858141460974,1.0,12/28,25.94%,PRKAG2;ADIPOR2;SIRPA;RAC1;PRKAA2;CX3CR1;NOS1AP;SIRT1;SIRT5;FITM2;PDK4;MFSD12
prerank,negative chemotaxis (GO:0050919),-0.4170842833081274,-1.3742739485807207,0.0712166172106825,0.4769293552819725,1.0,9/33,6.77%,SEMA3D;SEMA3C;SLIT2;ROBO1;NTN1;SEMA7A;SEMA6A;SEMA4B;PDGFA
prerank,positive regulation of dendrite development (GO:1900006),0.6305604196328352,1.373600850515243,0.1206581352833638,0.7918601304185774,1.0,2/10,9.69%,PTN;BMP7
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6225896248790178,1.3734668787706794,0.13636363636363635,0.789431971975103,1.0,2/10,0.85%,DCN;HRG
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.44320502881582785,-1.3725591706570222,0.08333333333333333,0.4798245984763554,1.0,7/25,6.75%,EGFR;THBS1;APP;ITGA6;NRP1;PTGES3;FZD7
prerank,positive regulation of reproductive process (GO:2000243),-0.4205870164669032,-1.3725572096129652,0.06497175141242938,0.47825950772251297,1.0,4/31,8.18%,PLCB1;LHFPL2;PDE3A;SMURF2
prerank,regulation of response to stress (GO:0080134),0.6201991700791654,1.372113070158014,0.11091549295774648,0.791940046126997,1.0,2/10,6.49%,CORO2B;ADCY8
prerank,positive regulation of intracellular protein transport (GO:0090316),0.38452064153508364,1.3720518669178672,0.04808877928483354,0.7892013216592717,1.0,26/144,12.94%,CEMIP;SEC16B;PIK3R1;AKAP5;MICALL2;TCF7L2;SEC16A;JUP;ANK3;PIK3R2;YWHAZ;ZIC1;VAMP2;MTCL1;SORL1;PINK1;RAB29;TENM1;TMEM30A;SAE1;SAR1A;TP53;FYN;HTRA2;GSK3A;CD81
prerank,positive regulation of locomotion (GO:0040017),-0.43434788138531955,-1.3715276909742695,0.08446866485013624,0.47935024542644494,1.0,6/27,10.88%,CAVIN1;SPOCK2;NTN1;THBS1;PPM1F;STX3
prerank,protein homotrimerization (GO:0070207),0.5642565387685909,1.3712532122410317,0.14521452145214522,0.7867825410414097,1.0,3/14,7.40%,SLC1A5;CLYBL;ASIC1
prerank,protein trimerization (GO:0070206),0.5642565387685909,1.3712532122410317,0.14521452145214522,0.7867825410414097,1.0,3/14,7.40%,SLC1A5;CLYBL;ASIC1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3854241338978356,1.3708436853393262,0.05263157894736842,0.7855850641240415,1.0,22/138,10.41%,ROR1;PDGFRA;PTN;NTRK3;EPHA7;ROR2;MERTK;PTPRT;NTRK2;ERBB4;EPHB1;CD8B;FGFR1;EPHA6;PTPRU;PTK2;EFS;EPHB6;AXL;AHI1;FGR;EPHA3
prerank,regulation of urine volume (GO:0035809),-0.5704238381066457,-1.3706692414384865,0.1182033096926714,0.4800192069708969,1.0,3/10,10.29%,NPR3;NPR1;ADCY6
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43162521872655585,1.3705494150093565,0.07387140902872777,0.7838202971178175,1.0,22/65,18.75%,RORA;CPEB1;TBL2;EPAS1;EGLN2;HP1BP3;MDM4;TWIST1;PINK1;MTOR;AK4;BMP7;KCND2;TP53;PTGIS;FAM162A;SCN2A;MYC;TSC1;ADAM8;SUV39H2;HIF1A
prerank,peptidyl-amino acid modification (GO:0018193),0.6216148550888521,1.370216483755015,0.1438721136767318,0.7823620821702343,1.0,4/10,23.24%,METAP1D;ATP7A;FKBP10;FKBP7
prerank,cardiac cell development (GO:0055006),-0.5578964814991796,-1.369381733788682,0.14446952595936793,0.4819960281275507,1.0,3/11,9.16%,CXADR;NOTCH1;MYH11
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4927055955889767,-1.3689148028772078,0.10377358490566038,0.481664129972131,1.0,7/18,12.37%,SAMHD1;DERA;FUCA1;OGA;MANBA;NGLY1;NAGA
prerank,mesenchymal to epithelial transition (GO:0060231),0.6138853883802262,1.3679471930424767,0.13932980599647266,0.7889089491499841,1.0,2/10,2.53%,BASP1;SALL1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4228060841809337,1.3673002225372537,0.08221024258760108,0.788764900746414,1.0,22/72,20.55%,ENPP1;ERCC1;ANKLE1;FAN1;FEN1;POLK;ERCC5;PDE12;RPA1;ERCC4;RFC3;EDC3;GTF2H3;EDC4;ERCC2;GTF2H1;DXO;FBH1;REXO4;CUL4A;DDX1;DDB1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.573680908768761,1.3670794936946091,0.1256198347107438,0.7837860955370689,1.0,5/16,6.74%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.573680908768761,1.3670794936946091,0.1256198347107438,0.7837860955370689,1.0,5/16,6.74%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,positive regulation of bone resorption (GO:0045780),0.5984993992556524,1.3669922329290884,0.12321428571428572,0.7813191004300324,1.0,4/11,18.99%,SPP1;PRKCA;ADAM8;ATP6AP1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.3669302510646424,-1.3667438265854395,0.054140127388535034,0.48576389166603046,1.0,27/54,29.79%,NSA2;RPL5;RPL10;RPL35A;RPL10A;RPL11;RPLP0;RPL26;RPL23A;MRPL20;WDR12;PES1;NIP7;NPM1;PAK1IP1;RRP15;LAS1L;GTF3A;WDR74;NOP2;RSL1D1;RPF2;NHP2;LTO1;RPL24;NOP16;NOP53
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5201672160111676,1.3658586641147281,0.10492845786963434,0.7830408153467351,1.0,4/22,9.31%,APOD;MDFIC;LRRK2;SP100
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.44455566163121596,-1.3650893544133436,0.09455587392550144,0.4884741563970034,1.0,6/26,4.57%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,negative regulation of cell differentiation (GO:0045596),0.3715094806433808,1.3648956044041483,0.03617269544924154,0.7843068582401292,1.0,34/181,12.43%,RORA;ENPP1;PPARA;MEIS1;SPRY1;ADGRV1;WNT5A;PTEN;ITGAV;LRP3;NPHP3;MEIS2;NR1H2;SPRED1;REST;TBX3;RUNX1T1;ZBTB16;IL17RD;CNTN4;ADAMTS12;ZFP36L2;SPRED2;TWIST1;SOX2;BMP7;ZFPM2;TGFBR1;IQCB1;ABCA5;SOX9;TWIST2;PDCD4;IGF2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.43841727692196053,-1.3648369748970337,0.08757062146892655,0.48755424359504146,1.0,12/27,24.34%,NFKB1;MAP3K5;CUL1;UBB;MAP2K7;MAP3K8;CCDC88C;UBC;UBA52;IKBKB;TAOK2;IKBKG
prerank,prostanoid biosynthetic process (GO:0046457),-0.5002335845674826,-1.3648284802123343,0.11455847255369929,0.4860281523190754,1.0,8/15,20.89%,PTGDS;PTGS1;PTGES3;PLA2G4A;PTGS2;EDN1;CD74;MIF
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5937983661681837,1.3646714192552472,0.14795918367346939,0.782475399816358,1.0,4/12,12.11%,DCN;HRG;ADAMTS12;IL12A
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6251247349943772,1.3640273192225696,0.13537906137184116,0.7823205726330247,1.0,2/10,5.63%,DCN;LRRK2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6165321009817138,1.3640109740284996,0.1368421052631579,0.7795980976287967,1.0,3/10,9.11%,MAP4K4;IQSEC1;MTOR
prerank,defense response to fungus (GO:0050832),0.5526940324985476,1.3634997585793687,0.1414141414141414,0.7789928901042633,1.0,2/17,0.85%,CLEC4E;HRG
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4690206284316947,-1.3627677060976324,0.09336609336609336,0.4901129598775646,1.0,5/21,7.73%,CAV1;APC;DVL1;GSK3B;LRP6
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.46950517997857777,1.362712271997043,0.1,0.7793955148749968,1.0,6/36,4.67%,VAMP5;GGA2;RAB34;SPTBN1;ANK3;VAMP2
prerank,glutamate receptor signaling pathway (GO:0007215),0.4734807560911873,1.3626913386857622,0.10708898944193061,0.77671838973198,1.0,17/37,21.37%,GRIA3;GRID2;GRIN2B;GRIK2;GRIA4;FMR1;GRIK4;GRIN2A;GRIK1;GRM5;GRM7;GRIN3A;GRM1;GRIA2;HOMER3;CDK5R1;HOMER2
prerank,mesenchymal cell differentiation (GO:0048762),-0.3799235707127277,-1.362286321431465,0.053125,0.4899695706074608,1.0,12/51,7.73%,RANBP3L;ROCK2;DDX5;MEF2C;RBPJ;LEF1;FOXC1;NOTCH1;TGFB2;WNT4;GSK3B;LRP6
prerank,alanine transport (GO:0032328),-0.5628147879773058,-1.3615568711563597,0.09360730593607305,0.49025341658974914,1.0,5/10,30.78%,SLC6A6;SLC6A17;SLC36A4;SLC7A10;SLC36A2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3441454621973781,-1.3608346524555974,0.038461538461538464,0.4906368437999328,1.0,18/76,11.60%,TSPAN5;RBPJ;EGFR;MAML2;NOTCH3;NOS3;WWP2;NOTCH1;TGFB2;CCN3;SREBF2;IL6ST;EPN2;PRAG1;ITGB1BP1;GATA2;NIBAN2;GALNT11
prerank,response to axon injury (GO:0048678),0.5475633363560027,1.3597971269560094,0.1163575042158516,0.7857418455714844,1.0,1/18,0.04%,APOD
prerank,negative regulation of lyase activity (GO:0051350),0.5490942539040311,1.359740104267305,0.14,0.7832415028641746,1.0,3/16,5.81%,AKAP5;ADGRV1;MTRR
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36143118812061287,1.3590850327086779,0.033105022831050226,0.7832369733104285,1.0,33/214,10.91%,ROR1;PDGFRA;NTRK3;EPHA7;XCL1;ROR2;SPRY1;SLC30A10;NTRK2;PTEN;ERBB4;C5AR1;EPHB1;PTPRR;P2RY1;CNKSR3;YWHAZ;SPRED1;GCNT2;HTR2B;PTPN22;CCL15;RPS6KA6;GLIPR2;NECAB2;SPRED2;GPR183;PRKCA;HTR2C;TLR4;MAP2K1;CCL25;PYCARD
prerank,regulation of cholesterol storage (GO:0010885),0.5646082373306884,1.3588555799834297,0.13458262350936967,0.7814424030362577,1.0,3/15,4.06%,PPARA;PPARD;NR1H2
prerank,outer dynein arm assembly (GO:0036158),0.5772032308439715,1.3588531074704084,0.13504273504273503,0.7787351083311044,1.0,3/14,3.61%,CCDC63;ODAD4;DNAAF4
prerank,positive regulation of cytokinesis (GO:0032467),0.4856705118149972,1.3588073697327172,0.09779179810725552,0.7762273306777617,1.0,3/32,0.93%,SVIL;CDC14B;RXFP3
prerank,arachidonic acid metabolic process (GO:0019369),-0.4042498508422859,-1.3583918217271786,0.05917159763313609,0.49535149031724396,1.0,14/35,25.42%,PTGDS;PTGS1;PTGES3;PLA2G4A;CYP1B1;MGLL;GPX1;PTGS2;CYP2U1;ALOX12;PLA2G4C;FAAH;CYP2S1;CBR1
prerank,regulation of protein kinase C signaling (GO:0090036),0.5703152313504851,1.3573131584537355,0.1559792027729636,0.779811177434266,1.0,3/14,2.15%,ADGRV1;WNT5A;CD40
prerank,muscle organ development (GO:0007517),0.4352151454248606,1.3569177609085465,0.08776978417266187,0.7786724567134117,1.0,12/54,11.74%,LAMA2;ITGA11;UTRN;CXCL10;VAMP5;SMTN;SGCE;SOX6;CAPN3;CHD2;FKTN;SPEG
prerank,neural crest cell migration (GO:0001755),-0.39700001488875675,-1.3567795883366298,0.058333333333333334,0.4981923252076409,1.0,10/36,10.82%,FN1;SEMA3D;SEMA3C;SEMA7A;NRP1;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B
prerank,ribosome assembly (GO:0042255),-0.3826188545045712,-1.35675810529605,0.06542056074766354,0.4966818226642624,1.0,21/47,29.79%,RPS14;RPL5;RPS19;RPS27;RPS15;RPL10;RPS5;RPL11;RPLP0;MRPS7;RPL23A;MRPL20;NPM1;MPV17L2;PWP2;NOP2;RPF2;RPL24;EIF2A;MRPS2;NOP53
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5115029701971336,-1.3562229351163553,0.12468193384223919,0.4966592620758204,1.0,5/15,28.42%,MOXD1;PAOX;SAT2;DDC;SRM
prerank,inositol lipid-mediated signaling (GO:0048017),0.4390638996756527,1.3555851016972194,0.09182209469153516,0.7811796589111277,1.0,12/50,7.88%,PDGFRA;PLCL1;PIK3R1;OGT;FGFR1;GAB2;PIK3R2;IRS1;IRS2;ADAP2;PI4KA;RPS6KB1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5585836401542242,1.355407015765019,0.13012477718360071,0.7792297423900252,1.0,5/16,10.90%,RBM24;ZC3H12D;DND1;ZFP36L2;DHX36
prerank,retinal metabolic process (GO:0042574),0.5967049453512769,1.3543613201644622,0.13451327433628318,0.7809745859208687,1.0,3/12,11.79%,RDH10;RDH11;ABCA4
prerank,axon guidance (GO:0007411),0.3648456929220287,1.3538824104409861,0.02546296296296296,0.7802458469327722,1.0,45/201,12.73%,LAMA1;ROBO2;LAMA2;PIK3R1;EPHA7;PLXNC1;CHN1;WNT5A;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;EPHA6;UNC5A;DSCAM;CNTN4;IRS2;DAB1;DSCAML1;PTPRO;UNC5C;PTK2;RELN;PALLD;EPHB6;DCC;NRXN3;PRKCA;NEXN;CNTN6;OPHN1;LYPLA2;EPHA3;PTPRA;DOK5;FYN;USP33;UNC5D;PLXNB2;GFRA1;ARHGAP35;SH3KBP1;KIF5C
prerank,regulation of amyloid-beta clearance (GO:1900221),0.551321221229518,1.3537513320942338,0.11716171617161716,0.7781070403956764,1.0,3/16,6.89%,LRP1;HDAC1;SRF
prerank,vascular transport (GO:0010232),0.4076348084738043,1.3536149685127377,0.06666666666666667,0.7760031596528788,1.0,9/81,2.36%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3
prerank,adenine nucleotide transport (GO:0051503),-0.48664906481717296,-1.3531783700054443,0.117096018735363,0.5029279511039025,1.0,8/17,25.67%,ABCC4;LRRC8C;ABCC6;LRRC8D;SLC25A5;SLC35B2;SLC17A9;SLC25A4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4027648112339526,-1.3528308837356418,0.09116809116809117,0.5023657884443675,1.0,12/35,14.25%,HMBOX1;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;RTEL1;ATM;MAP3K4
prerank,microtubule-based transport (GO:0099111),0.5929724454649155,1.3527246499348056,0.13953488372093023,0.7769669168847714,1.0,4/12,11.26%,ADCY10;DNAAF4;SPA17;CABYR
prerank,DNA replication initiation (GO:0006270),0.45890948347685323,1.3523285288086186,0.12693498452012383,0.7758885619637457,1.0,13/37,15.56%,MCM7;CDC7;POLA1;GMNN;RPA1;POLE4;NOC3L;MCM4;CDT1;POLE3;MCM10;DBF4;ORC2
prerank,base-excision repair (GO:0006284),0.44883700539232446,1.3522821976997141,0.12148148148148148,0.773473517005823,1.0,13/48,13.74%,POLG;LIG3;FEN1;POLQ;ERCC5;NEIL3;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,long-term synaptic potentiation (GO:0060291),0.5301568021318636,1.3520457842391467,0.14015748031496064,0.7718469241127547,1.0,5/21,6.02%,GRIN2B;VAMP2;MPP2;CRHR2;GRIN2A
prerank,fibrinolysis (GO:0042730),0.5756305016017664,1.3518577628168467,0.1243432574430823,0.7700869371368506,1.0,2/13,8.22%,HRG;PLAU
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.43369774914151643,-1.3516528516232766,0.07731958762886598,0.5039204337011667,1.0,10/27,8.02%,PHLDB2;TJP1;ARHGEF18;WASF2;SHANK3;F11R;CGNL1;SHANK1;TMEFF2;RHPN2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5727355777192034,1.3510579637477345,0.14776632302405499,0.7707726830377324,1.0,6/13,12.02%,PPARA;NFATC3;PPARD;REST;SRF;SOX9
prerank,positive regulation of viral genome replication (GO:0045070),0.47972780304399204,1.3504168139651211,0.10759493670886076,0.7707693365633584,1.0,10/29,17.73%,PPARA;PPID;TOP2B;PPIH;PDE12;STAU1;CNOT7;ADAR;HACD3;TOP2A
prerank,regulation of leukocyte activation (GO:0002694),-0.4968050181719642,-1.3501710144682613,0.1188118811881188,0.5062184963314232,1.0,7/14,22.19%,CD200;GPER1;CD74;MFHAS1;MIF;SHPK;MYO18A
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4223665847701461,1.3494597336039564,0.09598853868194843,0.7719650968525575,1.0,25/62,21.85%,MEIS1;KMT2E;HDAC1;L3MBTL1;AGO4;MEIS2;KMT2A;ZBTB16;WDR5;PRKCB;AGO3;LYN;TNRC6B;HOXA9;MAFB;ASH2L;AGO1;CBFB;CDC73;KMT2C;HSPA9;RBM15;RBBP5;HOXA5;CREBBP
prerank,negative regulation of defense response (GO:0031348),0.4047580651404938,1.348709901105714,0.07085561497326204,0.7725270022551245,1.0,10/77,7.85%,RORA;PPARA;TRAF3IP1;NR1H4;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,regulation of protein metabolic process (GO:0051246),-0.3830348859164029,-1.3486701837348072,0.05405405405405406,0.5087678504467841,1.0,14/44,18.15%,ROCK2;LTBP4;APP;KLF4;VPS35;ACE;KLF2;APOE;SSH1;FURIN;TRAF3;MAP2K5;NEDD8;TMEM9
prerank,modulation of chemical synaptic transmission (GO:0050804),0.39037963331896475,1.3481667104313018,0.07052896725440806,0.7721662648594985,1.0,38/107,20.42%,HCRT;ATP1A2;PTEN;CHRNB4;GRID2;CEL;GRID1;GRIK2;GRIK5;ABR;FMR1;GRIK4;LRRK2;GRIK1;TMEM108;RIMS2;RELN;OPHN1;GRM5;LRRC4C;DGKI;RIMS1;DLG4;NRG3;PSMC5;UNC13A;DLGAP3;NMU;TPRG1L;GRM7;CDK5;CAMK2A;GRM1;CLSTN1;SYT1;USP46;NPTX2;PXK
prerank,Golgi to plasma membrane transport (GO:0006893),0.4482581848450043,1.347864838015493,0.10364963503649635,0.7708749085115827,1.0,12/47,11.21%,VAMP5;CCDC22;GGA2;STXBP6;RAB34;SPTBN1;ANK3;VAMP2;LLGL1;COMMD1;VAMP4;EXOC1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4196413156194932,1.347349514844152,0.1039136302294197,0.7703302281326665,1.0,18/68,16.64%,ENPP1;PDE9A;ACSF2;TPST1;LRRK2;AMPD2;AK4;OPA1;ACOT7;ACSL6;ACLY;MFN1;ENTPD7;AK3;SULT6B1;ACOT2;EFL1;ADSS1
prerank,heme catabolic process (GO:0042167),-0.5259501202593976,-1.347213993886459,0.10730593607305935,0.5097163886239335,1.0,2/14,2.90%,ABCG2;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5259501202593976,-1.347213993886459,0.10730593607305935,0.5097163886239335,1.0,2/14,2.90%,ABCG2;HMOX2
prerank,serine family amino acid catabolic process (GO:0009071),0.6077297179732197,1.3468575414942372,0.1504424778761062,0.769853666889902,1.0,2/10,2.07%,THNSL2;GLDC
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.44064656321552,-1.3464583672677533,0.09234828496042216,0.5103309666028025,1.0,16/25,35.25%,CSGALNACT1;B3GALT1;NDST1;NDST3;EXT1;B3GALNT1;FUT9;B3GNT2;HAS1;B3GNT9;NDST4;HAS2;B3GNT3;HAS3;B3GNT6;B4GAT1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3682460906749251,-1.3462151188009757,0.06896551724137931,0.5093837621111373,1.0,12/49,12.69%,LRCH1;F11R;CST3;ECM1;RDX;SH3BP4;WNK1;SH3RF2;CPEB2;ARL2;GMIP;NOS1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5445360792978879,-1.3461436820886727,0.12362030905077263,0.5080651452991861,1.0,6/11,17.95%,ADIPOR2;KDR;CD34;GATA2;ITGB3;MCAM
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5988056786423772,1.3449828266482404,0.16055846422338568,0.7747419485301634,1.0,2/11,1.20%,COLEC12;UNC93B1
prerank,regulation of nuclear division (GO:0051783),0.5301721275042905,1.3445774804245016,0.11804384485666104,0.7738049654987579,1.0,6/20,11.28%,L3MBTL1;PKMYT1;FBXO5;CDK13;RCC1;MKI67
prerank,kidney development (GO:0001822),0.4248767636620778,1.3444623070480444,0.08940852819807428,0.7717333522305547,1.0,10/65,5.65%,ROBO2;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3;ZBTB16;PRKX;NF1
prerank,negative regulation of defense response to virus (GO:0050687),0.6103245013260785,1.3444043120598814,0.1503623188405797,0.7695418235346001,1.0,2/10,2.76%,TRAF3IP1;TSPAN6
prerank,regulation of interferon-gamma production (GO:0032649),0.41354819681324134,1.3440621792738314,0.08559782608695653,0.7684975846404624,1.0,13/71,12.11%,XCL1;TXK;PDE4B;NR1H4;SCRIB;PTPN22;PDCD1LG2;CD276;TLR8;AXL;TLR4;PYCARD;IL12A
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5549093810590883,-1.3438068582541118,0.13646532438478748,0.5129938326505616,1.0,7/11,19.18%,EZR;RDX;DAB2;RAB21;VPS11;MSN;MTMR2
prerank,positive regulation of response to wounding (GO:1903036),-0.42956121246422513,-1.3437636084317437,0.10148514851485149,0.5115720814920635,1.0,8/24,5.81%,OCLN;MYLK;ITGB1;ACTG1;VTN;KANK1;ANXA1;SCARF1
prerank,regulation of viral entry into host cell (GO:0046596),-0.4303946930509252,-1.3435424366077209,0.10393258426966293,0.5106584081920684,1.0,16/30,29.49%,LY6E;GSN;TRIM25;TRIM5;TRIM11;IFITM3;TRIM14;IFITM1;TRIM27;CD74;SNX3;IFITM2;TRIM6;P4HB;CIITA;MID2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5811879509155943,1.3434588389039213,0.14886164623467601,0.7685015649258662,1.0,7/13,23.58%,FGFR1;PDPK1;SIRT6;IGF2;SP1;HMGB1;ADAM17
prerank,outflow tract septum morphogenesis (GO:0003148),-0.44715160658586933,-1.3434189579775837,0.10443864229765012,0.5095398921093843,1.0,10/24,9.88%,SMAD6;SEMA3C;ROBO1;NRP2;NRP1;BMPR2;TGFB2;TBX1;ACVR1;TBX2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5809568380163799,1.3428168685002055,0.1423670668953688,0.7685989143425475,1.0,8/12,20.63%,MBTPS2;H6PD;DGKQ;CLCN2;SREBF1;KPNB1;ABCA2;MBTPS1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.35064099188395004,-1.3426446576498945,0.06415094339622641,0.5100171243597932,1.0,22/65,19.03%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;INTS3;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;PSMC1;PABIR1;PSMB10;CHFR;PSME2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5464338510991689,-1.342578345711977,0.13942307692307693,0.508679762107408,1.0,4/11,4.87%,SLIT2;NBL1;RIN3;CCN3
prerank,positive regulation of vasculogenesis (GO:2001214),-0.573106520904292,-1.3425141523153854,0.15172413793103448,0.5073649399781399,1.0,6/10,13.99%,RAPGEF2;KDR;RAP1A;CD34;CEACAM1;RRAS
prerank,negative regulation of neurogenesis (GO:0050768),0.4637329222561737,1.34170041617283,0.11738484398216939,0.7705631390197085,1.0,7/34,9.09%,PTN;PTEN;NGFR;REST;SORL1;NF1;APPL2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3958726339037756,1.340886510534259,0.06496815286624204,0.7713549400630907,1.0,18/98,11.12%,CEMIP;LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;ANK3;YWHAZ;MTCL1;PRKCI;CLIP3;NECAB2;NKD2;EPHA3;TP53;FYN
prerank,amino acid import across plasma membrane (GO:0089718),0.49938968973686615,1.3407737636955768,0.1305732484076433,0.7695022890475505,1.0,4/24,4.87%,SLC1A3;SLC1A5;SLC6A13;SLC7A8
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.37079729151964,1.3403838180534178,0.03799019607843137,0.7686133248158875,1.0,22/151,10.91%,ROR1;PDGFRA;NTRK3;XCL1;ROR2;SLC30A10;NTRK2;ERBB4;C5AR1;P2RY1;GCNT2;HTR2B;PTPN22;CCL15;GLIPR2;NECAB2;GPR183;PRKCA;HTR2C;MAP2K1;CCL25;PYCARD
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4026532502320609,-1.3402355332281373,0.08814589665653495,0.5119277700039263,1.0,10/35,9.02%,FLT1;MEF2C;CAV1;THBS1;SPARC;COL4A3;CAV2;APOE;XDH;ATOH8
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5599205636476867,-1.3386589652446672,0.12093023255813953,0.5145843747168652,1.0,8/10,25.17%,RDX;CEACAM1;PRKG1;SERPINE2;PRKCD;CD9;ALOX12;ADAMTS18
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4550948538164761,-1.3386057501660065,0.11886304909560723,0.51319131407802,1.0,6/21,10.59%,FOXP1;PRKCH;ELF1;RUNX1;SLC39A10;ELF2
prerank,acidic amino acid transport (GO:0015800),0.5336434019995656,1.33849288490758,0.1625615763546798,0.7736332291810574,1.0,4/17,8.61%,SLC1A3;SLC6A13;GJA1;SLC25A22
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.41813069683368104,-1.3373610494961083,0.0989010989010989,0.515048082658278,1.0,12/32,15.22%,THBS1;KLF4;FOXC2;KDR;JCAD;NOTCH1;ANXA1;ITGB1BP1;GATA2;FGFBP1;MAP2K5;PTGS2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5162745669438794,-1.3368996659552268,0.13647642679900746,0.5148473048635661,1.0,4/13,7.09%,CAV1;CAMK2D;SRI;CALM1
prerank,neuron fate commitment (GO:0048663),0.5720905682252072,1.3365892849222627,0.15289982425307558,0.7787487561411005,1.0,3/14,12.13%,ISL2;TGFBR1;MYT1L
prerank,regulation of acrosome reaction (GO:0060046),-0.5636543318216685,-1.33584227419609,0.15418502202643172,0.516257315765885,1.0,1/10,0.46%,PLCB1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4238056731477515,-1.3351197262551968,0.1016949152542373,0.5167133751580951,1.0,12/28,15.01%,FOXP1;XIAP;SAMHD1;CD55;ERAP1;TRIM5;CASP8;IRF1;ELMOD2;GATA6;CX3CL1;TRAF3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.35016437277494594,-1.3346482195434564,0.04905660377358491,0.5164845202707354,1.0,28/66,20.91%,PLCB1;EGFR;FHL1;ADAMTS1;KANK2;KLF4;RDX;CCND2;ANXA1;APC;CDK6;HYAL1;INO80;WEE1;FAM107A;PSME3;CCND1;PLK5;CDKN1A;ANKRD17;DCUN1D3;AKT1;DLG1;PSME2;RBL1;RGCC;RBL2;E2F1
prerank,keratan sulfate metabolic process (GO:0042339),-0.41460090391162746,-1.334487674628444,0.09444444444444444,0.5153914567534424,1.0,9/31,9.35%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2;HEXB
prerank,transport across blood-brain barrier (GO:0150104),0.3997673852170257,1.333907529228533,0.07763157894736843,0.7869878814158424,1.0,11/83,5.83%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3;SLC7A8;FABP5
prerank,sodium ion homeostasis (GO:0055078),0.511939627326441,1.333135399791597,0.12706270627062707,0.7875591290460944,1.0,3/21,6.01%,ATP1A2;ATP1A3;SLC9A1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3496372329256541,-1.3331323725969955,0.056140350877192984,0.5176893567942352,1.0,18/61,14.66%,IGF1;ROBO1;NET1;NOTCH2;F11R;RASGRF1;GPR4;SHOC2;NOTCH1;RAC1;RAPGEF1;NGF;PRAG1;PIK3CB;MAPRE2;ALS2;GRB2;ADGRG1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4676252109310602,-1.332975719490796,0.11722488038277512,0.5166522264565102,1.0,7/18,11.63%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,Notch signaling pathway (GO:0007219),-0.3568150519136208,-1.3324218644968424,0.06752411575562701,0.516655697058492,1.0,16/59,13.77%,PBX1;RBPJ;SORBS2;MAML2;NOTCH3;NOTCH2;NOTCH1;ADAM10;MIB1;MDK;GALNT11;HEYL;APH1A;HEY2;APH1B;YBX1
prerank,positive regulation of synaptic transmission (GO:0050806),0.41409352540647826,1.3312723904667225,0.09007832898172324,0.792771836980304,1.0,17/72,11.37%,AKAP5;GRIN2B;NRXN1;CACNG3;GRIK2;VAMP2;FMR1;MPP2;CRHR2;GRIN2A;ADCY8;RIMS2;RELN;LGMN;CACNG4;RIMS1;DLG4
prerank,neuromuscular junction development (GO:0007528),0.49626119618732817,1.3307368364895231,0.15286624203821655,0.7923712522243945,1.0,8/24,17.36%,PDZRN3;ANK3;NEDD4;LRRK2;CACNB4;UNC13A;F2R;UNC13C
prerank,ion homeostasis (GO:0050801),-0.41313610417340635,-1.3292946122393487,0.1043956043956044,0.523441078277849,1.0,6/30,6.46%,SLC4A10;FHL1;CAMK2D;WNK4;WNK1;SLC4A3
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2984091878032812,-1.3287116542358717,0.02631578947368421,0.5235411138318836,1.0,45/151,16.18%,FLT1;RAPGEF2;SOX5;MEF2C;EGFR;FOXC1;GAS1;KLF4;NRP1;BMPR2;MAGI2;IQGAP1;KDR;RAP1A;NOTCH1;WNT4;WWOX;ANXA1;PDE3A;SEMA6A;RAPGEF1;MAPK14;TBX1;CD44;ACVR1;ACVRL1;ITGB1BP1;MAPT;SMAD3;HYAL1;EEF1A1;SFRP1;NR4A1;RAB35;HSPB1;NOS1;NR3C1;FLT4;CPNE3;RAMP2;PLK5;MAP2K5;ERN1;KIDINS220;ZPR1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5788453612814439,1.328613543296998,0.17217391304347826,0.7984454349780016,1.0,4/11,14.07%,JAK1;ANK3;PRKCA;LYN
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5560318573736203,-1.3282236823758897,0.14009661835748793,0.5234164993438519,1.0,5/10,21.46%,PODXL;DPP4;WNK1;SKAP1;PIEZO1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.36328870330153956,-1.3281846287309809,0.08118081180811808,0.5220252069217794,1.0,25/49,30.16%,ACER2;NDRG1;MAPK14;ATR;BID;ATM;CDC5L;NBN;GRB2;CLOCK;DONSON;HUS1;E2F1;PRPF19;BATF;ATRIP;HINFP;CHEK2;BRIP1;CHEK1;RHNO1;GADD45A;SESN2;E2F7;TRIAP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4263099021107747,-1.3271606916362844,0.11382113821138211,0.5234548657133076,1.0,10/25,17.86%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;NOS1AP;PTGS2;EDN1;AKT1
prerank,protein import into nucleus (GO:0006606),0.4149699347261207,1.3271111541624552,0.08422459893048129,0.8019603884468585,1.0,25/66,23.31%,PRICKLE1;CBLB;CSE1L;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;KPNA1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;TNPO2;IPO9;NUP54;NUP155;KPNB1;RANBP2;KPNA2;IPO4;IPO8;NUP35
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4553879509678217,-1.3269536847302243,0.12,0.522515671622576,1.0,5/19,12.95%,TJP1;AFDN;NOTCH1;PPM1F;DENND6A
prerank,pulmonary valve development (GO:0003177),-0.473031228317519,-1.3266649856044532,0.1275,0.5217825392300501,1.0,8/18,4.36%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;BMPR2;NOTCH1;TGFB2
prerank,intraciliary retrograde transport (GO:0035721),0.5808124189581745,1.3258254191564751,0.15586690017513136,0.8045727204765084,1.0,4/12,16.55%,WDR35;DYNC2LI1;TTC21B;IFT43
prerank,monocyte differentiation (GO:0030224),-0.5576662765711575,-1.3256896100932103,0.16851441241685144,0.5228349410604977,1.0,7/10,30.87%,PIR;IL31RA;PDE1B;CSF1R;MYH9;PPARG;MT1G
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.580446271189128,1.3255233760474785,0.1542649727767695,0.8033363281038503,1.0,1/11,1.32%,RTP4
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.596353620127464,1.3254741622519368,0.14555765595463138,0.801139576928731,1.0,1/10,0.31%,GHR
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.595341296567681,1.3250346856182666,0.17222222222222222,0.8004543610708094,1.0,3/10,11.68%,OGT;DGKQ;PDK2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3682136579086221,-1.3250156599122456,0.08108108108108109,0.5232445649802364,1.0,11/47,8.29%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;KANK1;RAC1;NEDD9;CDC42;EFNA5;ITGB1BP1
prerank,protein import (GO:0017038),0.40021725498637556,1.3244732738674252,0.096569250317662,0.8001982019787917,1.0,27/84,18.83%,PRICKLE1;CSE1L;ABCD2;PEX2;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;SLC25A17;HSPA4;CLU;PEX19;TNPO2;IPO9;PEX12;NUP155;PEX3;ALDH3A2;KPNB1;PEX14
prerank,glycolipid metabolic process (GO:0006664),-0.36679932516569946,-1.3236877636360818,0.08196721311475409,0.5254337545028405,1.0,21/47,28.68%,ST3GAL6;ST3GAL4;SMPD3;FUCA1;ST6GALNAC3;HEXB;UGCG;NAGA;B3GALNT1;ESYT3;SMPD1;ST3GAL2;GM2A;ARSA;PSAP;GLTP;ST8SIA6;ASAH1;PIGW;NEU1;SCCPDH
prerank,neutrophil migration (GO:1990266),0.42399259179851706,1.3230937239277072,0.10267229254571027,0.8032368795310704,1.0,7/58,5.34%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,cognition (GO:0050890),0.4522503679715743,1.3230070843304478,0.11047345767575323,0.8012505768546797,1.0,17/42,21.06%,CHD7;C5AR1;SOBP;METTL23;NF1;SETD5;PTCHD1;RP9;GRM5;TUSC3;CUX2;LHCGR;CYFIP1;GPR155;MGAT3;BBS4;CTNS
prerank,nucleoside salvage (GO:0043174),-0.5479477308002785,-1.3225801930043968,0.16,0.5270322085769865,1.0,7/10,39.15%,UPP2;TK2;DCK;CDA;TK1;UPP1;UCKL1
prerank,positive regulation of telomerase activity (GO:0051973),-0.40039482822632533,-1.3221205806981842,0.09329446064139942,0.5267576497409008,1.0,8/33,14.25%,HMBOX1;KLF4;PTGES3;PARN;NEK7;MAP2K7;CCT4;MAP3K4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5411660046547151,-1.3220058274751454,0.16326530612244897,0.5257117034716084,1.0,4/11,15.82%,CAMK2D;NOS1;NOS1AP;CACNB1
prerank,gliogenesis (GO:0042063),-0.48431996136442446,-1.321909703272201,0.15671641791044777,0.5245288934740079,1.0,4/15,5.70%,NFIB;TGFB2;ANXA1;CDK6
prerank,positive regulation of secretion (GO:0051047),0.5901930069313943,1.321072715444716,0.1680960548885077,0.8064049579031387,1.0,2/11,7.80%,GPLD1;TRH
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5630556965350626,1.319963264843623,0.15452930728241562,0.8084296412436542,1.0,11/14,28.49%,SEC24B;SAR1A;SCAP;SEC24A;SEC23A;MIA3;TBC1D20;SEC24C;SEC23B;SEC13;SEC24D
prerank,positive regulation of binding (GO:0051099),-0.3348538861037439,-1.3195754196194285,0.029166666666666667,0.5296576500357403,1.0,28/84,18.27%,IGF1;RAPGEF2;CAV1;FOXC1;HMBOX1;APP;CLDN5;HIP1R;VTN;SKI;NGF;B2M;APOE;GSK3B;RPL11;PARP9;RALB;TERT;HIPK2;CLN5;RAN;AMFR;DDX11;MARK3;MET;HFE;HMGB2;EGF
prerank,cellular lipid catabolic process (GO:0044242),0.48431889825200514,1.3194777311764572,0.14883720930232558,0.8079225581322937,1.0,7/27,15.44%,LPIN3;CEL;PPARD;ACADL;ABHD12;NUDT19;LPIN2
prerank,response to glucose (GO:0009749),0.43864226814149154,1.3191707461589643,0.11578947368421053,0.8067244077524428,1.0,11/46,10.49%,ZBTB20;TCF7L2;TRA2B;GPLD1;VAMP2;EIF2B1;IRS2;ADCY8;PRKACA;GCK;ZBED3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5931275847438663,1.3187858963025239,0.17881944444444445,0.8059265328947951,1.0,2/10,1.70%,XCL1;WNT5A
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5844389967803627,1.3187076478324156,0.16163410301953818,0.8038755537843602,1.0,4/12,9.80%,TLR6;ADGRB1;TLR4;CYBA
prerank,negative regulation of T cell activation (GO:0050868),0.4531698413264746,1.3177108331600276,0.130568356374808,0.8053652857087069,1.0,7/35,12.37%,PAG1;GLMN;TNFAIP8L2;PTPN22;PDCD1LG2;TNFRSF21;CD86
prerank,mesoderm development (GO:0007498),-0.4609772073525027,-1.3177089066703211,0.12403100775193798,0.5330462730819866,1.0,5/18,7.27%,FOXC2;TIE1;MESD;TBX1;BMX
prerank,chloride transmembrane transport (GO:1902476),0.43140270214209414,1.3174462766435455,0.1373134328358209,0.804051811547566,1.0,13/48,13.85%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;LRRC8A
prerank,regulation of dendrite extension (GO:1903859),0.5230147068907762,1.317336466201798,0.14748784440842788,0.802173014272683,1.0,7/18,18.62%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4025054634585579,1.3169531245116028,0.09421265141318977,0.8013645904904785,1.0,8/72,3.03%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;FGFR1
prerank,response to light stimulus (GO:0009416),0.430749543126235,1.3169291950254287,0.10152990264255911,0.7991254458243082,1.0,13/55,15.54%,GPR88;COPS3;TYR;USP1;ERCC5;CDKN2D;ERCC4;UVSSA;GPR52;SPRTN;REV1;ERCC2;CRY2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.47326291563988965,-1.316605746996728,0.1507537688442211,0.5345843808887405,1.0,7/15,27.79%,SAMHD1;PTPN2;NLRC5;ISG15;USP18;YTHDF2;TTLL12
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.41959188240572654,-1.3160181286737938,0.10773480662983426,0.5347774125869557,1.0,10/26,17.86%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;NOS1AP;PTGS2;EDN1;AKT1
prerank,organelle transport along microtubule (GO:0072384),-0.40943666942414486,-1.315467178864513,0.12813370473537605,0.5348923599307747,1.0,15/31,26.57%,NDEL1;CDC42;UBB;MAPT;TRAK2;BICD2;BORCS5;RAB1A;RAB6A;DYNC1I1;TMEM201;BICDL1;KIF5B;COPG2;BICD1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4869247171011723,1.3153083307936346,0.14733542319749215,0.8031921910693385,1.0,11/27,18.62%,VAMP2;RIMS2;SYT3;SYT7;ARL8B;PPP3CB;RIMS1;SYT5;VAMP7;SYT6;SYT1
prerank,membrane lipid catabolic process (GO:0046466),-0.5301080794244849,-1.3152861274347725,0.1571753986332574,0.5339143651709864,1.0,4/10,12.37%,CYP1B1;FUCA1;ENPP2;NAGA
prerank,synapse organization (GO:0050808),0.3742939904443491,1.3151572185990394,0.07063197026022305,0.801487091926664,1.0,35/125,17.36%,PDZRN3;ADGRL3;PTEN;C5AR1;FARP1;NRXN2;NRXN1;GPC4;ANK3;REST;PCDHB16;NEDD4;DSCAM;LRRK2;PCDHB4;PCDHB11;C1QA;PPFIA2;LRFN5;C1QC;RAB29;CACNB4;GRM5;LRRC4C;CBLN1;UNC13A;PPFIA4;F2R;KIRREL3;NTNG1;NRCAM;CYFIP1;SLITRK1;CDK5;UNC13C
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5419233070733371,-1.31467123444522,0.15632183908045977,0.534114304791513,1.0,3/10,19.39%,NOTCH1;PPM1F;RGCC
prerank,positive regulation of dendrite extension (GO:1903861),0.5307084702719739,1.314508266575445,0.16150081566068517,0.8017347838227902,1.0,7/17,18.62%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.41380881390525465,-1.3144417014940026,0.11420612813370473,0.5332632685764513,1.0,9/27,15.82%,AHNAK;CAMK2D;CALM1;ANK2;DMD;JPH1;NOS1;JPH2;CACNB1
prerank,regulation of endothelial cell migration (GO:0010594),-0.3237706267052629,-1.3139398974624408,0.04680851063829787,0.5332783221321786,1.0,35/85,18.27%,ANXA3;ROCK2;FOXP1;TEK;BMPER;SLIT2;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;KDR;RAC1;SCARB1;APOE;AAMP;FGF1;ACVRL1;ITGB1BP1;ATOH8;PIK3CB;PIK3CD;ETS1;ITGB3;CEACAM1;FLT4;PTK2B;RRAS;EDN1;BCAS3;EPHA2;DNAJA4;AKT1;EGF
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.43709432375405805,-1.313697209634066,0.13279132791327913,0.5311724507557258,1.0,12/24,20.45%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,canonical glycolysis (GO:0061621),-0.43709432375405805,-1.313697209634066,0.13279132791327913,0.5311724507557258,1.0,12/24,20.45%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4578709359285694,-1.3132419047854895,0.12594458438287154,0.5308773808182126,1.0,4/20,6.34%,PLCE1;CAV1;ZDHHC21;ATP2B1
prerank,visual system development (GO:0150063),-0.3952072788507306,-1.3132365771622674,0.09177215189873418,0.529492166850367,1.0,12/37,12.81%,SMOC1;PBX1;FOXC1;RBP4;TGFB2;PBX4;ATF6;SH3PXD2B;HIPK1;ZDHHC16;FREM2;HIPK2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5092718746541999,1.3129894293157205,0.1323283082077052,0.8056402577157293,1.0,6/21,15.42%,MED12;SRF;TWIST1;DHX36;MED1;PAXIP1
prerank,retinoid metabolic process (GO:0001523),0.4094646989356832,1.3127076947140162,0.10854816824966079,0.8044919109408523,1.0,8/71,4.65%,LRP1;ADH1A;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,cellular potassium ion homeostasis (GO:0030007),0.5703548268197359,1.3126924138541294,0.1449016100178891,0.802262232098303,1.0,3/13,5.33%,ATP1A2;ATP1A3;KCNMA1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.5055758265525954,-1.3126394356215942,0.13145539906103287,0.5296543265531583,1.0,4/13,7.21%,DKK3;NFKB1;ERLIN1;APOE
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5029384592964162,-1.3122396827553293,0.16464891041162227,0.5293786422914337,1.0,4/14,11.78%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.543426846297272,1.3120330412505194,0.1717171717171717,0.8025369127626004,1.0,6/15,15.82%,LRP1;FAP;FSCN1;CARMIL2;CLASP2;CLASP1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5450282701249659,1.3113004303128415,0.16134453781512606,0.8030725015511476,1.0,7/16,12.56%,PTN;RBM24;SOX6;NUDT21;DHX36;SOX9;HOXB4
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.38070487465618347,1.3101113860606488,0.093711467324291,0.8055104891030818,1.0,27/117,17.12%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;CD81;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5997486704091849,1.309791671984563,0.1634446397188049,0.8044346887537963,1.0,1/10,0.11%,ENPP1
prerank,rRNA metabolic process (GO:0016072),-0.2954847079564271,-1.3097689780216726,0.029239766081871343,0.5347150136131492,1.0,57/160,22.29%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RPL10;RPL35A;MAPT;DDX27;RPL10A;RPL11;RPL36A;DIS3L;RPL34;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RPL31;IMP3;EXOSC3;NIFK;RPL23A;RPL19;RPL36;WDR12;PES1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52
prerank,positive regulation of cellular component movement (GO:0051272),-0.42063978022939996,-1.3094880457425464,0.11171662125340599,0.534154998910947,1.0,10/24,23.89%,CAVIN1;SPOCK2;NTN1;RPS19;ETS1;PDPN;CCDC25;TUBB2B;CSF1R;CCL19
prerank,neuron projection regeneration (GO:0031102),0.6001846540727788,1.3088381376548714,0.16845878136200718,0.8062301497578216,1.0,1/10,0.19%,PTN
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.35688178717243413,-1.3087730211956254,0.07523510971786834,0.5345782713563846,1.0,20/56,27.48%,SMAD6;BMPER;BMPR2;TGFB2;DAB2;SNX25;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;SMAD7;INHBB;ACVR2A;GREM1;SMAD4;EMILIN1;TTK
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4675495087525534,-1.3086805165544682,0.12437810945273632,0.5334277612616364,1.0,8/17,21.46%,PODXL;FOXC2;TGFB2;RET;SKAP1;CIB1;ADAM9;PIEZO1
prerank,negative regulation of nuclear division (GO:0051784),0.5583278142252693,1.3083759524265968,0.16087751371115175,0.8057695707511778,1.0,3/11,9.77%,FBXO5;BMP7;NME6
prerank,plasma membrane tubulation (GO:0097320),-0.5035942032781231,-1.3081945138312692,0.15876777251184834,0.5334290806535432,1.0,3/13,3.98%,FNBP1L;PACSIN2;CAVIN2
prerank,negative regulation of cyclase activity (GO:0031280),0.5464502555285413,1.308127293530091,0.17229729729729729,0.8044988374724801,1.0,2/14,1.67%,AKAP5;ADGRV1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4843305283406072,-1.3080663522276892,0.14084507042253522,0.5323677892414509,1.0,2/15,0.90%,CD200;IL31RA
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.45186391617295574,-1.3077790273691607,0.11578947368421053,0.5318179075408173,1.0,4/20,10.18%,IGF1;FOXC1;LAMTOR5;NIBAN2
prerank,mitotic recombination (GO:0006312),0.5276167334536664,1.3070878705321654,0.14759535655058043,0.8062430187220136,1.0,4/15,13.21%,TEP1;ERCC1;MSH3;RAD52
prerank,cGMP metabolic process (GO:0046068),0.5703310177415364,1.3069507563505685,0.17413793103448275,0.8045570487659065,1.0,1/12,0.28%,PDE9A
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.46132479628040896,-1.3068066801078198,0.1339712918660287,0.5329443628548045,1.0,7/18,8.88%,FN1;CD200;ITGB8;TGFB2;CD34;SMAD3;LRRC32
prerank,epithelial cell migration (GO:0010631),-0.38265143310742544,-1.3064948491622483,0.08668730650154799,0.53238945865735,1.0,9/37,5.23%,KANK2;NOS3;FSTL1;NRP1;DPP4;ANLN;CYP1B1;KANK1;GIPC1
prerank,engulfment of apoptotic cell (GO:0043652),-0.47820355211275173,-1.3064842760940356,0.14138817480719795,0.5310526209558455,1.0,4/15,5.15%,RHOBTB1;THBS1;RHOBTB2;RAC1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5174650684324439,-1.3062132784364426,0.15384615384615385,0.5304230157560484,1.0,3/12,3.95%,IGF1R;UVRAG;INSR
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45313818952942686,1.3055067679372045,0.1413373860182371,0.8079202442466947,1.0,10/34,12.54%,GRID2;GRIN2B;GABRA1;MPP2;LRRK2;GRIN2A;GABRG3;GABRG2;GLRA1;GSK3A
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.45450723485198197,1.3053816978282446,0.13836477987421383,0.8062054391771887,1.0,11/35,21.18%,CDH6;PCDHB16;DCHS1;CDH11;PCDHB4;PCDHB11;CDH10;PCDHGB4;CDH9;ATP2C1;PCDHB14
prerank,amino acid transmembrane transport (GO:0003333),-0.3616937069889886,-1.3049716430766436,0.08709677419354839,0.5322780326611312,1.0,12/45,11.97%,SLC47A1;SLC16A2;SLC6A6;SLC38A11;SLC22A4;SLC7A1;SLC3A2;LRRC8D;SLC38A5;SLC38A10;SLC7A5;SFXN1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.38383824865266764,1.3047930849303855,0.08461538461538462,0.8063298274769136,1.0,16/100,8.25%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;PTEN;PIP4K2A;FGFR1;ENTPD5;NEDD4;IRS2;PTPN13;PTK2;TWIST1
prerank,triglyceride metabolic process (GO:0006641),0.4276123392305542,1.3038361304763721,0.13285714285714287,0.8078048856176138,1.0,11/48,15.44%,LPIN3;SEL1L;LIPC;LIPH;FABP5;FABP4;AGMO;GK;FABP3;GPAT3;LPIN2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.39902103632685926,-1.303584127535521,0.10714285714285714,0.5345271637337455,1.0,13/33,12.85%,TJP1;BMPER;THBS1;KLF4;SEMA6A;KLF2;EPN2;PPP1R16B;FGF1;PIK3CB;CEACAM1;PKM;SMAD1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4712654518778385,-1.3030882637259469,0.13819095477386933,0.5344847712996906,1.0,12/16,37.31%,NOS3;GUCY1A1;APOE;NOS1;DDAH1;AGT;DDAH2;GUCY1B1;NDNF;MAFA;CD36;NOS2
prerank,intracellular lipid transport (GO:0032365),-0.4447636943541666,-1.3030264594080874,0.11405835543766578,0.5333321128776572,1.0,5/21,5.48%,PRKAG2;ABCD3;ABCD4;CERT1;PRKAA2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4547986641581057,-1.3029895274728267,0.1564102564102564,0.5321070654300892,1.0,6/17,20.77%,LPGAT1;PLA2G4A;LCLAT1;PLAAT3;PLA2G4E;PLA2G4C
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4162610624217385,-1.3029176239325913,0.12432432432432433,0.53095062727656,1.0,11/28,20.46%,CASP8AP2;GABARAP;CRADD;NGF;CASP8;BAX;BAG3;BID;TNFRSF1A;TRADD;ZDHHC3
prerank,regulation of blood coagulation (GO:0030193),-0.42314378756796545,-1.3028868138518532,0.1388888888888889,0.52966925861085,1.0,11/27,15.37%,CAV1;THBD;THBS1;ST3GAL4;VTN;CD34;APOE;SERPINE1;EPHB2;SERPINE2;EDN1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.42910258302877435,-1.3024509852085302,0.13746630727762804,0.5296116557089516,1.0,12/25,20.45%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,cell differentiation in hindbrain (GO:0021533),0.5722062414565212,1.3023855194067107,0.17253521126760563,0.8112862884432863,1.0,8/11,28.29%,GRID2;OPHN1;CBLN1;ATP7A;FAIM2;PROX1;AGTPBP1;KNDC1
prerank,negative regulation of catalytic activity (GO:0043086),-0.43439641402735346,-1.3013695888808716,0.13218390804597702,0.5312332636693353,1.0,13/24,24.20%,NOTCH1;NES;PARP9;NOS1;SIRT1;IFIT1;NOSIP;HDAC6;APBA3;CCAR2;OXA1L;PLN;MT3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5052099429469264,1.3011275797961852,0.17457627118644067,0.8139253307545112,1.0,7/19,11.67%,PTGFR;RYR2;STIMATE;PRKACA;ADGRL1;GRM5;TRPM2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.47482727438834765,-1.3009777526424409,0.13554987212276215,0.5308723186445772,1.0,5/15,9.80%,RSPO3;WNT5B;CSNK1D;GPC3;SFRP1
prerank,peptidyl-arginine modification (GO:0018195),-0.48352751711674824,-1.300897119774377,0.14354066985645933,0.5297364612811486,1.0,13/15,47.90%,ART3;PRMT7;PRMT8;KRTCAP2;PADI2;PARK7;PRMT1;PRMT5;NDUFAF5;ART1;PADI1;PADI4;ART4
prerank,cell projection organization (GO:0030030),-0.4002492911029565,-1.300861963025799,0.13043478260869565,0.5285140191824229,1.0,8/30,6.77%,ITGB1;PACSIN2;PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.45733494193382884,-1.2998955275574633,0.13984168865435356,0.5297603616588722,1.0,8/20,23.30%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC;TTBK1;STOX1
prerank,female gamete generation (GO:0007292),0.4646700450243574,1.298788066677812,0.15668202764976957,0.8209770428067853,1.0,3/29,6.87%,PTN;NANOS3;DIAPH2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3295440187770739,-1.2985238304490487,0.05179282868525897,0.5321538921614465,1.0,17/74,10.45%,EYA2;IGF1;BCL2L1;EYA1;EYA4;NOS3;THBS1;ITGA6;MCL1;TNFSF10;FAS;GSK3B;ACVR1;CASP8;GPX1;SERPINE1;ICAM1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5000364098656005,-1.298242087414736,0.1746031746031746,0.5315754039976087,1.0,5/13,10.77%,ROCK2;ACTG1;RAC1;CDC42;FHOD1
prerank,negative regulation of TOR signaling (GO:0032007),-0.39127422980818877,-1.2975326520065418,0.12166172106824925,0.5322692113877695,1.0,12/36,16.15%,FNIP1;RNF152;DEPTOR;SESN1;PRKAA2;SH3BP4;UBR1;UBR2;TBC1D7;ATM;SIRT1;PRKAA1
prerank,positive regulation of histone methylation (GO:0031062),0.48496229632345994,1.2972504021341376,0.15605095541401273,0.824820585940563,1.0,8/24,19.19%,AUTS2;OGT;KMT2A;WDR5;SNW1;PAXIP1;RIF1;CHTOP
prerank,L-glutamate transmembrane transport (GO:0015813),0.5899204482345983,1.2971671836491392,0.19120135363790186,0.8229447166211957,1.0,2/10,8.61%,SLC1A3;SLC25A22
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.36239854575389585,-1.2970284439286721,0.10876132930513595,0.5323401113889111,1.0,13/45,11.06%,CAMK2D;NCAM1;TRIM25;TRIM5;B2M;CD44;IRF2;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G
prerank,neuron development (GO:0048666),0.36544327070159516,1.2966823217967236,0.06498194945848375,0.8226636294266259,1.0,36/141,16.35%,NCDN;LAMB1;ISL2;ETV1;GPM6B;TENM3;NTRK2;MICALL2;CNTNAP2;LRP12;TENM4;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;TENM2;SRF;DOCK7;STMN2;NPY;TENM1;LGI4;OPHN1;PLP1;STMN4;MYT1L;GPRIN1;STMN1;ATP7A;LYN;EPHA5;PBX2;GDNF;TBC1D23;GPRIN3
prerank,transepithelial transport (GO:0070633),0.5300985968309357,1.2966779560792099,0.16498316498316498,0.820469769347413,1.0,2/15,2.27%,SLC1A3;GPLD1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.34811171739806085,-1.2961448150478536,0.11538461538461539,0.5334739523368609,1.0,20/58,15.79%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;ACER3;SGMS2;CERT1;DEGS2;SPNS2;VAPA;VAPB;ELOVL4;ELOVL7;SPTSSA;KDSR;ST3GAL2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.42607840909476125,-1.2956051130972397,0.14168937329700274,0.5335445819671613,1.0,11/21,36.20%,OSBPL8;MBOAT1;PLA2G4A;PLAAT3;PLA1A;PLA2G4E;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5309174656881244,1.2955797823763795,0.16151202749140894,0.8225832548723992,1.0,6/17,17.79%,GPLD1;SORL1;CIDEA;BSCL2;ADRA2A;PDE3B
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.374579942618067,1.295484183908725,0.10757946210268948,0.8207751577128042,1.0,26/116,17.12%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5028198888335008,1.295439688953207,0.16225165562913907,0.8187659346821949,1.0,4/20,6.01%,ATP1A2;ATP1A3;KCNMA1;SLC9A1
prerank,secondary palate development (GO:0062009),0.5520110310289581,1.2953855269621295,0.1825938566552901,0.8168251136289397,1.0,2/14,1.70%,CHD7;WNT5A
prerank,transcription preinitiation complex assembly (GO:0070897),0.5695065126333194,1.2951315836945876,0.17830882352941177,0.8156823955437152,1.0,6/12,22.14%,TAF12;TAF1B;BDP1;TAF11;GTF2B;GTF2A2
prerank,response to hexose (GO:0009746),0.4885022803195525,1.294856905161984,0.16773162939297126,0.8147042372223902,1.0,6/25,10.49%,TCF7L2;GPLD1;VAMP2;EIF2B1;IRS2;ZBED3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.4027619367982912,-1.2941115851929053,0.11884057971014493,0.5362767013109103,1.0,7/26,12.68%,PICALM;FNBP1L;INPP5F;GPR107;AP2A1;CLTB;GAK
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5001183668180136,-1.2938136685217705,0.16009280742459397,0.5358018790705174,1.0,7/13,28.32%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.42623026357045873,1.2936793303206864,0.13859910581222057,0.8171042917678757,1.0,13/41,17.33%,IL34;NTRK2;UNC119;DLG3;DOCK3;RELN;GRM5;FYN;DLG4;CASS4;AREG;EFNA1;ADRA2A
prerank,cellular response to cAMP (GO:0071320),-0.4050840243265122,-1.2928336091040196,0.11515151515151516,0.537090303772362,1.0,11/30,23.30%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,regulation of muscle cell differentiation (GO:0051147),-0.39807700421917397,-1.2918790689147825,0.10674157303370786,0.5381779676935234,1.0,12/31,17.83%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD;CDK9
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.49769671321726017,-1.2912075691870277,0.162227602905569,0.538567762338949,1.0,3/13,3.95%,SORBS1;IGF1;INSR
prerank,regulation of mitotic nuclear division (GO:0007088),0.4113424514262763,1.2909751468111723,0.12588401697312587,0.8254773928860217,1.0,13/55,12.43%,EDN3;L3MBTL1;PHIP;DUSP1;PKMYT1;FBXO5;CDK13;BMP7;NME6;RCC1;MKI67;NUSAP1;IGF2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4762082717773215,1.2906443131673149,0.1803030303030303,0.8246294417271701,1.0,4/25,5.93%,TBX18;RYR2;JUP;ATP2A2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5105772159440026,-1.290620660592158,0.1650485436893204,0.5387620944727858,1.0,3/12,3.95%,SORBS1;IGF1;INSR
prerank,receptor recycling (GO:0001881),0.5828514764982965,1.2897628921054871,0.1903914590747331,0.8260821890490708,1.0,4/10,20.92%,PHETA2;SORL1;PHETA1;ARFGEF2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5525357942439253,1.2895651149539626,0.1810344827586207,0.8246679080677353,1.0,2/13,1.67%,AKAP5;ADGRV1
prerank,negative regulation of anoikis (GO:2000811),-0.48188333528921506,-1.289477276975934,0.15458937198067632,0.5404529045187503,1.0,4/14,4.26%,CAV1;ITGB1;MCL1;NOTCH1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.4421136946672292,-1.2893021087524004,0.15521628498727735,0.5396666505407193,1.0,12/20,31.32%,PTGES3;PSMG2;NDUFAF1;MKKS;PSMG3;HOPX;HSPD1;PFDN6;HSPA1A;PTGES3L;BBS12;BBS10
prerank,regulation of focal adhesion assembly (GO:0051893),0.4140446919360096,1.2887743746004077,0.14644351464435146,0.8256244762212952,1.0,15/54,11.13%,APOD;DLC1;HRG;GPM6B;PEAK1;PTEN;MAP4K4;ARHGAP6;SLC9A1;DUSP22;COL16A1;PTK2;EPHA3;PTPRA;SLK
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.39337770058814814,-1.2880756760024343,0.11695906432748537,0.5416162790509568,1.0,15/32,25.00%,SORBS1;PRKAG2;ADIPOR2;PRKAA2;APOE;CEACAM1;ASXL3;CREB1;GPER1;AKT1;CREBL2;FITM2;STAR;ASAH1;PDK4
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5169859607681306,-1.2880221087028252,0.16548463356973994,0.540447529672894,1.0,5/11,9.97%,RAPGEF2;MEF2C;ANXA1;PIK3CB;PIK3CD
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.5371755057789385,-1.2878520518744334,0.19246861924686193,0.5395550797049726,1.0,5/10,17.68%,TSN;DICER1;DROSHA;TERT;AGO2
prerank,regulation of neuron projection development (GO:0010975),0.3547799663134005,1.287547817668099,0.07075471698113207,0.8282521959238136,1.0,42/163,17.25%,ROR1;PTN;NTRK3;ROR2;CHN1;TENM3;CTNNA2;WNT5A;NTRK2;PTEN;CSMD3;CDKL5;PRKCI;LRRK2;DISC1;PTPRO;PPFIA2;TANC2;PRKD1;RELN;DCC;STMN2;P3H1;RAB29;LPAR1;EPHA3;LRRC4C;PLXNB2;RETREG3;ARHGAP35;GSK3A;LRRC7;LYN;NTNG2;NTNG1;BRSK2;NCS1;DENND5A;IL1RAPL1;CBFA2T2;RTN4RL1;CDK5
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.464853123934998,-1.286435816619237,0.15601023017902813,0.5418463085901442,1.0,6/17,19.39%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC
prerank,glucan biosynthetic process (GO:0009250),-0.5029256589442072,-1.286049104431653,0.17960088691796008,0.5403362677452613,1.0,6/12,13.49%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),-0.5029256589442072,-1.286049104431653,0.17960088691796008,0.5403362677452613,1.0,6/12,13.49%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3055158167742832,-1.285982858120908,0.046610169491525424,0.5391814046854034,1.0,26/104,12.85%,CRIM1;SMAD6;CAV1;BMPER;LEMD3;NBL1;BMPR2;MAGI2;SKIL;NOTCH1;CCN3;SKI;UBE2D3;CD109;UBB;ASPN;SNX25;ACVR1;SMURF2;SMAD3;SNX6;PRDM16;BCL9L;SPRED3;HIPK2;SMAD1
prerank,energy reserve metabolic process (GO:0006112),-0.45032119720614766,-1.2858771771053112,0.15306122448979592,0.5381453937147945,1.0,11/19,28.50%,PRKAG2;LEPR;GBE1;GSK3B;UGP2;PPP1R3C;PID1;MRAP2;MT3;PHKG2;PYGL
prerank,protein-containing complex disassembly (GO:0032984),-0.3433969700767364,-1.2857686926127152,0.07667731629392971,0.5372361017854625,1.0,12/54,9.94%,CAV1;UVRAG;HSPA8;GABARAP;EPG5;APC;DVL1;GABARAPL1;GSK3B;LRP6;VCP;PYM1
prerank,transition metal ion homeostasis (GO:0055076),-0.4008536387791645,-1.2854293945559903,0.13858695652173914,0.5368462930767436,1.0,6/28,8.27%,PICALM;XIAP;NEO1;HMOX2;B2M;BDH2
prerank,regulation of lipid kinase activity (GO:0043550),0.5775196506225484,1.2851909581393717,0.16635859519408502,0.8350626530318307,1.0,2/11,4.02%,PIK3R1;PIK3R2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.531198855406779,1.2851889400162606,0.16262975778546712,0.8329194066474811,1.0,5/15,12.04%,GGT5;GGT7;ABHD16A;HOGA1;ABHD12
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4140909257651219,1.2836602927395147,0.15242165242165243,0.8368086579195398,1.0,13/50,16.20%,RORA;RAB34;PTCH2;ZIC1;IFT81;GLI1;GLI3;GAS8;TXNDC15;HERC4;EVC;FGFR2;PDCL
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5258160365017928,1.282784404229645,0.17132867132867133,0.8380835342102805,1.0,2/15,4.84%,KYNU;FAH
prerank,modulation by symbiont of entry into host (GO:0052372),-0.46694731667723244,-1.2827774027912637,0.16705336426914152,0.5425023777900192,1.0,5/16,8.92%,CAV1;TRIM25;TRIM5;TRIM14;EXOC2
prerank,negative regulation of synaptic transmission (GO:0050805),0.48742656060189876,1.2825936909533922,0.17313915857605178,0.8367128732524265,1.0,4/23,12.10%,PTEN;PNKD;LRRK2;CBLN1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4798553378441525,-1.2825283078390521,0.15308641975308643,0.5418284133938366,1.0,7/15,28.32%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.538379162200755,-1.2817412931648247,0.16593886462882096,0.5427327132132408,1.0,6/10,22.71%,FN1;LAPTM4B;GATA6;FURIN;TSKU;TYROBP
prerank,negative regulation of centrosome duplication (GO:0010826),0.5743692750085404,1.2814704826352017,0.18232044198895028,0.8387745066134106,1.0,4/11,11.23%,MDM1;TRIM37;KAT2A;TMEM67
prerank,extracellular transport (GO:0006858),0.5621551397102138,1.2807474170673343,0.19784172661870503,0.8394519238627589,1.0,5/12,13.70%,ADCY10;DNAAF4;SPA17;CABYR;TSG101
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.46563582652138935,1.280271251847456,0.16338880484114976,0.8392396680438464,1.0,8/28,12.54%,ENPP1;PIP4K2A;IRS1;RPS6KB1;APPL2;PRKCB;TNS2;GSK3A
prerank,negative regulation of phosphorylation (GO:0042326),0.3835181053079009,1.2794814179332248,0.11292346298619825,0.8401858314630708,1.0,21/85,14.51%,DYNLL1;NTRK3;PPARA;PTEN;TRAF3IP1;CDKN2A;PFKFB1;NPRL2;LRRK2;IRS2;CBFA2T3;CDKN2D;PTPN13;BMP7;ZBED3;DNAJC10;ANKLE2;PIP5KL1;CDKN2C;LYN;ATG14
prerank,positive regulation of heart contraction (GO:0045823),0.5175093694623496,1.2794602091827931,0.18677685950413223,0.8381499071287347,1.0,4/19,5.93%,EDN3;ATP1A2;RYR2;ATP2A2
prerank,phasic smooth muscle contraction (GO:0014821),0.6052405263403137,1.2790701260992914,0.18617021276595744,0.8376464312781449,1.0,2/10,4.84%,EDN3;HTR2B
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.4524396229540292,-1.2790373772657142,0.16326530612244897,0.5484361387627716,1.0,9/18,26.76%,LBP;NMI;IFI35;KARS1;PLCG2;DYSF;DOCK2;TYROBP;SBNO2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.34578255477102865,1.2789228833695254,0.06744186046511629,0.8361237598870672,1.0,29/208,10.91%,RORA;ROR1;MAP3K14;EDA2R;CCDC22;WNT5A;TRAF4;CD40;TSPAN6;NR1H4;LURAP1;GJA1;PDPK1;HTR2B;TLR6;CAPN3;CARD19;TNFRSF19;PINK1;PRKD1;TRIM8;PRKCB;TLE1;BIRC2;IRAK1;LPAR1;NDFIP2;DHX36;PYCARD
prerank,granulocyte differentiation (GO:0030851),-0.46248025552118915,-1.278825385017588,0.18246445497630331,0.5477588411507792,1.0,6/18,15.10%,LEF1;LBR;RXRA;JAGN1;TAL1;CDKN1A
prerank,regulation of macrophage differentiation (GO:0045649),0.5278422546341929,1.2786332167223808,0.1917808219178082,0.8351477653001663,1.0,3/15,8.66%,IL34;C1QC;PRKCA
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5816358773007042,1.2779136746351882,0.19963031423290203,0.8359878397563836,1.0,3/11,14.80%,IL34;PRKCA;RIPK1
prerank,leukotriene biosynthetic process (GO:0019370),0.5269114406074976,1.2775098514580292,0.18927973199329984,0.8355186640916075,1.0,2/14,2.23%,GGT5;GGT7
prerank,vasodilation (GO:0042311),-0.4912308796139735,-1.2773280329102084,0.18262806236080179,0.5503044457556797,1.0,6/13,19.69%,NOS3;SOD2;KLF2;NOS1;GPER1;ADRB2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.44214416319574257,-1.2771754874768277,0.15211970074812967,0.5494807250217829,1.0,5/20,9.80%,NBL1;GLI2;ACVR1;ACVRL1;SFRP1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.498649533176191,1.276766302893346,0.1649659863945578,0.836351470359566,1.0,7/18,24.54%,C5AR1;GPLD1;LYN;BAG6;CMKLR1;SPG21;BCAR1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.5669378033248373,1.2758389033254551,0.21575342465753425,0.8379147831767086,1.0,5/12,21.51%,TIPIN;GMNN;CDT1;KAT7;WDR18
prerank,tyrosine metabolic process (GO:0006570),0.5679103666476182,1.2756270176849616,0.19814814814814816,0.8366770149577252,1.0,2/11,4.84%,TYR;FAH
prerank,pinocytosis (GO:0006907),0.5865908046801674,1.2755957415743495,0.2003610108303249,0.8347336977519896,1.0,3/10,11.56%,RAB34;PYCARD;MAPKAPK3
prerank,protein localization to cell periphery (GO:1990778),-0.2868302715090847,-1.2755894893956399,0.02912621359223301,0.5525817657683799,1.0,28/133,9.21%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;LIN7A;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;PACS1;RAMP1;TTC7B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;TTC7A
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.44944295829430914,-1.275303053202452,0.16267942583732056,0.5520599206402546,1.0,8/19,9.80%,TEK;PTPRJ;NRP1;S100A10;KDR;RAC1;PPM1F;SFRP1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.47776041051178564,-1.2751449305873166,0.18872549019607843,0.551195413403289,1.0,7/15,16.70%,EGFR;IGF1R;KDR;BMX;PTK2B;TEC;AATK
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5097323313145191,-1.2743416144223914,0.1791767554479419,0.5522649818742783,1.0,3/12,13.87%,EPHA4;NOTCH1;SERPINE2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.582808168900295,1.2725282656297503,0.2127659574468085,0.8444930697872279,1.0,3/10,6.26%,GPLD1;IRS1;IRS2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5555507347420485,1.272497026399159,0.19349005424954793,0.8425315401089561,1.0,3/12,5.51%,MYO7A;NKD1;DSCAM
prerank,muscle tissue morphogenesis (GO:0060415),-0.4560598925653456,-1.27245933171282,0.15839243498817968,0.5561000282309868,1.0,5/16,19.16%,MYLK;NOTCH1;TBX1;HEY2;TGFBR3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3532134232496595,1.272270462088118,0.09307875894988067,0.8415101480603763,1.0,34/159,12.68%,ROBO2;ADGRL3;TENM3;CDH6;PTPRT;GRID2;GPC4;MMP24;PCDHB16;TENM4;DCHS1;CDH11;DSCAM;CDH15;CDH3;CNTN4;PCDHB4;TENM2;PCDHB11;DSCAML1;LRFN5;PALLD;ADGRL1;NEXN;TENM1;CNTN6;AMIGO3;LRRC4C;CLDN15;UNC5D;PLXNB2;CBLN1;CDH10;CADM3
prerank,positive regulation of organelle organization (GO:0010638),-0.38545298489733865,-1.2718912379116676,0.13297872340425532,0.5564372935941176,1.0,18/32,32.92%,SORBS3;STX18;UVRAG;ANXA1;GSK3B;SURF4;P2RX7;SYNJ1;ATL3;LMAN1;ADRB2;SHCBP1L;PFDN2;LIG4;IRGM;AKT2;DOC2B;TREM2
prerank,midbody abscission (GO:0061952),-0.4558470089136246,-1.2712046927273717,0.16445623342175067,0.5571009369724573,1.0,13/17,38.37%,CHMP2B;MITD1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4184559984331794,-1.2710844749689205,0.1558073654390935,0.5549010758536754,1.0,8/23,12.22%,PPP1R13B;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4184559984331794,-1.2710844749689205,0.1558073654390935,0.5549010758536754,1.0,8/23,12.22%,PPP1R13B;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.48740299064115583,-1.270996568396273,0.18599562363238512,0.55384058971628,1.0,8/13,17.68%,BTG2;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,regulation of lymphocyte activation (GO:0051249),0.5386136529106114,1.270594399942999,0.20618556701030927,0.8460163954689373,1.0,2/12,9.78%,PAG1;KAT2A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3510001081021282,1.2699847032324805,0.09914320685434516,0.8463486036872673,1.0,17/138,7.65%,RORA;PPARA;TEAD1;HDAC1;TAF9B;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;NR2C1;TAF3
prerank,carnitine shuttle (GO:0006853),-0.5082749628907262,-1.2698840669176734,0.18475750577367206,0.5555928581890691,1.0,2/11,5.48%,PRKAG2;PRKAA2
prerank,establishment of protein localization to organelle (GO:0072594),0.3943773732908327,1.2696570698145544,0.13404825737265416,0.8456241090430439,1.0,21/72,18.72%,PRICKLE1;CSE1L;NUP214;RYR2;FAM53C;NUTF2;POM121;CD68;PINK1;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;PEX19;TNPO2;IPO9;NUP155;KPNB1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4585822773134512,1.269475087785139,0.16429699842022116,0.8442902149722038,1.0,5/29,8.14%,SPRY1;PTEN;SPRED1;IL17RD;SPRED2
prerank,regulation of phagocytosis (GO:0050764),0.4148814406110302,1.2689837990167432,0.16129032258064516,0.8442193792981372,1.0,9/53,10.91%,IL15RA;MERTK;ITGAV;TUB;LYAR;CYBA;FGR;SYT7;PYCARD
prerank,regulation of exocytosis (GO:0017157),0.4274239500253336,1.268221478673419,0.1620795107033639,0.8449775839088816,1.0,15/46,18.99%,CADPS2;STXBP6;VAMP2;RAB8A;CADPS;RAB3C;RIMS2;RAB15;CLASP2;CLASP1;IL1RAPL1;STXBP5;RAB2B;SYT1;ATP6AP1
prerank,insulin receptor signaling pathway (GO:0008286),-0.3290130635505284,-1.267591518650841,0.08424908424908426,0.5605546427692414,1.0,14/69,7.28%,SORBS1;FOXO1;IGF1R;FER;ATP6V0A4;FOXC2;INSR;RHOQ;GRB14;APC;GRB10;CAV2;GAB1;GSK3B
prerank,positive regulation of cell division (GO:0051781),0.43335049991911345,1.2674685605680416,0.15625,0.8457740990504682,1.0,4/38,4.84%,SVIL;CDC14B;RXFP3;HTR2B
prerank,presynaptic endocytosis (GO:0140238),0.4682987195394346,1.2670512314944602,0.19055374592833876,0.8453359934031114,1.0,9/24,19.49%,CEL;VAMP2;OPHN1;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,chondrocyte differentiation (GO:0002062),-0.3863481092048756,-1.2667331859393802,0.13850415512465375,0.561576208412134,1.0,9/32,5.49%,NFIB;SOX5;MEF2C;WNT5B;OSR1;BMPR2;RUNX1;CCN3;SULF2
prerank,regulation of dendrite development (GO:0050773),0.4287231875717814,1.2665873181984855,0.15578635014836795,0.8451129816091162,1.0,10/37,16.69%,PTN;CSMD3;CDKL5;NEDD4;ADGRB3;DCC;BMP7;SDC2;TNIK;HECW1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3854184341240956,-1.266266424777427,0.13432835820895522,0.5614620900484616,1.0,13/33,19.39%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;ANXA1;HYAL1;PLCG2;CCND1;EZH2;ANKRD17;AKT1;RGCC
prerank,positive regulation of hemostasis (GO:1900048),-0.5368396362173655,-1.265871490785381,0.1813953488372093,0.5600241348076354,1.0,6/10,28.40%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,positive regulation of coagulation (GO:0050820),-0.5368396362173655,-1.265871490785381,0.1813953488372093,0.5600241348076354,1.0,6/10,28.40%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,aortic valve development (GO:0003176),-0.37798971255103275,-1.265754625061922,0.1346704871060172,0.5591496213006248,1.0,8/34,4.26%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;BMPR2;TIE1;NOTCH1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3553823941273076,1.2649950095464773,0.10666666666666667,0.8491677795433945,1.0,33/152,17.33%,ADGRL3;CXCL10;PTGFR;ADCY5;AKAP5;CALCRL;GPR3;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;LPAR3;ADGRB3;ADGRL1;ADCY7;GNA11;LPAR1;GPR26;IAPP;GNAO1;S1PR2;LGR5;LHCGR;GPR37;ADGRE5;PTGER4;ADRA2A
prerank,membrane assembly (GO:0071709),0.44056320722783304,1.2649778817445527,0.16148148148148148,0.8472013938053564,1.0,7/34,6.92%,PTEN;NRXN2;CEL;NRXN1;SPTBN1;ANK3;FLOT2
prerank,eye development (GO:0001654),0.41001289719070894,1.2646208900372726,0.1375886524822695,0.8465982024669294,1.0,3/54,3.58%,LAMA1;MEIS1;MEIS2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5768529638842186,1.2646117069823226,0.21503496503496503,0.8446348517994288,1.0,1/10,0.04%,APOD
prerank,inorganic cation transmembrane transport (GO:0098662),0.33394274709375216,1.2645978203230406,0.0703125,0.8426993769070927,1.0,47/268,13.69%,SLC1A3;KCNK2;KCNS2;TRPA1;SLC6A13;SLC6A8;ATP1A2;SLC24A5;SLC30A10;NALCN;MCOLN2;ITGAV;ASIC2;KCNQ3;SCN2B;SLC30A5;SLC39A7;SLC9A9;ATP1A3;ATP2A2;SLC9A1;CACNA1G;TRPV3;KCNG1;KCNH4;ASIC1;KCNAB1;TRPC3;KCNC2;TMEM175;HCN2;SLC30A3;HCN1;KCND2;HCN3;P2RX4;TRPM2;TRPC7;KCNK1;KCNN2;KCNH7;KCNJ8;ATP6V0E1;KCNAB3;SCN1A;SCN2A;RYR3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3051866810254829,-1.2645698744466551,0.06842105263157895,0.5610352758875073,1.0,24/108,9.83%,DAPK1;ROBO1;CASP8AP2;ARL6IP5;TNFSF10;ACER2;HIP1R;GSN;MAP3K5;FAS;UACA;COL4A3;EGLN3;CRADD;NGF;CASP2;PPM1F;XDH;VCP;MAPT;SMAD3;CASP8;BAD;BAX
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.42227990059702636,1.263988152047426,0.15417867435158503,0.84301686580596,1.0,16/46,18.62%,ATP1A2;NRXN1;CACNG3;LRRK2;GRIK1;RELN;OPHN1;CACNG4;GRM5;DGKI;UNC13A;TPRG1L;GRM7;CDK5;GRM1;SYT1
prerank,regulation of hemopoiesis (GO:1903706),0.5824033417403625,1.2638759321364457,0.22711267605633803,0.8415050742414261,1.0,5/10,21.85%,PTN;PRKCB;MAFB;CBFB;CREBBP
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5421545332421955,1.2631553433542977,0.19047619047619047,0.8422992138869086,1.0,7/13,23.31%,CBLB;KPNA1;NUP54;KPNB1;RANBP2;KPNA2;NUP35
prerank,response to reactive oxygen species (GO:0000302),0.41231371787507975,1.2629849532889577,0.1529745042492918,0.8409413318936134,1.0,6/54,6.15%,APOD;PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4816685994140907,1.2627582508166117,0.19743178170144463,0.8398834634285095,1.0,3/22,3.59%,GHR;ERBB4;TSLP
prerank,response to ATP (GO:0033198),0.5076030441887714,1.2626361168598568,0.1821247892074199,0.8383626043616271,1.0,6/18,13.69%,P2RY1;DGKQ;TRPC3;P2RX4;HSP90B1;RYR3
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5397385926849982,1.2625056423944176,0.19689119170984457,0.8368995793682529,1.0,7/12,18.62%,RIMS2;SYT7;RIMS1;SYT5;UNC13A;UNC13C;SYT1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5436020878861095,1.2624542053667924,0.17881944444444445,0.8351436543319283,1.0,3/13,3.66%,DCN;BGN;VCAN
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4899767123036263,1.2622046847207549,0.17419354838709677,0.8341615840450133,1.0,10/20,20.63%,MBTPS2;NR1H4;ACADL;DGKQ;SREBF1;LDLRAP1;ARV1;KPNB1;ABCA2;MBTPS1
prerank,ear morphogenesis (GO:0042471),0.498319740277798,1.2619585649048581,0.18137254901960784,0.8332062326106687,1.0,4/20,8.25%,CHD7;ZIC1;MYO6;TWIST1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4803415417242233,-1.2607215469107291,0.1875,0.5702083119271061,1.0,7/14,13.59%,MEF2C;SLIT2;IGFBP5;TPM1;IGFBP3;SERPINE1;PRKG1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5095055038808413,-1.2606820119756674,0.1724137931034483,0.5678187067074704,1.0,8/11,39.74%,SRI;CALM1;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5095055038808413,-1.2606820119756674,0.1724137931034483,0.5678187067074704,1.0,8/11,39.74%,SRI;CALM1;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4109814031680042,1.2602804602034738,0.16690042075736325,0.8376568459396928,1.0,12/48,11.03%,ADCY5;ADCY10;SLC35B3;GMPS;COASY;ADCY8;ADCY3;ADCY2;PAPSS2;AMPD2;ADCY7;ACOT7
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4462350304712969,1.259853552954295,0.19213313161875945,0.837345900508201,1.0,6/33,5.41%,DCN;PTEN;NR2F2;PTPRR;MCC;ADGRB1
prerank,negative regulation of blood coagulation (GO:0030195),0.43609110353279257,1.2595344577363072,0.16442451420029897,0.8366660598015225,1.0,6/38,9.63%,PDGFRA;HRG;KLKB1;C1QTNF1;PLAU;F8
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5035069386443652,1.2595197349670617,0.16996699669966997,0.8347990272409164,1.0,7/18,13.87%,PTEN;NRXN1;RIMS2;RELN;RIMS1;DLG4;CUX2
prerank,positive regulation of GTPase activity (GO:0043547),-0.2839152128146259,-1.259288416802623,0.040268456375838924,0.5703355768172449,1.0,55/188,15.41%,PKP4;TBC1D4;PICALM;RAPGEF2;SIPA1L1;TIAM2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;SIPA1L2;RASGRF1;S100A10;TBC1D8;RAP1A;RAP1GAP2;NDEL1;ARHGAP42;TBC1D22B;CAV2;SRGAP2;RAPGEF1;GSK3B;ARHGEF15;RANGAP1;RUNDC1;RSU1;RALBP1;PLXNB1;NGEF;SGSM2;SFRP1;MAPRE2;GMIP;APC2;GRTP1;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;TBC1D22A;BCR;TBC1D10B;RAPGEF3;TBCK;CX3CL1;EZH2;RAP1GDS1;TBC1D13;RGS10
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5148286280376037,-1.2592020497628238,0.19772727272727272,0.5692633706382544,1.0,4/11,6.96%,MECOM;RUNX1;CD34;ETV6
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5070074784286818,1.2588854076796527,0.19932998324958123,0.8353356385346197,1.0,4/17,6.86%,PPARA;PFKFB1;PDE12;CBFA2T3
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4234696324440811,1.2587876264463767,0.16593245227606462,0.8338002440711191,1.0,5/37,9.69%,CEMIP;SPRED1;DGKQ;SPRED2;BMP7
prerank,activation of protein kinase activity (GO:0032147),0.3654488644928272,1.2587751411758357,0.12086513994910941,0.8319267126078332,1.0,19/106,10.05%,NTRK3;GHR;NRG1;ADCY5;WNT5A;MAP4K4;PDPK1;PRR5;TLR6;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;PINK1;PRKACA;ADCY7;MTOR;IRAK1
prerank,regulation of complement activation (GO:0030449),0.4341345218652183,1.2582123421319582,0.16079632465543645,0.8322128800193038,1.0,9/40,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,plasma membrane repair (GO:0001778),-0.49259816972431825,-1.2580278147448871,0.17422434367541767,0.5711211301117779,1.0,4/13,15.86%,MYOF;AHNAK2;SMPD1;DYSF
prerank,negative regulation of bone mineralization (GO:0030502),0.5400116927784699,1.2579789967209143,0.1949579831932773,0.8312182596953928,1.0,2/13,6.37%,ENPP1;BCOR
prerank,regulation of fibrinolysis (GO:0051917),0.5355212744092311,1.2576175288572378,0.21514629948364888,0.8306595817954698,1.0,3/13,5.10%,HRG;FAP;KLKB1
prerank,cell junction assembly (GO:0034329),-0.30203074336953734,-1.257572160784268,0.07296137339055794,0.5710697332265738,1.0,17/100,8.10%,SDK1;PKP4;FN1;TJP1;LIMS2;SPOCK2;ACTB;SHANK3;CDH1;ITGA6;CLDN5;CDH8;ACTG1;CTNND1;CDC42;DNER;DNM3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3738569179059658,1.2571586662715373,0.13256113256113256,0.830502444398793,1.0,11/95,4.65%,CEMIP;DCN;LUM;HSPG2;BGN;DSE;GPC4;VCAN;B4GALT2;GCNT2;GPC5
prerank,vasculogenesis (GO:0001570),-0.3874317583807618,-1.2569995795641407,0.14745308310991956,0.5714780142330502,1.0,13/32,22.66%,ITGB8;CAV1;KDR;NOTCH1;RASIP1;SOX17;HEY2;RAMP2;SOX18;RASA1;TGFBR3;TGFBR2;APLNR
prerank,synaptonemal complex assembly (GO:0007130),0.5102528725863907,1.2569972650449006,0.20689655172413793,0.8272864372097581,1.0,4/15,19.98%,STAG3;TEX11;BAG6;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.5102528725863907,1.2569972650449006,0.20689655172413793,0.8272864372097581,1.0,4/15,19.98%,STAG3;TEX11;BAG6;TRIP13
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5238668030255151,1.2568726712764018,0.23460898502495842,0.8258571549442182,1.0,2/14,1.70%,XCL1;WNT5A
prerank,neuromuscular process controlling balance (GO:0050885),0.5474188355124106,1.2565485038697553,0.23580034423407917,0.8251375021191368,1.0,3/12,8.62%,MYO7A;NRXN1;CLRN1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3946381837044523,1.2561143857065038,0.15163934426229508,0.8249030920880523,1.0,15/64,11.13%,CASK;UTRN;GPM6B;PEAK1;CDKN2A;MAP4K4;JUP;NF1;SLC9A1;PTK2;PLAU;EPHA3;CCL25;PTPRA;SLK
prerank,alpha-amino acid catabolic process (GO:1901606),0.44380858295406816,1.2553817973936603,0.17488076311605724,0.8257576963345316,1.0,7/29,10.21%,THNSL2;KYNU;FAH;ACADSB;MTRR;BLMH;HOGA1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.48325695947909464,1.2535681996858468,0.20418006430868169,0.8307281834621602,1.0,8/22,15.42%,MED12;SRF;PSMC4;TP53;DHX36;PSMC5;MED1;PAXIP1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4017448555880781,1.2525647189483007,0.15330520393811534,0.8326318507128798,1.0,13/52,10.41%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3;EPB41L2;GPSM2;NKD2;EPHA3
prerank,embryonic axis specification (GO:0000578),-0.4619180201790572,-1.2522972508944312,0.16203703703703703,0.5828928727453903,1.0,3/15,9.95%,SMAD6;COBL;CXXC4
prerank,cell-substrate junction assembly (GO:0007044),-0.38365585147986675,-1.252200816041552,0.1657142857142857,0.5819174501694505,1.0,13/33,13.62%,SORBS1;FN1;ACTN2;PTPRK;THSD1;ITGA6;PLEC;LAMA3;ITGB4;CD151;TRIP6;BCR;DST
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.44671747351431845,-1.2516522656938642,0.15113350125944586,0.582126141731044,1.0,6/17,13.64%,BCL2L1;SOD2;BAD;BAX;BID;BOK
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.37979022905480914,1.2516050349066477,0.15641711229946523,0.834652315140462,1.0,23/75,17.63%,ISL2;CTNNA2;FARP1;ABITRAM;ANK3;ADGRB1;NEFH;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;OPHN1;SDC2;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;SLITRK1;CDK5;CDHR1
prerank,import into nucleus (GO:0051170),0.3850790409467735,1.2513892221002667,0.152832674571805,0.8336363685500889,1.0,21/73,18.72%,PRICKLE1;CSE1L;GEMIN2;NUP214;FAM53C;NUTF2;POM121;SNUPN;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;SNRPF;TNPO2;IPO9;GEMIN8;NUP155;KPNB1
prerank,GPI anchor metabolic process (GO:0006505),0.4519316916983268,1.25093865836838,0.17886178861788618,0.8335647088351458,1.0,6/26,13.17%,PIGV;GPLD1;PIGQ;PIGP;PIGA;PIGL
prerank,blood vessel morphogenesis (GO:0048514),0.40173263844104395,1.2508198957590615,0.16496350364963502,0.8321632960566316,1.0,3/54,2.78%,LAMA1;COL4A1;GLMN
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.35940075275512273,-1.250638715141111,0.13920454545454544,0.5835539108052196,1.0,6/37,4.25%,IGF1;MEF2C;ADAMTS1;IGFBP5;TPM1;SOD2
prerank,electron transport chain (GO:0022900),0.5288086399916458,1.2503254736577576,0.20435510887772193,0.8321639255852435,1.0,2/15,4.16%,POR;SDHB
prerank,regulation of inclusion body assembly (GO:0090083),-0.5001491721592318,-1.250306769593437,0.21204819277108433,0.5831814045024837,1.0,7/11,32.31%,SNCAIP;DNAJA4;DNAJB1;HSPA1A;DNAJB2;HSPA1B;HSPA2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.39652344906758746,1.2502111857282179,0.16246498599439776,0.8307755218587185,1.0,11/59,11.96%,CYP7B1;ACOX2;OSBPL3;OSBPL6;LIPC;LIPH;PER2;HSD17B8;HOGA1;GAMT;ACLY
prerank,negative regulation of glycolytic process (GO:0045820),0.573689320458565,1.2498010461838618,0.21288014311270126,0.8287130952369747,1.0,3/10,6.86%,PPARA;PFKFB1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.573689320458565,1.2498010461838618,0.21288014311270126,0.8287130952369747,1.0,3/10,6.86%,PPARA;PFKFB1;CBFA2T3
prerank,development of primary male sexual characteristics (GO:0046546),-0.37593494728096466,-1.2497080962236042,0.14749262536873156,0.5835000879522791,1.0,6/34,4.38%,KITLG;CSDE1;LHFPL2;TGFB2;WNT4;NCOA4
prerank,protein import into mitochondrial matrix (GO:0030150),0.4928448150963448,1.2496513897813177,0.20394736842105263,0.8274548260323863,1.0,6/18,20.82%,DNAJC19;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21
prerank,axon development (GO:0061564),0.3781206569495695,1.2494046351505268,0.144,0.8265608988969055,1.0,23/78,17.25%,ISL2;CTNNA2;SEMA5A;ANK3;ADGRB1;NEFH;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;PLP1;ARHGAP35;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;GRM7;SLITRK1;RTN4RL1;CDK5
prerank,negative regulation of protein binding (GO:0032091),-0.3229127015728756,-1.2493682597403644,0.08445945945945946,0.5831504649679075,1.0,23/71,18.23%,CAV1;ACTB;TMBIM6;DAB2;DVL1;MITD1;PTPRF;B2M;GSK3B;ITGB1BP1;NES;STYX;BAX;RALB;TLE5;ATP2A3;CTSZ;CDKN1A;DDX11;PRKCD;HFE;AKT1;IFIT1
prerank,negative regulation of kinase activity (GO:0033673),-0.32601516636988054,-1.2490643146549816,0.11877394636015326,0.582778567651215,1.0,24/62,23.73%,PRKAG2;PPM1E;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;LRP6;ITGB1BP1;MAPT;YWHAG;HSPB1;CEACAM1;PPIA;TRIM27;PRDX3;PAK2;AKT1;GSKIP;DUSP19;CAMK2N1;WWTR1;QARS1;DBNDD2
prerank,vesicle organization (GO:0016050),-0.3499267697731442,-1.2482222946272306,0.11392405063291139,0.5839709936735795,1.0,10/46,7.29%,CAV1;FNBP1L;LAPTM4B;SRGN;SQSTM1;CHMP2B;CD34;CAV2;VPS18;HOOK1
prerank,regulation of stem cell proliferation (GO:0072091),0.4935951070246361,1.2479838540610055,0.21392190152801357,0.8301339781457474,1.0,4/17,11.21%,KDF1;GJA1;EIF2AK2;AGO3
prerank,positive regulation of lipid localization (GO:1905954),0.5614396831050436,1.2477389624803803,0.20490367775831875,0.8292531715587894,1.0,1/11,0.48%,LRP1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4206480349581654,1.2475256286886645,0.17445482866043613,0.828261686115441,1.0,16/39,21.59%,STEAP3;SEL1L;RAB8A;RAB3C;RCN3;RAB15;TMEM167A;MTTP;TVP23B;LTBP2;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,regulation of protein kinase B signaling (GO:0051896),0.33672899415329977,1.2473822677403337,0.08868144690781797,0.8270048091846423,1.0,43/193,17.41%,PDGFRA;NTRK3;PIK3R1;NRG1;PPARA;NTRK2;PTEN;SEMA5A;TCF7L2;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PLEKHA1;PINK1;AXL;TSPYL5;RCN3;FYN;P2RX4;TGFBR1;IAPP;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;PIK3CG;MAZ;ADAM8;RHOG
prerank,inhibitory synapse assembly (GO:1904862),0.5586831808671601,1.2469059813423315,0.22141560798548093,0.8270239692872672,1.0,3/11,10.52%,WNT5A;GABRA1;GABRG2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5700222249161909,1.246742379986941,0.22678571428571428,0.8257900422119248,1.0,1/10,0.33%,SH3RF1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3458867105870182,-1.2463301338037474,0.11666666666666667,0.5878800856531049,1.0,9/48,5.90%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;PRKDC;RAC1;NEDD9;CDC42
prerank,positive regulation of cell adhesion (GO:0045785),-0.31949436857071534,-1.245777514558455,0.10181818181818182,0.5881512965572459,1.0,21/74,13.13%,EPHA4;PTPRJ;AFDN;VIT;TPM1;FOXC2;TGFB2;RAC1;PPM1F;RSU1;ECM2;FRMD5;HYAL1;CITED2;NPNT;STX3;ARL2;MDK;RET;TGM2;ATM
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.49624381091733183,1.2456532406006149,0.2238562091503268,0.8280016502773236,1.0,8/19,17.84%,CDKL5;CAPRIN1;CDKL3;RELN;DHX36;CUX2;IL1RAPL1;CUL7
prerank,regulation of angiogenesis (GO:0045765),-0.272893947604622,-1.2452686909109638,0.027972027972027972,0.5882223478705474,1.0,58/192,17.68%,FLT1;ANXA3;ROCK2;TEK;ITGB8;BMPER;ADAMTS1;FOXC1;ITGB1;NOS3;THBS1;KLF4;SPARC;TIE1;ECM1;CLDN5;KDR;RUNX1;TGFB2;CYP1B1;AMOT;COL4A3;VEGFD;VEGFC;CD34;SEMA6A;GAB1;PGK1;HIPK1;HK2;PPP1R16B;FGF1;NPR1;HYAL1;STAB1;SFRP1;GATA2;SERPINE1;PIK3CD;NIBAN2;ETS1;CTSH;HSPB1;CEACAM1;HIPK2;GATA6;GTF2I;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6;SIRT1;EPHA2;NAXE;HHEX;ERBB2;AGO2
prerank,regulation of cellular component organization (GO:0051128),-0.28616494154937855,-1.2447858744371256,0.06557377049180328,0.5883636503421114,1.0,30/135,14.68%,PLCE1;SNCAIP;TJP1;PICALM;RAPGEF2;ROCK2;MLLT3;LTBP4;NET1;PACSIN2;MARK4;HIP1R;CAMK2D;RAP1A;HSPA8;SOCS2;TFRC;RAPGEF1;APOE;RAB5A;RAB5C;STK38L;FAM107A;PTPN1;NCLN;CEACAM1;SNX17;HIP1;AGTR1;ARHGEF11
prerank,positive regulation of response to stimulus (GO:0048584),0.4150230967303109,1.2446157585838067,0.19025157232704404,0.8301091385582675,1.0,6/40,6.32%,ACOX2;WNT5A;CDKN2A;ANKLE1;FMR1;ECHDC3
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4801808665854928,-1.2445626021643699,0.18475750577367206,0.5877038513304557,1.0,5/13,18.69%,NOS3;CALM1;GCH1;AKT1;PRKG2
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.377541238900857,-1.2441043900627244,0.1359773371104816,0.587692131263581,1.0,15/33,28.65%,GCLC;PRODH;SLC39A8;GOT2;RIMKLB;OAT;NIT2;DDAH1;DDAH2;CAD;GLUL;PYCR2;FPGS;PYCR3;GGT1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4807239423255206,1.2439548509951808,0.19601328903654486,0.8307959095491863,1.0,11/19,26.38%,PRDX5;MTOR;TENM1;ZC3H8;DHX36;CHD8;AR;MAF1;POLR3F;RPTOR;ELL
prerank,plasma membrane invagination (GO:0099024),-0.3838258569258694,-1.2427608759806648,0.18356164383561643,0.5901367996764806,1.0,5/29,5.90%,GULP1;SNX18;DOCK1;GSN;CDC42
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4795436022541297,1.2427107010654967,0.20627062706270627,0.8335411270184782,1.0,4/21,8.15%,CDC14B;PTEN;FBXO5;GOLGA2
prerank,substantia nigra development (GO:0021762),0.4283652273302817,1.2426489629346906,0.19202363367799113,0.8320223584713854,1.0,9/37,14.39%,DYNLL1;GNB4;BASP1;SEC16A;MBP;PLP1;S100A1;HSPA5;NDRG2
prerank,positive regulation of nervous system development (GO:0051962),0.41443428801202775,1.242609700757143,0.16886930983847284,0.8304013963989378,1.0,12/42,17.98%,SRPX2;EPHB1;GRID2;NRXN1;SERPINF1;SYNDIG1;IL1RAP;NAP1L1;SNW1;CUX2;IL1RAPL1;CLSTN1
prerank,positive regulation of transferase activity (GO:0051347),0.3465531325269207,1.242554838340458,0.1214017521902378,0.828820340815338,1.0,30/142,15.70%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;SERINC1;EPHA6;SORL1;HNRNPA2B1;PARM1;PINK1;EPHB6;AXL;RFC3;EPHA3;POLG2;IGF2;GSK3A;DCUN1D5;AXIN1;SERINC5;EPHA5;HNRNPD;MYC;FGFR2
prerank,dendrite self-avoidance (GO:0070593),0.4950753991527356,1.2420389379325345,0.21551724137931033,0.8289929698219335,1.0,6/16,9.95%,DSCAM;CNTN4;DSCAML1;PALLD;NEXN;CNTN6
prerank,carnitine metabolic process (GO:0009437),0.5418566026663005,1.2420269731178948,0.22003577817531306,0.8273117560433363,1.0,7/12,26.27%,ACADL;CRAT;TMLHE;ALDH9A1;CPT1A;CPT1C;CROT
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5259416000772371,1.241898068544501,0.23720136518771331,0.8260811881216307,1.0,2/13,2.01%,ZFYVE28;CBLB
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4340572544621434,1.2415986350116568,0.18926974664679583,0.8253749483777861,1.0,10/35,14.69%,PDE9A;PDE7B;HTR2B;RIMS2;DGKQ;ADCY2;HTR2C;SOX9;AKAP6;EPHA5
prerank,embryonic heart tube development (GO:0035050),-0.47201598234789943,-1.2413367439557381,0.20971867007672634,0.5926955911679549,1.0,5/14,9.88%,MEGF8;ACVR1;SOX17;CITED2;TBX2
prerank,triglyceride biosynthetic process (GO:0019432),0.49347155864397085,1.2411646405969547,0.21247892074198987,0.8252642859526891,1.0,5/18,15.44%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,homeostasis of number of cells (GO:0048872),-0.5038075190751885,-1.241086074065026,0.22142857142857142,0.5921486068481301,1.0,5/12,11.32%,NOS3;NOTCH1;CCN3;CX3CR1;UBAP2L
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5355336407150639,1.240599395331812,0.21428571428571427,0.8255967229755218,1.0,2/13,2.72%,XCL1;MR1
prerank,negative regulation of programmed cell death (GO:0043069),-0.25355681886872034,-1.2405639492314553,0.0,0.5924089571068619,1.0,115/355,22.66%,MECOM;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;IL31RA;LEF1;BCL2L1;EGFR;IGF1R;OSR1;KANK2;XIAP;THBS1;NOTCH2;ANXA5;FSTL1;NFKB1;MCL1;PTMA;KDR;SQSTM1;PRKDC;TMBIM6;CCND2;FAS;ARHGAP10;GCLC;SOCS2;ANXA1;DAB2;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;HIPK3;CD38;BNIP2;UBB;NGF;CASP2;CAT;CARD14;GSK3B;CD44;SH3RF2;GLO1;RPL10;CASP3;CFL1;CITED2;SFRP1;NFKBIA;KLHL20;BNIP3L;NIBAN2;RNF144B;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;HSPB1;BAG3;BID;FLT4;GATA6;FLNA;PTK2B;TPT1;CX3CL1;ARL6IP1;PRELID1;MET;SIRT1;ANXA4;PRKAA1;PDPN;PRDX3;PAK2;SIAH2;YME1L1;CD74;LAPTM5;UBC;HNRNPK;RASA1;AKT1;NUAK2;WNT11;HGF;NPM1;DCPS;DNAJC3;CIB1;SON;PIM2;ASNS;MIF;NAA35;CFLAR;BIRC3;MGMT;DDAH2;HIGD1A;NUPR1;MYO18A;UBA52;SIX4;UFM1;PPIF
prerank,clathrin coat assembly (GO:0048268),-0.45210122763870675,-1.2402986650716603,0.18622448979591838,0.5919343717520067,1.0,7/15,23.01%,PICALM;HIP1R;CLTB;HIP1;CALY;AP2S1;PIK3C2A
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4092084220576653,-1.2402820351939567,0.15789473684210525,0.5907499910768254,1.0,10/27,16.86%,CSNK1D;GBP5;ARFRP1;OPTN;GAK;BICD2;VPS13A;ARL1;VPS13D;RAB6A
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40035438197046214,-1.2401217445889432,0.1683673469387755,0.5899654163975783,1.0,11/24,16.48%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5195553060444229,-1.2400288098594712,0.22787610619469026,0.589066380067414,1.0,3/10,7.13%,RARB;RXRA;TBX1
prerank,regulation of DNA binding (GO:0051101),-0.3497384932948999,-1.240017864041294,0.11455108359133127,0.5878927125625485,1.0,16/44,25.65%,IGF1;LEF1;FOXC1;SKI;SMO;NGF;NFKBIA;SUMO3;HMGB2;CSNK2B;EGF;E2F1;ILRUN;TXN;SUMO1;KDM1A
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.4455227554706255,-1.2394560345106107,0.19285714285714287,0.5880923594223644,1.0,10/16,28.50%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;AOAH;PHKA2;PHKG2;PYGL
prerank,excitatory postsynaptic potential (GO:0060079),0.4924136370405143,1.2393718283495045,0.19023569023569023,0.8283318828385802,1.0,5/19,6.02%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A
prerank,gene expression (GO:0010467),-0.25510513188552475,-1.2392119658037268,0.028985507246376812,0.5876172562776951,1.0,136/348,28.46%,TSPAN5;MEF2A;RPS14;AGFG1;RPS9;SMG6;RPS16;PTMA;RPLP1;RPL13;DRG1;THOC2;RPL27A;THOC1;RPS2;RPL37A;RPL5;WDR33;RPL8;RPS7;RPL41;RPS18;NUP50;RPS20;RPS19;RPS24;RPS27;DROSHA;RPS15;RPL21;RPL10;RPL35A;HNRNPF;RPS15A;RPL10A;RPS5;RPL11;TSPAN17;ABCF1;ALKBH5;RPL36A;EEF1A1;SRSF3;RRAGC;LMF1;NR4A2;SNRNP40;RPL34;POLR2B;NUP98;RPLP2;RPS29;NUP153;RPL32;RPL4;THOC3;RPLP0;POLR2H;SRSF4;RBM4;RPL30;RPL26;RPS4X;HNRNPH1;RPS21;RPL29;SMG5;POLR2G;NOX4;ATXN1;RPS8;POLR2C;RNASEL;NUP43;MRPS7;RAE1;NUP205;RPL31;RPS23;SRSF7;RPL23A;SRSF2;NUFIP1;ALYREF;SRBD1;HNRNPK;HHEX;MRPS17;AGO2;RPL19;RPL36;HOXD3;SEH1L;GSPT2;CREBL2;CLP1;RBM15B;MRPS18A;MRPS18B;RPL17;RPL23;E2F1;RBM8A;NCBP2;DDX20;DDX39A;MRPL24;DDX25;RPS11;NXT1;MRPL55;HSPD1;GSPT1;MAGOH;RPL15;RPL38;HARS2;DUSP11;MRPL36;MRPL35;BICD1;RPL13A;POLR2I;RPS25;POLDIP3;U2AF2;POLR2K;RPS12;MRPS12;RBMS2;FARSB;TSPAN33;MRPL34;RPL24;RPL18A;FASTKD2
prerank,phosphate ion transport (GO:0006817),-0.45337274313452347,-1.2388884614444038,0.1867612293144208,0.5873242954635621,1.0,4/16,12.21%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32114486662887776,-1.2383032969758432,0.09420289855072464,0.587736626863962,1.0,22/67,14.61%,FLT1;ROCK2;DOCK1;WASF2;NRP2;NRP1;KDR;CLEC14A;VEGFD;RAC1;VEGFC;CDC42;NCK1;MAPK14;AAMP;PIK3CB;HSPB1;ITGB3;FLT4;PTK2B;BAIAP2;ELMO2
prerank,negative regulation of inflammatory response (GO:0050728),0.3413127164910767,1.2380683851193672,0.10613207547169812,0.8314097800866588,1.0,29/182,12.46%,RORA;GGT5;ADORA2B;PPARA;ADCY5;CALCRL;NR1H4;TNFAIP8L2;PPARD;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ENPP3;ADCY2;PRKACB;LRFN5;CD200R1;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;PTGIS;GPR27;HTR4;FNDC4
prerank,regulation of immune effector process (GO:0002697),0.42303258506270114,1.237480006014549,0.17862595419847327,0.8318446122507768,1.0,9/41,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,response to chemokine (GO:1990868),-0.4821608669333022,-1.2373383585186157,0.20190023752969122,0.5890824557485462,1.0,3/13,5.92%,LRCH1;FOXC1;WNK1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4214182653762766,1.2364819590687373,0.18410041841004185,0.833891439502061,1.0,7/39,7.26%,CASK;SPRY4;CORO2B;CDKN2A;MAP4K4;GCNT2;PTPRO
prerank,endodermal cell differentiation (GO:0035987),0.43205474242347736,1.2362256590987448,0.18025078369905956,0.8331236322191835,1.0,7/31,8.64%,LAMB1;ITGAV;COL7A1;ITGB5;COL12A1;RTF1;COL4A2
prerank,regulation of microtubule-based process (GO:0032886),-0.3650853702997119,-1.2360014577303766,0.14285714285714285,0.5914922745836755,1.0,16/36,19.08%,PHLDB2;DIAPH1;MARK4;APC;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;CYLD;MACF1;BICD2;PRKAA1;ERBB2;MARK2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3710488979387058,1.2355159594818008,0.16,0.8340861790257665,1.0,23/82,19.99%,DYNLL1;ATF5;DCTN3;HAUS3;HAUS1;HMMR;DCTN2;HAUS8;PRKACA;CEP192;CEP135;TP53;SSNA1;CEP250;CEP152;CSNK1E;CENPF;CLASP1;ALMS1;PCM1;ATAD5;TUBA1A;CEP43
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3504759930802307,-1.2353213931094649,0.14285714285714285,0.5921503552161608,1.0,24/48,29.16%,BCL2L1;MCL1;PRKDC;CASP2;HIPK1;FNIP2;CRIP1;DYRK2;BAX;HIPK2;ATM;BOK;SIRT1;TMEM109;EPHA2;E2F1;IKBKE;BCL2L11;CHEK2;BRCA1;MSH2;SFN;DDIT4;TNFRSF1B
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5179703319706456,1.2352465786013564,0.23623445825932504,0.8333139730142192,1.0,4/14,8.14%,ZEB1;SPRY1;SPRED1;SPRED2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5074231159754794,1.2348580882278881,0.23378839590443687,0.8329642545977431,1.0,5/15,11.18%,SEMA5A;FGFR1;PRKD1;LGMN;P2RX4
prerank,regulation of response to oxidative stress (GO:1902882),0.5521633123023197,1.2347824803670957,0.22163120567375885,0.8315350795419435,1.0,5/11,18.50%,ACOX2;GGT7;PINK1;AIFM2;ALOX5
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4748040435783417,-1.2347641656775188,0.20224719101123595,0.5923711652872191,1.0,4/13,13.27%,NOS3;PRODH;NOS1;DDAH1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.30854758552775857,-1.233953031900014,0.10139860139860139,0.5934133810840021,1.0,34/73,28.33%,ACTB;PPHLN1;HDAC4;DDX21;SF3B1;PRMT7;WBP2;GPX1;PPM1D;SMARCA5;MYO1C;MYBBP1A;POLR2H;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;CTCF;POLR1H;TAF1C;POLR1G;HDAC6;SPHK2;POLR1C;PHF2;PHF1;MTF2;CGGBP1;SPI1;ZFP57;POLR2K;HDAC5;BMI1
prerank,mRNA methylation (GO:0080009),-0.4594304351334856,-1.2334117208427606,0.20050125313283207,0.5936157288034953,1.0,4/15,8.67%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5026216760819666,1.2330369167330146,0.2276707530647986,0.8361413341205293,1.0,6/15,13.81%,ENTPD2;ENTPD5;AK1;AK4;ENTPD7;AK8
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.33668393326169316,-1.232424093401496,0.10443037974683544,0.5950756902205115,1.0,16/51,14.33%,HMBOX1;SMG6;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;STN1;SMG5;ATM;HNRNPC;MAP3K4;TEN1
prerank,peptide cross-linking (GO:0018149),-0.40577761049522787,-1.2314718506973241,0.15489130434782608,0.5964176312941641,1.0,3/25,5.01%,FN1;THBS1;ANXA1
prerank,positive regulation of DNA binding (GO:0043388),-0.3801373573309205,-1.2314371992415094,0.14166666666666666,0.5953021483648501,1.0,11/31,26.33%,IGF1;FOXC1;SKI;NGF;NIBAN2;HMGB2;EGF;TXN;TRIM6;PARK7;RB1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4743819326782321,-1.2305356288342635,0.24545454545454545,0.5965067075469691,1.0,7/13,17.38%,SEMA7A;TGFB2;CUEDC2;PLCG2;SIRT1;CD74;LAPTM5
prerank,regulation of synapse maturation (GO:0090128),0.5730739100946366,1.2305058617181945,0.2460456942003515,0.8437702927923294,1.0,4/10,8.82%,NRXN1;YWHAZ;RELN;ADGRL1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3933090868933001,-1.2298962360984074,0.17403314917127072,0.5969336546792822,1.0,11/25,25.15%,RBPJ;AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;AGT;RTN4;DOK1;CNOT9
prerank,negative regulation of apoptotic process (GO:0043066),-0.2496371881606998,-1.2298314877297902,0.0,0.5958979901574064,1.0,108/444,16.68%,IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;PRKCH;MEF2C;IL31RA;LEF1;CAV1;BCL2L1;FNIP1;EGFR;IGF1R;ITGB1;RETREG1;OSR1;XIAP;THBS1;NOTCH2;ANXA5;FSTL1;KLF4;NFKB1;MCL1;PTMA;KDR;SQSTM1;PRKDC;TMBIM6;CCND2;FAS;ARHGAP10;SOD2;NOTCH1;GCLC;SOCS2;ANXA1;DAB2;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;SIX1;HIPK3;CD38;BNIP2;UBB;NGF;CASP2;NRBP2;CAT;CARD14;TBX1;APOE;GSK3B;CD44;SH3RF2;GLO1;RPL10;CASP3;LAMTOR5;SNX6;CFL1;CITED2;GPX1;SFRP1;NFKBIA;KLHL20;BNIP3L;NIBAN2;RNF144B;NR4A2;CX3CR1;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;MDK;HSPB1;BAG3;BID;FOXQ1;PTRH2;FZD3;FLT4;GATA6;FLNA;PTK2B;TPT1;CX3CL1;ARL6IP1;MAP2K5;PRELID1;PRKCD;TRIM27;SIRT1;ANXA4;PRKAA1;PDPN;PRDX3;PAK2;SIAH2;YME1L1
prerank,positive regulation of neuron death (GO:1901216),0.40791264422310625,1.2297748984751329,0.17510853835021709,0.8447313188878478,1.0,13/46,15.09%,EPHA7;WNT5A;GRIN2B;REST;FOS;TLR6;NF1;C1QA;TLR4;DAXX;FYN;EIF2S1;CLU
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34007949820181893,1.2294520147191987,0.1245593419506463,0.8441906616083534,1.0,50/173,20.27%,SEC16B;DYNLL1;KDELR3;COL7A1;COPA;SEC16A;KDELR2;DCTN3;GRIA1;SPTBN1;ANK3;GBF1;TMEM115;COPZ2;DCTN2;IER3IP1;TRAPPC2L;COPB1;CNIH4;GOLGA2;RAB29;COG6;DCTN4;F8;SEC24B;SAR1A;VAMP4;SCFD1;RAB2A;VAMP7;MCFD2;BGLAP;COG1;DYNLL2;TRIP11;AREG;ERGIC2;SEC24A;TMED3;SEC23A;TMED9;COPG1;MIA3;TRAPPC12;TBC1D20;CNIH3;TRAPPC2;TRAPPC5;COPB2;ACTR10
prerank,myotube differentiation (GO:0014902),-0.4490470111420558,-1.2293920783656112,0.21634615384615385,0.595868055766449,1.0,4/17,4.92%,IGF1;MEF2C;JAM2;SKI
prerank,regulation of protein binding (GO:0043393),-0.2916473488658999,-1.2293416610619625,0.06862745098039216,0.5948066331914911,1.0,32/114,15.54%,RAPGEF2;CAV1;ACTB;HDAC4;APP;CLDN5;HIP1R;TMBIM6;VTN;DAB2;DVL1;MITD1;B2M;PRMT7;GSK3B;ITGB1BP1;RPL11;NES;STYX;BAX;PRMT8;RALB;TLE5;TERT;HIPK2;RAN;AMFR;CTSZ;CDKN1A;DDX11;MARK3;PRKCD
prerank,regulation of cell communication (GO:0010646),0.43015189977004964,1.2292965961970503,0.1966966966966967,0.8430810848679661,1.0,3/35,3.83%,TBX18;MTCH1;RYR2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3135437198272947,-1.2289799506840493,0.10970464135021098,0.5946536715691426,1.0,24/73,13.82%,FN1;ITGB8;PLPP3;DOCK1;ADAMTS1;ITGB1;SEMA7A;ITGA10;ITGBL1;NRP1;FYB1;LAMA3;DAB2;NEDD9;ADAM10;CDC42;ITGB4;LAMA5;ITGB1BP1;ZYX;ITGB3;CEACAM1;DST;PTK2B
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.41645300258607953,-1.2282891529717164,0.16957605985037408,0.5953939541931202,1.0,6/21,8.83%,TUT7;SAMD4A;CNOT10;PARN;PAN3;CNOT8
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5247588636208538,1.2282708884504707,0.23304347826086957,0.8451283327711384,1.0,4/12,14.34%,KDELR3;KDELR2;TAPT1;HSPA5
prerank,sphingosine metabolic process (GO:0006670),-0.4353282261204631,-1.2282612790270255,0.20935960591133004,0.5942908270315366,1.0,4/17,4.52%,SPTLC2;PLPP3;ACER2;ACER3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4249357433895024,-1.227553206884924,0.18085106382978725,0.5949995894340977,1.0,8/20,21.31%,GLYR1;PRKAA2;SOX4;RPS6KA5;NOS1;PRKAA1;TADA2B;RUVBL2
prerank,skeletal system morphogenesis (GO:0048705),0.41056588231684815,1.2274252119405338,0.19420289855072465,0.8465528752561178,1.0,11/42,15.81%,PDGFRA;ANKRD11;FGFR1;HOXC9;DSCAML1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.515883698067539,-1.227358696285495,0.23370786516853934,0.5942818868609295,1.0,5/10,28.79%,APC;CDC42;RCC2;ECT2;SPAG5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.47781302298895373,1.2264102521673497,0.2079866888519135,0.8486567328913296,1.0,9/20,21.61%,MEIS1;MEIS2;ZBTB16;HOXA9;MAFB;LDB1;CDC73;HSPA9;HOXA5
prerank,response to ionizing radiation (GO:0010212),-0.31746966349267924,-1.2262499273711014,0.12878787878787878,0.596240866671222,1.0,33/70,29.74%,EYA1;NET1;ANXA1;MAPK14;RNF8;INTS3;INO80;BRCC3;ATM;EEF1D;GRB2;KAT5;CDKN1A;SMPD1;SIRT1;PRKAA1;CLOCK;DCUN1D3;HUS1;EYA3;FANCD2;RFWD3;RAD51;BRSK1;LIG4;BRCA1;ECT2;RHOB;RHNO1;GADD45A;MSH2;UIMC1;TANK
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.48246321465347386,-1.2260957063879119,0.20094562647754138,0.5955138326457954,1.0,7/13,36.65%,STX3;TYROBP;GPD1L;ABCA7;STX4;RANGRF;RIC3
prerank,T-helper cell differentiation (GO:0042093),-0.45970671266915,-1.2260061005592964,0.21105527638190955,0.5946200082647732,1.0,2/14,0.98%,FOXP1;LEF1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.4825392217363315,-1.2259328974212425,0.21052631578947367,0.5936788893709148,1.0,4/12,12.21%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,negative regulation of neuron differentiation (GO:0045665),0.4638238101299411,1.2258638380801106,0.22131147540983606,0.8491225187575677,1.0,9/22,21.72%,REST;CNTN4;SOX2;BMP7;SOX9;MED1;CALR;HEY1;DTX1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.38118105579814604,-1.2258342828614048,0.15733333333333333,0.5927824844331117,1.0,7/29,6.68%,IGF1;NOTCH2;RASGRF1;SHOC2;NOTCH1;RAPGEF1;NGF
prerank,positive regulation of T cell proliferation (GO:0042102),-0.32807637103881016,-1.2258006758277962,0.1267123287671233,0.5917016506186095,1.0,8/55,6.18%,IGF1;IL18;IGFBP2;ANXA1;IL6ST;SLC7A1;TFRC;NCK1
prerank,negative regulation of proteolysis (GO:0045861),-0.3697294519140174,-1.2257445617404752,0.16139240506329114,0.5907284197545916,1.0,12/34,22.17%,EPHA4;PTPN3;GAS1;CST3;ECM1;TMEM59;SERPINE2;AKT1;CLN8;TIMP3;HDAC6;CAMK2N1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.44920141430213956,1.225730531122647,0.20890937019969277,0.8479182005499858,1.0,7/27,12.54%,ENPP1;PIP4K2A;IRS1;RPS6KB1;PRKCB;TNS2;GSK3A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.49902755335313526,-1.2256835500845413,0.21266968325791855,0.5897133699303038,1.0,5/11,16.48%,MEF2C;EFNB2;FZD7;FRS2;MYOCD
prerank,negative regulation of reproductive process (GO:2000242),0.4906789288218881,1.2255878038078958,0.22030981067125646,0.8467483055904199,1.0,3/17,3.91%,SULF1;GJA1;DUSP1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.44497859326320055,-1.2251839461195955,0.22276029055690072,0.5900579771807223,1.0,7/17,4.36%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;NOTCH1;TGFB2
prerank,regulation of transmembrane transport (GO:0034762),-0.3778131918920114,-1.2251020173045999,0.1834862385321101,0.5891652920504493,1.0,8/31,12.29%,OCLN;ACTB;SLC2A1;WWP2;KCNJ13;CTTNBP2NL;KCNJ2;KCNJ12
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.45117536729965413,-1.2245482170581503,0.21026894865525672,0.589454748335623,1.0,6/17,17.38%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4298445520090787,1.224482729056301,0.19908814589665655,0.8490643987225647,1.0,7/33,8.22%,PIK3R1;PTEN;PIK3R2;HTR2B;IRS1;NF1;PLEKHA1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.45153130045771683,1.2244413994112606,0.20512820512820512,0.8475638402338057,1.0,6/24,14.60%,NAA10;TTLL6;GGCX;AGBL4;TPGS1;VKORC1L1
prerank,activation of adenylate cyclase activity (GO:0007190),0.4344876852598444,1.2244393517928764,0.19490254872563717,0.8458857472232101,1.0,7/35,8.89%,ADORA2B;ADCY5;ADCY8;ADCY3;ACR;ADCY2;ADCY7
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3909548382095854,-1.2241726034502685,0.16844919786096257,0.5893096699367459,1.0,10/25,25.16%,EPHA4;PSMF1;RPL5;RPS7;RPL11;HIPK2;HFE;RPL23;TRIM39;ALAD
prerank,blood vessel diameter maintenance (GO:0097746),-0.3641396625580498,-1.223911023691835,0.17933130699088146,0.588839521799062,1.0,15/34,16.11%,ROCK2;EDNRA;NOS3;GCLC;ACE;KLF2;BDKRB2;ITGB1BP1;NPR1;ADCY6;SCPEP1;NOS1;AGTR1;EDN1;GPER1
prerank,signal peptide processing (GO:0006465),-0.5120028111809231,-1.2238338967961178,0.21634615384615385,0.5878967219163372,1.0,5/11,15.69%,SPCS2;SEC11C;CLN5;FURIN;PCSK5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.47439565922877414,-1.223816280926403,0.22602739726027396,0.5868296764374364,1.0,6/14,23.89%,IL18;NFKBIZ;ANXA1;PRKCZ;SOCS5;CCL19
prerank,metal ion export (GO:0070839),0.4364076319916966,1.223786999914562,0.20793650793650795,0.8467834125824703,1.0,7/31,14.03%,ATP1A2;KCNT2;ATP1A3;KCNIP2;SLC9A1;KCNE4;ATP7A
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.49312932075265836,1.2236917733912274,0.22660098522167488,0.8454566436211942,1.0,7/17,15.15%,ATP1A2;GJA1;RYR2;ATP1A3;PRKACA;GJC3;GJA5
prerank,protein-containing complex subunit organization (GO:0043933),0.3587060113737133,1.2236870004251452,0.1446700507614213,0.8438081520956359,1.0,22/109,12.06%,LAMC1;WIPF1;TEAD1;PPID;CD40;EPRS1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;LLGL1;CAPN3;WASF3;MDM4;KIFAP3;IL1RAP;TP53;RIMS1;DLG4;SOX9;TUBGCP4
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5320649392348125,1.2235745788601815,0.21960072595281308,0.842550879729222,1.0,2/12,1.10%,CXCL10;TMEM102
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4320759100942886,-1.2232341459174658,0.20714285714285716,0.587272076753066,1.0,6/17,14.60%,CAV1;OSR1;KLF7;CEACAM1;APOLD1;MAFG
prerank,regulation of chemokine production (GO:0032642),0.4321405042827134,1.222431679020933,0.20875912408759123,0.8450627259378838,1.0,6/36,10.91%,IL33;WNT5A;TSLP;TLR4;EIF2AK2;PYCARD
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.43676967739350037,-1.2220796709862058,0.1897810218978102,0.589302552931686,1.0,5/18,16.99%,TMBIM6;NRDE2;PTBP3;TERT;ESR1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4248018153153134,1.221252932166377,0.19881305637982197,0.8478418414426215,1.0,4/35,2.23%,GGT5;ACSS3;PAM;GGT7
prerank,multivesicular body assembly (GO:0036258),-0.37593209363936897,-1.2210923060646761,0.16857142857142857,0.5908709317905756,1.0,14/30,28.53%,VPS37A;CHMP2B;VPS37B;IST1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;VPS28;VPS36;CHMP4C;CHMP2A;RAB11A
prerank,macrophage activation (GO:0042116),-0.3637532195503511,-1.2204664581481541,0.16714697406340057,0.5914276617362281,1.0,11/34,18.27%,FOXP1;APP;LBP;NMI;CD93;IFI35;MAPT;PLCG2;CX3CL1;DYSF;IFNGR1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4444647347749674,-1.2204440753138586,0.2163355408388521,0.5903546588578317,1.0,9/15,17.68%,BTG2;TENT4A;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4825686320403836,1.2198169620245902,0.22950819672131148,0.851342524623273,1.0,4/18,9.78%,CORO2B;CCT5;CEP295;CEP135
prerank,neuron projection morphogenesis (GO:0048812),0.3434119499314929,1.2194536436840475,0.13267813267813267,0.8509681539172506,1.0,35/137,17.25%,EPB41L3;ISL2;DOCK10;CTNNA2;PTEN;EPHB1;CNTNAP2;FARP1;ABITRAM;MAP4K4;ANK3;ADGRB1;NEFH;LRRK2;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;BMP7;DLG4;ATP7A;CTTN;SDC2;SGK1;NTNG2;NTNG1;TNIK;FGFR2;BRSK2;NRCAM;IMPACT;SLITRK1;CDK5
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.47745702139749713,-1.2194391334600119,0.22325581395348837,0.5918512722172702,1.0,4/13,2.72%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.48846010824179914,1.2192736892697524,0.2222222222222222,0.849972785410794,1.0,6/18,15.32%,POR;EDN3;FXN;PDP1;ATP7A;GDNF
prerank,nucleotide-excision repair (GO:0006289),0.3570001065747603,1.2188852808881672,0.15104166666666666,0.8496330974185989,1.0,32/101,21.66%,COPS3;ERCC1;ISY1;LIG3;FAN1;POLK;ERCC5;POLA1;RPA1;ERCC4;POLL;UVSSA;XPC;COMMD1;BRCA2;RFC3;TP53;GTF2H3;XRCC1;POLB;COPS4;ATXN3;ERCC2;GTF2H1;MMS19;CUL4A;POLE;POLR2L;USP45;DDB1;CDK7;RFC4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3614072264323092,1.2186853764187293,0.15304798962386512,0.8487305980878042,1.0,26/95,18.21%,MORF4L1;LIG3;MCM7;FAN1;FEN1;POLQ;ERCC5;CDC7;RPA1;ERCC4;POLL;MMS22L;BRCA2;ZFYVE26;REV3L;MCM4;RECQL;SPIDR;POLN;XRCC1;RAD52;PSMD14;MCMDC2;HELQ;WRN;FBH1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5087755547038442,1.2184379854717082,0.23037542662116042,0.8480260460500334,1.0,4/14,15.44%,LPIN3;CHKA;SELENOI;LPIN2
prerank,negative regulation of secretion (GO:0051048),0.5592027613231827,1.218337971516426,0.25905797101449274,0.8467656533688576,1.0,2/10,6.45%,NRG1;SPX
prerank,regulation of developmental growth (GO:0048638),-0.381001266929899,-1.218217955899144,0.16266666666666665,0.5939753935869251,1.0,7/29,7.28%,IGF1;PLCB1;APP;INSR;SIX1;APOE;GSK3B
prerank,phospholipid biosynthetic process (GO:0008654),-0.3535395890734378,-1.218035497022342,0.14814814814814814,0.5933234170230229,1.0,14/36,29.94%,SGMS1;MBOAT1;SGMS2;AGPAT4;CPNE3;FDPS;NUS1;PIP5K1A;DOLPP1;SPHK2;FITM2;AGPAT5;SAMD8;MVD
prerank,protein localization to plasma membrane (GO:0072659),-0.277516744513089,-1.217916660742096,0.08,0.5925528605546255,1.0,27/129,9.21%,TSPAN5;RAPGEF2;ROCK2;ACTN2;BSG;AFDN;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;PACS1;RAMP1;TTC7B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;TTC7A
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4509909072863876,1.217540706882993,0.20063191153238547,0.848028109681022,1.0,7/25,12.54%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A;GLRA1;GSK3A
prerank,protein localization to synapse (GO:0035418),0.5349735049149984,1.2174727178049871,0.24561403508771928,0.8466162453240909,1.0,5/12,18.59%,NRXN2;NRXN1;DLG4;PCLO;MPP4
prerank,positive regulation of ATPase activity (GO:0032781),0.4089280024886149,1.2173429497710806,0.208955223880597,0.8454262543421582,1.0,11/41,19.19%,DYNLL1;RYR2;DNAJC24;MSH3;ALDOB;DNAJC10;DYNLL2;DHX9;MSH6;SSBP1;CHTOP
prerank,negative regulation of lymphocyte activation (GO:0051250),0.46489340471405494,1.21704538528071,0.23709677419354838,0.8449324277911344,1.0,3/21,4.96%,PAG1;TNFAIP8L2;PTPN22
prerank,negative regulation of viral process (GO:0048525),-0.3336739531579832,-1.216840886242744,0.14675767918088736,0.5942710588598171,1.0,18/57,20.87%,MAVS;TRIM5;TRIM11;IFITM3;TRIM14;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;PPIA;TRIM35;TRIM27;ISG15;UBP1;IFIT1;HEXIM1;IFITM2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3970030888286034,-1.2161726499345789,0.20159151193633953,0.5949833756545266,1.0,5/25,15.71%,TMTC2;CAV1;CNNM2;CNNM4;JPH2
prerank,regulation of chemotaxis (GO:0050920),0.4347187788966532,1.2161479291556714,0.22815533980582525,0.8465330046011786,1.0,6/30,11.18%,PDGFRA;MYCBP2;ADGRA2;ZSWIM8;GPR183;P2RX4
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.30328178240094505,-1.2159469422505065,0.0851063829787234,0.5944524362579009,1.0,20/88,9.97%,TEK;CAV1;THBS1;NRP2;NRP1;BMPR2;SPARC;TIE1;ECM1;KDR;VEGFD;VEGFC;CAV2;APOE;XDH;PPP1R16B;ACVRL1;ATOH8;NR4A1;PIK3CD
prerank,metanephros development (GO:0001656),0.4553984167295153,1.2158659317265716,0.22366288492706646,0.8458771412631167,1.0,4/26,9.69%,ROBO2;BASP1;NF1;BMP7
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5599636106645185,1.215830644447373,0.23897058823529413,0.8443746662594539,1.0,4/10,17.29%,SCRIB;PDCD1LG2;PRKAR1A;LGALS9
prerank,dendritic spine morphogenesis (GO:0060997),0.4936904515396324,1.2156953983500292,0.2596491228070175,0.84327841085166,1.0,3/15,2.25%,DOCK10;PTEN;EPHB1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4173399171543268,-1.2156751867261275,0.18232044198895028,0.594020510260221,1.0,9/20,23.65%,ACTN2;OSR1;CAMK2D;GOPC;CAB39;TCAF2;STK39;CASQ2;PLN
prerank,regulation of protein ubiquitination (GO:0031396),0.35246121990964724,1.2156496174057378,0.15572715572715573,0.8418363674664738,1.0,24/108,16.43%,FANCI;PRICKLE1;OGT;MYCBP2;PRMT3;ADGRB1;LRRK2;PSMD10;PER2;PINK1;TSPYL5;COMMD1;BIRC2;DAXX;NDFIP2;TGFBR1;SPRTN;GSK3A;PTTG1IP;AXIN1;UBE2D1;PAXIP1;NDFIP1;USP4
prerank,skeletal muscle organ development (GO:0060538),0.4516102875409849,1.2154045065810228,0.22495894909688013,0.8411248919677521,1.0,3/26,2.11%,SVIL;MSC;BASP1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.33610449229609524,1.215300897369197,0.12895377128953772,0.8399419054441176,1.0,37/150,17.41%,PDGFRA;PIK3R1;NRG1;SEMA5A;TCF7L2;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PINK1;AXL;TSPYL5;FYN;P2RX4;TGFBR1;IAPP;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;PIK3CG;MAZ;ADAM8;RHOG
prerank,fat cell differentiation (GO:0045444),-0.32643260313801176,-1.2150783910944403,0.14695340501792115,0.5944894946545308,1.0,12/57,10.39%,SMAD6;FOXO1;WNT5B;BBS9;OSBPL8;KLF4;OSBPL11;ERAP1;PRDM16;NR4A1;FAM120B;NR4A2
prerank,protein localization to phagophore assembly site (GO:0034497),0.5403850002579211,1.214565807257171,0.26455026455026454,0.841085437199509,1.0,6/11,21.08%,ATG9B;WDR45B;ATG9A;WIPI2;PACS2;MFN2
prerank,regulation of aerobic respiration (GO:1903715),0.4988551287401591,1.214464091090665,0.25601374570446733,0.8398395094751137,1.0,7/15,19.91%,CBFA2T3;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,endoderm formation (GO:0001706),0.4156502185428135,1.2144276719884182,0.21462639109697934,0.8383551266318381,1.0,7/35,8.64%,LAMB1;ITGAV;COL7A1;ITGB5;DUSP1;COL12A1;COL4A2
prerank,protein catabolic process (GO:0030163),-0.32008588672248867,-1.214206664228826,0.12056737588652482,0.5957761020169923,1.0,25/59,25.43%,DDI2;UBE2G1;HSPA8;DENND3;TRIM24;OGA;APOE;VCP;MANBA;NGLY1;RNF41;CEACAM1;CLPX;CLN5;USE1;SIAH2;LAMP2;CLN8;STT3B;PRPF19;RNF5;PSMA8;CLN6;TPP1;CHEK2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.40034158143588083,-1.2139899781085506,0.19012345679012346,0.5952568259444053,1.0,8/24,8.02%,PHLDB2;TJP1;ARHGEF18;WASF2;F11R;CGNL1;TMEFF2;RHPN2
prerank,selective autophagy (GO:0061912),-0.32827652737240504,-1.2133878806828422,0.16,0.5957942842311151,1.0,25/56,22.49%,VIM;RETREG1;BECN1;SQSTM1;ATG13;WDFY3;UBB;USP30;ATG2B;DYNC1H1;ATM;UBE2N;DYNC1I1;ATG2A;UBC;LGALS8;AMBRA1;ARL13B;DYNC1LI1;HDAC6;KLHL3;MAP1LC3B;CFTR;UBA52;UFM1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3853919154591751,-1.213336383089671,0.181360201511335,0.5948076909698308,1.0,11/26,16.73%,FOXP1;KANK2;SMARCA4;DAB2;VPS18;SFRP1;HEYL;VPS11;SIRT1;PER1;CLOCK
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3152955097910683,-1.2133315695964382,0.13385826771653545,0.5937242233616434,1.0,17/68,10.93%,LEF1;WNT5B;CAV1;PLPP3;WNT9A;WNT4;APC;DVL1;FZD4;FZD7;GSK3B;LRP6;RAB5A;WNT6;SFRP1;NR4A2;BCL9L
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.29683229961250074,-1.2132275737637306,0.12941176470588237,0.5929092764386451,1.0,23/86,18.28%,RBPJ;THBS1;BMPR2;FOXD1;NOTCH1;TGFB2;DAB2;GIPC1;CCN1;ACVR1;ACVRL1;CITED2;SH2B1;HIPK2;CDH5;TGFB1I1;GDF11;HFE;ACVR2B;TWSG1;CSNK2B;SOX11;SDCBP
prerank,ncRNA processing (GO:0034470),-0.2644435308121208,-1.2129497353831509,0.031446540880503145,0.5924865559065282,1.0,68/200,22.29%,RPS14;RPS9;DGCR8;RPS16;TUT7;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;DICER1;RPS27;DROSHA;RPP30;RPS15;RPL21;PDCD11;RPL10;RPL35A;INTS3;SMAD3;DDX27;RPL10A;RPL11;RPL36A;RPL34;KARS1;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;SMAD1;RPL29;EXOSC2;INTS9;INTS10;INTS1;RPL31;IMP3;EXOSC3;ADAT1;RPL23A;AGO2;RPL19;RPL36;WDR12;PES1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.47587771383469263,1.2128119621693094,0.2421602787456446,0.8425190820320166,1.0,8/19,23.41%,IL34;PTK2;JAM3;AKIRIN1;CMKLR1;RARRES2;MAPK1;CAMK1D
prerank,regulation of cell motility (GO:2000145),-0.2768702525152459,-1.2127532196727437,0.09392265193370165,0.5918631829210891,1.0,37/121,18.67%,PLXNA2;LMO4;ROCK2;CAVIN1;PLXNA4;EGFR;SPOCK2;NTN1;DIAPH1;AMOT;MINK1;RAC1;INPP5F;CDK6;PRAG1;FGF1;PLXNB1;FRMD5;ARHGAP18;ENPP2;SPATA13;ROBO4;LMNA;CEACAM1;AMOTL2;FLNA;MACF1;SERPINE2;TMSB4X;PLXNA1;PKN2;CCDC25;ERBB2;AKT1;EGF;SPINT2;ERBB3
prerank,nucleosome disassembly (GO:0006337),-0.4543029578562672,-1.2125099414562783,0.22962962962962963,0.5903923937114516,1.0,11/14,42.39%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,chromatin disassembly (GO:0031498),-0.4543029578562672,-1.2125099414562783,0.22962962962962963,0.5903923937114516,1.0,11/14,42.39%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,negative regulation of immune response (GO:0050777),0.33882820728374524,1.2123245593614764,0.17411764705882352,0.8425967255539313,1.0,31/154,17.39%,GGT5;ADORA2B;ADCY5;CALCRL;TRAF3IP1;ADORA2A;DHX58;CRHR2;ADCY8;ADCY3;CALCA;ENPP3;LYAR;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4;COL3A1
prerank,extracellular matrix assembly (GO:0085029),0.4629236778003943,1.2121367717523561,0.21052631578947367,0.8417020241362709,1.0,4/23,4.93%,LAMB1;GPM6B;TNXB;MFAP4
prerank,protein targeting to mitochondrion (GO:0006626),0.3846197549545438,1.2121030147065295,0.2065063649222065,0.8402758223790805,1.0,19/52,24.46%,TIMM10;DNAJC19;IMMP2L;PMPCA;PITRM1;TIMM44;AGK;DNAJC15;PAM16;HSPA4;IMMP1L;GRPEL1;TIMM21;MFN2;GDAP1;CHCHD4;FIS1;TOMM34;SAMM50
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4002731177981338,-1.211842250617065,0.19220779220779222,0.5911771725231246,1.0,8/24,13.82%,EPHA4;CTSC;UBB;APOE;TMF1;GPX1;PSME3;PTK2B
prerank,axoneme assembly (GO:0035082),0.43386009583783264,1.2114907646950674,0.21947449768160743,0.8408585231602671,1.0,8/30,18.53%,RSPH9;DNAAF3;TTC12;DNAI4;CCDC65;GAS8;CCDC39;SPEF1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.34573782785865526,-1.210881540701076,0.1262135922330097,0.5927078800253263,1.0,11/44,13.97%,ANO6;ACTN2;ATP1B3;WNK4;WNK1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3821709744570293,-1.2107690983535562,0.1686746987951807,0.59193444210488,1.0,14/30,28.68%,DKK3;LTBP4;XIAP;FSTL1;SMURF2;SMAD3;TWSG1;SOX11;TGFBR3;SMAD7;FSTL3;SMAD4;TRIM33;FKBP1A
prerank,secretion (GO:0046903),-0.4496283870056761,-1.2106751926771286,0.20623501199040767,0.5911278615069893,1.0,4/14,9.39%,TPD52;SLC22A4;SLC22A6;NPR1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.33520745102006844,-1.2104198304323244,0.15217391304347827,0.5907750757837166,1.0,20/47,24.23%,APOOL;MICOS10;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;TIMM9;ATP5MC2;GHITM;ATP5F1D;ATP5MC1;TIMM13;CHCHD3;TIMM8B;ROMO1;LETM1;NDUFA13;APOO;UQCC3;TIMM10B
prerank,meiosis I (GO:0007127),0.46241346565927505,1.2102452231340124,0.2116564417177914,0.843757296315075,1.0,7/23,15.64%,SGO1;MEIKIN;ZCWPW1;SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,superoxide metabolic process (GO:0006801),-0.38040248772497276,-1.2100992724102841,0.16666666666666666,0.5906362786524391,1.0,14/29,27.12%,SH3PXD2A;NOS3;SOD2;SH3PXD2B;PRDX1;NOX4;SOD3;ALOX12;NRROS;CYBB;MT3;CYB5R4;NCF2;NOXO1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.44090422795647255,-1.209340215437842,0.2469733656174334,0.5916333674290897,1.0,7/16,19.48%,SIK3;LAMTOR5;CLEC16A;PIP4P1;GPR137;SEH1L;RRAGB
prerank,digestive tract morphogenesis (GO:0048546),0.5074000611770265,1.2089004241390107,0.23170731707317074,0.847128490547263,1.0,1/14,0.14%,PDGFRA
prerank,T cell differentiation (GO:0030217),0.40966411698070715,1.2083663069477963,0.20726172465960666,0.847407108134679,1.0,7/40,11.92%,CHD7;MR1;RABL3;PTPN22;ZFP36L2;GLI3;LMBR1L
prerank,regulation of cellular response to heat (GO:1900034),-0.30470219607534743,-1.2077980736697969,0.13333333333333333,0.594744050387179,1.0,22/77,15.99%,PTGES3;CAMK2D;HSPA8;HSPH1;CD34;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;ATR;CAMK2G;NUP98;NUP153;BAG3;ATM;NUP43;HIKESHI;RAE1;NUP205;SIRT1
prerank,regulation of peptide hormone secretion (GO:0090276),0.3795555028095288,1.2077479347186628,0.18498659517426275,0.8480045643715998,1.0,11/67,10.49%,CHD7;RAPGEF4;CACNA1E;ITPR1;PER2;PRKCA;KCNC2;HTR2C;SYT7;GCK;PPP3CB
prerank,sodium ion transmembrane transport (GO:0035725),0.36256361043085383,1.2077188252134052,0.17955439056356487,0.8465486748862812,1.0,16/84,13.62%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;SLC9A9;ATP1A3;SLC9A1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,multivesicular body organization (GO:0036257),-0.36904051109657937,-1.2069738148857565,0.1681159420289855,0.5958192228067128,1.0,14/31,28.53%,VPS37A;CHMP2B;VPS37B;IST1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;VPS28;VPS36;CHMP4C;CHMP2A;RAB11A
prerank,negative regulation of type I interferon production (GO:0032480),-0.3532119537236365,-1.2062927239997525,0.17350157728706625,0.5965259641717484,1.0,17/40,22.94%,NPLOC4;SIRPA;MAVS;TRIM25;PCBP2;RNF125;CYLD;NLRX1;NLRC5;UBE2L6;TBK1;HAVCR2;ISG15;TNFAIP3;ILRUN;REL;IKBKE
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.42219645230575675,-1.2062508010952426,0.21479713603818615,0.5956081099993168,1.0,8/19,15.15%,ELF1;KLF4;IRAK2;RUNX1;MAVS;PARP9;TLE5;MAP2K5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.29247643775998333,-1.2060596229475697,0.11842105263157894,0.59507895228312,1.0,29/94,16.14%,PLCB1;NFKB1;IRAK2;PSMC6;SQSTM1;IL1R1;PELI1;PSMD9;PSMF1;PSMB7;CUL1;TOLLIP;UBB;PSMD8;RPS6KA5;PSMD12;NFKBIA;MAP3K8;TAB2;PSMA3;PSMA6;PSMD4;IRAK4;PSME3;PSMD7;UBE2N;PSMB6;PSMC1;PSMB10
prerank,catecholamine metabolic process (GO:0006584),-0.44215337449616654,-1.205988042926912,0.22911694510739858,0.5942178240205441,1.0,1/14,0.20%,SNCAIP
prerank,lymphocyte migration (GO:0072676),0.42204644558168847,1.2055462270962891,0.21947449768160743,0.8528175465989399,1.0,8/32,20.39%,XCL1;MSMP;CCL15;CCL25;MYO1G;ADAM8;CCL2;CCL14
prerank,mammary gland development (GO:0030879),0.45974214413053616,1.2054391443188732,0.23255813953488372,0.8516200211815907,1.0,5/21,12.48%,NRG1;ERBB4;TBX3;WNT3;ARHGAP35
prerank,response to hydrogen peroxide (GO:0042542),-0.334532189484595,-1.2053835021838426,0.16199376947040497,0.5948407152785604,1.0,21/45,27.34%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;CAT;GPX1;STK25;ANKZF1;PRKCD;SIRT1;PRDX3;APTX;TNFAIP3;ADAM9;HDAC6;PPIF;OSER1;PARK7;ECT2;RHOB
prerank,cellular response to chemokine (GO:1990869),0.3958568312830374,1.2053653848641261,0.20689655172413793,0.8503483293112181,1.0,5/46,5.34%,XCL1;CXCL10;CXCL1;DUSP1;CCL15
prerank,regulation of glucose import (GO:0046324),-0.38147170747477616,-1.2043391217344919,0.20245398773006135,0.5965034692025364,1.0,8/30,5.46%,SORBS1;PRKAG2;IGF1;OCLN;OSBPL8;INSR;RHOQ;GRB10
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.30128353307210975,-1.2041033104086227,0.13636363636363635,0.5960842461415794,1.0,13/80,5.90%,PLCE1;DPYSL3;OCLN;FNBP1L;WASF2;NRP1;MARK4;ANLN;NDEL1;RHOQ;APC;RAC1;CDC42
prerank,oxoacid metabolic process (GO:0043436),0.44524690035081643,1.2040741992076969,0.21061093247588425,0.853454340687737,1.0,3/27,5.29%,ENPP1;TPST1;GRHPR
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4310479386026447,-1.2037949525832836,0.208955223880597,0.5958048168294432,1.0,6/17,18.80%,COX15;COX6C;COX5B;AFG1L;COX4I1;COX6B1
prerank,intracellular protein transmembrane transport (GO:0065002),0.405890565458123,1.203688118245924,0.2027439024390244,0.8532240734277186,1.0,17/42,22.21%,DNAJC19;PEX2;PEX7;SEC63;SEC61B;TIMM44;DNAJC15;HSPA5;RTN2;PAM16;PEX12;PEX14;PEX6;GRPEL1;TIMM21;CHCHD4;C2CD5
prerank,negative regulation of axon extension (GO:0030517),-0.3648595055120247,-1.2036406581009589,0.19220055710306408,0.595237111336514,1.0,14/30,28.07%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B;RTN4;MT3;SEMA3F;RTN4R;RNF6
prerank,neuron projection development (GO:0031175),0.33052636267303664,1.2035006386732474,0.14709371293001186,0.8522929350780628,1.0,39/168,16.35%,NCDN;EPB41L3;LAMB1;DOCK10;GPM6B;ADGRV1;MICALL2;PTEN;EPHB1;CNTNAP2;MAP4K4;LRP12;PPP1R9A;NEDD4;UNC5A;NEFH;LRRK2;CNTN4;TMEM108;DOCK7;STMN2;NPY;BMP7;OPHN1;PLP1;STMN4;DLG4;IFT88;GPRIN1;STMN1;ATP7A;LYN;CTTN;GDNF;SGK1;TNIK;TBC1D23;GRM7;GPRIN3
prerank,cytoskeleton organization (GO:0007010),-0.2835871504244461,-1.2034151743306931,0.08597285067873303,0.5948289181956996,1.0,25/114,9.16%,PLCE1;RHOBTB1;MICAL2;MARK1;FGD5;SYNE3;LARP4;DIAPH1;TPM1;PACSIN2;LRCH3;BRWD3;ARHGAP10;RHOBTB2;RAC1;NEDD9;PLD2;CAPZB;ARAP3;SEMA6A;APOE;CDC42BPB;RHOC;MAST3;CFL1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.49466705819647,-1.2026827091387817,0.2219679633867277,0.5957214532460873,1.0,5/11,21.49%,VCPIP1;STX18;VAPB;ARL6IP1;RTN4
prerank,myeloid cell development (GO:0061515),-0.4336435653358538,-1.2024558201300006,0.21065989847715735,0.5952789685637151,1.0,9/18,29.05%,FOXP1;APP;ALAS1;ABCB10;NRROS;DMTN;SRC;NCKAP1L;ALAS2
prerank,cell part morphogenesis (GO:0032990),-0.4685406332371149,-1.2023220451510264,0.26697892271662765,0.5945725717995565,1.0,2/13,2.52%,MTM1;PACSIN2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.36493130704076515,1.2021031874306993,0.19661458333333334,0.8558113507719294,1.0,10/87,4.55%,PDGFRA;DLC1;LRP1;RND3;HRG;GPM6B;IQGAP3;CORO2B;FSCN1;RAC3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.48247701050952696,1.2020442933383457,0.24120603015075376,0.8544482743964447,1.0,4/16,11.47%,TRA2B;PRDX6;CELF4;SNW1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5182558685410465,1.2018949511070889,0.2517123287671233,0.8534375176266171,1.0,6/13,19.02%,MBTPS2;NR1H2;USP19;CLU;ALOX5;EIF2AK3
prerank,filopodium assembly (GO:0046847),-0.44942028709370446,-1.201693672632006,0.23598130841121495,0.5952175695954586,1.0,5/16,10.42%,FGD5;EZR;SRGAP2;DNM3;SPATA13
prerank,sensory perception of pain (GO:0019233),0.45416502291323546,1.2014682506516654,0.25326797385620914,0.8534294400975664,1.0,4/21,11.18%,TRPA1;NIPSNAP1;PTGES;P2RX4
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.341259484445055,1.200503997194576,0.15679012345679014,0.8553952289226795,1.0,31/124,17.25%,NCDN;LAMB1;GPM6B;MICALL2;CNTNAP2;WDPCP;LRP12;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;DOCK7;FAM161A;PLEKHA1;KIFAP3;STMN2;NPY;OPHN1;PLP1;STMN4;GPRIN1;FAM161B;STMN1;LYN;CTTN;GDNF;TBC1D23;GPRIN3;CYFIP1;CDK5
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5085620903290617,-1.200277280656449,0.2529274004683841,0.59789421617457,1.0,6/10,18.24%,NOTCH1;LRP6;PHACTR4;ARHGAP12;LIN7C;SOX11
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4782387573257587,-1.2001550684511686,0.25688073394495414,0.5971350014069589,1.0,5/11,21.66%,RNF185;VCP;TOR1A;RNF5;UGGT1
prerank,skeletal system development (GO:0001501),0.334548626967651,1.200152744040683,0.14963503649635038,0.8551186189584578,1.0,44/148,20.87%,COL13A1;CHD7;SULF1;TRPS1;COL10A1;WNT5A;ANKRD11;FGFR1;VCAN;GJA1;TBX3;SOX6;ZBTB16;CDH11;CREB3L2;HAPLN2;COL1A2;ALX4;PAPSS2;P3H1;BMP7;TGFBR1;SOX9;IGF2;BGLAP;ATP7A;TRIP11;EVC;HAPLN3;FBN1;HAPLN1;FGFR2;STC1;PTGER4;FRZB;BMP2;HHIP;EIF2AK3;DDRGK1;TRAPPC2;BMP5;PLS3;CMKLR1;RAB33B
prerank,regulation of fibroblast migration (GO:0010762),-0.405787582158408,-1.1996895442222848,0.22055137844611528,0.597197372295986,1.0,9/20,24.22%,ITGB1;THBS1;RAC1;PRR5L;ITGB1BP1;HAS1;RFFL;DMTN;HYAL2
prerank,cellular response to interleukin-15 (GO:0071350),0.5086757124650736,1.199212918213746,0.25084175084175087,0.8554375870057196,1.0,2/13,3.37%,IL15RA;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5086757124650736,1.199212918213746,0.25084175084175087,0.8554375870057196,1.0,2/13,3.37%,IL15RA;JAK1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3948076102914619,1.1991795236652099,0.21037868162692847,0.8540123598835971,1.0,9/48,12.11%,TXK;PDE4B;SCRIB;PTPN22;CD276;TLR8;TLR4;PYCARD;IL12A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4314744737780219,-1.1990998300168794,0.23923444976076555,0.5976801398992846,1.0,6/16,14.01%,THBS1;JCAD;PPP1R16B;GATA2;FGFBP1;AGTR1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.39340875910150125,1.199084314688997,0.2163323782234957,0.8528099504717536,1.0,10/46,9.97%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43249071606165235,1.1990652389468048,0.2229299363057325,0.8513570388888644,1.0,10/35,13.74%,POLG;LIG3;FEN1;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5084271753339753,1.198488930224525,0.23426573426573427,0.8519192703603086,1.0,2/14,6.09%,CCDC22;PSMD10
prerank,sensory perception of taste (GO:0050909),0.5401243794350197,1.1984103925097958,0.2757352941176471,0.8506304798236775,1.0,2/10,7.40%,ASIC2;ASIC1
prerank,ribosome biogenesis (GO:0042254),-0.2625357794846729,-1.1982682842464816,0.061224489795918366,0.5988028906548504,1.0,86/187,30.70%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RIOK1;RPL10;RPL35A;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RAN;RPL31;IMP3;EXOSC3;RPL23A;RPL19;RPL36;WDR12;PES1;NIP7;NPM1;PAK1IP1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52;GTF3A;GLUL;WDR74;PWP2;RPL15;RPL38;MRM2;LTV1;LSG1;RPF2;MRPL36;RPL13A;EXOSC4;RPS25;LTO1;RPL24;RPL18A;WDR75;RRP36;NOP16;BMS1;EIF2A;PIH1D2;NOP53;RRP9;WDR46;RPL22
prerank,embryonic skeletal system development (GO:0048706),0.4172929959481124,1.1980333833803907,0.21550387596899226,0.8504627359225414,1.0,8/35,13.52%,PDGFRA;SULF1;WNT5A;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4
prerank,regulation of stem cell differentiation (GO:2000736),0.3630035178274778,1.1978521952126508,0.1974025974025974,0.8495784902938956,1.0,27/89,19.22%,PDGFRA;PTN;PSMD1;RBM24;KMT2A;PSMD10;ZFP36L2;PSMA5;PSMB5;PSMC4;NUDT21;OCIAD1;EIF2AK2;PSMA4;PSMC5;HOXB4;PSMB9;SMYD5;PUS7;GDNF;PSMA7;JAG1;PSMD14;LDB1;PSMA2;PSMD11;CBFB
prerank,actin filament organization (GO:0007015),-0.27215593859563325,-1.1977581962771116,0.07602339181286549,0.5990791343875003,1.0,37/151,14.61%,NEBL;TMOD3;RHOBTB1;BAIAP2L1;DPYSL3;SHROOM4;SHROOM3;TPM1;MYO1D;HIP1R;GSN;RUFY3;RHOBTB2;RAC1;NEDD9;CGNL1;ARHGAP17;COBL;CDC42;VILL;INPPL1;RHOC;FHOD1;MYO1C;MYO1E;ARHGAP12;CD2AP;LMOD1;SHROOM2;TMOD1;TRPV4;FLNA;DSTN;SHROOM1;HIP1;BAIAP2;ELMO2
prerank,positive regulation of cellular component organization (GO:0051130),-0.2876757952231938,-1.197537683748487,0.08737864077669903,0.5986591918470934,1.0,31/107,16.09%,TRABD2B;ATP10A;FNIP1;IGF1R;SHANK3;INSR;RUNX1;TGFB2;GPC3;DAB2;TFRC;APOE;GSK3B;VCP;RHOC;FNIP2;HYAL1;GPX1;BAX;CAMK2B;CD151;AJUBA;BID;SURF4;ABCB4;CDH5;TAL1;RAPGEF3;SMPD1;MMP1;LMAN1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4241374136292312,-1.196412837339198,0.23037974683544304,0.6005519701822293,1.0,2/17,3.21%,RAPGEF2;ADRA1B
prerank,receptor catabolic process (GO:0032801),-0.3988136010148998,-1.1959729895901623,0.22408963585434175,0.600723252155789,1.0,5/24,8.79%,BECN1;RNF43;UVRAG;SNX25;AP2A1
prerank,SNARE complex assembly (GO:0035493),0.5462212606719113,1.1959300495044227,0.2859744990892532,0.8549771181282169,1.0,3/10,10.82%,STXBP6;VAMP2;VAMP4
prerank,mitotic cytokinetic process (GO:1902410),-0.40692013941070415,-1.1956963782774184,0.23958333333333334,0.6004499363856417,1.0,14/20,38.37%,CHMP2B;MITD1;KLHDC8B;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.38771867280973565,-1.1951487400213283,0.22105263157894736,0.5998529449704599,1.0,9/23,26.16%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.38771867280973565,-1.1951487400213283,0.22105263157894736,0.5998529449704599,1.0,9/23,26.16%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3439189444660212,1.1947162154160555,0.16216216216216217,0.8576978764589887,1.0,10/101,6.09%,CEMIP;IL34;EDN3;WNT5A;CD40;FGFR1;HTR2B;LRRK2;MTCP1;PSMD10
prerank,recombinational repair (GO:0000725),0.36501078062711256,1.1941073089158454,0.19485791610284167,0.8583633089299596,1.0,22/77,18.21%,MORF4L1;LIG3;FAN1;FEN1;POLQ;ERCC5;RPA1;ERCC4;POLL;MMS22L;BRCA2;ZFYVE26;REV3L;RECQL;SPIDR;POLN;XRCC1;RAD52;PSMD14;HELQ;WRN;FBH1
prerank,regulation of cholesterol transport (GO:0032374),0.46461288270611506,1.1933971003596793,0.2358490566037736,0.8593377032738866,1.0,3/20,4.06%,LRP1;OSBPL6;NR1H2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3073988068828697,-1.1933523839523767,0.16194331983805668,0.6034454370692768,1.0,22/73,13.95%,ROBO1;CASP8AP2;TNFSF10;ACER2;HIP1R;FAS;COL4A3;EGLN3;CRADD;NGF;CASP2;XDH;VCP;MAPT;SMAD3;CASP8;BAD;BAX;BID;ATP2A3;BOK;HIP1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.29816803948255144,-1.1931829646716807,0.14122137404580154,0.60287252743868,1.0,22/80,12.46%,EPHA4;PICALM;ROCK2;VIM;LARP4;THBS1;ELAVL1;PRKDC;NIBAN1;SAMD4A;SMPD3;LARP4B;RPL5;SIRT3;SOX4;CASP3;PYM1;CPEB3;PLA2G6;RPL26;EIF3D;RPS4X
prerank,negative regulation of JNK cascade (GO:0046329),-0.3701032691050777,-1.1926860484228001,0.19384615384615383,0.6031587091206354,1.0,8/31,16.20%,MECOM;SIRPA;HIPK3;SH3RF2;HDAC3;CYLD;MAPK8IP1;PER1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3673179326656232,-1.1925946492270285,0.2169811320754717,0.6023516201877522,1.0,13/29,24.22%,CAV1;THBS1;TNFSF10;WWOX;SFRP1;RET;BID;CYLD;GPER1;PAK2;AGT;BCL10;HYAL2
prerank,regulation of cell aging (GO:0090342),-0.4782923779721488,-1.1925755140898198,0.2367816091954023,0.6013806633281906,1.0,6/11,26.03%,NEK6;LMNA;VASH1;MIF;PNPT1;RSL1D1
prerank,regulation of secretion by cell (GO:1903530),0.3862421722151279,1.1925701193952953,0.21203438395415472,0.8608563435308628,1.0,14/54,12.84%,HCRT;CHRNB4;DNAJC1;VAMP2;FMR1;RAB8A;LLGL1;RAB3C;RIMS2;HTR1A;P3H1;RIMS1;RAB15;ARFIP1
prerank,cellular response to lipid (GO:0071396),0.32420629710218213,1.1922833425359445,0.14501160092807425,0.8603286299876904,1.0,35/191,14.07%,RORA;CXCL10;ADCY5;ATP1A2;WNT5A;CXCL1;GPLD1;PDE4B;NR1H4;NCOA3;PDCD1LG2;SPP1;ATP1A3;IRS1;ADCY8;ADCY3;CD68;ADCY2;AXL;TLR4;WNT3;PLAA;IRAK1;EPHA3;PYCARD;SNW1;SOX9;HTRA2;CD86;PDCD4;TESC;NRIP1;MED1;MAP4K1;LYN
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4905653498065596,-1.1915815906850833,0.2505800464037123,0.6030386385510779,1.0,4/10,10.36%,SHANK3;APP;RAB5A;CAMK2B
prerank,regulation of embryonic development (GO:0045995),-0.3541916001031008,-1.1913952805968333,0.1826625386996904,0.6025154338379853,1.0,9/34,11.51%,PHLDB2;PLCB1;INSR;B4GALT5;TRIP12;SOX17;CFL1;NIBAN2;DAG1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.46189933728545524,-1.1908652589910413,0.24752475247524752,0.6028438588646136,1.0,5/12,15.08%,CYP26B1;DHRS3;KLF2;TRIM16;EZH2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.37538383710191797,1.1905743632289236,0.1986013986013986,0.8619264855210184,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,vesicle coating (GO:0006901),0.37538383710191797,1.1905743632289236,0.1986013986013986,0.8619264855210184,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,COPII vesicle coating (GO:0048208),0.37538383710191797,1.1905743632289236,0.1986013986013986,0.8619264855210184,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,positive regulation of histone modification (GO:0031058),-0.3584995443530189,-1.190476123298921,0.1873198847262248,0.6028653230361135,1.0,13/33,25.89%,GLYR1;RPS6KA5;SAP30BP;AKAP8;NOS1;UBE2N;CDK9;ZBTB7B;TADA2B;RUVBL2;APLNR;KDM1A;BRCA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4611856004963038,1.190352615200788,0.24587458745874588,0.8597058824798994,1.0,9/21,20.55%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4611856004963038,1.190352615200788,0.24587458745874588,0.8597058824798994,1.0,9/21,20.55%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.41114037823222516,1.1902357463882531,0.2241112828438949,0.8586447043064239,1.0,7/34,10.09%,PDGFRA;PIK3R1;PIK3R2;IRS1;PTK2;PRKD1;FGR
prerank,regulation of humoral immune response (GO:0002920),0.40463240609121154,1.1899671984458104,0.20916030534351146,0.858180374688667,1.0,9/44,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,negative regulation of binding (GO:0051100),-0.3016826187704969,-1.1891211814413716,0.1606425702811245,0.6053837287450811,1.0,22/81,15.54%,LEF1;CAV1;ACTB;TMBIM6;SMO;DAB2;DVL1;MITD1;GSK3B;ITGB1BP1;NES;STYX;BAX;NFKBIA;ARHGAP28;SUMO3;RALB;TLE5;CTSZ;CDKN1A;DDX11;PRKCD
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.42971876313555063,-1.1889843814910432,0.26097560975609757,0.6046972519121172,1.0,4/16,4.38%,DDX5;RBFOX2;PPARGC1B;NCOA4
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3462844091842659,-1.1887517008597706,0.18153846153846154,0.6042381891695486,1.0,10/36,18.05%,MECOM;FOXO1;EZR;SIRPA;SH3RF2;HDAC3;CYLD;PPIA;PER1;DLG1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.40557678548387815,-1.1883015606575476,0.23869346733668342,0.6043445525037621,1.0,8/20,13.64%,BCL2L1;MCL1;FAS;CASP2;GSK3B;CASP3;BAX;BOK
prerank,mitochondrion distribution (GO:0048311),-0.47435818216673276,-1.188087990835121,0.26405867970660146,0.6039000890562468,1.0,5/12,17.36%,MEF2A;MTM1;MAPT;TRAK2;MSTO1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.34917568654474285,1.1880146992063216,0.19638242894056848,0.8636873150758215,1.0,27/110,17.33%,ADGRL3;CXCL10;PTGFR;ADCY5;CALCRL;GPR3;ADGRB2;ADGRB1;ADORA2A;ADCY8;ADCY3;CALCA;ADCY2;LPAR3;ADGRB3;ADGRL1;ADCY7;LPAR1;GPR26;IAPP;GNG2;S1PR2;LGR5;LHCGR;ADGRE5;PTGER4;ADRA2A
prerank,protein localization to lysosome (GO:0061462),0.42394898407104215,1.187902902014102,0.2453125,0.8625990520313941,1.0,8/28,12.94%,SORL1;NEDD4;SZT2;SNX16;AP3M1;RNF128;HGS;CD81
prerank,positive regulation of lipid storage (GO:0010884),-0.395830957691279,-1.1877499621445335,0.23857868020304568,0.6037204842582291,1.0,4/21,6.66%,NFKB1;OSBPL11;SREBF2;SCARB1
prerank,zinc ion transmembrane transport (GO:0071577),0.454499733943432,1.1874752058796176,0.25,0.8625618924973086,1.0,7/22,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A13;SLC39A14
prerank,amino sugar metabolic process (GO:0006040),-0.5133152111456434,-1.1870296013034933,0.24342105263157895,0.6045869743422649,1.0,3/10,5.10%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.45837286727114973,1.1869721578940295,0.25274725274725274,0.8628683462947243,1.0,5/22,9.69%,IL1RN;GCNT2;FLOT2;MBP;BMP7
prerank,cGMP biosynthetic process (GO:0006182),-0.49497756703913287,-1.1868776823798999,0.26450116009280744,0.603910784423478,1.0,4/10,27.99%,GUCY1A1;NPR1;GUCY2C;GUCY1B1
prerank,maturation of LSU-rRNA (GO:0000470),-0.38343001667420923,-1.1868623530810962,0.2048780487804878,0.6029417901694605,1.0,11/26,27.54%,NSA2;RPL10A;NIFK;WDR12;PES1;RRP15;LAS1L;NOP2;RSL1D1;RPF2;NHP2
prerank,tRNA 5'-leader removal (GO:0001682),0.5150061232295854,1.1863959221675149,0.26181818181818184,0.8632910465213922,1.0,4/13,9.77%,RPP40;POP5;PRORP;POP7
prerank,positive regulation of cell differentiation (GO:0045597),-0.259399182950303,-1.186366911591501,0.07142857142857142,0.6032037454449829,1.0,50/237,12.31%,RANBP3L;IGF1;PLCB1;RAPGEF2;KITLG;CDON;SOX5;PRKCH;MEF2C;LEF1;BOC;IL18;FOXC1;CCN2;NBL1;MEF2A;SLC6A6;NFKB1;BMPR2;IGFBP3;KDR;RAP1A;CDS1;TGFB2;WNT4;DAB2;CD34;IL6ST;MAPK9;CDC42;MAPK14;BNIP2;NGF;CCN1;PKDCC;ACVR1;ACVRL1;SMAD3;IFITM1;SFRP1;CCN4;SPAG9;VHL;NPNT;BCL9L;RPS6KA1;MDK;HEYL;RBM4;CEACAM1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.43998207600955097,1.1861385013571029,0.2384,0.8627169158574145,1.0,10/26,13.87%,PTEN;NRXN1;LRRK2;TMEM108;RIMS2;RELN;RIMS1;DLG4;CBLN1;CUX2
prerank,glucan catabolic process (GO:0009251),-0.43191739434100385,-1.1860008535396849,0.24299065420560748,0.6032159919300008,1.0,9/15,28.50%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;PHKA2;PHKG2;PYGL
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.49605824005901655,1.185618215978363,0.2778702163061564,0.8631474140424995,1.0,2/14,4.72%,ACOX2;CRAT
prerank,tryptophan metabolic process (GO:0006568),0.5217063776854223,1.185576646734437,0.26618705035971224,0.8618169510038647,1.0,3/11,17.56%,KYNU;ATP7A;KMO
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4369679687985294,-1.1854356139204956,0.26150121065375304,0.6035915943935832,1.0,4/17,5.48%,PRKAG2;CAV1;ADIPOR2;PRKAA2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.535779130569234,1.1852873716313594,0.25846702317290554,0.8614111046638989,1.0,6/11,27.34%,REST;PINK1;NONO;HIF1A;ATF4;NR4A3
prerank,cytoplasmic translational initiation (GO:0002183),-0.4225690950062528,-1.1852735436804491,0.23703703703703705,0.6030087487852197,1.0,6/17,16.94%,EIF5;EIF2S2;MCTS1;RBM4;EIF3D;EIF4H
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3300021134211196,-1.185102533084535,0.18575851393188855,0.6024094165174554,1.0,12/46,9.64%,MAP3K1;PIEZO2;CASP8AP2;NFKB1;F11R;FAS;CRADD;MAP2K4;CASP2;CASP8;BAD;IRF1
prerank,aortic valve morphogenesis (GO:0003180),-0.37354105521012126,-1.1847533925509592,0.19113573407202217,0.60233300702692,1.0,7/30,4.26%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;TIE1;NOTCH1
prerank,regulation of cholesterol esterification (GO:0010872),-0.4994927932650778,-1.1842940615072248,0.2660332541567696,0.6024995545874886,1.0,4/10,20.22%,APOE;STARD4;AGTR1;AGT
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3326821186820341,1.1841029575802444,0.1816009557945042,0.8640737055695059,1.0,22/142,11.67%,PDGFRA;PTGFR;ADCY5;ATP1A2;WNT5A;C5AR1;P2RY1;CCR9;ACKR2;RYR2;ADCY8;CALCA;C1QTNF1;CALB1;LPAR3;TRPC3;PRKACA;CCKBR;LPAR1;DLG4;IAPP;TRPC7
prerank,COPII-coated vesicle budding (GO:0090114),0.36495021956233564,1.183762555735973,0.2129120879120879,0.8638469842606383,1.0,23/68,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;SAR1A;PPP6C;SCFD1;MCFD2;SCAP;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;MIA3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,ERBB signaling pathway (GO:0038127),0.36845509595756365,1.1836091850534984,0.20568335588633288,0.8629152127026137,1.0,13/64,13.06%,PIK3R1;NRG1;SLC30A10;ERBB4;PTPRR;NRG2;PDPK1;NRG4;PTK2;PRKCA;SOX9;CUL5;GAREM1
prerank,microtubule depolymerization (GO:0007019),0.4802465052557985,1.1834832430269013,0.23488773747841105,0.8618768432040241,1.0,6/17,15.36%,NCKAP5L;STMN2;CCSAP;STMN4;STMN1;KIF2A
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33920785980335905,1.183128440041672,0.17312348668280872,0.8616387249947407,1.0,28/125,15.82%,DYNLL1;BUB1B;CENPU;EFHC1;DCTN2;SGO1;CENPE;SUN2;GPSM2;NSL1;PTPA;TBCE;SPDL1;RCC1;NUSAP1;RMDN1;CENPC;INCENP;CEP126;NUP107;EML1;BUB1;STMN1;DYNLL2;CLASP2;KIF2A;CENPF;CLASP1
prerank,ceramide transport (GO:0035627),-0.4683174533763809,-1.1828889669554687,0.25635103926096997,0.6050824951742921,1.0,5/12,20.98%,CERT1;PLTP;ABCB4;PSAP;GLTP
prerank,cellular defense response (GO:0006968),0.39456339087902037,1.1822314390959858,0.22822822822822822,0.8632996512365041,1.0,5/40,5.64%,ADORA2B;CLEC5A;C5AR1;CCR9;ADORA2A
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.39684590708177514,1.1822275557023145,0.23554913294797689,0.8618467625866665,1.0,9/43,6.89%,PPARA;TEAD1;GNL3;NFATC3;NGFR;PPARD;REST;FOS;SRF
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3961122450016181,-1.1821854172540964,0.21614583333333334,0.6059229371679509,1.0,14/20,37.20%,SLC8A3;MICU1;MCUB;SMDT1;YME1L1;MCUR1;LETM1;MCU;SLC8B1;MICU2;PMPCB;STOML2;SLC25A23;SPG7
prerank,neurotrophin signaling pathway (GO:0038179),-0.40487715518120126,-1.1819378086197792,0.2297650130548303,0.6055713380771578,1.0,10/21,19.23%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF;CASP3;FRS2;GRB2;KIDINS220;SOS1
prerank,regulation of cellular component size (GO:0032535),-0.36215534293185186,-1.1818538566607317,0.21937321937321938,0.604801476081118,1.0,7/30,8.25%,PICALM;EZR;RDX;RIN3;RAP1GAP2;RAC1;LAMTOR5
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2932159846502573,-1.1818323978776166,0.16591928251121077,0.6038682606697934,1.0,29/94,16.97%,DDX5;BCL2L1;PPP1R13B;ARL6IP5;MCL1;PRKDC;MAP3K5;CYP1B1;PRODH;CUL1;JMY;CASP2;PPM1F;FNIP2;CRIP1;BAD;BAX;MYBBP1A;HIPK2;ATP2A3;ATM;BOK;HINT1;CDKN1A;ERN1;PRKCD;CUL3;AIFM1;EPHA2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5467435274917396,1.181433425815813,0.27845884413309985,0.863187887446071,1.0,2/10,4.06%,ABCD2;NR1H2
prerank,RNA catabolic process (GO:0006401),0.39182532117711794,1.1809781136835567,0.23356643356643356,0.8633713075640196,1.0,13/46,17.92%,RNASEH2C;AGO4;FEN1;ZC3H12D;ZFP36L2;AGO3;MTREX;RNASEH2B;DIS3L2;HNRNPD;RNASEH1;PPP1R8;DXO
prerank,glycolytic process (GO:0006096),-0.37203646661440637,-1.1809615500019595,0.25287356321839083,0.6051292972953861,1.0,14/28,20.82%,HK1;LDHA;PGK1;PFKFB2;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS;PGM1
prerank,negative regulation of T cell proliferation (GO:0042130),0.4278067103808482,1.1809159706904666,0.2643312101910828,0.8621224145000381,1.0,7/28,17.29%,GLMN;SCRIB;PDCD1LG2;TNFRSF21;CD86;PRKAR1A;LGALS9
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4951598313445502,1.1806180032967288,0.27001862197392923,0.8617074443259088,1.0,5/13,14.93%,WNT5A;TSLP;AXL;TRIM44;DHX9
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.42846364009788107,-1.17991057323949,0.2300469483568075,0.6069447199675292,1.0,7/16,10.44%,PDGFD;PTPRJ;FER;NRP1;PDGFA;PDGFC;PTPN1
prerank,positive regulation of RNA splicing (GO:0033120),0.41734909855745417,1.179848398180519,0.26006191950464397,0.8628714884484687,1.0,8/29,17.90%,PIK3R1;TRA2B;PRDX6;CELF4;SNW1;RBM20;HNRNPLL;HABP4
prerank,myelin assembly (GO:0032288),0.5406813692573788,1.1797979984120377,0.297153024911032,0.8616034221407601,1.0,2/10,4.49%,EPB41L3;TENM4
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3728936941959375,-1.1788996167844474,0.22514619883040934,0.6086435162462022,1.0,6/30,6.76%,ROBO1;NET1;F11R;GPR4;RAC1;PRAG1
prerank,zinc ion transport (GO:0006829),0.45361982564803566,1.1788350094800952,0.24324324324324326,0.863571786492251,1.0,7/21,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A13;SLC39A14
prerank,peroxisome organization (GO:0007031),0.44292309835707894,1.1787589478640543,0.2609375,0.8624320170683415,1.0,10/25,18.90%,SEC16B;ABCD2;PEX2;PEX7;PEX11A;PEX19;PEX12;PEX3;PEX14;PEX6
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4684212220809196,-1.1774866123424055,0.27102803738317754,0.6115064274952453,1.0,4/12,3.37%,PODXL;PROM1;MAGI2;IQGAP1
prerank,regulation of neuron differentiation (GO:0045664),0.35938470059048133,1.1773506116713073,0.21136063408190225,0.8659435197150152,1.0,18/76,18.46%,ZEB1;ZFHX3;TCF4;FGFR1;REST;LRRK2;CNTN4;BEND6;SOX2;BMP7;MED1;NRCAM;IMPACT;BRINP1;CALR;BMP2;HEY1;RHOA
prerank,epithelial tube morphogenesis (GO:0060562),-0.3586379996379549,-1.1772939746888034,0.19220055710306408,0.6110353933793019,1.0,9/32,8.00%,MEF2C;SLIT2;PODXL;RASIP1;GLI2;MEGF8;ACVR1;ACVRL1;SOX17
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.47493044756226155,-1.1767483080092385,0.2511737089201878,0.6114933563680248,1.0,4/11,20.55%,NRP1;RAC1;HGF;MST1R
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2697999421135369,-1.1766782685705872,0.12903225806451613,0.610693878657615,1.0,44/152,16.14%,RSPO3;WNT5B;CAV1;EGFR;XIAP;NFKB1;RNF146;SMARCA4;CSNK1D;PSMC6;PSMD9;RSPO2;KANK1;TBL1X;SKI;PSMF1;GPC3;PSMB7;LGR4;SULF2;WNK1;WLS;SOX4;TNKS2;VCP;SMURF2;PSMD8;PSMD12;SFRP1;GID8;TERT;PSMA3;DKK2;PSMA6;PSMD4;CSNK1G3;PSME3;MACF1;PSMD7;PSMB6;PSMC1;FAM53B;ATP6AP2;PSMB10
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2702420583577855,-1.1761271088105663,0.1111111111111111,0.6111469202734622,1.0,36/150,12.75%,PRKAG2;SMAD6;PPM1E;CAV1;OCLN;SLIT2;PLPP3;TRIB2;DEPTOR;SIRPA;PARD3;IGFBP3;PRKDC;NIBAN1;DVL1;ERRFI1;NCK1;CEP85;CALM1;PPM1F;MVP;SNX25;XDH;PRR5L;LRP6;ITGB1BP1;YWHAG;DMD;SFRP1;PPEF2;EPHB2;TARDBP;HSPB1;CEACAM1;SPRED3;PRKCZ
prerank,urogenital system development (GO:0001655),-0.46851683804625477,-1.1761132197767394,0.2684563758389262,0.6101990756057097,1.0,4/11,17.96%,OSR1;ANXA1;EPHB2;EPHB3
prerank,regulation of gastrulation (GO:0010470),-0.46336796337292335,-1.175972898548346,0.27611940298507465,0.6095966104629416,1.0,2/14,2.04%,PHLDB2;OSR1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.38748709610453835,-1.1758525799759023,0.2136986301369863,0.6089324961777538,1.0,10/24,16.26%,CCN1;CD44;TMEFF2;RHOC;ACVRL1;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,tRNA 5'-end processing (GO:0099116),0.4916702720569099,1.1754767213774124,0.28970331588132636,0.8710019848699958,1.0,8/15,23.78%,RPP40;POP5;PRORP;POP7;RPP21;POP4;TRMT10C;SSB
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4601555553232472,-1.175208803781437,0.2660098522167488,0.6095124248076583,1.0,3/12,4.21%,DPYSL3;CTPS1;CTPS2
prerank,organophosphate biosynthetic process (GO:0090407),-0.3420745175227609,-1.1749424292058468,0.19710144927536233,0.6091971972015362,1.0,7/37,7.94%,MBOAT1;TPK1;ITPKB;AGPAT4;NFS1;IP6K2;TPI1
prerank,homologous chromosome segregation (GO:0045143),0.4496236817770378,1.17486991713527,0.2504145936981758,0.8717868701714915,1.0,4/20,12.24%,SGO1;MEIKIN;ZCWPW1;CENPC
prerank,mitotic spindle organization (GO:0007052),0.3272261570774053,1.1748111534639718,0.19181286549707602,0.8705470082817568,1.0,34/153,15.82%,DYNLL1;BUB1B;CENPU;CCDC61;LSM14A;EFHC1;AAAS;DCTN2;SGO1;CENPE;SUN2;GPSM2;GOLGA2;CEP192;NSL1;PTPA;TBCE;SPDL1;RCC1;RMDN1;CENPC;INCENP;CEP126;NUP107;EML1;BUB1;MAP9;STMN1;DYNLL2;CLASP2;KIFC2;KIF2A;CENPF;CLASP1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.4369782469022991,-1.1747843989115831,0.2582278481012658,0.6086872023742439,1.0,5/15,7.89%,RAI2;RICTOR;TGFB2;STOX2;CELF1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31604159300113327,-1.1746604944755628,0.16891891891891891,0.608011014976811,1.0,18/55,16.14%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;PSMC1;PSMB10
prerank,protein-containing complex assembly (GO:0065003),0.3141952794115912,1.1743584117889836,0.15748898678414097,0.8707119901408577,1.0,75/259,19.85%,SEC16B;LAMC1;WIPF1;TEAD1;HDAC1;PPID;TCF7L2;CD40;COL7A1;PYGO1;SEC16A;EPRS1;RSPH9;GRIA1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;BCL9;LRRK2;TLE2;NOL3;SLC9A1;LLGL1;ADCY8;CAPN3;COL16A1;WASF3;TRAPPC2L;MDM4;GOLGA2;KIFAP3;OPA1;TLE1;IL1RAP;F8;SEC24B;DNAJB12;PPP6C;GSDMD;TP53;RIMS1;SCFD1;DLG4;WDCP;MCFD2;SOX9;TUBGCP4;CAND1;AXIN1;RIPK1;FERMT2;TFAP4;DHX9;AREG;MYC;DET1;PDZD11;FERMT3;TRAPPC10;PPP6R3;SEC24A;DNAJB14;SEC23A;ASH2L;TSPAN4;MDN1;PEX14;TBC1D20;ST13;CNIH3;TRAPPC2;TRAPPC5;CDC73
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3485828503297906,-1.1736425368819148,0.19382022471910113,0.6096847157355975,1.0,18/36,28.33%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;YAF2;BMI1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.3903721847841672,-1.1733597609290847,0.23497267759562843,0.6093987748323056,1.0,3/21,2.31%,IGF1;ADAMTS1;IGFBP5
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.32823969828272964,1.1733474775214792,0.19691577698695137,0.87283996963516,1.0,43/161,18.28%,TBX18;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CHD8;AMER2;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LZTS2;PSMA2
prerank,sterol metabolic process (GO:0016125),-0.3085423492213303,-1.1732157134170687,0.19434628975265017,0.6088189992552865,1.0,20/60,21.56%,PRKAG2;CYP26B1;LBR;CYP39A1;CYP1B1;FDX1;RXRA;APOE;LIPA;PIP4P1;SOAT1;PMVK;FDXR;CYP51A1;INSIG1;INSIG2;CLN8;OSBPL1A;EBP;TSKU
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.46618806589118134,-1.173125979933358,0.2645631067961165,0.6080801933456053,1.0,5/12,25.14%,TNKS2;PARP10;PARP1;PARP2;PARP12
prerank,positive regulation of signal transduction (GO:0009967),-0.25059458460880646,-1.172761154911443,0.06201550387596899,0.6079724817937737,1.0,60/238,16.38%,SORBS1;TSPAN5;IGF1;VWF;TEK;LIMS2;RBPJ;RSPO3;ROBO1;MAML2;NOS3;TPD52L1;SHANK3;NRP1;SMARCA4;VPS35;FAS;JCAD;NOTCH1;RSPO2;TGFB2;VTN;KANK1;CCN3;SKI;SMO;GRB10;SULF2;IL6ST;CAV2;CRADD;KLF2;EPN2;WLS;SHANK1;CCBE1;FGF1;ITGB1BP1;CITED2;SFRP1;BAX;TRIM16;MYO1C;CD63;DLG5;ITGB3;TERT;PRKCZ;TTC23;GKAP1;FLNA;MACF1;PTK2B;CDKN2AIP;ERN1;ESM1;SIRT1;ATP6AP2;GPER1;ING5
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4589595017941295,-1.1727451017457067,0.25790754257907544,0.6070398344952996,1.0,5/13,18.43%,ANO6;AZIN1;P2RX7;ACSL5;SLC26A6
prerank,negative regulation of blood pressure (GO:0045776),-0.4525854272371294,-1.1726035128788652,0.25485436893203883,0.606486974614042,1.0,4/13,12.69%,NOS3;BMPR2;SCPEP1;NOS1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.31471879084046567,-1.1724876585524227,0.17525773195876287,0.6058422845663122,1.0,23/55,27.96%,THBS1;CYP1B1;RAC1;MAPK14;XDH;RNF41;AGTR1;GRB2;CDKN1A;ACE2;PID1;SIRT5;MPV17;AGT;ROMO1;TGFBR2;SPHK2;MT3;CBR1;BRCA1;NOXO1;GADD45A;ARF4
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3455643351591576,-1.17225424116616,0.2,0.6054526560715467,1.0,19/38,28.33%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;RHNO1;YAF2;BMI1
prerank,visual perception (GO:0007601),0.3523079061376723,1.1718581411887223,0.2093628088426528,0.8766822925284161,1.0,7/84,3.76%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4079356387435365,1.1714333287292884,0.24962630792227206,0.8766955167976213,1.0,16/34,22.62%,PTPRT;PTPRQ;DUSP1;PTPN22;DUSP22;PTPRO;PTPN13;TNS2;UBASH3B;DUSP8;PTPN18;PTPN11;DUSP10;DUSP6;PTPRZ1;DUSP7
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3198613615424067,1.1709826872356375,0.18509615384615385,0.876866496567365,1.0,30/166,15.29%,RORA;PPARA;TEAD1;HDAC1;TAF9B;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;POLR1A;NR2C1;TAF3;TBPL1;TAF1D;TAF1B;SNW1;GTF2H3;ESR2;HDAC10;MED1;ERCC2;NRBF2;GTF2H1;AR
prerank,heart development (GO:0007507),0.3232091208843539,1.170952092417273,0.18386714116251482,0.8755245343663061,1.0,24/150,12.50%,SCUBE1;CHD7;ECE1;FLRT2;DLC1;NTRK3;PTEN;ERBB4;SALL1;DNAAF4;HTR2B;NF1;BCOR;ADAP2;SRF;PTK2;BMP7;KAT2A;FGF12;ZFPM2;NDUFV2;TGFBR1;SOX9;RBM20
prerank,positive regulation of growth (GO:0045927),-0.3078668527830425,-1.170880866303939,0.16722408026755853,0.6079345544783943,1.0,21/64,20.47%,PLCB1;EGFR;INSR;TGFB2;ADAM10;CDC42;PPM1F;HYAL1;SFRP1;INO80;RPS6KA1;EXOSC2;MFSD2A;CDKN2AIP;PABIR1;ZPR1;ERBB2;AKT1;SDCBP;CIB1;LGI1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.38260703259202283,-1.170619452390784,0.24725274725274726,0.6076204759964481,1.0,11/24,29.54%,CAMK2D;SRI;CALM1;DMD;JPH1;NOS1;JPH2;GSTO1;CASQ2;FKBP1A;JPH3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.36911364431996163,-1.1704552420724703,0.22888283378746593,0.6070613525752517,1.0,15/29,40.32%,TPM1;S1PR1;NOTCH1;TGFBR3;PKP2;SMAD7;FKBP1A;TTN;TNNC1;TNNI3;TBX20;NOG;TCAP;MYL3;MYH6
prerank,regulation of cellular pH (GO:0030641),-0.36617665997723925,-1.1702203416994201,0.22371967654986524,0.6067322157605547,1.0,9/29,18.67%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;LACC1;SLC4A8;SLC9A5;SLC26A6;SLC9B1
prerank,regulation of protein phosphorylation (GO:0001932),-0.2499534781019838,-1.1701662291584232,0.07476635514018691,0.605905861414779,1.0,42/256,8.11%,PLCE1;FN1;ROCK2;TEK;LEPR;OCLN;BMPER;SLIT2;PECAM1;FNIP1;EGFR;KRAS;PLPP3;FER;APP;CSNK1D;SIRPA;LIMCH1;IGFBP3;KDR;PRKDC;NIBAN1;CCND2;INSR;FAS;VEGFD;RAC1;DAB2;VEGFC;MAVS;TFRC;EFNA5;PDGFA;CARD14;TBX1;CCN1;XDH;PRR5L;LRP6;FGF1;FNIP2;RALBP1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5216795754422876,1.1698334771845278,0.2774674115456238,0.8779502810476206,1.0,6/10,22.12%,CDC7;WIZ;CDT1;DBF4;SSBP1;ATRX
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3931415101669953,1.1694755975913975,0.22972972972972974,0.8776687061353727,1.0,4/42,5.34%,XCL1;CXCL10;CXCL1;CCL15
prerank,positive regulation of protein ubiquitination (GO:0031398),0.35186464283211183,1.1693833613907352,0.2216142270861833,0.8765885462137314,1.0,18/80,16.08%,FANCI;PRICKLE1;MYCBP2;LRRK2;PSMD10;PINK1;TSPYL5;COMMD1;BIRC2;NDFIP2;SPRTN;GSK3A;PTTG1IP;DCUN1D5;AXIN1;UBE2D1;PAXIP1;NDFIP1
prerank,platelet aggregation (GO:0070527),-0.36223612721139564,-1.1691405588743826,0.24233983286908078,0.607523153174521,1.0,12/33,14.24%,FN1;VCL;ACTB;GNAS;ACTG1;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4492126447630279,-1.1690650836475804,0.255125284738041,0.6067578214282329,1.0,12/14,54.23%,IL18;PAEP;IL17D;CD84;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4301829625292059,1.1690041619949516,0.2610759493670886,0.8764296331620172,1.0,7/25,12.03%,TRA2B;GEMIN2;BCAS2;MPHOSPH10;SLU7;DBR1;SRSF10
prerank,transport along microtubule (GO:0010970),-0.4525260724753922,-1.1689811202288667,0.2857142857142857,0.6060698350556675,1.0,10/13,31.52%,APP;CDC42;BAG3;BORCS5;DYNC1I1;SPG11;COPG2;APBA1;CAMSAP3;DYNC1I2
prerank,positive regulation of TOR signaling (GO:0032008),-0.33650607608228256,-1.168733060702118,0.22448979591836735,0.6057582276144695,1.0,12/40,19.48%,FNIP1;RICTOR;SIK3;LAMTOR5;RRAGC;CLEC16A;PIP4P1;HDAC3;LAMTOR3;GPR137;SEH1L;RRAGB
prerank,inorganic anion transport (GO:0015698),-0.3226848114662576,-1.1686405914523619,0.16901408450704225,0.6050336837562258,1.0,8/53,4.04%,CLIC4;SLC13A4;SLC4A10;ANO6;XPR1;SLC26A7;ANO1;SLC26A11
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3895370621240684,1.1683851392850861,0.23232323232323232,0.8771363205793369,1.0,11/43,12.54%,ENPP1;OGT;PIP4K2A;SORL1;IRS1;RPS6KB1;PRKCB;TNS2;ERFE;IGF2;GSK3A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5149415245210112,1.168275108367225,0.29294755877034356,0.876104850860631,1.0,4/11,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.516953975716425,1.1681664014179562,0.2943327239488117,0.8750342592234794,1.0,3/10,10.90%,CPEB1;NUDT21;DHX36
prerank,calcium-mediated signaling (GO:0019722),0.34610804982636817,1.167331364892933,0.2300531914893617,0.8764324233614988,1.0,20/93,11.67%,PTGFR;CCR9;ACKR2;RYR2;PDPK1;PPP1R9A;HTR2B;CAMKK2;LRRK2;STIMATE;ATP2A2;SLC9A1;PRKACA;ADGRL1;KSR2;PPP3CB;GRM5;RCAN3;P2RX4;TRPM2
prerank,regulation of actin filament-based process (GO:0032970),0.363076754520789,1.1667080465188127,0.25,0.877214968164177,1.0,9/70,4.55%,DLC1;LRP1;RND3;HRG;GPM6B;IQGAP3;CORO2B;FSCN1;RAC3
prerank,regulation of lymphocyte migration (GO:2000401),-0.48768266479840716,-1.1665798219805739,0.26605504587155965,0.6093623621573407,1.0,6/10,31.46%,JAM2;AKT1;WASL;MSN;SLC8B1;STK10
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5100800503801926,1.1665219554051236,0.2841726618705036,0.8764746660093095,1.0,1/11,0.79%,XCL1
prerank,protein localization to chromatin (GO:0071168),-0.41001539371718143,-1.1664999803164673,0.25586854460093894,0.6086230257141053,1.0,8/18,28.38%,PPHLN1;ESR1;CHMP7;MCM9;RUVBL2;MCM8;MSH2;SGF29
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2958656732082945,-1.1664794216491237,0.16785714285714284,0.6077410129866395,1.0,28/71,23.08%,CTSC;DDI2;UBB;VCP;NGLY1;CASP8;CTSO;RNF41;CTSH;CLPX;PSMA6;CTSZ;NEDD8;YME1L1;ISG15;CTSS;CHMP4B;UBC;USP9X;CHFR;CLPP;PDCD6IP;TNFAIP3;HDAC6;PRPF19;UBA52;PSMA8;CHMP4C
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.37567252029145864,1.1664783459556933,0.251453488372093,0.8752190802698269,1.0,22/52,22.84%,RBFOX1;TRA2B;NOVA1;RBM24;REST;FMR1;KHDRBS3;WTAP;CELF4;SMU1;DDX17;RBFOX3;ZBTB7A;RBM5;HNRNPL;SRSF6;KHDRBS1;FXR1;RBM15;RBM25;SRSF12;CELF6
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.29701946681894376,-1.1664007242185326,0.1703056768558952,0.6069702694490902,1.0,30/87,22.48%,SMAD6;ARHGEF18;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;SKI;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;ZYX;PRKCZ;SMAD1;FURIN;CDH5;SIRT1;UBC;USP9X;TWSG1;TGFBR3;ADAM9;TGFBR2;NRROS;UBA52;SMAD7
prerank,synaptic vesicle exocytosis (GO:0016079),0.3994167945100131,1.1662850497514812,0.2552552552552553,0.8744338248715178,1.0,14/40,18.62%,VAMP2;SNAP23;RIMS2;SNPH;SNAP29;SYT7;RIMS1;SYT5;DNAJC5;UNC13A;PCLO;CDK5;UNC13C;SYT1
prerank,negative regulation of metabolic process (GO:0009892),0.37346196417432503,1.1659760534698536,0.2298050139275766,0.8741138232942928,1.0,10/54,9.97%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,T cell mediated immunity (GO:0002456),-0.44945790787236833,-1.165762045951118,0.2553191489361702,0.607652723473979,1.0,5/13,20.48%,CD55;CTSH;GNL1;BTN3A3;CD46
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4083647739065239,1.1654572819067277,0.24816446402349487,0.8744780223978825,1.0,10/32,23.11%,LPIN3;CHAT;CHKA;STARD10;LPIN2;CSNK2A2;SLC44A1;PCYT1A;ABHD3;SLC44A5
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.31745414721292686,-1.16515574065328,0.21428571428571427,0.6082191675684803,1.0,18/47,25.13%,FOXO1;EGFR;IGF1R;ARL6IP5;FAS;TGFB2;MAPK8IP3;MAP2K2;PPIA;MAPK8IP1;STK25;PER1;TGFBR3;MID1;QARS1;TAOK2;NOD2;GREM1
prerank,positive regulation of translational initiation (GO:0045948),0.4565636022887424,1.1651521668058098,0.27121464226289516,0.8741533863900376,1.0,8/18,24.63%,BOLL;RPS6KB1;MTOR;HABP4;KHDRBS1;YTHDF1;EIF2B5;POLR2D
prerank,magnesium ion transport (GO:0015693),-0.4671486549729815,-1.1651389635431944,0.27941176470588236,0.60732802023187,1.0,4/12,12.39%,SLC41A1;NIPAL2;MRS2;CNNM4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2942345911300923,-1.1649010356278109,0.19622641509433963,0.6069355001928122,1.0,21/73,16.14%,KITLG;FOXC1;PSMC6;PRKDC;LMO2;PSMD9;RUNX1;PSMF1;PSMB7;PSMD8;PSMD12;GATA2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;TAL1;PSMB6;PSMC1;PSMB10
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.4433788990134879,-1.1646161966200357,0.27970297029702973,0.6067520635797037,1.0,4/13,26.02%,MAPT;PRKCD;TYROBP;ITGB2
prerank,regulation of microtubule polymerization (GO:0031113),-0.33676282508656247,-1.1644928823517,0.20958083832335328,0.6061238643464506,1.0,13/40,20.97%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;CDH5;MET;CDK5RAP2;CAMSAP2;EML2;NUMA1;FES
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3618007200541365,-1.1640618818993556,0.24382716049382716,0.6063944044644436,1.0,6/34,8.30%,PICALM;ROCK2;ACTN2;GOPC;GSK3B;MAPT
prerank,sarcomere organization (GO:0045214),-0.36603762901957515,-1.1639998021548723,0.21148825065274152,0.6056501452968185,1.0,15/27,41.17%,ACTN2;TPM1;CSRP2;TNNT3;SIX4;MYOM2;KRT19;TTN;CASQ1;MYPN;MYLK3;TCAP;OBSCN;MYH6;CSRP1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.43668778897106053,1.1637185494520277,0.2647527910685805,0.8777161333073764,1.0,13/26,23.90%,GPR37L1;REST;LRRK2;NOL3;PYCR1;PINK1;FYN;HTRA2;GPR37;PDE8A;BAG5;MAPK7;ATF4
prerank,postsynaptic membrane organization (GO:0001941),0.46325605743772547,1.1634436496851404,0.28524590163934427,0.8772661448118352,1.0,5/17,15.66%,NRXN2;CEL;NRXN1;DLG4;LHFPL4
prerank,regulation of cation channel activity (GO:2001257),0.3483083736866376,1.1633901245759941,0.22310756972111553,0.8760275078156466,1.0,20/89,11.37%,KCNS2;GRIA3;GRIN2B;CACNG3;GRIA4;GRIA1;DLG3;ANK3;VAMP2;DLG2;GRIN2A;KCNG1;KCNAB1;RELN;PRKACA;CACNB4;CACNG4;SHISA6;FGF12;DLG4
prerank,positive regulation of biosynthetic process (GO:0009891),0.39781810623628294,1.1630065993349763,0.25625920471281294,0.8759482853363096,1.0,10/40,9.80%,ZBTB20;PPARA;TLR6;MTPN;LARP6;ADGRB1;AMELX;MTOR;TLR4;CYBA
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.43947725789900915,1.1629820638638528,0.27564102564102566,0.8746422035037155,1.0,14/25,29.00%,HTATSF1;SETD5;ZNF326;EAF2;CCNK;THOC5;LDB1;KAT7;DDX39B;CCNT2;EAF1;ELL;WDR43;HMGN1
prerank,histone H3-K4 methylation (GO:0051568),0.4285063744365252,1.1628326567927558,0.272,0.8737500458373788,1.0,13/26,24.08%,OGT;KMT2A;CXXC1;WDR5;DYDC2;PAXIP1;ASH2L;SETD4;MEN1;KMT2C;RBBP5;KDM6A;TET2
prerank,regulation of protein kinase activity (GO:0045859),-0.27636479709660894,-1.1625086748566913,0.13636363636363635,0.6086009992862241,1.0,30/106,17.97%,PRKAG2;PLCE1;RAPGEF2;PPM1E;TRIB2;DEPTOR;IQGAP1;RAP1A;UVRAG;DVL1;CEP85;PPM1F;CCN1;LRP6;ITGB1BP1;YWHAG;HSPB1;ALS2;CEACAM1;TAB2;PTK2B;PPIA;RAP2C;CDKN1A;TRIM27;SIRT1;PAK2;AKT1;RAP2B;LCP2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.45048021793801696,-1.1624502904385718,0.2780373831775701,0.607821891342459,1.0,2/13,3.21%,CAV1;ADRA1B
prerank,negative regulation of protein secretion (GO:0050709),-0.34009950552178503,-1.1621581489247694,0.22258064516129034,0.6077193039376066,1.0,12/38,22.57%,CD200;PSMD9;CCN3;APOE;KCNB1;SFRP1;RHBDF2;CYP51A1;CHGA;RAB11FIP1;RAB11FIP5;INHBB
prerank,negative regulation of cellular senescence (GO:2000773),0.4962620387440881,1.1621401500785815,0.289134438305709,0.8747542865242501,1.0,4/13,8.25%,SLC30A10;FBXO5;ZKSCAN3;TWIST1
prerank,early endosome to late endosome transport (GO:0045022),-0.39023543889632767,-1.1618461494998722,0.26732673267326734,0.6075571922936303,1.0,4/20,7.81%,EEA1;BECN1;HOOK1;RAB5A
prerank,sensory organ development (GO:0007423),0.3742919283647109,1.1615640364479944,0.25176803394625175,0.8753082324256795,1.0,8/51,10.07%,CHD7;ECE1;MEIS1;MYO7A;MEIS2;SIPA1L3;SOX2;AHI1
prerank,embryonic limb morphogenesis (GO:0030326),0.40559895045686395,1.1609797620305153,0.2606774668630339,0.8760023378171883,1.0,7/34,9.85%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3
prerank,positive regulation of blood coagulation (GO:0030194),-0.42710896127385173,-1.1608068736789705,0.2561576354679803,0.6093671308309525,1.0,4/17,3.63%,ANO6;THBD;THBS1;ST3GAL4
prerank,cytosolic transport (GO:0016482),-0.2750060705122483,-1.1603794642809084,0.14027149321266968,0.6095162070526858,1.0,31/108,19.93%,ERC1;VTI1A;EEA1;BECN1;MYO1D;VPS35;DOP1B;HOOK1;RAB5A;SNX32;AP2A1;ARFRP1;SNX6;KLHL20;SPAG9;MON2;GAK;CLN5;TBC1D10B;VPS51;VPS29;VPS13A;TRIM27;ARL1;TMEM87B;RAB6A;LAPTM5;VPS54;WDR91;PLEKHJ1;TBC1D5
prerank,cellular response to estradiol stimulus (GO:0071392),-0.41300607065724143,-1.1603665107374912,0.26150121065375304,0.6086317658778923,1.0,8/18,21.31%,EGFR;LCOR;SFRP1;KAT5;GPER1;ESR1;CCDC62;RUVBL2
prerank,regulation of gene expression (GO:0010468),-0.22285533276611255,-1.1603264324322284,0.0,0.6078168937502101,1.0,225/903,18.77%,BNC2;PRDM6;FN1;IGF1;PICALM;APBB2;SLC24A3;ROCK2;FOXP1;ITGB8;ERC1;MEF2C;DENND4A;RBPJ;LEF1;OCLN;ROBO1;LARP4;KRAS;MBNL1;AFDN;FOXC1;HDAC4;OSR1;EZR;FOXN3;NOS3;NOTCH2;PPARGC1B;APP;CDH1;GTF2IRD1;AHNAK;KLF4;NFKB1;ZNF462;GPBP1L1;KDM4A;KAT6B;FOXD1;ESRRG;CLDN5;RDX;PRRX2;SIRPA;SMARCA2;KDR;VPS35;GSN;YBX3;AHNAK2;INSR;WWP2;NOTCH1;RUNX1;TGFB2;WNT4;ACTG1;NFKBIZ;TDRD7;TAPBP;ASCC2;SMO;DVL1;RPL5;CD34;PRKAA2;MAPK9;NFYC;TFRC;CDK6;ADAM10;PRDM2;SLC39A8;SIX1;MEGF8;RPS7;PPP2R1A;TRIM5;TRIM11;MOG;AFF4;MAPK14;SOX4;NGF;PRDM11;FZD7;CRABP2;DICER1;NOVA2;TRIM14;PPM1F;APOE;GSK3B;PLAG1;IRF2;XDH;CELF1;FGF1;ACVRL1;SOX17;HNRNPF;PCBP2;LAMTOR5;MAPT;SMAD3;ANK2;WNT6;CRIP1;GZF1;RPL11;VSX1;ACTR8;PTBP3;ATOH8;CASP8;RPS6KA5;RC3H1;CITED2;PIK3CB;GPX1;MYBL1;SFRP1;GATA2;HMG20B;PIK3CD;RFX3;MYCBP;CCN4;ETS1;EPHB2;CASZ1;NFYA;TNRC6A;PARP10;VHL;PARP9;SLC7A5;UBAP2;MBNL2;CTSH;GCFC2;TARDBP;MZF1;MAP2K2;AJUBA;MYBBP1A;FASTK;ACTA2;TLE5;FUS;TERT;TNRC6C;HNRNPH1;PTRH2;PLCG2;HNRNPDL;HEY2;SMAD1;NR3C1;TMEM119;ATM;ATXN1;ACTR5;YBX1;MSL3;HINT1;NOS1AP;ZNF205;PTHLH;WNT16;RAMP2;TICAM1;P2RX7;CDH5;CIAO3;CAVIN4;TOB1;ZNF219;TRAF3;EZH2;NFYB;POGZ;CHD3;TRIM27;SRRM4;SIRT1;MATR3;GPER1;PRKAA1;ZPR1;PER1;MED23;TRRAP;NFKB2;CLOCK;HAVCR2;BTN3A3;FAM50A;ESR1;DNAJA4;HFE;CD74;HNRNPK;ACVR2B;BHLHE40;AGO2;SOX18;AKT1;DNMT3B;SOX11;OGG1;IFNGR1;EGF;SLC22A2;MSN;ACE2;PQBP1;SUFU;HOXD3;CTCF;EFEMP1;PID1;APBB1;WNT11
prerank,positive regulation of mRNA processing (GO:0050685),0.437205482171503,1.15991161360232,0.26533996683250416,0.8782844605002145,1.0,5/21,11.47%,TRA2B;PRDX6;CELF4;DHX36;SNW1
prerank,ceramide catabolic process (GO:0046514),-0.4361754398650064,-1.1585035944828064,0.2535211267605634,0.6116049837733598,1.0,8/14,28.37%,ACER2;ACER3;HEXB;NAGA;GM2A;ASAH1;ASAH2;NEU1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5064951222519433,1.1584075315735645,0.29508196721311475,0.8823050323444294,1.0,7/11,23.90%,MBTPS2;TP53;HSPA5;CREB3L1;ATF6B;DDIT3;ATF4
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.47834757447297926,-1.1583206460806834,0.2866666666666667,0.6111920541476135,1.0,4/10,24.20%,HDAC6;AOC3;OXA1L;MT3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30382851339879047,1.1574894400653075,0.15543478260869564,0.8841038059065893,1.0,47/308,12.02%,IL33;PTN;GHR;LRP1;HCRT;OGT;WNT5A;TXK;GPR3;PLA2R1;THRA;GLMN;LURAP1;GJA1;LOXL2;REST;ACADL;FBXO5;GCNT2;SOX6;NCOA3;HTR2B;ZBTB16;SORL1;SIRT6;EPAS1;FABP5;FABP4;OMA1;GLIPR2;HMCES;PER2;BSCL2;TWIST1;G0S2;APPL2;MTOR;TAPT1;KAT2A;KSR2;FGR;EIF2AK2;ZBED3;SMTNL2;TGFBR1;VAMP7;SOX9
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.47554132189359133,1.1573906785491075,0.2927241962774958,0.8830272353792447,1.0,7/16,18.60%,MCM7;RPA1;MCM4;RECQL;MCMDC2;WRN;SSBP1
prerank,positive regulation of autophagy (GO:0010508),-0.2909259438889455,-1.1571583921919657,0.17407407407407408,0.6132707817769172,1.0,23/81,16.45%,DAPK1;FOXO1;RNF152;KDR;SESN1;ATF6;PRKAA2;SH3BP4;TRIM5;TRIM14;GSK3B;BAD;PIK3CB;BNIP3L;OPTN;TMEM59;PAFAH1B2;TICAM1;KAT5;TRIM27;SIRT1;PRKAA1;TBK1
prerank,negative regulation of cell aging (GO:0090344),0.4712409255092613,1.157126605487335,0.27177700348432055,0.882540477860974,1.0,6/16,15.64%,SLC30A10;FBXO5;ZKSCAN3;TWIST1;FOXM1;MAP3K3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.43806178773684756,1.1570810630273645,0.2812006319115324,0.8813318843046626,1.0,2/23,2.16%,GHR;ERBB4
prerank,regulation of macrophage migration (GO:1905521),-0.4961877912234447,-1.1567723152867146,0.2913907284768212,0.6134440929753864,1.0,4/10,13.82%,CD200;MTUS1;CX3CR1;PTK2B
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.34013435356312527,-1.1566750056461843,0.2012012012012012,0.612805212077783,1.0,17/36,27.52%,ATR;ATM;CDC5L;NBN;CLOCK;DONSON;SETMAR;HUS1;E2F1;PRPF19;ATRIP;CDC45;HINFP;CHEK2;BRIP1;CHEK1;RHNO1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.29929677733793236,-1.1564817250502324,0.17266187050359713,0.6124205848057724,1.0,24/72,22.17%,SLIT2;SHANK3;KANK3;HIP1R;ATXN7;HSPA8;KANK1;APC;CRYAB;APOE;SHANK1;SSH1;APC2;ARPIN;LIMA1;CDH5;PRKCD;CAMSAP2;EML2;CHADL;CIB1;KATNB1;TWF2;PFDN4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2678715760932133,-1.156412094168101,0.17486338797814208,0.6116729356850371,1.0,41/129,19.03%,CAV1;EGFR;XIAP;NFKB1;RNF146;CSNK1D;PSMC6;PSMD9;KANK1;TBL1X;PSMF1;GPC3;PSMB7;LGR4;WNK1;WLS;SOX4;TNKS2;VCP;SMURF2;PSMD8;PSMD12;SFRP1;GID8;PSMA3;DKK2;PSMA6;PSMD4;CSNK1G3;PSME3;PSMD7;PSMB6;PSMC1;FAM53B;ATP6AP2;PSMB10;HHEX;TMEM9;EGF;GSKIP;PSME2
prerank,dendritic spine organization (GO:0097061),0.42788263953786015,1.1562558537677197,0.29042904290429045,0.8827911479632029,1.0,7/26,11.37%,DOCK10;PTEN;EPHB1;ITGA3;LGMN;FYN;DLG4
prerank,nuclear membrane organization (GO:0071763),-0.4051019068880779,-1.1562036075915523,0.2537688442211055,0.6112433850693851,1.0,12/19,36.77%,TARDBP;TOR1A;GPER1;CHMP4B;CHMP7;TOR1AIP1;EMD;CHMP2A;UBXN2A;NSFL1C;VPS4A;PLK1
prerank,histone deacetylation (GO:0016575),0.38033422084032914,1.1560437441965803,0.24927113702623907,0.8821519361741528,1.0,8/43,7.98%,MIER2;HDAC1;MORF4L1;REST;SIRT6;BRMS1L;BRMS1;PER2
prerank,embryonic organ morphogenesis (GO:0048562),0.3854827253363473,1.1556881930828926,0.2525697503671072,0.8819956087393925,1.0,10/42,15.81%,PDGFRA;RYR2;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4;FBN1;FGFR2;HOXA9
prerank,regulation of platelet aggregation (GO:0090330),-0.4130238471608705,-1.1555638660319578,0.2638190954773869,0.6119483773833264,1.0,10/17,25.17%,F11R;CEACAM1;PRKG1;SERPINE2;PRKCD;PDPN;CD9;ALOX12;DMTN;ADAMTS18
prerank,amyloid fibril formation (GO:1990000),-0.317840069869591,-1.1553287957089504,0.18900343642611683,0.611625892393765,1.0,17/51,18.01%,TSPAN5;SNCAIP;APP;CST3;GSN;ADAM10;UBB;B2M;MAPT;APH1A;APH1B;FURIN;UBE2L6;SIAH2;UBC;USP9X;MFGE8
prerank,prostaglandin biosynthetic process (GO:0001516),-0.39884146705813894,-1.1553212508473347,0.25653206650831356,0.6107540305218656,1.0,4/18,4.08%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,acylglycerol metabolic process (GO:0006639),-0.3333861065350318,-1.1547683302769425,0.24342105263157895,0.6113215241520437,1.0,10/37,14.46%,CAV1;DGKH;MGLL;PGS1;APOE;DGKG;ABHD2;LMF1;DGKZ;PLAAT3
prerank,eye morphogenesis (GO:0048592),0.4560189368437473,1.1546473251446299,0.27184466019417475,0.8842811626313599,1.0,3/19,5.65%,TENM3;NKD1;NF1
prerank,negative regulation of transposition (GO:0010529),-0.4290844810686638,-1.1546009452053632,0.2423469387755102,0.6107972203854213,1.0,4/16,11.79%,TUT7;MYBL1;TEX15;UBR2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.49840303704870875,1.1540858512639587,0.3185550082101806,0.8847679733692094,1.0,3/14,6.26%,GPLD1;IRS1;IRS2
prerank,regulation of transferase activity (GO:0051338),-0.41001261353551544,-1.1540692382339373,0.2710997442455243,0.6111390863746267,1.0,6/17,20.35%,HMBOX1;SMG6;ATM;NLRC5;PARP4;JMJD8
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.39425175414339847,1.1539130279945675,0.26706231454005935,0.8839633517240972,1.0,10/40,15.91%,CCDC22;PTEN;GLMN;PDCL3;PTK2;COMMD1;AXIN1;CLU;ARAF;CSNK2A2
prerank,protein localization to cilium (GO:0061512),0.41242136436309645,1.1537544595140132,0.2770897832817337,0.8831004740547495,1.0,7/32,10.59%,ODAD4;WDR35;ZNF423;TUB;RAB29;TTC21B;TCTN2
prerank,neuropeptide signaling pathway (GO:0007218),0.36733036601280356,1.1537005649378265,0.26062322946175637,0.8819100245296844,1.0,11/58,16.07%,RXFP3;SORCS3;PDYN;SORL1;NPY;GLRA3;GLRA1;GLRA2;NMU;GLRB;GPR37
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4532351814569644,-1.1534535261238124,0.2894736842105263,0.6117943894564475,1.0,7/12,36.41%,GCLC;BDH2;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,cytosolic calcium ion transport (GO:0060401),-0.3551567922053302,-1.1531089405392785,0.22727272727272727,0.6117889527089143,1.0,9/28,15.71%,CACNA1C;SLC35G1;ATP2B1;MICU1;MCUB;SMDT1;JPH1;ATP2A3;JPH2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.48990681170118566,-1.1522410369339027,0.29539951573849876,0.6131554104574831,1.0,1/10,0.26%,EPHA4
prerank,negative regulation of protein kinase activity (GO:0006469),-0.28618991331698523,-1.1520219114422814,0.2077922077922078,0.6128077914381767,1.0,30/88,24.22%,PRKAG2;PTPRB;PPM1E;CAV1;SLC8A3;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;MVP;LRP6;ITGB1BP1;YWHAG;PTPN1;HSPB1;CEACAM1;PPIA;CDKN1A;TRIM27;PAK2;AKT1;GSKIP;NPM1;DUSP19;CAMK2N1;WWTR1;QARS1;DBNDD2;HYAL2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4881014458048439,1.1509609443299638,0.31272727272727274,0.8899880759477063,1.0,4/13,16.58%,PRICKLE1;TBX3;SOX9;SRA1
prerank,axon extension (GO:0048675),-0.3834811752660805,-1.1507632988841816,0.24022346368715083,0.6150830849177993,1.0,4/23,2.72%,ALCAM;SLIT2;NRP2;NRP1
prerank,cyclooxygenase pathway (GO:0019371),-0.4842957796837889,-1.15055732937504,0.2823779193205945,0.6147318624011223,1.0,3/10,3.06%,PTGDS;PTGS1;PTGES3
prerank,regulation of bone mineralization (GO:0030500),0.37024509600134625,1.1504981482484067,0.2468265162200282,0.890279570531623,1.0,4/55,1.67%,ENPP1;PTN;GPM6B;ADGRV1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.5124510463725066,1.150286261494546,0.2956204379562044,0.8896457348094285,1.0,3/10,6.31%,DNAJC19;MTMR4;MTMR1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5234479805044242,1.1502396364805034,0.31239092495637,0.8884538811325503,1.0,5/10,19.12%,TLR6;CD68;TLR4;MYD88;MIA3
prerank,negative regulation of ossification (GO:0030279),-0.3717613885125793,-1.1497960444486235,0.2513812154696133,0.6156950958000692,1.0,6/23,4.26%,SMAD6;MEF2C;RBPJ;ECM1;SRGN;NOTCH1
prerank,stem cell differentiation (GO:0048863),-0.3391739232593452,-1.1496989283355106,0.22822822822822822,0.6150309671988461,1.0,7/39,9.80%,MLLT3;MEF2C;OSR1;TGFB2;ACE;LRP6;SFRP1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.28446545374611787,-1.149004154413651,0.18072289156626506,0.6159029395859051,1.0,30/87,19.39%,FBXL7;FHL1;KANK2;KLF4;PSMC6;PSMD9;PSMF1;APC;PSMB7;AVEN;CUL1;CDK6;PSMD8;PSMD12;WEE1;FAM107A;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;CDKN1A;PSMC1;PSMB10;DCUN1D3;DLG1;PSME2;RBL1;RGCC
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5299172470605025,1.1483815130117214,0.31542461005199307,0.8907248733814078,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,t-circle formation (GO:0090656),0.5299172470605025,1.1483815130117214,0.31542461005199307,0.8907248733814078,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5299172470605025,1.1483815130117214,0.31542461005199307,0.8907248733814078,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.33673392662248447,-1.1482108234870985,0.23529411764705882,0.6169589407393729,1.0,11/37,16.15%,PHLDB2;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;MAPRE2;CYLD;BICD2;PRKAA1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4798965048712601,1.148029416672005,0.30434782608695654,0.890535910368439,1.0,6/14,21.51%,IL34;PTK2;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.3181398631223388,-1.1476753034191407,0.2033898305084746,0.6174315175332429,1.0,8/46,3.64%,IGF1;FOXP1;OGN;IL18;THBS1;IGFBP5;IGFBP3;PRKDC
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3069389720151479,-1.1474313449921556,0.1919191919191919,0.61713181704482,1.0,17/60,19.55%,HMBOX1;KLF4;PTGES3;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;PCNA;ATM;MAP3K4;HGF;RGCC;HNRNPA1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3307489455273409,1.1471978441868855,0.22481572481572482,0.8921408993092372,1.0,20/117,11.03%,GGT5;ADH1A;PPARA;SLC6A8;ACSF2;PPARD;MCCC1;KYNU;GRHPR;ACADSB;ABAT;ECHDC3;MTHFD1L;PER2;FA2H;PDHX;CKM;HOGA1;GAMT;ACOT7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42931138609404196,-1.147068147616434,0.2756892230576441,0.6171830521334343,1.0,6/15,12.85%,TJP1;BMPER;KLF4;FGF1;PKM;SMAD1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4623309039091331,1.146955115306889,0.2878289473684211,0.8916304542564365,1.0,7/16,19.91%,PDE12;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,positive regulation of protein modification process (GO:0031401),-0.24943584544450992,-1.146901255153805,0.1069182389937107,0.6166776901590381,1.0,50/203,16.11%,TRABD2B;ROCK2;TEK;LEPR;PECAM1;FNIP1;EGFR;KRAS;APP;CSNK1D;LIMCH1;KDR;NIBAN1;CCND2;INSR;FAS;VEGFD;RAC1;DAB2;VEGFC;MAVS;ACE;TFRC;PPP1R7;EFNA5;RAMP1;CARD14;CALM1;TBX1;CCN1;PPP1R16B;FGF1;RALBP1;HDAC3;ITGB3;CAMTA1;RALB;TMEM119;FLT4;NOS1AP;PPIA;UBE2N;CCND1;CDH5;KAT5;RAPGEF3;SMPD1;PRKCD;SIRT1;GPER1
prerank,regulation of interleukin-6 production (GO:0032675),0.34330197256545913,1.146589874897363,0.24643320363164722,0.891508569281432,1.0,13/96,10.91%,IL33;WNT5A;IL16;TSLP;PTPN22;TLR6;TLR8;TWIST1;CD200R1;MBP;TLR4;CYBA;PYCARD
prerank,regulation of macrophage activation (GO:0043030),0.40943731216184515,1.1463564802528348,0.2683658170914543,0.8909741697310818,1.0,5/30,9.41%,IL33;WNT5A;TLR6;LRFN5;TLR4
prerank,mitotic spindle assembly (GO:0090307),0.3870343106765709,1.1462942508795206,0.27232142857142855,0.8898296109670586,1.0,20/42,25.52%,CCDC61;LSM14A;AAAS;GOLGA2;CEP192;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;RHOA;KPNB1;SMC3;KIF11;KIF23;TPX2;TOGARAM1;STAG1;KIFC1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.39982071490379345,1.1459898485354614,0.2784992784992785,0.8895236623763197,1.0,10/37,16.58%,ENTPD2;RNASEH2C;ENTPD5;NUDT9;MTREX;RNASEH2B;ENTPD7;HNRNPD;RNASEH1;PPP1R8
prerank,atrioventricular valve development (GO:0003171),-0.43659333172414155,-1.1455386544200765,0.2757009345794392,0.6194008136806789,1.0,5/14,11.63%,BMPR2;NOTCH1;TGFB2;ACVR1;HEYL
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36460181641675377,1.145423304881545,0.2609308885754584,0.8900604219215528,1.0,9/52,6.24%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.45924101139561774,-1.1452655527813214,0.3063063063063063,0.6192013710118347,1.0,9/12,50.62%,IL18;PAEP;IL17D;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,synaptic membrane adhesion (GO:0099560),0.49025783254248845,1.1450135567832327,0.29421487603305785,0.8901470243143332,1.0,6/14,18.74%,GPC4;LRFN5;LRRC4C;NTNG1;SLITRK1;GPC6
prerank,positive regulation of telomere capping (GO:1904355),-0.4070543206367202,-1.1444567602097941,0.2949640287769784,0.6203698701946971,1.0,5/17,14.25%,TNKS2;NEK7;MAP2K7;RTEL1;MAP3K4
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3157999698471966,-1.1443991983393536,0.21904761904761905,0.6196163536870218,1.0,16/47,20.22%,APP;KLF4;NFKB1;VPS35;APOE;RPL10;SSH1;TCOF1;NFKBIA;EIF2B4;NOLC1;AGTR1;EDN1;AKT1;WDR91;AGT
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2349652509788741,-1.1443390713265649,0.07042253521126761,0.6188738498289188,1.0,108/341,23.64%,FBXL7;WWP1;NPLOC4;VPS37A;RNF146;UBE2G1;ASB2;PSMC6;SQSTM1;RNF43;RNF185;PELI1;PSMD9;WWP2;ARIH1;CDC23;TBL1X;UBE2D3;PSMF1;PSMB7;TRIP12;TRIM25;ANAPC10;PTTG1;TOLLIP;VPS37B;IFI27;RNF8;VCP;UBE2H;MIB1;SMURF2;PCBP2;UBA6;KCTD21;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;KLHL20;RNF11;GID8;RNF144B;RNF114;SPSB4;RCHY1;KCTD6;PSMA3;PSMA6;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;PSMB6;KAT5;UCHL1;ELOC;PSMC1;SIAH3;UBE2L6;SIRT1;PSMB10;HECTD3;TGFB1I1;FBXL14;NEDD8;SIAH2;CUL3;CLOCK;ANAPC16;ANAPC11;USP9X;ANAPC15;PPP1R11;RAD23B;BUB3;CHFR;ANKIB1;PSME2;WDR91;KLHL25;KCTD2;FZR1;CDC34;TNFAIP3;MAEA;KLHL3;ANAPC2;PSMC3;RNF166;KBTBD7;RNF5;VPS28;TNFAIP1;RFFL;FBXO22;MVB12B;ZFAND2B;PSMA8;ADRM1;FBXO10;SMURF1;RLIM;RNF111
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4096548682472199,1.1441891643150452,0.3018292682926829,0.8916583713665837,1.0,2/33,1.89%,APOD;PTEN
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4341200797281825,1.1440075089462511,0.2805071315372425,0.8909305550012234,1.0,6/23,12.54%,PPARA;PFKFB1;CBFA2T3;GCK;ERFE;GSK3A
prerank,regulation of neuron projection arborization (GO:0150011),0.47471843257510293,1.143570903138437,0.3047945205479452,0.8910586690796455,1.0,8/15,20.74%,WNT5A;GRIP1;DLG4;NTNG2;NTNG1;DVL3;MAP3K13;DVL2
prerank,protein K48-linked ubiquitination (GO:0070936),-0.29985989445304706,-1.1435002363451154,0.20388349514563106,0.6200996889235646,1.0,17/54,21.80%,RNF152;RNF146;UBE2G1;PELI1;UBE2D3;IFI27;RNF8;UBE2H;UBE2A;AMFR;CUL3;CDC34;TNFAIP3;KLHL3;KBTBD7;RNF5;RFFL
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.39305473082518794,-1.1431292696831534,0.2607594936708861,0.6201460986513393,1.0,6/22,17.38%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,cellular response to amyloid-beta (GO:1904646),0.3971409868279982,1.1427210707163262,0.29393939393939394,0.8926520537121142,1.0,11/35,11.12%,LRP1;GJA1;NGFR;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;GRM5;FYN
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.40841394274382703,-1.1426825077250304,0.25326370757180156,0.62036516342863,1.0,3/18,4.82%,IGF1;IL18;IGFBP2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3483917662097359,1.1425688482957355,0.2684931506849315,0.8918137486882987,1.0,15/72,15.08%,COPS3;ERCC1;ISY1;LIG3;POLK;ERCC5;RPA1;ERCC4;UVSSA;RFC3;GTF2H3;XRCC1;COPS4;ERCC2;GTF2H1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2721986857754893,-1.1424980468498724,0.17180616740088106,0.6199304119361221,1.0,31/112,17.62%,SMAD6;SOX5;ARHGEF18;MEF2C;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;WNT4;WWOX;SKI;PDE3A;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;SFRP1;ZYX;PRKCZ;SMAD1;NR3C1;FURIN;CDH5;SIRT1;UBC;USP9X;TWSG1
prerank,regulation of actin filament polymerization (GO:0030833),-0.2909793788217027,-1.142420826852524,0.20146520146520147,0.6192613090351351,1.0,17/69,15.54%,BAIAP2L1;SLIT2;FER;ESAM;KANK3;HIP1R;KANK1;NCK1;SSH1;ARHGAP18;COTL1;ARHGAP28;LMOD1;PTK2B;PLEKHG2;BAIAP2;PRKCD
prerank,nucleoside catabolic process (GO:0009164),-0.4584375384565217,-1.1421281070612843,0.2866817155756208,0.6190997266989744,1.0,4/11,10.80%,UPP2;DERA;UPB1;NT5E
prerank,heme biosynthetic process (GO:0006783),-0.38748112163775383,-1.1418571774442354,0.3015075376884422,0.6189140588802484,1.0,7/22,12.56%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.42986899295513353,1.1416969019141823,0.29949238578680204,0.8934703199103736,1.0,7/22,17.44%,CASK;CDH3;PRKD1;MED1;AREG;FGFR2;SRSF6
prerank,autonomic nervous system development (GO:0048483),-0.4127946987338451,-1.1415819435623655,0.24752475247524752,0.6187376702853518,1.0,4/17,10.02%,FN1;NRP1;SOX4;PHACTR4
prerank,monocyte chemotaxis (GO:0002548),0.3947514642757825,1.1410983046068295,0.2754777070063694,0.894266793860836,1.0,6/32,10.57%,XCL1;MSMP;CCL15;CALCA;PTPRO;CCL25
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3977996379636806,-1.141030100948936,0.2889447236180904,0.6193222365175772,1.0,7/19,14.14%,CSGALNACT1;NDST1;NDST3;EXT1;UGDH;GLCE;HS3ST3B1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.37078772987973413,1.140215567493944,0.2838983050847458,0.8959121595372861,1.0,12/53,20.39%,CALCRL;HTR2B;HTR5A;LPAR3;HTR1A;NPY;HTR2C;HTR4;LHCGR;HTR6;CHRM2;CCL2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.27093787814360165,-1.1397442420224069,0.18357487922705315,0.6217521075277991,1.0,25/108,9.46%,PHLDB2;CLIC4;TJP1;RHOBTB1;ROCK2;SORBS3;EZR;DIAPH1;F11R;RICTOR;IQGAP1;HIP1R;RHOQ;RHOBTB2;RAC1;PRKAA2;ARHGAP17;EFNA5;PDGFA;GSK3B;RHOC;MAPT;TRIM36;PLXNB1;ARHGAP18
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5084890392594574,1.1395918578906818,0.30093457943925234,0.8966779638855535,1.0,2/11,8.62%,MERTK;AXL
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4777080007105588,-1.1388458805381299,0.302158273381295,0.6231239486562484,1.0,2/10,8.32%,ANO6;RAB31
prerank,positive regulation of lipid transport (GO:0032370),0.5033658159506387,1.138834043820803,0.3362218370883882,0.897940364248825,1.0,2/12,5.26%,LRP1;SPP1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31110968197991723,1.1382234133635423,0.21444954128440366,0.8986128970312983,1.0,27/199,9.97%,TBX18;PLCL1;HOXC10;ALDH1A1;SPRY1;PTEN;PTPRR;NR1H4;NOVA1;MCC;GJA1;NR1H2;SPRED1;LOXL2;ZNF423;IL17RD;TRPV3;SPX;SRF;DOCK7;RPS6KA6;PTPRO;CIDEA;SPRED2;TLR4;BRCA2;NRDC
prerank,endocrine system development (GO:0035270),-0.38762914321004,-1.1382104808197906,0.2882205513784461,0.6237990919331685,1.0,9/21,18.77%,DKK3;WNT4;GLI2;SIX1;TBX1;MDK;STRA6;HOXD3;WNT11
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.26108350236571426,-1.1381999053377845,0.16,0.6229512891424221,1.0,46/153,19.89%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;CAMK2D;PRKDC;TOP1;VRK3;TLK1;MAPK9;WNK1;HIPK3;MAPK14;GSK3B;HIPK1;TLK2;STK38L;MAST3;DYRK2;RPS6KA5;CAB39;ATR;RPS6KA1;MAP2K2;PRKCZ;HIPK2;ATM;CSNK1G3;ERN1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;STK32B;AKT1;CSNK1A1;SBK1;VRK2;MARK2;ULK3;MKNK1
prerank,regulation of wound healing (GO:0061041),-0.32496008877593596,-1.1376289436035836,0.23384615384615384,0.6234772271305746,1.0,11/42,10.44%,CAV1;OCLN;MYLK;ITGB1;ACTG1;VTN;KANK1;ANXA1;CD109;SERPINE1;EPHB2
prerank,regulation of receptor binding (GO:1900120),-0.4835293609588238,-1.1374923512827118,0.3125,0.6229616119037182,1.0,5/10,17.14%,PTPRF;B2M;ATP2A3;GREM2;HFE
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.387133649741094,-1.1372993387249912,0.2677595628415301,0.6225582272429615,1.0,13/19,38.37%,DRG1;CHMP2B;CHMP4B;PDCD6IP;CHMP1A;CHMP4C;HSPA1A;CHMP2A;HSPA1B;TPR;PLK1;HNRNPU;CHMP3
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.29902456598565186,-1.1372108959620506,0.19444444444444445,0.6219381655198177,1.0,24/59,22.72%,ROCK2;CAMK2D;PRKDC;WNK1;HIPK3;GSK3B;HIPK1;ACVR1;CDC42BPB;DYRK2;HIPK2;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;AKT1;CSNK2B;SBK1;MARK2;TGFBR2;TTBK1;STK39;CAD
prerank,cellular response to copper ion (GO:0071280),-0.4248574219420208,-1.136765439616213,0.3244444444444444,0.6222830554728308,1.0,12/16,37.35%,MT2A;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;HSF1;AQP1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4518825032829428,-1.136716201681747,0.31542056074766356,0.6215289275186089,1.0,5/12,26.93%,TMEFF2;AP2A1;EDN1;SELENOS;TAF7
prerank,T cell migration (GO:0072678),0.4739797042308508,1.1364573990853875,0.30390492359932086,0.9033969541968248,1.0,4/13,16.97%,CXCL10;GPR183;MYO1G;PIK3CG
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2519408505142866,-1.1352779899712262,0.10638297872340426,0.6243023105053765,1.0,67/193,23.97%,FBXL7;NPLOC4;RNF146;UBE2G1;ASB2;SQSTM1;RNF43;RNF185;PSMD9;ARIH1;CDC23;PSMF1;TRIP12;TRIM25;ANAPC10;PTTG1;TOLLIP;UBB;RNF8;UBE2H;MIB1;SMURF2;UBA6;KCTD21;RC3H1;UBE2A;RNF125;RNF11;RNF144B;RNF114;SPSB4;RCHY1;KCTD6;FBXL4;AMFR;ELOC;UBE2L6;FBXL14;NEDD8;SIAH2;CUL3;ANAPC16;ISG15;ANAPC11;UBC;ANAPC15;PPP1R11;BUB3;CHFR;ANKIB1;WDR91;KLHL25;FZR1;CDC34;KLHL3;ANAPC2;RNF166;RNF5;RFFL;FBXO22;UBA52;ADRM1;FBXO10;SMURF1;RLIM;RNF111;RNF20
prerank,regulation of protein autophosphorylation (GO:0031952),0.3932036491005716,1.135247917216012,0.2873900293255132,0.9062859861898895,1.0,2/36,0.66%,ENPP1;EPHA7
prerank,regulation of TORC1 signaling (GO:1903432),-0.34213845221957623,-1.1351144258260821,0.2558139534883721,0.6238311064476988,1.0,11/33,19.48%,RNF152;SIK3;SESN1;LAMTOR5;RRAGC;CLEC16A;PIP4P1;ATM;GPR137;SEH1L;RRAGB
prerank,Rho protein signal transduction (GO:0007266),0.36478185971288074,1.1347764848097093,0.2615606936416185,0.9066739732751986,1.0,19/53,19.38%,ARHGEF3;RHOJ;ARHGAP6;NGFR;CTNNAL1;LIMK1;COL1A2;EPS8L1;ARHGAP4;ARHGAP1;RTKN;CDC42EP1;CDC42EP4;ADRA2A;RHOG;ARHGAP29;CDC42EP3;RHOA;PLEKHG5
prerank,histone lysine demethylation (GO:0070076),-0.37340522651854446,-1.134665279855075,0.264,0.6241439854990796,1.0,10/25,25.65%,KDM4A;KDM4C;RIOX2;PHF8;HR;KDM4B;KDM3B;PHF2;KDM2B;KDM1A
prerank,endothelial cell differentiation (GO:0045446),0.5030659973797815,1.1344640492830915,0.33098591549295775,0.9063726919685474,1.0,1/12,0.06%,SCUBE1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4506590982113985,-1.1336964290821103,0.3097560975609756,0.6256988128415464,1.0,5/12,16.95%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,regulation of intracellular protein transport (GO:0033157),-0.3433108207076144,-1.1336691424630005,0.27323943661971833,0.6249058037502424,1.0,10/32,17.59%,PTPN14;RUFY3;NDEL1;IFI27;PRR5L;CEP290;PTPN1;OAZ1;BCAS3;OAZ2
prerank,mRNA splice site selection (GO:0006376),0.4052237515349176,1.133624781738856,0.2896,0.9079319841131254,1.0,13/30,22.84%,ISY1;NOL3;CELF4;SLU7;LUC7L2;SRSF10;SRSF9;SF3A3;SRSF6;PRPF39;LUC7L3;SRSF12;CELF6
prerank,endothelial cell proliferation (GO:0001935),-0.41442280217457117,-1.1335879012626733,0.2696078431372549,0.6242278144797935,1.0,6/17,8.29%,TEK;BMPER;BMPR2;CD34;ACVRL1;ITGB1BP1
prerank,gland development (GO:0048732),-0.3061574822792149,-1.133345959890877,0.21348314606741572,0.6240126221477245,1.0,20/59,19.16%,DKK3;CAV1;EZR;ARID5B;WNT4;ANXA1;COBL;GLI2;SIX1;TBX1;LSR;CITED2;MDK;STRA6;MET;EPHB3;MSN;HOXD3;WNT11;TGFBR3
prerank,nuclear migration (GO:0007097),-0.44101016702642365,-1.1329288503412855,0.3213429256594724,0.6241406825044595,1.0,3/13,3.79%,SYNE2;SYNE3;CLMN
prerank,fluid transport (GO:0042044),-0.46088232943723445,-1.1328214041688858,0.31542056074766356,0.6235465626211811,1.0,8/12,53.64%,PDPN;SLC26A6;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7
prerank,cellular response to virus (GO:0098586),0.40955587545689004,1.1327160796951168,0.29709035222052066,0.9097316257939868,1.0,9/30,19.67%,CXCL10;GBF1;FMR1;IL12A;MAPK11;LGALS9;RRP1B;HIF1A;GSDME
prerank,carbohydrate transport (GO:0008643),-0.4626230824987905,-1.132342082265452,0.28019323671497587,0.6239180234118279,1.0,9/11,46.94%,SLC26A6;AQP11;SLC2A2;SLC23A2;SLC23A1;AQP1;SLC50A1;SLC2A5;AQP9
prerank,steroid metabolic process (GO:0008202),0.34603825604292543,1.132261474138323,0.25259067357512954,0.90997140460678,1.0,2/72,0.29%,HSD11B1;CYP7B1
prerank,peptide metabolic process (GO:0006518),-0.2868956493841651,-1.1322239741238231,0.20901639344262296,0.6233631919941511,1.0,29/75,30.40%,AEBP1;CPE;CPD;ERAP1;ACE;SPCS2;DMD;GPX1;SEC11C;ETHE1;CLN5;FURIN;GSTA4;APEH;PCSK5;GSTT1;TRHDE;ABCB9;GSTM5;MME;BACE2;TPP1;PSEN2;GGT1;CARNMT1;THOP1;GSTK1;SPPL3;CPZ
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4678652388504247,1.1321445282429596,0.2891156462585034,0.9090558538630408,1.0,5/15,11.48%,EDA;HDAC1;ANKRD11;AMELX;MSX1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3855303741809044,-1.1318640346128799,0.2617801047120419,0.6234219284254555,1.0,10/20,28.60%,ROCK2;RHOQ;RAB13;FHOD1;LLGL2;DLG1;STRIP1;IKBKB;FMNL1;NCKAP1L
prerank,establishment of protein localization to membrane (GO:0090150),-0.2928074660025772,-1.1316154826361597,0.22183098591549297,0.6232333120795888,1.0,14/66,12.72%,SYNE3;EGFR;AFDN;VPS37A;NACA;PARD3;ZDHHC21;VPS37B;ARL6;FRMPD1;MYO1C;RAB3IP;BID;ZDHHC14
prerank,brain morphogenesis (GO:0048854),0.4898077193693159,1.1315528903447563,0.31762652705061084,0.9097530076285192,1.0,2/12,1.89%,CTNNA2;PTEN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4545759382074423,1.1314649021339591,0.30201342281879195,0.908714241459944,1.0,8/17,25.08%,CTNNA2;FCHSD2;WASF3;ARFIP1;CYFIP1;GMFB;ARFIP2;ABI2
prerank,ESCRT complex disassembly (GO:1904896),-0.4692022530538744,-1.1312331955224335,0.2880184331797235,0.6224659006252365,1.0,5/10,27.10%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),-0.4692022530538744,-1.1312331955224335,0.2880184331797235,0.6224659006252365,1.0,5/10,27.10%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,coenzyme A biosynthetic process (GO:0015937),0.5061920125966055,1.1309834610542442,0.32771535580524347,0.9063193255150841,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5061920125966055,1.1309834610542442,0.32771535580524347,0.9063193255150841,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5061920125966055,1.1309834610542442,0.32771535580524347,0.9063193255150841,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.35745753179863765,-1.1308197405179556,0.2664835164835165,0.6227211358584507,1.0,3/26,0.60%,EPHA4;PICALM;ROCK2
prerank,cartilage development (GO:0051216),-0.31639664337057205,-1.129561097308539,0.22653721682847897,0.625124291483015,1.0,10/49,7.33%,NFIB;SOX5;ITGB8;MEF2C;WNT5B;OSR1;RUNX1;CCN3;SULF2;CD44
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.45305043777307374,1.1294749076323711,0.3271812080536913,0.9100383465911877,1.0,3/20,2.62%,PTEN;NR2F2;CDKN2A
prerank,sphingolipid metabolic process (GO:0006665),-0.2707015288581503,-1.1288806095806383,0.18867924528301888,0.6259351805638292,1.0,35/108,21.50%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;SMPD3;ACER3;SGMS2;CERT1;PPP2R1A;DEGS2;SPNS2;VAPA;ST6GALNAC3;VAPB;HEXB;ENPP2;ELOVL4;UGCG;B3GALNT1;ELOVL7;ESYT3;SPTSSA;KDSR;SMPD1;GM2A;CLN8;ARSA;ORMDL2;CERS2;PSAP;GLTP;SPHK2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.504932646738837,1.1272909371771966,0.3205574912891986,0.9163120196110425,1.0,4/11,15.74%,TLR6;CYBA;LYN;TIRAP
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.45737090012500903,-1.1271262792332308,0.291044776119403,0.6296440042826552,1.0,4/11,25.14%,PARP10;PARP9;PARP4;PARP12
prerank,neutrophil activation (GO:0042119),0.4926425539523839,1.127015757799404,0.32372881355932204,0.9159640828763251,1.0,2/12,13.18%,KMT2E;PREX1
prerank,cellular response to hypoxia (GO:0071456),0.3220754282559441,1.126894188661489,0.25304136253041365,0.9150593609184997,1.0,35/126,19.13%,RORA;CPEB1;HIF1AN;PSMD1;TBL2;EPAS1;PSMD10;EGLN2;HP1BP3;PSMA5;PSMB5;MDM4;TWIST1;PINK1;MTOR;AK4;BMP7;PSMC4;KCND2;TP53;PSMA4;PSMC5;PTGIS;FAM162A;PSMB9;SCN2A;MYC;PSMA7;PSMD14;ADAM8;SUV39H2;PSMA2;HIF1A;PSMD11;ARNT
prerank,negative regulation by host of viral transcription (GO:0043922),0.49282400496917955,1.1267147358864205,0.3339253996447602,0.914372743278793,1.0,2/12,4.28%,HDAC1;REST
prerank,negative regulation of hippo signaling (GO:0035331),-0.4595102052738844,-1.1263872303369338,0.30071599045346065,0.6306628950674025,1.0,5/12,16.76%,MAPK14;DLG5;AJUBA;MARK3;VGLL4
prerank,protein heterooligomerization (GO:0051291),0.46089080294958185,1.1263677282610371,0.3018242122719735,0.9142656832984596,1.0,4/17,10.20%,GRIN2B;KCNC2;HSD17B8;NUDT21
prerank,negative regulation of heart contraction (GO:0045822),0.5012974744493157,1.1256172782360037,0.3149171270718232,0.9155398408212136,1.0,2/11,6.45%,ATP1A2;SPX
prerank,central nervous system neuron differentiation (GO:0021953),0.3940371221867289,1.1250563656530572,0.2997032640949555,0.9161265132114133,1.0,7/33,14.03%,NTRK2;GRID2;MDGA2;NPY;OPHN1;CBLN1;ATP7A
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2941154349878528,-1.1250483280018562,0.24814814814814815,0.6329401050312393,1.0,19/65,18.27%,AFAP1L2;PTPRJ;EGFR;FER;PTPN3;HIP1R;CDC42;ERRFI1;MVP;ITGA1;PTPN2;CCDC88A;CEACAM1;RHBDF2;HIP1;GRB2;GPER1;AKT1;EGF
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.49959244671571845,1.124180882268844,0.3220640569395018,0.9177689430850743,1.0,3/11,5.41%,GHR;PIK3R1;IRS1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4054311256147487,1.1240640067349827,0.3126934984520124,0.9168143789671799,1.0,8/29,11.21%,AGO4;SPOUT1;ZC3H7B;LIN28B;HNRNPA2B1;MRPL44;SRRT;AGO3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.43638310037661165,-1.1240401521652064,0.31422018348623854,0.6345337995320222,1.0,7/13,25.13%,NBL1;FSTL1;GREM2;CHRDL1;CD46;NRROS;GREM1
prerank,endochondral bone morphogenesis (GO:0060350),0.5139380540777775,1.1238919675923882,0.3382899628252788,0.9160536972260019,1.0,1/11,0.07%,COL13A1
prerank,embryonic digestive tract development (GO:0048566),0.44818659167513086,1.1236714828198096,0.31918505942275044,0.9155397076091623,1.0,2/18,2.53%,PDGFRA;SALL1
prerank,regulation of viral transcription (GO:0046782),-0.3298168463849685,-1.123343063465914,0.2735294117647059,0.6353682494621298,1.0,17/39,29.49%,TRIM11;IFITM3;TRIM14;POLR2B;POLR2H;POLR2G;POLR2C;TRIM27;UBP1;CDK9;NELFCD;HEXIM1;GTF2F2;CTDP1;POLR2I;POLR2K;MID2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4047189089367721,-1.1232756555458656,0.2909090909090909,0.634679266516834,1.0,4/16,4.26%,IGF1;MEF2C;RBPJ;NOTCH1
prerank,proteoglycan metabolic process (GO:0006029),0.4129119537963325,1.1230716168083739,0.32473444613050073,0.9163053057157288,1.0,2/26,0.66%,CHST8;SULF1
prerank,positive regulation of protein binding (GO:0032092),-0.3022752508987742,-1.1229584176707559,0.24714828897338403,0.6345884660339792,1.0,16/56,15.42%,RAPGEF2;CAV1;APP;CLDN5;HIP1R;VTN;B2M;APOE;GSK3B;RPL11;RALB;TERT;HIPK2;RAN;AMFR;MARK3
prerank,protein import into peroxisome membrane (GO:0045046),0.4311588153727557,1.1219241280867776,0.33751962323390894,0.9189732016096084,1.0,10/22,23.26%,ABCD2;PEX2;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;GDAP1;FIS1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.46485840992659416,1.1219011011599072,0.31993006993006995,0.9177380281444577,1.0,5/15,11.18%,HRG;SEMA5A;PRKD1;LGMN;P2RX4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.391462988490117,-1.1216451537513725,0.30710659898477155,0.6370347039073933,1.0,2/17,4.08%,LPGAT1;PLA2G4A
prerank,positive regulation of MAPK cascade (GO:0043410),0.29683456047264467,1.1208884446011713,0.23642533936651583,0.9199720639328878,1.0,33/245,10.91%,ROR1;PDGFRA;NTRK3;IL34;XCL1;ROR2;EDN3;SLC30A10;NTRK2;CD40;ERBB4;C5AR1;P2RY1;FGFR1;GPR37L1;GCNT2;HTR2B;PTPN22;CCL15;LRRK2;GLIPR2;NECAB2;GPR183;PRKCA;SOX2;HTR2C;TENM1;MAP2K1;IRAK1;LPAR1;EIF2AK2;CCL25;PYCARD
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.44974004495635267,1.1207332709434084,0.3137931034482759,0.9192232918891349,1.0,5/17,15.29%,ATP1A2;ATP1A3;BMP7;MED1;AR
prerank,positive regulation of cell death (GO:0010942),0.3530050168476885,1.1204423930300496,0.28116343490304707,0.9188848176524612,1.0,13/59,15.09%,LRP1;SLC6A13;ACOX2;WNT5A;GRIN2B;FOS;LRRK2;C1QA;DAXX;FYN;EIF2S1;RIPK1;CLU
prerank,regulation of viral release from host cell (GO:1902186),-0.3766964422475216,-1.1203710625409167,0.28493150684931506,0.6394643984590197,1.0,5/21,6.69%,CHMP2B;TRIM25;TRIM5;TRIM11;VPS37B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.41492564552161476,1.120147538449671,0.3059360730593607,0.9185781817815674,1.0,3/23,4.06%,TXK;JAK1;NR1H2
prerank,regulation of dendritic spine development (GO:0060998),-0.3883501958174722,-1.1197270967844901,0.27925531914893614,0.6402385186339374,1.0,7/19,11.77%,MEF2C;SHANK3;APOE;SHANK1;CAMK2B;CPEB3;DLG5
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2286614261269654,-1.1194304233812382,0.078125,0.6401805157013067,1.0,91/348,18.77%,FN1;IGF1;SLC24A3;ROCK2;ITGB8;MEF2C;RBPJ;LEF1;OCLN;ROBO1;KRAS;AFDN;PPHLN1;OSR1;EZR;NOS3;APP;KLF4;FOXD1;CLDN5;RDX;MAGI2;VPS35;GSN;INSR;NOTCH1;ACTG1;SMO;INPP5F;RPL5;CD34;MAPK9;TFRC;RPS7;KLF2;MAPK14;NGF;PPM1F;GSK3B;CELF1;FGF1;LAMTOR5;SMAD3;ANK2;WNT6;RPL11;CITED2;PIK3CB;GATA2;PIK3CD;ETS1;PTPN1;EPHB2;TNRC6A;ATF7IP;CTSH;CD63;ACTA2;TNRC6C;PLCG2;HEY2;SMAD1;TMEM119;ATM;NOS1AP;WNT16;RAMP2;TICAM1;P2RX7;CDH5;MAP2K5;GPER1;PRKAA1;ZPR1;MED23;DNAJA4;HFE;CD74;LAPTM5;AGO2;AKT1;DNMT3B;SOX11;IFNGR1;EGF;SLC22A2;MSN;HOXD3;CTCF;PID1;WNT11
prerank,regulation of centriole replication (GO:0046599),0.44605617467754627,1.1192375401658305,0.3273615635179153,0.9204271237263971,1.0,4/17,9.78%,MDM1;CEP295;TRIM37;KAT2A
prerank,activation of protein kinase B activity (GO:0032148),0.40588286843378235,1.1191840252007956,0.3136645962732919,0.9193358557153337,1.0,7/29,9.11%,NTRK3;NRG1;WNT5A;PDPK1;PRR5;PINK1;MTOR
prerank,keratinocyte differentiation (GO:0030216),-0.3566143680091505,-1.1190040342074024,0.26136363636363635,0.6404337260885962,1.0,13/29,25.19%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;BCR;WNT16;EPHA2;ADAM9;PIP5K1A;ASAH1;DSP;EXPH5
prerank,epithelial cell differentiation (GO:0030855),0.33269480381751676,1.118687704179901,0.2720105124835742,0.9197407600248165,1.0,9/88,9.06%,SCUBE1;HDAC1;BASP1;ERBB4;SCRIB;CASP6;E2F4;EDF1;GLI1
prerank,nucleotide metabolic process (GO:0009117),0.40681853243112925,1.1184690088777525,0.3155339805825243,0.9191165539583152,1.0,8/23,13.81%,NMNAT3;AK1;ENPP3;AK4;FHIT;DCTD;RNASEH2B;AK8
prerank,base conversion or substitution editing (GO:0016553),0.49176849440029013,1.1182794042309552,0.3375224416517056,0.9184855212218146,1.0,2/11,15.51%,ADARB2;ADAR
prerank,cellular response to type I interferon (GO:0071357),-0.3215259518808738,-1.1180370903386907,0.2870662460567823,0.6410833313145379,1.0,10/41,9.69%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IRF1;IFITM1
prerank,type I interferon signaling pathway (GO:0060337),-0.3215259518808738,-1.1180370903386907,0.2870662460567823,0.6410833313145379,1.0,10/41,9.69%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IRF1;IFITM1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.26364598955129875,-1.1180351832002045,0.21105527638190955,0.6402367932679665,1.0,34/118,19.63%,PHLDB2;EPHA4;MEF2C;PDLIM5;BMPER;SIPA1L1;LARP4;SHANK3;SPARC;RUFY3;CAPZB;EFNA5;TBX1;GSK3B;MAPT;CFL1;RC3H1;SFRP1;ETS1;BCL9L;DAG1;CEACAM1;FLT4;LFNG;LZTS3;ARHGAP44;PAK2;EPHA2;ERBB2;EPHB3;PID1;MARK2;VASH1;SARM1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.34431769224497555,-1.1167931621998746,0.2972972972972973,0.6424766477135136,1.0,11/32,16.30%,DDX5;PPP1R13B;JMY;HIPK1;DYRK2;MYBBP1A;HIPK2;BOK;HINT1;SIRT1;TMEM109
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.36332670317761245,-1.1167436121026755,0.2837465564738292,0.6417472012472295,1.0,11/23,36.20%,MBOAT1;PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;PLA2G4C;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4
prerank,muscle tissue development (GO:0060537),-0.43665539182020585,-1.1166817148664172,0.33175355450236965,0.6410935543299584,1.0,4/13,14.79%,PGM5;SMO;CSRP2;STRA6
prerank,heterochromatin organization (GO:0070828),-0.41429116261872534,-1.116123444545278,0.29213483146067415,0.6416759612980616,1.0,6/14,16.93%,MECOM;PRDM16;SMCHD1;SIRT1;SNAI1;BAHD1
prerank,protein modification process (GO:0036211),-0.28147644141095146,-1.116106314511876,0.2289156626506024,0.6408718962629144,1.0,31/76,27.55%,ST3GAL6;ST8SIA4;CPE;PRKDC;WWP2;UBE2D3;ST3GAL1;FBXL2;MANBA;ST8SIA2;MMP15;CSNK1G3;USP25;PARP4;UBE2L6;NEDD8;YES1;QPCT;MCRS1;CDC34;ICMT;FBXO22;UBA52;PHEX;FBXW2;PARP1;BAP1;ADPRH;NAGPA;PHKA2;RABGGTA
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.43434014074410865,-1.1158011461744244,0.3188720173535792,0.6407991089628267,1.0,3/13,6.45%,DDO;ACOT8;GOT2
prerank,regulation of myelination (GO:0031641),0.41404330894670793,1.1157831884873555,0.3068535825545171,0.9257923402859839,1.0,5/25,13.88%,PTN;TENM4;LGI4;TNFRSF21;MYRF
prerank,positive regulation of phospholipid transport (GO:2001140),-0.462960317442969,-1.115712155356845,0.3392461197339246,0.640181189794856,1.0,5/10,19.84%,APOE;ABCA3;ABCB4;PRELID1;DBI
prerank,positive regulation of cellular process (GO:0048522),0.28235166928218997,1.1156380905293717,0.18106995884773663,0.9249775944407673,1.0,97/565,15.70%,PDGFRA;PTN;COLEC12;NTRK3;IL34;IL15RA;LRP1;ZFHX3;NRG1;MERTK;TMEM102;HOXC10;PTGFR;EDN3;MEIS1;ACOX2;HDAC1;WNT5A;NTRK2;TAF9B;PTEN;PHIP;ERBB4;ITGAV;FLT3LG;FGFR1;ANKLE1;GAB2;MEIS2;TSLP;TIPIN;RYR2;POU3F3;TBX3;FBXO5;TENM4;GCNT2;HTR2B;CDC7;FMR1;TUB;MTPN;IRS1;CDH3;PSMD10;IRS2;ECHDC3;SRF;FXN;LYAR;PTK2;TRPC3;HTR1A;CDK13;PRKCA;CCKBR;GLI1;LGMN;TSPYL5;TLR4;CYBA;CACUL1;SLC25A33;DHX36;PYCARD;POFUT2;RTKN2;NAP1L1;P2RX4;TGFBR1;ACLY;SOX9;IL12A;EXOSC9;CD86;IGF2;FAM98B;CD81;GAREM1;AKAP6;DHPS;MYRF;LYN;DOT1L;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;AREG;AR;GDNF;CNOT7;MYC;N6AMT1;FGFR2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3268607590804922,-1.1154986689451856,0.26704545454545453,0.639877967222611,1.0,9/39,10.62%,SLIT2;NRP1;TIE1;KDR;RASIP1;GLI2;SIX1;LRP6;NPNT
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.281355493948684,-1.1154416489975154,0.24621212121212122,0.6391782128736936,1.0,29/74,23.30%,RBPJ;PSMC6;PSMD9;NOTCH1;EGLN3;PSMF1;HIF3A;PSMB7;UBB;PSMD8;CITED2;PSMD12;VHL;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;ELOC;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;PSMA8;STOX1
prerank,response to retinoic acid (GO:0032526),-0.2938240179462849,-1.11523296711456,0.21232876712328766,0.6388884917975091,1.0,16/59,15.29%,WNT5B;ACER2;WNT9A;RBP4;RXRA;FZD4;FZD7;TBX1;WNT6;TRIM16;CTSH;RET;ATM;GATA6;PTK2B;CREB1
prerank,chromatin assembly (GO:0031497),0.379052759557252,1.1152049926837524,0.3111455108359133,0.9252142030795862,1.0,10/38,12.75%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;NOC2L;DAXX;TP53;NAP1L1;SOX9;POLE3
prerank,sensory perception of light stimulus (GO:0050953),0.33237048403846237,1.115139906730995,0.2701664532650448,0.9241622963458753,1.0,7/87,3.76%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,response to amyloid-beta (GO:1904645),0.37034754362499134,1.1150354187518,0.30712166172106825,0.923233899328383,1.0,11/44,11.12%,LRP1;GJA1;NGFR;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;GRM5;FYN
prerank,cell differentiation in spinal cord (GO:0021515),0.5072431359148959,1.1150279190430985,0.3206831119544592,0.9219712218257918,1.0,2/10,4.52%,MDGA2;SOX6
prerank,regulation of potassium ion transport (GO:0043266),0.3903474346273893,1.1146630152672163,0.31398809523809523,0.9219483812585199,1.0,9/31,13.15%,DPP6;DPP10;ANK3;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4670245549947265,1.114549347112767,0.31932773109243695,0.9210439254691676,1.0,6/15,17.33%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,protein localization to membrane (GO:0072657),-0.24500333097959276,-1.114235237496095,0.18181818181818182,0.6406361851441514,1.0,35/187,9.21%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;SYNE3;LIN7A;RAPGEF6;EZR;SHANK3;CDH1;F11R;CPE;RDX;MAGI2;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;DVL1;PACS1;RAMP1;TTC7B;SH3PXD2B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;FRMPD1;TTC7A
prerank,regulation of ossification (GO:0030278),0.37996055496713854,1.1141233104150545,0.31085043988269795,0.9212525426667645,1.0,4/36,5.17%,ENPP1;PTN;WNT5A;ZBTB16
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.40195528803125286,1.1137504505028897,0.31645569620253167,0.921186047840808,1.0,12/31,22.10%,DNAJC19;PEX2;PEX7;TIMM44;DNAJC15;PAM16;PEX12;PEX14;PEX6;GRPEL1;TIMM21;CHCHD4
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4585364037681633,1.1135453950048344,0.32451499118165783,0.9193253493125463,1.0,6/15,15.59%,NANOS3;ZFP36L2;DHX36;CNOT1;CNOT7;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4585364037681633,1.1135453950048344,0.32451499118165783,0.9193253493125463,1.0,6/15,15.59%,NANOS3;ZFP36L2;DHX36;CNOT1;CNOT7;TNRC6B
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.46884491910875137,-1.113532967634562,0.3387096774193548,0.6416056003255426,1.0,4/10,23.43%,KLF4;TLE5;MAP2K5;SIGIRR
prerank,cardiac muscle cell differentiation (GO:0055007),-0.38832159900953644,-1.1127637219669162,0.30183727034120733,0.6426712863923162,1.0,7/21,16.48%,MEF2C;CXADR;SIK1;ACVR1;MYH11;CBY1;MYOCD
prerank,glutamate metabolic process (GO:0006536),-0.3921802933144487,-1.112600826108116,0.30412371134020616,0.6423024759506308,1.0,4/19,9.04%,GCLC;PRODH;GOT2;OAT
prerank,primary neural tube formation (GO:0014020),0.39359191002928606,1.1122772442352165,0.29767441860465116,0.9223100720539678,1.0,4/30,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3906284166022875,1.1122037846168211,0.3223270440251572,0.9212791110748352,1.0,5/35,5.15%,DLC1;SPRY4;SPRY1;ITGA3;ARHGAP24
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.38543158805489147,-1.1118535516100125,0.3008130081300813,0.6433854681910582,1.0,5/19,4.27%,MEF2C;RBPJ;RBP4;NOTCH1;RUNX1
prerank,nuclear pore complex assembly (GO:0051292),-0.4671272873603761,-1.1117481385488288,0.3364485981308411,0.642826292533151,1.0,5/10,21.49%,NUP98;NUP153;TMEM170A;NUP205;RTN4
prerank,positive regulation of cytokine production (GO:0001819),0.2931419642062679,1.1117379447190434,0.2535675082327113,0.9216322059500692,1.0,34/292,10.91%,RORA;IL33;SULF1;XCL1;WNT5A;TXK;PLA2R1;CD40;IL16;PDE4B;GLMN;NR1H4;LURAP1;TSLP;SCRIB;SPTBN1;HTR2B;PTPN22;TLR6;SORL1;CD276;DHX58;TLR8;TWIST1;MBP;TLR4;DDX41;KAT2A;CYBA;IRAK1;FGR;EIF2AK2;DHX36;PYCARD
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.33612862908421914,-1.111279262867855,0.28532608695652173,0.6432386499080928,1.0,7/35,7.66%,NR3C2;DDX5;RBFOX2;PPARGC1B;NCOA4;TMF1;WBP2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3716872761053903,-1.111002065624079,0.3086734693877551,0.643114029217852,1.0,7/22,6.94%,IGF1;ROCK2;MEF2A;CAMK2D;NOTCH1;IL6ST;LMCD1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2509333633776678,-1.1108948609379434,0.20833333333333334,0.6426007831651873,1.0,49/166,19.47%,SORBS1;IGF1;VIM;LARP4;EGFR;THBS1;KLF4;LPGAT1;ELAVL1;PRKDC;NIBAN1;INSR;SAMD4A;GIPC1;LARP4B;RPL5;GLI2;KLF2;SOX4;SCARB1;SMAD3;DYRK2;PYM1;STARD4;PTPN2;CPEB3;RPL26;EIF3D;RPS4X;PTH1R;PCNA;STN1;ASS1;DDAH1;MFSD2A;NOS1AP;ZNF205;PTGS2;EDN1;SIRT1;EIF3E;EPM2AIP1;ERBB2;AKT1;ABCB10;EGF;HGF;RGCC;NPM1
prerank,mitochondrial protein processing (GO:0034982),0.5023570220013165,1.1102450151753915,0.3462897526501767,0.9252802777074445,1.0,4/11,17.57%,OMA1;IMMP2L;PMPCA;IMMP1L
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.4485095509074737,1.1098103885584478,0.34563758389261745,0.9254879585832219,1.0,4/16,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,negative regulation of wound healing (GO:0061045),-0.36050631683038004,-1.1096899253614407,0.3163841807909605,0.6448095857709291,1.0,7/28,9.85%,PHLDB2;THBD;VTN;CD34;CD109;APOE;SERPINE1
prerank,focal adhesion assembly (GO:0048041),-0.38250679861613723,-1.1091592560532313,0.31283422459893045,0.6453246364647235,1.0,4/21,2.45%,SORBS1;ACTN2;PTPRK;THSD1
prerank,in utero embryonic development (GO:0001701),0.4133143517942678,1.109068304362905,0.3328,0.9267320913896088,1.0,7/25,18.02%,CHD7;PTPRR;TGFBR1;IGF2;ARNT2;FGFR2;BMP2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2732925796564001,-1.1090057586355688,0.2139917695473251,0.6448761617349561,1.0,20/79,15.79%,ST3GAL6;IGF1;CSGALNACT1;ST8SIA4;B3GALT1;BMPR2;ST3GAL4;B4GALT5;ST6GALNAC2;CHST11;ST3GAL3;MGAT1;LARGE1;FOXL1;ST8SIA2;B3GALNT1;FUT9;ST3GAL5;ST3GAL2;GCNT1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4690701677971401,1.1086865606205734,0.3385146804835924,0.926712651822408,1.0,3/12,5.32%,NUP214;AAAS;NEDD4
prerank,cell-matrix adhesion (GO:0007160),0.3255503490627015,1.108599433562991,0.29411764705882354,0.9257437749321917,1.0,12/95,7.56%,COL13A1;DLC1;ITGA11;ITGA8;PEAK1;ITGAV;ITGA3;ITGB5;SGCE;ACTN1;ADAMTS12;PPFIA2
prerank,cellular component disassembly (GO:0022411),0.3592040158062346,1.108540315089628,0.32193732193732194,0.9246894003943048,1.0,2/53,0.41%,SCUBE1;LAMC1
prerank,pancreas development (GO:0031016),0.4810227976727009,1.1084495204936036,0.3345070422535211,0.9237318825547565,1.0,2/12,3.14%,TCF7L2;NPHP3
prerank,negative regulation of protein transport (GO:0051224),-0.35984585027326194,-1.1080432821328579,0.2986666666666667,0.6464019052426199,1.0,7/25,18.81%,WWP2;PPM1F;APOE;PKDCC;RHBDF2;CYP51A1;SNX3
prerank,positive regulation of transport (GO:0051050),0.3355070398001933,1.1078371014497537,0.3257372654155496,0.9244864307414219,1.0,14/85,10.91%,IL15RA;LRP1;MERTK;GPLD1;KMT2A;FMR1;TUB;CDH3;CLIP3;LYAR;CYBA;PLAA;KCTD7;PYCARD
prerank,positive regulation of cell cycle process (GO:0090068),0.3300047018705916,1.10749159919464,0.3032258064516129,0.9244950959453128,1.0,13/91,12.43%,SVIL;CDC14B;RXFP3;EDN3;PHIP;FEN1;CDC7;CEP295;GPSM2;WIZ;NUSAP1;USP19;IGF2
prerank,positive regulation of macrophage migration (GO:1905523),0.428126185503048,1.107214458909158,0.32460732984293195,0.9242016357828085,1.0,7/19,21.51%,IL34;PTK2;P2RX4;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,chromatin assembly or disassembly (GO:0006333),0.49573612667659533,1.1071922092436075,0.34615384615384615,0.9230370259871197,1.0,5/11,21.09%,CHAF1B;NOC2L;TP53;SUV39H2;HIRIP3
prerank,spindle assembly (GO:0051225),0.33656872883613814,1.1070751638311933,0.29195088676671216,0.922159136101666,1.0,21/67,18.72%,CCDC61;HAUS3;HAUS1;LSM14A;AAAS;STARD9;HAUS8;GOLGA2;CEP192;RCC1;TUBGCP4;MAP9;CLASP2;TUBGCP6;KIFC2;KIF2A;CLASP1;GOLGA8B;SMC1A;RHOA;KPNB1
prerank,renal absorption (GO:0070293),-0.4640422073123662,-1.1067914817729942,0.33640552995391704,0.6486390935424978,1.0,6/10,28.60%,GSN;WNK4;KCNQ1;KLHL3;HYAL2;HAS2
prerank,neuromuscular synaptic transmission (GO:0007274),0.4278737854950194,1.1060006971774101,0.34183673469387754,0.924626273484397,1.0,4/18,10.19%,CHRNB4;CHAT;FCHSD2;ERC2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3728110980001409,-1.1050349237172479,0.3171912832929782,0.6520697876486479,1.0,5/21,7.54%,MEF2C;MAGI2;CALM1;MTMR9;ITGA1
prerank,water transport (GO:0006833),-0.44382858050702007,-1.1049944059174168,0.33175355450236965,0.651331426316293,1.0,8/12,55.32%,PDPN;CFTR;AQP11;AQP1;AQP9;AQP6;AQP7;SLC5A1
prerank,tube closure (GO:0060606),0.3907037191160631,1.104646573433505,0.30340557275541796,0.9279457148776488,1.0,4/31,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,regulation of NMDA receptor activity (GO:2000310),0.3880030978113325,1.104491080695999,0.3123076923076923,0.927214192567498,1.0,10/32,12.93%,GRIA3;GRIN2B;GRIA4;GRIA1;DLG3;DLG2;GRIN2A;RELN;DLG4;LRRC7
prerank,cellular response to interleukin-7 (GO:0098761),0.44460614583890046,1.1041534527439771,0.31993299832495814,0.9258697227121045,1.0,4/17,6.26%,JAK1;TSLP;IRS1;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.44460614583890046,1.1041534527439771,0.31993299832495814,0.9258697227121045,1.0,4/17,6.26%,JAK1;TSLP;IRS1;IRS2
prerank,positive regulation of phosphorylation (GO:0042327),0.2945507654879164,1.1040068137955608,0.2831661092530658,0.9251591835658632,1.0,31/240,10.56%,ROR1;PDGFRA;NTRK3;IL34;ZBTB20;EPHA7;ROR2;MERTK;NTRK2;CD40;ERBB4;EPHB1;PFKFB1;GLMN;P2RY1;FGFR1;ENTPD5;EPHA6;FMR1;DSCAM;CAMKK2;LRRK2;CLIP3;PTK2;PINK1;EPHB6;AXL;RB1CC1;DAXX;EPHA3;WDFY2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.40509502188854807,1.1039960398095225,0.31790123456790126,0.9239554830169652,1.0,8/26,17.33%,ADCY5;GPLD1;NR1H4;ADCY8;PPP3CB;EPHA5;BRSK2;ADRA2A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3917431284669189,-1.1038882349809325,0.33729216152019004,0.6534327407538272,1.0,6/17,16.11%,MEF2C;TPM1;SOD2;PRKG1;CDKN1A;GPER1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.31033519903999296,-1.103821317498639,0.26380368098159507,0.6527834893046127,1.0,5/41,4.78%,PTGS1;PLA2G4A;CYP1B1;ACOT8;MGLL
prerank,potassium ion homeostasis (GO:0055075),0.4183353157028724,1.1036571363433385,0.3465346534653465,0.9239039548030401,1.0,4/23,5.33%,ATP1A2;SLC12A6;ATP1A3;KCNMA1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3266048944225032,1.1033741434485136,0.29172141918528255,0.9235864331171155,1.0,16/90,9.82%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;SIRT6;EPAS1;FABP5;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4493733005026286,-1.1033004794033885,0.336322869955157,0.653309986723219,1.0,5/11,22.48%,TGFB2;ACVR1;TGFBR3;TGFBR2;SMAD7
prerank,positive regulation of immune effector process (GO:0002699),-0.3428861109642408,-1.103226434067085,0.3070652173913043,0.6526546345823929,1.0,4/27,6.56%,PTPRJ;DDX60;LBP;RPS19
prerank,positive regulation of protein secretion (GO:0050714),-0.27992143637860006,-1.1031926939518601,0.24528301886792453,0.6519376593086518,1.0,16/69,14.24%,IGF1;MYRIP;EZR;PSMD9;RBP4;TGFB2;UNC13B;WLS;SOX4;NNAT;BAD;CD2AP;ACSL4;MYH10;GOLPH3L;PPIA
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3882654909243459,1.1030060947190021,0.3127962085308057,0.9235576848521498,1.0,3/29,7.14%,STAG3;ZCWPW1;TEX11
prerank,extracellular matrix disassembly (GO:0022617),0.3588666976479882,1.102749450674087,0.32193732193732194,0.92320073077874,1.0,2/53,0.41%,SCUBE1;LAMC1
prerank,cellular response to fatty acid (GO:0071398),0.4866218058817574,1.102589564607436,0.3379073756432247,0.9224645698802013,1.0,2/12,5.41%,NR1H4;IRS1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.44943999132972823,-1.1025370730644866,0.3288888888888889,0.6528425410805446,1.0,5/11,26.23%,ANXA1;RC3H1;SOCS5;SMAD7;JAK3
prerank,prostaglandin metabolic process (GO:0006693),-0.3568728770894285,-1.1024375143497172,0.3360655737704918,0.6522707999553032,1.0,4/26,4.08%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.44974056446869987,1.1023120337935766,0.3345008756567426,0.9221123472082192,1.0,5/16,22.59%,VAMP2;ARL8B;VAMP7;PLEKHM2;ULBP1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5177746203138887,1.1020489218121619,0.3473282442748092,0.9218062819801919,1.0,2/10,9.92%,WNT5A;WNT3
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4422809223080136,-1.1019741004084467,0.3595238095238095,0.6526605928633147,1.0,5/12,13.00%,HDAC4;NOTCH1;CCN3;HDAC3;TMEM119
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4752566423415205,1.1011879058048166,0.33086876155268025,0.9222940073071908,1.0,2/11,8.79%,PTEN;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4752566423415205,1.1011879058048166,0.33086876155268025,0.9222940073071908,1.0,2/11,8.79%,PTEN;INPP5J
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4352436050866862,-1.1010624232325756,0.33783783783783783,0.6540617771463945,1.0,5/12,21.36%,CSGALNACT1;FUT8;UGP2;EXTL2;GFUS
prerank,regulation of phosphatase activity (GO:0010921),0.41853286630819847,1.1009380708716814,0.343042071197411,0.9219715960260394,1.0,9/24,18.02%,GPATCH2;PPP6R2;PTPA;PPP1R26;HSP90B1;ZCCHC9;TSC1;PPP6R3;BMP2
prerank,regulation of telomere maintenance (GO:0032204),0.4035002356781496,1.1006889447581634,0.33591331269349844,0.9215900656664874,1.0,8/26,15.40%,GNL3;ERCC1;SIRT6;ERCC4;PIF1;DHX36;HNRNPD;MYC
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2798450993093722,-1.1006004979274764,0.26778242677824265,0.6544813214307598,1.0,14/79,6.23%,CRIM1;SMAD6;BMPER;SLIT2;LEMD3;NBL1;THBS1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SULF2;EPN2
prerank,response to thyroid hormone (GO:0097066),-0.4294899190162693,-1.100594691907409,0.33080808080808083,0.6536669811901226,1.0,5/13,16.95%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,male gonad development (GO:0008584),-0.331093696936169,-1.100149193671224,0.3018292682926829,0.6540326334592119,1.0,5/34,4.38%,KITLG;CSDE1;TGFB2;WNT4;NCOA4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.2979502564098386,-1.1001428698008167,0.2857142857142857,0.6532193596433854,1.0,16/53,15.99%,EYA2;DDX5;EYA1;EGFR;EYA4;RNF8;ATR;SPRED3;PCNA;BRCC3;ATM;SMCHD1;UBE2N;NSMCE4A;PRKCD;SIRT1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4524229117753598,1.0998318393255204,0.3494983277591973,0.9231595491590141,1.0,5/16,17.73%,TOP2B;ERCC4;HFM1;EME2;TOP2A
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3347462714877828,-1.0997031023575086,0.29429429429429427,0.6535424111738973,1.0,8/33,14.64%,ANO6;WWP2;KCNJ13;WNK1;KCNJ2;KCNQ1;KCNJ12;P2RX7
prerank,regulation of membrane repolarization (GO:0060306),-0.42381807713188335,-1.0995453892107556,0.3581395348837209,0.6531443206944804,1.0,3/13,10.98%,CAV1;KCNJ2;KCNQ1
prerank,regulation of cytoplasmic translation (GO:2000765),0.4653779844326931,1.0991602802646792,0.3494809688581315,0.9241842532120054,1.0,5/14,14.93%,CPEB1;RBM24;FMR1;DHX36;DHX9
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.43572111949223225,-1.0991395806461008,0.3503184713375796,0.653302792946938,1.0,4/12,10.59%,ELF1;RUNX1;RC3H1;ELF2
prerank,"transcription, DNA-templated (GO:0006351)",-0.24134106693449275,-1.0989971019888498,0.19047619047619047,0.6528234035488498,1.0,61/207,24.09%,SOX5;PIR;MLLT3;DDX5;GLIS3;KLF13;TSC22D1;MEF2A;NFKB1;PTMA;ELOA;DDX21;GTF2H5;DRG1;TRIM24;HIPK3;AFF4;SNAPC3;CRCP;RRAGC;UBTF;RBMX;NR4A2;NFYA;MAF;SMARCA5;POLR2B;RPAP1;POLR2H;POLR3G;POLR2G;POLR2C;ELOC;CEBPD;GTF2E2;BTF3;TTF1;GMEB2;MLLT1;PMF1;CDK9;NELFCD;HOXD3;GTF3C6;CREBL2;ZBTB7B;TAF1C;GTF2H4;LEO1;E2F1;POLRMT;POLR1C;NCBP2;POLR3K;GTF3A;TAF2;TWNK;GTF2F2;CTDP1;HSF2BP;PARP1
prerank,phosphorylation (GO:0016310),-0.2247438309670236,-1.098955660942321,0.20512820512820512,0.6520961618767602,1.0,100/384,19.17%,PRKAG2;DAPK1;MAP3K1;ROCK2;PRKCH;MARK1;ERG;DCLK1;TRIB2;FER;APP;BMPR2;CSNK1D;MARK4;NEK6;IGFBP3;CAMK2D;PRKDC;MAP3K5;DGKH;INSR;TOP1;TGFB2;SIK3;MINK1;WNK4;HK1;PRKAA2;TLK1;MAPK9;CDK6;ADAM10;CDK17;SNRK;WNK1;HIPK3;TOLLIP;PRAG1;NRBP2;SIK1;PGK1;BMX;GSK3B;HIPK1;ACVR1;CDC42BPB;ACVRL1;FNIP2;TLK2;DGKG;NEK7;STK38L;DYRK2;RPS6KA5;LIPE;CDK19;PIK3CB;PIK3CD;GNPTAB;CAMK2B;EPHB2;CDKL2;RET;FASTK;SRPK1;DGKZ;PRKCZ;HIPK2;PRKAG3;ATM;BCR;PRKG1;PTK2B;RNASEL;STK25;TBCK;STK17B;CDC42BPG;CREB1;ERN1;MARK3;PRKCD;TEC;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;AATK;ACVR2B;ERBB2;CDK9;AKT1;NUAK2;CSNK1A1;PRKG2;WNT11;VRK2;MARK2;MAP4K3
prerank,sodium ion transport (GO:0006814),0.3277389002211178,1.0987157606394224,0.32470892626131953,0.9244664488102707,1.0,14/85,13.62%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;CATSPER3;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,regulation of cartilage development (GO:0061035),0.4374151943693816,1.0980096669503885,0.34782608695652173,0.9256003087603261,1.0,6/18,12.02%,TRPS1;SOX6;ZBTB16;TAPT1;KAT2A;SOX9
prerank,amyloid-beta metabolic process (GO:0050435),-0.40676406470721005,-1.0979424203899926,0.3482587064676617,0.6538473322951569,1.0,7/16,25.69%,ACE;APH1A;APH1B;APEH;MME;BACE2;PSEN2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.43583223142670896,1.0971359046873723,0.3435374149659864,0.9272066678290137,1.0,6/17,19.03%,ERCC5;NEIL3;TERF1;MUTYH;MBD4;TERF2IP
prerank,negative regulation of protein modification process (GO:0031400),-0.2705397862958523,-1.0971263252923882,0.23809523809523808,0.6550941293114205,1.0,24/79,16.15%,OCLN;SLIT2;PLPP3;SNTA1;SIRPA;IGFBP3;PRKDC;NIBAN1;PRKAA2;YWHAB;GSK3B;XDH;PRR5L;LRP6;PPP1R16B;MAPT;DMD;EPHB2;TARDBP;CRTAP;PPIA;CDYL;SIRT1;PRKAA1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4018081191660917,-1.0968303794868348,0.3221957040572792,0.6550506630979286,1.0,5/16,27.35%,CLDN5;CLDN12;CLDN11;CLDN10;CLDN1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.42676731386732,1.0967925955111533,0.34925864909390447,0.9271748354707151,1.0,6/20,18.75%,EPAS1;PINK1;DAXX;TGFBR1;DCUN1D5;HIF1A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.45125040018990104,-1.0967015070394734,0.3640776699029126,0.6545813800062349,1.0,5/10,20.94%,PRKCH;FOXC1;TRIM16;NUMA1;ETV4
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4039061305950741,1.0966460038755104,0.33444816053511706,0.926456303001013,1.0,5/24,6.84%,PIK3R1;HRG;MAP4K4;IQSEC1;COL16A1
prerank,B cell receptor signaling pathway (GO:0050853),-0.341905030947478,-1.0966113596200715,0.30303030303030304,0.6539848803265249,1.0,9/32,18.48%,MEF2C;CD38;BMX;BAX;PIK3CD;PLCG2;TEC;SH2B2;BLNK
prerank,sterol transport (GO:0015918),0.42792074343003134,1.0964520830993214,0.3370253164556962,0.9258937209922626,1.0,8/19,26.02%,NPC1L1;LDLRAP1;ARV1;OSBP;NPC2;OSBPL5;MSR1;LCAT
prerank,cellular response to osmotic stress (GO:0071470),-0.376353671836672,-1.095585661533985,0.3248081841432225,0.6558911444832638,1.0,5/21,13.30%,MYLK;YBX3;LRRC8D;CAB39;TRPV4
prerank,cellular response to ketone (GO:1901655),0.3792695099492233,1.0954137228233194,0.32985074626865674,0.9281614548900217,1.0,10/35,17.12%,PTGFR;ADCY5;SPP1;ADCY8;ADCY3;ADCY2;MAP4K1;GNG2;AR;PTGER4
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2931697936450767,-1.0953397915033494,0.2533783783783784,0.6557342598208905,1.0,27/57,29.30%,RPS16;RPL5;RPS7;RPS19;RPS24;RPS15;RIOK1;RPL35A;RPL11;RPL26;WDR12;PES1;NIP7;NPM1;PAK1IP1;GTF3A;GLUL;WDR74;RPL38;LTV1;RPF2;MRPL36;RPS25;LTO1;RRP36;NOP16;TGS1
prerank,protein phosphorylation (GO:0006468),-0.22477016399754401,-1.0950806756568754,0.13513513513513514,0.655562355428533,1.0,121/478,19.17%,FLT1;PRKAG2;DAPK1;EPHA4;MAP3K1;ROCK2;TEK;ERC1;PRKCH;MARK1;ERG;DCLK1;EGFR;TRIB2;IGF1R;FER;APP;BMPR2;RICTOR;CSNK1D;MARK4;NEK6;IGFBP3;KDR;CAMK2D;PRKDC;MAP3K5;INSR;GTF2H5;TOP1;TGFB2;SIK3;MINK1;WNK4;EPHB4;VRK3;PRKAA2;TLK1;MAPK9;CDK6;ADAM10;CDK17;SNRK;WNK1;HIPK3;MAPK14;PRAG1;NRBP2;SIK1;BMX;GSK3B;PKDCC;HIPK1;ACVR1;CDC42BPB;ACVRL1;FNIP2;TLK2;NEK7;STK38L;MAST3;DYRK2;RPS6KA5;LIPE;CDK19;PIK3CD;CAB39;CAMK2B;EPHB2;ATR;CDKL2;RPS6KA1;RET;EEF2K;FASTK;SRPK1;PRKCZ;HIPK2;PRKAG3;ATM;CSNK1G3;FLT4;BCR;PRKG1;PTK2B;RNASEL;STK25;TBCK;STK17B;CDC42BPG;CREB1;ERN1;MARK3;PRKCD;FLT3;TEC;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;AATK;MAP3K10;ACVR2B;ERBB2;STK32B;CDK9;AKT1;CSNK2B;EPHB3;FGFR3;NUAK2;EFEMP1;CSNK1A1;PRKG2;SBK1;WNT11;VRK2;MARK2;TGFBR3;MAP4K3
prerank,positive regulation of endocytosis (GO:0045807),-0.3102264557776766,-1.0947010611539194,0.29337539432176657,0.6557648992468184,1.0,16/45,17.52%,ANO6;VTN;GPC3;DAB2;CDC42;B2M;RAB21;APOE;RAB31;SERPINE1;CD151;HIP1;TOR1A;SMPD1;HFE;HNRNPK
prerank,regulation of microtubule-based movement (GO:0060632),0.49370920067020485,1.094205400167165,0.38047138047138046,0.9310424700102327,1.0,3/11,9.67%,NEFH;TTC21B;CCDC65
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.29933310420982745,-1.0941798123868287,0.28,0.6563266587158875,1.0,10/49,13.64%,SGMS1;CAV1;BCL2L1;BECN1;MCL1;BAD;BAX;BID;CYLD;BOK
prerank,cellular amino acid catabolic process (GO:0009063),0.3261844130825367,1.0940200479725037,0.3195739014647137,0.9304238128528122,1.0,15/87,10.90%,GLDC;SLC25A21;MCCC1;KYNU;FAH;ACADSB;MTRR;ABAT;BLMH;HNMT;ASPA;DLST;HOGA1;ALDH5A1;BCAT1
prerank,purine nucleotide catabolic process (GO:0006195),-0.4269545689239904,-1.093708650948643,0.3371824480369515,0.6566075882378883,1.0,6/13,19.98%,XDH;GPX1;NT5E;HINT1;GDA;NT5C1A
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3786388095060529,1.093459403006884,0.3352941176470588,0.9310623946417099,1.0,5/36,5.41%,DCN;HRG;NR2F2;JUP;ADGRB1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4855565417250182,1.0930759975743018,0.34513274336283184,0.9310779870784551,1.0,5/11,14.93%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,cation transport (GO:0006812),-0.24273963660975195,-1.0928653777317585,0.22485207100591717,0.6579551006356865,1.0,24/166,12.29%,TRPM3;TRPM6;SLC47A1;ANO6;PIEZO2;SLC8A3;KCNK5;SLC6A6;ANO1;SLC9B2;SLC22A4;KCNJ13;KCNQ4;SLC7A1;SLC3A2;SLC41A1;SLC38A5;KCNK9;KCNJ2;SCN7A;SLC6A17;TRPC6;SLC1A1;KCNJ12
prerank,positive regulation of chromosome organization (GO:2001252),0.4468685361744562,1.0927018160513693,0.3741496598639456,0.9311309059473671,1.0,4/15,10.90%,GNL3;FEN1;SIRT6;DHX36
prerank,negative regulation of MAP kinase activity (GO:0043407),0.36502034856213506,1.092474457766784,0.34609929078014184,0.9306646215659611,1.0,9/44,14.07%,SPRY4;SPRY1;DUSP1;PTPN22;SORL1;NF1;BMP7;PDCD4;LYN
prerank,regulation of autophagy (GO:0010506),-0.2336416488828792,-1.0924038246820478,0.19047619047619047,0.6582685416352734,1.0,52/216,16.15%,PRKAG2;DAPK1;FOXO1;LEPR;RNF152;FOXK1;KDM4A;MCL1;ACER2;EXOC4;VPS35;ATG13;RASIP1;SREBF2;ATF6;PRKAA2;SH3BP4;TRIM5;FBXL2;TRIM14;GSK3B;MTMR9;SNX32;CASP3;DAPL1;LAMTOR5;MAPT;TLK2;SNX6;BAD;EEF1A1;PIK3CB;RRAGC;OPTN;TMEM59;PIP4K2C;GAPDH;HSPB1;TAB2;PRKAG3;LAMTOR3;ATM;BOK;VPS29;RAB39B;TICAM1;KAT5;UCHL1;ERN1;MET;TRIM27;PRKAA1
prerank,chordate embryonic development (GO:0043009),0.3491106282573929,1.0917249709594903,0.33618233618233617,0.9318608876093698,1.0,5/55,3.03%,CHD7;SULF1;WNT5A;PTPRR;FGFR1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.24540495377184143,-1.0913774430880805,0.23636363636363636,0.6601032110987499,1.0,40/151,17.89%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;PLA2G4A;ACER3;B4GALT5;SGMS2;CERT1;ALAS1;NFS1;DEGS2;SPNS2;VAPA;APOE;LARGE1;GCH1;VAPB;DMD;ELOVL4;ASS1;ELOVL7;MFSD2A;FURIN;MOCS1;CHKB;SPTSSA;KDSR;GSTA4;PCSK5;ST3GAL2;GCNT1;GSTT1;ESD;PCTP;CSNK2B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3913166502834972,1.0911105407045245,0.3470948012232416,0.9326164166647033,1.0,7/28,15.09%,CCDC22;PTEN;FMR1;PTK2;PSMC5;AXIN1;CLU
prerank,positive regulation of programmed cell death (GO:0043068),-0.23158550141918807,-1.0907887117806347,0.1574074074074074,0.6608455785297184,1.0,79/272,22.61%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;ITGA6;MCF2L;TNFSF10;MARK4;HIP1R;IGFBP3;SQSTM1;MAP3K5;FAS;CYP1B1;UNC13B;APC;ATF6;CRADD;JMY;UBB;SOX4;IP6K2;NGF;CASP2;CASP3;NGEF;CASP8;BAD;SFRP1;BAX;BNIP3L;TNFAIP8;ADAMTSL4;BID;APH1A;TGM2;GADD45B;APH1B;ATM;BOK;PLEKHG2;ING4;ARHGEF11;STK17B;TRIM35;SMPD1;SIRT1;GPER1;ING5;AIFM1;DCUN1D3;LAPTM5;UBC;MAP3K10;TFPT;APBB1;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;RASGRF2;GADD45G;TRADD;ARHGEF12;HDAC6;E2F1;SPHK2;CCAR2;DDX20;UBA52;TIAM1;ARHGEF1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4392825319673212,1.0903988325378526,0.3357142857142857,0.9336730122807699,1.0,6/17,18.55%,GJA1;N4BP2L2;FERMT2;KAT7;LTBP3;CCNE1
prerank,pre-miRNA processing (GO:0031054),0.4526335360750824,1.090275195893135,0.35500878734622143,0.9328919732247829,1.0,6/14,17.42%,AGO4;LIN28B;MRPL44;AGO3;ADAR;AGO1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4649186025006035,1.090118651740656,0.3483754512635379,0.9322073293327962,1.0,3/13,7.03%,GPR37L1;LRRK2;PYCR1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.37478200673997686,1.0900754136604793,0.3249630723781389,0.9311395633325605,1.0,11/37,13.50%,TENM3;GRID2;TENM4;DCHS1;TENM2;ADGRL1;TENM1;AMIGO3;CBLN1;CADM3;NECTIN3
prerank,regulation of inflammatory response (GO:0050727),0.2989313637213852,1.0900565670402083,0.2982456140350877,0.9300207533955811,1.0,21/190,9.56%,RORA;IL33;XCL1;PPARA;WNT5A;IL16;NR1H4;TSLP;TNFAIP8L2;PPARD;VAMP2;CASP4;ADAMTS12;ENPP3;BCL6;LRFN5;PTGES;PLA2G7;CD200R1;TLR4;BIRC2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2654206866284275,-1.0900067308223935,0.2523364485981308,0.6621781527072235,1.0,25/101,12.98%,VIM;LARP4;EZR;THBS1;KLF4;ELAVL1;RDX;VPS35;PRKDC;NIBAN1;SAMD4A;LARP4B;RPL5;SOX4;CASP8;BAD;NFKBIA;PYM1;PERP;IST1;CPEB3;RPL26;EIF3D;RPS4X;VPS11
prerank,neuron remodeling (GO:0016322),-0.45214964674732894,-1.0897314712311426,0.3925438596491228,0.6620124023479887,1.0,3/10,5.81%,ANKS1A;APP;SCARF1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3800733134304185,1.0897166167208394,0.32274247491638797,0.9299266801295625,1.0,6/31,13.43%,CDC14B;PTEN;GOLGA2;PINK1;DCUN1D5;AXIN1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42317985773167943,1.0896346149575127,0.35760517799352753,0.9290190920650427,1.0,3/21,3.66%,DCN;BGN;VCAN
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3029287915918394,-1.0893133681378089,0.28012048192771083,0.6623006512071362,1.0,22/48,27.47%,ACTB;DDX21;SF3B1;WBP2;SMARCA5;MYO1C;MYBBP1A;POLR2H;SERTAD1;ARID1B;POLR1H;TAF1C;POLR1G;SPHK2;POLR1C;PHF2;SMARCD1;ELOF1;PADI2;CDCA4;CHEK1;POLR2K
prerank,regulation of postsynapse organization (GO:0099175),0.3897852065403239,1.089170765827132,0.359375,0.929366391638032,1.0,8/28,8.23%,ARHGAP22;WNT5A;CDKL5;LRRK2;PPFIA2;ABHD17C;ABHD17B;TANC2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3611785948439887,1.089034289357466,0.33236574746008707,0.9286290853417941,1.0,6/44,7.98%,CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D;PER2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4178251571608319,-1.088986819349722,0.3356009070294785,0.6623373505232855,1.0,5/13,29.18%,ITGB1;SREBF2;CD9;ITGB2;PPARG
prerank,cellular response to interleukin-4 (GO:0071353),0.4931343767376401,1.0886159779717506,0.38475177304964536,0.9287555206440923,1.0,1/10,0.79%,XCL1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.22535637047034643,-1.088230181394201,0.18840579710144928,0.6634747833496847,1.0,85/348,18.28%,PDGFD;PRKAG2;IGF1;RAPGEF2;ROCK2;TEK;LEPR;CAV1;PTPRJ;PECAM1;FNIP1;EGFR;KRAS;APP;NRP1;BMPR2;CSNK1D;IQGAP1;LIMCH1;CSPG4;KDR;NIBAN1;RAP1A;CCND2;INSR;FAS;TGFB2;VTN;VEGFD;RAC1;DAB2;VEGFC;MAVS;TFRC;EFNA5;NGF;PDGFA;CARD14;CALM1;TBX1;CCN1;CD44;ACVR1;FGF1;ACVRL1;FNIP2;RALBP1;PDGFC;RPS6KA5;ENPP2;CAB39;CX3CR1;HDAC3;ITGB3;RALB;ALS2;PLCG2;NOS1;TAB2;TMEM119;FLT4;PTK2B;PPIA;NBN;CCND1;RAPGEF3;CX3CL1;RAP2C;CDKN1A;TEC;SIRT1;GPER1;TBK1;PAK2;GDF11;HFE;CD74;TWSG1;ERBB2;CDK9;AKT1;CSNK2B;LCP2;EGF;SDCBP
prerank,receptor internalization (GO:0031623),-0.30792726929952446,-1.0880695064214208,0.28,0.6630595471614099,1.0,12/44,14.58%,PICALM;CAV1;ITGB1;ACKR3;TFRC;RAMP1;RAB5A;DNM3;RAB31;CEACAM1;GRB2;RAMP2
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4490315777868626,1.0879593756049086,0.3803786574870912,0.9297713024473294,1.0,3/16,5.15%,AUTS2;OGT;ARHGAP24
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.42718160078517686,-1.0878580078985545,0.35046728971962615,0.6628058822424495,1.0,5/12,22.72%,UPP2;TK2;DCK;CDA;CAD
prerank,striated muscle tissue development (GO:0014706),-0.3388440476856014,-1.087742052735709,0.31733333333333336,0.6622593546919832,1.0,7/29,5.87%,MEF2C;CAV1;PGM5;BMPR2;MYL6;RBP4;SIX1
prerank,glucose homeostasis (GO:0042593),-0.2724858891207905,-1.0873111553082002,0.3008130081300813,0.6624998587787406,1.0,16/83,10.31%,FOXO1;LEPR;IGF1R;FOXK1;ADIPOR2;KLF7;INSR;RBP4;HK1;PRKAA2;SOX4;HK2;KCNB1;LRRC8D;BAD;PTPN2
prerank,regulation of receptor internalization (GO:0002090),-0.31765443485721245,-1.0871857930710727,0.3267605633802817,0.662004840061867,1.0,14/35,26.88%,MAGI2;RIN3;INSR;CD63;EGF;SDCBP;MTMR2;TBC1D5;ANKRD13D;NTF3;GREM1;FLOT1;ARRB2;ARF1
prerank,xenobiotic transport (GO:0042908),-0.39721434047810894,-1.0864844541664094,0.3538083538083538,0.6629640344921425,1.0,5/16,10.69%,ABCG2;SLC47A1;SLC22A4;ABCA3;SLC7A5
prerank,cellular response to interferon-gamma (GO:0071346),-0.2692204133781799,-1.0864050189379741,0.25390625,0.662359759788039,1.0,20/88,11.59%,DAPK1;GBP7;SIRPA;CAMK2D;NCAM1;TRIM25;GBP5;TRIM5;B2M;CD44;IRF2;GBP4;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G;GAPDH;GBP6
prerank,positive regulation of nervous system process (GO:0031646),0.4370204909702715,1.0862115853234584,0.3572621035058431,0.9343841690500196,1.0,5/18,13.88%,HCRT;TENM4;RIMS2;RIMS1;MYRF
prerank,regulation of macroautophagy (GO:0016241),-0.2545726968043873,-1.0861726553187836,0.24675324675324675,0.6621599201638623,1.0,33/105,22.25%,PRKAG2;EXOC4;KDR;VPS35;ATG13;SESN1;PRKAA2;NRBP2;SNX32;CASP3;LAMTOR5;SNX6;RRAGC;CLEC16A;BNIP3L;GAPDH;PAFAH1B2;PRKAG3;LAMTOR3;UCHL1;ERN1;SIRT1;PRKAA1;TBK1;ATP6V0E2;AKT1;ATP6V0A2;RRAGB;EXOC8;HDAC6;ATG101;ATP6V0D2;ATP6V0A1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.28119598525129336,-1.0861117626771077,0.27715355805243447,0.661489009417213,1.0,21/71,15.29%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ACER3;SGMS2;CERT1;DEGS2;SPNS2;VAPA;LARGE1;VAPB;ELOVL4;ELOVL7;ST3GAL5;SPTSSA;KDSR;SMPD1
prerank,positive regulation of cell population proliferation (GO:0008284),0.2779617538758694,1.086079549559602,0.27510460251046026,0.933642009148458,1.0,86/423,17.41%,PDGFRA;PTN;NTRK3;IL34;LAMC1;LAMB1;NRG1;HOXC10;PTGFR;EDN3;MEIS1;HDAC1;WNT5A;NTRK2;PTEN;TCF7L2;PHIP;ERBB4;C5AR1;ITGAV;FLT3LG;FGFR1;GAB2;MEIS2;TSLP;TIPIN;GJA1;POU3F3;TBX3;FBXO5;GCNT2;HTR2B;CDC7;IRS1;PRKCI;SIRT6;IRS2;FXN;PTK2;HTR1A;CDK13;CCKBR;GLI1;LGMN;TSPYL5;CACUL1;SLC25A33;ZFPM2;RTKN2;NAP1L1;TGFBR1;SOX9;CD86;IGF2;FAM98B;CD81;GAREM1;DHPS;PIM1;LYN;NME1;DOT1L;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;DHX9;AREG;AR;GDNF;CNOT7;MYC;MAP3K3;FGFR2;NDUFS4;GDF9;NOX1;CCPG1;STAMBP;MAZ;CALR;ADRA2A;ASH2L;RHOG
prerank,retinoic acid metabolic process (GO:0042573),-0.41498511358911183,-1.085978238749526,0.35167464114832536,0.6610012211147814,1.0,2/14,1.57%,ALDH1A2;CYP26B1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.467740683857083,-1.0858449807544537,0.35926773455377575,0.660556563038249,1.0,3/10,7.28%,MARK4;APC;GSK3B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4949859511421156,1.085751433285006,0.3672014260249554,0.9335398548067028,1.0,5/10,14.93%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,regulation of DNA repair (GO:0006282),-0.3098719046616123,-1.0856271787799745,0.29260450160771706,0.6602521392582462,1.0,12/44,17.83%,EYA2;EYA1;EGFR;EYA4;TRIP12;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;SIRT1;CDK9
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.347577518119138,1.0849714611359045,0.3305439330543933,0.9349404981627357,1.0,14/57,13.79%,GRIA3;GRIN2B;CACNG3;GRIA4;GRIA1;DLG3;DLG2;GRIN2A;RELN;CACNG4;SHISA6;DLG4;LRRC7;DLGAP3
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.44265923311566596,-1.0847932838581817,0.3640552995391705,0.6615849394880411,1.0,3/10,4.26%,CST3;DPP4;NOTCH1
prerank,GTP metabolic process (GO:0046039),0.44722525504454963,1.0847149454128444,0.36084142394822005,0.934543017173823,1.0,9/15,21.60%,LRRK2;AK4;OPA1;MFN1;ENTPD7;AK3;EFL1;IMPDH2;GNAI3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.45989245450060956,-1.0846515624943398,0.37089201877934275,0.6611456656309386,1.0,2/10,1.78%,ROCK2;IL18
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.26419733041829474,-1.0845729734434042,0.28451882845188287,0.6605374885049728,1.0,36/95,23.64%,SMAD6;DKK3;CAV1;LEMD3;LTBP4;THBS1;SKIL;SKI;DAB2;GIPC1;CD109;UBB;ASPN;SNX25;SMURF2;SMAD3;SNX6;PRDM16;CITED2;BCL9L;SPRED3;HIPK2;SIRT1;TGFB1I1;UBC;HTRA4;SOX11;SDCBP;TGFBR3;VASN;ADAMTSL2;TGFBR2;UBA52;SMAD7;SMURF1;RNF111
prerank,toxin transport (GO:1901998),0.48921530583723905,1.0843941520518594,0.3978685612788632,0.9344401092896089,1.0,3/10,8.89%,ANTXR2;RAB40B;RAB29
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.40770533531587705,1.0838965469937556,0.344391785150079,0.9348984984681515,1.0,4/22,9.78%,IL2RA;FANCA;BCL6;KAT2A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.374967694609051,-1.083850407784066,0.34615384615384615,0.6615970882289441,1.0,6/21,16.21%,SNTA1;ANK2;KCNQ1;FLNA;NOS1AP;SCN4B
prerank,fatty acid beta-oxidation (GO:0006635),0.3490655485745031,1.0838024071667116,0.3361581920903955,0.9340435280540157,1.0,7/51,6.34%,ACOX2;ABCD2;PEX2;PPARD;ACADL;CRAT;ACADS
prerank,B cell activation (GO:0042113),-0.27948286184800747,-1.0832554747069865,0.28205128205128205,0.6623477507561011,1.0,17/68,18.48%,MEF2C;PTPRJ;TPD52;ITGB1;HDAC4;CTPS1;CASP8;DNAJB9;PIK3CD;PTPN2;EPHB2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.40421073879456715,-1.0825885661715478,0.3788235294117647,0.6632332773799512,1.0,5/14,13.58%,LIMS2;ITGB1BP1;PHACTR4;CD63;FLNA
prerank,kinetochore organization (GO:0051383),0.46775896544644013,1.082314290643591,0.36177474402730375,0.9377842165196335,1.0,5/13,15.58%,CENPE;CENPC;CDT1;CENPW;CENPF
prerank,innate immune response in mucosa (GO:0002227),-0.4423424583477561,-1.0818880904214077,0.35267857142857145,0.6642724710756612,1.0,8/10,53.58%,RPL39;RNASE3;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,regulation of vasoconstriction (GO:0019229),-0.34464676983667564,-1.081838181378889,0.3397790055248619,0.6636019483748063,1.0,7/27,6.34%,CAV1;BMPR2;ADRA1B;ZDHHC21;ACE;BDKRB2;ATP2B1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3888001066865933,1.081644537463139,0.3354330708661417,0.9388065492401738,1.0,8/29,15.32%,RBM24;FMR1;DND1;TAF15;PAIP1;TENT5A;EIF4ENIF1;GDNF
prerank,cellular response to organonitrogen compound (GO:0071417),-0.26087320721773555,-1.0816116434039815,0.2912621359223301,0.6634007719937112,1.0,18/99,10.98%,RAPGEF2;MEF2C;SLIT2;ACTB;EZR;DIAPH1;IGFBP5;CDH1;RAP1A;SH3BP4;PDE3A;RAPGEF1;LAMTOR5;SSH1;SFRP1;RRAGC;CPEB3;KCNQ1
prerank,ncRNA transcription (GO:0098781),-0.4209044931553374,-1.0813711016700958,0.3787528868360277,0.6632133826775168,1.0,5/13,22.51%,CAVIN1;SNAPC3;NIFK;POLR1G;GTF3A
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.43530911212708817,1.0813513848809526,0.36807817589576547,0.9385673180942832,1.0,4/18,10.51%,NRXN1;CACNG3;RELN;CACNG4
prerank,positive regulation of response to external stimulus (GO:0032103),0.30782004026962395,1.0812284000196997,0.3047858942065491,0.9377930867949376,1.0,13/128,9.80%,IL33;PTN;HRG;WNT5A;IL16;TSLP;DHX58;TLR8;AKIRIN2;PLA2G7;PRKCA;TLR4;CYBA
prerank,cellular response to starvation (GO:0009267),-0.24226734146313778,-1.0811904334937652,0.2342857142857143,0.6629024022016415,1.0,44/147,23.55%,PRKAG2;FOXO1;XPR1;FNIP1;RNF152;BMPR2;BECN1;MAP3K5;FAS;HSPA8;SREBF2;GABARAP;SESN1;PRKAA2;GABARAPL1;SIK1;DAPL1;LAMTOR5;SFRP1;RRAGC;CLEC16A;MYBBP1A;RALB;PRKAG3;LAMTOR3;MFSD2A;CDKN1A;SIRT1;PRKAA1;ATP6V0E2;MAP1LC3A;LAMP2;NUAK2;SEH1L;RRAGB;HNRNPA1;ASNS;MAP1LC3B;WDR45;ATP6V0D2;INHBB;KLF10;NPRL3;ATP6V1G1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.21803399105968752,-1.080952758536933,0.18604651162790697,0.6626836072104184,1.0,119/428,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2827609260783966,-1.080669747681075,0.2737642585551331,0.6626038083598866,1.0,15/66,9.80%,NFIB;CAV1;ROBO1;PTPRK;THBS1;SPARC;TGFB2;CAV2;CDK6;B2M;APOE;XDH;ATOH8;KLF9;SFRP1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.30589870915575684,1.0800820765807715,0.32595325953259535,0.9403649282812491,1.0,19/140,11.57%,PDGFRA;PTGFR;ADCY5;C5AR1;P2RY1;CCR9;ACKR2;RYR2;ADCY8;CALCA;C1QTNF1;LPAR3;TRPC3;CCKBR;HTR2C;LPAR1;P2RX4;DLG4;IAPP
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.44725219404607663,-1.0794405247127108,0.34965034965034963,0.6650137746221372,1.0,3/11,4.00%,PICALM;ACTN2;GOPC
prerank,protein heterotetramerization (GO:0051290),0.47033372159627634,1.0794100961319943,0.3870967741935484,0.9414346122190226,1.0,3/13,10.20%,GRIN2B;HSD17B8;NUDT21
prerank,cardiac myofibril assembly (GO:0055003),0.4443635961452239,1.0791819659298538,0.37954939341421146,0.9409695944146287,1.0,1/15,0.14%,PDGFRA
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2254206671485302,-1.0790855750580504,0.14473684210526316,0.6650401474919415,1.0,47/259,11.90%,ABLIM1;RAPGEF2;ABCC4;ANO6;FGD5;ACTN2;VCL;FNBP1L;BBS9;EXOC6;MYLK;RAPGEF6;ITGB1;NTN1;EZR;CDC14A;NRP1;PARVB;S1PR1;EXOC4;FXYD5;GSN;RAP1A;RAB23;NOTCH1;EXOC5;MINK1;OFD1;RAC1;SRGAP2;ARL6;KIF24;CYS1;DNM3;CEP290;CEP162;EHD4;EXOC2;RFX3;IFT140;SPATA13;RAB3IP;CCDC88A;GALNT11;RP2;CD2AP;TMEM237
prerank,potassium ion export across plasma membrane (GO:0097623),0.4529579553294457,1.078996159796837,0.37005163511187605,0.9403913097993756,1.0,3/13,10.97%,KCNT2;KCNIP2;KCNE4
prerank,neutrophil degranulation (GO:0043312),-0.21833948379498824,-1.078799075101167,0.17777777777777778,0.6650400357860579,1.0,119/425,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4381467993756786,1.0782090832708502,0.37305699481865284,0.9417018518137487,1.0,7/18,18.02%,COLGALT1;FSCN1;IER3IP1;CARMIL2;CLASP2;CLASP1;BMP2
prerank,inorganic anion transmembrane transport (GO:0098661),0.33634968613532074,1.0781789463225329,0.349002849002849,0.9406457746421529,1.0,16/63,15.71%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;SLC25A30;GABRB1;LRRC8A;SLC25A14;GLRB
prerank,skeletal muscle tissue development (GO:0007519),0.3779251672598217,1.077061975239501,0.36084142394822005,0.9431839610455149,1.0,2/32,0.73%,SVIL;MSC
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3206656972075284,1.076600843933713,0.3390501319261214,0.9434581288051127,1.0,28/84,22.86%,RBFOX1;TRA2B;NOVA1;RBM24;REST;PRDX6;FMR1;KHDRBS3;WTAP;CELF4;SMU1;DDX17;CWC22;RBFOX3;SNW1;SRSF10;ZBTB7A;SRSF9;RBM5;HNRNPL;SRSF6;KHDRBS1;FXR1;RBM15;RBM25;SRSF12;CELF6;DAZAP1
prerank,cellular protein modification process (GO:0006464),-0.20262967366940635,-1.076443044027001,0.0,0.6702374043424686,1.0,297/982,24.42%,PRKAG2;FN1;DAPK1;ST3GAL6;PTPRB;FBXL7;MAP3K1;ROCK2;PRKCH;PPM1E;MARK1;PTPRJ;ERG;ST8SIA4;B3GALT1;DCLK1;TRIB2;FER;PTPRK;LMO7;THBS1;PTPN3;IGFBP5;GAN;MTM1;APP;FSTL1;CPE;PTP4A2;CST3;BMPR2;KLHL13;CSNK1D;ASB2;PTPN4;MARK4;PSMC6;NEK6;IGFBP3;CAMK2D;PPM1L;ST3GAL4;PRKDC;MAP3K5;PTPN14;INSR;PSMD9;WWP2;PTPRG;TGFB2;ART3;SOCS2;B4GALT5;EGLN3;UBE2D3;SIK3;MINK1;ANXA1;PSMF1;HIF3A;WNK4;GPC3;ST3GAL1;PSMB7;PRKAA2;TLK1;MAPK9;CUL1;CDK6;ADAM10;CDK17;SERPIND1;SNRK;WNK1;PPP2R1A;HIPK3;OGA;PTPRF;ST6GALNAC2;PRSS23;FBXL2;SIRT3;PRAG1;NRBP2;NUCB1;SIK1;PPM1F;TNKS2;APOE;CCN1;BMX;GSK3B;HIPK1;ACVR1;ZC3HAV1;RAB5A;UBE2F;CDC42BPB;UST;ACVRL1;TNC;FNIP2;MSLN;ST3GAL3;MGAT1;LARGE1;LAMB2;TLK2;NEK7;MANBA;NGLY1;STK38L;KLHL11;CTTNBP2NL;DCAF8;PSMD8;DYRK2;SSH1;PIGU;RPS6KA5;LIPE;FBXL19;CDK19;PSMD12;PPM1D;PIK3CD;ASB5;KLHL20;PPEF2;SHISA5;RAB13;CAMK2B;PTPN1;PARP10;VHL;PARP9;PPP3CC;ST8SIA2;CUL9;CDKL2;NEURL2;SPSB4;UGCG;GPAA1;LHPP;RET;FASTK;SRPK1;TGM2;KCTD6;B3GALNT1;PRKCZ;PSMA3;LOXL1;HIPK2;PSMA6;PRKAG3;ATM;MMP15;PSMD4;CSNK1G3;PSME3;FBXL4;GOLM1;BCR;FUT9;PRKG1;RAB38;PPP2R5D;PTK2B;PSMD7;RNASEL;ST3GAL5;USP25;PSMB6;F5;STK25;TBCK;STK17B;CDC42BPG;ELOC;CREB1;ERN1;PSMC1;MARK3;PRKCD;CHRDL1;FBXO32;PARP4;TEC;ST3GAL2;SBF1;UBE2L6;SIRT1;PSMB10;PRKAA1;RAB1A;DYRK1B;TBK1;PAK2;PKN2;FBXL14;NEDD8;CUL3;AATK;FNTB;ISG15;DCUN1D3;OARD1;ASB7;ACVR2B;RBBP7;ERBB2;MAN2A1;NAA80;YES1;B3GNT2;CDK9;AKT1;MFGE8;PPP1CB;QPCT;NUAK2;PPP2R5B;CSNK1A1;PRKG2;CCDC8;WNT11;SIRT5;VRK2;PSME2;STT3B;MARK2;MAP4K3;MTMR2;KLHL25;PTPN5;MCRS1;MKNK1;DNAJC3;MACROD1;NUS1;CDC34;RAB1B;ASB8;GPS1;PKN3;PIM2;SOCS5;KLHL3;ASB6;TGFBR2;PSMC3;WDR45;ICMT;PIGK;KBTBD7;PENK;FBXO22;NEK10;B3GNT9;CDKL4;FBXL8;UBA52;TTBK1;PHEX;FBXW2;PASK;STK39;CISH;FBXL18;PSMA8;IKBKE;ACVR2A;FSTL3;FBXO10;SOCS3;CTDP1;ST8SIA6;BRD2;F13A1;CDK16;PLK4;IKBKB;FN3K;PAK4;PTPRE;MPI;COQ8A;GRK4;TAOK2;PARP1;MT3;PARP2;BAP1;RSKR;PTPN6
prerank,mesonephric tubule development (GO:0072164),0.44225806910198784,1.0755249781992398,0.3775167785234899,0.9457157434162083,1.0,2/15,2.53%,ROBO2;SALL1
prerank,neurotransmitter secretion (GO:0007269),0.36259966669439836,1.0753913216462463,0.35964912280701755,0.9449920078070115,1.0,14/44,18.62%,NRXN2;PTPRN2;NRXN1;VAMP2;RIMS2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4357197078066428,-1.0751635179388022,0.37555555555555553,0.6728040976325751,1.0,4/11,18.31%,FOXO1;NOTCH1;LMNA;GLRX3
prerank,response to cholesterol (GO:0070723),0.4296313089377539,1.074996396428671,0.3847487001733102,0.9450814126658446,1.0,2/17,2.27%,GRAMD1B;GPLD1
prerank,positive regulation of hormone secretion (GO:0046887),0.44191510440537685,1.0748890477720057,0.3767123287671233,0.9442771726896253,1.0,3/17,11.81%,EDN3;SPP1;VAMP7
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4682308680618994,1.0748550542959054,0.38571428571428573,0.9432378342050167,1.0,2/12,5.48%,GNL3;CCT5
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3841170246782369,-1.0746144389707142,0.35294117647058826,0.673480792182298,1.0,3/18,4.84%,FLT1;MEF2C;COL4A3
prerank,cellular response to ATP (GO:0071318),0.4507440424249342,1.0738543993488632,0.3854166666666667,0.945405347430754,1.0,4/14,13.69%,P2RY1;P2RX4;HSP90B1;RYR3
prerank,cilium assembly (GO:0060271),0.2829802337014458,1.0738002191992864,0.31189710610932475,0.9444048080095898,1.0,77/296,20.84%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;DCTN3;HAUS3;DYNC2LI1;RSPH9;HAUS1;GBF1;CCDC57;DCTN2;RAB8A;DISC1;E2F4;DNAAF3;IFT81;HAUS8;FAM161A;KIFAP3;PRKACA;CEP192;TTC21B;SNAP29;CCDC65;CEP135;AHI1;RPGRIP1;TCTN2;IFT74;SSNA1;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;IQCB1;GAS8;SSX2IP;RFX2;TNPO1;IFT88;RAB11FIP3;CEP126;SCLT1;TXNDC15;ACTR2;DYNLL2;TRIP11;CEP250;KIF3C;CEP152;CCDC39;CSNK1E;PTPDC1;CLASP1;IFT43;CLUAP1;ALMS1;BBS1;PCM1;ATP6V0D1;WDR90;MKS1;CEP19;TUBA1A;CEP43;NUDCD3;DZIP1L;UNC119B;KIF3A;TTC39C;BBS4;ABLIM3
prerank,miRNA metabolic process (GO:0010586),-0.3733777075289326,-1.0734049069239706,0.3427835051546392,0.6757541605620047,1.0,5/20,6.98%,DGCR8;TUT7;PARN;DICER1;DROSHA
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3407476748179685,1.0733531649533024,0.3447782546494993,0.9447177135866984,1.0,17/56,18.46%,CECR2;UNC119;DCTN3;SPTBN1;ANK3;EFHC1;SEPTIN9;JTB;NUSAP1;INCENP;RTKN;STMN1;CEP55;STAMBP;SPIRE1;CUL7;RHOA
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2853455470542193,-1.0729259774855506,0.3037542662116041,0.6762171058452936,1.0,18/54,20.15%,FIGN;EZR;HOOK1;MAPT;TUBGCP5;KATNAL2;FIGNL2;CRIPT;CCDC88A;SLAIN2;DYNC1H1;TRPV4;CCDC88C;DST;DLG1;CAMSAP2;NUMA1;CIB1
prerank,neuromuscular process (GO:0050905),0.44693795316614293,1.072580635719644,0.3642495784148398,0.9461086521056197,1.0,2/16,3.00%,MYCBP2;NRXN1
prerank,receptor metabolic process (GO:0043112),-0.30054358292337,-1.071655576697762,0.3201320132013201,0.6786859356028146,1.0,11/53,8.32%,PICALM;CAV1;ITGB1;BECN1;UVRAG;ACKR3;TFRC;RAMP1;SNX25;DNM3;RAB31
prerank,cellular response to pH (GO:0071467),0.42995666246946984,1.0715279420796526,0.3696763202725724,0.94837014600882,1.0,5/17,17.54%,GPLD1;SLC9A1;ASIC1;IMPACT;MCOLN1
prerank,regulation of myotube differentiation (GO:0010830),-0.35748968525040686,-1.0712372217486759,0.35714285714285715,0.6789842010438181,1.0,12/24,28.15%,HDAC4;NOTCH1;CCN3;MAPK14;SIK1;HDAC3;TMEM119;PIEZO1;FBXO22;BHLHE41;BDNF;HDAC5
prerank,carboxylic acid transport (GO:0046942),-0.28256542588111355,-1.070783565379185,0.3079584775086505,0.6793559222404165,1.0,17/55,16.17%,SLC13A3;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC7A1;SLC3A2;SLC16A1;SLC16A4;SLC38A5;SLC7A5;SLC6A17;SLC1A1;SLC6A7;SLC16A9;SLC36A4;LLGL2
prerank,neutrophil mediated immunity (GO:0002446),-0.21688709238882148,-1.07078076072854,0.21951219512195122,0.6785677856865975,1.0,121/432,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;ACE;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;IRAK4;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,response to cAMP (GO:0051591),-0.3159455890211268,-1.070375766440688,0.322884012539185,0.6788578862886423,1.0,11/37,23.30%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,positive regulation of ossification (GO:0045778),0.3644068515637487,1.0703740416722887,0.37596302003081666,0.9510058392040245,1.0,5/39,5.17%,PTN;GPM6B;ADGRV1;WNT5A;ZBTB16
prerank,positive regulation of cell development (GO:0010720),-0.32733719286502805,-1.0702982671895982,0.38764044943820225,0.6782460562088262,1.0,13/31,26.31%,PDE3A;BAD;RFX3;NIBAN2;CX3CR1;TGM2;GPER1;SOX11;TYROBP;MME;SPEN;LIG4;NUMB
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4609504115548485,1.069951776035505,0.3890909090909091,0.951267441163257,1.0,8/12,29.19%,AMPD2;PRPS1L1;PRPS1;MTHFD1;HPRT1;PRPSAP2;GART;PRPSAP1
prerank,import into cell (GO:0098657),0.3612787664530883,1.0698103651099125,0.3580060422960725,0.9505626649334658,1.0,5/41,4.87%,SLC1A3;SLC6A13;ATP1A2;SLC12A6;SLC7A8
prerank,response to zinc ion (GO:0010043),0.39930162402830366,1.0697960064588423,0.3752066115702479,0.9494354229631502,1.0,6/25,12.98%,PAM;SLC30A5;SLC30A3;GLRA1;P2RX4;GLRA2
prerank,DNA strand elongation (GO:0022616),0.4218645691766239,1.069413691562499,0.38095238095238093,0.9494840200949712,1.0,5/18,10.71%,MCM7;GINS3;POLA1;RFC3;MCM4
prerank,cell-cell junction assembly (GO:0007043),-0.28375071312002137,-1.069100119821683,0.3380281690140845,0.6804578142446016,1.0,24/63,19.86%,PKP4;TJP1;VCL;ACTB;CLDN5;CDH8;ACTG1;GJB2;CTNND1;RHOC;GJC1;GJD3;CLDN12;GJB6;TRPV4;RAMP2;CDH5;CTNNA1;PAK2;PKN2;CD9;CLDN11;PKP2;CNTNAP1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3004923219843736,1.0690633637148141,0.35670356703567035,0.9494293677763154,1.0,33/149,17.82%,ROR1;EDA2R;EDA;WNT5A;CD40;IL18RAP;TLR6;MTPN;PRKCI;CAPN3;FLOT2;TRIM37;PRKD1;TRIM8;PRKCB;TLR4;IL1RAP;IRAK1;EIF2AK2;PYCARD;RTKN2;RNF31;UBE2V1;RIPK1;DHX9;CLU;AR;TIRAP;ZBTB7A;LGALS9;ADAM8;MYD88;CAMK2A
prerank,positive regulation of axon extension (GO:0045773),-0.3529393170497502,-1.0689819894005113,0.33062330623306235,0.6799698627964152,1.0,8/22,13.68%,NTN1;SEMA7A;NRP1;RUFY3;MEGF8;MAPT;GOLGA4;MACF1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.403146806743399,-1.0689368820079739,0.3641025641025641,0.6793040105918301,1.0,5/14,19.69%,RAPGEF2;PRKAR2A;PRKAR2B;SIRT1;ADRB2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3310215412466329,-1.0688597210568522,0.33707865168539325,0.6786772093156189,1.0,8/30,11.63%,FOXP1;DDX5;KDM4C;SMARCA4;DAB2;KLK2;SFRP1;HEYL
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3398081045193376,-1.0688417000376593,0.35240963855421686,0.6779395091803522,1.0,12/26,30.23%,ST3GAL4;B4GALT5;TPI1;LARGE1;RRM2B;ST3GAL2;GCNT1;GAL3ST2;ST8SIA6;SCCPDH;RRM1;GK5
prerank,N-terminal protein amino acid modification (GO:0031365),0.44467428139478765,1.068595589318541,0.39019963702359345,0.9498208498169013,1.0,3/14,9.92%,NAA10;METAP1D;NAA50
prerank,T cell activation involved in immune response (GO:0002286),-0.41079181529811437,-1.0684510985863487,0.3693304535637149,0.6781689849185163,1.0,5/12,35.39%,ICAM1;MDK;CD74;SLC11A1;LILRB1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.417900637343072,-1.068228416102896,0.37636761487964987,0.6779423466539463,1.0,5/12,12.69%,ATP1B3;WNK4;WNK1;DMD;NOS1
prerank,histone H4-K16 acetylation (GO:0043984),0.4211375032408007,1.0681541848699583,0.3576271186440678,0.9501127410976166,1.0,6/19,11.32%,OGT;KMT2A;WDR5;MSL1;KANSL1;JADE1
prerank,negative regulation of signal transduction (GO:0009968),0.28544297039680977,1.0678900368514517,0.3381535038932147,0.9497757433024693,1.0,39/249,14.70%,APOD;ENPP1;DCN;LRP1;SULF1;HRG;SPRY4;PTPRT;SPRY1;PTEN;HIF1AN;PIP4K2A;NKD1;PTCH2;NEDD4;IRS1;LRRK2;ADAMTS12;RPS6KB1;LRRC14;BEND6;DCC;LGMN;PRKCB;TLE1;NKD2;GLI3;TNS2;UBASH3B;CBLN1;IL12A;HGS;GSK3A;CNOT1;HERC4;LYN;CTNNBIP1;CREB3L1;ASXL1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3034293221133578,-1.0677512934114397,0.3081761006289308,0.6784052713738002,1.0,15/44,17.68%,ROCK2;PRR5L;ZC3HAV1;CELF1;CNOT8;BTG2;RC3H1;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;GTPBP1;AGO2
prerank,fatty acid catabolic process (GO:0009062),0.33071811374057103,1.0677380113475916,0.3542234332425068,0.9490914704738711,1.0,17/67,18.90%,LPIN3;ABCD2;CEL;PEX2;PPARD;ACADL;ACADS;ACAT2;SLC25A17;NUDT19;LPIN2;PECR;MMAA;MMUT;MCEE;ALDH3A2;ECI2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.419713565009984,-1.0676198657366824,0.3681710213776722,0.6779738475099647,1.0,6/12,15.99%,FOXP1;SMARCA4;DAB2;SFRP1;HEYL;SIRT1
prerank,protein deneddylation (GO:0000338),0.47764739865770867,1.0673858395695943,0.38747884940778343,0.9491137123511982,1.0,2/10,12.54%,COPS3;COPS4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.296549356261062,1.067257313262018,0.32965686274509803,0.9483844046107044,1.0,36/158,20.20%,ROR1;MAP3K14;EDA2R;CCDC22;CD40;TSPAN6;LURAP1;GJA1;HTR2B;TLR6;TNFRSF19;PINK1;PRKD1;TRIM8;PRKCB;BIRC2;IRAK1;LPAR1;NDFIP2;DHX36;LGALS1;RNF31;UBE2V1;F2R;RIPK1;MAP3K3;TIRAP;NDFIP1;LGALS9;MYD88;RHOA;ATP2C1;TERF2IP;PLEKHG5;GPR89A;DDX1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.30901444925110483,1.0667412921747281,0.3601003764115433,0.9488786732185435,1.0,33/107,21.56%,PIK3R1;ITPR1;MBTPS2;SEC16A;PIK3R2;SEL1L;CREB3L2;ATP2A2;CASP4;HERPUD1;TMX1;DNAJB12;TP53;RCN3;DNAJC10;USP19;HSP90B1;EIF2S1;HSPA5;CREB3L1;BAK1;BAG6;BRSK2;UBXN6;BBC3;EIF2AK3;DDRGK1;RHBDD1;MBTPS1;TNFRSF10B;ATG10;ATF6B;DDIT3
prerank,cellular response to cadmium ion (GO:0071276),-0.36076668239521975,-1.0667221992719975,0.3487179487179487,0.6794367469511079,1.0,16/24,33.24%,EGFR;MAPK9;MT2A;AKT1;MT3;SUMO1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;JUN;HSF1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.30306023721825276,-1.0662029407662514,0.347682119205298,0.6798891821213752,1.0,13/42,22.66%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3184578718530564,-1.066090165850773,0.3590504451038576,0.6793960982713246,1.0,10/31,14.14%,IGF1;CSGALNACT1;BMPR2;NDST3;EXT1;UGDH;CHST11;FOXL1;GLCE;HS3ST3B1
prerank,bone development (GO:0060348),-0.3171631315244366,-1.0657212180441693,0.3646723646723647,0.6795021519557434,1.0,8/39,7.73%,RANBP3L;CYP26B1;GNAS;RPL13;SKI;SULF2;SH3PXD2B;LRP6
prerank,positive regulation of developmental process (GO:0051094),0.29372804622905124,1.065591430039335,0.3408018867924528,0.9514733727320412,1.0,25/164,9.69%,PTN;DCN;EDN3;WNT5A;BASP1;NRXN1;FGFR1;PHLDB1;GRIP1;GJA1;REST;FBXO5;SOX6;NCOA3;FOXO6;FMR1;ZBTB16;SORL1;SRF;HMCES;PINK1;RELN;ADGRL1;TAPT1;BMP7
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4247543448471082,-1.0655530301931297,0.3778801843317972,0.6791660378393507,1.0,10/12,54.23%,SLC11A1;CCR2;ZBTB1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,protein export from nucleus (GO:0006611),0.3804499926902355,1.0654610481964968,0.3660436137071651,0.9507701487623711,1.0,9/27,17.09%,CSE1L;ANKLE1;NUP214;NUTF2;NUP42;RANBP3;STRADB;CALR;XPO6
prerank,cellular response to peptide (GO:1901653),0.3382036272442059,1.0652114655037264,0.34203296703296704,0.9504183974729952,1.0,13/56,11.12%,LRP1;GJA1;NGFR;PTPN22;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;TP53;GRM5;FYN
prerank,regulation of cellular protein localization (GO:1903827),-0.30234637861806607,-1.0651098130514465,0.32608695652173914,0.6795326888749122,1.0,16/45,18.27%,VCPIP1;NDEL1;GPC3;DVL1;PRKAA2;PPM1F;VCP;MAPT;PTPN1;SUMO3;RALB;TOR1A;KCNAB2;PRKAA1;HFE;EGF
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.36408528385114014,-1.064829787633424,0.35400516795865633,0.6794305667179854,1.0,6/21,11.65%,PGM2L1;DERA;HK1;TALDO1;HK2;PGM2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3983831186180672,1.0646652318999095,0.36633663366336633,0.9511029685293301,1.0,5/23,13.64%,ENPP1;PTCH2;GLI3;HERC4;RFX4
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4859984787005116,1.0644990887155892,0.3881932021466905,0.9505075140827849,1.0,2/11,8.19%,LIPC;PLA2G7
prerank,lipoxygenase pathway (GO:0019372),-0.40838520347549995,-1.0644676228244063,0.3624161073825503,0.6795801331086213,1.0,4/14,19.42%,PON3;GPX1;PTGS2;ALOX12
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3887739485158159,-1.0636518235807058,0.36319612590799033,0.680924163998256,1.0,6/17,20.48%,IL18;CD55;BACH2;GNL1;BTN3A3;CD46
prerank,negative regulation of endocytosis (GO:0045806),-0.3595390702548389,-1.0632477933991669,0.3565217391304348,0.6811567175753264,1.0,4/24,5.15%,PICALM;CAV1;MCTP1;RAC1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3965124555321367,1.0628086953755496,0.3701399688958009,0.9548073520171317,1.0,7/24,12.02%,TRPS1;LOXL2;SOX6;ZBTB16;ADAMTS12;TGFBR1;SOX9
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.28459899074657313,-1.0626855209695678,0.3527272727272727,0.681703037306333,1.0,23/59,24.34%,ROCK2;ERC1;IRAK2;UBB;AZI2;NFKBIA;NKIRAS1;TAB2;TICAM1;TBK1;TNFRSF1A;UBC;AKT1;TIFA;LY96;TRADD;BIRC3;TLR7;UBA52;REL;BCL10;IKBKB;IKBKG
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.47792233571817744,1.0626650618720899,0.38162544169611307,0.9541106187130313,1.0,4/11,18.97%,REST;PINK1;FYN;STK26
prerank,DNA-dependent DNA replication (GO:0006261),0.30231935037658275,1.0624774190676807,0.34944237918215615,0.9535627717245557,1.0,36/128,18.81%,POLG;PSMD1;MCM7;CDC7;GINS3;PSMD10;POLA1;GMNN;PSMA5;RPA1;PSMB5;POLE4;RFC3;PSMC4;NOC3L;REV3L;MCM4;PSMA4;RECQL;TEFM;PSMC5;CDT1;POLG2;POLB;POLE3;PSMB9;MCM10;DBF4;ORC2;PSMA7;PSMD14;MCMDC2;WRN;PSMA2;SSBP1;PSMD11
prerank,endothelial cell migration (GO:0043542),-0.30799471681529483,-1.0623979448416618,0.33240997229916897,0.6816640666243542,1.0,10/37,10.26%,NOS3;ID1;FSTL1;NRP1;DPP4;CYP1B1;CCN3;GIPC1;NR4A1;RAB13
prerank,negative regulation of growth (GO:0045926),-0.2444079623084816,-1.0623479716222166,0.2833333333333333,0.681006499117172,1.0,60/121,30.92%,APBB2;PTPRJ;SLIT2;FHL1;NOTCH2;BMPR2;SMARCA4;OSGIN2;SMARCA2;NOTCH1;TGFB2;CCN3;SH3BP4;PPP2R1A;IP6K2;PRDM11;ACVRL1;SOX17;SMAD3;MT2A;NPR1;HYAL1;SFRP1;ENO1;CDKN2AIP;ING4;CDKN1A;SIRT1;ING5;VGLL4;DCUN1D3;RBBP7;FGFR3;APBB1;WNT11;RERG;RTN4;SPHK2;CCAR2;BTG1;NDUFA13;CDA;PNPT1;MT3;HYAL2;HSPA1A;SMAD4;RB1;DNAJB2;SESN2;HSPA1B;MINAR1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,positive regulation of exocytosis (GO:0045921),0.3689464579364278,1.0622252421666183,0.3904320987654321,0.9532248031662441,1.0,12/35,18.99%,CADPS2;CADPS;RAB15;HGS;TSG101;CLASP2;SNF8;CLASP1;STXBP5;VPS4B;RAB2B;ATP6AP1
prerank,regulation of neuroinflammatory response (GO:0150077),0.41308101254844976,1.0621346186911444,0.39436619718309857,0.9523772671304832,1.0,1/19,0.10%,IL33
prerank,negative regulation of cell death (GO:0060548),-0.26187425278463616,-1.062101021681419,0.3107569721115538,0.6808202667404973,1.0,26/88,19.90%,MECOM;CD200;CCN2;KANK2;BECN1;VPS35;CCN3;CD34;SRGAP2;NCK1;SOX4;CCN5;CCN1;GSK3B;BNIP3L;CCN4;NENF;WNT16;TMEM109;CHMP4B;CHMP4A;AKT1;SOX11;WNT11;CHGA;DCPS
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.38746879013725366,1.0618692686608466,0.3830769230769231,0.9520997815164601,1.0,3/27,3.66%,DCN;BGN;VCAN
prerank,peptidyl-asparagine modification (GO:0018196),0.383407390699909,1.0618655116826383,0.39813374805598756,0.9509750543353385,1.0,7/31,12.21%,HIF1AN;RPN2;OSTC;DAD1;ALG5;MCFD2;TUSC3
prerank,regulation of superoxide anion generation (GO:0032928),-0.3924256253031807,-1.0618482110454288,0.35678391959798994,0.6806739195685149,1.0,9/14,50.89%,MAPT;PRKCD;TYROBP;ITGB2;AATF;CRP;GSTP1;F2RL1;CD177
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2723066830317299,-1.0617591960868409,0.328125,0.6801210808967955,1.0,20/70,16.14%,FOXC1;PSMC6;PRKDC;LMO2;PSMD9;RUNX1;PSMF1;PSMB7;PSMD8;PSMD12;GATA2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;TAL1;PSMB6;PSMC1;PSMB10
prerank,regulation of dendrite morphogenesis (GO:0048814),0.37792889185212686,1.061731221552738,0.3806646525679758,0.950298249919518,1.0,11/32,17.84%,CDKL5;NEDD4;CAPRIN1;CDKL3;ADGRB3;CUX2;SDC2;TNIK;IL1RAPL1;HECW1;CUL7
prerank,chondroitin sulfate metabolic process (GO:0030204),0.38373209122349633,1.0615392037930702,0.3953488372093023,0.9498604437886344,1.0,4/30,3.66%,DCN;BGN;DSE;VCAN
prerank,response to muscle stretch (GO:0035994),0.43481735306325653,1.061510677564176,0.3881578947368421,0.948819010369105,1.0,3/15,7.71%,RYR2;SLC9A1;PTK2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.41689977275720735,-1.0612307649742851,0.3815165876777251,0.6806381338382974,1.0,5/13,24.32%,PARP10;PARP9;PTGS2;NAXE;NAPRT
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4543689037121352,1.061080394304274,0.3979591836734694,0.9490758550123183,1.0,7/13,16.16%,LRRK2;AK4;OPA1;MFN1;ENTPD7;AK3;EFL1
prerank,protein-DNA complex disassembly (GO:0032986),-0.387756944989471,-1.0609670274142322,0.35572139303482586,0.6805430545167669,1.0,12/16,42.39%,ARID2;SMARCA4;SMARCC2;SMARCD3;RPL23;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,negative regulation of insulin secretion (GO:0046676),-0.37989551750673123,-1.060948574327807,0.37037037037037035,0.6798210925184272,1.0,5/17,9.80%,KLF7;PSMD9;CCN3;KCNB1;SFRP1
prerank,maturation of SSU-rRNA (GO:0030490),-0.32119607521579224,-1.0609147089074247,0.33421750663129973,0.6791442083676954,1.0,9/34,13.28%,RPS14;RPS16;DDX52;RPS19;LSM6;RIOK1;UTP3;RIOK3;RPS8
prerank,positive regulation of protein transport (GO:0051222),-0.271775961447987,-1.06088602163265,0.31153846153846154,0.6784464617253056,1.0,19/67,22.19%,IGF1;EZR;CNST;RUFY3;TGFB2;UNC13B;PRR5L;CEP290;CD2AP;MYH10;GOLPH3L;PPIA;OAZ1;BCAS3;OAZ2;APBB1;ADAM9;VPS28;MYO18A
prerank,regulation of ruffle assembly (GO:1900027),-0.358600745879164,-1.0606384378354707,0.37158469945355194,0.6783123475746834,1.0,5/23,8.74%,CAV1;RDX;NDEL1;KANK1;EPS8L2
prerank,positive regulation of protein polymerization (GO:0032273),-0.27710459463899867,-1.0605282879514923,0.328125,0.6778056538774924,1.0,14/65,15.68%,BAIAP2L1;OCLN;FER;DRG1;RAC1;NCK1;MAPT;ARL2;SLAIN2;LMOD1;PTK2B;BAIAP2;TPPP3;MET
prerank,protein O-linked glycosylation via serine (GO:0018242),0.48635903944224135,1.060429867746689,0.38817005545286504,0.9500427493900938,1.0,4/10,17.19%,GALNT13;POGLUT3;POGLUT2;GALNT2
prerank,determination of left/right symmetry (GO:0007368),-0.3151493638857522,-1.0599147074196584,0.34890965732087226,0.6786211574973562,1.0,15/36,21.05%,NOTCH1;OFD1;SMO;MEGF8;ARL6;TBX1;CITED2;RFX3;GALNT11;ZIC3;MKKS;DNAH11;ENKUR;BBS7;DNAH5
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.43635690309658726,1.0595993974782452,0.3955094991364421,0.9516408230244322,1.0,5/14,15.02%,NMNAT3;AK1;AK4;AK8;AK3
prerank,mRNA modification (GO:0016556),-0.35485731575602775,-1.059527024310674,0.3663101604278075,0.6788690957578216,1.0,4/22,8.67%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,nucleic acid-templated transcription (GO:0097659),-0.3096297890791491,-1.0592503622868314,0.36615384615384616,0.6788088776255125,1.0,13/42,20.91%,MEF2A;PTMA;DRG1;RRAGC;NR4A2;POLR2B;POLR2H;TERT;POLR2G;POLR2C;HOXD3;CREBL2;E2F1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.4612038171448458,1.059240176796277,0.40099833610648916,0.9516584646698653,1.0,4/12,14.03%,ODC1;HNMT;TRH;ATP7A
prerank,regulation of telomerase activity (GO:0051972),-0.3002355302497155,-1.0582495587858534,0.3258064516129032,0.6806173318270976,1.0,11/45,15.67%,HMBOX1;KLF4;PTGES3;SMG6;PARN;NEK7;MAP2K7;CCT4;ATM;MAP3K4;PARP4
prerank,response to interleukin-4 (GO:0070670),0.4859085644290758,1.0580365825745055,0.4198895027624309,0.9543840788184855,1.0,1/10,0.79%,XCL1
prerank,regulation of microtubule nucleation (GO:0010968),-0.436193267386622,-1.0569090500614373,0.3844444444444444,0.6832007930467846,1.0,6/10,35.55%,GIT1;EML2;HSPA1A;HSPA1B;RANGRF;MECP2
prerank,response to peptide hormone (GO:0043434),-0.2946992971218577,-1.056840188968145,0.35064935064935066,0.6826018595782047,1.0,13/43,19.16%,ROCK2;CAV1;IGFBP5;ANXA1;TRIM16;EIF2B4;CREB1;SIRT1;GPER1;EPM2AIP1;AKT1;ZBTB7B;TGFBR3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.34253070990001366,-1.0568185419276164,0.37037037037037035,0.6818864926212554,1.0,8/25,23.08%,LAPTM4B;CHMP2B;VCP;CHMP4B;CHMP4A;CHMP7;CHMP1A;CHMP4C
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.37759911686671643,-1.0567089486003662,0.37254901960784315,0.6814038646712579,1.0,8/18,14.28%,HIP1R;GSK3B;BAX;BID;BOK;SLC25A5;ZNF205;ACAA2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4493650957617528,1.0565901722069533,0.4076086956521739,0.957988413811358,1.0,1/12,0.21%,COLEC12
prerank,vasculature development (GO:0001944),0.42924100751826244,1.056562297222284,0.39297658862876256,0.9569470191039628,1.0,1/16,0.14%,PDGFRA
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.35846764221395766,1.0565535530368209,0.3724035608308605,0.9558557702465516,1.0,10/39,15.08%,ERCC1;FAN1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.372325335063594,-1.0564711039965404,0.3730964467005076,0.6812375275166778,1.0,7/18,13.00%,HDAC4;NOTCH1;CCN3;FZD7;FRS2;HDAC3;TMEM119
prerank,negative regulation of MAPK cascade (GO:0043409),0.3132370379124625,1.0563230679691977,0.3798449612403101,0.9554657490707646,1.0,15/87,9.69%,SPRY4;SPRY1;PTEN;PTPRR;DUSP1;CNKSR3;PIK3R2;SPRED1;SORL1;NF1;PSMD10;RPS6KA6;SPRED2;TLR4;BMP7
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.36789748424772845,1.0562617569191688,0.39906832298136646,0.9545292194521634,1.0,4/33,3.87%,PPARA;SEMA5A;TCF7L2;PDPK1
prerank,regulation of cellular response to stress (GO:0080135),-0.2509125817122743,-1.0562525314830724,0.28804347826086957,0.6810232284622171,1.0,29/115,15.99%,ROCK2;MCL1;PTGES3;NEK6;CAMK2D;ARMT1;HSPA8;HSPH1;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;ATR;CAMK2G;NUP98;NUP153;AJUBA;BAG3;CHCHD2;ATM;AMFR;NUP43;HIKESHI;RAE1;NUP205;MANF;SIRT1
prerank,cholesterol biosynthetic process (GO:0006695),0.3782642586784427,1.0562131071411014,0.3875,0.9535836460019901,1.0,7/31,11.96%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,regulation of axon regeneration (GO:0048679),0.45910691733871933,1.0561233052553558,0.39594843462246776,0.9527393096591757,1.0,1/12,0.19%,PTN
prerank,metanephric mesenchyme development (GO:0072075),-0.4445170073910779,-1.0557831960329518,0.38979118329466356,0.6814398021619896,1.0,3/10,5.87%,OSR1;WNT4;SIX1
prerank,cellular iron ion homeostasis (GO:0006879),-0.2882794639778456,-1.0557127639349917,0.3277027027027027,0.6808606169481125,1.0,21/55,24.44%,ABCG2;HMOX2;CUL1;TFRC;SCARA5;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;TMEM199
prerank,positive regulation of neuron differentiation (GO:0045666),0.35642487706637666,1.0556509334626651,0.3762811127379209,0.9532051359088176,1.0,15/40,25.27%,ZEB1;TCF4;FGFR1;REST;BEND6;NRCAM;IMPACT;BRINP1;BMP2;RHOA;MMD2;TRIM32;ZC4H2;CPNE1;VWC2
prerank,organelle fusion (GO:0048284),-0.3586327606830892,-1.0554013423774076,0.37866666666666665,0.680904830357538,1.0,8/22,20.96%,EEA1;VPS18;MIEF1;USP30;BAX;VPS11;CHCHD3;MIGA1
prerank,histone H4 deacetylation (GO:0070933),0.480554485593895,1.0551818488075448,0.4188191881918819,0.9536067293876824,1.0,2/10,4.28%,HDAC1;REST
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.34777309262476147,1.0551418936673236,0.39642324888226527,0.9526107035603859,1.0,8/46,9.41%,SPRY1;PTEN;PTPRR;CNKSR3;SPRED1;RPS6KA6;SPRED2;TLR4
prerank,positive regulation of histone acetylation (GO:0035066),-0.35176902242471203,-1.055059813239684,0.36712328767123287,0.6810328091608355,1.0,9/23,26.16%,GLYR1;WBP2;RPS6KA5;NOS1;TADA2B;RUVBL2;SPHK2;BRCA1;SMAD4
prerank,tetrapyrrole metabolic process (GO:0033013),0.4190584719635884,1.0549574414851883,0.3979591836734694,0.9520996309889567,1.0,5/18,17.20%,MMAB;MTRR;ABCB6;MMAA;MMUT
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.41652003050403275,1.0545119178346518,0.3986820428336079,0.9524442756820691,1.0,3/22,2.62%,PTEN;NR2F2;CDKN2A
prerank,neuronal action potential (GO:0019228),0.40674048646006766,1.05450461784973,0.3925686591276252,0.9513547532604892,1.0,6/22,21.36%,ANK3;CACNA1G;SCN1A;SCN2A;SCN8A;CACNA1I
prerank,negative regulation of protein polymerization (GO:0032272),-0.3309780089904997,-1.0540405028228177,0.3888888888888889,0.6828482746242241,1.0,9/27,21.46%,SLIT2;KANK3;HIP1R;KANK1;SSH1;CDH5;PRKCD;EML2;TWF2
prerank,cellular response to organic cyclic compound (GO:0071407),0.29808940449375926,1.0538350491813167,0.3871763255240444,0.9523434229269855,1.0,28/141,13.82%,RORA;ADCY5;ATP1A2;NR1H4;P2RY1;JUP;NCOA3;CASP6;SPP1;ATP1A3;LRRK2;PDE12;ADCY8;ADCY3;ADCY2;HCN2;HCN1;GABRG2;HCN3;P2RX4;SPIDR;TRPM2;HSP90B1;AKAP6;NRIP1;RYR3;MED1;GABRB1
prerank,protein polyubiquitination (GO:0000209),-0.2241760834194385,-1.0533415322849033,0.27586206896551724,0.6838215624524288,1.0,88/297,23.60%,FBXL7;WWP1;RNF152;LMO7;UNKL;RNF146;UBE2G1;PSMC6;PELI1;PSMD9;WWP2;ARIH1;CDC23;UBE2D3;PSMF1;PSMB7;TRIP12;CUL1;ANAPC10;TRIM5;UBB;TRIM14;TNKS2;IFI27;HERC6;RNF8;UBE2H;SMURF2;TRIM36;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;KLHL20;ZFP91;RNF144B;RNF41;RNF114;UBR2;PSMA3;PSMA6;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;UBE2N;PSMB6;TRAF3;PSMC1;FBXO32;TRIM27;ANAPC13;UBE2L6;PSMB10;FBXL14;SIAH2;CUL3;ANAPC11;UBC;CHFR;ANKIB1;PSME2;FZR1;CDC34;TNFAIP3;KLHL3;ANAPC2;PSMC3;RNF166;PRPF19;KBTBD7;RNF5;TRAF1;RFFL;FBXO22;FBXL8;MKRN1;UBA52;FBXW2;FBXL18;PSMA8;FBXO10;SMURF1;RLIM
prerank,regulation of protein localization to membrane (GO:1905475),0.3809659370057528,1.05308749238183,0.40746500777604977,0.9536281414129957,1.0,10/28,18.74%,GPC4;SPTBN1;GPC5;NECAB2;FYN;AR;LDLRAP1;ZDHHC2;CDK5;GPC6
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.2995685285323639,-1.0530549305038501,0.3687315634218289,0.6837471967283426,1.0,14/42,14.88%,TEK;PTPRJ;NRP1;S100A10;KDR;RAC1;CDK6;PPM1F;GSK3B;SFRP1;PLEKHA2;PTK2B;RRAS;CX3CL1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.297494882893559,-1.0530473334838535,0.35347432024169184,0.6830036888612814,1.0,8/39,7.11%,PODXL;CDH1;KLF4;RDX;FXYD5;NOTCH1;WNK1;PPM1F
prerank,positive regulation of viral process (GO:0048524),0.32880978548807893,1.0526416511592143,0.38579387186629527,0.9538997120880758,1.0,17/60,22.35%,PPARA;PPID;MDFIC;PPIH;PDE12;STAU1;AXL;NELFA;DHX9;CNOT7;ADAR;HACD3;TBC1D20;POLR2L;DDB1;NELFB;KPNA2
prerank,cellular glucose homeostasis (GO:0001678),0.3551674159975394,1.052501138836892,0.3894736842105263,0.9532756735069493,1.0,8/41,10.39%,PIK3R1;ZBTB20;TRA2B;NGFR;PIK3R2;ADCY8;PRKACA;GCK
prerank,synaptic vesicle recycling (GO:0036465),0.368880844797866,1.052163893573778,0.38006230529595014,0.9531993226019583,1.0,10/31,19.49%,CEL;VAMP2;OPHN1;SYT7;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,regulation of cell projection organization (GO:0031344),0.45445092643948487,1.0518988254966526,0.40463458110516937,0.952926848837407,1.0,4/13,18.88%,ERMN;NTNG2;NTNG1;SPRY2
prerank,cell chemotaxis (GO:0060326),0.3322929437068408,1.0517106204294195,0.3927007299270073,0.9524730086385187,1.0,5/60,3.26%,PDGFRA;SEMA5A;EPHB1;CCR9;ACKR2
prerank,response to gamma radiation (GO:0010332),-0.3436365425862272,-1.0514557499372676,0.35872235872235875,0.686210332994564,1.0,11/24,25.78%,CRYAB;TLK2;ATR;RPL26;ATM;PRKAA1;TMEM109;DCUN1D3;FANCD2;KDM1A;LIG4
prerank,cell projection assembly (GO:0030031),-0.3480990852928856,-1.0510920871519362,0.3729281767955801,0.6863766690140947,1.0,6/22,6.77%,PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3194713683724098,-1.0510583340838124,0.3710144927536232,0.6857173008010097,1.0,15/33,27.34%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;ANKZF1;PRKCD;SIRT1;TNFAIP3;HDAC6;PPIF;OSER1;PARK7;ECT2;RHOB
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.3205456676690605,-1.05100031930402,0.3411764705882353,0.6851016299131942,1.0,7/33,8.29%,MEF2C;THBS1;KLF4;NOTCH1;APOE;ACVRL1;ITGB1BP1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.45386494797198695,1.0509237723822438,0.41196581196581195,0.9538772425712496,1.0,2/13,3.59%,PTPRT;TSLP
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.44938543610903225,1.0507670182696043,0.3968804159445407,0.9532809009922517,1.0,1/13,0.10%,IL33
prerank,protein O-linked mannosylation (GO:0035269),-0.3629927922887711,-1.0505573679008224,0.37438423645320196,0.6854959559044391,1.0,4/18,8.23%,TMTC2;TMTC1;TMTC4;LARGE1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4634610890499627,1.0500729631712309,0.40974729241877256,0.9544364781121227,1.0,5/11,15.70%,WNT5A;SOX9;CTNNBIP1;MYC;FGFR2
prerank,gastrulation (GO:0007369),-0.3918607756122919,-1.0496751962629547,0.4049382716049383,0.6869159811281478,1.0,4/15,15.84%,GPC3;MEGF8;UGDH;MKKS
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.35157675338296923,-1.0496382696493058,0.35714285714285715,0.6862507694041561,1.0,7/23,16.48%,IGF1;MEF2C;EFNB2;MAPK14;NIBAN2;EDN1;MYOCD
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4328653679521436,1.049597463967107,0.4,0.954814719057623,1.0,5/16,21.24%,BOD1;SGO1;NAA50;SMC1A;MAU2
prerank,ceramide metabolic process (GO:0006672),-0.28369081024905013,-1.0489428117721649,0.38275862068965516,0.6872177788378504,1.0,9/49,7.43%,SGMS1;SPTLC2;PLPP3;ACER2;ACER3;SGMS2;PPP2R1A;DEGS2;ST6GALNAC3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4301579423389213,1.048764033958696,0.3903654485049834,0.9563347817513831,1.0,8/16,17.44%,CDK13;CELF4;DDX17;SLU7;RBM17;DHX9;SRSF9;SRSF6
prerank,negative regulation of cell adhesion (GO:0007162),0.32062365171339463,1.0486080125090553,0.3916554508748318,0.9557473446482111,1.0,12/72,8.21%,PLXNC1;HRG;TGFBI;SEMA5A;CORO2B;SIPA1;DUSP1;GCNT2;DSCAM;PTPRO;PTK2;JAM3
prerank,cardiac muscle cell development (GO:0055013),0.4097725063170309,1.0485533093001378,0.4074074074074074,0.9548201293026535,1.0,1/20,0.14%,PDGFRA
prerank,monocarboxylic acid transport (GO:0015718),0.3374165916096263,1.048178581021131,0.39914163090128757,0.9549242110028059,1.0,6/51,3.46%,ABCC3;SLC6A13;SLC6A8;SLC16A12;NR1H4;NCOA2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.39540733946461265,-1.0481720246654296,0.40311804008908686,0.688415765219804,1.0,6/14,15.11%,ELAVL1;YBX3;MAPK14;TARDBP;HNRNPC;ANGEL2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.2956828162553487,-1.0480304190800742,0.33222591362126247,0.6880096598189527,1.0,14/43,22.66%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;ACVR1;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,amino acid import (GO:0043090),0.40392675079652324,1.0476981787943143,0.38421955403087477,0.9553793458688387,1.0,3/21,4.87%,SLC1A3;SLC6A13;SLC7A8
prerank,protein localization to kinetochore (GO:0034501),-0.3953185538080264,-1.0476289679419106,0.3879093198992443,0.688285978582778,1.0,7/14,27.48%,MTBP;ZW10;CENPT;BUB3;RCC2;IK;TTK
prerank,nucleus organization (GO:0006997),-0.2952345952612499,-1.047458655029257,0.3438485804416404,0.6879795092744674,1.0,16/47,20.04%,LEMD3;ATXN7;CHMP2B;RPS19;NUP98;REEP3;TOR1A;TMEM170A;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;NUMA1;PDCD6IP;CHMP1A
prerank,placenta development (GO:0001890),0.44632615193105496,1.0471621624218272,0.42538593481989706,0.9559477542365993,1.0,3/12,17.84%,ADAM19;PTK2;CUL7
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3495905198018138,-1.0471188222509529,0.39276485788113696,0.6880933415751398,1.0,11/22,20.81%,DDX5;RPS7;RPS20;UBB;RPS15;ATR;SPRED3;ATM;EEF1E1;HEXIM1;RPL23
prerank,DNA methylation (GO:0006306),0.39824626283578834,1.0470739756141803,0.424390243902439,0.9551496434666131,1.0,9/23,22.92%,KMT2E;FOS;MTRR;DMAP1;N6AMT1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3409905438257796,1.047050726717552,0.39823008849557523,0.9541401226359085,1.0,15/49,21.56%,KMT2E;HDAC1;L3MBTL1;AGO4;KMT2A;WDR5;AGO3;TESC;TNRC6B;ASH2L;AGO1;CBFB;KMT2C;RBM15;RBBP5
prerank,regulation of apoptotic process (GO:0042981),-0.20642817261144208,-1.046984411590514,0.25,0.6876880114043546,1.0,192/676,22.66%,PAWR;DAPK1;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;ARHGEF18;MEF2C;IL31RA;ANO6;LEF1;ACTN2;SLIT2;TIAM2;BCL2L1;EGFR;IGF1R;ITGB1;NET1;OSR1;PPP1R13B;XIAP;THBS1;ARL6IP5;NOTCH2;ANXA5;FSTL1;GAS1;NFKB1;ITGA6;MCL1;MCF2L;TNFSF10;ACER2;PTMA;HIP1R;IGFBP3;KDR;SQSTM1;PRKDC;MAP3K5;TMBIM6;CCND2;FAS;NDRG1;ARHGAP10;CYP1B1;GCLC;SOCS2;UNC13B;EGLN3;ANXA1;APC;DAB2;TRIM24;ATF6;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;CRADD;HIPK3;JMY;CD38;DDX42;BNIP2;UBB;SOX4;IP6K2;NGF;CASP2;CAT;CARD14;GSK3B;CD44;SH3RF2;VCP;GLO1;RPL10;CASP3;NGEF;CFL1;CASP8;MADD;BAD;CITED2;SFRP1;BAX;NFKBIA;KLHL20;PERP;BNIP3L;NIBAN2;RNF144B;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;TARDBP;HSPB1;ADAMTSL4;BAG3;BID;APH1A;TGM2;GADD45B;APH1B;ATM;FLT4;GATA6;FLNA;BOK;PTK2B;PLEKHG2;TPT1;HIP1;PPIA;ING4;ARHGEF11;CX3CL1;PLK5;ARL6IP1;STK17B;TRIM35;PRELID1;SMPD1;FLT3;SIRT1;GPER1;ANXA4;PRKAA1;PDPN;ING5;PRDX3;PAK2;SIAH2;YME1L1;AIFM1;DCUN1D3;CD74;PLSCR3;UBC;MAP3K10;HNRNPK;RASA1;AKT1;NUAK2;TFPT;APBB1;WNT11;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;HGF;NPM1;DNAJC3;CIB1;RASGRF2;AGT;GADD45G;TRADD;SON;ARHGEF12;PIM2;ASNS;MIF;E2F1;NAA35;CFLAR;RTN4;SPHK2;CCAR2;BIRC3;DDX20;MGMT;DDAH2;HIGD1A;NUPR1;MYO18A;UBA52;SIX4;TIAM1;UFM1;ARHGEF1;PPIF
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4306873146567957,-1.046725630960175,0.3912087912087912,0.687598612749047,1.0,6/11,25.67%,YBX3;PELI1;CASP8;BIRC3;NUPR1;SLC25A4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3293684910033873,-1.0466207388751156,0.3670520231213873,0.6871140092730773,1.0,13/29,27.79%,SAMHD1;MAVS;PTPN2;PTPN1;RNASEL;NLRC5;ISG15;USP18;PTPN6;YTHDF2;TRIM6;ZBP1;TTLL12
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.41678911515579675,-1.0460056285167243,0.41509433962264153,0.6879618023739174,1.0,6/12,25.89%,SMCHD1;CDYL;PCGF5;RBM15B;RLIM;BRCA1
prerank,cellular response to light stimulus (GO:0071482),0.32532039040693883,1.0458200259853117,0.37228260869565216,0.9569408814020152,1.0,12/66,15.40%,GPR88;POLK;FMR1;NEDD4;ERCC4;NOC2L;GPR52;TP53;DHX36;EIF2S1;BAK1;MYC
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4036332463721214,1.045794781183146,0.4171875,0.9559434934933999,1.0,4/22,9.11%,ZBTB20;PPARA;PPARD;MTOR
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.41138149352552195,-1.045659394807664,0.39443155452436196,0.6881381087586569,1.0,3/13,4.26%,RBPJ;CPE;NOTCH1
prerank,cellular response to drug (GO:0035690),-0.3429582161735875,-1.045569024114367,0.3803191489361702,0.6876075787530949,1.0,7/25,10.98%,PPM1E;MEF2C;ACER2;TFRC;PPM1F;RBM22;KCNQ1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.41328392068942577,1.0454762878667716,0.4187604690117253,0.9558270408294219,1.0,7/19,16.75%,CAMKK2;PINK1;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36184573951342286,1.0451788531596955,0.39384615384615385,0.955709864969698,1.0,6/32,6.62%,HCRT;CHRNB4;PNKD;FMR1;LRRK2;RIMS2
prerank,mitotic DNA replication (GO:1902969),0.4749897485461202,1.0448235028981898,0.41454545454545455,0.9557527096262135,1.0,7/10,27.85%,GINS3;POLA1;MCM4;MCMDC2;GINS1;MCM3;MCM2
prerank,acute inflammatory response (GO:0002526),-0.3420579893103258,-1.0447951121287016,0.3670212765957447,0.6887252513163054,1.0,2/23,2.85%,ANO6;LBP
prerank,cellular component assembly (GO:0022607),0.2808214913175134,1.0446529985961572,0.38375973303670746,0.9552389170250579,1.0,40/253,12.06%,LAMC1;GPM6B;WIPF1;TEAD1;PPID;WNT5A;CD40;STAG3;RHOJ;EPRS1;RSPH9;SPTBN1;ANK3;FSCN1;TEAD2;YWHAZ;LRRTM3;RAC3;KMT2A;VAMP2;FANCA;PPIH;MYO1B;NEFH;LLGL1;CAPN3;WASF3;TEX11;MDM4;CHAF1B;KIFAP3;NOC2L;IL1RAP;OPHN1;TP53;RIMS1;DLG4;GAS8;SOX9;TUBGCP4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3255467366498748,1.0444460061620333,0.3760217983651226,0.9547922077816399,1.0,13/70,15.91%,LPIN3;GPLD1;NR1H2;CHAT;LIPC;PLA2G7;CHKA;MBOAT7;STARD10;PLA2G12A;LPIN2;ABHD4;CSNK2A2
prerank,central nervous system neuron development (GO:0021954),0.43324069082931815,1.0442895730812174,0.3983193277310924,0.954192206748433,1.0,5/15,14.03%,NTRK2;PTEN;NPY;ARHGAP35;ATP7A
prerank,cellular response to hormone stimulus (GO:0032870),0.3234380546252504,1.0437498613893539,0.39377537212449254,0.9547843553262911,1.0,7/69,6.47%,ROBO2;GHR;ATP1A2;NCOA2;NCOA3;ATP1A3;BRD8
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.376895010760831,-1.0435860191327857,0.4049382716049383,0.6910363354040803,1.0,6/16,23.08%,CHMP4B;CHMP4A;CHMP7;VPS28;VPS36;CHMP4C
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.33780673365958724,-1.0434555259867357,0.4128686327077748,0.6906273206600041,1.0,10/25,19.65%,RBPJ;BMPR2;FOXD1;NOTCH1;CCN1;ACVRL1;CDH5;ACVR2B;SOX11;NUMA1
prerank,DNA replication (GO:0006260),0.30599584158657345,1.0432501013939712,0.39147286821705424,0.9552643635590489,1.0,21/105,14.04%,RBMS1;POLG;TIPIN;MCM7;FEN1;CDC7;POLA1;RPA1;PIF1;POLL;RFC3;REV3L;MCM4;TOP3A;NAP1L1;POLG2;POLB;POLE3;REV1;MCM10;DBF4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.40721684097877564,1.0432012829938717,0.41788617886178864,0.9543612356988123,1.0,2/19,0.85%,DCN;HRG
prerank,response to cadmium ion (GO:0046686),-0.34547241564299314,-1.0428716708311454,0.3858267716535433,0.69136438700592,1.0,16/26,33.24%,EGFR;MAPK9;MT2A;AKT1;MT3;SUMO1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;JUN;HSF1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4056007002906596,1.0427100494070194,0.40237691001697795,0.9548210729468968,1.0,5/20,11.21%,AGO4;SPOUT1;ZC3H7B;MRPL44;AGO3
prerank,vasoconstriction (GO:0042310),0.4685214704956897,1.0425733109881405,0.41872791519434627,0.9541784739710708,1.0,2/11,4.84%,EDN3;HTR2B
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2917348084544831,-1.0422516037438452,0.3727810650887574,0.692187860233825,1.0,15/41,25.90%,TJP1;PODXL;PLPP3;AFDN;CD44;CITED2;MDK;DENND6A;CX3CL1;SKAP1;PIEZO1;SMAD7;FSTL3;MAGI1;FLOT1
prerank,regulation of lipid metabolic process (GO:0019216),0.3128745239580778,1.0419261990823978,0.396,0.9551343672180803,1.0,25/88,21.85%,RORA;PPARA;NCOA2;PPARD;C1QTNF2;SC5D;IRS2;CHD9;EDF1;NCOA1;HMGCS1;MBOAT7;CARM1;MED1;SREBF1;ELOVL6;IDI1;NR1D2;PANK2;NPC2;SP1;BBS4;RARRES2;ACACA;CREBBP
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4016054040198169,1.041423105519112,0.41047297297297297,0.9556454243714495,1.0,7/21,19.98%,BUB1B;FBXO5;TEX14;BUB1;CENPF;KLHL22;TRIP13
prerank,regulation of insulin secretion (GO:0050796),0.3069494268880489,1.0413826516255196,0.3974522292993631,0.954706986953574,1.0,17/101,10.49%,RAPGEF4;ADCY5;CACNA1E;TCF7L2;ITPR1;NR1H4;REST;IRS1;TM7SF3;IRS2;TRH;PER2;PRKCA;KCNC2;SYT7;GCK;PPP3CB
prerank,dephosphorylation (GO:0016311),0.2912539923759601,1.0402493130943753,0.38968824940047964,0.9571612750456086,1.0,23/147,10.69%,CDC14B;PTPRT;THNSL2;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;PLPPR3;PTPRU;PTPRO;PTPN13;SSH2;PLPPR2;PPP2R2A;PPP2R3A;PPP6C;PPP3CB;PLPP6;PDP1;PTPRA
prerank,regulation of endopeptidase activity (GO:0052548),-0.2744076673728355,-1.04015732559448,0.36363636363636365,0.6967667151153376,1.0,21/59,22.79%,PICALM;SPOCK2;VTN;SERPIND1;SERPINE1;SERPINI1;SERPINA2;GAPDH;APH1A;PSMA3;APH1B;PSME3;SERPINE2;FURIN;PRELID1;AKT1;PSME2;TIMP3;AGT;BIRC3;SERPINB8
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.38322028929327623,-1.0398874407007312,0.425,0.6967204887886721,1.0,8/15,33.07%,JMY;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4;WHAMM;ACTR3
prerank,regulation of cytokine production (GO:0001817),0.29654182628954884,1.0397144915486727,0.3765432098765432,0.9577383310014197,1.0,17/126,11.38%,IL33;TXK;PLA2R1;GLMN;LURAP1;ICOSLG;DTX4;HTR2B;CD276;TRIM56;POLA1;BCL6;CIDEA;KAT2A;FGR;EIF2AK2;ASB1
prerank,generation of neurons (GO:0048699),0.2812569536679074,1.0395808670723912,0.397212543554007,0.9570890120969338,1.0,26/190,11.42%,SH3RF1;ADGRL3;RUNX2;AUTS2;WNT5A;NTRK2;ASTN2;FGFR1;DNAAF4;MYEF2;LRP12;CDKL5;MTPN;DISC1;DOCK7;ASTN1;SNPH;PER2;RELN;OLIG2;BHLHE22;WNT3;MAP2K1;OPHN1;SMARCA1;PLXNB2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3256333688469636,1.0395406307256922,0.4022346368715084,0.9561492685610646,1.0,7/68,6.65%,ENPP1;MMAB;PDXK;MCCC1;GSTO2;MTRR;MTHFD1L
prerank,cellular response to insulin stimulus (GO:0032869),0.29888274385981867,1.0394739089559044,0.37041719342604296,0.9553026632908467,1.0,22/124,13.09%,ENPP1;LPIN3;PIK3R1;CPEB1;PHIP;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;RAB15;PDK2;IGF2;GSK3A;ATP6V0E1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.375949822897249,1.0390619219416664,0.4052795031055901,0.9554631880002469,1.0,6/28,9.07%,PTN;AKAP5;ADCY8;CALB1;RELN;LGMN
prerank,ventricular septum morphogenesis (GO:0060412),-0.33157081699784285,-1.0390113126095015,0.3952254641909814,0.6981973826602148,1.0,15/27,22.66%,SLIT2;ROBO1;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;CITED2;HEYL;HEY2;SOX11;TGFBR3;TGFBR2;SMAD7;APLNR
prerank,hepaticobiliary system development (GO:0061008),-0.3579770383930604,-1.0388871146362835,0.368,0.6977607435697324,1.0,8/20,22.23%,ARID5B;WNT4;COBL;LSR;CITED2;MET;TGFBR3;PHF2
prerank,regulation of cell development (GO:0060284),-0.30767527462967287,-1.0385444496533849,0.3954154727793696,0.697851517688727,1.0,15/36,26.24%,FOXO1;NOTCH2;RPS19;CX3CR1;HEYL;HEY2;CX3CL1;CLOCK;BHLHE40;HMGB2;AKT1;FBXO22;BHLHE41;YTHDF2;HES6
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3682779966122993,1.0383319130199236,0.40059790732436473,0.9566864422592986,1.0,8/31,12.93%,SCRIB;DLG3;MTCL1;PARD3B;DLG2;PRKCI;OPHN1;LRRC7
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.28626758157501253,-1.0379693109543262,0.35738831615120276,0.6978114922179284,1.0,21/51,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,mitotic nuclear membrane organization (GO:0101024),-0.28626758157501253,-1.0379693109543262,0.35738831615120276,0.6978114922179284,1.0,21/51,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,cellular response to gamma radiation (GO:0071480),-0.37613085635604493,-1.037823473083086,0.4160756501182033,0.6974524810692696,1.0,6/17,16.30%,CRYAB;TLK2;ATR;RPL26;ATM;TMEM109
prerank,neutral amino acid transport (GO:0015804),0.37200143711184397,1.037789259634532,0.40435458786936235,0.9573055585298834,1.0,3/28,4.87%,SLC1A5;SLC43A1;SLC7A8
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2845753921224735,1.0375891644054422,0.3941860465116279,0.9568905369810987,1.0,42/184,18.28%,DYNLL1;CDC14B;BUB1B;PSMD1;DCTN3;HAUS3;HAUS1;FBXO5;HMMR;DCTN2;CENPE;CDC16;PSMD10;ZFP36L2;PSMA5;PSMB5;HAUS8;PRKACA;CEP192;APPL2;XPC;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;CEP250;TFAP4;CEP152;CSNK1E;CENPF;CLASP1;PSMA7;PSMD14;ALMS1;CDC26;PCM1;PSMA2
prerank,negative regulation of receptor binding (GO:1900121),-0.44768076595129014,-1.0371896491825559,0.4251781472684085,0.698305107398706,1.0,4/10,17.14%,PTPRF;B2M;ATP2A3;HFE
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2666032830754097,1.0371236359329996,0.38918345705196183,0.9572711020731755,1.0,59/390,14.07%,ROR1;COL4A6;PDGFRA;FLRT2;NTRK3;GHR;PIK3R1;EPHA7;SULF1;NRG1;ROR2;CHN1;MERTK;PTPRT;NTRK2;PHIP;ERBB4;EPHB1;GPLD1;ITGAV;CD8B;GRIN2B;FGFR1;NGFR;PIK3R2;ELMO1;SPRED1;EPHA6;IRS1;IRS2;ANKS1B;PTK2;EFS;SPRED2;PRKD1;EPHB6;AXL;COL4A2;ITSN1;CYBA;AHI1;FGR;EPHA3;FYN;MAPKAPK3;PDK2;UBASH3B;DNM1;IGF2;GSK3A;CASS4;MTSS1;ATP6V0E1;ACTR2;CRK;STMN1;GFRA2;SH2D2A;LYN
prerank,regulation of immune response (GO:0050776),0.2966632153345879,1.036912677093308,0.3880048959608323,0.9568772413454422,1.0,17/135,10.09%,COLEC12;TREML4;CD40;CD8B;PIANP;PTPN22;CD276;DHX58;SH2D1A;COL1A2;OSCAR;BCL6;CD200R1;ADCY7;APPL2;BIRC2;FGR
prerank,nitrogen compound transport (GO:0071705),0.2929376244369553,1.0369111831071791,0.40762812872467225,0.9558239687743414,1.0,19/141,12.95%,SLC1A5;SLC48A1;HRG;SLC6A13;SLC6A8;LRP1B;CALCRL;SLC7A11;SLC43A1;VAMP2;SLC7A8;RUFY1;ABCB6;TMEM30A;SEC14L1;RCN3;SLC7A3;HSP90B1;SLC25A29
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3100848149520606,1.0365617136168184,0.3994673768308921,0.9558597936299558,1.0,26/83,20.52%,CDK14;CDKN2A;FBXO5;CDC7;POLA1;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CDT1;CUL5;CDKN2C;DBF4;MYC;KLF11;CDK5;CAMK2A;CCNE1;KHDRBS1;CUL4A;TFDP1;POLE;LATS2;INHBA
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2482530771724222,-1.0365573903818794,0.323943661971831,0.6991756997222717,1.0,34/110,23.52%,FOXO1;ROCK2;WWP1;IL18;APP;KLF4;WWP2;GPC3;APC;KLF2;APOE;GSK3B;VCP;SMURF2;NFKBIA;ASB5;RNF41;APC2;AGTR1;MAP2K5;OAZ1;PAEP;RAB1A;OAZ2;AKT1;ABCB10;FZR1;AGT;RAB1B;TNFAIP3;VPS28;NDUFA13;BCL10;SMURF1
prerank,cellular protein catabolic process (GO:0044257),-0.2745698339950231,-1.0365564426433194,0.3829787234042553,0.6984316275043132,1.0,19/59,22.87%,CTSC;UBE2G1;DENND3;AP2A1;CASP8;BNIP3L;CTSO;CTSH;CLPX;PSMA6;CTSZ;AFG1L;SIAH2;YME1L1;CTSS;CLPP;AP2S1;RNF5;AP2B1
prerank,determination of bilateral symmetry (GO:0009855),-0.34027225338679057,-1.03647653862543,0.39385474860335196,0.6978944751922976,1.0,10/24,21.05%,NOTCH1;ARL6;TBX1;CITED2;GALNT11;ZIC3;MKKS;DNAH11;BBS7;DNAH5
prerank,response to lipid (GO:0033993),-0.25015849080274005,-1.0361626757134588,0.36444444444444446,0.697944888989068,1.0,21/105,13.46%,SMAD6;FOXO1;FOXP1;FER;NOS3;LBP;ACER2;PELI1;RBP4;SOCS2;ANXA1;RXRA;ALPL;IFNAR1;PAQR7;GCH1;TRIM16;CTSH;NOS1;TAB2;GATA6
prerank,heterochromatin assembly (GO:0031507),0.4072648310088746,1.036156564747867,0.4192982456140351,0.9560461011887955,1.0,3/20,5.03%,HDAC1;CDKN2A;RRP8
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4713133489571135,1.035886920261267,0.4157088122605364,0.9557990116824073,1.0,3/10,15.04%,ADGRV1;IFT88;PDZD7
prerank,phospholipid dephosphorylation (GO:0046839),0.3489381879227772,1.035843619739551,0.4015384615384615,0.9548807330197836,1.0,8/37,10.68%,PTEN;SACM1L;MTMR4;PLPPR3;MTMR1;INPP5J;PLPPR2;PLPP6
prerank,DNA methylation or demethylation (GO:0044728),0.4068742348186097,1.0357176245683455,0.42786069651741293,0.9531695651342096,1.0,8/19,22.92%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,DNA alkylation (GO:0006305),0.4068742348186097,1.0357176245683455,0.42786069651741293,0.9531695651342096,1.0,8/19,22.92%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,regulation of ATP metabolic process (GO:1903578),0.33360627469105947,1.0353691742753972,0.39622641509433965,0.9531784959824295,1.0,20/54,23.31%,OGT;NUP214;AAAS;POM121;PINK1;AK4;GCK;SLC25A33;NUP42;NUP107;ATP7A;COX7A2L;ZBTB7A;NUP54;NUP155;HIF1A;UQCC2;RANBP2;FIS1;NUP35
prerank,response to organophosphorus (GO:0046683),0.42136562504356495,1.0353417571201051,0.4082934609250399,0.9522213737306374,1.0,7/16,23.88%,DGKQ;TRPC3;RFC3;P2RX4;NDUFS4;ABCC9;STAT1
prerank,Ras protein signal transduction (GO:0007265),-0.2374411087312614,-1.0352516255460913,0.33152173913043476,0.6995135473095991,1.0,31/137,16.26%,PLCE1;IGF1;RAPGEF2;ROCK2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAP1A;RAC1;RASGRP3;RAPGEF1;MAPK14;ARHGDIB;EPS8L2;CFL1;PHACTR4;RGL2;RALB;RRAS;AGTR1;GRB2;ADGRG1;ARHGEF11;RAPGEF3;RAP2C;CDKN1A;GRAP;PDPN
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3800712901801505,1.035005253995463,0.4318555008210181,0.9521923034932718,1.0,3/25,3.79%,PDE4B;GLMN;SPTBN1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.23465212850475242,-1.0348286027005311,0.38372093023255816,0.6998429158681653,1.0,35/170,15.94%,PRDM6;IGF1;ROCK2;FOXP1;APP;CDH1;ZNF462;SIRPA;YBX3;NFKBIZ;TAPBP;CDK6;PRDM2;MEGF8;TRIM5;TRIM11;AFF4;PRDM11;NOVA2;TRIM14;APOE;MTMR9;PCBP2;CRIP1;HMG20B;UBAP2;TARDBP;HNRNPDL;YBX1;PTHLH;CIAO3;CAVIN4;TOB1;POGZ;TRIM27
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3701041852020012,1.0348260254229382,0.4102167182662539,0.9517108036575164,1.0,4/30,10.91%,XCL1;TSLP;TLR4;PYCARD
prerank,apoptotic DNA fragmentation (GO:0006309),0.4261724141532386,1.0344223293341475,0.4340567612687813,0.9519168996280375,1.0,1/16,0.46%,CECR2
prerank,autophagy of nucleus (GO:0044804),0.4289105456527622,1.0343147090564386,0.41695501730103807,0.9512005612013237,1.0,6/16,17.76%,ATG9B;WDR45B;RB1CC1;ATG9A;ULK2;WIPI2
prerank,peptidyl-serine modification (GO:0018209),-0.2313077471383696,-1.0336682788329874,0.3619631901840491,0.7020117627810082,1.0,49/166,21.19%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;CAMK2D;PRKDC;TOP1;VRK3;TLK1;MAPK9;WNK1;HIPK3;MAPK14;NTMT1;GSK3B;HIPK1;TLK2;STK38L;MAST3;DYRK2;RPS6KA5;CAB39;ATR;RPS6KA1;PRKCZ;HIPK2;ATM;CSNK1G3;GALNT1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;STK32B;AKT1;CSNK1A1;SBK1;VRK2;MARK2;ULK3;MKNK1;GALNT3;PKN3;TGFBR2
prerank,mitochondrion localization (GO:0051646),-0.36027661496294267,-1.0335523963204847,0.4014423076923077,0.7015430548206614,1.0,3/19,2.47%,MARK1;MEF2A;MTM1
prerank,chromatin organization (GO:0006325),-0.23543615846792912,-1.0335344553308918,0.375,0.7008569206345231,1.0,43/132,26.33%,MECOM;HDAC4;PBRM1;KDM4A;KDM4C;SMARCA4;SMARCA2;CBX3;TOP1;PRDM16;INO80;HDAC8;HDAC3;SMARCA5;SMARCC2;JARID2;EZH2;DDX11;SIRT1;SNAI1;BAZ1A;FAM50A;ESR1;BAZ2B;INO80C;CHD1;HMGB2;KDM4B;TADA2B;NPM1;CHD1L;SMARCD3;RUVBL2;PHF1;MTF2;HDAC11;SMARCD1;MYSM1;TAF6L;PADI2;ACTL6B;SPI1;RB1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2824007464509855,-1.032891030466518,0.41830065359477125,0.7018589425744396,1.0,18/47,26.02%,THBS1;MAPK14;XDH;MAPT;RNF41;PLCG2;AGTR1;GRB2;CDKN1A;PRKCD;ACE2;PID1;AGT;ROMO1;TGFBR2;TYROBP;CBR1;ITGB2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4266361338350408,1.0327453235613084,0.4077328646748682,0.9550546869414935,1.0,6/15,22.76%,TLR6;TLR4;EIF2AK2;MYD88;DHX33;NLRP2B
prerank,chromosome organization (GO:0051276),0.30524051539377156,1.0326044941400045,0.40784313725490196,0.9544453406308513,1.0,25/99,20.55%,HDAC1;L3MBTL1;TCF7L2;COPS3;TOP2B;MSH3;SOX2;XPC;HMGN3;CDT1;COPS4;POLE3;CENPW;HDAC10;DOT1L;MYC;ZBTB7A;LDB1;TOP2A;SAFB;MSH6;NUP155;CUL4A;GATAD1;DDB1
prerank,regulation of cell morphogenesis (GO:0022604),-0.3260020319772359,-1.0322783236118973,0.4234527687296417,0.7026095682463238,1.0,10/30,16.26%,LARP4;SPARC;CAPZB;EFNA5;CD44;CFL1;BCL9L;MACF1;MFSD2A;PDPN
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3837659597067463,1.0316793435309441,0.39708265802269044,0.9562293184809336,1.0,8/24,16.57%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1;ACTR2;AKIRIN1;CYFIP1
prerank,heart looping (GO:0001947),-0.300472431738199,-1.0316537910462487,0.40705128205128205,0.703469429453249,1.0,12/39,22.66%,MEF2C;MICAL2;NOTCH1;SMO;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,detection of calcium ion (GO:0005513),0.4406896130331975,1.0310004335929686,0.43127147766323026,0.9572784381171736,1.0,4/13,18.62%,RYR2;KCNIP2;STIM1;SYT1
prerank,error-prone translesion synthesis (GO:0042276),0.39960750718100724,1.0308189404631842,0.4324786324786325,0.9567903624898105,1.0,7/21,14.01%,POLK;RPA1;RFC3;REV3L;POLH;REV1;POLI
prerank,positive regulation of cyclase activity (GO:0031281),-0.3958508138392197,-1.030585755647155,0.4251207729468599,0.7054514330561875,1.0,5/14,12.69%,CACNA1C;NOS3;MAPK14;ORAI1;NOS1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.27193100382314156,-1.030473066068551,0.3824561403508772,0.7049677535436698,1.0,18/67,13.71%,CAV1;TBC1D19;PODXL;FER;RABEP2;RDX;TBC1D8;RAC1;TBC1D22B;CAPZB;CDC42;PPP1R16B;RAB5A;ATP8B1;IFT140;TBC1D22A;CYLD;TBC1D10B
prerank,UV-damage excision repair (GO:0070914),0.44920999375383663,1.0301174877274146,0.42439862542955326,0.9579958672220148,1.0,3/12,9.11%,ERCC1;POLA1;XPC
prerank,response to fatty acid (GO:0070542),0.4155840816519846,1.0298993872158173,0.433931484502447,0.9576615140273501,1.0,4/17,12.02%,GLDC;NR1H4;IRS1;SOX9
prerank,sympathetic nervous system development (GO:0048485),-0.3874539770239186,-1.02936089835225,0.4289340101522843,0.7069232191027266,1.0,5/15,18.24%,NRP2;NRP1;SOX4;FZD3;SOX11
prerank,regulation of axonogenesis (GO:0050770),0.33406669092167407,1.0289123283785901,0.4298375184638109,0.9595621542597738,1.0,6/51,3.83%,ROBO2;PLXNC1;CHN1;NTRK2;PTEN;NGFR
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3228636484393448,-1.0286530847432656,0.41379310344827586,0.7080670485257103,1.0,9/27,21.18%,CDC23;UBE2D3;ANAPC10;UBE2H;UBE2A;ANAPC13;ANAPC11;FZR1;ANAPC2
prerank,regulation of interleukin-4 production (GO:0032673),-0.3525882021135012,-1.0286029991766288,0.4170731707317073,0.7074342987775855,1.0,4/21,16.77%,LEF1;SLC7A5;PRKCZ;HAVCR2
prerank,synaptic vesicle endocytosis (GO:0048488),0.35769624599433236,1.0284329388720617,0.4072398190045249,0.9599980272179554,1.0,13/33,21.14%,CEL;VAMP2;ITSN1;OPHN1;SYT5;DNM1;CDK5;DNAJC6;AMPH;FCHO2;SYT1;CANX;SNAP91
prerank,response to glucocorticoid (GO:0051384),0.37348855939301306,1.0284256154417935,0.4052795031055901,0.9589813747269283,1.0,3/26,7.17%,IL1RN;REST;ZFP36L2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4054608928677727,-1.0283179592846434,0.4160756501182033,0.7074338107354318,1.0,7/12,38.41%,SETMAR;HUS1;ORC1;CHEK2;HUS1B;CDC6;TICRR
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2665415729014767,-1.0282775909339534,0.39271255060728744,0.7067694000407928,1.0,27/69,25.76%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFS6;NDUFA8;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;COA6;NDUFA1;NDUFS2;NDUFS8
prerank,defense response to tumor cell (GO:0002357),0.46959506167950693,1.0282602105982002,0.43872113676731794,0.9584814958934187,1.0,2/10,4.92%,DLEC1;RBMS3
prerank,antibacterial humoral response (GO:0019731),-0.3766574515248574,-1.0281570995164637,0.4357682619647355,0.706349434079945,1.0,6/16,36.37%,PLA2G6;RNASE7;RPL39;SLPI;RNASE3;JCHAIN
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.38118354926814624,-1.0281199211146188,0.39172749391727496,0.7056875450133572,1.0,5/15,5.51%,IGF1;ROCK2;MEF2A;CAMK2D;IL6ST
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3981320193829586,1.0278699405970566,0.43094841930116473,0.9586502777831245,1.0,10/21,18.46%,GPM6B;PEAK1;SLC9A1;PTK2;EPHA3;PTPRA;SLK;CLASP1;LDB1;RHOA
prerank,regulation of store-operated calcium entry (GO:2001256),0.46173886812083864,1.0277388383176638,0.41605839416058393,0.9579872157002335,1.0,4/10,21.37%,GRAMD2A;STIM1;HOMER3;HOMER2
prerank,chloride transport (GO:0006821),0.3166339080323915,1.0266593813446618,0.3912448700410397,0.9603312070884993,1.0,16/74,13.85%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;SLC4A1;CLCN6;GLRA2;GABRB1;LRRC8A
prerank,carbohydrate derivative transport (GO:1901264),-0.35914086728449857,-1.0266192684109117,0.3888888888888889,0.7086962112312292,1.0,4/18,13.88%,LBP;PLTP;SCARB1;MFSD2A
prerank,positive regulation of cell junction assembly (GO:1901890),0.32936104484264783,1.0262661222681047,0.4043795620437956,0.9605226626871968,1.0,10/56,9.53%,HRG;SRPX2;EPHB1;CNTNAP2;GRID2;NRXN1;MAP4K4;COL16A1;SYNDIG1;IL1RAP
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24401536896653003,-1.0262469866054673,0.37117903930131,0.7089083506841471,1.0,33/108,18.83%,TRABD2B;RSPO3;APP;SMARCA4;NXN;RNF43;RUNX1;RSPO2;OTULIN;KANK1;WWOX;SKI;GPC3;GRB10;SULF2;PPP2R1A;WLS;FZD7;FOXL1;SFRP1;CXXC4;TMEM237;TERT;MACF1;CBY1;FAM53B;ATP6AP2;VGLL4;ESR1;HHEX;TAX1BP3;SNX3;GSKIP
prerank,peptidyl-lysine modification (GO:0018205),0.2961220423595357,1.0262156220735847,0.4015645371577575,0.9596303809717964,1.0,25/99,19.68%,LOXL4;PLOD1;NUP214;LOXL3;LOXL2;AAAS;VCPKMT;POM121;VIPAS39;PIAS2;SAE1;NUP42;NUP107;P3H3;HDAC10;ATP7A;SENP6;NDUFAB1;VPS33B;NUP54;PLOD2;NUP155;USPL1;ATPSCKMT;SUMO2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2896873723705129,-1.0260250764999042,0.41590214067278286,0.7087453980239679,1.0,10/43,10.62%,IGF1;MEF2C;BMPR2;WNT4;IL6ST;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4000148823027815,1.0257124002937306,0.421474358974359,0.9601257798551052,1.0,5/20,8.67%,ATP1A2;RYR2;ATP2A2;SLC9A1;PRKACA
prerank,regulation of fatty acid oxidation (GO:0046320),0.42382017667623073,1.025607400741908,0.4187192118226601,0.9594125863893975,1.0,5/16,12.17%,PPARA;ACADL;APPL2;SOX9;FABP3
prerank,regulation of establishment of planar polarity (GO:0090175),0.309534266947867,1.0255105546989205,0.4176548089591568,0.9586498031352679,1.0,22/88,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;NPHP3;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMA7;PSMD14;PSMA2;RHOA;SPEF1;PSMD11
prerank,positive regulation of macroautophagy (GO:0016239),-0.2846831418911405,-1.0254727652212583,0.4166666666666667,0.7093917526381738,1.0,16/48,16.60%,SPTLC2;KDR;UVRAG;SESN1;PRKAA2;HSPB8;BNIP3L;OPTN;PIP4K2C;BAG3;RALB;PAFAH1B2;SLC25A5;SIRT1;TBK1;VPS13D
prerank,cellular metal ion homeostasis (GO:0006875),0.298724207510766,1.025225560100323,0.4168765743073048,0.9584716311215089,1.0,13/102,9.09%,EDN3;ATP1A2;SLC24A5;CD40;RYR2;HTR2B;ATP1A3;KCNMA1;CCL15;ATP2A2;SLC9A1;ATP13A3;HTR2C
prerank,regulation of neuron death (GO:1901214),0.310259974859918,1.0249073572139862,0.4172366621067031,0.9583837897251135,1.0,19/82,13.30%,WNT5A;EPHB1;GRID2;GRIN2B;REST;FOS;SORL1;DHCR24;LRRK2;EGLN2;C1QA;CD200R1;DCC;RAB29;DAXX;FYN;HTRA2;EIF2S1;TRIM2
prerank,bile acid and bile salt transport (GO:0015721),0.38124599852294555,1.024676212696369,0.4173354735152488,0.9580358323771466,1.0,4/24,9.04%,ABCC3;NR1H4;NCOA2;NCOA1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3293484868639492,1.0243995166293727,0.4218533886583679,0.9568707012441664,1.0,24/56,25.64%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFV2;NDUFAF7;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFAF2;NDUFB6;DMAC1;NDUFB8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3293484868639492,1.0243995166293727,0.4218533886583679,0.9568707012441664,1.0,24/56,25.64%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFV2;NDUFAF7;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFAF2;NDUFB6;DMAC1;NDUFB8
prerank,positive regulation of bone mineralization (GO:0030501),0.35522055427622157,1.0243606825343519,0.43431221020092736,0.9559557190683119,1.0,3/35,1.67%,PTN;GPM6B;ADGRV1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3451408076982819,-1.0243385486500283,0.4266666666666667,0.7116144744906157,1.0,9/21,22.59%,SLC8A3;MICU1;MCUB;SMDT1;TGM2;RAP1GDS1;MCUR1;LETM1;MCU
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.24373575912181106,-1.0243316645657687,0.39712918660287083,0.7108947703521603,1.0,34/109,19.23%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;RAC1;PSMB7;MAPK9;CUL1;MAP2K4;CALM1;MAP2K7;PSMD8;PSMD12;PIK3CB;PPP3R1;PLCG2;TAB2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;GRB2;PSMB6;PSMC1;TEC;PSMB10;PAK2;LCP2;VAV1;PSME2;SOS1
prerank,mammary gland epithelium development (GO:0061180),0.4259300499012546,1.024290294930054,0.4270833333333333,0.9551690468808797,1.0,3/14,9.92%,ERBB4;SCRIB;WNT3
prerank,neural tube closure (GO:0001843),0.3542540821950033,1.0241059212203958,0.3945371775417299,0.9547664386029029,1.0,4/34,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.33612497565867927,-1.0240089069305016,0.40458015267175573,0.7109689067132811,1.0,14/23,44.40%,TPM1;TGFBR3;PKP2;HOPX;SMAD7;DSG2;FKBP1A;TNNC1;TNNI3;IRX3;MYL3;MYH6;ID2;ISL1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.34387630271602804,-1.0238297515144898,0.428169014084507,0.7106496878714744,1.0,9/21,25.69%,ERAP1;ADAM10;RBMX;DAG1;APH1A;ADAM9;MYH9;BACE2;PSEN2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.24291967556208308,-1.0236413454761595,0.36923076923076925,0.7104219716656568,1.0,42/128,23.64%,SMAD6;DDX5;ARHGEF18;ITGB1;PTPRK;ID1;F11R;BMPR2;CLDN5;PARD3;TGFB2;SKI;MEGF8;UBB;ACVR1;ACVRL1;SMURF2;SMAD3;LRRC32;ZYX;SLC33A1;PRKCZ;SMAD1;FURIN;CDH5;SIRT1;TGFB1I1;HFE;UBC;USP9X;ACVR2B;TWSG1;TGFBR3;ADAM9;TGFBR2;NRROS;UBA52;SMAD7;INHBB;ACVR2A;SMURF1;RNF111
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4515198862171725,1.0236318976425114,0.4353146853146853,0.9552658209688044,1.0,3/12,13.84%,CLIP3;STMN2;STMN1
prerank,gene silencing by miRNA (GO:0035195),0.35883836842398176,1.0232715234334138,0.4216300940438871,0.9553558918562498,1.0,11/32,19.89%,AGO4;SPOUT1;ZC3H7B;AGO3;CNOT1;CNOT7;WTIP;ADAR;TNRC6B;AGO1;ZC3H7A
prerank,glycogen catabolic process (GO:0005980),-0.37758442365440564,-1.023237233008012,0.40384615384615385,0.7107366568724015,1.0,5/15,11.65%,PYGB;PGM2L1;CALM1;GAA;PGM2
prerank,ganglioside metabolic process (GO:0001573),-0.3496645218900255,-1.0230877437220174,0.43989071038251365,0.7103995150111817,1.0,8/20,23.36%,ST8SIA4;ST6GALNAC3;HEXB;ST8SIA2;ST3GAL5;GM2A;ST8SIA6;CLN6
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3595858846921315,-1.0226804264882152,0.43765281173594134,0.7107212268865583,1.0,3/18,0.60%,EPHA4;PICALM;ROCK2
prerank,calcineurin-mediated signaling (GO:0097720),0.46600255709497496,1.0225786259899887,0.44727891156462585,0.9554923388659151,1.0,3/10,10.49%,NFATC3;ADGRB2;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.46600255709497496,1.0225786259899887,0.44727891156462585,0.9554923388659151,1.0,3/10,10.49%,NFATC3;ADGRB2;PPP3CB
prerank,organic cation transport (GO:0015695),-0.3580412566726111,-1.0224872547727013,0.42216358839050133,0.7104816341168602,1.0,3/19,8.11%,SLC47A1;SLC22A4;RALBP1
prerank,embryonic organ development (GO:0048568),0.31885306297130245,1.022188436882845,0.430939226519337,0.9556552143718073,1.0,6/61,4.58%,COL13A1;TEAD1;FLT3LG;SALL1;TEAD2;KMT2A
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4340054807486821,-1.0221779081339764,0.434052757793765,0.7098882153083205,1.0,3/10,22.87%,AP2A1;AP2S1;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4340054807486821,-1.0221779081339764,0.434052757793765,0.7098882153083205,1.0,3/10,22.87%,AP2A1;AP2S1;AP2B1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.409308634880005,1.022154138101845,0.41522491349480967,0.9547592792495971,1.0,3/17,9.07%,CXCL10;PLA2G7;LGMN
prerank,Fc receptor signaling pathway (GO:0038093),-0.2440562695780172,-1.0221518505636864,0.40594059405940597,0.7092170600271728,1.0,34/110,19.23%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;RAC1;PSMB7;MAPK9;CUL1;MAP2K4;CALM1;MAP2K7;PSMD8;PSMD12;PIK3CB;PPP3R1;PLCG2;TAB2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;GRB2;PSMB6;PSMC1;TEC;PSMB10;PAK2;LCP2;VAV1;PSME2;SOS1
prerank,activin receptor signaling pathway (GO:0032924),-0.38609501663040846,-1.022111911375721,0.4195121951219512,0.7085777377370057,1.0,5/15,22.99%,ACVR1;SMAD3;ACVR2B;INHBB;ACVR2A
prerank,establishment of epithelial cell polarity (GO:0090162),-0.35252479106708795,-1.0220756278698464,0.40097799511002447,0.7079333886244739,1.0,4/19,5.90%,EZR;CYTH1;PARD3;CDC42
prerank,telomere capping (GO:0016233),-0.37253961291110177,-1.0218514556633187,0.4317073170731707,0.7077842370696636,1.0,6/16,15.81%,PRKDC;DCLRE1A;STN1;TEN1;NBN;DCLRE1B
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3521272234247114,-1.0213428968345626,0.4304461942257218,0.7083678580067807,1.0,8/19,23.78%,RENBP;UGDH;UAP1;UGP2;UAP1L1;PMM1;NANS;MPI
prerank,nuclear pore organization (GO:0006999),-0.39099641316092837,-1.020899786796,0.4217171717171717,0.7087607211387287,1.0,6/14,21.49%,NUP98;NUP153;TMEM170A;NUP205;SEH1L;RTN4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3338549697678068,-1.020894255423133,0.41847826086956524,0.708049381886056,1.0,11/23,20.45%,IGF1;APP;NFKB1;INSR;PRKAA2;PFKFB2;P2RX7;PRKAA1;EGF;PRXL2C;GAPDHS
prerank,substrate-dependent cell migration (GO:0006929),-0.38367842394580876,-1.020270239132484,0.4225352112676056,0.7088781375279741,1.0,6/14,11.76%,ANKS1A;NTN1;NRP1;VEGFC;ITGB1BP1;CD2AP
prerank,negative regulation of developmental growth (GO:0048640),0.36872482965359576,1.0201289307310213,0.43164362519201227,0.9598608753597939,1.0,4/30,8.54%,PTEN;NKD1;CDKL3;DCC
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3072983976790513,1.01990175872506,0.4173441734417344,0.9595307339441519,1.0,22/76,19.81%,PRICKLE1;CCDC22;PTEN;RNF180;LRRK2;PSMD10;CBFA2T3;PTK2;NKD2;ZYG11B;HECTD1;GSK3A;AXIN1;DDA1;CLU;CSNK1E;DET1;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,renal filtration (GO:0097205),0.4716397769931028,1.0195142061020959,0.44565217391304346,0.9596987336708354,1.0,3/10,9.55%,SULF1;ITGA3;TBC1D8B
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4269834161764806,1.019389552527259,0.4397905759162304,0.9590722083476835,1.0,5/14,19.47%,XCL1;PTPN22;CD81;LGALS9;RASAL3
prerank,glutathione biosynthetic process (GO:0006750),-0.4123977093852792,-1.0191775951235997,0.4580335731414868,0.7110520337978755,1.0,6/11,36.41%,GCLC;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,response to interferon-gamma (GO:0034341),0.3160552932259448,1.0191617239810578,0.41713483146067415,0.9587102267899338,1.0,10/67,10.57%,XCL1;WNT5A;CD40;EPRS1;KYNU;CCL15;PDE12;SP100;TLR4;CCL25
prerank,lipid transport (GO:0006869),0.30000692027446557,1.0190874985602218,0.42366412213740456,0.9579140746810492,1.0,8/97,4.00%,ABCA9;NPC1L1;ABCC3;ABCA6;ABCD2;NR1H4;NCOA2;PPARD
prerank,protein prenylation (GO:0018342),0.45275274006927096,1.0190530448225252,0.42783505154639173,0.9570332354390674,1.0,3/10,14.64%,PTAR1;PGGT1B;CHML
prerank,regulation of cellular respiration (GO:0043457),-0.364232550144416,-1.0185300388185894,0.44362745098039214,0.7120044225182861,1.0,6/17,16.31%,IL10RB;IFNAR1;VCP;PRDM16;PRELID1;NOA1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3094189957837912,-1.0180900764464311,0.40437158469945356,0.7124519399382653,1.0,4/34,0.60%,EPHA4;IGF1;PICALM;ROCK2
prerank,cellular response to glucose stimulus (GO:0071333),0.3638449952725268,1.01808690516947,0.4504792332268371,0.9589463074638607,1.0,5/30,8.67%,ZBTB20;TRA2B;PTPRN2;ADCY8;PRKACA
prerank,regulation of phosphorylation (GO:0042325),0.2914412339755582,1.0178026239906661,0.4290953545232274,0.9587773519749251,1.0,30/120,17.45%,DYNLL1;OGT;PHIP;SRPX2;CDKN2A;GLMN;NUP214;MCM7;AAAS;DSCAM;POM121;CDKN2D;PTK2;BMP7;GCK;GRM5;NUP42;PLXNB2;ANKLE2;NUP107;CDKN2C;LYN;ATG14;AR;NDUFS4;ZBTB7A;PRKRIP1;NUP54;LDB2;LDB1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4023128134435151,-1.017580662051753,0.43859649122807015,0.7130656032414037,1.0,4/12,22.66%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,membrane depolarization during action potential (GO:0086010),0.37514551143609554,1.0171570584283212,0.41788617886178864,0.95967613620999,1.0,9/26,21.36%,ATP1A2;SCN2B;CACNA1G;HCN2;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,androgen metabolic process (GO:0008209),0.40371651914209344,1.0171391654749646,0.43283582089552236,0.9587292408320782,1.0,3/18,17.24%,SPP1;MED1;HSD17B11
prerank,regulation of catabolic process (GO:0009894),0.39776583551634126,1.0167899658028727,0.4306930693069307,0.9587961343222408,1.0,8/18,22.98%,FAP;ODC1;HGS;SNF8;ZDHHC2;CENATAC;RARRES2;FAF1
prerank,negative regulation of chemotaxis (GO:0050922),0.3587487704911285,1.0165370025085891,0.4301242236024845,0.9585458370006047,1.0,3/31,1.98%,ROBO2;HRG;SEMA5A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3849181934587328,1.0161899955704494,0.4376012965964344,0.9585568364496646,1.0,5/24,8.47%,NAT10;ERCC4;TERF1;PIF1;TENT4B
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.3761714131032591,-1.0155931627511268,0.4267990074441687,0.717358293177481,1.0,3/16,4.37%,VIM;RUNX1;WNT4
prerank,cellular response to calcium ion (GO:0071277),0.31775650816494866,1.0155713923589873,0.4407252440725244,0.9593908022664633,1.0,22/67,18.99%,ADGRV1;WNT5A;GPLD1;ADCY8;CAPN3;RASGRP2;SYT3;LGMN;SYT7;CPNE7;TRPM2;SYT5;CPNE4;RYR3;CPNE8;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1
prerank,protein transport (GO:0015031),0.26651658260524047,1.0155274129973997,0.4365426695842451,0.9585445488661051,1.0,78/332,20.54%,LRP1;VAMP5;STEAP3;UNC93B1;GGA2;LRP1B;CALCRL;UNC119;RAB34;RAB20;RABGAP1L;TBC1D16;RABL3;COPA;SPTBN1;NGFR;ANK3;VAMP2;SEL1L;COPZ2;RAB8A;NAPB;RUFY1;RAB3C;MYO6;SYNDIG1;VIPAS39;TBC1D1;TRIM23;VPS26C;RAB29;PRKCB;TBC1D8B;SLU7;RAB24;SAR1A;VAMP4;RCN3;RAB15;SCFD1;HSP90B1;ARHGAP1;ARFIP1;ATP6V0E1;AP3D1;TBC1D9;CTTN;TMEM167A;CLU;CENPF;VPS33B;MTTP;SCAMP2;USP6NL;TMED3;TMED9;TBC1D17;MCOLN1;BBS1;TVP23B;ATP6V0D1;LTBP2;ATP6V1G2;COPG1;ATP6AP1;MIA3;SVBP;VPS45;CANX;RAB3GAP2;SCAMP3;ARL5C;COPB2;ARL4A;SCG2;UNC119B;NAPG;KIF3A
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2966060037632187,-1.0154075318905735,0.43543543543543545,0.7170983079008292,1.0,20/35,38.37%,DRG1;CHMP2B;DYNC1H1;RAE1;CHMP4B;NUMA1;PDCD6IP;CHMP1A;CHMP4C;TACC3;HSPA1A;CHMP2A;FSD1;HSPA1B;NUP62;TPR;PLK1;HNRNPU;PSRC1;CHMP3
prerank,regulation of endocytosis (GO:0030100),-0.2683730271721799,-1.0149993366049233,0.41118421052631576,0.7174023567126239,1.0,18/61,19.99%,PICALM;PACSIN2;HIP1R;MCTP1;GPC3;DAB2;APOE;RAB5A;RAB5C;PTPN1;CD151;SNX17;HIP1;SMPD1;MTMR2;RAB4A;CALY;AP2S1
prerank,regulation of T cell activation (GO:0050863),0.33350942689618324,1.0149390633328985,0.4277198211624441,0.9593417218738995,1.0,5/42,10.91%,PAG1;TNFAIP8L2;PTPN22;KAT2A;PYCARD
prerank,glycerolipid metabolic process (GO:0046486),-0.4180592757589101,-1.0144731758487544,0.45348837209302323,0.7179872584998722,1.0,5/11,20.57%,DGKG;DGKZ;PGP;PNPLA3;PIP5K1A
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3072309655661737,-1.0143654773092072,0.41975308641975306,0.7175249735140188,1.0,7/36,14.64%,CAV1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7
prerank,tryptophan catabolic process (GO:0006569),0.44747244061290065,1.0139276349692983,0.42987249544626593,0.9614267710010087,1.0,2/11,17.56%,KYNU;KMO
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3773470441987035,1.0138861145251203,0.42736486486486486,0.9605559004873898,1.0,5/23,8.79%,PTEN;SACM1L;MTMR4;MTMR1;INPP5J
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.37292727060229774,-1.0138687779836293,0.41708542713567837,0.7179812285672761,1.0,5/17,16.21%,SNTA1;ANK2;KCNQ1;NOS1AP;SCN4B
prerank,Golgi localization (GO:0051645),-0.4197066445831351,-1.01375887666728,0.451063829787234,0.7174999276898677,1.0,4/11,14.83%,UVRAG;CDC42;ARCN1;STK25
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3374234354606423,1.0137438872470415,0.45241581259150804,0.9600096610473086,1.0,6/46,5.32%,PIK3R1;TCF7L2;JUP;PIK3R2;ZIC1;NEDD4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2576591336194643,-1.0131977653584858,0.4387755102040816,0.7182119490201639,1.0,28/72,24.72%,ELF1;IRAK2;RUNX1;OTULIN;HIPK1;CASP8;MADD;PTPN2;PTPN1;CYLD;RNASEL;TNFRSF1A;CD74;IFNGR1;VRK2;TRADD;TNFAIP3;AGPAT2;USP18;CFLAR;TRAF1;BIRC3;SOCS3;IKBKB;SIGIRR;IKBKG;PTPN6;SUMO1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.34244612977343075,1.0131826280761835,0.4382716049382716,0.9606685648816011,1.0,6/40,9.69%,PTN;GPM6B;ADGRV1;FBXO5;AMELX;BMP7
prerank,regulation of intracellular signal transduction (GO:1902531),0.26086883920066106,1.0131742861672248,0.43257261410788383,0.9597062964606842,1.0,90/420,18.89%,DLC1;NTRK3;CHN1;ARHGAP22;ARHGAP32;AKAP5;TAGAP;FBXO9;HDAC1;L3MBTL1;WNT5A;NTRK2;TAF9B;PTEN;TRAF4;ARHGEF3;ITGAV;PIP4K2A;RHOJ;TAF12;AKAP7;ABR;MAP4K4;ARHGAP6;PDPK1;PIK3R2;SPRED1;ENTPD5;RAC3;PRR5;PTPN22;ARHGAP24;ANKRD54;CHD4;LRRK2;CAPN3;MBD3;TAF15;ARHGEF6;RPA1;TAF3;PTPN13;MDM4;NOC2L;MTOR;ITSN1;BIRC2;DAXX;RFC3;ARAP2;OPHN1;ARHGAP4;TP53;PYCARD;RCN3;TOP3A;ARHGAP31;ARHGAP35;SSRP1;ARHGAP1;FAM13B;PREX1;AKAP6;CRK;LYN;ARHGEF19;GPAT3;PRKAR1A;RRS1;ARAF;SGK1;TNIK;CSNK2A2;FGD2;MAPK11;CDK5;PAK5;RHOG;A2M;CASTOR1;WRN;TTI1;TAF10;SYDE1;ARHGAP29;BRD7;RHOA;WWC1;ULK4;KALRN
prerank,myelination in peripheral nervous system (GO:0022011),-0.4027896455048632,-1.0131595198973062,0.46539379474940334,0.7175733118417449,1.0,4/13,6.78%,ADGRG6;PARD3;SKI;DICER1
prerank,indolalkylamine catabolic process (GO:0046218),0.45475052902063096,1.0122141863557341,0.44567219152854515,0.9615674937946495,1.0,2/10,17.56%,KYNU;KMO
prerank,protein-DNA complex assembly (GO:0065004),0.2917320362698847,1.0119617898574669,0.44036697247706424,0.9613109262814576,1.0,32/116,18.81%,TCF4;PSMD1;MCM7;NAP1L3;ERCC5;PSMD10;ASF1A;GMNN;PSMA5;RPA1;PSMB5;CHAF1B;SPTY2D1;XPC;DAXX;PSMC4;MCM4;PSMA4;NAP1L1;PSMC5;GTF2H3;SOX9;CDT1;PSMB9;ERCC2;GTF2H1;ORC2;PSMA7;PSMD14;PSMA2;CUL4A;PSMD11
prerank,positive regulation of neurogenesis (GO:0050769),0.3141447729516625,1.0118313491007602,0.4324693042291951,0.9606864157487146,1.0,12/68,11.47%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;CAPRIN1;SERPINF1;DISC1;CDKL3;NAP1L1;PLXNB2;SNW1
prerank,protein kinase A signaling (GO:0010737),-0.3995295958459519,-1.0114173295882978,0.4410377358490566,0.7211461790767899,1.0,3/12,10.26%,EZR;RDX;RAB13
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2889799363132327,-1.0111844515540254,0.41233766233766234,0.7209853542856097,1.0,13/40,20.69%,LBP;GBP7;DROSHA;GBP4;GBP2;PGLYRP1;GBP6;RNASE7;MPEG1;HMGB2;PPP1R11;CHGA;ROMO1
prerank,phospholipid homeostasis (GO:0055091),0.45378820230201167,1.010838225997414,0.46808510638297873,0.9626496289412142,1.0,3/11,21.46%,RCN3;FABP3;TLCD1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.40549691670670257,1.0107843855136607,0.4617996604414261,0.9618229168704776,1.0,4/19,8.47%,NAT10;TERF1;PIF1;TENT4B
prerank,replication fork processing (GO:0031297),-0.29558381520936794,-1.0104401235309832,0.45808383233532934,0.7221873858558318,1.0,16/38,27.97%,SAMHD1;THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;ALYREF;CDK9;SETMAR;RFWD3;ZRANB3;RAD51;CENPX;GEN1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.355746163776766,1.0099747206226917,0.4153605015673981,0.9632081577155995,1.0,3/34,4.96%,XCL1;WNT5A;PTPN22
prerank,membrane organization (GO:0061024),-0.217801265952944,-1.0097928919199384,0.4,0.7231080785087898,1.0,68/227,23.26%,MYOF;PICALM;FNBP1L;LEMD3;EGFR;ACTB;AGFG1;PACSIN2;STX18;HIP1R;SYT9;HSPA8;ACTG1;CERT1;DAB2;CHMP2B;TFRC;MITD1;EPN2;FZD4;VAPA;UBB;RAB5A;DNM3;ANK2;AP2A1;VAPB;NAPA;CLTB;GAPVD1;CCDC88A;USO1;GAK;GCA;HIP1;REEP3;TOR1A;IGF2R;GRB2;TMEM170A;SYNJ1;DYSF;CHMP4B;CHMP4A;CHMP7;UBC;SYNGR2;WASL;REPS1;EGF;SNX3;ADRB2;PDCD6IP;AP2S1;CHMP1A;GLTP;A4GALT;TOR1AIP1;COX18;CFTR;UBA52;TMEM33;AP2B1;ARPC5;PIK3C2A;CHMP4C;ARPC4;OXA1L
prerank,regulation of multicellular organism growth (GO:0040014),0.41465803100222587,1.0097479973409633,0.41681574239713776,0.9629414511921104,1.0,1/15,0.31%,GHR
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3717890109857565,1.009703206540929,0.45354330708661417,0.9621009924979206,1.0,4/28,4.57%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45725700684302817,1.009459364807213,0.4558058925476603,0.9618776327006422,1.0,3/10,18.50%,HNMT;DMGDH;SLC44A1
prerank,positive regulation of protein import (GO:1904591),0.3664588300867304,1.0093483360579703,0.4411302982731554,0.9612242173868168,1.0,4/30,4.57%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,response to organic cyclic compound (GO:0014070),0.3272726928127646,1.0093289025413066,0.4484240687679083,0.9603163874810698,1.0,7/52,7.12%,GGT5;GLDC;GGT7;KYNU;SPP1;LRRK2;CDKN2D
prerank,negative regulation of catabolic process (GO:0009895),0.33647358255468096,1.0087189791604314,0.43636363636363634,0.9610953512790414,1.0,7/47,8.09%,PPARA;PFKFB1;ADGRB1;CBFA2T3;MDM4;CIDEA;BSCL2
prerank,sensory perception of chemical stimulus (GO:0007606),0.4190338624067782,1.008323368001294,0.4619289340101523,0.9613181307924741,1.0,2/15,6.50%,C5AR1;ADCY3
prerank,cholesterol transport (GO:0030301),0.33783800762871635,1.008317030853541,0.44413012729844414,0.9603626778164909,1.0,11/45,19.36%,NPC1L1;CEL;LIPC;SOAT2;ABCA5;RELCH;SERAC1;CLU;LDLRAP1;OSBP;NPC2
prerank,primary alcohol metabolic process (GO:0034308),0.3696020180819429,1.0082921137101584,0.43846153846153846,0.9594849542007224,1.0,3/25,2.38%,ADH1A;RDH10;RDH11
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3736278156214047,-1.0082803192937044,0.45073891625615764,0.7263415632497197,1.0,3/15,7.21%,PLTP;SCARB1;APOE
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.26549347216841057,-1.008128546763325,0.43795620437956206,0.7259584352375217,1.0,22/61,19.03%,PRKAG2;CAV1;PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;SIRT1;PSMB10;OAZ2;SIRT5;PSME2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.25008946128274534,-1.008057283539544,0.4262295081967213,0.7254191066531426,1.0,25/82,18.28%,EPHA4;ROCK2;ANKS1A;SIPA1L1;ACTB;ARHGEF28;EFNB2;ACTG1;EPHB4;RAC1;CDC42;EFNA5;EFNB1;AP2A1;NGEF;GIT1;EPHB2;APH1A;APH1B;EPHA2;YES1;RASA1;WASL;EPHB3;SDCBP
prerank,calcium import into the mitochondrion (GO:0036444),-0.42126183317169713,-1.0080568030024457,0.43488372093023253,0.7246956469654542,1.0,5/10,22.59%,MICU1;MCUB;SMDT1;MCUR1;MCU
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3374041485667072,-1.008029594781935,0.44808743169398907,0.7240328389391246,1.0,3/21,6.91%,FOXP1;PRKCH;SLC39A10
prerank,P-body assembly (GO:0033962),0.4374868549983315,1.0076147495949526,0.4506283662477558,0.960456187378669,1.0,4/12,13.86%,LSM14A;LSM4;EDC3;EIF4ENIF1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25754973923531915,1.007592006564827,0.474120082815735,0.9595537557006663,1.0,120/497,19.42%,ENPP1;ZEB1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;HDAC1;L3MBTL1;WNT5A;NR2F2;TCF7L2;BASP1;EIF4A3;SALL1;NANOS3;CDKN2A;THRA;EPRS1;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;LSM14A;SCML4;MDFIC;RUNX1T1;ZNF423;FMR1;ZBTB16;CAPRIN1;TLE2;FOXS1;BCOR;CAPN3;CALCA;CBFA2T3;GMNN;BRMS1;PAX9;BCL6;TERF1;ZKSCAN3;PER2;TWIST1;L3MBTL4;TLE1;DAXX;BMP7;GLI3;EIF2AK2;EIF2AK1;TP53;ZC3H8;MPHOSPH8;DHX36;ZFPM2;SNW1;DAP;EPC1;ZNF318;SOX9;TWIST2;PDCD4;GSK3A;DPF2;HIC2;BTAF1;CNOT1;PHC1;PRDM5;ZMYND15;MALSU1;HDAC10;EIF4ENIF1;PUS7;KDM5C;TSPYL2;CREB3L1;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;CNOT7;CRY2;CENPF;ZHX3;SPINDOC;TSC1;ZBTB7A;CBFA2T2;IGF2BP3;NONO;MBTD1;CIART;NR1D2;CALR;CDK5;MBD2;LDB1;SUV39H2;BMP2;MBD1;KAT7;HEY1;BRD7;ILF3;KHDRBS1;DEDD2;PEX14;THAP7;EIF2AK3;CREBZF;FXR1;NACC1;IKZF4
prerank,positive regulation of heart rate (GO:0010460),0.4211474352342378,1.0075653622944336,0.4567901234567901,0.9586680827017238,1.0,3/17,5.93%,EDN3;RYR2;ATP2A2
prerank,mRNA stabilization (GO:0048255),0.3380356066787765,1.0075513135507113,0.44610778443113774,0.9577403060205186,1.0,12/40,17.68%,RBM24;DND1;BOLL;ELAVL4;TAF15;PAIP1;TENT5A;EIF4ENIF1;DHX9;GDNF;TIRAP;MYD88
prerank,response to calcium ion (GO:0051592),0.29345210238780856,1.007538655745467,0.45663265306122447,0.9568108903639441,1.0,29/102,19.44%,ADGRV1;WNT5A;GPLD1;RYR2;NEDD4;KCNMA1;KCNIP2;ADCY8;CAPN3;RASGRP2;SYT3;TRPC3;LGMN;SYT7;CPNE7;TRPM2;SYT5;CPNE4;RYR3;CPNE8;STIM1;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1;TRPC1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3370555129168272,-1.007469769544053,0.4198473282442748,0.724731770352566,1.0,8/21,13.93%,AMPD3;NUDT3;NUDT4;XDH;NUDT7;NT5E;ACAT1;HINT1
prerank,protein deacylation (GO:0035601),0.3803748962688498,1.0073986631332563,0.43829113924050633,0.9562521492196735,1.0,6/23,13.60%,HDAC1;SIRT6;ABHD17C;ABHD17B;LYPLA2;HDAC10
prerank,histone monoubiquitination (GO:0010390),0.3700235375659881,1.0073386114949752,0.4274193548387097,0.9554739959752261,1.0,4/24,9.25%,RNF40;BCOR;TRIM37;RNF168
prerank,adipose tissue development (GO:0060612),-0.4099664967739653,-1.0073232040216613,0.43387470997679817,0.7243989330629695,1.0,3/11,7.13%,SPTLC2;ARID5B;SH3PXD2B
prerank,response to cytokine (GO:0034097),-0.23122946042534176,-1.0069048921993824,0.4556213017751479,0.7246828930594034,1.0,23/141,10.31%,ALDH1A2;DPYSL3;LEF1;BCL2L1;HDAC4;APP;MCL1;IRAK2;PTPN4;PTPN14;IL1R1;ANXA1;IL6ST;ADAM10;IFITM3;CASP3;GCH1;SMAD3;MAP2K7;CASP8;IFITM1;KLHL20;PTPN2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.31136910979072685,-1.0066269477020309,0.42857142857142855,0.7239922966075445,1.0,12/31,28.24%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;POLR2K;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.31136910979072685,-1.0066269477020309,0.42857142857142855,0.7239922966075445,1.0,12/31,28.24%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;POLR2K;CMTR2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4337048838654799,1.0061900983830863,0.45200698080279234,0.9579050689703527,1.0,1/12,0.79%,XCL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.2534451859110275,-1.0061847205226957,0.3983402489626556,0.7243604192494083,1.0,21/80,16.65%,DAPK1;FNIP1;XIAP;THBS1;ARL6IP5;KLF4;TNFSF10;MAP3K5;UACA;NGF;PPM1F;CD44;LAMTOR5;BAD;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIRT1;GPER1;SIAH2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4181398937400742,-1.0061416015604905,0.4634703196347032,0.7237392897782984,1.0,7/11,20.48%,CD200;THBS1;CD34;GATA6;PTGS2;ATP6AP2;CD46
prerank,histone H3-K4 trimethylation (GO:0080182),0.43726854581317903,1.0058651306360893,0.47309833024118736,0.9578718154834868,1.0,2/11,4.58%,OGT;KMT2A
prerank,signal release from synapse (GO:0099643),0.34095937337042925,1.0051226519160545,0.4622222222222222,0.9590906790433195,1.0,13/43,18.62%,NRXN2;PTPRN2;NRXN1;VAMP2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,regulation of hormone secretion (GO:0046883),0.4182092419897936,1.0046850870233413,0.4652317880794702,0.9594215206544171,1.0,2/15,4.67%,EDN3;VAMP2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.31856563050948233,1.0037868229758418,0.46164383561643835,0.9610465266146787,1.0,14/54,16.89%,DPP6;DPP10;KCNIP1;NEDD4;KCNMA1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3;AKAP6;GNG2;GABBR2;KCNJ10
prerank,negative regulation of cytokine production (GO:0001818),0.27916499590598454,1.0036765331811783,0.45892018779342725,0.9604222192901438,1.0,23/163,12.41%,APOD;XCL1;PPARA;TRAF3IP1;ABCD2;NR1H4;PTPN22;PDCD1LG2;TLR6;DHX58;TLR8;CIDEA;CD200R1;AXL;NAV3;ADCY7;APPL2;TLR4;TNFRSF21;PYCARD;ASB1;IL12A;PDCD4
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.31886463915439117,1.003454229904851,0.4642857142857143,0.9601154835244224,1.0,10/56,12.47%,CLEC4E;UNC93B1;TLR6;TLR8;LGMN;TLR4;IRAK1;MAPKAPK3;S100A1;HSP90B1
prerank,regulation of filopodium assembly (GO:0051489),0.33568765926560307,1.0030970295739206,0.45058139534883723,0.9601800635007798,1.0,8/38,11.67%,PIK3R1;ABITRAM;MYO10;FSCN1;FMR1;TENM2;TENM1;TRPM2
prerank,regulation of MAPK cascade (GO:0043408),0.2764108841019411,1.0030100882634312,0.44196951934349354,0.9594847645897143,1.0,15/157,6.09%,ROR1;NTRK3;EPHA7;ROR2;NTRK2;EPHB1;FGFR1;MAP4K4;GPR37L1;DUSP1;PIK3R2;YWHAZ;SPRED1;NF1;PSMD10
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.24862443681620205,-1.0028050128031112,0.4595744680851064,0.7312852875505064,1.0,19/86,15.68%,BAIAP2L1;OCLN;FER;APP;DRG1;RAC1;NCK1;APOE;MAPT;GPX1;ARL2;SLAIN2;LMOD1;TRPV4;PTK2B;BAIAP2;CX3CL1;EDN1;MET
prerank,calcium ion transport (GO:0006816),0.2933216453532624,1.0027777849418464,0.4630102040816326,0.9592275309938241,1.0,18/113,11.67%,TRPA1;SLC24A5;CACNA1E;NALCN;CALCRL;MCOLN2;ITGAV;ITPR1;CACNG3;RYR2;ATP2A2;CACNA1G;TRPV3;TRPC3;FYN;P2RX4;TRPM2;TRPC7
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3330799660402718,-1.0027506055374642,0.44963144963144963,0.7307049927412905,1.0,6/23,14.38%,NMI;UACA;CCN3;IFI35;CYLD;TMSB4X
prerank,atrial septum development (GO:0003283),-0.38576905349148966,-1.0026849622348544,0.4418052256532066,0.7301514921360668,1.0,5/13,12.73%,NOTCH2;BMPR2;TGFB2;ANK2;HEY2
prerank,regulation of cell differentiation (GO:0045595),0.2784080248589062,1.002613076185431,0.4553140096618358,0.9587777865634735,1.0,34/148,17.13%,ZFHX3;TRPS1;RUNX2;EDN3;PTPRQ;FGFR1;PHLDB1;ST7;REST;NF1;SRF;FLOT2;BCL6;PTK2;PRKACA;PRKCB;DDX17;BIRC2;OCIAD1;EPHA3;EIF2AK2;MCRIP1;TGFBR1;IGF2;SMYD5;CLASP2;AR;GDNF;FGFR2;CLASP1;MAFB;TRIP4;NR1D2;TAF8
prerank,iron ion transmembrane transport (GO:0034755),0.43756835636061336,1.0024770905937612,0.4509090909090909,0.9582113346734583,1.0,4/10,17.97%,SLC25A37;ABCB6;ABCB7;SLC39A14
prerank,stress-activated MAPK cascade (GO:0051403),-0.2637419003856248,-1.0024579869459855,0.4336569579288026,0.7299968362747523,1.0,22/61,24.35%,NFKB1;IRAK2;MAP3K5;MINK1;MAPK9;CUL1;MAP2K4;MAPK14;UBB;MAP2K7;MAP3K8;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKB;TAOK2;IKBKG;NOD2
prerank,membrane repolarization (GO:0086009),0.41261310046343874,1.0018047460957538,0.4469964664310954,0.9592259941088155,1.0,3/15,10.97%,ATP1A2;KCNIP2;KCNE4
prerank,cardiac ventricle development (GO:0003231),0.39347794158368504,1.0017729052522264,0.46570972886762363,0.958366801826707,1.0,7/20,18.37%,SALL1;TMEM65;MDM4;HECTD1;DAND5;GJA5;HEY1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.29798047584028664,1.0015377416717859,0.4426877470355731,0.9581481585454074,1.0,25/84,19.24%,NTRK2;EIF4A3;NANOS3;EPRS1;LSM14A;FMR1;SORL1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;EIF4ENIF1;PUS7;RTN2;CLU;CNOT7;TSC1;IGF2BP3;RTN3;CALR;ORMDL3;ILF3;EIF2AK3;FXR1
prerank,sulfur compound biosynthetic process (GO:0044272),0.2950154501524131,1.00151008939156,0.4338896020539153,0.9572753675536873,1.0,13/104,7.79%,DCN;GGT5;LUM;BGN;GGT7;DSE;SLC35B3;VCAN;B4GALT2;GSTO2;B4GALT3;GSTA3;PAPSS2
prerank,regulation of cell growth (GO:0001558),-0.21643035386311144,-1.0009634552778053,0.48360655737704916,0.7331188745444612,1.0,68/204,24.37%,PLCE1;APBB2;PTPRJ;SLIT2;EGFR;FHL1;LTBP4;NET1;BMPR2;SMARCA4;OSGIN2;SMARCA2;CAMK2D;TGFB2;SOCS2;CCN3;SH3BP4;TFRC;ADAM10;CDC42;PPP2R1A;IP6K2;PRDM11;ACVRL1;SOX17;SMAD3;NPR1;HYAL1;SFRP1;INO80;FAM107A;RPS6KA1;CEACAM1;ENO1;EXOSC2;MFSD2A;AGTR1;CDKN2AIP;ARHGEF11;CDKN1A;SIRT1;PABIR1;VGLL4;OGFR;DCUN1D3;RBBP7;ERBB2;AKT1;SDCBP;APBB1;WNT11;RERG;CIB1;AGT;LGI1;RTN4;SPHK2;CCAR2;BTG1;NDUFA13;CDA;CISH;NUBP1;PAK4;TAOK2;MT3;HYAL2;BAP1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.25441843699864986,-1.0008017531607274,0.4323308270676692,0.7328373951196384,1.0,22/75,18.27%,TEK;NRP2;NRP1;BMPR2;ECM1;KDR;JCAD;VEGFD;VEGFC;PPP1R16B;GATA2;NR4A1;PIK3CD;FGFBP1;MDK;ITGB3;FLT4;AGTR1;SIRT1;HMGB2;AKT1;EGF
prerank,ureteric bud development (GO:0001657),0.3995693917698565,1.0007497344733276,0.4451939291736931,0.9585674443660904,1.0,2/17,2.53%,ROBO2;SALL1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.35317683792303234,-1.0004333863904638,0.4386792452830189,0.7330625318544299,1.0,6/17,24.35%,ARL6IP5;TGFB2;STK25;MID1;TAOK2;NOD2
prerank,protein processing (GO:0016485),0.29521518170067684,1.0002451068892975,0.4624203821656051,0.9591237405020916,1.0,15/102,12.42%,ECE1;ECE2;OGT;PCSK2;KLKB1;ADAM19;CASP4;OMA1;CPM;FXN;LGMN;PITRM1;SEC11A;HTRA2;SPRTN
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.367591451961645,0.9999986172981425,0.46645367412140576,0.9588631348930045,1.0,2/25,1.70%,XCL1;WNT5A
prerank,protein localization to nucleus (GO:0034504),0.29495608836552145,0.9998193466607185,0.4573934837092732,0.9584383268482688,1.0,26/102,18.72%,PRICKLE1;CSE1L;NUP214;FAM53C;NUTF2;POM121;TAF3;APPL2;FAM53A;BMP7;MSX1;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;RRS1;ZBTB7A;TNPO2;CALR;TAF8;IPO9;CTDNEP1;WRN;NUP155;KPNB1
prerank,anion transmembrane transport (GO:0098656),0.3120276722724422,0.9997281257862759,0.4544198895027624,0.9577460980275349,1.0,6/67,4.87%,SLC1A3;SLC6A13;SLC6A8;SLC16A12;SLC25A21;SLC7A8
prerank,cell cycle G1/S phase transition (GO:0044843),0.31362957399769625,0.9994726097829759,0.45670391061452514,0.957535563452824,1.0,21/61,21.61%,CDKN2A;CDC7;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CUL5;CDKN2C;DBF4;CCNA2;MYC;CAMK2A;CCNE1;KHDRBS1;CUL4A;POLE;LATS2;INHBA;CDK7
prerank,apoptotic cell clearance (GO:0043277),0.36205085235595696,0.9994320462304641,0.456656346749226,0.9567044457961261,1.0,5/30,7.91%,LRP1;ITGAV;TXNDC5;ADGRB1;XKR6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3262590301006383,0.9994284542611659,0.4553314121037464,0.9557698524439024,1.0,5/47,5.46%,HRG;RECK;SPOCK3;SORL1;SERPINF1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.28073805955635306,0.9992516971247638,0.46163215590742995,0.9553535741820854,1.0,25/140,13.18%,DLC1;CHN1;ARHGAP22;ARHGAP32;TAGAP;ARHGEF3;ITGAV;RHOJ;RABL3;ABR;ARHGAP6;PIK3R2;RAC3;ARHGAP24;ARHGEF6;RELN;ITSN1;ARAP2;OPHN1;ARHGAP4;ARHGAP31;ARHGAP35;ARHGAP1;FAM13B;PREX1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2931219829339897,0.9992228514425235,0.45466321243523317,0.9545031557917063,1.0,24/94,19.99%,DYNLL1;DCTN3;HAUS3;HAUS1;DCTN2;HAUS8;PRKACA;CEP192;CEP135;AHI1;TCTN2;SSNA1;TMEM67;IQCB1;SCLT1;CEP250;CEP152;CSNK1E;CLASP1;ALMS1;PCM1;MKS1;TUBA1A;CEP43
prerank,coenzyme A metabolic process (GO:0015936),0.4164854149708629,0.9991264859278134,0.4638447971781305,0.9538674065116922,1.0,5/14,21.63%,COASY;ACOT7;ACLY;PANK2;SLC25A16
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3803378742961076,-0.9990667404136078,0.4743276283618582,0.7357506373025263,1.0,4/13,10.98%,CACNA1C;ANK2;GJC1;KCNQ1
prerank,positive regulation of filopodium assembly (GO:0051491),0.36688766917485943,0.9989877241015424,0.47416413373860183,0.9533307866117425,1.0,5/24,9.15%,PIK3R1;FSCN1;FMR1;TENM2;TENM1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.39899675885263713,0.9988745052229702,0.4573913043478261,0.9527008253430999,1.0,2/19,6.59%,CHRNB4;COLQ
prerank,DNA biosynthetic process (GO:0071897),0.4241199716087958,0.9985163592171441,0.4666666666666667,0.9527185824240292,1.0,7/16,19.87%,POLA1;CDKN2D;POLL;RFC3;POLH;WRN;POLE
prerank,lipid translocation (GO:0034204),-0.3355785538490246,-0.9977501356858373,0.44562334217506633,0.7383120510623938,1.0,4/21,8.54%,ATP10A;ATP8A1;ATP11B;ATP8B1
prerank,protein deacetylation (GO:0006476),0.3319373930948047,0.9976925579803353,0.45918367346938777,0.9541553276665505,1.0,6/41,7.08%,MIER2;HDAC1;MORF4L1;SIRT6;BRMS1L;BRMS1
prerank,manganese ion transport (GO:0006828),0.41657479380088136,0.9975443687038905,0.47058823529411764,0.9536391706350703,1.0,6/14,19.44%,SLC30A10;TRPC3;TRPC7;SLC39A14;ATP2C1;TRPC1
prerank,thymus development (GO:0048538),-0.38116412002558653,-0.9966843118993107,0.435,0.7402777484380415,1.0,3/13,17.96%,SIX1;TBX1;EPHB3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3135123673066444,-0.9966480415788459,0.44598337950138506,0.7396416535734096,1.0,6/26,12.66%,IGF1;LMCD1;GSK3B;DYRK2;CAMTA1;PLCG2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3573632127710352,0.9965490406045001,0.46214511041009465,0.9555160775942786,1.0,13/29,24.05%,COPA;COPZ2;COPB1;COG6;COG1;TRAPPC10;GOLGA5;COPG1;COPB2;NAPG;RAB33B;COPZ1;GOSR1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3833269993288707,-0.9965410975777418,0.45925925925925926,0.7391605430554324,1.0,7/14,17.38%,SEMA7A;MAVS;PLCG2;TICAM1;SIRT1;CD74;LAPTM5
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.36717671353987424,0.9963003358937286,0.4849445324881141,0.955294933382795,1.0,5/26,9.07%,MEIS2;CCDC57;RPS6KB1;PRKCA;LGMN
prerank,diol biosynthetic process (GO:0034312),-0.365044603266146,-0.9960284328173348,0.4488778054862843,0.7396950216319891,1.0,4/15,8.26%,SPTLC2;ACER2;ACER3;GCH1
prerank,regulation of dephosphorylation (GO:0035303),-0.36642199169529904,-0.9957947342962474,0.47115384615384615,0.7395627528782478,1.0,5/15,12.96%,SMG6;PPP1R16A;MTMR9;PPP1R16B;SMG5
prerank,negative regulation of interleukin-17 production (GO:0032700),0.45069207208920525,0.9957273606747391,0.4573502722323049,0.9559796440322555,1.0,3/10,21.56%,TLR4;IL12A;DDIT3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.41119838056803837,0.9954587623551496,0.4634551495016611,0.9558463157038896,1.0,6/16,20.08%,NECAB2;PRKCA;GSK3A;MRAP;SLC39A14;PDE6H
prerank,positive regulation of ion transport (GO:0043270),-0.2719537699373258,-0.9951002609130083,0.45141065830721006,0.7406437689009729,1.0,12/48,19.73%,ANO6;ACTN2;FHL1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7;SCN4B;DLG1;PKP2
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3378318756294659,-0.9950518317796222,0.49144254278728605,0.7400357419374939,1.0,4/21,6.14%,ROCK2;KLF7;RUNX1;ERRFI1
prerank,cellular response to interleukin-1 (GO:0071347),-0.2266199193964063,-0.9950133791612257,0.48520710059171596,0.7394144445476992,1.0,35/143,15.39%,PLCB1;NFKB1;IRAK2;PSMC6;SIRPA;SQSTM1;IL1R1;PELI1;PSMD9;PSMF1;PSMB7;CUL1;TOLLIP;UBB;GBP2;PSMD8;RPS6KA5;RC3H1;HYAL1;PSMD12;SFRP1;NFKBIA;RBMX;MAP3K8;TAB2;PSMA3;PSMA6;PSMD4;IRAK4;PSME3;PSMD7;UBE2N;PSMB6;CX3CL1;PSMC1
prerank,positive regulation of apoptotic process (GO:0043065),-0.20791911581286046,-0.9943764940724744,0.5252525252525253,0.7402469401884496,1.0,85/293,22.61%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;TPD52L1;ITGA6;MCF2L;TNFSF10;HIP1R;IGFBP3;SQSTM1;MAP3K5;FAS;TGFB2;CYP1B1;UNC13B;APC;ATF6;CRADD;JMY;UBB;SOX4;IP6K2;NGF;PRDM11;CASP2;SIK1;CASP3;NGEF;CASP8;BAD;SFRP1;BAX;BNIP3L;TNFAIP8;ADAMTSL4;MYBBP1A;BID;APH1A;TGM2;TLE5;GADD45B;PTRH2;APH1B;ATM;BOK;PLEKHG2;ING4;ARHGEF11;STK17B;TRIM35;SMPD1;SIRT1;GPER1;ING5;AIFM1;DCUN1D3;UBC;MAP3K10;TFPT;APBB1;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;RASGRF2;GADD45G;TRADD;ARHGEF12;E2F1;SPHK2;CCAR2;BTG1;DDX20;NUPR1;UBA52;TIAM1;ARHGEF1
prerank,aerobic electron transport chain (GO:0019646),-0.25948648844107103,-0.9942592651136928,0.4691358024691358,0.7398093949452156,1.0,26/68,25.76%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFS6;NDUFA8;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;NDUFA1;NDUFS2;NDUFS8
prerank,regulation of monocyte differentiation (GO:0045655),0.417258520940219,0.9937892300503641,0.4653130287648054,0.9597244976456765,1.0,1/14,0.31%,IL34
prerank,signal transduction by p53 class mediator (GO:0072331),-0.30809976202073897,-0.9935887742782407,0.45,0.740784023891686,1.0,9/30,14.36%,DDX5;PPP1R13B;ACER2;NDRG1;JMY;MYBBP1A;BOK;HINT1;NBN
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3519228498168033,-0.9935387805620502,0.45707656612529,0.7402100113175603,1.0,7/18,15.22%,FOXC2;KDR;JCAD;ANXA1;GATA2;FGFBP1;PTGS2
prerank,negative regulation of viral genome replication (GO:0045071),-0.2863503595250928,-0.9931709980475808,0.47416413373860183,0.7404235228084167,1.0,12/40,25.63%,MAVS;IFITM3;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;ISG15;IFIT1;IFITM2;BANF1;TRIM6
prerank,aminoglycan catabolic process (GO:0006026),0.3590042734004277,0.9931265562612852,0.4485981308411215,0.9607156649639688,1.0,7/28,15.45%,HSPG2;GPC4;GPC5;GNS;GUSB;IDUA;SDC2
prerank,histone lysine methylation (GO:0034968),0.34926251405288794,0.9927556906038798,0.46904024767801855,0.9608518359163276,1.0,14/33,23.21%,KMT2A;CXXC1;WDR5;DYDC2;PRDM5;DOT1L;PAXIP1;N6AMT1;ASH2L;SUV39H2;EHMT2;MEN1;RBBP5;KDM6A
prerank,cellular response to UV-A (GO:0071492),0.44069350354154874,0.9927552701630282,0.46853146853146854,0.9599234766545727,1.0,1/11,1.67%,PPID
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3790425400627491,-0.9925900473522522,0.4539170506912442,0.7411947184079916,1.0,4/13,13.55%,ZDHHC21;ETS1;MDK;FUT9
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3933248996728906,0.9924105109600896,0.4551386623164764,0.9600399772507342,1.0,6/18,15.40%,PEX2;NF1;TP53;B4GALT7;MED25;MYC
prerank,cellular response to organic substance (GO:0071310),-0.23463857929725715,-0.9922481930536382,0.480225988700565,0.7413338782570457,1.0,42/116,23.68%,DPYSL3;LEF1;SLIT2;IL18;ARL6IP5;IGFBP5;KLF4;BMPR2;PTPN4;PTPN14;CYP1B1;SOCS2;RAMP1;ACVR1;ACVRL1;SMAD3;SFRP1;PTPN2;SLC1A1;NOS1;CPNE3;RAMP2;PLK5;MAP2K5;FLT3;TBK1;ACVR2B;ERBB2;CDK9;NDOR1;PID1;PTPN5;DCPS;CIB1;HDAC6;TGFBR2;TWF2;CSF1R;ACVR2A;MME;SIGIRR;EMD
prerank,phosphate-containing compound metabolic process (GO:0006796),0.268994481760664,0.9920263519997408,0.48842592592592593,0.9601696882831777,1.0,26/198,10.49%,ENPP1;EPHA7;PLA2G2C;THNSL2;PTEN;PIP4K2A;PFKFB1;DUSP12;HTR2B;LRRK2;IPMK;NADK;GFPT2;PLPPR3;ALDOB;ENPP3;PI4KA;PFKM;INPP5J;MTOR;PLPPR2;ACYP2;PLAA;GCK;GK;PPP3CB
prerank,regulation of osteoclast differentiation (GO:0045670),0.35681465964051806,0.9917152376129388,0.445141065830721,0.9601280165861618,1.0,9/33,17.83%,MTOR;TLR4;CAMK4;UBASH3B;BGLAP;LRRC17;FBN1;MAFB;GPR137B
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.33171965794127256,-0.9914280539415085,0.480719794344473,0.7426621107957747,1.0,3/22,0.60%,EPHA4;PICALM;ROCK2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.44748216973007926,0.9913727712227971,0.47794117647058826,0.9601744233885482,1.0,3/10,10.52%,GABRA1;GABRG3;GABRG2
prerank,regulation of cellular metabolic process (GO:0031323),0.32692575691010634,0.9912666651248754,0.44045911047345765,0.9595433870464838,1.0,12/45,19.52%,PPARA;TBC1D16;PINK1;PDK2;ACLY;MBOAT7;FOXM1;PANK2;COQ7;NPC2;ABCA2;PDK3
prerank,peroxisomal membrane transport (GO:0015919),0.36439990464481653,0.9912461115223008,0.4555052790346908,0.9586810247556605,1.0,12/27,23.26%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;PEX6;GDAP1;FIS1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3936501492006328,-0.9910558865656628,0.4786516853932584,0.7428652629618923,1.0,6/11,27.35%,CYC1;UQCRB;UQCRQ;UQCRC2;UQCC3;UQCRC1
prerank,protein polymerization (GO:0051258),-0.26850967258419567,-0.9909316385032745,0.43309859154929575,0.7424560083581835,1.0,15/55,17.92%,DIAPH1;GSN;RAC1;COBL;ARL6;MAPT;GAS7;FAM107A;MAP7D3;TRPV4;TPPP3;PSTPIP1;CHMP4B;CHMP4A;WASL
prerank,RNA transport (GO:0050658),0.3064168541315437,0.9907016429423713,0.45113788487282463,0.959337887133828,1.0,17/71,19.19%,RBFOX1;EIF4A3;NUP214;FMR1;POM121;THOC7;HNRNPA2B1;SRSF11;SLU7;CASC3;KIF5C;SLBP;SRSF9;THOC5;SRSF6;NUP155;CHTOP
prerank,myoblast differentiation (GO:0045445),0.41094757061980175,0.9905539586785973,0.4940577249575552,0.9588346976198443,1.0,5/14,9.55%,NRG1;TCF7L2;REST;EPAS1;DDX17
prerank,regulation of lamellipodium assembly (GO:0010591),0.3451941325746583,0.9904496072338046,0.4836193447737909,0.9582382227128858,1.0,6/34,8.62%,PIK3R1;HRG;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,hemidesmosome assembly (GO:0031581),-0.3966460341743468,-0.9902989911737902,0.43946188340807174,0.7432584732673492,1.0,7/11,17.05%,ITGA6;PLEC;LAMA3;ITGB4;CD151;DST;LAMC2
prerank,ganglion development (GO:0061548),-0.40141337895524404,-0.9899832694514766,0.5012048192771085,0.7433592532200441,1.0,3/11,13.11%,NRP2;NRP1;FZD3
prerank,proteolysis (GO:0006508),0.2654401821289105,0.9899669997812186,0.5016872890888638,0.9587219701014285,1.0,31/252,12.42%,ECE1;GGT5;PGPEP1L;ECE2;OGT;ADGRV1;ATG4A;FAP;MMP24;MMP25;PCSK2;CAPN5;HTRA3;CASP6;CPQ;KLKB1;ADAM19;CASP4;CAPN3;CPM;ADAMTS12;PSMB5;PLAU;LGMN;CAPN6;PSMC4;PITRM1;ERMP1;HTRA2;ENDOU;SPRTN
prerank,histone methylation (GO:0016571),-0.318628949978377,-0.9897664649074831,0.44148936170212766,0.7431410354381894,1.0,6/26,15.08%,SMYD3;NTMT1;PRMT7;SMYD2;PRMT8;EZH2
prerank,negative regulation of peptidase activity (GO:0010466),0.3262657779005454,0.9895554013090577,0.47901591895803186,0.9590382984746869,1.0,4/47,5.46%,LRP1;HRG;SPOCK3;SERPINF1
prerank,membrane depolarization (GO:0051899),0.35131445672550576,0.9894906212106046,0.4795144157814871,0.9582894782843443,1.0,12/32,22.80%,CACNA1E;CACNA1G;CACNB4;CACNG4;P2RX4;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I;CACNA1A;ABL1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.32171844734741034,-0.9892423944585838,0.46216216216216216,0.7437955393342522,1.0,5/25,8.64%,MEF2C;SHANK3;MINK1;SHANK1;CACNG2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.35606163182054945,0.9890292815641062,0.46511627906976744,0.9586479906250162,1.0,5/27,15.67%,LPIN3;CHKA;SELENOI;LPIN2;ABHD4
prerank,cellular response to oxidative stress (GO:0034599),0.28320857444310726,0.9885148087477104,0.48350253807106597,0.959154405470008,1.0,23/118,14.60%,PDGFRA;ETV5;PLA2R1;ERCC6L2;FOS;PRDX6;ALDH3B1;CAMKK2;LRRK2;PRDX5;CCS;PYCR1;PINK1;PRKD1;CYBA;TP53;ERMP1;PDK2;HTRA2;EIF2S1;RAD52;LONP1;VKORC1L1
prerank,regulation of MAP kinase activity (GO:0043405),0.2917619091214949,0.988416974663655,0.4947916666666667,0.9585038128747105,1.0,11/92,5.65%,IL34;SPRY4;EDN3;SPRY1;CD40;FGFR1;DUSP1;HTR2B;SORL1;LRRK2;NF1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.4487109376787386,0.9883858870876885,0.46678023850085176,0.956746124627926,1.0,2/10,9.27%,IL1RN;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.4487109376787386,0.9883858870876885,0.46678023850085176,0.956746124627926,1.0,2/10,9.27%,IL1RN;MBP
prerank,dopaminergic neuron differentiation (GO:0071542),-0.345917832522709,-0.9881873111516355,0.4560975609756098,0.7457631055858168,1.0,3/19,15.35%,LRP6;NR4A2;MANF
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3038292491201544,0.9881677211887135,0.4717741935483871,0.9564552552694086,1.0,19/77,17.00%,SH3RF1;TCF7L2;PHIP;ITGAV;NOL3;PSMD10;HERPUD1;FXN;PINK1;NOC2L;OPA1;RTKN2;BCL2L2;TGFBR1;RIPK1;CLU;AR;CSNK2A2;MAZ
prerank,regulation of cellular senescence (GO:2000772),0.35437355300399437,0.9881632397798362,0.49261083743842365,0.9555668039564862,1.0,5/28,8.25%,SLC30A10;CDKN2A;FBXO5;ZKSCAN3;TWIST1
prerank,negative regulation of cell projection organization (GO:0031345),-0.2758841381661636,-0.9880945831687652,0.45483870967741935,0.745279885732407,1.0,10/48,13.30%,EPHA4;RAPGEF2;DPYSL3;EFNB2;KANK1;PRAG1;APOE;ADCY6;GAK;TRPV4
prerank,positive regulation of defense response (GO:0031349),0.2914644265726583,0.988010576701232,0.4761290322580645,0.9550720870428524,1.0,10/89,9.80%,IL33;WNT5A;IL16;TSLP;TLR8;NPAS2;AKIRIN2;PLA2G7;TLR4;CYBA
prerank,ion transport (GO:0006811),0.2849911913721394,0.9875441580811063,0.4852752880921895,0.9554309301529523,1.0,17/111,14.34%,SLC1A3;SLC15A1;VDAC2;TRPA1;SLC24A5;CHRNB4;SLC12A6;SLC9A9;SLC9A1;PLP2;SLC25A22;GLRA1;SLC4A1;KCNN2;GABRB1;LRRC8A;SLC25A26
prerank,hemopoiesis (GO:0030097),-0.24677612506439697,-0.987077353078238,0.5131578947368421,0.7471320505537876,1.0,13/87,7.46%,FLT1;MECOM;KITLG;TEK;NOTCH2;KDR;RUNX1;TGFB2;CD34;SNRK;MFAP5;ETV6;HIPK1
prerank,positive regulation of metabolic process (GO:0009893),0.28781688110668613,0.9866214693647524,0.4942528735632184,0.9570684665162077,1.0,16/103,9.82%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;SIRT6;EPAS1;FABP5;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,negative regulation of cell population proliferation (GO:0008285),0.25914424076457515,0.9866025522821126,0.523454157782516,0.9562116005843501,1.0,69/351,16.57%,APOD;DLC1;COL18A1;KDF1;ATF5;HRG;ROR2;WNT5A;CXCL1;PTEN;ERBB4;GPLD1;CDKN2A;GLMN;FAP;PEX2;MCC;DLG3;REST;TBX3;TMEM115;ADGRB1;NF1;CBFA2T3;CDKN2D;PTPRU;MDM4;PER2;IFNLR1;P3H1;SOX2;APPL2;TENM1;MAP2K1;TNS2;EIF2AK2;TP53;FKTN;GAS8;SPEG;SOX9;IL12A;FABP3;HGS;ST18;DIS3L2;MTSS1;TESC;BNIPL;P3H3;CDKN2C;B4GALT7;LYN;NME1;MED25;THAP12;WNK2;CTNNBIP1;F2R;TFAP4;AR;CNOT7;MYC;KLF11;MN1;CDK10;TSC1;RBM5;CHERP
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2951617619667749,0.9864256008294013,0.47435897435897434,0.9557946127743985,1.0,20/88,14.46%,CCDC22;STXBP6;TXNDC5;GBF1;VAMP2;MYO1B;SORL1;EPS15;LLGL1;SNAP23;COMMD1;AP1S1;SCFD1;EXOC1;VAMP7;HGS;ACBD3;CLVS1;RABIF;SH3D19
prerank,regulation of membrane depolarization (GO:0003254),-0.33755512023478995,-0.9864170130952268,0.45742092457420924,0.7480039752091345,1.0,3/18,3.59%,FHL1;PTPN3;CAMK2D
prerank,response to amino acid (GO:0043200),0.35396191156084805,0.9864069061549217,0.47772657450076805,0.9549438512213235,1.0,10/31,18.69%,CPEB1;MTOR;GLRA3;GLRA1;GLRA2;MEAK7;GLRB;RRAGA;RRAGD;CAPN2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.35777476824493076,-0.9862552841019774,0.46633416458852867,0.7476879467502707,1.0,5/17,13.00%,NPR3;CCN1;PLXNB1;SFRP1;TMEM119
prerank,smooth muscle tissue development (GO:0048745),-0.40837146335973246,-0.9861739532511543,0.46004319654427644,0.7471610151807925,1.0,3/10,14.79%,MYLK;SMO;STRA6
prerank,positive regulation of cilium assembly (GO:0045724),0.394993123019171,0.9860790654994883,0.46078431372549017,0.9549564296286245,1.0,5/18,13.00%,SEPTIN9;TAPT1;CEP135;ARHGAP35;ENTR1
prerank,telomere organization (GO:0032200),-0.28505529402894264,-0.9860221862431615,0.49019607843137253,0.7468239664646975,1.0,27/43,37.09%,PTGES3;PRKDC;ATR;RTEL1;TERT;PCNA;STN1;ATM;NBN;RAD51D;DCLRE1B;HUS1;POLD2;PARP1;RPA2;ACD;LTO1;POLD4;POLD1;CTC1;RAD50;H3-3A;TINF2;HUS1B;MRE11;RPA3;APEX1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3603869369067551,-0.9859666420076311,0.49264705882352944,0.7462446147775409,1.0,4/16,10.80%,DPYSL3;UPP2;UPB1;NT5E
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2486877805380272,0.985803847776428,0.5528455284552846,0.9548574740834228,1.0,141/834,16.89%,RORA;IL33;LPIN3;DCN;PIK3R1;ZFHX3;ATF5;ETV1;CXCL10;RUNX2;PPARA;HOXC10;AUTS2;MEIS1;TEAD1;OGT;ETV5;HDAC1;GNL3;WNT5A;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;SALL1;THRA;SMAD5;NR1H4;CDK8;MAML3;NCOA2;MEIS2;PGR;NFATC3;NGFR;MED12;THAP3;METTL23;JUP;PPARD;PIK3R2;NR1H2;REST;TBX3;FOS;NCOA3;KMT2A;MYCN;BCL9;EPAS1;HLF;SSBP4;SLC9A1;E2F4;BRD8;CRTC2;GLIS1;SRF;CSRNP3;NPAS2;MYO6;AKIRIN2;FIZ1;CSRNP2;MED6;TWIST1;PRKD1;PFKM;CDK13;SOX2;NCOA1;GLI1;TLR4;DDX17;KAT2A;GLI3;AHI1;ZBED3;PPP3CB;TP53;SMARCA1;DHX36;ZFPM2;MED10;SNW1;EPC1;FOXJ2;SOX9;IGF2;TFEB;HOXB4;ST18;DPF2;KDM1B;CD81;ACTR2;NRIP1;NFIX;HOXC4;MYDGF;RFX4;PEG3;MED1;SREBF1;ZFP64;ARNT2;MED25;DOT1L;SSBP2;ELK1;BPTF;ASXL1;RIPK1;CHD8;FOXM1;DHX9;EAF2;PBX2;AR;GDNF;ATF2;MYC;PAXIP1;LPIN2;PRDM10;LAGE3;FOXJ3;FGFR2;PLAC8;AKIRIN1;ONECUT2;DVL3;CCNK;USP16;JAG1;HAX1;TOX2;ATMIN
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.35585781429846997,0.9852273961012152,0.450920245398773,0.9555737660144774,1.0,12/29,21.85%,HDAC1;TCF7L2;PYGO1;BCL9;TLE2;TLE1;MYC;ASH2L;CDC73;MEN1;RBBP5;CREBBP
prerank,regulation of cardiac muscle contraction (GO:0055117),0.34482186228295353,0.9852016282248433,0.4660633484162896,0.9547550539276939,1.0,9/34,16.97%,PDE4B;RYR2;ATP2A2;SLC9A1;PRKACA;P2RX4;GJA5;STC1;PIK3CG
prerank,DNA double-strand break processing (GO:0000729),-0.35140806312954886,-0.9851689221054244,0.49104859335038364,0.7476069062104375,1.0,10/18,32.44%,RBBP8;ATM;NBN;UBE2N;KAT5;SETMAR;BRCA1;RNF138;RAD50;BARD1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3600711173546518,-0.9848603665767897,0.4527363184079602,0.7476482462401542,1.0,3/17,4.37%,VIM;RUNX1;WNT4
prerank,mitochondrion morphogenesis (GO:0070584),-0.39984404364045195,-0.9847872480963547,0.46403712296983757,0.747119155318867,1.0,7/11,43.10%,MTM1;PID1;PNPT1;DNM1L;NUBPL;WASF1;SLIRP
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3009282654568655,0.9846381163257509,0.4637096774193548,0.9554823611600952,1.0,8/75,5.46%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;ADGRB1;SERPINF1
prerank,histone H3 deacetylation (GO:0070932),0.40236303610679813,0.9836812809577966,0.4897260273972603,0.9572432550183785,1.0,3/15,7.98%,HDAC1;SIRT6;PER2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3360781070146248,-0.983148359811335,0.4864864864864865,0.7505621181416917,1.0,6/21,9.65%,CACNA1C;CAMK2D;SRI;CALM1;ANK2;DMD
prerank,Golgi organization (GO:0007030),0.2826024797301897,0.9831177758392121,0.4745972738537794,0.9579644187573557,1.0,29/112,19.53%,SEC16B;SEC16A;YWHAZ;GBF1;DNAJC28;LRRK2;GOLGA2;PRKD1;RAB30;RAB29;VAMP4;RAB2A;SYNE1;COG1;TRIP11;CLASP2;VRK1;HACE1;CLASP1;USP6NL;UBXN2B;TMED3;TMED9;GOLGA8B;GOLGA5;CUL7;TRAPPC12;TBC1D20;PLEKHM2
prerank,negative regulation of hormone secretion (GO:0046888),0.4480204055549507,0.9830931357476806,0.4761092150170648,0.9571351200600285,1.0,2/10,12.64%,GJA1;RAB11FIP3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.42396891565668127,0.9830258522012189,0.477797513321492,0.9564328150481145,1.0,4/12,17.84%,MCM7;CDC7;MCM4;MCMDC2
prerank,positive regulation of potassium ion transport (GO:0043268),-0.286991350268536,-0.9829359399619082,0.4766666666666667,0.750351698818333,1.0,8/38,13.97%,ACTN2;FHL1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,protein targeting to peroxisome (GO:0006625),0.3543859334996737,0.9827700093677316,0.45427728613569324,0.9562534673433702,1.0,12/29,23.26%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;PEX6;GDAP1;FIS1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.23253764992167741,-0.9824532366556127,0.5022222222222222,0.7508663683678027,1.0,38/109,23.01%,PLCB1;PITPNM2;MTM1;LPGAT1;PLA2G4A;CDS1;PIK3C2B;INPP5F;INPP4B;INPP5D;BMX;MTMR9;RAB5A;INPPL1;PIK3CB;LCLAT1;PIK3CD;PIP4P1;PIP4K2C;PLEKHA2;PLCG2;VAC14;PLAAT3;SYNJ1;PIK3R6;INPP5B;SBF1;MTMR14;MTMR2;RAB4A;PLA2G4E;PIP5K1A;PLA2G4C;PIP5K1B;CSF1R;PITPNM1;MTMR11;PIK3C2A
prerank,cellular response to cytokine stimulus (GO:0071345),0.254727969565796,0.9820456138369271,0.5248677248677248,0.9574631239024007,1.0,54/416,12.54%,RORA;GHR;IL34;PIK3R1;ZEB1;IL1RN;IL2RA;XCL1;CXCL10;PTPRT;WNT5A;CXCL1;IL1R2;CD40;IL16;FLT3LG;EPRS1;GAB2;JAK1;DUSP1;FSCN1;YWHAZ;FOS;CCL15;SMPD4;PDE12;COL1A2;ADAMTS12;ZFP36L2;BCL6;PTPN13;IL5;UBE2G2;TWIST1;PLP2;AXL;PRKACA;IFNLR1;SOX2;TLR4;IL1RAP;IRAK1;TNFRSF21;CCL25;TP53;PYCARD;FYN;PTGIS;SOX9;IL12A;HTRA2;CD86;HSP90B1;GSK3A
prerank,regulation of ERAD pathway (GO:1904292),0.43132887278875703,0.9819574536670421,0.46689895470383275,0.956814464231588,1.0,5/11,16.70%,HERPUD1;USP19;ATXN3;BAG6;USP13
prerank,positive regulation of innate immune response (GO:0045089),-0.31054182687137494,-0.9816549921353194,0.4948453608247423,0.7520841489945268,1.0,10/30,15.89%,LBP;NMI;MAVS;GBP5;RPS19;IFI35;RIOK3;POLR3G;NLRC5;POLR3D
prerank,sphingosine biosynthetic process (GO:0046512),-0.3961501430004204,-0.9816076798369039,0.4823529411764706,0.7507745177285855,1.0,3/11,4.52%,SPTLC2;ACER2;ACER3
prerank,sphingoid biosynthetic process (GO:0046520),-0.3961501430004204,-0.9816076798369039,0.4823529411764706,0.7507745177285855,1.0,3/11,4.52%,SPTLC2;ACER2;ACER3
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.44912351024057606,0.9816023813612165,0.4964788732394366,0.9569460755172984,1.0,4/10,11.54%,THRA;PSMC4;TP53;PSMC5
prerank,lipoprotein catabolic process (GO:0042159),0.4414046086075969,0.9815763141627434,0.4846938775510204,0.9561369517613056,1.0,3/11,10.32%,ABHD17C;ABHD17B;LYPLA2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.35883328689326016,0.9814364516150015,0.48055987558320373,0.9556282281491959,1.0,4/29,4.06%,ZBTB20;PPARA;GPLD1;NR1H2
prerank,phospholipid translocation (GO:0045332),-0.3046847145616981,-0.9813630735012814,0.4808743169398907,0.7506571801442906,1.0,10/28,18.60%,ATP10A;ANO6;ATP8A1;ATP11B;ATP8B1;MFSD2A;ABCB4;P2RX7;PLSCR3;ATP8A2
prerank,protein modification by small protein conjugation (GO:0032446),-0.20028112262340342,-0.9812315476313545,0.515625,0.7502938059855647,1.0,78/361,17.49%,FBXL7;WWP1;EYA1;RNF152;LMO7;GAN;MGRN1;VCPIP1;KLHL13;UBE2G1;ASB2;KLHL24;RNF43;PRKDC;WWP2;ARIH1;OTULIN;CDC23;UBE2D3;HIF3A;TRIM24;HLTF;CUL1;TRIM5;NUP50;TRIM11;FBXL2;UBB;STX1A;VPS18;TRIM14;RANGAP1;RNF8;VCP;MSL2;UBE2F;UBE2H;MIB1;SMURF2;UBR1;UBA6;FBXO25;TSPAN17;UBE2A;ASB5;KLHL20;VHL;CUL9;RNF41;NUP98;NUP153;SPSB4;UBR2;SUMO3;RCHY1;PCNA;HERC2;VPS11;TRIM63;AMFR;NUP43;UBE2N;CAND2;RAE1;TRIM35;ELOC;NUP205;FBXO32;TRIM27;SIRT1;NEDD8;CUL3;ANAPC16;ISG15;DCUN1D3;ANAPC11;UBC;USP9X
prerank,regulation of T cell differentiation (GO:0045580),0.34612331653626854,0.9811147417963052,0.48396946564885496,0.9556505155515258,1.0,4/33,10.11%,IL2RA;FANCA;KAT2A;CAMK4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.32531552847134937,0.98071737370293,0.46255506607929514,0.9558174846408641,1.0,4/49,3.59%,GHR;CD40;ERBB4;TSLP
prerank,establishment of skin barrier (GO:0061436),0.41732787971141144,0.9806669698823612,0.4858569051580699,0.9541918806653158,1.0,3/15,13.84%,KDF1;FA2H;STMN1
prerank,regulation of water loss via skin (GO:0033561),0.41732787971141144,0.9806669698823612,0.4858569051580699,0.9541918806653158,1.0,3/15,13.84%,KDF1;FA2H;STMN1
prerank,cAMP-mediated signaling (GO:0019933),0.3662964305883402,0.9799464994321715,0.49523809523809526,0.9553296708572526,1.0,7/24,14.69%,PDE7B;RIMS2;DGKQ;ADCY2;SOX9;AKAP6;EPHA5
prerank,cellular response to dsRNA (GO:0071359),0.39502509417496,0.9799323473742623,0.4845360824742268,0.9544886170365988,1.0,2/15,6.48%,COLEC12;PDE12
prerank,protein autophosphorylation (GO:0046777),0.27433838519676385,0.9795078304049316,0.5077473182359953,0.9547419990635581,1.0,35/157,16.06%,PDGFRA;NTRK2;PEAK1;TXK;ERBB4;EPHB1;FGFR1;PDPK1;CDKL5;PRKX;CAMKK2;LRRK2;PTK2;PINK1;PRKD1;MTOR;IRAK1;FGR;CAMK4;EIF2AK2;EIF2AK1;SLK;MAPKAPK3;STK16;MAP4K1;MELK;PIM1;LYN;WNK2;RIPK1;VRK1;TNIK;MAP3K3;FGFR2;ULK2
prerank,endodermal cell fate commitment (GO:0001711),0.4353004958534251,0.9794461638476923,0.47266313932980597,0.9540292737042847,1.0,2/10,8.78%,RTF1;SOX2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.31994771156211876,-0.979248493574618,0.4921875,0.7546265966925314,1.0,2/22,4.15%,ALDH1A2;RBP1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.42287517466752333,0.9790084607658902,0.5008695652173913,0.954355711175062,1.0,3/12,10.49%,GPLD1;ADCY8;PPP3CB
prerank,organic hydroxy compound transport (GO:0015850),-0.29317625410776155,-0.9789792771202795,0.46418338108882523,0.7545863383956221,1.0,7/36,8.54%,ABCC4;SLCO1C1;RBP4;RXRA;SLC16A1;RALBP1;ATP8B1
prerank,T cell homeostasis (GO:0043029),-0.3969502495544006,-0.9788459107972081,0.5060827250608273,0.7542156357313556,1.0,7/10,35.61%,FAS;AKT1;PPP2R3C;JAK3;NCKAP1L;FADD;PMAIP1
prerank,organic substance transport (GO:0071702),0.28005563152173923,0.9788126261629125,0.49572649572649574,0.954016235087234,1.0,7/120,2.33%,ABCA9;SLC48A1;HRG;ABCA6;LRP1B;CALCRL;ABCD2
prerank,regulation of glycolytic process (GO:0006110),0.30364282850189867,0.9786973841068177,0.4946808510638298,0.9534737248394232,1.0,9/68,6.86%,ZBTB20;PPARA;OGT;PFKFB1;NUP214;ENTPD5;AAAS;POM121;CBFA2T3
prerank,mRNA destabilization (GO:0061157),0.3364692661984098,0.9784977456268041,0.4896755162241888,0.9531589158112242,1.0,10/38,15.34%,RBM24;ZC3H12D;DND1;PDE12;ZFP36L2;DHX36;DIS3L2;CNOT1;FTO;RC3H2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3976413313342812,0.9782529306910556,0.47299509001636664,0.9529679369947605,1.0,1/16,0.79%,XCL1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.4062474756079668,-0.9780792395773215,0.4897025171624714,0.7553652907158563,1.0,2/10,5.23%,RAPGEF2;GIPC1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.2596748739602939,-0.9780635248362003,0.5016949152542373,0.7546913710230722,1.0,7/56,3.95%,FLT1;EPHA4;TEK;EGFR;FER;KDR;INSR
prerank,mesoderm formation (GO:0001707),0.39822952637077935,0.9780195180840225,0.4802065404475043,0.9527429261366649,1.0,2/17,2.66%,ITGA8;ITGA3
prerank,cell-cell junction maintenance (GO:0045217),-0.40544876780275013,-0.9779235516640998,0.49311926605504586,0.7543390218466213,1.0,1/11,0.33%,TJP1
prerank,hippo signaling (GO:0035329),-0.31795981501628595,-0.9778099782547259,0.5113350125944585,0.7539258836051244,1.0,10/26,20.19%,TJP1;AMOT;TEAD4;YWHAB;TJP2;CASP3;AMOTL2;MOB1B;NPHP4;AMOTL1
prerank,protein insertion into ER membrane (GO:0045048),0.3333489923274038,0.9775044142819831,0.471976401179941,0.9533092055152713,1.0,16/37,24.06%,VAMP2;UBL4A;EMC2;SEC61B;EMC9;TRAM2;EMC8;BAG6;GET3;ALDH3A2;EMC10;TRAM1L1;SERP1;UBE2J2;CCDC47;EMC4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.24256392964828363,-0.9773520660689218,0.5020242914979757,0.7543938656327567,1.0,24/86,17.88%,IGF1;PTPRJ;PECAM1;EGFR;APP;NRP1;CSPG4;VTN;EFNA5;PDGFA;CD44;ACVR1;ENPP2;SFRP1;ITGB3;PLCG2;PRKCZ;PTK2B;RAP2C;PRKCD;TEC;PAK2;CD74;RAP2B
prerank,regulation of cytoplasmic transport (GO:1903649),0.4301125275471849,0.9771705049415755,0.49094202898550726,0.9533867870495851,1.0,5/11,21.55%,LRRK2;MAP2K1;ATP9A;MAPK1;DENND10
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.25832819746380553,-0.9768282799878285,0.4858156028368794,0.7549188345515925,1.0,12/66,14.88%,IGF1;FOXP1;APP;SIRPA;GBP5;CASP8;GIT1;TRIM16;CX3CR1;HSPB1;P2RX7;CX3CL1
prerank,tRNA metabolic process (GO:0006399),0.3907329060426016,0.9768229610131139,0.47923875432525953,0.9534602394786341,1.0,8/17,23.78%,POP5;DTD1;POP7;SARS1;RPP21;DTD2;AARS1;SSB
prerank,cellular response to superoxide (GO:0071451),-0.41359150087386365,-0.976793273679996,0.4700665188470067,0.7543143870135594,1.0,4/10,16.03%,NOS3;SOD2;PRDX1;SOD3
prerank,aerobic respiration (GO:0009060),0.382164428490624,0.9766325920570509,0.4790322580645161,0.9531009638712211,1.0,6/20,15.03%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4099241485969776,0.9763329602671518,0.49310344827586206,0.9530424163901202,1.0,4/14,12.98%,ENTPD2;ENTPD5;NUDT9;ENTPD7
prerank,myelination (GO:0042552),0.3258664349346787,0.9759448615960417,0.4912536443148688,0.9532638926665826,1.0,12/46,13.88%,EPB41L3;ABCD2;NF1;SBF2;MBP;DEGS1;LGI4;SOX10;PLP1;TNFRSF21;SCN2A;MYRF
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.248716484991245,0.9756217677470151,0.5636172450052577,0.9532664793025647,1.0,107/509,19.21%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;MAP3K14;NRG1;ROR2;EDA2R;CCDC22;ADGRV1;WNT5A;NTRK2;SEMA5A;TCF7L2;CD40;ERBB4;ITGAV;FLT3LG;NRG2;TSPAN6;FGFR1;GAB2;LURAP1;GPR37L1;GJA1;PDPK1;PIK3R2;GCNT2;HTR2B;TLR6;NEDD4;IRS1;DHX58;IRS2;NRG4;WDR24;PTK2;TNFRSF19;PINK1;PRKD1;RELN;AXL;SOX2;TRIM8;PRKCB;TSPYL5;TLR4;BIRC2;IRAK1;LPAR1;FGR;NDFIP2;EIF2AK2;TP53;DHX36;RTKN2;FYN;RPL37;P2RX4;TGFBR1;IAPP;SOX9;CD86;PDCD4;IGF2;CASS4;LGALS1;TRIM44;MYDGF;RNF31;LYN;UBE2V1;F2R;RIPK1;FERMT2;FGF5;AREG;MIOS;MAP3K3;FGFR2;TIRAP;GPR37;NDFIP1;ZCCHC3;HAX1;PIK3CG;RRAGA;MAZ;HTR6;LGALS9;ADAM8;ADRA2A;RHOG;MYD88;BMP2;RRAGD;NFAT5;RHOA;BBC3;WWC1;SPRY2;ATP2C1;TERF2IP;RNF13;KSR1;PDGFRB
prerank,regulation of vacuole organization (GO:0044088),-0.34075901312077483,-0.9755600209242141,0.48936170212765956,0.7567189552259243,1.0,8/20,25.09%,MTM1;LAPTM4B;RAB5A;ENO1;TBC1D14;RAB1B;NPRL3;ADPRH
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3504745293649155,-0.9755362642597325,0.5095238095238095,0.7560781809248738,1.0,7/16,21.96%,RBM22;SNRPC;CWC15;SNRNP200;SART1;DCPS;NCBP2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.32892734915262656,0.9753360516479536,0.48493975903614456,0.9532500107802081,1.0,12/40,19.24%,ANKLE1;USP1;FBXO5;FMR1;NPAS2;UBE2V2;POLH;UBE2V1;MYC;WDR76;FEM1B;FXR1
prerank,camera-type eye morphogenesis (GO:0048593),0.4380814793031128,0.9752862901796371,0.5090579710144928,0.9525174521546385,1.0,2/10,5.65%,TENM3;NF1
prerank,negative regulation of DNA binding (GO:0043392),-0.3133012087254809,-0.9751634388889502,0.4712041884816754,0.7563056183076503,1.0,10/28,25.65%,LEF1;SMO;NFKBIA;SUMO3;HEY2;SOX11;E2F1;ILRUN;SUMO1;KDM1A
prerank,RNA metabolic process (GO:0016070),0.27676339538067324,0.9749967077291517,0.4975728155339806,0.9524597019884803,1.0,35/127,21.16%,RBMS1;RNASEH2C;AGO4;NOVA1;ADARB2;ELAVL4;PCBP3;HNRNPA2B1;MRPL44;MPHOSPH10;WTAP;DDX17;NOL9;DHX36;AGO3;MTREX;TENT2;RNASEH2B;FTO;HNRNPUL1;HNRNPD;DHX9;RNASEH1;ADAR;LAGE3;RBM5;PPP1R8;HNRNPL;AGO1;DEDD2;RBM6;POLR2L;TFIP11;DDX39B;RBPMS
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.37668352512237213,-0.9748698741552524,0.4943820224719101,0.7563149278449862,1.0,5/13,17.21%,PRR5L;ZC3HAV1;CNOT8;RC3H1;GTPBP1
prerank,regulation of autophagosome maturation (GO:1901096),-0.3770642336717161,-0.9744089485852662,0.4608294930875576,0.7567316032715743,1.0,6/13,32.17%,UVRAG;CLEC16A;TMEM39A;ADRB2;IRGM;PHF23
prerank,L-amino acid transport (GO:0015807),0.3547671327366666,0.9741196437439877,0.4815950920245399,0.9539947632951811,1.0,4/28,12.38%,SLC1A3;SLC7A8;SLC25A22;SLC7A3
prerank,autophagy of peroxisome (GO:0030242),-0.38142557740409516,-0.9739310281512681,0.4744186046511628,0.7571509526767469,1.0,5/12,26.78%,SQSTM1;USP30;ATM;MAP1LC3B;PEX5
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.32536352106079314,-0.9739140949669858,0.4910941475826972,0.7564840379408676,1.0,5/24,10.50%,ERAP1;TAPBP;ACE;B2M;TAP2
prerank,regulation of phosphate metabolic process (GO:0019220),0.4013693671506001,0.9737393088171623,0.49667774086378735,0.9542062587866077,1.0,2/16,3.65%,SRPX2;MCM7
prerank,regulation of lipid catabolic process (GO:0050994),0.38129457307603165,0.9734827275182899,0.47058823529411764,0.9540373001369611,1.0,6/19,22.62%,CIDEA;BSCL2;ADRA2A;PDE3B;RARRES2;TYSND1
prerank,glycerophospholipid metabolic process (GO:0006650),0.29761373758788123,0.9730118593657894,0.5048275862068966,0.9544836298414776,1.0,15/75,13.98%,PIGV;GPLD1;PIGQ;SERINC1;PRDX6;SMPD4;PIGP;ENPP6;PLA2G7;CPNE7;ABHD12;AGK;PIGA;PIGL;SERINC5
prerank,digestive tract development (GO:0048565),0.35081541539412203,0.9729435429338245,0.50231124807396,0.9537862732591237,1.0,8/32,15.70%,CLMP;SALL1;NPY;GLI1;GLI3;CHD8;CCDC39;FGFR2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3237627057778215,-0.9728001342045166,0.49625935162094764,0.7586139018760658,1.0,9/22,22.29%,RNF185;UBB;AMFR;UBC;EDEM1;MAN1A2;RNF5;UGGT1;UBA52
prerank,cellular response to metal ion (GO:0071248),0.27872940127285156,0.9727785952212085,0.5227272727272727,0.953365198433155,1.0,32/123,18.99%,ADGRV1;WNT5A;GPLD1;ANK3;FOS;DLG2;LRRK2;ADCY8;CAPN3;RASGRP2;SYT3;ADCY7;LGMN;DAXX;SYT7;GLRA1;CPNE7;P2RX4;DLG4;TRPM2;SYT5;GLRA2;CPNE4;RYR3;CPNE8;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1
prerank,regulation of interleukin-2 production (GO:0032663),0.322533606890713,0.9726685229141089,0.49921996879875197,0.952792147059536,1.0,4/43,3.79%,XCL1;PDE4B;GLMN;SPTBN1
prerank,metal ion homeostasis (GO:0055065),-0.2903549873126874,-0.972387615286909,0.48338368580060426,0.7589202712836208,1.0,3/40,1.13%,TMTC2;SLC12A7;CAV1
prerank,glial cell differentiation (GO:0010001),-0.3140785415031616,-0.9722277553344255,0.4742857142857143,0.7586166841811759,1.0,3/28,1.55%,NFIB;SLC8A3;ADGRG6
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3352539939306851,0.9721992834306081,0.4878048780487805,0.9532757455130224,1.0,9/37,15.08%,ERCC1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4167947581243387,0.9721800963223158,0.4973821989528796,0.9524672569542737,1.0,5/12,21.33%,REST;ZFP36L2;N4BP2L2;JAG1;NELFB
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.263948175411588,-0.9717529001580526,0.5,0.7590689677242515,1.0,18/50,19.03%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;PSMB10;OAZ2;PSME2
prerank,regulation of JNK cascade (GO:0046328),-0.23279483029155432,-0.971644272572513,0.5188679245283019,0.7586423231526354,1.0,35/101,24.82%,MECOM;PLCB1;EGFR;IGF1R;CCN2;TPD52L1;APP;SIRPA;MAP3K5;MAPK8IP3;MINK1;FZD7;SH3RF2;HDAC3;GADD45B;HIPK2;CYLD;FLT4;PTK2B;WNT16;MAPK8IP1;TRAF3;PER1;MAP3K10;SDCBP;TGFBR3;MFHAS1;GADD45G;DUSP19;TRAF1;CCL19;EDAR;TAOK2;NOD2;CD27
prerank,establishment of spindle localization (GO:0051293),0.4085289386251161,0.9713402032858744,0.49331103678929766,0.9539482392731867,1.0,6/14,18.72%,LLGL1;ZBED3;NUSAP1;CLASP2;CLASP1;KPNB1
prerank,cellular response to hexose stimulus (GO:0071331),0.36465322617979073,0.9712135817992532,0.4991568296795953,0.9534167357621196,1.0,4/23,8.67%,ZBTB20;TRA2B;ADCY8;PRKACA
prerank,response to tumor necrosis factor (GO:0034612),0.2892372190323852,0.9712103821749943,0.5019659239842726,0.9525632774795761,1.0,11/91,10.91%,GGT5;XCL1;CD40;GGT7;CCL15;SMPD4;ADAMTS12;ZFP36L2;TNFRSF21;CCL25;PYCARD
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2837590799706306,-0.9710760272915795,0.5045592705167173,0.759323347553993,1.0,13/39,20.49%,TEK;ANO6;THBS1;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5;GPER1;RGCC;ECSCR;TNFAIP3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3951233657421469,-0.9710151150642898,0.49417249417249415,0.7587705787252609,1.0,1/12,0.01%,SORBS1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.34071115964833554,-0.9708651813397525,0.49033816425120774,0.7584366048777134,1.0,7/18,22.29%,RNF185;UBB;AMFR;UBC;RNF5;UGGT1;UBA52
prerank,nucleosome assembly (GO:0006334),0.3445181287490435,0.9706939674511819,0.4913657770800628,0.9531866413619994,1.0,8/31,12.02%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;UBN1;SOX9
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3102257967423964,-0.969950100173863,0.4959349593495935,0.7599873725897947,1.0,10/25,21.66%,RNF185;VCP;NGLY1;TOR1A;CUL3;YME1L1;CLPP;HDAC6;RNF5;UGGT1
prerank,defense response to bacterium (GO:0042742),-0.2329253191886775,-0.9697800100825581,0.5023923444976076,0.7597109356455328,1.0,23/105,17.80%,ANXA3;LBP;GBP7;MAVS;RPS19;DROSHA;GBP4;GBP2;PGLYRP1;STAB1;SERPINE1;OPTN;PLA2G6;GBP6;RPL30;RNASE7;PRKCD;ANKRD17;MPEG1;RAB1A;ISG15;HMGB2;PPP1R11
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3245778286905924,-0.9695178623082723,0.49606299212598426,0.7596521814021312,1.0,7/24,12.56%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.308777074119658,0.9691843690261287,0.4970674486803519,0.9564258711672636,1.0,13/52,19.63%,KDELR3;FKBP14;CXXC1;EXTL3;SRPRA;GSK3A;TATDN2;MYDGF;HSPA5;TSPYL2;CUL7;ATP6V0D1;SSR1
prerank,protein modification by small protein removal (GO:0070646),0.256699489891155,0.9687600273207718,0.5209251101321586,0.9566874321246355,1.0,57/252,18.81%,IL33;STAMBPL1;OGT;TAF9B;PTEN;COPS3;MBD6;PSMD1;USP1;PSMD10;UCHL3;OTULINL;PSMA5;USP42;PSMB5;MDM4;BIRC2;KAT2A;RNF128;PSMC4;TP53;PSMA4;USP33;JOSD1;TGFBR1;PSMC5;USP19;HGS;POLB;COPS4;PSMB9;KDM1B;ATXN3;UBE2D1;SENP6;CCNA2;ASXL1;RIPK1;AR;MYC;YOD1;USP34;USP4;PSMA7;USP21;USP16;USP13;STAMBP;PSMD14;USP49;INO80E;TAF10;PSMA2;USP14;RHOA;HIF1A;PSMD11
prerank,positive regulation of cell growth (GO:0030307),-0.2311144782316449,-0.9685774512319348,0.49159663865546216,0.7612895711930665,1.0,24/96,18.28%,IGF1;EGFR;NTN1;SEMA7A;RUFY3;TGFB2;ADAM10;CDC42;NGF;MAPT;HYAL1;SFRP1;INO80;RPS6KA1;GOLGA4;EXOSC2;MACF1;MFSD2A;CDKN2AIP;EDN1;PABIR1;ERBB2;AKT1;SDCBP
prerank,regulation of double-strand break repair (GO:2000779),0.3267274531438371,0.9684626236190094,0.49783549783549785,0.956658008937608,1.0,13/39,20.57%,SIRT6;ZCWPW1;MRNIP;TWIST1;SLF1;SPIDR;FIGNL1;ACTR2;FOXM1;SLF2;SPIRE1;TERF2IP;PPP4R2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3489516098137598,0.9682400906771405,0.505,0.9564156290130466,1.0,8/26,19.61%,OGT;KMT2A;VCPKMT;SETD5;SMYD5;SUV39H2;SETD4;ATPSCKMT
prerank,regulation of biomineral tissue development (GO:0070167),0.3605993149072147,0.9682045358285913,0.48172757475083056,0.9556490419299963,1.0,3/26,8.25%,ENPP1;FBXO5;TWIST1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.23473012866516324,-0.9680151207926482,0.5482456140350878,0.7619921608497778,1.0,24/88,19.75%,TRABD2B;FNIP1;STX18;SMPD3;TFRC;GSK3B;VCP;RHOC;FNIP2;SMAD3;HYAL1;BAX;SDC4;AJUBA;BID;CDH5;TAL1;CX3CL1;MMP1;SDC1;SDCBP;RGCC;CHGA;PDCD6IP
prerank,endothelial tube morphogenesis (GO:0061154),-0.4119034254259385,-0.9677670479088106,0.5180995475113123,0.7619076633886742,1.0,3/10,17.89%,RBPJ;ACVRL1;CSNK2B
prerank,regulation of protein polymerization (GO:0032271),-0.2835550313608662,-0.9676185150523751,0.49707602339181284,0.7615967471736572,1.0,16/35,31.12%,ESAM;MAPT;ARHGAP18;ARL2;COTL1;ARHGAP28;PLEKHG2;TPPP3;RASA1;CAMSAP2;TTBK1;FCHSD1;TPPP;HCLS1;CAMSAP3;PFN2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.40141927722374227,0.9673222936985301,0.4991596638655462,0.957137064289592,1.0,1/15,0.79%,XCL1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.390288489779359,0.9672099190780801,0.4967948717948718,0.9565455110488337,1.0,6/17,15.21%,UBL4A;EMC2;EMC9;EMC8;BAG6;GET3
prerank,positive regulation of axonogenesis (GO:0050772),0.3250931128428381,0.9671998021290272,0.49927431059506533,0.9557248836737634,1.0,6/43,6.35%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;LIMK1
prerank,negative regulation of response to stimulus (GO:0048585),0.30682829564823766,0.9668119998272152,0.51,0.955933392779571,1.0,16/60,18.73%,CASK;SLC30A10;GGT7;NR1H2;FBXO5;ZKSCAN3;TWIST1;APPL2;UBASH3B;LYN;CLU;MAP3K3;ADRA2A;COL3A1;ALOX5;HHIP
prerank,MAPK cascade (GO:0000165),0.25386822879070775,0.9667958826575888,0.5531215772179627,0.9551271910699519,1.0,69/295,19.21%,PDGFRA;PIK3R1;IL2RA;NRG1;ERBB4;ITGAV;FLT3LG;NRG2;GRIN2B;FGFR1;JAK1;PSMD1;MAP4K4;SPTBN1;DLG3;PIK3R2;SPRED1;HTR2B;DLG2;IRS1;IL17RD;CAMKK2;LRRK2;NF1;PSMD10;IRS2;NRG4;ZFP36L2;PSMA5;ABHD17C;PTK2;PSMB5;IL5;ABHD17B;MBP;MAP2K1;PSMC4;PTPRA;PSMA4;FYN;DLG4;PSMC5;GFRA1;SOX9;PSMB9;LRRC7;GFRA2;FGF5;AREG;GDNF;MYC;ARAF;TNIK;MAP3K3;FGFR2;MAPK11;PSMA7;PTGER4;PSMD14;LGALS9;CAMK2A;CCM2;RASA3;PSMA2;ZDHHC9;MAPK12;PSMD11;KSR1;PDGFRB
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.277897861461075,-0.9667682131377677,0.47635135135135137,0.7629886739855183,1.0,15/44,20.63%,FNIP1;XIAP;THBS1;KLF4;NGF;CD44;LAMTOR5;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIAH2;AKT1;HGF;CAST
prerank,RNA stabilization (GO:0043489),0.33658819105721616,0.966671683493865,0.48714069591527986,0.9546062182282342,1.0,9/33,15.32%,RBM24;DND1;TAF15;PAIP1;TENT5A;DHX36;TENT2;EIF4ENIF1;GDNF
prerank,calcium ion transmembrane transport (GO:0070588),0.2921887533122618,0.9666632055634291,0.5109961190168176,0.9537809401722107,1.0,16/86,11.67%,TRPA1;SLC24A5;NALCN;MCOLN2;ITGAV;GRIN2B;ATP2A2;GRIN2A;CACNA1G;TRPV3;TRPC3;MICU3;PMPCA;P2RX4;TRPM2;TRPC7
prerank,positive regulation of cation channel activity (GO:2001259),-0.28514291396054764,-0.9664173131536932,0.48089171974522293,0.7631387021501299,1.0,12/40,22.01%,ACTN2;SHANK3;CALM1;ANK2;STAC;EPHB2;LRRC38;TMSB4X;JPH2;CTSS;ADRB2;GSTO1
prerank,peptidyl-threonine modification (GO:0018210),-0.24798805864492246,-0.9662195007378447,0.5244755244755245,0.7629438787280161,1.0,27/66,22.72%,ROCK2;CAMK2D;PRKDC;WNK1;HIPK3;GSK3B;HIPK1;ACVR1;CDC42BPB;DYRK2;GALNT11;HIPK2;GALNT1;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;AKT1;CSNK2B;SBK1;MARK2;GALNT3;TGFBR2;TTBK1;STK39;CAD
prerank,response to exogenous dsRNA (GO:0043330),0.3763520785797331,0.9660318447343127,0.4772344013490725,0.954613515862728,1.0,1/18,0.21%,COLEC12
prerank,regulation of interleukin-10 production (GO:0032653),0.32277296707609077,0.966003954441301,0.49127906976744184,0.9538345500350245,1.0,6/44,10.91%,XCL1;TSLP;PDCD1LG2;TLR4;TNFRSF21;PYCARD
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4179100677085248,0.9659926130196405,0.5053956834532374,0.9530206525522906,1.0,2/13,10.09%,GAB2;FGR
prerank,regulation of cell population proliferation (GO:0042127),0.2438035217628912,0.9653331265101567,0.6067073170731707,0.9539682529954073,1.0,131/691,17.41%,PDGFRA;PTN;DLC1;NTRK3;IL34;COL18A1;ATF5;CXCL10;NRG1;HRG;ROR2;HOXC10;PTGFR;EDN3;MEIS1;HDAC1;GNL3;CXCL1;NTRK2;PTEN;TCF7L2;PHIP;ERBB4;GPLD1;ITGAV;FLT3LG;CDKN2A;GLMN;FGFR1;GAB2;MEIS2;TSLP;TIPIN;DLG3;JUP;POU3F3;REST;TBX3;FBXO5;GCNT2;TMEM115;HTR2B;CDC7;IRS1;ADGRB1;IRS2;DUSP22;CBFA2T3;AMELX;FXN;HP1BP3;CDKN2D;PTPRU;BCL6;PTK2;MDM4;HTR1A;CDK13;IFNLR1;P3H1;CCKBR;GLI1;LGMN;TENM1;TSPYL5;BIRC2;CACUL1;MAP2K1;TNS2;SLC25A33;EIF2AK2;TP53;RTKN2;FKTN;NAP1L1;AGO3;TGFBR1;GAS8;SPEG;SOX9;FABP3;HGS;CD86;IGF2;ST18;DIS3L2;FAM98B;CD81;MEAK7;TESC;GAREM1;BNIPL;P3H3;CDKN2C;DHPS;LYN;NME1;DOT1L;THAP12;WNK2;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;TFAP4;CLU;AREG;AR;GDNF;CNOT7;MYC;SGK1;FGFR2;KLF11;CDK10;TSC1;RBM5;CHERP;GDF9;JAG1;NOX1;CCPG1;STAMBP;IGFBP7;MAZ;CALR;ADRA2A;ASH2L;RHOG
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.259880337850654,-0.9651253574110416,0.5283687943262412,0.7649052853207986,1.0,18/56,23.51%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;CDC23;ANXA1;HYAL1;CCND1;RAD51C;ANKRD17;CUL3;ANAPC11;AKT1;RGCC;RCC2;STOX1;LSM10
prerank,regulation of extracellular matrix organization (GO:1903053),0.3949611553335624,0.9650804343166461,0.5104,0.9538220562808862,1.0,2/15,2.80%,LRP1;FAP
prerank,barbed-end actin filament capping (GO:0051016),0.3811624632874521,0.964779242177143,0.5032467532467533,0.9529730263015584,1.0,1/18,0.32%,SVIL
prerank,actin filament capping (GO:0051693),0.3811624632874521,0.964779242177143,0.5032467532467533,0.9529730263015584,1.0,1/18,0.32%,SVIL
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2756551152894088,0.963903709650314,0.5387453874538746,0.9545103937499868,1.0,27/113,15.74%,NRG1;ERCC1;FSCN1;ERCC5;TLR6;RPA1;ERCC4;IL5;TERF1;MPP7;TLR4;PSMC4;SLF1;TP53;ASAP1;PSMC5;SPIDR;GTF2H3;CDT1;ERCC2;MED25;BAK1;FERMT2;GTF2H1;CLU;SLF2;TIRAP
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24071199429344217,0.9630295161695829,0.6546184738955824,0.9560304450020852,1.0,196/1082,17.02%,RORA;IL33;LPIN3;DCN;PIK3R1;ZFHX3;ATF5;ETV1;CXCL10;RUNX2;PPARA;HOXC10;AUTS2;MEIS1;TEAD1;RGMB;OGT;ETV5;KMT2E;HDAC1;WNT5A;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;ERBB4;SALL1;THRA;SMAD5;NR1H4;CDK8;MAML3;NCOA2;MEIS2;PGR;NFATC3;MED12;THAP3;METTL23;JUP;POU3F3;PPARD;PIK3R2;NR1H2;TEAD2;REST;TBX3;FOS;NCOA3;ZIC1;KMT2A;MDFIC;ZNF423;ZBTB16;CXXC1;SPP1;MYCN;CAMKK2;BCL9;EPAS1;HLF;CREB3L2;SSBP4;SLC9A1;SERTAD2;E2F4;BRD8;CRTC2;ASF1A;CAPN3;GLIS1;TRIM56;TAF15;SRF;CSRNP3;NPAS2;MYO6;AKIRIN2;LYAR;SPIN1;FIZ1;CSRNP2;ZKSCAN3;MED6;TWIST1;PRKD1;PFKM;SOX2;BICRAL;EDF1;NCOA1;GLI1;XPC;MTOR;SP100;TLR4;DDX17;BRCA2;BMP7;KAT2A;NSD1;GLI3;ENY2;MAP2K1;AHI1;CAMK4;SOX10;ZBED3;PPP3CB;TP53;ZC3H8;SMARCA1;DHX36;ZFPM2;MED10;SNW1;TGFBR1;PSMC5;EPC1;ZNF318;FOXJ2;ESR2;SOX9;UTP15;CD86;IGF2;TFEB;HOXB4;ST18;DPF2;KDM1B;HIVEP3;CD81;TESC;ACTR2;TRIM44;NRIP1;NFIX;AXIN1;HOXC4;MYDGF;RFX4;PEG3;BICRA;MED1;SREBF1;MYRF;ZFP64;ARNT2;MED25;DOT1L;SSBP2;ELK1;BPTF;UBE2V1;ASXL1;F2R;RIPK1;CHD8;FOXM1;HNRNPD;TFAP4;DHX9;EAF2;PBX2;GTF2H1;PRMT2;AR;GDNF;ATF2;MYC;LPIN2;PRDM10;LAGE3;FOXJ3;FGFR2;MAFB;MMS19;PLAC8;AKIRIN1;ONECUT2;TRIP4;DVL3;CCNK;THOC5;USP21;USP16;JAG1;HAX1;TOX2;ATMIN;MAZ;NR1D2
prerank,chromatin remodeling (GO:0006338),-0.23289588288338525,-0.9630152201702086,0.5048076923076923,0.769400437862972,1.0,30/100,21.31%,ACTB;HDAC4;PBRM1;KDM4A;KDM4C;SMARCA4;SMARCA2;CBX3;TOP1;ACTR8;INO80;SMARCA5;HNRNPC;ACTR5;SMARCC2;JARID2;CHD3;SIRT1;ARID1B;BAZ1A;BAHD1;ESR1;BAZ2B;INO80C;KDM4B;TADA2B;NPM1;CHD1L;SMARCD3;RUVBL2
prerank,organic acid transport (GO:0015849),0.28706448152813396,0.9626653648020975,0.5157894736842106,0.9561564359128194,1.0,9/94,4.87%,SLC1A5;ABCC3;SLC6A13;NR1H4;NCOA2;PPARD;SLC7A11;SLC43A1;SLC7A8
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3149471104554426,0.9622030611754124,0.5147058823529411,0.9565353784801841,1.0,13/45,17.92%,PIK3R1;MYCN;LIN28B;NMD3;MAP2K1;TP53;UTP15;RBM20;DIMT1;RIPK1;HNRNPLL;HABP4;DXO
prerank,intracellular protein transport (GO:0006886),0.2530250011998993,0.9618720788833048,0.5890710382513661,0.9565710205348466,1.0,72/304,20.16%,PRICKLE1;UNC93B1;GGA2;RAB20;CSE1L;RABGAP1L;TBC1D16;CACNG3;RABL3;ANKLE1;COPA;SEC16A;NUP214;NGFR;COPZ2;FAM53C;SORL1;NUTF2;POM121;NAPB;CLIP3;MYO6;SYNDIG1;VIPAS39;TBC1D1;TRIM23;VPS26C;RAB29;APPL2;FAM53A;TBC1D8B;BCS1L;SLU7;RAB24;SRPRA;SAR1A;NUP42;SCFD1;RANBP3;TNPO1;PTTG1IP;ARFIP1;NUP107;AKAP6;AP3D1;EIF4ENIF1;NXT2;TBC1D9;STRADB;SNF8;RTN2;CTTN;VPS33B;USP6NL;TNPO2;CALR;XPO6;TMED3;IPO9;TMED9;TBC1D17;NUP155;LTBP2;KPNB1;KIF13B;HOMER3;VPS45;RAB3GAP2;XPO1;ARL5C;COPB2;ARL4A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3436155641212872,0.9612947952945295,0.5331278890600925,0.957295858978547,1.0,6/33,10.61%,TEAD1;GNL3;NGFR;FOS;SRF;TP53
prerank,fatty acid transport (GO:0015908),0.39601892372227093,0.9612523584595973,0.5178875638841567,0.9565694255316479,1.0,5/17,14.48%,PPARD;FABP5;FABP4;FABP3;SLC25A17
prerank,microtubule polymerization (GO:0046785),-0.30237611672670184,-0.9609100214693681,0.4830287206266319,0.7740338624205992,1.0,8/28,15.48%,CSNK1D;NDEL1;MAPT;TUBGCP5;MAP7D3;SLAIN2;TRPV4;TPPP3
prerank,regulation of protein sumoylation (GO:0033233),0.39140856158684345,0.9608919122380697,0.5069204152249135,0.9566676327073121,1.0,3/17,10.22%,GNL3;CAPN3;SAE1
prerank,protein localization to organelle (GO:0033365),-0.22080235633192277,-0.9607169722834887,0.5615763546798029,0.7738095643777461,1.0,32/133,17.91%,BBS9;APP;PACSIN2;CSNK1D;VPS35;DVL1;GBP5;SIX1;TOLLIP;VAPA;ARL6;STX1A;UBAC2;GBP2;ANK2;RPL11;ARFRP1;TSPAN17;IFT140;OPTN;RAB35;LMNA;GAK;YBX1;TOR1A;BICD2;CROCC;ARL1;RAB6A;ISG15;HHEX;LAMP2
prerank,cilium-dependent cell motility (GO:0060285),0.3656515559058225,0.960681746924101,0.5153473344103393,0.9564150705151182,1.0,5/22,15.25%,RSPH9;EFHC1;CCDC65;GAS8;CCDC39
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2711947978255918,-0.9604293897764904,0.49702380952380953,0.7738139727310338,1.0,18/40,23.63%,LEF1;FOXC1;NOTCH1;TGFB2;DAB2;SMAD3;BCL9L;MDK;EZH2;PDPN;TGFB1I1;SNAI1;SDCBP;RGCC;TGFBR2;TIAM1;WWTR1;AXIN2
prerank,positive regulation of protein depolymerization (GO:1901881),0.4235807790679281,0.9604134927752539,0.5176056338028169,0.9562942143073809,1.0,2/11,8.59%,SEMA5A;STMN2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.290280051690936,-0.9601415924277168,0.49271137026239065,0.7738251146651912,1.0,12/33,19.24%,IGF1;BCL2L1;TFRC;MAPT;GPX1;SLC25A5;ACAA2;ADCK1;PRELID1;GHITM;AKT1;HGF
prerank,cytokine-mediated signaling pathway (GO:0019221),0.24636352904775743,0.9599222689714025,0.6162551440329218,0.9568239740225736,1.0,61/532,12.57%,RORA;IL33;GHR;IL34;IL15RA;PIK3R1;ZEB1;IL1RN;MAP3K14;IL2RA;XCL1;CXCL10;EDA2R;EDA;CXCL1;IL1R2;CD40;IL16;FLT3LG;IL18RAP;GAB2;JAK1;PSMD1;TSLP;FSCN1;YWHAZ;FOS;CCL15;IRS1;IFIT2;PSMD10;IRS2;COL1A2;PSMA5;BCL6;HNRNPA2B1;PSMB5;IL5;TWIST1;PLP2;PRKACA;IFNLR1;SOX2;TRIM8;APPL2;SP100;IL1RAP;BIRC2;IRAK1;PSMC4;CCL25;TP53;PSMA4;PYCARD;FYN;PSMC5;IL12A;CD86;PDCD4;HSP90B1;ST18
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3744724237758889,-0.9593727136175781,0.5212264150943396,0.775013821538425,1.0,2/12,10.91%,PPHLN1;ATF7IP
prerank,lytic vacuole organization (GO:0080171),0.3426107830389905,0.9593689447254256,0.5180722891566265,0.9574792694338241,1.0,8/32,15.60%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3212482807462488,-0.9593301182954576,0.49736842105263157,0.7744271844633717,1.0,9/21,24.36%,COX15;PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L;COA6
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3389966965846074,-0.9591392862585242,0.5,0.7742192341975378,1.0,3/19,4.37%,VIM;RUNX1;WNT4
prerank,cellular response to nutrient levels (GO:0031669),-0.25448860395531214,-0.9591156700568113,0.5618374558303887,0.7735761641325173,1.0,22/62,22.74%,FOXO1;FNIP1;BMPR2;HSPA8;SREBF2;PRKAA2;KCNB1;SFRP1;RRAGC;CLEC16A;FAM107A;RALB;MFSD2A;SIRT1;PRKAA1;MAP1LC3A;LAMP2;RRAGB;MAP1LC3B;WDR45;INHBB;KLF10
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.24756601736374087,0.9589921336955135,0.5794491525423728,0.957673680201406,1.0,97/417,18.84%,ZEB1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;HDAC1;L3MBTL1;WNT5A;NR2F2;TCF7L2;BASP1;SALL1;CDKN2A;THRA;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;SCML4;MDFIC;RUNX1T1;ZNF423;ZBTB16;TLE2;FOXS1;BCOR;CAPN3;CALCA;CBFA2T3;GMNN;BRMS1;PAX9;BCL6;ZKSCAN3;EIF4A2;PER2;TWIST1;L3MBTL4;TLE1;DAXX;BMP7;GLI3;TP53;ZC3H8;MPHOSPH8;ZFPM2;SNW1;DAP;EPC1;ZNF318;SOX9;TWIST2;PDCD4;DPF2;HIC2;BTAF1;PHC1;PRDM5;ZMYND15;HDAC10;KDM5C;CREB3L1;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;CNOT7;CRY2;CENPF;ZHX3;SPINDOC;ZBTB7A;CBFA2T2;NONO;MBTD1;CIART;NR1D2;CALR;CDK5;MBD2;LDB1;SUV39H2;BMP2;MBD1;KAT7;HEY1;BRD7;ILF3;KHDRBS1;DEDD2;PEX14;THAP7
prerank,UV protection (GO:0009650),0.42784426266216713,0.9586235629335104,0.518581081081081,0.957826684788864,1.0,3/10,4.93%,FEN1;ERCC5;MFAP4
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3831332457906165,-0.9585112806339733,0.5045871559633027,0.7743715500053631,1.0,4/12,7.34%,ACTB;ACTG1;LAMA3;LAMA5
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.40507481452697786,-0.9584820058641805,0.5166666666666667,0.7737362101211612,1.0,5/10,25.89%,JARID2;SIRT1;DNMT3B;KDM1A;BRCA1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.38268433818836084,0.9580685162606998,0.49393414211438474,0.9584421581828139,1.0,3/17,12.02%,KDF1;AHI1;SOX9
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3874620262653663,0.9580123738684946,0.5177065767284992,0.9577485145083051,1.0,5/16,8.66%,PDE9A;MTPN;SLC9A1;TRPC3;PRKCA
prerank,regulation of cardiac conduction (GO:1903779),0.31064654277425363,0.9579916933099247,0.5198863636363636,0.9569711266892245,1.0,12/54,15.15%,ATP1A2;ITPR1;RYR2;TMEM65;ATP1A3;ATP2A2;PRKACA;FXYD4;RYR3;ASPH;STIM1;GJA5
prerank,cellular senescence (GO:0090398),0.34625212238289027,0.9578630354578613,0.5105008077544426,0.9564967143602274,1.0,5/27,9.97%,CDKN2A;TBX3;SRF;OPA1;MAP2K1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2941781782823391,0.9578391947346747,0.5558441558441558,0.9557285817164257,1.0,28/79,26.42%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,positive regulation of phagocytosis (GO:0050766),0.32258789866834575,0.9577694633085662,0.5173410404624278,0.9550820717811203,1.0,7/47,10.91%,IL15RA;MERTK;TUB;LYAR;APPL2;CYBA;PYCARD
prerank,plasma membrane organization (GO:0007009),0.30577765682623165,0.9577502965229459,0.5285714285714286,0.9543104537172304,1.0,9/61,10.42%,PLSCR4;EPB41L3;ABCD2;SPTBN1;ANK3;DEGS1;FA2H;SYT7;ARL8B
prerank,response to X-ray (GO:0010165),-0.36053061201148057,-0.9572790694571641,0.5209302325581395,0.7760953395250922,1.0,8/14,40.73%,ANXA1;BRCC3;ATM;LIG4;MSH2;XRCC4;XRRA1;XRCC5
prerank,nucleic acid metabolic process (GO:0090304),0.29883815392558616,0.9572709248198752,0.5155615696887687,0.954718310968835,1.0,7/69,8.81%,ENPP1;POLG;ANKLE1;FEN1;PDE12;HNRNPA2B1;WTAP
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2754255599250109,0.9570510608884253,0.5487179487179488,0.9544644654842851,1.0,12/113,8.66%,PTN;LAMC1;LAMB1;WNT5A;SEMA5A;TCF7L2;C5AR1;HTR2B;CDH3;PDCL3;PRKD1;PRKCA
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3036509864181793,-0.9568533665548088,0.5140449438202247,0.7764445654640161,1.0,5/29,7.68%,IL31RA;FER;NMI;SOCS2;IFNAR1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2445077181512186,0.9566675837149028,0.6122881355932204,0.9546792365539304,1.0,95/476,17.02%,RORA;ZFHX3;ATF5;RUNX2;PPARA;TEAD1;RGMB;KMT2E;HDAC1;WNT5A;NR2F2;TCF4;PHIP;ERBB4;SALL1;SMAD5;NR1H4;MED12;POU3F3;PPARD;NR1H2;TEAD2;REST;FOS;ZIC1;KMT2A;MDFIC;ZNF423;ZBTB16;CXXC1;SPP1;MYCN;CAMKK2;CREB3L2;CAPN3;TRIM56;TAF15;NPAS2;SPIN1;ZKSCAN3;SOX2;BICRAL;EDF1;NCOA1;GLI1;XPC;SP100;BRCA2;BMP7;KAT2A;NSD1;GLI3;ENY2;MAP2K1;CAMK4;SOX10;PPP3CB;TP53;SMARCA1;TGFBR1;PSMC5;EPC1;ZNF318;ESR2;SOX9;CD86;TFEB;HIVEP3;TESC;TRIM44;AXIN1;BICRA;MED1;MYRF;ARNT2;ELK1;UBE2V1;F2R;CHD8;FOXM1;HNRNPD;TFAP4;GTF2H1;PRMT2;AR;MYC;MAFB;MMS19;TRIP4;DVL3;USP21;USP16;ATMIN;MAZ;NR1D2
prerank,male meiosis I (GO:0007141),0.3951833898555978,0.9566530067879855,0.536115569823435,0.9538895457531488,1.0,4/16,15.64%,SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,protein homotetramerization (GO:0051289),-0.26597493831040003,-0.9566038060550376,0.5469255663430421,0.7763607430247301,1.0,13/49,17.60%,ALDH1A2;SAMHD1;SOD2;GBP5;B2M;UPB1;KCNJ2;CBR4;KCNJ12;ACOT13;CBY1;ACACB;ALDOA
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.34774820979795756,0.9564442438166092,0.5057096247960848,0.9536122388083219,1.0,5/27,10.09%,PDGFRA;IRS1;PTK2;PRKD1;FGR
prerank,cellular response to oxygen-containing compound (GO:1901701),0.25286294991304326,0.9563310758662574,0.5993449781659389,0.9530707226185209,1.0,47/291,14.07%,RORA;PDGFRA;CXCL10;CPEB1;WNT5A;CXCL1;GPLD1;ERCC6L2;PDE4B;NR1H4;P2RY1;FOS;NCOA3;PDCD1LG2;IRS1;CAMKK2;PRDX5;CD68;PRKD1;AXL;KCNC2;MTOR;TLR4;HCN2;WNT3;HCN1;PLAA;IRAK1;EPHA3;HCN3;GLRA1;DHX36;PYCARD;P2RX4;SNW1;PDK2;SOX9;HTRA2;CD86;PDCD4;HSP90B1;GLRA2;TESC;AKAP6;NRIP1;RYR3;LYN
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.25780073488860517,-0.9563225614851347,0.5389830508474577,0.7763360858886611,1.0,18/53,19.03%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;PSMB10;OAZ2;PSME2
prerank,negative regulation of axonogenesis (GO:0050771),0.3537143509607922,0.9562532438280495,0.5351437699680511,0.9524467458860435,1.0,9/27,22.35%,PTEN;NGFR;CDKL3;DCC;ULK2;RHOA;EFNB3;MCF2;GDI1
prerank,cellular response to glucose starvation (GO:0042149),-0.27119438248049216,-0.9561648847131635,0.5245901639344263,0.7760188923208785,1.0,11/41,20.89%,PRKAG2;BECN1;SESN1;PRKAA2;SIK1;MYBBP1A;PRKAG3;PRKAA1;NUAK2;HNRNPA1;ASNS
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.36774893522231983,0.9560686892528429,0.5087440381558028,0.9521226070983354,1.0,4/22,8.59%,NTRK3;NTRK2;TMEM108;STMN2
prerank,defense response to virus (GO:0051607),0.28259078097003687,0.9559180704738106,0.538558786346397,0.9516955250280099,1.0,12/100,11.69%,MAP3K14;CXCL10;RTP4;CD40;IFIT2;TLR8;PDE12;TRIM56;IFNLR1;EIF2AK2;PYCARD;AGBL4
prerank,leukotriene metabolic process (GO:0006691),0.3750121805093496,0.9558598380801445,0.49916805324459235,0.9510248845307895,1.0,1/19,0.52%,GGT5
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.27476650386996304,-0.9556038696999698,0.5652173913043478,0.7767148222141322,1.0,13/40,19.24%,IGF1;BCL2L1;TNFSF10;BAD;GPX1;BAX;BID;PRELID1;GPER1;GHITM;PLSCR3;AKT1;HGF
prerank,artery development (GO:0060840),0.365545845968086,0.9555133068524309,0.5049180327868853,0.9511542839677389,1.0,5/23,15.15%,ROBO2;NF1;TGFBR1;HECTD1;GJA5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2875681742917041,0.9552475868390065,0.5321100917431193,0.9510485642574774,1.0,34/87,25.64%,TIMMDC1;DMAC2;OMA1;IMMP2L;NDUFS7;TMEM126A;NDUFS5;BCS1L;SLC25A33;NDUFV2;NDUFAF7;COX16;NDUFV3;NDUFC2;SURF1;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;UQCC2;TMEM126B;TIMM21;NDUFA10;CHCHD4;LYRM7;NDUFS1;NDUFAF2;COX17;NDUFB6;SAMM50;DMAC1;NDUFB8
prerank,regulation of protein export from nucleus (GO:0046825),-0.3184350071937498,-0.9551237902522505,0.517948717948718,0.7771585340872281,1.0,7/23,14.82%,PTPN14;RBM22;GSK3B;IFI27;RANGAP1;BAG3;RAPGEF3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.29446571473110084,0.9549840718309487,0.5509138381201044,0.950087885802913,1.0,28/78,26.42%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.29446571473110084,0.9549840718309487,0.5509138381201044,0.950087885802913,1.0,28/78,26.42%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,apoptotic process (GO:0006915),0.2576334082122056,0.9549458429477443,0.5523917995444191,0.9493700114816684,1.0,42/203,15.40%,DLC1;IL2RA;MAGI3;OGT;FAP;NGFR;PPARD;ELMO1;CASP6;ZBTB16;IFIT2;DHCR24;ADORA2A;CASP4;CAPN3;ARHGEF6;KREMEN1;TNFRSF19;DCC;MTOR;DDX41;TNFRSF21;PYCARD;JADE1;IAPP;DAP;CASP12;PDCD4;FAM162A;DPF2;MRPS30;BNIPL;ATN1;SCN2A;MELK;ERCC2;BAK1;RIPK1;BAG6;YARS1;AIFM2;MYC
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4365381967805797,0.9547675582137217,0.5119705340699816,0.9490634008038055,1.0,3/10,17.29%,XCL1;CD81;LGALS9
prerank,protein localization to cell surface (GO:0034394),-0.3043139133400787,-0.9545525073340664,0.4986225895316804,0.7777878417725546,1.0,10/26,23.52%,VCL;PTPRK;MESD;ANK2;PIGU;FLNA;UNC50;WNT11;PIGK;SMURF1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.33894125418116217,0.9543949692703991,0.5273264401772526,0.9492638326623581,1.0,10/31,23.40%,REST;CACNA1G;SYT3;SYT7;SYT5;ADRA2A;SYT6;SYT1;CACNA1I;SYT4
prerank,positive regulation of protein catabolic process (GO:0045732),-0.23949833109648247,-0.9543526244937449,0.5630252100840336,0.7775946342652514,1.0,24/84,20.53%,FOXO1;WWP1;EZR;RDX;VPS35;WWP2;GPC3;APC;APOE;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2;VPS11;FURIN;OAZ1;VGLL4;OAZ2;MSN;FZR1;TNFAIP3;ADAM9
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3611078716707309,0.9543511453244364,0.5096153846153846,0.9485581785187145,1.0,6/24,12.36%,LIG3;POLK;RPA1;RFC3;XRCC1;POLB
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3806718169158837,-0.954271028237353,0.5162907268170426,0.77709942813101,1.0,4/12,17.22%,FOXP1;KLF4;MAP2K5;CD74
prerank,activation of GTPase activity (GO:0090630),0.28610822306784056,0.9541864645612136,0.5348525469168901,0.9481705062385074,1.0,12/89,7.41%,NTRK3;ARHGAP22;RABGAP1L;TBC1D16;SIPA1;ABR;SCRIB;GARNL3;ARHGAP24;SIPA1L3;DOCK7;TBC1D1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.22886286947304124,-0.9539540277888283,0.615,0.7771351216440837,1.0,34/121,18.20%,VIM;ELAVL1;PSMC6;PSMD9;SAMD4A;HSPA8;PSMF1;PSMB7;YWHAB;PARN;UBB;PRR5L;ZC3HAV1;CNOT8;PSMD8;RC3H1;PSMD12;HSPB1;PSMA3;PSMA6;PSMD4;PSME3;EXOSC2;PSMD7;PSMB6;PSMC1;PRKCD;EXOSC3;PABPC1;PSMB10;GTPBP1;UBC;AKT1;SERBP1
prerank,regulation of gluconeogenesis (GO:0006111),0.35375421582557637,0.9538986552866121,0.5141509433962265,0.9481163472738555,1.0,5/27,11.68%,OGT;DGKQ;GCK;ERFE;PDK2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.42990258162221734,0.9538581283613816,0.5061946902654867,0.9474067950671554,1.0,2/10,7.93%,SEMA5A;CARMIL2
prerank,osteoclast differentiation (GO:0030316),-0.3102346275281815,-0.953675716992273,0.5128205128205128,0.7771232144094421,1.0,13/22,32.92%,FOXP1;MAPK14;OSTM1;GLO1;EPHA2;CSF1R;TYROBP;SRC;SBNO2;SNX10;CSF1;EFNA2;TREM2
prerank,regulation of mononuclear cell migration (GO:0071675),0.35401880239352207,0.9536651563640632,0.5056726094003241,0.9471553431276276,1.0,8/23,21.51%,IL34;PTK2;LYN;AKIRIN1;BMP5;CMKLR1;RARRES2;MAPK1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.251723897022275,-0.9536326480916348,0.5597269624573379,0.7765369774074375,1.0,9/57,10.08%,DAPK1;ARL6IP5;TNFSF10;MAP3K5;UACA;PPM1F;CASP8;BAD;PERP
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.34921476696664044,0.9535507605556083,0.5227629513343799,0.946663469581004,1.0,2/27,1.70%,PDGFRA;WNT5A
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24676754259069628,-0.9534886903423775,0.551094890510949,0.7761713907359405,1.0,28/69,28.08%,MEF2C;RETREG1;SOD2;SIX1;NGF;NRBP2;APOE;SNX6;CX3CR1;MDK;FOXQ1;PTK2B;CX3CL1;ZPR1;RASA1;ERBB3;SIX4;KDM2B;CLCF1;MT3;NTF3;CRLF1;LIG4;PARK7;VSTM2L;BDNF;NDNF;MSH2
prerank,positive regulation of peptidase activity (GO:0010952),-0.3218139443837368,-0.9532513653568794,0.5314861460957179,0.7760699659204611,1.0,10/20,29.74%,VCP;CTSH;APH1A;APH1B;PSME3;PRELID1;PSME2;NDUFA13;VSIR;TANK
prerank,cellular response to alkaloid (GO:0071312),0.3862755160910998,0.9531075780708574,0.5121951219512195,0.9469847013309964,1.0,4/17,13.69%,RYR2;CASP6;SPIDR;RYR3
prerank,long-term memory (GO:0007616),-0.32768523119497955,-0.9530630470009094,0.531578947368421,0.7758354321719058,1.0,4/19,10.54%,RASGRF1;APOE;SHANK1;CPEB3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.2884285678195248,-0.9530132610037936,0.5206611570247934,0.7752799446909838,1.0,7/31,10.36%,EPHA4;PDLIM5;SIPA1L1;SHANK3;NGEF;CFL1;CAMK2B
prerank,oligodendrocyte differentiation (GO:0048709),0.3760932099738742,0.9529635056865896,0.5167785234899329,0.9465781476502689,1.0,9/19,23.38%,SOX6;EIF2B1;SOX10;SOX9;MYRF;CDK5;PTPRZ1;NSUN5;EIF2B5
prerank,nuclear membrane reassembly (GO:0031468),-0.25874213566856935,-0.9523461301479399,0.5804195804195804,0.7762989845238042,1.0,21/54,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,regulation of protein localization (GO:0032880),-0.2598488824649909,-0.9521688940199355,0.5514705882352942,0.7760615767350806,1.0,8/58,8.31%,PICALM;AFDN;DVL1;TRIM25;TRIM5;TRIM14;PPM1F;CEP290
prerank,regulation of amyloid fibril formation (GO:1905906),-0.35420657389305965,-0.9521566669062812,0.5322195704057279,0.7754052865055789,1.0,3/15,7.21%,APP;CRYAB;APOE
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2388351560157268,-0.9518451844144694,0.5421686746987951,0.7754092661128662,1.0,23/80,19.93%,ERC1;VTI1A;VPS35;SNX32;ARFRP1;SNX6;SGSM2;SPAG9;SURF4;CLN5;TBC1D10B;VPS51;VPS29;TRIM27;LMAN1;ARL1;TMEM87B;RAB6A;SNX3;VPS54;PLEKHJ1;TBC1D14;TBC1D5
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4313943057438162,0.9517985415979813,0.5464285714285714,0.9488311450130159,1.0,4/10,12.02%,LOXL2;SOX6;ZBTB16;SOX9
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23670192448929292,0.9517666716127297,0.713,0.9481164733082366,1.0,289/1668,17.45%,TBX18;RORA;IL33;GBX1;ZNF367;LPIN3;DCN;PIK3R1;ZEB1;ZBTB20;ISL2;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;PKNOX2;CXCL10;RUNX2;ARID3A;PPARA;HOXC10;AUTS2;MEIS1;MIER2;TEAD1;OGT;ETV5;TEF;HDAC1;PPID;WNT5A;TAF9B;PTEN;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;SALL1;AGO4;CDKN2A;THRA;SMAD5;NR1H4;PEX2;CDK8;ZFHX4;MAML3;ZIC4;PER3;HTATSF1;NCOA2;MEIS2;PGR;NFATC3;ZNF740;MED12;THAP3;METTL23;MYT1;JUP;POU3F3;PPARD;PIK3R2;NR1H2;TEAD2;LOXL2;REST;TBX3;FOS;ZBTB24;SOX6;NCOA3;ZIC1;KMT2A;FOXO6;HOXC9;ZBTB16;CHD4;IFRD1;MYCN;DMRTA2;BCL9;ZFP37;RTF1;SIRT6;EPAS1;HLF;CREB3L2;SSBP4;SLC9A1;FOXS1;PSMD10;BCOR;E2F4;ZBTB46;BRD8;CRTC2;GLIS1;DUSP22;TENM2;SRF;CSRNP3;BRMS1L;BRMS1;NPAS2;PAX9;ZBTB2;TRIM37;MYO6;AKIRIN2;LYAR;BCL6;FIZ1;DGKQ;ALX4;NR2C1;TAF3;CSRNP2;ZKSCAN3;MDM4;PER2;MED6;PIAS2;TWIST1;PRKD1;PFKM;CDK13;CHD2;SOX2;MXI1;NOC2L;NCOA1;PHF6;GLI1;OLIG2;PRKCB;TTC21B;SP100;TLR4;WIZ;DDX17;BHLHE22;KAT2A;NSD1;GLI3;ZBTB43;ENY2;HOXC8;AHI1;SOX10;ZBED3;PPP3CB;TP53;N4BP2L2;SMARCA1;DHX36;ZFPM2;MED10;AGO3;ZNF292;ZBTB39;ZNF25;MED8;SNW1;MSX1;PSMC5;HOXB9;ZBTB26;EPC1;RFX2;GTF2H3;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TWIST2;IGF2;TFEB;HOXB4;ST18;SAP30;DPF2;ELP4;PPIL4;KDM1B;HIVEP3;CD81;HIC2;CNOT1;DMRTA1;ACTR2;PRDM5;ATN1;NRIP1;NFIX;HOXC4;MYDGF;ZFP1;HDAC10;RFX4;CRK;PEG3;MED1;SREBF1;CUX2;ZFP64;ARNT2;UBE2D1;MED25;DOT1L;SSBP2;ELK1;BPTF;ZSCAN18;PRKAR1A;SNF8;CREB3L1;ASXL1;ZBTB32;MYNN;RIPK1;CHD8;FOXM1;CIAO1;HOXC5;TFAP4;DHX9;EAF2;DMAP1;PBX2;GTF2H1;ZBTB25;SAFB2;AR;GDNF;ATF2;MYC;LPIN2;PRDM10;CRY2;ORC2;TNRC6B;LAGE3;FOXJ3;ZHX3;DCAF1;FGFR2;KLF11;HOXA9;MAFB;ZKSCAN5;KDM2A;IMPACT;PLAC8;EFNA1;AKIRIN1;ZBTB7A;AASS;ZNF467;ONECUT2;ZNF3;DVL3;CCNK;SRA1;USP16;ZFP62;JAG1;HAX1;TOX2;ATMIN;ZIC5;MAZ;NR1D2;CALR;ZBTB12;DNMT3A;SARS1;CREG1;MBD2;AGO1;LDB2;LDB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.30061491905637727,-0.9516898362765093,0.5390835579514824,0.7750889089247028,1.0,7/27,15.33%,KHNYN;NYNRIN;PARN;DICER1;RPP30;RNASE4;ERN1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.25609057957237974,0.9513097271026176,0.5947136563876652,0.9485209853044106,1.0,59/248,18.28%,PRICKLE1;HDAC1;WNT5A;LYPD6;CDK14;SEMA5A;TCF7L2;BICC1;ADGRA2;RNF220;NKD1;NPHP3;PSMD1;MCC;JUP;GPC5;RBMS3;CDH3;LRRK2;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;ZBED3;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;WNK2;DAAM2;LGR5;CHD8;CSNK1E;AMER2;FGFR2;USP34;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LRRK1;LZTS2;PSMA2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.37228986648943085,-0.9511419084119813,0.5169300225733634,0.7756284886249228,1.0,4/12,10.44%,NFIB;EPHA4;GLI2;EPHB2
prerank,protein targeting to lysosome (GO:0006622),0.36906642433410686,0.9510857257434887,0.5232358003442341,0.9482804026866473,1.0,6/20,15.09%,SORL1;NEDD4;SNX16;AP3M1;HGS;CLU
prerank,covalent chromatin modification (GO:0016569),0.407543789934358,0.9509269928814352,0.5188356164383562,0.9478833128255145,1.0,2/14,5.94%,HDAC1;SETD5
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3107036729147039,-0.9506916518795077,0.529891304347826,0.7760828930828899,1.0,6/24,9.10%,SORBS1;IGF1;INSR;PPP1R3B;GSK3B;DYRK2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4154294888902044,0.9506528993693194,0.5132743362831859,0.9478166510632763,1.0,2/10,6.34%,ACADL;ACADS
prerank,regulation of cell-substrate adhesion (GO:0010810),0.31833996724879166,0.9506248958322996,0.5291479820627802,0.9470749656469085,1.0,6/42,7.71%,FBLN2;CORO2B;GCNT2;NF1;PTPRO;PTK2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3024062500834352,-0.950583396287793,0.5075,0.7756655306506269,1.0,13/24,32.92%,PPHLN1;PPM1D;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;PHF1;MTF2;SPI1;BMI1;H3-3A;PHF19
prerank,lipid droplet formation (GO:0140042),-0.39300146089539095,-0.9504306898273687,0.5176211453744494,0.775340619900475,1.0,4/10,23.41%,CDS1;CDS2;PLA2G4C;FITM2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.4472796025287937,0.9501966550150143,0.5369369369369369,0.9474713015316228,1.0,5/10,16.08%,CORO2B;TERF1;NDFIP2;SNX12;NDFIP1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.41257021404535615,0.9499404585701802,0.5295169946332737,0.9473801929071544,1.0,1/13,0.70%,COL4A1
prerank,regulation of cell killing (GO:0031341),-0.34772128219726345,-0.94987570379553,0.5091324200913242,0.7760209768606574,1.0,5/16,10.45%,CD55;TGFB2;RAC1;FZD7;ICAM1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.29325703662135816,0.9493828840500409,0.536096256684492,0.9480683037939023,1.0,10/67,11.12%,PDGFRA;GHR;TXK;ERBB4;FGFR1;PTK2;RELN;FGR;EPHA3;FYN
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3432882473572398,0.9490886598986247,0.5190476190476191,0.9480516085874,1.0,6/30,11.96%,NPC1L1;DHCR24;ACAT2;PLPP6;HMGCS1;ACLY
prerank,regulation of translational initiation (GO:0006446),0.3009982835058047,0.9490771902104923,0.5296551724137931,0.9472872122630391,1.0,23/63,24.63%,EIF4G3;EIF3H;FMR1;BOLL;RPS6KB1;EIF4A2;GLE1;PAIP1;IMPACT;EIF5B;MTIF2;HABP4;KHDRBS1;YTHDF1;EIF2AK3;CTIF;DDX1;NCK2;EIF4B;EIF2B5;ATF4;MIF4GD;POLR2D
prerank,cellular protein localization (GO:0034613),0.25010755333586343,0.9490050477434026,0.5862831858407079,0.9466989851680265,1.0,38/285,10.37%,EPB41L3;UNC93B1;GGA2;RTP4;WNT5A;MYO7A;ATG9B;RAB20;CNTNAP2;RABGAP1L;TBC1D16;GRID2;RABL3;COPA;WDR45B;GJA1;NGFR;COPZ2;LRRK2;SEPTIN9;NAPB;CAPN3;CEP68;MYO6;PTPRU;SYNDIG1;VIPAS39;TBC1D1;TRIM23;JAM3;VPS26C;RAB29;ITSN1;TBC1D8B;SLU7;RAB24;AHI1;SAR1A
prerank,negative regulation of cellular component movement (GO:0051271),0.3922107698599506,0.9488825334714095,0.5371329879101899,0.9462067914660254,1.0,5/15,18.40%,SPOCK3;ACTN1;SP100;CRK;FBLN1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2221317349572287,-0.9488145022513743,0.6318407960199005,0.7779502620192854,1.0,46/132,27.62%,RPS14;PTGES3;PRKDC;EIF5;SF3B1;RPL5;EIF2S2;SCAF11;RPS19;DICER1;PRMT7;RPS27;KHDC4;RPS15;MCTS1;CELF1;RPL10;RPS5;RPL11;SNRPC;GCFC2;SNRPE;RPLP0;SRPK1;SNRNP200;MRPS7;SNRPD1;RPL23A;SART1;EIF4H;MRPL20;CLP1;PRPF19;DDX20;PUF60;SF3A2;USP39;CELF5;PWP2;RPL38;SMN1;NOP2;RPF2;CPSF6;CPSF7;STRAP
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2679468300072582,-0.9483381030175357,0.5512820512820513,0.7784093306874144,1.0,12/41,20.84%,ACTN2;ANK2;STAC;KCNJ2;KCNQ1;KCNJ12;NOS1;FLNA;NOS1AP;CTSS;ACE2;KCNJ15
prerank,mitotic cell cycle phase transition (GO:0044772),0.25700972145837325,0.9475571158472141,0.5899198167239404,0.9488171550037152,1.0,53/203,21.66%,DYNLL1;CDK14;CDKN2A;CCNJ;DCTN3;HAUS3;PKMYT1;HAUS1;CDC7;CCDC57;DCTN2;CDC16;CDKN2D;HAUS8;RPS6KB1;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;CACUL1;PPP6C;BCAT1;SSNA1;RCC1;CUL5;CDKN2C;MELK;DBF4;CLASP2;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;MYC;BRSK2;CLASP1;ALMS1;CAMK2A;PCM1;CCNE1;KHDRBS1;CUL4A;TUBA1A;POLE;CEP43;LATS2;INHBA;FBXL22;CCND3;CDK7;BTRC
prerank,glycerophospholipid catabolic process (GO:0046475),0.34110456469817363,0.9469713991204642,0.5273865414710485,0.9495407448437456,1.0,7/27,12.04%,PRDX6;LIPC;SMPD4;ENPP6;PLA2G7;ABHD16A;ABHD12
prerank,RNA splicing (GO:0008380),0.2806069201486038,0.9469417208782638,0.5549872122762148,0.9488249764421927,1.0,28/95,22.42%,TRA2B;GEMIN2;NOVA1;SNRNP35;ZRSR2;NOL3;LSM4;BCAS2;SRSF11;MPHOSPH10;SMU1;RP9;SLU7;DBR1;SNRNP48;SRSF10;PRPF18;SNRPF;NONO;SF3A3;PPIG;ZCRB1;LUC7L3;PRPF8;DDX39B;DHX15;WBP4;HNRNPH3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.29672527639240975,0.9468735836937399,0.5204359673024523,0.948192017331117,1.0,12/59,13.50%,ROBO2;TENM3;PTPRT;DSCAM;CNTN4;DSCAML1;PALLD;NEXN;CNTN6;PLXNB2;CADM3;NECTIN3
prerank,positive regulation of integrin activation (GO:0033625),-0.39061370537558426,-0.9467832527128556,0.5472103004291845,0.7814853006615522,1.0,5/11,24.78%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3406076794288209,-0.9463409324524324,0.537712895377129,0.7818208788314653,1.0,5/18,16.99%,DDX5;EGFR;MAP2K2;TERT;ESR1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.41588406661810284,0.9462514801523396,0.5451327433628319,0.9489885773163895,1.0,5/12,17.70%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.22848450921504493,-0.9460583881735631,0.616822429906542,0.7817811695611531,1.0,32/98,21.19%,SLCO1C1;THBS1;KLF4;MAGI2;INSR;IL10RB;INPP5F;MAPK14;APOE;XDH;IFNAR1;NFKBIA;STARD4;RNF41;CD63;CHCHD2;AGTR1;GRB2;CDKN1A;PRELID1;RAB1A;ACACB;GHITM;AKT1;EGF;ACE2;PID1;TBC1D5;AGT;RAB1B;ROMO1;TGFBR2
prerank,glucose import (GO:0046323),-0.36279404775897467,-0.9458675554946901,0.5507900677200903,0.7815440369634382,1.0,8/13,48.84%,SLC2A1;SLC2A4;RAB4B;SLC27A4;SLC27A1;SLC2A3;SLC2A10;TRARG1
prerank,regulation of signal transduction (GO:0009966),0.25672920987534265,0.945633568579616,0.593279258400927,0.9497808965532284,1.0,28/190,11.70%,RORA;SULF1;TMEM204;MTCH1;OGT;TSPEAR;SEMA5A;ITGA3;RGS20;ZIC1;MDFIC;ANKRD54;LRRK2;TMEM108;LLGL1;IFT81;KCTD8;DGKQ;PRKD1;RGS8;GLI1;SP100;IRAK1;DOK5;FYN;USP33;SNW1;UBASH3B
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.34021528277705576,-0.9454445911770029,0.520618556701031,0.7818331451680406,1.0,5/16,9.65%,CACNA1C;CAMK2D;CALM1;ANK2;DMD
prerank,positive regulation of translation (GO:0045727),-0.23071462477019955,-0.9453384065991545,0.5708502024291497,0.781399235796563,1.0,20/94,13.78%,VIM;LARP4;THBS1;RPS9;ELAVL1;PRKDC;NIBAN1;YBX3;SAMD4A;LARP4B;RPL5;SOX4;PYM1;CPEB3;RPL26;EIF3D;RPS4X;PKM;POLR2G;NGRN
prerank,regulation of translation (GO:0006417),0.2613313683110203,0.945142664152851,0.574052812858783,0.9502193717442764,1.0,44/173,19.24%,EIF4G3;PRR16;PLD1;NAT10;EIF4A3;NANOS3;EPRS1;EIF3H;LSM14A;FMR1;MTPN;LARP6;CAPRIN1;RPS6KB1;EIF4A2;GLE1;PAIP1;MTOR;MTRF1;EIF2AK2;GRM5;DHX36;PLXNB2;CNOT1;MALSU1;EIF4ENIF1;RBM4B;PUS7;HNRNPD;DHX9;CNOT7;IMPACT;TSC1;IGF2BP3;CYFIP1;EIF5B;CALR;MTIF2;EIF3C;ILF3;YTHDF1;EIF2AK3;CTIF;FXR1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.39745514735979,-0.9447741675811803,0.5540229885057472,0.7821035584908375,1.0,5/10,34.72%,TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,positive regulation of behavior (GO:0048520),-0.3914958575380437,-0.9446975018370545,0.533175355450237,0.7816420572245328,1.0,1/10,0.87%,MEF2C
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3546549302782045,-0.9444681635447051,0.5211267605633803,0.7815022368217454,1.0,4/14,22.66%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,glycine metabolic process (GO:0006544),0.425681410046541,0.9443812779853056,0.5314685314685315,0.9513441403222807,1.0,2/12,13.26%,GLDC;AMT
prerank,lymphocyte differentiation (GO:0030098),-0.24244097557456715,-0.9440331100352202,0.5563636363636364,0.7818656798809531,1.0,20/68,21.24%,PBX1;LEPR;PTPRJ;TPD52;ITGB1;HDAC4;SOX4;DNAJB9;PIK3CD;PTPN2;PLCG2;SLC25A5;LFNG;FLT3;VCAM1;HHEX;BLNK;NFIL3;KLF6;RHOH
prerank,snRNA 3'-end processing (GO:0034472),0.3795621714166071,0.9436454131503823,0.5220949263502455,0.9524946084785636,1.0,5/19,15.89%,INTS8;INTS14;EXOSC9;EXOSC8;EXOSC5
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3832712534610963,0.9430872846621042,0.5396551724137931,0.9531486886515169,1.0,3/16,9.13%,PPARA;PINK1;AK4
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3419656614229622,0.9426269432954054,0.5263157894736842,0.9535292951012251,1.0,9/27,15.59%,FMR1;MYCN;MAP2K1;TP53;EIF4ENIF1;RIPK1;DHX9;WTIP;TNRC6B
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2748696847733089,0.9423956979438604,0.5407503234152652,0.9533446836671275,1.0,27/100,19.94%,PRICKLE1;OGT;GLMN;EIF3H;RNF180;LRRK2;PSMD10;HERPUD1;CBFA2T3;COMMD1;NKD2;FHIT;ZYG11B;HECTD1;GSK3A;DDA1;BAG6;CLU;CSNK1E;DET1;ARAF;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A;XPO1
prerank,ncRNA catabolic process (GO:0034661),0.3459509743613816,0.9422870122708221,0.5349593495934959,0.9528493917622384,1.0,10/28,19.04%,LIN28B;TENT4B;MTREX;EXOSC9;DIS3L2;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.35580893258765156,0.9422021892050686,0.5072463768115942,0.9522985571135133,1.0,3/23,6.74%,ZFYVE28;CBLB;DUSP22
prerank,positive regulation of protein sumoylation (GO:0033235),0.42471053754207755,0.9420010584925328,0.5444839857651246,0.9520489989849659,1.0,2/10,10.22%,GNL3;SAE1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4004974911103514,0.9419946728330931,0.5316239316239316,0.9512696045630138,1.0,1/13,1.01%,VDAC2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.40799581650353334,0.9409525139715817,0.5157894736842106,0.9531182090794468,1.0,2/12,8.42%,DOCK10;GPR183
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2687985539167095,-0.940900091594508,0.5615615615615616,0.7887415410805978,1.0,11/41,22.02%,IGF1;LBP;SIRPA;CD34;DICER1;CX3CL1;TRIM27;HAVCR2;TNFAIP3;SELENOS;ILRUN
prerank,protein deubiquitination (GO:0016579),0.2511628522403971,0.9403133945557774,0.589086859688196,0.9540202478244508,1.0,55/242,18.81%,IL33;STAMBPL1;OGT;TAF9B;PTEN;MBD6;PSMD1;USP1;PSMD10;UCHL3;OTULINL;PSMA5;USP42;PSMB5;MDM4;BIRC2;KAT2A;ENY2;RNF128;PSMC4;TP53;PSMA4;USP33;JOSD1;TGFBR1;PSMC5;USP19;HGS;POLB;PSMB9;KDM1B;ATXN3;UBE2D1;CCNA2;ASXL1;RIPK1;AR;MYC;YOD1;USP34;USP4;PSMA7;USP21;USP16;USP13;STAMBP;PSMD14;USP49;INO80E;TAF10;PSMA2;USP14;RHOA;HIF1A;PSMD11
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3084239904209531,-0.9402526007869071,0.5348258706467661,0.7896680671975786,1.0,7/24,14.67%,TEK;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.24571882382119037,-0.9401376006568718,0.6062717770034843,0.7892924227055863,1.0,16/61,19.39%,EYA2;EYA1;EGFR;EYA4;RNF8;RTEL1;PCNA;BRCC3;SMCHD1;NBN;UBE2N;SIRT1;USP9X;PPP1R10;HGF;RGCC
prerank,positive regulation of DNA repair (GO:0045739),-0.2715529624759001,-0.9400473587608845,0.5574912891986062,0.7888281504233203,1.0,11/46,15.99%,EYA2;EYA1;EGFR;EYA4;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;DDX11;SIRT1
prerank,RNA interference (GO:0016246),-0.33847694469512696,-0.9393171436004284,0.5310344827586206,0.7899918528282347,1.0,8/17,19.19%,TSN;DICER1;DROSHA;NRDE2;CELF1;TERT;AGO2;CLP1
prerank,peripheral nervous system development (GO:0007422),0.3598733991284666,0.9392735152392173,0.5697865353037767,0.9559333285833488,1.0,8/23,20.25%,ASIC2;ADGRB2;ADGRB1;NF1;SOX10;GDNF;ALDH3A2;SCN8A
prerank,response to interferon-beta (GO:0035456),-0.3140721104422495,-0.9391145406605332,0.5329815303430079,0.7898155616065543,1.0,10/22,29.08%,IFITM3;IRF1;IFITM1;CDC34;IFITM2;NDUFA13;IKBKE;PNPT1;TRIM6;IRGM
prerank,Golgi inheritance (GO:0048313),0.42086774989688147,0.938517787150499,0.546572934973638,0.9570738712614122,1.0,4/11,15.37%,YWHAZ;GBF1;GOLGA2;VRK1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.25858739950635284,0.9384953664864198,0.5794930875576036,0.9563546146594247,1.0,23/175,12.86%,MAP3K14;XCL1;EDA2R;EDA;CD40;PSMD1;CCL15;SMPD4;PSMD10;ADAMTS12;ZFP36L2;PSMA5;PSMB5;BIRC2;PSMC4;TNFRSF21;CCL25;TP53;PSMA4;PYCARD;PSMC5;ST18;PSMB9
prerank,negative regulation of complement activation (GO:0045916),0.4205699472656339,0.9382264336875712,0.532258064516129,0.9562373926503128,1.0,3/10,17.52%,SUSD4;CR2;A2M
prerank,sensory perception of smell (GO:0007608),0.4184447674359448,0.9380630769763849,0.541095890410959,0.955885099685578,1.0,3/11,22.63%,ADCY3;BBS4;UBR3
prerank,histone H4-K5 acetylation (GO:0043981),0.38665918953824785,0.9377913551423975,0.5304347826086957,0.9549795989144688,1.0,4/15,11.32%,OGT;WDR5;KANSL1;JADE1
prerank,histone H4-K8 acetylation (GO:0043982),0.38665918953824785,0.9377913551423975,0.5304347826086957,0.9549795989144688,1.0,4/15,11.32%,OGT;WDR5;KANSL1;JADE1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.34200970140867537,0.9376504330488382,0.5416012558869702,0.9545769763707518,1.0,2/26,2.01%,ZFYVE28;CBLB
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3301144966470354,-0.9371908829765266,0.5635491606714629,0.7936618085035335,1.0,6/17,16.15%,ERLIN1;SREBF2;APOE;FGF1;RAN;PRKAA1
prerank,protein secretion (GO:0009306),0.29467786697022214,0.9370111944845391,0.5605839416058395,0.9554511345678692,1.0,17/56,21.59%,STEAP3;SEL1L;RAB8A;RAB3C;RIMS2;RCN3;RAB15;TMEM167A;MTTP;TVP23B;LTBP2;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,regulation of adaptive immune response (GO:0002819),-0.329741781526284,-0.9367855895056789,0.5520833333333334,0.7939232118956433,1.0,10/18,35.60%,IL6ST;IRF1;TRIM27;SIRT1;SKAP1;FCGR2B;IRF7;SAMSN1;FADD;IL4I1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.38606943069062283,0.9365904192194614,0.5284974093264249,0.9557416824640226,1.0,4/15,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.38416738512293525,-0.9364513075780964,0.5274725274725275,0.7940342191823865,1.0,2/11,1.60%,DDX5;EGFR
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.285430721184732,-0.9363770387616077,0.5441176470588235,0.7935190289005233,1.0,14/33,22.33%,FHL1;KANK2;KLF4;APC;CDK6;WEE1;FAM107A;PLK5;CDKN1A;DCUN1D3;DLG1;RBL1;RBL2;CDK2AP2
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2769115575392305,-0.9362442654207549,0.5659824046920822,0.7931597594454413,1.0,11/33,22.71%,PICALM;ACTN2;GOPC;STX3;TOR1A;KCNAB2;HFE;EGF;TAX1BP3;RAB11FIP5;TYROBP
prerank,regulation of organelle assembly (GO:1902115),-0.24315955834740818,-0.9362200799409852,0.5954198473282443,0.7925265721032957,1.0,21/72,20.44%,TBC1D19;EZR;RABEP2;STX18;RDX;GSN;TBC1D8;TBC1D22B;RAB5A;IFT140;VPS11;TBC1D22A;CYLD;TBC1D10B;TBC1D13;MSN;NPM1;TBC1D14;PDCD6IP;TBC1D5;RAB1B
prerank,negative regulation of platelet activation (GO:0010544),0.3790524814816921,0.9359679245456498,0.511744966442953,0.9564899757510219,1.0,1/16,0.14%,PDGFRA
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.26489150373017706,-0.9356297799734868,0.5981873111782477,0.7931944769669568,1.0,12/45,22.99%,BMPR2;TGFB2;DAB2;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;INHBB;ACVR2A
prerank,glycerolipid catabolic process (GO:0046503),-0.3215261559697593,-0.9354835738210481,0.5409429280397022,0.7928289526761182,1.0,5/19,9.86%,GPCPD1;PLA2G4A;MGLL;GDPD3;ABHD2
prerank,sphingolipid catabolic process (GO:0030149),-0.35009612124236394,-0.9353930502313856,0.5690072639225182,0.7923532484574798,1.0,7/15,26.54%,ACER2;ACER3;ENPP2;SMPD1;SMPDL3A;ASAH1;ASAH2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.28248274270681556,0.935385953150277,0.5673202614379085,0.9571799908196279,1.0,20/85,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMA7;PSMD14;PSMA2;RHOA;PSMD11
prerank,regulation of B cell apoptotic process (GO:0002902),-0.37382130145545506,-0.9353501203471483,0.5594405594405595,0.7917761655289579,1.0,2/12,1.54%,FOXP1;FNIP1
prerank,aorta morphogenesis (GO:0035909),-0.3341918282942068,-0.9352316074294205,0.537712895377129,0.7913766414695184,1.0,6/17,12.73%,RBPJ;MYLK;TBX1;ACVRL1;TBX2;HEY2
prerank,protein acetylation (GO:0006473),-0.289957740548509,-0.9351044042272356,0.5472222222222223,0.7909863063372813,1.0,12/30,22.75%,FOXO1;NAA40;MAPT;ESCO1;ING4;KAT5;SIRT1;ING5;CLOCK;NAA80;NAA35;NAT9
prerank,neuron maturation (GO:0042551),-0.32772408473439524,-0.9349045461815347,0.5623471882640587,0.7907644095521775,1.0,7/18,15.96%,ANKS1A;APP;B4GALT5;SCARF1;CLN5;CX3CL1;SRRM4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.28840400535949984,0.9348222327449329,0.5750670241286864,0.9577641283639979,1.0,19/74,16.16%,SPRY1;PTEN;PHLDB1;SPRED1;LOXL2;GCNT2;IL17RD;GLIPR2;SPRED2;TWIST1;MTOR;EPHA3;MCRIP1;TGFBR1;OLFM1;CLASP2;FERMT2;CLASP1;EFNA1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.31246436174346015,-0.9347947779214416,0.5549738219895288,0.7903487473128604,1.0,4/23,8.34%,DKK3;LTBP4;SMURF2;SMAD3
prerank,regulation of coagulation (GO:0050818),0.4199922180483938,0.9344945636936994,0.5431034482758621,0.9578410856450315,1.0,3/11,14.71%,HRG;F2R;HS3ST5
prerank,heart process (GO:0003015),-0.3567946572559368,-0.9342878109497911,0.5670588235294117,0.790879317491852,1.0,3/14,12.99%,ACE;GPX1;NOX4
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3363777251897525,0.9341371166054292,0.5272435897435898,0.9579762526740017,1.0,7/29,14.51%,PDGFRA;IRS1;PTK2;PRKD1;FGR;CD81;ATG14
prerank,regulation of acute inflammatory response (GO:0002673),0.37302472023725425,0.9340806695860358,0.5420560747663551,0.9573484808618619,1.0,4/18,21.69%,KLKB1;PTGES;ADAM8;OSMR
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.38409253172992985,0.9337696589236941,0.5535117056856187,0.9573218926577045,1.0,4/14,14.26%,ANK3;SLC9A1;TESC;WNK2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2535248047151277,0.9336308513369626,0.5901060070671378,0.9569107071441659,1.0,25/190,11.90%,RORA;PPARA;CCDC22;PTEN;ITPR1;TSPAN6;NR1H4;DUSP1;PIK3R2;SPRED1;NPRL2;NF1;PSMD10;HERPUD1;CARD19;PLEKHA1;TWIST1;PINK1;NOC2L;TLE1;BMP7;PYCARD;RTKN2;BCL2L2;TRIM59
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.35826192904968085,-0.933592910553333,0.5401459854014599,0.7918177875342921,1.0,3/13,13.13%,RNF152;SESN1;ATM
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4212862467723963,0.9335040002182934,0.5431654676258992,0.9564633185722174,1.0,3/10,10.97%,ANK3;KCNAB1;KCNE4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3807976538801485,0.9333865019070052,0.5580589254766031,0.9559734386858708,1.0,4/17,9.46%,ATP1A2;SCN2B;CACNA1G;HCN2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.23262450845617752,0.9333557439402503,0.804,0.9552776374001472,1.0,341/1646,19.90%,TBX18;RORA;CHD7;GBX1;ZNF367;ZEB1;ZBTB20;ISL2;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;XCL1;PKNOX2;NRG1;RUNX2;ARID3A;PRICKLE1;PPARA;HOXC10;MEIS1;TEAD1;RGMB;OGT;ETV5;TEF;KMT2E;HDAC1;L3MBTL1;WNT5A;CDK14;NR2F2;TCF7L2;TCF4;PHIP;BASP1;ERBB4;SALL1;CDKN2A;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;HTATSF1;NCOA2;MEIS2;PGR;NFATC3;ZNF740;MED12;MYT1;POU3F3;PPARD;NR1H2;TEAD2;LOXL3;LOXL2;REST;TBX3;FOS;FBXO5;ZBTB24;SCML4;SOX6;ZIC1;KMT2A;FOXO6;MDFIC;RUNX1T1;HOXC9;ZNF423;RRP8;ZBTB16;FOXN2;CXXC1;SPP1;CHD4;IFRD1;MYCN;DMRTA2;CAMKK2;ZFP37;EPAS1;HLF;TLE2;CREB3L2;SETD5;FOXS1;BCOR;E2F4;ZBTB46;CAPN3;GLIS1;TRIM56;CALCA;TAF15;POLA1;CBFA2T3;SRF;GMNN;CSRNP3;HP1BP3;BRMS1;NPAS2;PAX9;ZBTB2;SPIN1;BCL6;DGKQ;ALX4;NR2C1;CSRNP2;ZKSCAN3;MDM4;PER2;MED6;PIAS2;TWIST1;SPTY2D1;CHD2;SOX2;MXI1;BICRAL;L3MBTL4;EDF1;NCOA1;PHF6;GLI1;XPC;OLIG2;TENM1;PRKCB;TTC21B;SP100;TLE1;WIZ;DDX17;BHLHE22;DAXX;SRRT;BRCA2;BMP7;KAT2A;NSD1;GLI3;ZBTB43;ENY2;MAP2K1;HOXC8;CAMK4;SOX10;PPP3CB;TP53;ZC3H8;NFXL1;MPHOSPH8;SMARCA1;DHX36;ZFPM2;ZNF292;ZBTB39;ZNF25;MED8;SNW1;MSX1;TGFBR1;PSMC5;DAP;HOXB9;ZBTB26;EPC1;RFX2;ZNF318;FOXJ2;ESR2;PROX2;SOX9;SRSF10;MYT1L;ZNF112;CDT1;TWIST2;CD86;PDCD4;IGF2;TFEB;HOXB4;ST18;SAP30;DPF2;ELP4;HIVEP3;HIC2;BTAF1;NUP107;TESC;PHC1;DMRTA1;TRIM44;ZNF628;PRDM5;ZMYND15;NFIX;AXIN1;CARM1;HOXC4;ZFP1;HDAC10;RFX4;CRK;PEG3;BICRA;MED1;SREBF1;CUX2;MYRF;ARNT2;SSBP2;ZNF326;ELK1;BPTF;ZSCAN18;TGFBRAP1;KDM5C;PRKAR1A;UBE2V1;SNF8;CREB3L1;F2R;ZBTB32;MYNN;CHD8;FOXM1;CIAO1;HOXC5;HNRNPD;TFAP4;DHX9;DMAP1;PBX2;GTF2H1;ZBTB25;SAFB2;PRMT2;MLF1;AR;ATF2;CNOT7;MYC;WTIP;CRY2;CENPF;FOXJ3;ZHX3;KLF11;HOXA9;MAFB;ZKSCAN5;MMS19;KDM2A;SPINDOC;ZBTB7A;ZNF467;ONECUT2;TRIP4;ZNF3;CBFA2T2;DVL3;CCNK;NONO;SRA1;USP21;USP16;USP13;ZFP62;MBTD1;TOX2;ATMIN;ZIC5;CIART;MAZ;NR1D2;CALR;ZBTB12;CREG1;CDK5;MBD2;ZBTB11;RHOG;LDB1;SMARCAL1;SAFB;PHF20L1;ZNF32;MLF2;RAI1;SUV39H2;ZXDB;BMP2;MBD1;KAT7;NFAT5;RNF187;SKOR2;HDGFL2;HEY1;BRD7;CCNE1;ILF3;REXO4;KHDRBS1;HIF1A;WWC1;DEDD2;PEX14;THAP7;ZNF711;CARF;TERF2IP;CREBZF;ARNT;CBFB;NR2C2;TFDP1;NACC1;ABCA2;IKZF4;SP1;E2F5;OLIG1;TASP1;MTA3;TRAPPC2;CNBP;HIVEP2;LRRFIP1;HOXB2;MAP3K2
prerank,inositol phosphate catabolic process (GO:0071545),0.3967902292644493,0.9333529589995184,0.5428051001821493,0.954509400817155,1.0,2/12,8.79%,PTEN;INPP5J
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.38014659921114125,0.9333158272011787,0.540268456375839,0.9538145038435156,1.0,5/14,20.85%,XCL1;HMCES;PAXIP1;RIF1;NECTIN2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.39406987306349134,-0.9328439931943836,0.5590909090909091,0.7928943309367549,1.0,3/10,9.80%,MLLT3;ACE;SFRP1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.26725810141061723,0.9327662445421403,0.5816831683168316,0.9544441822835542,1.0,30/124,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;TCF7L2;AGO4;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PPP3CB;PSMA4;AGO3;PSMC5;GNAO1;PSMB9;ARHGEF19;GNG2;TNRC6B;DVL3;PSMA7;PSMD14;AGO1;CAMK2A;FRZB;PSMA2;RHOA;PSMD11
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3056996207170499,-0.9325696256271269,0.559228650137741,0.7928821495968954,1.0,4/25,5.15%,PICALM;APP;RIN3;RAC1
prerank,ncRNA metabolic process (GO:0034660),-0.26923256476400775,-0.9325094456160467,0.5398230088495575,0.7923365194772836,1.0,10/37,19.81%,DGCR8;TUT7;PARN;DICER1;DROSHA;MAPT;RAN;NIFK;AGO2;MEPCE
prerank,regulation of mast cell activation (GO:0033003),0.42136769021928916,0.9324080978400937,0.5545454545454546,0.954572538992718,1.0,5/10,28.66%,TSLP;LYN;NECTIN2;MILR1;PLSCR1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4230143987995167,0.9321910651576963,0.5371024734982333,0.9543812902002067,1.0,1/10,1.47%,ATP1A2
prerank,linoleic acid metabolic process (GO:0043651),0.36951873483684117,0.9320123511002447,0.5459183673469388,0.9540614270791903,1.0,4/17,21.94%,ELOVL2;ELOVL1;ALOX5;ELOVL5
prerank,C-terminal protein amino acid modification (GO:0018410),0.4067103483376938,0.931937413815289,0.5416666666666666,0.9535111913972183,1.0,3/11,15.84%,GPLD1;AGBL4;FOLH1
prerank,regulation of innate immune response (GO:0045088),-0.25055999711064547,-0.931842975046553,0.6033898305084746,0.7931597147065197,1.0,14/57,15.89%,XIAP;SAMHD1;ERAP1;NMI;GBP5;IFI35;CASP8;IRF1;PTPN1;PARP9;RIOK3;POLR3G;RNASEL;POLR3D
prerank,erythrocyte differentiation (GO:0030218),-0.2558961685586184,-0.9317988627271878,0.5907590759075908,0.7925947419835483,1.0,13/44,21.82%,RPS14;ALAS1;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;ABCB10;TGFBR3;MFHAS1;DMTN
prerank,response to prostaglandin E (GO:0034695),-0.3798319466438562,-0.9316472182352714,0.5483870967741935,0.7922899362918122,1.0,4/10,23.89%,SFRP1;ADCY6;TGFBR3;CCL19
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.38258436707897625,0.9315463510648034,0.5524126455906821,0.9537552386202122,1.0,2/17,5.08%,NR1H2;LIPC
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.22821624848229602,-0.9309898598332464,0.6527196652719666,0.7931415981450147,1.0,35/86,27.18%,PSMC6;PSMD9;EGLN3;PSMF1;HIF3A;PSMB7;KLF2;UBB;PSMD8;PSMD12;INO80;VHL;BAG3;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;ELOC;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;PSMA8;STOX1;DNAJB1;BACH1;HSPA1A;LIMD1;ATF3;CHEK1
prerank,receptor-mediated endocytosis (GO:0006898),0.26163187955536665,0.9309446461588331,0.5944309927360775,0.9545358278797327,1.0,12/132,6.30%,COLEC12;LRP1;LRP1B;HSPG2;CALCRL;MASP1;LRP3;SORL1;NEDD4;FCHSD2;EPS15;TMEM108
prerank,proteasome assembly (GO:0043248),-0.3835859612140044,-0.9307828754494817,0.5742092457420924,0.7929630714902889,1.0,5/11,22.98%,PSMD9;PSMG2;PSMD4;POMP;ADRM1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3437675390199796,0.9306599477086678,0.5640625,0.9544591409575403,1.0,3/26,7.50%,TRAF3IP1;DHX58;LYAR
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.31456953501144713,0.9306204356285456,0.552870090634441,0.9537973905525268,1.0,10/38,16.75%,MICALL2;LRRK2;PINK1;SAE1;HTRA2;GSK3A;RNF31;SREBF1;CSNK2A2;HAX1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2665370063875274,0.93046861207962,0.5848101265822785,0.9533989164984411,1.0,17/119,8.79%,PIK3R1;PIGV;PTEN;PIP4K2A;PIGQ;SACM1L;PIK3R2;MTMR4;EFR3A;MTMR1;RUFY1;PIGP;PI4KA;PTPN13;CDIPT;PLEKHA1;INPP5J
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2783478847449235,-0.9304544586674255,0.5816023738872403,0.793142183617502,1.0,22/36,43.15%,LEF1;GLI2;SOX4;MDK;SART1;SOX12;CD46;RHOH;PNP;VSIR;NCKAP1L;IL7;SOCS1;NKAP;IL4I1;VNN1;ZBTB1;ZAP70;GATA3;TESPA1;IL12RB1;IL4
prerank,histone modification (GO:0016570),-0.2212262612967083,-0.9303034461599036,0.6195121951219512,0.7927980451548221,1.0,24/109,16.63%,EYA2;EYA1;HDAC4;EYA4;KDM4A;KAT6B;SIN3B;ATXN7;TBL1X;NTMT1;PRMT7;MIER1;PHF20;RPS6KA5;UBE2A;PRMT8;MIER3;MSL3;UBE2N;KAT5;EZH2;PRKCD;SIRT1;TRRAP
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.38558628014416124,-0.930179613308116,0.5448577680525164,0.7923978340910864,1.0,5/10,25.65%,UPP2;UPB1;NT5E;NT5C1A;NT5M
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3184078945124053,-0.9301100103669211,0.5340314136125655,0.7918840359712961,1.0,6/20,31.04%,FDX1;FDXR;STAR;HSD17B10;CYP46A1;TSPO
prerank,regulation of interleukin-13 production (GO:0032656),-0.3690831975533907,-0.9299998087582766,0.5630841121495327,0.7914632819300091,1.0,2/13,1.78%,LEF1;IL18
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.33636990089384605,0.929586070501584,0.5610932475884244,0.9548883226531943,1.0,9/30,17.08%,ACOX2;ABCD2;PEX2;ELOVL2;ACSL6;ACOT2;ELOVL6;ELOVL1;HACD3
prerank,positive regulation of proteolysis (GO:0045862),0.2910473629653787,0.9294882244414048,0.5886426592797784,0.9543818167371282,1.0,15/55,19.56%,OGT;GPLD1;CAPN3;PINK1;NKD2;NRDC;RCN3;ASPH;SH3D19;BAK1;PACSIN3;ADAM8;ADRA2A;MAPK12;RHBDD1
prerank,glycolipid biosynthetic process (GO:0009247),0.31534093178915457,0.9291772438221705,0.5570570570570571,0.9543845946944916,1.0,6/38,13.17%,ST8SIA1;PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,positive regulation of vacuole organization (GO:0044090),0.41351115938782695,0.9291746748828621,0.5654450261780105,0.9536221301882203,1.0,1/10,2.30%,PIP4K2A
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.28376775582930386,0.92833756386926,0.5702592087312415,0.95502278532819,1.0,14/70,14.07%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.2615431042328257,-0.927977759711493,0.5771812080536913,0.7955234619901702,1.0,18/48,20.26%,NOS3;THBS1;FOXC2;ATP5F1B;KDR;JCAD;ANXA1;MAPK14;GATA2;ETS1;FGFBP1;HSPB1;TMSB4X;PTGS2;SIRT1;AKT1;CIB1;NUS1
prerank,amide biosynthetic process (GO:0043604),0.3088532574070302,0.9278971627363515,0.5645390070921986,0.9553278567656358,1.0,12/47,17.21%,PAM;CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;CERS6;SLC25A2;SLC25A15
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3295135612119042,0.9278589739472128,0.5538461538461539,0.9546654664115235,1.0,6/33,16.75%,IL34;PRKCA;TESC;CTNNBIP1;RIPK1;HAX1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3025292410958808,0.9277711788311874,0.5596590909090909,0.9541086275591039,1.0,7/51,10.91%,WNT5A;IL16;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,cilium organization (GO:0044782),0.2497079635910881,0.9276589120958663,0.6126526082130965,0.9536146277726897,1.0,52/209,20.84%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;GBF1;CCDC57;RAB8A;DISC1;IFT81;FAM161A;KIFAP3;SNAP29;CCDC65;AHI1;TCTN2;IFT74;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;IQCB1;SSX2IP;RFX2;IFT88;RAB11FIP3;CEP126;SCLT1;TXNDC15;ACTR2;FAM161B;DYNLL2;CEP250;PTPDC1;IFT43;CLUAP1;BBS1;PCM1;ATP6V0D1;WDR90;MKS1;CEP19;NUDCD3;DZIP1L;UNC119B;KIF3A;TTC39C;BBS4;ABLIM3
prerank,regulation of type I interferon production (GO:0032479),-0.23226192413549898,-0.9274517265827678,0.65,0.7960780243670331,1.0,28/84,22.94%,NPLOC4;NFKB1;PRKDC;POLR3E;MAVS;TRIM25;CRCP;PCBP2;IRF1;RNF125;GAPDH;POLR2H;POLR3G;CYLD;NLRX1;TRAF3;NLRC5;POLR3D;UBE2L6;TBK1;NFKB2;ISG15;PQBP1;TNFAIP3;POLR1C;ILRUN;POLR3K;IKBKE
prerank,cellular amide metabolic process (GO:0043603),-0.22193447146019643,-0.9274453628269318,0.6278026905829597,0.7954238986211521,1.0,12/102,6.65%,AEBP1;ST6GAL1;PLPP3;CPE;CPD;SLC25A32;PCCA;SMPD3;ACOT8;ST3GAL1;PPP2R1A;AASDHPPT
prerank,natural killer cell activation (GO:0030101),-0.31292616822864994,-0.9273027071579241,0.548469387755102,0.7950798676367113,1.0,5/23,12.23%,PBX1;ELF4;CASP8;PIK3CD;PRDX1
prerank,carbohydrate homeostasis (GO:0033500),-0.24237456214744096,-0.9262803692419581,0.6209386281588448,0.7968328545502935,1.0,11/67,10.31%,LEPR;IGF1R;ADIPOR2;KLF7;INSR;RBP4;PRKAA2;SOX4;KCNB1;BAD;PTPN2
prerank,positive regulation of cellular respiration (GO:1901857),-0.3806345284246707,-0.9262491778451298,0.5497630331753555,0.7962474850439342,1.0,6/11,26.33%,IL10RB;IFNAR1;VCP;PRELID1;NUPR1;PARK7
prerank,regulation of protein processing (GO:0070613),-0.3153587067251351,-0.9262356634412274,0.5362694300518135,0.7956089570342877,1.0,5/21,13.87%,GAS1;RUNX1;CCBE1;TMEM59;SERPINE2
prerank,inorganic ion transmembrane transport (GO:0098660),0.4142834182501778,0.9258377025438873,0.5719424460431655,0.9573896907024028,1.0,3/12,21.24%,ASIC2;KCNJ8;ABCC9
prerank,entry into host (GO:0044409),-0.36152301228580164,-0.9255181694534742,0.5537383177570093,0.7966725085484242,1.0,5/13,15.68%,CDH1;CTNND1;PPIA;GRB2;MET
prerank,apoptotic nuclear changes (GO:0030262),0.35160598392202147,0.9255083912819968,0.5555555555555556,0.9574727486402338,1.0,5/24,18.80%,CECR2;KPNA1;TOP2A;KPNB1;DEDD2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.34164238357686266,0.9254647991052645,0.5668202764976958,0.9568189272363867,1.0,5/27,12.95%,SLC1A3;SLC7A8;SLC25A22;SLC7A3;SLC25A29
prerank,mRNA polyadenylation (GO:0006378),-0.3008576930251694,-0.9251870880892805,0.5594059405940595,0.7961062973594711,1.0,10/26,26.26%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,RNA polyadenylation (GO:0043631),-0.3008576930251694,-0.9251870880892805,0.5594059405940595,0.7961062973594711,1.0,10/26,26.26%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,response to interleukin-6 (GO:0070741),-0.3908127068187533,-0.9251831361715811,0.5538116591928252,0.7954492774221832,1.0,2/10,2.62%,ST3GAL6;NFKB1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2829303286766775,0.924781205110875,0.5755494505494505,0.9577536441751768,1.0,14/71,14.07%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,T cell activation (GO:0042110),0.28619934202597025,0.9246979577613266,0.5755208333333334,0.957206019325177,1.0,9/69,11.92%,CHD7;CD8B;SCRIB;ICOSLG;PTPN22;CD276;RAB29;PPP3CB;LMBR1L
prerank,myeloid cell differentiation (GO:0030099),-0.2584332323017833,-0.9238226559122018,0.6179401993355482,0.7981020394424834,1.0,24/47,32.47%,RPS14;RUNX1;SNRK;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;PRDX3;MFHAS1;KAT8;NCOA6;SPI1;JAK3;RASGRP4;KAT6A;ALAS2;CEBPA;HCLS1;EPO;ATP5IF1;CDKN2B
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.36753032063356583,0.9237552910027897,0.553448275862069,0.9588434494204321,1.0,8/18,23.87%,CRTC2;ADCY8;PRKD1;RELN;EPHA5;CRTC3;CAMK1D;ADCY1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2539151039070643,0.9235016622908256,0.6196032672112018,0.9587159828994601,1.0,31/172,15.91%,LPIN3;PIK3R1;PLD1;PTEN;PIP4K2A;SACM1L;PIK3R2;MTMR4;CHAT;LIPH;MTMR1;RUFY1;PI4KA;DGKQ;PTPN13;CDIPT;PLEKHA1;INPP5J;CHKA;CPNE7;AGK;PTDSS2;MBOAT7;SELENOI;TAMM41;STARD10;GPAT3;PLA2G12A;LPIN2;ABHD4;CSNK2A2
prerank,cellular response to interleukin-6 (GO:0071354),-0.29460981928327784,-0.9230630317610734,0.592391304347826,0.7991818359391175,1.0,4/26,5.51%,ST3GAL6;FER;NFKB1;IL6ST
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2691772623333878,0.9230177895404107,0.598014888337469,0.9591648478519526,1.0,16/114,12.86%,MAP3K14;EDA2R;EDA;CD40;PSMD1;PSMD10;PSMA5;PSMB5;BIRC2;PSMC4;TP53;PSMA4;PYCARD;PSMC5;ST18;PSMB9
prerank,regulation of spindle assembly (GO:0090169),-0.2894585949758292,-0.9229854473275341,0.5932203389830508,0.798670881109531,1.0,16/25,38.37%,DRG1;CHMP2B;DYNC1H1;CHMP4B;NUMA1;PDCD6IP;CHMP1A;CHMP4C;HSPA1A;CHMP2A;SPAG5;HSPA1B;TPR;PLK1;HNRNPU;CHMP3
prerank,negative regulation of response to wounding (GO:1903035),-0.3273027441587333,-0.9229420835861442,0.5703883495145631,0.7981007934528158,1.0,6/19,11.42%,EPHA4;INPP5F;CD109;GIT1;SERPINE1;MDK
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.41334715592966376,0.9226423476911462,0.5549645390070922,0.959337258394644,1.0,1/11,1.70%,WNT5A
prerank,regulation of cellular component movement (GO:0051270),0.30109405208678686,0.9224136580754956,0.5669064748201439,0.9591592945067705,1.0,11/49,14.07%,NRG1;MYCBP2;ERBB4;NRG2;ZSWIM8;ACTN1;NRG4;SP100;TGFBR1;MEMO1;LYN
prerank,positive regulation of receptor internalization (GO:0002092),-0.3086910904305107,-0.9222423087864349,0.5810055865921788,0.7991282787547959,1.0,8/22,26.26%,MAGI2;INSR;CD63;EGF;TBC1D5;NTF3;GREM1;ARRB2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.37867203096799296,-0.9216470351298242,0.5672645739910314,0.7997936882352643,1.0,2/11,3.97%,GSN;FAS
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.33119387454914734,0.9213284061469887,0.5723076923076923,0.9610426047268499,1.0,7/27,12.81%,PLA2R1;SPRED1;PSMD10;SPRED2;TWIST1;MSX1;PTTG1IP
prerank,autophagy of mitochondrion (GO:0000422),-0.2724236964971061,-0.9211252236321795,0.5672514619883041,0.8003331528981176,1.0,15/38,21.26%,BECN1;SQSTM1;ATG13;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;AMBRA1;MARK2;MAP1LC3B;WDR45
prerank,nuclear membrane disassembly (GO:0051081),0.38611653514080946,0.9209296552167275,0.5885328836424958,0.961307572416189,1.0,5/14,17.70%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,negative regulation of angiogenesis (GO:0016525),0.27627671035910056,0.9208194427233539,0.5866141732283464,0.9608150246426663,1.0,8/84,5.46%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;ADGRB1;SERPINF1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2918032727725606,-0.9205017786463163,0.554945054945055,0.8010418038423832,1.0,8/28,18.27%,EGFR;NOTCH3;WWP2;GATA2;NIBAN2;LFNG;AKT1;EGF
prerank,regulation of lipase activity (GO:0060191),-0.3549749151964982,-0.9201323814175353,0.5913461538461539,0.8012291408392501,1.0,4/13,15.69%,RHOC;LMF1;FURIN;PCSK5
prerank,spermatid development (GO:0007286),0.3256000720452772,0.9200096727185652,0.5646687697160884,0.9620826806781004,1.0,5/32,13.34%,CCDC63;SYCP3;RFX2;DPY19L2;ZMYND15
prerank,modulation by host of viral genome replication (GO:0044827),-0.3542910262574439,-0.9199408913912102,0.5638051044083526,0.801015842671398,1.0,3/13,7.47%,FBXL2;VAPA;IFI27
prerank,cobalamin metabolic process (GO:0009235),0.3722799024682375,0.919107569300822,0.5702054794520548,0.9635374810905827,1.0,4/17,17.20%,MMAB;MTRR;MMAA;MMUT
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2943260157291388,0.9189462756230447,0.5919778699861687,0.9631886651004985,1.0,15/53,20.28%,GLMN;DNAAF4;FMR1;PINK1;PRKACA;COMMD1;OPHN1;PSMC5;USP19;ARAF;PSMD14;USP14;DDRGK1;XPO1;PRKCG
prerank,cardiac muscle cell action potential (GO:0086001),0.32697815950017417,0.9182617574183561,0.5523349436392915,0.9641238834189455,1.0,8/30,15.77%,ATP1A2;SCN2B;KCNIP2;CACNA1G;HCN2;FGF12;SCN1A;CACNA2D1
prerank,endoplasmic reticulum organization (GO:0007029),0.28446983814269655,0.9180683711267711,0.5888738127544098,0.9638616139147824,1.0,10/72,12.49%,SEC16B;REEP2;SEC16A;VAMP2;LRRK2;SMPD4;ZBED3;SEC61B;TRAM2;LNPK
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3502189886682615,0.9179847859136138,0.568,0.9633042461943446,1.0,3/22,5.65%,AKAP5;ADGRV1;NF1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3600778687212205,-0.9179258399649948,0.5599078341013825,0.8051123048422432,1.0,1/13,0.01%,SORBS1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.25149200201420124,-0.9178172778269931,0.6215277777777778,0.8047266127854413,1.0,12/52,12.98%,PPP1R13B;ATG13;SREBF2;UBE2D3;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID;VPS11
prerank,regulation of cholesterol efflux (GO:0010874),-0.2815301819718939,-0.9173951554286566,0.5880597014925373,0.8049574879632228,1.0,7/30,9.84%,CAV1;SREBF2;PLTP;RXRA;APOE;ABCA3;NFKBIA
prerank,ruffle organization (GO:0031529),-0.3300793991709845,-0.9171664388399893,0.5899280575539568,0.804804371008198,1.0,6/16,23.71%,TPM1;RAC1;LIMA1;PIP5K1A;CSF1R;CORO1B
prerank,regulation of cell cycle phase transition (GO:1901987),0.273048931517374,0.9164660591161851,0.6020942408376964,0.9663000066810344,1.0,24/91,18.81%,BUB1B;PSMD1;FBXO5;CDC16;PSMD10;PSMA5;PSMB5;XPC;PSMC4;TP53;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;DBF4;ERCC2;TFAP4;MN1;PSMA7;PSMD14;CDC26;PSMA2;PSMD11
prerank,negative regulation of cell activation (GO:0050866),0.3894914379362663,0.9162180929993523,0.5620567375886525,0.9661400139423071,1.0,1/14,0.14%,PDGFRA
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2865262161957481,0.9157023061912394,0.5827439886845828,0.9666020513997357,1.0,17/58,18.77%,ERCC1;LIG3;POLQ;POLA1;ERCC4;POLL;RNF168;UBE2V2;POLB;CYREN;PAXIP1;KDM2A;ZBTB7A;NHEJ1;PSMD14;SMARCAL1;RIF1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.36770729026132853,0.9150972637819353,0.5817555938037866,0.9673545294999292,1.0,2/18,2.66%,DLC1;ITGA3
prerank,positive regulation of ATP metabolic process (GO:1903580),0.33071538497383574,0.914902310284078,0.5714285714285714,0.9671012046472053,1.0,5/32,8.27%,ZBTB20;PPARA;PFKFB1;ENTPD5;PINK1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.32219145184970144,0.9148666644217998,0.5625965996908809,0.9664347322084462,1.0,7/36,14.80%,WNT5A;TXK;TSLP;CASP4;AXL;TRIM44;RIPK1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.27942312810178693,0.9148448330359604,0.606353591160221,0.9657290725107134,1.0,14/73,14.07%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,regulation of neuron migration (GO:2001222),0.3310146565025552,0.9145075400278989,0.5495356037151703,0.9658060243935165,1.0,9/26,18.79%,IGSF10;CTNNA2;PLAA;PLXNB2;NTNG2;NTNG1;COL3A1;CAMK2A;ULK4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.31814515615956246,0.91418548600898,0.5856269113149847,0.9658542616627466,1.0,2/35,0.27%,PDGFRA;NTRK3
prerank,positive regulation of gene expression (GO:0010628),0.23415006463913418,0.913880548189358,0.6922279792746114,0.9658541233719471,1.0,96/442,19.54%,IL33;SEC16B;NTRK3;PIK3R1;PRR16;WNT5A;NTRK2;PLD1;TXK;PLA2R1;NAT10;LRP3;EIF4A3;AGO4;GLMN;LURAP1;GJA1;POU3F3;RBM24;ANK3;HTR2B;RBMS3;PTPN22;FMR1;TLR6;LARP6;MYCN;CDH3;ADAM19;RIMS2;ELAVL4;PDCL3;C1QTNF1;POLR1A;DGKQ;RPS6KB1;TWIST1;TENT4B;MTOR;TLE1;TLR4;BMP7;KAT2A;WNT3;MAP2K1;FGR;TAF1D;EIF2AK2;TP53;TAF1B;DHX36;RIMS1;AGO3;PLXNB2;TGFBR1;SOX9;HGS;RBM20;GSK3A;FAM98B;OLFM1;TESC;MED1;CUX2;ACTG2;SNF8;RIPK1;FGF5;HNRNPD;CLU;AR;ATF2;MYC;TNRC6B;HNRNPLL;MAPK11;PIK3CG;MAZ;PTGER4;LGALS9;ADRA2A;AGO1;EIF3C;MYD88;HABP4;BMP2;HEY1;YTHDF1;HIF1A;SPRY2;MBIP;EIF2AK3;FXR1;PIK3R3;SP1;DDRGK1
prerank,second-messenger-mediated signaling (GO:0019932),0.2794411988164784,0.9137837411045134,0.6029609690444145,0.9653482488425844,1.0,12/82,11.18%,EDN3;CCR9;ACKR2;RYR2;PDPK1;PPP1R9A;HTR2B;CAMKK2;LRRK2;KSR2;RCAN3;P2RX4
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.36802721426459795,-0.9137487200577056,0.5804988662131519,0.8120754623765603,1.0,5/11,26.10%,MAVS;TICAM1;TYROBP;ITGB2;SPI1
prerank,transcription by RNA polymerase I (GO:0006360),-0.2732226990720926,-0.9137462262542536,0.6142857142857143,0.8114067534906715,1.0,11/34,21.86%,CAVIN1;GTF2H5;TCOF1;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,regulation of defense response (GO:0031347),-0.2319161351521339,-0.9137406059424805,0.6363636363636364,0.810742221173991,1.0,38/76,30.15%,FOXP1;XIAP;SEMA7A;SAMHD1;IL1R1;ERAP1;MGLL;ANXA1;APOE;CELF1;CASP8;IRF1;LACC1;ELMOD2;PSMA6;CYLD;AGTR1;TMSB4X;TRAF3;PTGS2;ACE2;USP18;SHPK;BIRC3;BCL6B;NOD2;PIK3AP1;TKFC;HCK;PARK7;SBNO2;ZBP1;CASP1;FCGR2B;GGT1;LRP8;LRRC19;CCR2
prerank,negative regulation of RNA splicing (GO:0033119),-0.3148996780295632,-0.9136275888100603,0.5870646766169154,0.8103118722980354,1.0,5/19,16.15%,TMBIM6;PTBP3;RBMX;SRSF4;SRSF7
prerank,aggrephagy (GO:0035973),-0.29040198573917153,-0.9135619391894466,0.5905511811023622,0.8098005184266877,1.0,13/27,22.29%,VIM;SQSTM1;WDFY3;UBB;DYNC1H1;UBE2N;DYNC1I1;UBC;ARL13B;DYNC1LI1;HDAC6;CFTR;UBA52
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.23952378289515902,-0.9133419985331425,0.6568265682656826,0.8096492639552739,1.0,8/63,6.18%,MEF2C;IL18;ANXA1;IL6ST;SLC7A1;TFRC;CD38;NCK1
prerank,regulation of peptidase activity (GO:0052547),-0.315975153391552,-0.9128871091990576,0.5886889460154242,0.8100448549306638,1.0,6/19,14.02%,CAV1;CST3;ECM1;CTSH;PSMA3;FURIN
prerank,regulation of cell cycle (GO:0051726),-0.19578147232837712,-0.9127226925571267,0.8089887640449438,0.8097560931797906,1.0,76/271,22.17%,MECOM;APBB2;AFAP1L2;PTPRK;PPP1R13B;XIAP;THBS1;CDC14A;NOTCH2;MAGI2;IQGAP1;NEK6;NOTCH1;TGFB2;APC;CDK6;ADAM10;JMY;PRCC;PRDM11;SIK1;LRP6;TBRG1;PLAGL1;SMAD3;RPS15A;NEK7;MADD;CITED2;IRF1;SFRP1;NR4A1;PHACTR4;TARDBP;LIN52;MYBBP1A;GADD45B;HIPK2;ZBTB49;ATM;CYLD;GATA6;NBN;ING4;CCND1;CDKN1A;ERN1;ANKRD17;TRNP1;SIRT1;GPER1;DCUN1D3;CDK9;SETMAR;SDCBP;JUNB;WDR12;APBB1;PES1;RGCC;TXLNG;GADD45GIP1;CHMP1A;HBP1;GADD45G;SON;PIM2;RPL23;MIF;MAEA;RPRD1B;ZBTB17;BIRC3;FBXL8;NUPR1;CAMK2N1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2361744054103645,-0.9126075236378028,0.67003367003367,0.8093303652189326,1.0,22/62,27.47%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;GTF2F2;CTDP1;ELOF1;TCEA1;POLR2I;POLR2K
prerank,DNA conformation change (GO:0071103),0.3585046299833363,0.9124236646654493,0.5728987993138936,0.9680375496084018,1.0,6/17,22.80%,NAA10;TOP2B;TOP3A;TOP2A;HMGB1;ABL1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3470619518961844,0.9123796277113357,0.582018927444795,0.9673943444193636,1.0,6/22,16.72%,NUBP2;FXN;CIAO1;ABCB7;MMS19;ISCA1
prerank,regulation of cell adhesion (GO:0030155),0.26001019478336246,0.9120122547423025,0.6245259165613148,0.9675089733484323,1.0,15/129,8.66%,EPHA7;PLXNC1;ZFHX3;HRG;TMEM102;TGFBI;SEMA5A;ITGAV;SIPA1;DUSP1;PRKX;DSCAM;PTK2;PLAU;PRKCA
prerank,cortical cytoskeleton organization (GO:0030865),0.309558594818751,0.911943693456596,0.5812220566318927,0.9669349443339023,1.0,6/41,7.23%,EPB41L3;RND3;RAC3;LLGL1;FMNL2;RHOBTB3
prerank,GPI anchor biosynthetic process (GO:0006506),0.3276942326284071,0.9117414283510569,0.5688225538971807,0.9667084885804659,1.0,5/30,13.17%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,B cell proliferation (GO:0042100),-0.32543765362402977,-0.9115294607402432,0.5606060606060606,0.8111738065124744,1.0,2/17,3.05%,MEF2C;CTPS1
prerank,negative regulation of translation (GO:0017148),0.2732657419930662,0.9113759936070024,0.6036269430051814,0.9668578890183385,1.0,23/87,19.24%,CPEB1;EIF4A3;NANOS3;EPRS1;RBM24;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;FTO;MALSU1;EIF4ENIF1;PUS7;CNOT7;TSC1;IGF2BP3;CALR;ILF3;YTHDF1;EIF2AK3;FXR1
prerank,cation transmembrane transport (GO:0098655),-0.2613517238565626,-0.9111960900728536,0.6175548589341693,0.811241590024735,1.0,7/44,11.97%,TRPM3;TRPM6;SLC7A1;SLC3A2;SLC38A5;SLC7A5;SFXN1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3064992308193688,-0.911164352820666,0.5694822888283378,0.8106511671453314,1.0,9/22,29.86%,MINK1;XDH;GADD45B;MAP3K4;MFHAS1;GADD45G;SPI1;GADD45A;AGER
prerank,positive regulation of insulin secretion (GO:0032024),0.31569909073100144,0.9110169304578619,0.5805471124620061,0.9670104377628914,1.0,8/36,10.49%,TCF7L2;GPLD1;TM7SF3;IRS2;ADCY8;TRH;GCK;PPP3CB
prerank,cellular response to oxygen levels (GO:0071453),-0.3790132791159817,-0.9107828878707394,0.5704225352112676,0.810833934623657,1.0,5/10,24.98%,ATP6V0A2;ATP6V1G1;CCDC115;TMEM199;NDUFS2
prerank,telomere maintenance (GO:0000723),-0.25067870685768107,-0.910740302398942,0.6597938144329897,0.8102803017982831,1.0,24/50,30.56%,PTGES3;PRKDC;ATR;RTEL1;TERT;PCNA;STN1;ATM;TEN1;NBN;RAD51D;DCLRE1B;HUS1;POLD2;PARP1;RPA2;ACD;RAD51;LTO1;POLD4;POLD1;CTC1;RAD50;XRCC3
prerank,positive regulation of catabolic process (GO:0009896),-0.238571316129979,-0.910716181761553,0.651685393258427,0.8096738832548427,1.0,11/65,11.30%,FOXO1;WWP1;WWP2;GPC3;APC;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3845060572552702,0.9107137031067153,0.5824372759856631,0.9670168343613499,1.0,4/13,11.48%,PLA2R1;SPRED1;SPRED2;MSX1
prerank,lymphocyte mediated immunity (GO:0002449),-0.36357500577086743,-0.910532150811297,0.5665914221218962,0.8094551381601984,1.0,4/12,20.48%,CD55;GNL1;BTN3A3;CD46
prerank,glycoprotein metabolic process (GO:0009100),-0.24769037582588033,-0.9104155636369833,0.6580645161290323,0.8090486263426644,1.0,17/53,20.55%,FUT8;ST8SIA4;ST3GAL4;B4GALT5;OGA;ST6GALNAC3;LARGE1;MANBA;NGLY1;MGAT4B;ST8SIA2;ST3GAL2;GCNT1;MAN2A1;STT3B;GAL3ST2;MAN1A2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2601935251607237,-0.9103823147472454,0.6238244514106583,0.8084447024280758,1.0,11/43,22.02%,IGF1;LBP;SIRPA;CD34;DICER1;CX3CL1;TRIM27;HAVCR2;TNFAIP3;SELENOS;ILRUN
prerank,regulation of centrosome cycle (GO:0046605),0.35256846957002974,0.9102217099742598,0.5865384615384616,0.9674552279764556,1.0,2/21,2.23%,ATF5;NAT10
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3863705066566242,0.9096979240708538,0.5523156089193825,0.967961065723514,1.0,4/13,9.07%,AKAP5;ADCY8;RELN;LGMN
prerank,AMP metabolic process (GO:0046033),-0.35697356702277794,-0.9096706592307139,0.5721040189125296,0.8093786362485689,1.0,4/13,10.80%,AMPD3;ADSS2;XDH;NT5E
prerank,negative regulation of B cell activation (GO:0050869),-0.309454266778359,-0.909500766409623,0.6049723756906077,0.8091265422657286,1.0,10/21,33.49%,RC3H1;SFRP1;ATM;LAPTM5;TNFAIP3;TYROBP;FCGR2B;BANK1;SAMSN1;FOXJ1
prerank,regulation of fibroblast proliferation (GO:0048145),0.3035946366557146,0.9093880971668181,0.597684515195369,0.9679727773823661,1.0,10/45,16.19%,PDGFRA;WNT5A;PEX2;NF1;TP53;B4GALT7;MED25;DHX9;MYC;NDUFS4
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3520478904025244,0.9092932981562079,0.5752066115702479,0.9674544699596489,1.0,6/21,16.20%,RAB34;GLI1;GAS8;TXNDC15;EVC;PDCL
prerank,cellular response to lipopolysaccharide (GO:0071222),0.26758587971676895,0.9092740898280509,0.6248366013071895,0.966753928235046,1.0,14/101,12.41%,CXCL10;WNT5A;CXCL1;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.4101023014352543,0.9091747773699953,0.6026365348399246,0.9662218971772273,1.0,4/11,19.24%,FMR1;DHX9;WTIP;FXR1
prerank,protein mannosylation (GO:0035268),-0.3029437931349375,-0.9090512038881943,0.5771276595744681,0.8095734890390636,1.0,6/22,14.78%,TMTC2;TMTC1;TMTC4;LARGE1;FKRP;DPY19L4
prerank,ATP transport (GO:0015867),-0.3829148026199657,-0.9090441272535787,0.569937369519833,0.8089237629622362,1.0,4/10,25.67%,ABCC6;SLC25A5;SLC17A9;SLC25A4
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3146446161455866,-0.9084672873089982,0.5906593406593407,0.809604657127547,1.0,4/20,6.80%,IL18;IL1R1;CD55;B2M
prerank,phospholipid catabolic process (GO:0009395),-0.3019219772688003,-0.9081909424052107,0.5904255319148937,0.8095905360856942,1.0,8/24,20.77%,GPCPD1;PLA2G4A;GDPD3;ENPP2;SMPD1;SMPDL3A;PLA2G4E;PLA2G4C
prerank,neuron differentiation (GO:0030182),0.24936102131432963,0.9080491107321415,0.652989449003517,0.9682210090174946,1.0,21/165,12.13%,ISL2;RUNX2;TENM3;WNT5A;NTRK2;MYO7A;MYEF2;TENM4;MTPN;TENM2;SRF;SNPH;OLIG2;TENM1;BHLHE22;WNT3;MAP2K1;OPHN1;SMARCA1;TGFBR1;MYT1L
prerank,response to estradiol (GO:0032355),0.3240363398722467,0.9077511209820598,0.573051948051948,0.9681995780885172,1.0,3/31,4.54%,GGT5;GGT7;NCOA3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.320829341212386,-0.9073134948423218,0.5956416464891041,0.8109631240232159,1.0,3/17,7.54%,MAGI2;CALM1;ITGA1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2258586114056716,-0.9071364995229131,0.6929460580912863,0.810687878954061,1.0,46/91,33.11%,ABCG2;APP;HMOX2;CUL1;TFRC;SLC39A8;SLC31A2;SCARA5;SLC39A10;MT2A;ACO1;CYB561A3;SLC30A9;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;MT3;TMEM199;SMAD4;ARF1;ATOX1;SLC11A1;ALAS2;LCN2;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;IREB2;HMOX1;BMP6;SLC30A1
prerank,positive chemotaxis (GO:0050918),0.355714518914081,0.907072447961986,0.5537918871252204,0.9690777907294483,1.0,2/17,3.60%,SEMA5A;SCRIB
prerank,inositol phosphate-mediated signaling (GO:0048016),0.35839144637260967,0.9069927899854469,0.5963756177924218,0.9685141032858423,1.0,4/19,10.49%,EDN3;NFATC3;ADGRB2;PPP3CB
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.35613727213406965,0.9065795008986445,0.5955249569707401,0.9672375354271187,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.35613727213406965,0.9065795008986445,0.5955249569707401,0.9672375354271187,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.35613727213406965,0.9065795008986445,0.5955249569707401,0.9672375354271187,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,regulation of neurotransmitter transport (GO:0051588),0.3651476414311913,0.9064091104915214,0.5819397993311036,0.9669075460470692,1.0,3/16,5.00%,HCRT;CHRNB4;FMR1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3217006064490188,0.9063502680800898,0.6037735849056604,0.9663156316180725,1.0,5/32,8.62%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,fatty acid elongation (GO:0030497),-0.3662674495102843,-0.9061026463561764,0.557919621749409,0.8123472767230516,1.0,4/13,13.29%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,dendritic cell migration (GO:0036336),0.36668412568914605,0.9058734728761744,0.578397212543554,0.9668029037133321,1.0,6/16,25.55%,GPR183;TRPM2;PIK3CG;ALOX5;HMGB1;CCR5
prerank,response to muramyl dipeptide (GO:0032495),-0.36076648466725175,-0.9058494652411586,0.6018099547511312,0.8122417635391876,1.0,1/12,1.09%,VIM
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3070498229138787,0.9054266837811573,0.5850746268656717,0.9671587483327138,1.0,11/41,18.75%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,membrane protein proteolysis (GO:0033619),-0.2625325270300582,-0.9054203198843237,0.6754966887417219,0.8125090120064493,1.0,9/37,13.03%,NFKB1;ERAP1;ADAM10;RBMX;CTSH;DAG1;RET;APH1A;APH1B
prerank,glutathione metabolic process (GO:0006749),0.3096633113212632,0.9053471537713875,0.593939393939394,0.9666173014440607,1.0,3/38,7.45%,GGT5;GGT7;GSTA3
prerank,regulation of axon guidance (GO:1902667),0.4092964559970573,0.9050461244792489,0.584070796460177,0.966607262646148,1.0,2/10,5.13%,MYCBP2;ZSWIM8
prerank,positive regulation of type 2 immune response (GO:0002830),0.38564782122690267,0.9049991942006708,0.5614035087719298,0.9659739344915032,1.0,3/14,12.94%,XCL1;CD86;CD81
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2710367285007369,0.9047218335455598,0.6124661246612466,0.9658919492593608,1.0,6/85,3.69%,LAMC1;LAMB1;TCF7L2;C5AR1;PEX2;MCC
prerank,rRNA modification (GO:0000154),0.344345925373951,0.9045719799814791,0.5714285714285714,0.9655284690193005,1.0,10/21,30.64%,NAT10;DIMT1;NSUN3;MTERF4;METTL5;ZCCHC4;NOP10;DKC1;NSUN4;FTSJ3
prerank,negative regulation of immune system process (GO:0002683),-0.3242098554572307,-0.9043499691669644,0.5699745547073791,0.8142990098850277,1.0,1/16,0.41%,CD200
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3365193703913317,-0.9042778853937947,0.6105769230769231,0.8138191860183086,1.0,2/15,2.98%,LEF1;SMARCA4
prerank,negative regulation of neuron projection development (GO:0010977),-0.24358808427628692,-0.9039210007577957,0.6498194945848376,0.8139975843441006,1.0,11/56,13.30%,EPHA4;DPYSL3;EFNB2;RUFY3;KANK1;PRAG1;APOE;NGEF;ADCY6;GAK;TRPV4
prerank,intestinal absorption (GO:0050892),0.3793731676404397,0.9035200548420049,0.5772495755517827,0.967288693748648,1.0,1/13,0.61%,NPC1L1
prerank,regulation of exit from mitosis (GO:0007096),0.3015991956387184,0.9026237183190846,0.6106983655274889,0.9687544351581782,1.0,3/38,6.02%,CDC14B;BUB1B;CDC16
prerank,cellular response to unfolded protein (GO:0034620),-0.2903915023335888,-0.9026208017557315,0.6059782608695652,0.8162093366691022,1.0,12/26,25.77%,TMBIM6;HSPA8;HSPB8;BAX;PTPN1;OPTN;BAG3;ERN1;ABCB10;HSPD1;HSPA14;HSPA1A
prerank,negative regulation of transport (GO:0051051),0.2990555734507601,0.9015725735424682,0.5942028985507246,0.9705572387236584,1.0,10/51,16.08%,NRG1;PTEN;ITGAV;NR1H2;PRKD1;EPHA3;NDFIP2;SNX12;PACSIN3;NDFIP1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2607993370738202,-0.9014327399140779,0.5953177257525084,0.8182170120616025,1.0,11/40,18.65%,BCL2L1;ARL6IP5;UBB;VCP;MAPT;BAD;BAX;PRELID1;PRDX3;AKT1;PID1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.37241458702673774,-0.9013450970030544,0.6,0.8177515241962751,1.0,8/11,34.43%,ITM2A;SOAT1;AGO2;ITM2B;BACE2;NECAB3;ITM2C;ABCA7
prerank,endosome organization (GO:0007032),-0.2599647958578141,-0.9011657946422434,0.6414473684210527,0.8175168482316452,1.0,15/41,26.07%,EEA1;LAPTM4B;SQSTM1;CHMP2B;VPS18;HOOK1;ALS2;VPS11;TMEM9;SNX3;PLEKHJ1;EXOC8;DNAJC13;WASHC4;ALS2CL
prerank,positive regulation of telomere maintenance (GO:0032206),0.31857602811850444,0.9008906816682699,0.5926493108728943,0.9713779392262424,1.0,7/31,17.17%,GNL3;ERCC1;SIRT6;HNRNPA2B1;DHX36;HNRNPD;PKIB
prerank,positive regulation of dendritic spine development (GO:0060999),0.35175930311754666,0.9007768157481273,0.6056105610561056,0.9709117584169187,1.0,6/20,13.87%,FOXO6;FMR1;CAPRIN1;RELN;DHX36;CUX2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.27856549076756637,0.900710226938213,0.627906976744186,0.9703424814932283,1.0,13/73,17.31%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;CD86;RIPK1;DHX9;CLU;TIRAP;LGALS9;ADAM8
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2412601068297309,0.9005714296422983,0.6919592298980748,0.969913469935846,1.0,45/234,17.82%,ROR1;EDA2R;EDA;WNT5A;PTEN;CD40;MBTPS2;IL18RAP;TAF12;JUP;TLR6;MTPN;PRKCI;CRTC2;ADCY8;CAPN3;SRF;FLOT2;TRIM37;PRKD1;RELN;TRIM8;PRKCB;TLR4;IL1RAP;IRAK1;EIF2AK2;PYCARD;RTKN2;ESR2;RNF31;UBE2V1;EPHA5;RIPK1;DHX9;CLU;AR;ATF2;TIRAP;ZBTB7A;TRIM26;LGALS9;ADAM8;MYD88;CAMK2A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.26141350880691533,0.9004728745624964,0.6362515413070283,0.969415130889194,1.0,33/122,19.24%,IL33;SLC25A37;PRR16;PLD1;NAT10;EIF4A3;FMR1;MTPN;LARP6;IRS1;IRS2;RPS6KB1;NMD3;GLI1;MTOR;TLR4;GCK;PLXNB2;CDT1;IGF2;HNRNPD;DHX9;AR;MYC;NOX1;PPP1R3E;LDB1;EIF3C;KAT7;YTHDF1;ATAD5;PDGFRB;FXR1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.37540735126472313,-0.9003603826911678,0.5822784810126582,0.8186866874780215,1.0,3/10,12.12%,CCT3;CCT4;CCT7
prerank,B cell homeostasis (GO:0001782),0.408745628663613,0.9003393874744628,0.5670840787119857,0.9689901105663744,1.0,1/10,0.78%,DOCK10
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.24658265780355465,0.8995334102550789,0.6650943396226415,0.9701477424639677,1.0,46/186,18.97%,LRP1;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CTNNBIP1;CHD8;AMER2;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LZTS2;PSMA2;PSMD11;APCDD1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2712918357088304,0.8993404094147937,0.6385224274406333,0.9698775988154618,1.0,9/78,6.24%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.390222058392433,0.8991786497324793,0.5836298932384342,0.9695196682542621,1.0,1/12,0.55%,PIK3R1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.33817396324613097,0.8991574209803036,0.5838709677419355,0.9688564586993007,1.0,5/25,8.36%,ITGAD;ITGAV;JUP;JAM3;CD200R1
prerank,gonad development (GO:0008406),0.3059750101050309,0.8989951899958052,0.5921237693389592,0.9684814380323722,1.0,4/41,2.53%,WNT5A;NR2F2;BASP1;SALL1
prerank,histone H4 acetylation (GO:0043967),0.2970261845594984,0.898767364668285,0.6116941529235382,0.9682678707707726,1.0,12/47,15.32%,OGT;MORF4L1;KMT2A;BRD8;WDR5;MSL1;BRCA2;KANSL1;JADE1;EPC1;DMAP1;ATF2
prerank,positive regulation of sodium ion transport (GO:0010765),0.39649974612094485,0.898470779569538,0.5905096660808435,0.9682567318732622,1.0,2/12,3.99%,CNKSR3;ANK3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.34069403458458136,0.8984553428100946,0.6045016077170418,0.9675597519809077,1.0,4/21,8.73%,SULF1;HS6ST3;HS6ST2;EXTL3
prerank,RNA processing (GO:0006396),0.24834026112382837,0.8983985646717403,0.6755196304849884,0.9669666877424469,1.0,49/176,22.68%,RBMS1;GEMIN2;NOVA1;ADARB2;SNRNP35;ZRSR2;NOL3;LIN28B;LSM4;ELAVL4;BCAS2;HNRNPA2B1;MRPL44;SRSF11;MPHOSPH10;TENT4B;PRKACA;SMU1;DDX17;RP9;SLU7;NUDT21;NOL9;SNRNP48;TENT2;PRPF18;HNRNPUL1;HNRNPD;SNRPF;ADAR;SRSF9;RBM5;NONO;HNRNPL;SF3A3;PPIG;DEDD2;ZCRB1;RBM6;LUC7L3;PRPF8;TFIP11;DDX39B;RBPMS;DHX15;RNGTT;WBP4;HNRNPH3;LSM3
prerank,response to lipopolysaccharide (GO:0032496),0.25124455452928357,0.8979020389394134,0.6503667481662592,0.9673952078401803,1.0,19/138,12.41%,GGT5;CXCL10;WNT5A;CXCL1;GGT7;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;LIAS;MAPKAPK3;IL12A;CD86;PDCD4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.25425688779667943,0.8977843127196714,0.6511350059737157,0.9669451236583838,1.0,33/145,18.81%,DYNLL1;PSMD1;DCTN3;HAUS3;HAUS1;FBXO5;CDC7;HMMR;DCTN2;PSMD10;PSMA5;PSMB5;HAUS8;PRKACA;CEP192;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;PSMB9;CEP250;CEP152;CSNK1E;CENPF;CLASP1;PSMA7;PSMD14;VPS4B;ALMS1;PCM1;PSMA2;PSMD11
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3359347953016413,-0.897735262962527,0.6153846153846154,0.8239652282316264,1.0,8/15,22.66%,IGF1;BCL2L1;GPX1;PRELID1;GHITM;AKT1;HGF;PPIF
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.25818870872990773,0.8976624383611818,0.6303258145363408,0.9664800258376522,1.0,12/107,9.09%,EDN3;SLC24A5;SLC30A10;CD40;RYR2;SLC30A5;SLC39A7;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.29134325596130545,-0.8973738200959441,0.6428571428571429,0.8241225442890743,1.0,4/24,6.17%,RBPJ;NOTCH1;ATF6;KLF2
prerank,positive regulation of cell killing (GO:0031343),0.3911692458453139,0.8973408266230972,0.5819112627986348,0.9665140451282241,1.0,4/13,20.74%,WNT5A;CYBA;NOX1;DVL2
prerank,neuron projection organization (GO:0106027),0.3815486277617448,0.8972179545546556,0.58,0.966092396282466,1.0,3/15,9.07%,ABCD2;ATP1A3;LGMN
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2666028881690165,0.8970159051644502,0.6400523560209425,0.965834443535363,1.0,13/95,12.41%,CXCL10;WNT5A;CXCL1;PDE4B;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,negative regulation of neuron death (GO:1901215),-0.22214081491093368,-0.8968812412053564,0.7068965517241379,0.8245267994854055,1.0,35/93,28.08%,CD200;MEF2C;RETREG1;VPS35;SOD2;CD34;SIX1;NGF;NRBP2;APOE;GSK3B;SNX6;MDK;FOXQ1;NENF;PTK2B;CHMP4B;CHMP4A;RASA1;AKT1;ERBB3;CHGA;SIX4;KDM2B;CLCF1;MT3;IKBKG;NTF3;CRLF1;LIG4;PARK7;VSTM2L;BDNF;NDNF;MSH2
prerank,DNA metabolic process (GO:0006259),0.2378035222208284,0.8967545487980055,0.7182320441988951,0.9657372122280817,1.0,72/270,22.46%,TCF7L2;POLG;ERCC1;LIG3;MCM7;FAN1;FEN1;POLK;POLQ;TOP2B;ERCC5;FANCA;CDC7;MSH3;ASF1A;NEIL3;POLA1;GMNN;RPA1;ERCC4;TERF1;POLL;XPC;SP100;POLE4;RFC3;UBE2V2;NOC3L;MCM4;POLH;RECQL;TOP3A;GTF2H3;MUTYH;CDT1;XRCC1;POLB;POLE3;RAD52;ALKBH3;MBD4;LONP1;POLI;MCM10;DBF4;DOT1L;RNASEH1;GTF2H1;CSNK1E;ORC2;MMS19;SMARCAL1;TOP2A;SMC1A;MSH6;WRN;REXO4;RIF1;TERF2IP;CNBP;POLE;USP45;MEN1;DDB1;ORC5;RFC4;TOPBP1;RAD54L;PWWP3A;HMGB1;KPNA2;FANCC
prerank,isotype switching (GO:0045190),-0.3738437319846185,-0.8959021297878142,0.58675799086758,0.8260036866460597,1.0,6/10,28.08%,RNF8;EXOSC3;BATF;HSPD1;LIG4;MSH2
prerank,polyol biosynthetic process (GO:0046173),-0.32067960529296263,-0.8958557122329448,0.6073298429319371,0.8254344616945052,1.0,3/16,6.65%,ACER3;ITPKB;IP6K2
prerank,gas transport (GO:0015669),0.41267470947050056,0.8957919283934744,0.6131907308377896,0.9672540030563777,1.0,2/10,15.40%,MB;MYC
prerank,protein K63-linked ubiquitination (GO:0070534),-0.26033942715214126,-0.8956562787606029,0.6710963455149501,0.8252504055325818,1.0,13/41,21.65%,RNF152;UBE2G1;PELI1;WWP2;TRIM5;RNF8;ZFP91;UBE2N;TRAF3;TRIM27;PRPF19;RNF5;TRAF1
prerank,mononuclear cell differentiation (GO:1903131),-0.2996484233152632,-0.8954173053403667,0.6256684491978609,0.8250933621911616,1.0,2/24,0.90%,PIR;IL31RA
prerank,lipid droplet organization (GO:0034389),0.33969157211763956,0.8952906996681403,0.5838926174496645,0.9677344130628497,1.0,3/22,8.09%,PPID;CIDEA;BSCL2
prerank,transcription by RNA polymerase II (GO:0006366),0.23255638547181165,0.895287025892512,0.7275711159737418,0.9670259906538956,1.0,52/305,17.13%,RORA;PPARA;TEAD1;HDAC1;TAF9B;C5AR1;INTS8;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;RTF1;LSM11;TAF15;NR2C1;TAF3;CDK13;SRRT;TBPL1;NUDT21;NELFA;ZC3H8;SNAPC5;INTS14;SNW1;GTF2H3;ESR2;SSRP1;ELP4;NFIX;ELL2;HDAC10;MED1;TRIP11;ERCC2;NRBF2;SLBP;EAF2;SNRPF;GTF2H1;AR;SYMPK;CCNK;IWS1;MAZ;NR1D2;TAF8
prerank,ether lipid metabolic process (GO:0046485),0.3796205040436131,0.8951826720341712,0.5754098360655737,0.9665551614778517,1.0,3/14,9.68%,PEX7;PLA2G7;AGMO
prerank,nuclear export (GO:0051168),0.272851614848503,0.8950521324536028,0.6465177398160316,0.9661363323110996,1.0,22/80,20.65%,CSE1L;EIF4A3;ANKLE1;NUP214;NUTF2;POM121;THOC7;SRSF11;SLU7;NUP42;RANBP3;CASC3;STRADB;SRSF9;THOC5;CALR;XPO6;SRSF6;NUP155;CHTOP;XPO1;DDX39B
prerank,negative regulation of biomineral tissue development (GO:0070168),0.34415333826649486,0.8945738043295299,0.5944625407166124,0.9665493111262055,1.0,1/21,0.11%,ENPP1
prerank,regulation of isotype switching (GO:0045191),-0.3312485802928016,-0.8944074086675853,0.5806451612903226,0.8267311829895938,1.0,3/14,9.89%,KMT5B;TFRC;SHLD2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.2757406739898813,-0.8941994516982165,0.6395348837209303,0.8265712310875595,1.0,11/31,29.47%,NFS1;GCH1;MOCS1;FDXR;CYP51A1;NOXRED1;PYCR2;STAR;MOCS3;PYCR3;FDFT1
prerank,response to steroid hormone (GO:0048545),-0.27733992288714954,-0.8939732789447259,0.6463768115942029,0.826439175961536,1.0,7/31,12.91%,CAV1;THBS1;TGFB2;WBP2;PAQR7;ABHD2;NR3C1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3518828220197719,0.8931551734362992,0.6051779935275081,0.9691907788408117,1.0,3/20,5.53%,PLA2R1;CD40;PRKCI
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3731700414238499,-0.8927622577373894,0.599128540305011,0.8279054491722135,1.0,2/10,5.90%,APC;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3731700414238499,-0.8927622577373894,0.599128540305011,0.8279054491722135,1.0,2/10,5.90%,APC;CDC42
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2617584913185653,0.8924901383442716,0.6430379746835443,0.970038843997919,1.0,11/93,9.84%,NTRK3;PTEN;CNKSR3;SH2D3C;MTCP1;DOCK7;PINK1;PRKD1;INPP5J;TENM1;NSD1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3754202329491472,-0.8923491004511037,0.6070588235294118,0.8281557447283632,1.0,2/10,5.90%,EZR;CDC42
prerank,response to metal ion (GO:0010038),0.2803131183720449,0.8922338906579665,0.6384720327421555,0.9698802232181342,1.0,9/67,9.60%,PAM;LOXL2;SLC30A5;NEDD4;KCNMA1;CAPN3;FXN;TRPC3;SLC30A3
prerank,innate immune response (GO:0045087),0.24004016819403284,0.8922182185490501,0.7020316027088036,0.9692120595174224,1.0,21/217,10.09%,COLEC12;CLEC4E;CXCL10;CLEC5A;CD40;MASP1;KYNU;MFAP4;DHX58;TLR8;TRIM56;PTK2;IFNLR1;TRIM8;MBL2;SP100;TLR4;CYBA;CR2;IRAK1;FGR
prerank,glycosphingolipid metabolic process (GO:0006687),-0.2532006492608751,-0.8916408947415686,0.6728971962616822,0.8290452703315455,1.0,16/42,24.76%,SMPD3;ST6GALNAC3;LARGE1;HEXB;UGCG;B3GALNT1;ESYT3;ST3GAL5;SMPD1;GM2A;ARSA;PSAP;GLTP;A4GALT;CLN6;ASAH1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3479548979412357,-0.8916396652401116,0.625974025974026,0.8283906438606264,1.0,4/13,9.88%,MEF2C;RBPJ;NOTCH1;TBX2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.355563528782259,-0.8916255435803945,0.6195899772209568,0.8277586726814723,1.0,7/12,31.26%,ACO1;ACO2;ASS1;IDH3B;IDH3A;IDH2;IREB2
prerank,protein kinase B signaling (GO:0043491),-0.29497687460300936,-0.8914096375782603,0.6227848101265823,0.8275940125420576,1.0,2/23,3.58%,IGF1;KDR
prerank,regulation of immunoglobulin production (GO:0002637),-0.2901113484870674,-0.8913671153572164,0.6304909560723514,0.827044112183862,1.0,3/23,10.44%,RBP4;DNAJB9;EPHB2
prerank,I-kappaB phosphorylation (GO:0007252),-0.3735087915618839,-0.8911575827596084,0.5948275862068966,0.8268734188690595,1.0,1/10,0.80%,ERC1
prerank,copper ion transport (GO:0006825),0.39965387044309214,0.891048779240336,0.6020942408376964,0.9711526546933151,1.0,5/11,25.21%,STEAP3;ATP7A;STEAP2;COX17;CUTC
prerank,adherens junction organization (GO:0034332),0.2876180610886698,0.8899686206464302,0.6291970802919709,0.9729353384859711,1.0,12/48,14.84%,CDH6;CADM2;JUP;DCHS1;CDH11;CDH15;CDH3;JAM3;CDH10;CADM3;NECTIN3;FERMT2
prerank,negative regulation of cell development (GO:0010721),-0.2915420005212055,-0.8898838551288059,0.6356164383561644,0.8289574954772067,1.0,4/25,7.28%,IGF1;NOTCH1;B2M;GSK3B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.332899028810288,-0.8896962112791367,0.6127450980392157,0.8286867199108905,1.0,3/15,6.13%,NEK6;CDC23;PTTG1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.29632575691027285,-0.8891791054229582,0.6095505617977528,0.829183958255762,1.0,10/23,25.69%,DIAPH1;CAMK2D;ANK2;NOS1;PTK2B;NOS1AP;CACNB1;CBARP;CASQ2;PSEN2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.25398569166288787,0.8890360185886638,0.6790123456790124,0.974383598222826,1.0,22/132,13.03%,DCN;ZBTB20;PPARA;GPLD1;ABCD2;PFKFB1;TPCN1;NPRL2;ENTPD5;ZSWIM8;IRS1;LRRK2;LIN28B;IRS2;TWIST1;PRKD1;TRIM8;NRDC;TFEB;GSK3A;PTTG1IP;CNOT1
prerank,icosanoid biosynthetic process (GO:0046456),-0.3727073335279425,-0.8889822989747617,0.6264501160092807,0.8289554446161446,1.0,5/10,36.41%,PLA2G4A;MGST3;PLA2G5;ALOX5AP;MGST2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3266644939054948,0.8887475754270634,0.6041009463722398,0.9743313533405424,1.0,4/26,6.02%,DUSP1;FBXO5;CENPE;CDC16
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.26686444799047426,0.8886633800926436,0.655217965653897,0.9737796727871454,1.0,12/76,11.85%,CCDC22;CDKN2A;PSMD10;BRMS1;TRIM37;LRRC14;COMMD1;BMP7;IRAK1;PYCARD;DAP;PTGIS
prerank,high-density lipoprotein particle assembly (GO:0034380),0.40348347831763026,0.8884586140424171,0.583904109589041,0.9735521245392839,1.0,2/10,8.67%,PRKACB;PRKACA
prerank,negative regulation of cell growth (GO:0030308),0.25285579798817776,0.8884128789536144,0.6749408983451537,0.9729503489909302,1.0,18/121,12.54%,ENPP1;HRG;CDKN2A;SIPA1;GJA1;NAIF1;SERTAD2;CDKN2D;CDKL3;BCL6;DCC;NME6;NDRG3;TP53;JADE1;MSX1;ESR2;GSK3A
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3491416325717521,0.8883731253664563,0.5769881556683587,0.9723385295456077,1.0,2/20,2.78%,RUNX2;SMAD5
prerank,lipid homeostasis (GO:0055088),0.2869376536183682,0.8877535189138398,0.6430594900849859,0.9730417919969,1.0,10/57,19.41%,ZBTB20;ACOX2;TLCD3B;IRS2;RCN3;FABP3;ABHD4;NR1D2;ORMDL3;ABCA2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.308283176112818,-0.8873675880170602,0.5980861244019139,0.8317547088168918,1.0,6/18,12.78%,RAP1A;SYN1;VPS18;GSK3B;RAB5A;SLC4A8
prerank,immunoglobulin mediated immune response (GO:0016064),0.3970416934351129,0.8873615836172153,0.6037037037037037,0.9732335029099453,1.0,2/10,12.94%,TLR8;CD81
prerank,protein ubiquitination (GO:0016567),-0.18434747416077107,-0.8868708133594613,0.972972972972973,0.8321927448075866,1.0,101/471,17.49%,FBXL7;WWP1;RNF152;LMO7;UNKL;GAN;MGRN1;VCPIP1;RNF146;KLHL13;UBE2G1;ASB2;KLHL24;PSMC6;RNF43;PRKDC;RNF185;PELI1;PSMD9;WWP2;ARIH1;OTULIN;CDC23;UBE2D3;PSMF1;HIF3A;PSMB7;TRIM24;HLTF;TRIP12;TRIM25;CUL1;TRIM5;TRIM11;FBXL2;UBB;VPS18;TRIM14;TNKS2;SH3RF2;HERC6;RNF8;VCP;MSL2;UBE2H;MIB1;SMURF2;UBR1;TRIM36;UBA6;FBXO25;TSPAN17;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;ASB5;KLHL20;RNF11;RNF144B;VHL;CUL9;RNF41;RNF114;SPSB4;UBR2;RCHY1;PCNA;HERC2;PSMA3;VPS11;PSMA6;TRIM63;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;UBE2N;CAND2;PSMB6;TRIM35;ELOC;PSMC1;FBXO32;TRIM27;UBE2L6;SIRT1;PSMB10;FBXL14;NEDD8;SIAH2;CUL3;ANAPC16;ISG15;ANAPC11;UBC;USP9X
prerank,regulation of proteolysis (GO:0030162),-0.2483529361129529,-0.8868449253433314,0.6812080536912751,0.8315988241837173,1.0,16/48,24.69%,CAV1;LTBP4;CST3;CASP8;BAD;PERP;IST1;SERPINE2;TRAF3;NEDD8;AKT1;CLN8;HDAC6;CAMK2N1;CLN6;CYFIP2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.36496865875711604,0.8862664705366264,0.5973154362416108,0.9750252889404871,1.0,3/14,11.25%,EARS2;SLC25A33;TEFM
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.22696197768817525,-0.8860130863987478,0.735632183908046,0.8328290986805581,1.0,12/76,14.38%,NR3C2;EGFR;EZR;APP;NMI;UACA;CCN3;IFI35;NFKBIA;TRIP6;CYLD;TMSB4X
prerank,negative regulation of DNA metabolic process (GO:0051053),0.33202510630709553,0.8858493646016724,0.6056338028169014,0.9752678361769982,1.0,4/24,7.73%,ERCC1;KMT2A;MSH3;ERCC4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3268881885233803,-0.8856205164722457,0.6308900523560209,0.8330297404642294,1.0,4/17,5.90%,BAIAP2L1;TEK;NRP1;CDC42
prerank,pharyngeal system development (GO:0060037),-0.3357863147728454,-0.8856165604494309,0.6229116945107399,0.8323840519137242,1.0,3/15,7.13%,BMPR2;TGFB2;TBX1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.35375457584491177,-0.8855950338680625,0.645320197044335,0.8317743585763325,1.0,2/13,3.70%,CAV1;RNF185
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.27151567496729756,-0.8855558578092386,0.6512345679012346,0.831195721110322,1.0,6/33,12.53%,PTPRJ;EZR;RC3H1;PTPN2;CEACAM1;DGKZ
prerank,regulation of mRNA metabolic process (GO:1903311),0.3949851140463364,0.8852385352387433,0.5897435897435898,0.9759707176330142,1.0,4/11,17.80%,DHX9;SAFB2;IWS1;SAFB
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.30352255462795547,0.8846885370755448,0.623546511627907,0.9765265844203157,1.0,11/42,14.01%,POLK;POLA1;CDKN2D;RPA1;RFC3;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,mitochondrion transport along microtubule (GO:0047497),0.37483160562902107,0.8839725320798685,0.588034188034188,0.9774834269926171,1.0,4/13,18.75%,LRPPRC;OPA1;SYBU;HIF1A
prerank,autophagosome organization (GO:1905037),-0.24370930445552258,-0.8839699465305412,0.6837060702875399,0.8338951273753483,1.0,17/50,21.26%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;RAB1A;ATG12;ATG2A;MAP1LC3A;AMBRA1;ULK3;RAB1B;ATG101;MAP1LC3B;WDR45
prerank,cellular response to heat (GO:0034605),-0.26430226700769505,-0.8834922024697013,0.6578947368421053,0.8342211349846674,1.0,8/35,14.34%,THBS1;ANO1;VCP;FGF1;MAPT;BAG3;TRPV4;HIKESHI
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.22109604882442652,-0.8834911180581414,0.7477064220183486,0.8335673566657139,1.0,32/93,24.82%,PLCB1;CCN2;ARL6IP5;TPD52L1;APP;MAP3K5;TGFB2;MINK1;FZD7;SH3RF2;XDH;GADD45B;HIPK2;FLT4;PTK2B;WNT16;MAP3K4;MAPK8IP1;STK25;TRAF3;MAP3K10;SDCBP;MFHAS1;GADD45G;DUSP19;TRAF1;MID1;CCL19;EDAR;TAOK2;NOD2;CD27
prerank,protein stabilization (GO:0050821),-0.19683090822695623,-0.8828341324559762,0.8375,0.8343702661381142,1.0,59/168,27.13%,EPHA4;IGF1;PLPP3;PTGES3;HIP1R;ATP1B3;TBL1X;CTNND1;DVL1;RPL5;CRYAB;RPS7;SOX4;RAB21;MTMR9;TBRG1;SOX17;CCT3;ANK2;RPL11;VHL;ATF7IP;GAPDH;CRTAP;NCLN;BAG3;CCT4;CCT7;FLNA;GLMP;HIP1;CDKN1A;CREB1;PRKCD;USP9X;LAMP2;AFM;CREBL2;PIM2;RPL23;RTN4;SMAD7;TYROBP;BAG2;TMEM88;HSPD1;SUGT1;MCM8;TRIM39;MT3;SUMO1;COG3;CHEK2;GOLGA7;HSPA1A;FLOT1;PARK7;ATP1B2;STK3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3428198936833606,0.8828237794270225,0.6070826306913997,0.9794055276021011,1.0,5/18,16.70%,PIK3R1;ATXN3;BAK1;BAG6;USP13
prerank,regulation of cytokinesis (GO:0032465),0.2666737673263918,0.8828194082359749,0.6461949265687583,0.9786984610019301,1.0,3/78,0.93%,SVIL;CDC14B;RXFP3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3180916701078202,0.8827869569547594,0.5928792569659442,0.9780524398174107,1.0,3/27,4.06%,PPARA;ITGAV;NR1H2
prerank,calcium ion transport into cytosol (GO:0060402),0.34145282561496054,0.8821137638744261,0.6073717948717948,0.9789198790208646,1.0,5/21,15.77%,GRIN2B;RYR2;GRIN2A;TRPM2;CACNA2D1
prerank,sodium ion import across plasma membrane (GO:0098719),0.35942354871322724,0.8817965558147182,0.6104347826086957,0.9789273958567152,1.0,3/17,9.46%,SLC9A9;SLC9A1;HCN2
prerank,cellular response to UV (GO:0034644),0.27108154812171337,0.8817896445851904,0.6640419947506562,0.9782265699163848,1.0,15/76,16.02%,PPID;ERCC1;POLK;MFAP4;FMR1;NEDD4;ERCC4;NOC2L;XPC;TP53;DHX36;EIF2S1;BAK1;MYC;IMPACT
prerank,response to UV (GO:0009411),0.2625174534207257,0.8816141383957438,0.6737235367372354,0.9779245956843234,1.0,21/95,15.40%,FEN1;POLK;USP1;ERCC5;MFAP4;FMR1;NEDD4;CDKN2D;ERCC4;UVSSA;NOC2L;TP53;POLH;DHX36;IL12A;SPRTN;REV1;EIF2S1;ERCC2;BAK1;MYC
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3382944689172407,0.8815619053841643,0.6374367622259697,0.9773266593891683,1.0,8/21,17.29%,ITGAV;HTR2B;ZFP36L2;MAP2K1;SOX9;MYC;PTGER4;LGALS9
prerank,regulation of mRNA processing (GO:0050684),0.31031307499453953,0.8814488820853961,0.6276923076923077,0.9768598927930503,1.0,8/32,18.68%,KHDRBS3;CWC22;SRSF10;DHX9;SAFB2;IWS1;SAFB;KHDRBS1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3179219863866731,0.8814002700770273,0.6269349845201239,0.9762572540440083,1.0,6/30,12.21%,RPN2;OSTC;DAD1;ALG5;MCFD2;TUSC3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2734751874858046,-0.8812316205062933,0.6353591160220995,0.8370771145441257,1.0,7/29,13.28%,RPS14;RPS16;RPS19;UTP3;RPS21;NOP9;RPS8
prerank,stem cell development (GO:0048864),0.35976025621055796,0.880974076907392,0.6049586776859505,0.9765649724780405,1.0,2/16,9.37%,NRG1;TAPT1
prerank,actin nucleation (GO:0045010),-0.2991271590080585,-0.8808494284127064,0.6458333333333334,0.8372247056977913,1.0,7/21,23.23%,JMY;LMOD1;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4
prerank,lysosome organization (GO:0007040),0.30908449171295616,0.8806921503032809,0.6223241590214067,0.976501866732261,1.0,8/36,15.60%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,regulation of mitochondrion organization (GO:0010821),0.29190317489288525,0.8805305022921325,0.642962962962963,0.9761600055731119,1.0,10/47,16.75%,TMEM102;LRRK2;OMA1;PINK1;IAPP;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.32517294177714495,0.8803866162288799,0.6109324758842444,0.9757939436337822,1.0,5/26,8.29%,KCNS2;VAMP2;NEDD4;KCNG1;KCNAB1
prerank,phosphatidic acid metabolic process (GO:0046473),-0.24452752623748253,-0.8795592263462322,0.6890459363957597,0.8393785688793719,1.0,12/48,20.68%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;PLA2G6;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,regulation of mRNA stability (GO:0043488),0.24764473609629914,0.8795390782615248,0.7002427184466019,0.9770073062904725,1.0,39/145,19.94%,NUP214;PSMD1;RBM24;YWHAZ;FMR1;DND1;PSMD10;PDE12;TAF15;ZFP36L2;PSMA5;PSMB5;PAIP1;PRKCA;TENT5A;PSMC4;PSMA4;DHX36;PSMC5;CSDC2;TNPO1;EXOSC9;PSMB9;FTO;EIF4ENIF1;HNRNPD;GDNF;RC3H2;EXOSC8;EXOSC5;PSMA7;IGF2BP3;PSMD14;PSMA2;YTHDF1;PSMD11;FXR1;ZC3H14;XPO1
prerank,cellular zinc ion homeostasis (GO:0006882),0.32697476685301274,0.8792415672969245,0.6112956810631229,0.9769889604077796,1.0,3/26,4.66%,SLC30A10;SLC30A5;SLC39A7
prerank,regulation of mitochondrial fission (GO:0090140),0.3279842401824684,0.879111847157172,0.6460587326120556,0.976578860553109,1.0,3/24,8.27%,DCN;LRRK2;PINK1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.36915815056552526,0.878457152016122,0.6158088235294118,0.9773823631623262,1.0,7/13,27.04%,UBE2G2;YOD1;BRSK2;EDEM2;UBE2J1;OS9;BCAP31
prerank,epithelial to mesenchymal transition (GO:0001837),0.28590482916801585,0.8782842889573265,0.6397058823529411,0.9770583870016392,1.0,15/47,18.75%,WNT5A;FGFR1;LOXL3;LOXL2;TBX3;AMELX;DDX17;BMP7;TGFBR1;SOX9;OLFM1;CUL7;BMP2;HEY1;HIF1A
prerank,regulation of cilium assembly (GO:1902017),-0.23720844729676024,-0.8782245832654568,0.7198581560283688,0.8415850299623692,1.0,14/62,15.40%,TBC1D19;RABEP2;MARK4;TBC1D8;TBC1D22B;IFT140;CCDC88A;TBC1D7;EVI5L;TBC1D22A;CYLD;TBC1D10B;CROCC;TBC1D13
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.31554536403629857,-0.8781284695134817,0.6593137254901961,0.8411474150840259,1.0,7/16,23.28%,ST8SIA4;ST6GALNAC3;LARGE1;ST8SIA2;ST3GAL5;A4GALT;ST8SIA6
prerank,regulation of cellular localization (GO:0060341),0.29035362913566826,0.8775893864334046,0.6476608187134503,0.9779763965188406,1.0,10/46,16.45%,ADCY5;TRIM67;NR1H4;LRRK2;PINK1;LYN;EPHA5;CSNK1E;BRSK2;DVL3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.34237703964169663,-0.8771977734383362,0.6355748373101953,0.8424916894756079,1.0,8/13,27.18%,SERTAD1;ARID1B;SMARCD1;ELOF1;PADI2;SPI1;CDCA4;CHEK1
prerank,protein import into peroxisome matrix (GO:0016558),0.38913064319051216,0.8771800525912595,0.6,0.9782314985151396,1.0,5/12,18.90%,PEX2;PEX7;PEX12;PEX14;PEX6
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2880795650076765,0.8769460170496809,0.6519174041297935,0.9780442386060304,1.0,14/46,24.01%,TIMM10;DNAJC19;PINK1;PITRM1;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21;MFN2;GDAP1;CHCHD4;FIS1;TOMM34
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.32571404638793733,-0.876942775693605,0.6237864077669902,0.8423967304173032,1.0,2/15,5.26%,CD55;HSPH1
prerank,mitochondrion organization (GO:0007005),-0.19704742838123898,-0.8764548851965116,0.8187919463087249,0.842803035718175,1.0,55/165,26.64%,CXADR;BCL2L1;MEF2A;NOS3;MTM1;ATP5F1B;ALAS1;CAV2;SIRT3;HK2;DNM3;MIEF1;USP30;BAX;BNIP3L;TIMM9;BID;CHCHD2;TERT;PYROXD2;TRAK2;RAB38;ADCK1;MTFR1L;AFG1L;PRDX3;VPS13D;YME1L1;AIFM1;ATP5F1D;MSTO1;TIMM13;CHCHD3;TOMM22;PID1;SIRT5;TIMM8B;MPV17;MIGA1;POLRMT;HIGD1A;FANCG;TWNK;OXA1L;VPS13C;HSPD1;PNPT1;PARP1;TIMM10B;TOMM5;FMC1;MIEF2;SLC25A4;PARK7;HSD17B10
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.21958733431206573,0.8762809613256906,0.8652482269503546,0.9788356004473373,1.0,172/807,19.42%,IL33;ZEB1;ZFHX3;TRPS1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;PPARA;MIER2;ETV5;HDAC1;L3MBTL1;PPID;WNT5A;TAF9B;NR2F2;TCF7L2;BASP1;SALL1;CDKN2A;THRA;NR1H4;PEX2;PER3;MEIS2;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;SCML4;MDFIC;RUNX1T1;ZNF423;ZBTB16;ZFP37;RTF1;SIRT6;TLE2;FOXS1;PSMD10;PRDX5;BCOR;CAPN3;GLIS1;CALCA;DUSP22;TENM2;CBFA2T3;GMNN;BRMS1L;BRMS1;PAX9;ZBTB2;TRIM37;LYAR;BCL6;NR2C1;TAF3;ZKSCAN3;MDM4;PER2;TWIST1;SOX2;MXI1;NOC2L;L3MBTL4;PHF6;SP100;TLE1;DAXX;BMP7;NSD1;GLI3;SOX10;TP53;N4BP2L2;ZC3H8;MPHOSPH8;ZFPM2;ZNF25;SNW1;DAP;EPC1;ZNF318;ESR2;SOX9;MYT1L;TWIST2;PDCD4;IGF2;SAP30;DPF2;KDM1B;HIC2;BTAF1;CNOT1;PHC1;PRDM5;ATN1;ZMYND15;NRIP1;NFIX;HDAC10;PEG3;MED1;CUX2;UBE2D1;MED25;BPTF;KDM5C;CREB3L1;ZBTB32;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;AR;CNOT7;MYC;CRY2;ORC2;CENPF;ZHX3;DCAF1;FGFR2;KLF11;KDM2A;IMPACT;SPINDOC;EFNA1;ZBTB7A;AASS;ZNF3;CBFA2T2;NONO;MBTD1;CIART;MAZ;NR1D2;CALR;DNMT3A;SARS1;CDK5;MBD2;LDB2;LDB1;SUV39H2;BMP2;MBD1;KAT7;SKOR2;HEY1;BRD7;ILF3;KHDRBS1;WWC1;RIF1;DEDD2;PEX14;THAP7;CREBZF;CBFB;EHMT2;NR2C2;NACC1;IKZF4
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22440826944642817,-0.8762763628756796,0.7344827586206897,0.8425378696457243,1.0,23/64,28.66%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;GTF2F2;CTDP1;ELOF1;TCEA1;POLR2I;POLR2K;TCEA2
prerank,anterior/posterior axis specification (GO:0009948),-0.3209960435902524,-0.8759875708149616,0.6141176470588235,0.8425208837019948,1.0,2/15,6.38%,SKI;WLS
prerank,cell proliferation in forebrain (GO:0021846),0.39372166875408754,0.875911682496056,0.6162361623616236,0.9789581290278156,1.0,4/10,25.77%,DOCK7;PCM1;KIF14;NUMBL
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3409803305911385,-0.875883788170186,0.6191588785046729,0.8421018535305772,1.0,2/12,1.13%,CACNA1C;CAV1
prerank,mitotic chromosome condensation (GO:0007076),-0.2800141127664136,-0.8756393834598951,0.684931506849315,0.8419759231573682,1.0,12/26,31.56%,SMC2;PHF8;TENT4A;PHF13;CSNK2B;CHMP1A;NCAPH2;SMC4;RB1;NCAPG2;TTN;SET
prerank,female gonad development (GO:0008585),0.3503452149701214,0.8755860755553219,0.6220735785953178,0.9789881270443398,1.0,5/19,23.38%,NR2F2;NUP107;LHCGR;INHBA;EIF2B5
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.36792205285246826,-0.8755198552423327,0.6197183098591549,0.8415838340102701,1.0,4/10,16.48%,PRKAA2;SIRT1;PRKAA1;MYOCD
prerank,polyamine metabolic process (GO:0006595),0.37665060428915337,0.8754640135510146,0.6115843270868825,0.9785547625443841,1.0,3/13,13.65%,ODC1;HDAC10;DHPS
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31163198128362213,0.8750365968431649,0.6381679389312978,0.9787744681194224,1.0,8/30,15.77%,GJA1;RYR2;SCN2B;CACNA1G;FGF12;KCNE4;SCN1A;CACNA2D1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2835497858514891,0.8748448120605632,0.6605374823196606,0.9785312052095975,1.0,8/54,8.66%,HRG;CD40;FGFR1;PDPK1;JUP;NF1;PRKD1;PRKCA
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2266648190523727,0.8747111817966696,0.7759914255091104,0.9781335594391506,1.0,94/366,22.83%,RORA;CHD7;ZFHX3;MSC;ATF5;NANOS3;RABL3;NCOA2;MYT1;TEAD2;REST;FBXO5;SOX6;ZNF423;MTPN;FOXN2;CXXC1;ZFP37;GMNN;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;DAXX;SRRT;BRCA2;NSD1;TP53;GRM5;NFXL1;TGFBR1;ESR2;SRSF10;IGF2;TFEB;SAP30;NUP107;ZNF628;CARM1;HDAC10;ARNT2;SSBP2;RBM4B;TGFBRAP1;CCNA2;UBE2V1;HNRNPD;MLF1;ATF2;WTIP;MAFB;ZKSCAN5;TSC1;TRIP4;NONO;CYFIP1;USP13;NR1D2;CALR;ZBTB11;LDB1;MLF2;BMP2;KAT7;SKOR2;REXO4;HIF1A;WWC1;THAP7;TERF2IP;EHMT2;NR2C2;SP1;TRAPPC2;CNBP;SMC3;DVL2;ORC5;HCFC2;GON4L;UTP4;APBB3;ASCC1;DDIT3;CREBBP;LIN54;SERTAD3;ATRX;MLLT6;NLK;RREB1;ABL1;HOXB7
prerank,mitochondrion disassembly (GO:0061726),-0.26599266797555465,-0.874588579627173,0.699438202247191,0.842869657203964,1.0,14/34,21.26%,BECN1;SQSTM1;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;AMBRA1;MARK2;MAP1LC3B;WDR45
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3434846817955473,0.8745037642750343,0.6174055829228243,0.9779067570137983,1.0,3/18,9.43%,ATP1A2;SLC43A1;COMMD1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.33526935139649616,0.8740465408054968,0.6275430359937402,0.978233265622698,1.0,5/23,18.72%,CECR2;KPNA1;FBH1;REXO4;KPNB1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.3992249863946312,0.8737691828467985,0.6070175438596491,0.9781717435909881,1.0,2/10,5.32%,ATP1A2;NEDD4
prerank,establishment of melanosome localization (GO:0032401),-0.3027181183505211,-0.8736888494486462,0.6632911392405063,0.8440769599730727,1.0,7/19,28.53%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3050727059665134,0.8736047699540593,0.6166419019316494,0.9778385864907575,1.0,6/35,14.70%,GHR;ERBB4;OCIAD1;HGS;DOT1L;F2R
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3318833739340111,0.8735830104138791,0.6416,0.9771819453838103,1.0,2/21,7.71%,IL34;PTK2
prerank,replicative senescence (GO:0090399),0.3799517411495302,0.8730759506423553,0.629695885509839,0.9775785221205666,1.0,3/12,10.61%,PLA2R1;CDKN2A;TP53
prerank,dicarboxylic acid transport (GO:0006835),0.31543558474417144,0.8727451714457685,0.5984732824427481,0.9775943120435334,1.0,2/28,3.74%,SLC1A3;GJA1
prerank,N-glycan processing (GO:0006491),0.34770068837180373,0.8726051055848911,0.627906976744186,0.9772288865636474,1.0,4/18,10.39%,ST8SIA1;PRKCSH;MAN1C1;MAN1B1
prerank,stabilization of membrane potential (GO:0030322),0.363103560177661,0.8725168300419164,0.636518771331058,0.9767251840889797,1.0,1/16,0.58%,KCNK2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.292311152757373,0.8725157784367515,0.6499282639885222,0.9760300111402764,1.0,11/45,16.57%,NANOS3;SPOUT1;GCNT2;MTPN;ZC3H7B;NUDT21;GRM5;RBM4B;ATG14;TSC1;CYFIP1
prerank,regulation of transport (GO:0051049),0.29631599175582074,0.8725123942448193,0.6467153284671533,0.9753432889507521,1.0,7/36,11.18%,TMEM102;VAMP2;LRRK2;MYO6;PINK1;POFUT2;SCFD1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3253211893034218,0.8722957238997546,0.6193447737909517,0.9751469629506048,1.0,2/24,5.65%,EPHA7;NF1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.36185437234850315,0.8719740662349879,0.6157804459691252,0.975186761656729,1.0,2/15,3.83%,NTRK2;NGFR
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.25211954761198874,-0.8717811097967483,0.7049689440993789,0.8474407835793022,1.0,10/39,17.14%,MYRIP;PSMD9;RBP4;SOX4;NNAT;BAD;ACSL4;SELENOT;GPER1;HFE
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2454873513473764,0.8717579572525791,0.7146341463414634,0.9749647783149151,1.0,23/128,15.82%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;SSNA1;MELK;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;BRSK2;CLASP1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24167227711946504,-0.8716056847457874,0.7142857142857143,0.8471631662152512,1.0,5/50,7.95%,NR3C2;EGFR;APP;NMI;IFI35
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3601223746754518,0.8709586531144187,0.617124394184168,0.9760706386765763,1.0,2/15,4.54%,KDF1;NCOA3
prerank,neurogenesis (GO:0022008),-0.24907851284206475,-0.870628477754777,0.7213114754098361,0.8485332870343577,1.0,9/43,13.35%,TGFB2;THOC2;ANXA1;CDK6;SIX1;MAPT;WDR62;CLN5;TRAK2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3082725349201067,-0.8700293989251776,0.6264501160092807,0.8491269115766654,1.0,2/19,0.43%,IGF1;PICALM
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3451002399901004,-0.8695479266600519,0.6221719457013575,0.849513786347993,1.0,4/13,13.29%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,protein dephosphorylation (GO:0006470),0.24616242555438622,0.8693921087817598,0.7310012062726177,0.9789276016922188,1.0,21/135,10.69%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;DUSP22;PTPRU;PTPRO;PTPN13;SSH2;PPP2R2A;TNS2;PPP2R3A;PPP6C;PPP3CB;PDP1;PTPRA
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.39470673897326064,0.8693781541954961,0.6141592920353982,0.9782634093404678,1.0,3/10,17.61%,FMR1;GNB5;GPR35
prerank,cellular response to retinoic acid (GO:0071300),-0.24442965762821076,-0.8691829695693785,0.7169230769230769,0.8496534444765319,1.0,10/42,15.29%,WNT5B;WNT9A;FZD4;FZD7;TBX1;WNT6;RET;ATM;PTK2B;CREB1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3124343292032665,0.8690339417992665,0.6168831168831169,0.9783732108486357,1.0,12/28,25.42%,ITPR1;CASP4;DNAJC10;BAK1;BAG6;BRSK2;BBC3;TNFRSF10B;DDIT3;TMEM117;ATF4;SELENOK
prerank,protein K63-linked deubiquitination (GO:0070536),0.30539860859625906,0.8688118565139584,0.6500754147812972,0.9781757098024295,1.0,8/31,17.14%,STAMBPL1;USP33;ATXN3;YOD1;USP16;USP13;STAMBP;PSMD14
prerank,regulation of regulated secretory pathway (GO:1903305),0.30384535146890684,0.8687382164685091,0.6476761619190404,0.9776517980177566,1.0,10/34,19.48%,LRRK2;RIMS2;SYT3;SYT7;RIMS1;RAB15;SYT5;SYT6;SYT1;RIMS4
prerank,receptor signaling pathway via STAT (GO:0097696),0.32025828923763394,0.8687006101030497,0.6476345840130505,0.9770409970332046,1.0,1/25,0.31%,GHR
prerank,zinc ion homeostasis (GO:0055069),0.31691430804896215,0.8686025736014891,0.6387096774193548,0.9765661159585135,1.0,3/28,4.66%,SLC30A10;SLC30A5;SLC39A7
prerank,microtubule bundle formation (GO:0001578),0.2883720405098737,0.8684847464087472,0.6378066378066378,0.9761381259385664,1.0,6/42,11.65%,NCKAP5L;RSPH9;AAAS;MTCL1;CAPN6;GAS8
prerank,homocysteine metabolic process (GO:0050667),0.3841046570570234,0.8682747372624291,0.6114081996434938,0.9759188871236721,1.0,4/11,17.20%,MTRR;BLMH;DPEP1;MMUT
prerank,protein maturation (GO:0051604),0.2579407550757975,0.8678767860557608,0.6836601307189543,0.9761350324845356,1.0,9/95,6.96%,ECE1;ECE2;OGT;NAA10;PCSK2;SORL1;ADAM19;CCS;CPM
prerank,JNK cascade (GO:0007254),-0.25210358075377415,-0.8678679385735052,0.7033898305084746,0.8517186624671277,1.0,16/40,24.35%,IRAK2;MAP3K5;MINK1;MAPK9;MAP2K4;UBB;MAP2K7;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKG;NOD2
prerank,regulation of transposition (GO:0010528),-0.3395791445773774,-0.8678480770207718,0.6297169811320755,0.8511110311605071,1.0,3/13,11.79%,MYBL1;TEX15;UBR2
prerank,regulation of axon extension (GO:0030516),-0.2513382169276389,-0.8678205494627313,0.7193548387096774,0.8505119340097904,1.0,8/37,13.68%,NTN1;SEMA7A;RUFY3;APOE;GSK3B;MAPT;GOLGA4;MACF1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.3401623103649516,-0.8677256115387811,0.6533957845433255,0.8500523516430781,1.0,7/13,33.32%,RUNX1;ZBTB7B;TGFBR2;PNP;NCKAP1L;SOCS1;NKAP
prerank,organelle organization (GO:0006996),0.22334599467344352,0.8675733720678938,0.7961985216473073,0.9760925951048182,1.0,91/388,19.29%,SEC16B;CECR2;PPID;PHIP;RAB34;MTFR2;ABCD2;SIPA1;PEX2;SEC16A;WDPCP;GBF1;DPYSL2;IRAG2;PRKCI;DNAJC28;LRRK2;PEX7;SMPD4;SIPA1L3;EPS15;FMNL2;WASF3;FAM161A;CIDEA;BSCL2;GOLGA2;FGD6;PINK1;PRKD1;PALLD;KIFAP3;RAB30;RAB29;MTX3;OPA1;WDR73;BCS1L;SAR1A;SLC25A33;ARHGAP4;RAB2A;POLG2;LNPK;SH3KBP1;KIF5C;CENPW;PEX11A;SYNE1;KIF9;FAM161B;COG1;LONP1;ATP7A;PCLO;TRIP11;CLASP2;SH3D19;PACSIN3;HACE1;MYC;PEX19;WTIP;TNIK;CLASP1;CEP55;FGD2;USP6NL;HAX1;UBXN2B;TMED3;PAK5;VPS4B;TMED9;GOLGA8B;GOLGA5;MCOLN1;PEX12;PDZD8;CUL7;MAST1;PEX3;SSBP1;YTHDF1;PEX14;PEX6;EIF2AK3;MIA3;TRAPPC12;TBC1D20;NIPSNAP2
prerank,cholesterol metabolic process (GO:0008203),0.2665677016955077,0.8675550491984773,0.6684931506849315,0.9754467665114649,1.0,13/68,16.30%,NPC1L1;CEL;PPARD;DHCR24;SOAT2;ACAT2;PLPP6;HMGCS1;ABCA5;ACLY;SCAP;LDLRAP1;IDI1
prerank,regulation of response to external stimulus (GO:0032101),0.24996868328985777,0.8672378756048618,0.7160647571606475,0.975497600289093,1.0,17/121,13.08%,PDGFRA;XCL1;HRG;WNT5A;ADGRA2;PTPN22;DHX58;CASP4;ADAMTS12;BCL6;PTGES;APPL2;BIRC2;FGR;P2RX4;CASP12;AREL1
prerank,purine-containing compound catabolic process (GO:0072523),-0.338625241358506,-0.8671392840339535,0.6506550218340611,0.8506416212840775,1.0,5/13,19.98%,XDH;GPX1;NT5E;GDA;NT5C1A
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3161978303836308,0.8666301895843028,0.6431924882629108,0.9761411446610192,1.0,12/27,25.73%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3168900232865427,0.8666012718097271,0.6228209191759112,0.9755089105857963,1.0,6/25,12.96%,ADK;GMPS;AMPD2;PRPS1L1;PRPS1;DGUOK
prerank,regulation of T cell cytokine production (GO:0002724),0.35617383523111557,0.8663780955063068,0.6374570446735395,0.9753095780385574,1.0,1/15,0.79%,XCL1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.22575561717092846,-0.8662262558990537,0.7632508833922261,0.851814793022282,1.0,14/64,22.05%,PLA2G4A;CYP1B1;ACOT8;MGLL;AIG1;GPX1;ACSL4;ACSL5;PTGS2;ALOX12;PNPLA3;PLA2G4C;SLC27A2;FAAH
prerank,mRNA export from nucleus (GO:0006406),0.25613943385605453,0.8656375317663703,0.7046035805626598,0.9762715444812522,1.0,28/102,21.21%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;DDX19A;ENY2;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;IWS1;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,negative regulation of cellular process (GO:0048523),0.22194231561606964,0.8654436045485596,0.8385416666666666,0.9760309574328213,1.0,96/521,16.57%,ENPP1;DLC1;CASK;COL18A1;PLXNC1;ATF5;HRG;ROR2;TGFBI;CXCL1;PTEN;SEMA5A;ERBB4;GPLD1;CDKN2A;SIPA1;GLMN;SUSD2;GJA1;DLG3;DUSP1;NR1H2;REST;FBXO5;TMEM115;HTR2B;ADGRB1;DSCAM;NAIF1;SERTAD2;ACTN1;PDE12;CBFA2T3;DUS2;GMNN;NPAS2;CDKN2D;PTPRU;BCL6;MDM4;PRKD1;IFNLR1;P3H1;APPL2;TENM1;SP100;BMP7;NME6;MAP2K1;TNS2;NDRG3;EIF2AK2;TNFRSF21;TP53;FKTN;JADE1;PLXNB2;MSX1;GAS8;SPEG;ESR2;HTRA2;FABP3;HGS;PDCD4;ST18;DIS3L2;TESC;SMYD5;BNIPL;P3H3;MALSU1;CDKN2C;TDRD9;ADAM22;LYN;NME1;THAP12;WNK2;TSPYL2;F2R;FERMT2;FOXM1;TFAP4;CLU;AR;CNOT7;MYC;KLF11;RNF167;IMPACT;CDK10;BRINP1;TSC1;RBM5;CHERP
prerank,response to unfolded protein (GO:0006986),-0.24183116271360983,-0.8653199314377328,0.7475083056478405,0.8531386491284205,1.0,17/48,25.84%,TMBIM6;HSPA8;HSPH1;HSPB8;BAX;PTPN1;OPTN;HSPB1;BAG3;ERN1;STT3B;DNAJB5;DNAJB1;HSPD1;HSPA14;HSPA1A;HSPB2
prerank,tRNA wobble uridine modification (GO:0002098),0.37131424931240903,0.8650624190186988,0.652317880794702,0.9762065225457746,1.0,4/14,17.74%,CTU1;ELP1;ELP4;TRMU
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2908036851740319,-0.8649766202989078,0.6441558441558441,0.8532008593615298,1.0,11/23,24.27%,BAD;BAX;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;COX18;NDUFA13;TIMM10B;BCL2L11
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.277881519676209,0.8645768240243658,0.6597222222222222,0.976554771921883,1.0,4/57,3.59%,GHR;CD40;ERBB4;TSLP
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2646885752583686,0.8644190254044972,0.6950732356857523,0.9762290036511926,1.0,8/75,5.65%,SPRY4;SPRY1;PTEN;NR2F2;CDKN2A;DUSP1;SORL1;NF1
prerank,detection of visible light (GO:0009584),0.352346156359397,0.8642216393993616,0.6333333333333333,0.9759763064734883,1.0,3/16,14.50%,GNA11;ABCA4;CEP250
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2927708918498489,0.8638969078842189,0.6409495548961425,0.9760538534872396,1.0,11/41,18.75%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,mRNA transport (GO:0051028),0.2545793657670139,0.8638901150024285,0.6975857687420585,0.9753836170911653,1.0,27/101,21.21%,EIF4A3;NUP214;AAAS;FMR1;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;KIF5C;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3304534228667819,-0.8635635640242567,0.65625,0.8555069922758546,1.0,8/13,38.05%,UPP2;OGG1;NEIL1;NT5M;NTHL1;SMUG1;NEIL2;DCTPP1
prerank,ribosomal large subunit assembly (GO:0000027),-0.28442798837613165,-0.8632577604093368,0.6757493188010899,0.8554869782718261,1.0,11/24,29.79%,RPL5;RPL10;RPL11;RPLP0;RPL23A;MRPL20;NOP2;RPF2;RPL24;FASTKD2;NOP53
prerank,protein O-linked glycosylation (GO:0006493),0.2526647130122891,0.8629134555681174,0.7116154873164219,0.9768181569258912,1.0,12/96,11.11%,GALNTL6;PLOD1;OGT;GALNT18;POMT1;GALNT13;GALNT15;RXYLT1;B3GNT8;GALNT10;POFUT2;FKTN
prerank,response to nitric oxide (GO:0071731),-0.32909350624576866,-0.8623506947054657,0.65807962529274,0.8566566882687832,1.0,1/13,0.46%,FOXO1
prerank,establishment of mitotic spindle localization (GO:0040001),0.3112846496348906,0.862261275387136,0.6585365853658537,0.9775770819449944,1.0,9/28,18.72%,GJA1;GPSM2;SPDL1;NUSAP1;INSC;CLASP2;CLASP1;UBXN2B;KPNB1
prerank,regulation of intracellular pH (GO:0051453),-0.2576939469401313,-0.8622045631021399,0.6887608069164265,0.8563188177875586,1.0,10/34,22.36%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;SLC4A8;SLC9A5;SLC26A6;SLC9B1;CFTR;SLC4A7
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.31297501184860926,-0.8619861527897212,0.670076726342711,0.856111563722213,1.0,5/17,16.12%,KLF4;ANXA1;TMSB4X;MAP2K5;ANXA4
prerank,response to interleukin-1 (GO:0070555),-0.21841759984691134,-0.8619725644728012,0.7509433962264151,0.8554825907177983,1.0,12/73,10.33%,HDAC4;APP;NFKB1;IRAK2;SIRPA;IL1R1;ANXA1;GBP2;RC3H1;HYAL1;SFRP1;RBMX
prerank,cell cycle G2/M phase transition (GO:0044839),0.24254216969263756,0.8616767257871513,0.727932285368803,0.978154348618479,1.0,23/129,15.82%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;SSNA1;MELK;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;BRSK2;CLASP1
prerank,cellular response to leucine (GO:0071233),-0.35646776672541947,-0.8615208792709295,0.6450116009280742,0.8551154509461919,1.0,3/10,11.79%,SESN1;UBR1;UBR2
prerank,response to leucine (GO:0043201),-0.35646776672541947,-0.8615208792709295,0.6450116009280742,0.8551154509461919,1.0,3/10,11.79%,SESN1;UBR1;UBR2
prerank,pyroptosis (GO:0070269),0.35608003633784713,0.8611533426865007,0.6486013986013986,0.9786056334968396,1.0,4/15,19.67%,CASP4;GSDMD;DHX9;GSDME
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3532671508336988,-0.8609530634948465,0.6373873873873874,0.8556315802329363,1.0,1/11,4.55%,NFKBIZ
prerank,fatty acid biosynthetic process (GO:0006633),0.27022414170036974,0.8607041667560273,0.6856368563685636,0.9789093399568174,1.0,18/63,21.94%,LIPC;LIPH;DEGS1;ELOVL2;HSD17B8;ACOT7;LIAS;ACLY;NDUFAB1;ELOVL6;ELOVL1;HACD3;ALOX5;ACSBG1;ABHD3;SCD5;ACACA;ELOVL5
prerank,amino acid transport (GO:0006865),0.2821469312342902,0.8603750956914704,0.6714490674318508,0.9789607994042652,1.0,4/49,4.87%,SLC1A5;SLC7A11;SLC43A1;SLC7A8
prerank,T cell receptor signaling pathway (GO:0050852),0.2457324813853767,0.8600362612007783,0.7263803680981595,0.9790103680363764,1.0,19/138,11.54%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;ICOSLG;PDPK1;PIK3R2;PTPN22;EIF2B1;CD276;PSMD10;PSMA5;PSMB5;PSMC4;TNFRSF21;PSMA4;FYN;PSMC5
prerank,regulation of intracellular transport (GO:0032386),0.29398360517101185,0.859195296204346,0.6593245227606461,0.9801639261097534,1.0,11/38,19.61%,NUP214;AAAS;NEFH;LRRK2;TTC21B;SCFD1;ATP9A;RINT1;CAPN10;WWC1;ATPSCKMT
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.2755263936213341,-0.8590409110187485,0.701058201058201,0.8588677260603328,1.0,9/27,23.89%,MAP3K1;IRAK2;UBB;TAB2;IRAK4;UBC;LY96;UBA52;HSPD1
prerank,regulation of mitotic cell cycle (GO:0007346),0.23695612154722773,0.8588077612569293,0.7406542056074766,0.9803470186213594,1.0,38/171,18.28%,BUB1B;L3MBTL1;PSMD1;MEIS2;SCRIB;PKMYT1;GBF1;FBXO5;RNF40;CCDC57;CDC16;PSMD10;PSMA5;PSMB5;RPS6KB1;CDK13;PRKCA;LGMN;XPC;PSMC4;PSMA4;TTC28;RCC1;MKI67;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;TFAP4;CDK10;BRINP1;PSMA7;SRA1;PSMD14;CDC26;CUL7;PSMA2
prerank,primary miRNA processing (GO:0031053),-0.3608826736228712,-0.8587340939930487,0.6405529953917051,0.8588715740547961,1.0,4/10,12.85%,DGCR8;DROSHA;SMAD3;SMAD1
prerank,endocytic recycling (GO:0032456),0.27612718069333475,0.8585855515535837,0.6960926193921853,0.9801752578494434,1.0,10/50,16.12%,CCDC22;MICALL2;EPS15;VPS39;VPS26C;RAB11FIP3;ENTR1;SNF8;SNX12;VPS52
prerank,wound healing (GO:0042060),0.26956782265707624,0.8585632059907348,0.6782608695652174,0.9795483986383454,1.0,9/62,11.51%,PDGFRA;NRG1;WNT5A;NF1;SRF;EVPL;SYT7;ARL8B;TGFBR1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.354149506079943,0.8582593916594207,0.6133768352365416,0.9795345426376295,1.0,3/15,12.81%,TAF9B;ARMC10;PTTG1IP
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.23142586114701166,-0.8579285278168394,0.7357859531772575,0.8598759993275538,1.0,25/54,31.37%,CAV1;NXN;SQSTM1;RPL5;SOX4;SH3RF2;RPL11;HDAC8;ISG15;DCUN1D3;AKT1;COPS9;TNFAIP3;VPS28;SMAD7;BAG2;SENP2;HSPA1A;ARRB2;PARK7;U2AF2;PRR7;HSPA1B;MINAR1;CAMLG
prerank,DNA repair (GO:0006281),0.22693699648624835,0.8578263985808336,0.7946428571428571,0.9797839881664279,1.0,66/284,20.55%,FANCI;ERCC6L2;ERCC1;LIG3;FAN1;FEN1;POLK;POLQ;USP1;ERCC5;FANCA;MSH3;ASF1A;NEIL3;POLA1;CDKN2D;RPA1;ERCC4;POLL;XPC;RNF168;FAAP100;COMMD1;BRCA2;RFC3;UBE2V2;TEX264;TP53;POLH;RECQL;FAAP20;GTF2H3;POLN;MUTYH;XRCC1;POLB;SPRTN;RAD52;FTO;ALKBH3;MBD4;ATXN3;POLI;ERCC2;DOT1L;EME2;UBE2V1;GTF2H1;CSNK1E;MMS19;APEX2;SMARCAL1;SMC1A;MSH6;WRN;FBH1;REXO4;TRAIP;POLE;TRIP13;MLH1;MTA1;DDX1;USP45;MEN1;DDB1
prerank,autophagosome maturation (GO:0097352),-0.25502037246399645,-0.8575979922284661,0.7049180327868853,0.8598884474914755,1.0,6/32,7.76%,UVRAG;GABARAP;EPG5;GABARAPL1;CALM1;VCP
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2643513118943439,0.8574607534647387,0.6978021978021978,0.9798828313937056,1.0,7/66,5.63%,IL34;EDN3;CD40;FGFR1;HTR2B;TLR6;LRRK2
prerank,global genome nucleotide-excision repair (GO:0070911),0.30967855314880993,0.8573676790523409,0.6518151815181518,0.9794128878371403,1.0,9/26,20.55%,ERCC1;ERCC4;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;USP45;DDB1
prerank,cellular response to amino acid starvation (GO:0034198),0.26295453116871426,0.8569306575393207,0.7255689424364123,0.9797058898285446,1.0,19/71,19.02%,NPRL2;SZT2;WDR24;PRKD1;MTOR;EIF2AK2;DAP;TFEB;ATP6V0E1;EIF2S1;ATF2;MIOS;IMPACT;RRAGA;CASTOR1;ATP6V0D1;RRAGD;ATP6V1G2;EIF2AK3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.3587763712629484,-0.8569298099712972,0.6420824295010846,0.8606209167067953,1.0,1/10,0.55%,RAPGEF2
prerank,striated muscle cell differentiation (GO:0051146),0.34431061219992987,0.8567624426736835,0.6527272727272727,0.9794246013129236,1.0,2/16,3.70%,NRG1;MYEF2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2441399063158351,-0.8567009364530772,0.6758620689655173,0.8604503354439474,1.0,8/40,20.12%,EGFR;PTPN3;CST3;AZIN1;FLNA;CYP51A1;SNX3;TIMP3
prerank,regulation of histone modification (GO:0031056),-0.3292621040005542,-0.8566477470091224,0.6517647058823529,0.8599238091568254,1.0,5/13,17.83%,AKAP8;MTHFR;UBE2N;MYOCD;CDK9
prerank,positive regulation of inflammatory response (GO:0050729),0.2569872788187368,0.8566018727409584,0.7148337595907929,0.9790763031302079,1.0,13/86,17.31%,IL33;WNT5A;IL16;TSLP;PLA2G7;TLR4;VAMP7;PDCD4;CD81;RIPK1;DHX9;PTGER4;ADAM8
prerank,positive regulation of glycolytic process (GO:0045821),0.3404056846440703,0.8562788784359648,0.6489533011272142,0.9784003791155906,1.0,3/20,4.53%,ZBTB20;PFKFB1;ENTPD5
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3404056846440703,0.8562788784359648,0.6489533011272142,0.9784003791155906,1.0,3/20,4.53%,ZBTB20;PFKFB1;ENTPD5
prerank,cell cycle checkpoint signaling (GO:0000075),0.37879515915605544,0.8562460408886909,0.6518650088809946,0.9777970829321663,1.0,1/12,0.92%,BUB1B
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.26243624145080585,0.8560901123659946,0.6896103896103896,0.9774646691619663,1.0,27/80,23.70%,KDELR3;COPA;KDELR2;GBF1;TMEM115;COPZ2;DNAJC28;CENPE;COPB1;KIFAP3;SCFD1;ATP9A;RINT1;KIF3C;KIF2A;ERGIC2;TMED3;TMED9;COPG1;COPB2;KIF3A;KIF11;KIF15;BNIP1;KIF23;COPZ1;KDELR1
prerank,defense response to protozoan (GO:0042832),-0.34244052207930664,-0.8559988107590181,0.6507177033492823,0.8606564591349894,1.0,4/12,11.59%,GBP7;GBP4;GBP2;GBP6
prerank,"phototransduction, visible light (GO:0007603)",0.35961391064107384,0.8556653422362259,0.6343537414965986,0.9776616484044501,1.0,2/14,11.79%,GNA11;ABCA4
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2330388313452227,-0.855345096267263,0.7526881720430108,0.8613422606958276,1.0,15/57,16.11%,TNFSF10;HIP1R;KDR;VPS35;GSK3B;RALBP1;MIEF1;BAD;BAX;BID;DDHD1;BOK;ZNF205;ADCK1;GPER1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.24963874588645849,-0.85524937490817,0.7452830188679245,0.8609039365412846,1.0,14/39,25.48%,ARID2;PRKDC;KMT5B;SHLD2;PARP9;FUS;SMCHD1;DDX11;SETMAR;MGMT;WDR48;PARP1;DTX3L;KMT5C
prerank,liver development (GO:0001889),-0.26719176838697783,-0.8548977767291169,0.7223880597014926,0.8609481671338196,1.0,8/32,15.68%,ARID5B;WNT4;ANXA1;COBL;LSR;CITED2;ZIC3;MET
prerank,glycosaminoglycan metabolic process (GO:0030203),0.27551033619366616,0.8548354430552498,0.703125,0.9787884498990638,1.0,13/54,15.45%,HSPG2;GPC4;GCNT2;GPC5;HS6ST2;GNS;GUSB;B4GALT7;IDUA;HS3ST6;HS3ST5;HEXA;SDC2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2621382440402628,0.8547884693782938,0.7157757496740548,0.9782170891191664,1.0,20/78,22.25%,PTEN;NR2F2;CDKN2A;CCNJ;PKMYT1;PSMD10;CDKN2D;CCNB2;CDKN2C;CCNA2;TFAP4;GTF2H1;CCNK;CCNE1;LATS2;MEN1;CDK5R1;CCND3;CDK7;CCNT2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3537931006778307,-0.8547640645197851,0.6375838926174496,0.8605871748576503,1.0,4/11,13.66%,CTPS2;TPK1;DCK;SLC19A3
prerank,protein N-linked glycosylation (GO:0006487),0.2661600009438647,0.8547474767089445,0.7210242587601078,0.9776219767231467,1.0,14/66,14.57%,RPN2;OSTC;ENTPD5;DAD1;ALG6;GFPT2;MAN1C1;ALG13;ALG5;MCFD2;TUSC3;TMEM258;B4GALT7;PMM2
prerank,sterol biosynthetic process (GO:0016126),0.301456162747664,0.8545583103522982,0.6620795107033639,0.9773566104889534,1.0,7/33,11.96%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2287158624747499,0.8544961559371087,0.7958057395143487,0.9768166933305912,1.0,71/264,22.69%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNUPN;SNRPB2;CDK13;CELF4;SMU1;DDX17;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;SRSF10;SYF2;CLNS1A;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;GEMIN8;CTNNBL1;ZCRB1;RBM6;POLR2L;DDX1;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,response to amino acid starvation (GO:1990928),0.26176811448569853,0.8544559538447134,0.713903743315508,0.9762518358315884,1.0,19/72,19.02%,NPRL2;SZT2;WDR24;PRKD1;MTOR;EIF2AK2;DAP;TFEB;ATP6V0E1;EIF2S1;ATF2;MIOS;IMPACT;RRAGA;CASTOR1;ATP6V0D1;RRAGD;ATP6V1G2;EIF2AK3
prerank,inner dynein arm assembly (GO:0036159),0.38878754268884824,0.8541228107352542,0.6533795493934142,0.9762774132354887,1.0,2/10,15.25%,DNAAF4;CCDC39
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3095225863445304,0.8536086380742341,0.6625,0.9767228308341364,1.0,10/27,18.79%,CTNNA2;PTEN;DISC1;GSK3A;NTNG2;NTNG1;BRSK2;NCS1;IL1RAPL1;ULK4
prerank,sphingoid metabolic process (GO:0046519),-0.33714477430947476,-0.8535262093943116,0.6394557823129252,0.8623961698252494,1.0,5/12,26.54%,PLPP3;DEGS2;KDSR;SPHK2;ASAH2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2778067173775758,-0.8534311217731306,0.673972602739726,0.8619509319861849,1.0,9/24,21.55%,BCL2L1;ACKR3;CD44;TPT1;SIRT1;SNAI1;CD74;MIF;CCAR2
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.24755619801488948,-0.8532276031537497,0.7262247838616714,0.8617043030205968,1.0,18/38,30.78%,PTPRJ;MAGI2;XDH;PIK3CB;DAG1;PHLPP2;SIRT1;GPER1;EPHA2;AKT1;PPP2R5B;CIB1;HYAL2;ARRB2;PPP2R5C;TRIB3;NOP53;BANK1
prerank,response to copper ion (GO:0046688),-0.29728121931036583,-0.8529990602725578,0.7099056603773585,0.8615193318838792,1.0,15/20,37.95%,MT2A;ATP5F1D;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;HSF1;ATP7B;AQP1;IL1A
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3186722395191381,0.8522161997891488,0.6661538461538462,0.9790778361864066,1.0,3/25,11.18%,ITPR1;LRRK2;P2RX4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2665784918879918,0.8521280335209054,0.6979310344827586,0.9786082731629909,1.0,10/69,15.74%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;RIPK1;DHX9;CLU;TIRAP
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3619076609194977,-0.8519713225256693,0.6370023419203747,0.862907424498769,1.0,4/11,16.40%,CAT;GPX1;PRDX1;PRDX3
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.218230915021579,-0.8518269711575114,0.7848605577689243,0.8625382424722602,1.0,12/75,13.30%,SLC12A7;SLC9A2;SLC8A3;KCNJ13;ATP1B3;SLC39A8;SLC39A10;KCNK9;KCNJ2;SLC12A8;KCNJ12;TRPV4
prerank,photoreceptor cell development (GO:0042461),0.35632799469351517,0.8517381014078117,0.6590106007067138,0.9788196550135821,1.0,3/14,17.63%,MYO7A;AHI1;CDHR1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3105938025333609,-0.8516045326313064,0.6761229314420804,0.8623651067512564,1.0,4/16,10.62%,FOXD1;SIX1;FGF1;NPNT
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.29968326210326346,0.8515842805488374,0.6934523809523809,0.9785043641302216,1.0,11/33,17.79%,HRG;RAC3;PTK2;JAM3;PLAU;TESC;LYN;EFNA1;FERMT3;PIK3CG;PDE3B
prerank,regulation of protein transport (GO:0051223),0.31109460229502084,0.8508534960873279,0.6506955177743431,0.9793937137910547,1.0,9/27,17.32%,DNAJC1;LLGL1;P3H1;NDFIP2;SCFD1;ARFIP1;SNX12;NDFIP1;STXBP5
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2122986657498997,-0.8507859166866972,0.8260869565217391,0.8633726409552581,1.0,23/87,20.39%,RBFOX2;SHOC2;TBX1;CD44;FGF1;HNRNPF;ITGB1BP1;HYAL1;SFRP1;NR4A1;FRS2;POLR2B;FGFBP1;POLR2H;HNRNPH1;POLR2G;POLR2C;GRB2;FGFR3;FGFRL1;FLRT1;HNRNPA1;GALNT3
prerank,ERAD pathway (GO:0036503),0.2520786279771772,0.8506534741826706,0.7182175622542595,0.9791639935322101,1.0,22/83,16.83%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;RCN3;TMEM67;DNAJC10;USP19;HSP90B1;ATXN3;HSPA5;BAG6;YOD1;BRSK2;UBXN6;USP13;DNAJB14
prerank,chromosome condensation (GO:0030261),-0.2514367524121648,-0.8502255246130037,0.7134328358208956,0.863879102496011,1.0,15/36,29.13%,SMC2;PHF8;TENT4A;PHF13;GPER1;AIFM1;CSNK2B;CHMP1A;NCAPH2;BANF1;SMC4;RB1;NCAPG2;DFFB;TTN
prerank,regulation of dopamine secretion (GO:0014059),0.31995652929130936,0.850017143925682,0.6624605678233438,0.9798255317386472,1.0,6/25,18.62%,SYT3;SYT7;SYT5;GDNF;SYT6;SYT1
prerank,regulation of RNA metabolic process (GO:0051252),-0.22196845394996637,-0.8495614367692202,0.7582781456953642,0.8645059064019344,1.0,17/59,18.41%,MBNL1;AHNAK;AHNAK2;NOVA2;CELF1;HNRNPF;PCBP2;PTBP3;RC3H1;MBNL2;FASTK;FUS;HNRNPH1;SRRM4;FAM50A;RASA1;PQBP1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.17575612489889478,-0.8495086792031444,0.9759036144578314,0.8639521620232489,1.0,108/336,26.43%,FOXO1;FOXP1;BCL2L1;XIAP;SAMHD1;VCPIP1;MCL1;ACER2;CBX3;PRKDC;UVRAG;KMT5B;APC;TRIP12;MAPK14;CASP2;RNF8;VCP;NRDE2;FNIP2;INTS3;TLK2;UBA6;CRIP1;PAXX;BTG2;DYRK2;BAX;UBE2A;RBBP8;INO80;RECQL5;ATR;CBX1;ZDHHC16;RTEL1;BID;OTUB1;RNF169;HERC2;WDHD1;ETAA1;ATM;BOK;GNL1;LIG1;POLE2;NBN;CDKN2AIP;CCND1;GRB2;PLK5;RAD51D;CDKN1A;NSMCE4A;DDX11;ENDOV;RAD51C;PARP4;SIRT1;NSMCE3;TRRAP;EPHA2;OARD1;APTX;HUS1;MUS81;OGG1;XRCC2;APBB1;USP3;NPM1;GTF2H4;MACROD1;CIB1;CHD1L;E2F1;MCM9;MGMT;PHF1;BATF;FANCG;WDR48;IKBKE;RFWD3;ZRANB3;TAOK2;PARP1;MCM8;PARP2;BCL2L11;IKBKG;ATRIP;SUMO1;RMI2;RAD51;BACH1;DTX3L;BRSK1;HINFP;CHEK2;NCOA6;KMT5C;TIGAR;BRCA1;PCLAF;PARK7;CHRNA4
prerank,cellular response to amino acid stimulus (GO:0071230),0.2991573389712324,0.8494965116308594,0.648036253776435,0.9802904247213043,1.0,10/33,18.69%,CPEB1;MTOR;GLRA1;FYN;GLRA2;RRAGA;CASTOR1;KLHL22;RRAGD;CAPN2
prerank,protein lipidation (GO:0006497),0.26777988679693604,0.84903467511108,0.6927453769559033,0.9806100514029937,1.0,21/59,27.32%,PIGV;GPLD1;PIGQ;WDR45B;PIGP;PIGA;PIGL;ZDHHC2;HHAT;ZDHHC6;WIPI2;ZDHHC9;ZDHHC8;ATG10;ZDHHC17;PIGN;SELENOK;MPPE1;PIGB;WIPI1;PIK3C3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3138751753433537,0.8489137486236846,0.6693163751987281,0.9802243390473615,1.0,3/26,8.56%,ATP1A2;FMR1;GNB5
prerank,response to nutrient levels (GO:0031667),0.34816136800241243,0.8487420060423946,0.6845425867507886,0.9799161051020608,1.0,4/17,13.02%,CD68;RPS6KB1;MTOR;MEAK7
prerank,toll-like receptor signaling pathway (GO:0002224),0.2526995919381779,0.848586316993657,0.7064220183486238,0.979544402378552,1.0,17/84,17.68%,COLEC12;UNC93B1;NR1H4;TLR6;TLR8;LGMN;TLR4;BIRC2;IRAK1;MAPKAPK3;S100A1;HSP90B1;UBE2D1;RIPK1;TIRAP;LGALS9;MYD88
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.34326530782874315,-0.8485801156711187,0.6651162790697674,0.8650607284643781,1.0,6/11,47.98%,SIRT1;TAF7;CIITA;PF4;IL4;TMEM106A
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.31895168789213213,-0.8480180818054894,0.6734177215189874,0.8655164558140213,1.0,4/15,6.99%,KHNYN;NYNRIN;DICER1;RPP30
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.3532058778032748,-0.8478765243485921,0.6430205949656751,0.8651816324140251,1.0,5/10,25.65%,CX3CR1;FZD3;CX3CL1;SMARCD3;KDM1A
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3659593075153381,0.8476593536909541,0.6568265682656826,0.9808638933936373,1.0,4/12,15.21%,SEC63;SEC61B;HSPA5;GET3
prerank,regulation of sodium ion transport (GO:0002028),0.295147796640549,0.8473102906433736,0.6870229007633588,0.9809735124188639,1.0,7/34,11.18%,NKAIN1;CNKSR3;ANK3;NKAIN2;NEDD4;FGF12;P2RX4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3415262191302313,0.8473063800334709,0.656093489148581,0.9803173008576582,1.0,3/17,10.20%,CPEB1;RNF40;NUDT21
prerank,rRNA catabolic process (GO:0016075),0.3466662789875828,0.8471666501503058,0.6286701208981001,0.9799451537487741,1.0,6/16,19.04%,EXOSC9;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,dendritic cell chemotaxis (GO:0002407),0.352785428656224,0.8471128420390868,0.671304347826087,0.9793942876456441,1.0,5/14,25.55%,GPR183;TRPM2;PIK3CG;HMGB1;CCR5
prerank,regulation of cell death (GO:0010941),0.24813620546347262,0.8468975695320886,0.7256410256410256,0.9791788042695793,1.0,13/94,9.69%,LRP1;ACOX2;EPHB1;HTR2B;DHCR24;LRRK2;PDE12;DUS2;NPAS2;PRKD1;DCC;RAB29;BMP7
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.2794078617932647,0.8467863440962435,0.6814814814814815,0.9787540166279826,1.0,8/42,14.95%,CECR2;HDAC1;CHD4;MBD3;SPTY2D1;SMARCA1;CHD8;DMAP1
prerank,eye photoreceptor cell development (GO:0042462),0.3546923064467403,0.8466807403408022,0.6655112651646448,0.9783321564398909,1.0,2/15,10.29%,MYO7A;RPGRIP1
prerank,negative regulation of ATPase activity (GO:0032780),0.33905920374239373,0.8463466074131138,0.6781609195402298,0.9783659444880171,1.0,5/16,20.42%,VCPKMT;TP53;PAM16;TSC1;PXK
prerank,regulation of neurogenesis (GO:0050767),0.2675900787617113,0.8455709676281395,0.6786226685796269,0.9793556471197714,1.0,9/55,11.47%,REST;SORL1;SERPINF1;DOCK7;PER2;APPL2;WNT3;NAP1L1;SNW1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.34276355679465753,0.8452270753193112,0.6477462437395659,0.9794027913841143,1.0,5/18,20.60%,DDX19B;DDX19A;ENY2;IWS1;MCM3AP
prerank,positive regulation of cholesterol efflux (GO:0010875),0.32636656550233445,0.8451878197858549,0.6498422712933754,0.9788179227840808,1.0,2/21,4.06%,LRP1;NR1H2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.314644106181892,0.8446533949487297,0.6814580031695721,0.9792934179833215,1.0,7/24,18.50%,NR1H2;LRRK2;HERPUD1;OPA1;CREB3L1;CLU;ALOX5
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.30452586283803396,-0.8444308474632454,0.7129186602870813,0.8713752359914136,1.0,3/16,10.02%,IGF1R;INSR;CLEC16A
prerank,regulation of cell-cell adhesion (GO:0022407),0.28315363554670686,0.8442457318620408,0.6804123711340206,0.9794840736679035,1.0,5/39,7.71%,EPHA7;TENM3;PTPRR;FLOT2;PTK2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2600333102662885,-0.8442251480430437,0.7207446808510638,0.8711322596736603,1.0,10/30,21.86%,CAVIN1;GTF2H5;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.30450604051120084,0.8441095582717147,0.676056338028169,0.9791404199661193,1.0,6/29,17.29%,CXCL10;PLA2G7;LGMN;IL12A;CALR;LGALS9
prerank,mesenchymal cell development (GO:0014031),-0.29347082241077704,-0.843946298292425,0.6758793969849246,0.8710579340258212,1.0,6/18,12.82%,FOXC1;NOTCH1;TCOF1;HEYL;HEY2;NOLC1
prerank,regulation of metal ion transport (GO:0010959),0.3500490778706135,0.8439070383885175,0.6614853195164075,0.9789476222114107,1.0,2/16,2.18%,SLC30A10;IL16
prerank,connective tissue development (GO:0061448),0.29621538043771006,0.8434715979251028,0.7183734939759037,0.9791901730085427,1.0,5/35,5.85%,SULF1;PGRMC2;SOX6;ZBTB16;CREB3L2
prerank,protein localization to condensed chromosome (GO:1903083),-0.33610112687905486,-0.8434205101389822,0.7228915662650602,0.8714220479516057,1.0,6/12,32.58%,MTBP;ZW10;BUB3;IK;TTK;ZWILCH
prerank,organelle assembly (GO:0070925),0.2190783086484347,0.8433383718329042,0.8364978902953587,0.97880182485819,1.0,78/384,18.18%,DYNLL1;CDC14B;ATG9B;TRAF3IP1;CCDC61;DZIP1;NPHP3;WDPCP;WDR35;HAUS3;WDR45B;HAUS1;GBF1;LSM14A;CCDC57;RAB8A;CENPE;STARD9;DISC1;ATP2A2;LSM4;E2F4;CAPN3;IFT81;HAUS8;FAM161A;BSCL2;GOLGA2;HPS1;ABCB6;SNAP29;RB1CC1;CCDC65;AHI1;TCTN2;IFT74;RCC1;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;EDC3;IQCB1;SSX2IP;RFX2;TUBGCP4;IFT88;CENPC;HGS;RAB11FIP3;CEP126;CENPW;SCLT1;TXNDC15;EIF2S1;ACTR2;ATG9A;TSG101;EIF4ENIF1;DYNLL2;CEP250;ATG14;SNF8;TUBGCP6;PTPDC1;CENPF;ULK2;IFT43;UBXN2B;CLUAP1;VPS4B;GOLGA8B;BBS1;WIPI2;PCM1;ATP6V0D1;WDR90
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.35533743766547476,-0.8432284710878793,0.6744730679156908,0.8711492762852975,1.0,3/10,11.86%,VTN;GRB10;ITGB3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.32555507605294276,0.8431361894799209,0.6930379746835443,0.9785611690071431,1.0,7/24,19.13%,TMEM204;NEDD4;PRKCB;HGS;ITGA5;HIF1A;ARNT
prerank,positive regulation of lyase activity (GO:0051349),0.3575329252903021,0.8431042987916011,0.6460481099656358,0.9779665772165789,1.0,3/14,6.99%,AKAP5;NF1;FXN
prerank,chemical homeostasis (GO:0048878),0.2700030626148038,0.8430667659047064,0.7085714285714285,0.9773914453260913,1.0,10/61,17.02%,ZBTB20;ACOX2;TLCD3B;IRS2;SLC66A1;TENT4B;SLC4A1;WNK2;ABHD4;NR1D2
prerank,positive regulation of organelle assembly (GO:1902117),0.2840655504513922,0.8425175283503831,0.711764705882353,0.9778452143174868,1.0,9/44,13.03%,PIP4K2A;FSCN1;GPSM2;IL5;TAPT1;ASAP1;ARHGAP35;ENTR1;CNOT1
prerank,defense response to symbiont (GO:0140546),0.2510577702582251,0.8424846419870158,0.7256637168141593,0.9772633611527461,1.0,14/92,15.89%,MAP3K14;RTP4;CD40;IFIT2;TLR8;PDE12;TRIM56;IFNLR1;EIF2AK2;PYCARD;AGBL4;SERINC5;CNOT7;EXOSC5
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.27292386335017815,0.8422886607028439,0.7052023121387283,0.9769936887590726,1.0,9/51,15.62%,EPB41L3;CNTNAP2;MAP4K4;LRRK2;BMP7;ATP7A;CTTN;SGK1;TNIK
prerank,dendritic cell differentiation (GO:0097028),0.32172815341278527,0.8418656670723984,0.6528662420382165,0.9771914597972994,1.0,6/22,19.88%,AXL;CAMK4;TRPM2;LYN;LGALS9;PRTN3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2983591184327102,0.8416915574938574,0.6833073322932918,0.9768966189331294,1.0,7/30,15.91%,MICALL2;PINK1;SAE1;HTRA2;GSK3A;RNF31;CSNK2A2
prerank,phospholipid metabolic process (GO:0006644),-0.21662072919636619,-0.8416270959681333,0.7935943060498221,0.8736488717457733,1.0,19/71,23.41%,PLPP3;MBOAT1;PLA2G4A;SMPD3;AGPAT4;TNFAIP8L3;ENPP2;PIP4P1;PGP;PLAAT3;SMPD1;CLN8;PLA2G4E;PNPLA3;PIP5K1A;AGPAT2;PLA2G4C;PLPPR1;FITM2
prerank,positive regulation of nuclear division (GO:0051785),0.312212920525685,0.8415654535642921,0.6708074534161491,0.9765167796548493,1.0,4/25,12.43%,EDN3;PHIP;NUSAP1;IGF2
prerank,regulation of protein dephosphorylation (GO:0035304),0.2924989193067576,0.8410010639782036,0.7052469135802469,0.9770453634013018,1.0,9/37,16.59%,DLC1;PPP6R2;PTPA;HSP90B1;ANKLE2;SYMPK;TSC1;PPP1R8;PPP6R3
prerank,vesicle transport along microtubule (GO:0047496),-0.2787774194203209,-0.8406572555306677,0.7052631578947368,0.8749656461221168,1.0,8/23,23.87%,NDEL1;DYNC1H1;TRAK2;RAB1A;DYNC1I1;KIF1C;BICDL1;KIF5B
prerank,regulation of protein secretion (GO:0050708),0.24348352898248304,0.8396648278532115,0.7798053527980535,0.979203967380388,1.0,17/119,12.84%,RAPGEF4;PPID;CACNA1E;ITPR1;DNAJC1;LLGL1;IER3IP1;PER2;PRKCA;P3H1;KCNC2;SYT7;GCK;PPP3CB;EXOC1;IL12A;ARFIP1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3614948623816237,0.8394353493823546,0.6441605839416058,0.9790349543475445,1.0,1/12,1.00%,PPARA
prerank,stress granule assembly (GO:0034063),-0.28529364467851503,-0.839352852728158,0.6873315363881402,0.8768814981390057,1.0,5/20,15.88%,CSDE1;MAPT;UBAP2L;DYNC1H1;RPS23
prerank,regulation of epithelial cell migration (GO:0010632),0.2762092442077752,0.8393325330309979,0.6921985815602837,0.978586919218633,1.0,6/51,7.71%,PTN;PTPRR;RHOJ;MCC;GLIPR2;PTK2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3222253049791745,0.8390909519705367,0.6671949286846276,0.9784168043123181,1.0,2/21,1.52%,SPRY4;SPRY1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3467731581071006,-0.839009021569124,0.6703539823008849,0.8768975432474437,1.0,3/11,12.73%,TGFB2;SOX4;HEY2
prerank,endomembrane system organization (GO:0010256),0.23097715875220007,0.8389617870819037,0.7962529274004684,0.9780363120920704,1.0,50/178,22.56%,SEC16B;PHETA2;SEC16A;SPTBN1;ANK3;GBF1;DNAJC28;LRRK2;SMPD4;SUN2;SYP;GOLGA2;PRKD1;RAB30;RAB29;RAB2A;DNM1;WASHC5;LNPK;SYNE1;AP3D1;COG1;TRIP11;CLASP2;PHETA1;HACE1;VPS33B;CLASP1;USP6NL;UBXN2B;TMED3;TMED9;GOLGA8B;GOLGA5;CTDNEP1;CUL7;NUP155;EIF2AK3;MIA3;TRAPPC12;TBC1D20;PLEKHM2;ARFGEF2;PI4K2A;ATL1;TLCD1;SERP1;BAG5;BNIP1;RAB22A
prerank,response to molecule of bacterial origin (GO:0002237),-0.21987522111296312,-0.8388032169733556,0.8362989323843416,0.8766455142193614,1.0,8/69,8.26%,SMAD6;FOXP1;FER;NOS3;LBP;PELI1;IFNAR1;GCH1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21192817041016873,0.8385607740792919,0.890495867768595,0.9782414600631921,1.0,104/572,17.45%,IL33;ZEB1;ZFHX3;TRPS1;PPARA;MIER2;ETV5;HDAC1;PPID;TAF9B;NR2F2;TCF7L2;SALL1;THRA;NR1H4;PEX2;PER3;MEIS2;NFATC3;PPARD;NR1H2;LOXL2;REST;TBX3;ZBTB16;NEDD4;ZFP37;RTF1;SIRT6;PSMD10;BCOR;GLIS1;DUSP22;TENM2;SRF;BRMS1L;BRMS1;ZBTB2;TRIM37;LYAR;BCL6;NR2C1;TAF3;ZKSCAN3;MDM4;PER2;TWIST1;SOX2;MXI1;NOC2L;PHF6;SP100;NSD1;GLI3;SOX10;TP53;N4BP2L2;ZFPM2;ZNF25;SNW1;EPC1;ESR2;SOX9;MYT1L;IGF2;SAP30;DPF2;KDM1B;CNOT1;PRDM5;ATN1;NRIP1;NFIX;HDAC10;PEG3;MED1;CUX2;UBE2D1;MED25;BPTF;ZBTB32;CHD8;FOXM1;DMAP1;AR;MYC;CRY2;ORC2;DCAF1;FGFR2;KLF11;IMPACT;EFNA1;ZBTB7A;AASS;ZNF3;MAZ;NR1D2;CALR;DNMT3A;SARS1;MBD2;LDB2;LDB1
prerank,synaptic vesicle cycle (GO:0099504),0.302461202702218,0.8381049285835271,0.6831530139103554,0.9785168289428318,1.0,7/30,17.25%,VAMP2;SYNDIG1;SYT7;RIMS1;DNAJC5;PCLO;CDK5
prerank,reverse cholesterol transport (GO:0043691),0.36221324481574424,0.8378663988341633,0.6598984771573604,0.9783529860455764,1.0,3/13,15.09%,LIPC;ABCA5;CLU
prerank,neural crest cell differentiation (GO:0014033),0.3355025769792999,0.8372654140398158,0.6766666666666666,0.9789325968838725,1.0,3/18,9.37%,NRG1;HTR2B;TAPT1
prerank,somite development (GO:0061053),0.36931119133486295,0.8369713956113697,0.6637168141592921,0.9789001752478045,1.0,2/11,10.13%,LOXL3;PPP2R3A
prerank,secondary alcohol metabolic process (GO:1902652),-0.23759141638811665,-0.8366776271034577,0.75,0.8799938636614724,1.0,12/42,23.36%,FDX1;RXRA;APOE;PIP4P1;SOAT1;IDH3B;CLN8;OSBPL1A;IDH3A;EBP;TSKU;CLN6
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3693236587773189,0.8365623551680392,0.6731107205623902,0.9790689193767356,1.0,2/12,9.69%,GCNT2;BMP7
prerank,regulation of TOR signaling (GO:0032006),-0.21728598750277525,-0.836504639152698,0.7992700729927007,0.879683281981842,1.0,15/67,16.15%,FNIP1;DEPTOR;RICTOR;PRKAA2;SH3BP4;UBR1;LAMTOR5;RRAGC;HDAC3;UBR2;TBC1D7;LAMTOR3;TBCK;SIRT1;PRKAA1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.30044752842515277,-0.8361258218419384,0.6666666666666666,0.8797492412073582,1.0,4/18,9.80%,PSMD9;CCN3;KCNB1;SFRP1
prerank,regulation of blood circulation (GO:1903522),0.2929942774648485,0.836076129171374,0.6757990867579908,0.9794171217545222,1.0,3/34,7.98%,ECE1;KCNIP2;PER2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.28509673760045795,0.8359209454872077,0.7068145800316957,0.9790868995661871,1.0,7/38,12.74%,IL34;UNC119;DLG3;RELN;GRM5;DLG4;CASS4
prerank,protein homooligomerization (GO:0051260),0.24254094608916926,0.8355881541712128,0.7697283311772316,0.9791096752389453,1.0,16/114,11.67%,SLC1A5;TRPA1;POLQ;MPP2;ADCY8;CLYBL;ASIC1;GOLGA2;KCNC2;APPL2;HCN1;GLRA3;GSDMD;VSTM5;PYCARD;TRPM2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2811756041813722,-0.8354542401481129,0.6778350515463918,0.8804171201409974,1.0,9/23,23.21%,WNT5B;SMO;SIX1;PIK3CD;MDK;EGF;AGT;SIX4;SOX8
prerank,regulation of cell size (GO:0008361),0.3216647969585319,0.8347558934767191,0.6737704918032786,0.98021124855639,1.0,4/23,9.11%,PRR16;PTEN;MTPN;MTOR
prerank,mitochondrial fission (GO:0000266),0.3440005007756321,0.834549805333348,0.7109243697478992,0.979970185310041,1.0,4/16,14.75%,MTFR2;OPA1;DNM1;MTFP1
prerank,positive regulation of cell cycle (GO:0045787),-0.22252935910731275,-0.8344348666880089,0.8214285714285714,0.8816655346653381,1.0,17/62,22.16%,EGFR;CCNYL1;APP;CCND2;TGFB2;LRP6;RPS15A;CITED2;CCND1;TAL1;ANKRD17;EIF4EBP1;PKN2;AKT1;RGCC;ASNS;NUPR1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3585516941114644,0.8337082441372927,0.6569965870307167,0.9810272627863955,1.0,4/13,14.78%,GRIN2A;LGMN;ASPH;BAK1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3142084996355568,-0.8336346790216219,0.6620370370370371,0.8825860418571152,1.0,11/14,50.62%,TYROBP;CSF1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;TRAF6;IL12B
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2658796335615726,-0.8333618323235138,0.7349081364829396,0.8824530807581439,1.0,9/28,25.48%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;NUDT16L1;DTX3L;KMT5C
prerank,cellular response to reactive oxygen species (GO:0034614),0.261996067751491,0.8333118870222744,0.720708446866485,0.9812024319240221,1.0,9/59,11.68%,PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5;FXN;PLEKHA1;TRPM2;PDK2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3667836900594392,0.8330087142866667,0.6778169014084507,0.9811509373955425,1.0,2/11,12.15%,TIMM10;AGK
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3162160138571801,0.8328230641511468,0.6533795493934142,0.9808743723055298,1.0,7/20,17.42%,AGO4;AGO3;CNOT1;CNOT7;WTIP;TNRC6B;AGO1
prerank,cellular copper ion homeostasis (GO:0006878),0.3529045231412608,0.8324169030066075,0.6724436741767764,0.9810744862150261,1.0,3/14,14.03%,CCDC22;ABCB6;ATP7A
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.332085524544644,-0.8323603114973079,0.6786516853932584,0.8836081139628699,1.0,5/13,16.99%,NR3C2;ABHD2;NR3C1;GPER1;ESR1
prerank,tRNA aminoacylation (GO:0043039),0.2894929404110211,0.8320955647761865,0.7175925925925926,0.9811049901608369,1.0,13/37,26.61%,EPRS1;CARS1;TARS1;YARS1;HARS1;SARS1;SARS2;AIMP1;PPA2;MARS2;AARS1;FARSA;YARS2
prerank,protein glycosylation (GO:0006486),0.23857444672378295,0.832077339504917,0.7743979721166033,0.9804956740822933,1.0,22/125,14.57%,PLOD1;ST8SIA1;OGT;GALNT18;RPN2;GCNT2;ENTPD5;DAD1;POMT1;ALG6;GFPT2;B3GNT8;MAN1C1;GOLGA2;GALNT10;ALG5;FKTN;TUSC3;TMEM258;B4GALT7;B3GALT5;PMM2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.30290781136749834,0.8318869804146185,0.6964006259780907,0.9796146119910506,1.0,5/29,15.24%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.30290781136749834,0.8318869804146185,0.6964006259780907,0.9796146119910506,1.0,5/29,15.24%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,gluconeogenesis (GO:0006094),0.2855753378586386,0.8309697033229655,0.6987951807228916,0.9808899411834074,1.0,6/39,11.24%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3
prerank,positive regulation of actin nucleation (GO:0051127),-0.34271227082059985,-0.8309519345868746,0.6650717703349283,0.8856120793860202,1.0,2/11,3.69%,WASF2;GSN
prerank,positive regulation of cartilage development (GO:0061036),0.3380019108098897,0.8306278592967647,0.7177280550774526,0.9809005075300962,1.0,5/17,12.02%,LOXL2;SOX6;ZBTB16;TAPT1;SOX9
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.28797216247305407,0.8304382765408662,0.7039274924471299,0.9806665850820081,1.0,6/34,12.59%,EDN3;PHIP;CDC16;NUSAP1;IGF2;ANAPC5
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3313147065842018,-0.8303756406259458,0.6964285714285714,0.8860529397620803,1.0,7/11,46.13%,ADRB2;ARRB2;ADM;DRD3;ADRB3;ARR3;ARRB1
prerank,cellular calcium ion homeostasis (GO:0006874),0.2339602394498797,0.8300427068473086,0.779236276849642,0.9808207974361349,1.0,16/133,9.09%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ADCY8;CALCA;HERPUD1;CALB1;ATP13A3;TRPC3;PRKACA;MICU3;HTR2C
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3352573363796498,0.8296621311192538,0.7083333333333334,0.9809452136128348,1.0,3/16,12.02%,ACADL;APPL2;SOX9
prerank,cellular response to nitrogen compound (GO:1901699),0.32326877116497177,0.8294079769295231,0.6760070052539404,0.9808180775297259,1.0,5/20,11.64%,NR1H4;FMR1;PDE12;DAXX;SPIDR
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3755972041306596,0.8294024122979984,0.6513761467889908,0.9801903612960075,1.0,2/10,14.03%,KYNU;ATP7A
prerank,protein autoubiquitination (GO:0051865),0.2640262001256167,0.8290883164181864,0.7402777777777778,0.9801860062822617,1.0,5/61,7.22%,SH3RF1;SH3RF3;RNF220;BFAR;TRIM37
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2445778533408809,0.8289810222508973,0.7650200267022697,0.9797451396729782,1.0,18/91,15.25%,PLD1;ITGAV;VAMP2;LRRK2;RAB8A;RUFY1;RAB3C;RIMS2;MAP2K1;FGR;OPHN1;SYT7;RAB15;SCFD1;ATP9A;RINT1;SNX12;PACSIN3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.32296193278740465,-0.8287622049195429,0.6930455635491607,0.888438745049728,1.0,8/13,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;GAL3ST3;B3GNT6;B4GAT1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.25325362293493436,-0.8287258178280876,0.7635327635327636,0.8878612761690832,1.0,6/31,10.44%,KMT5B;RBP4;TFRC;DNAJB9;SHLD2;EPHB2
prerank,rRNA 3'-end processing (GO:0031125),-0.34171354057513936,-0.828032774490508,0.6630434782608695,0.8885052091096706,1.0,4/10,15.85%,ERI1;RPS21;EXOSC2;EXOSC3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.21614661927702555,0.8277444977334824,0.8549946294307197,0.9815455756295681,1.0,82/327,22.97%,RORA;CHD7;ZFHX3;MSC;ATF5;NCOA2;MYT1;TEAD2;REST;SOX6;ZNF423;FOXN2;CXXC1;ZFP37;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;DAXX;SRRT;BRCA2;NSD1;TP53;NFXL1;TGFBR1;ESR2;SRSF10;IGF2;TFEB;SAP30;NUP107;ZNF628;CARM1;HDAC10;ARNT2;SSBP2;TGFBRAP1;UBE2V1;HNRNPD;MLF1;ATF2;WTIP;MAFB;ZKSCAN5;TRIP4;NONO;USP13;NR1D2;CALR;ZBTB11;LDB1;MLF2;BMP2;KAT7;SKOR2;REXO4;HIF1A;WWC1;THAP7;TERF2IP;NR2C2;SP1;TRAPPC2;CNBP;DVL2;HCFC2;GON4L;UTP4;APBB3;ASCC1;DDIT3;CREBBP;LIN54;SERTAD3;ATRX;MLLT6;NLK;RREB1;ABL1;HOXB7;ZMIZ1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.33979722820570446,-0.8275763531192121,0.6883408071748879,0.8880530271065973,1.0,4/11,19.81%,CCT3;CCT4;CCT7;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.33979722820570446,-0.8275763531192121,0.6883408071748879,0.8880530271065973,1.0,4/11,19.81%,CCT3;CCT4;CCT7;MEPCE
prerank,regulation of necroptotic process (GO:0060544),-0.2751257359764051,-0.8272602916930671,0.72264631043257,0.8879892733279023,1.0,12/23,26.98%,YBX3;PELI1;CASP8;CYLD;SDCBP;MLKL;PDCD6IP;CFLAR;BIRC3;SLC25A4;FLOT1;ZBP1
prerank,long-chain fatty acid import into cell (GO:0044539),0.3743493401060861,0.8270169944461202,0.6504347826086957,0.9823328780957868,1.0,2/10,7.88%,SPX;RPS6KB1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37776734673506945,0.826923128187595,0.6887298747763864,0.9818897755958632,1.0,3/10,10.42%,TSPAN6;DHX58;SEC14L1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.24534403859283796,0.826890921745274,0.7631241997439181,0.9813192956878855,1.0,20/84,18.81%,BUB1B;PSMD1;FBXO5;FBXO31;CDC16;PSMD10;CDC20B;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;PSMA7;PSMD14;CDC26;PSMA2;PSMD11
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.34946378869812234,0.8264677285002224,0.6701570680628273,0.9815365829342294,1.0,3/13,10.81%,GRIK2;SYP;SHISA6
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24811420871096992,0.8262290307757594,0.7640891218872871,0.9813747491166476,1.0,28/88,23.38%,FBXO9;PSMD1;FBXO31;DMAC2;PSMD10;PSMA5;PSMB5;AMN1;FBXO17;PSMC4;PSMA4;PSMC5;FBXW5;FBXL13;CUL5;PSMB9;PSMA7;PSMD14;PSMA2;CUL4A;PSMD11;FBXO4;FBXW4;FBXL22;BTRC;FBXL5;FBXL12;KIF14
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3435895023971729,-0.8260091453292567,0.7172897196261683,0.8897117907470129,1.0,3/11,11.48%,NSUN2;NRDE2;NUP153
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.34305980453179713,-0.8259544268404725,0.6782786885245902,0.8891657158939317,1.0,5/10,30.13%,NUFIP1;RUVBL2;TAF9;PIH1D2;RUVBL1
prerank,autophagosome assembly (GO:0000045),-0.22541387385614345,-0.8257324591670432,0.8178807947019867,0.8888992056878312,1.0,22/52,29.08%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;RAB1A;ATG12;ATG2A;MAP1LC3A;AMBRA1;RAB1B;ATG101;MAP1LC3B;WDR45;SMURF1;EMC6;ATG16L1;UBXN2A;RAB19;IRGM
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2733857781719854,-0.8254742598126951,0.7378640776699029,0.8887322494867673,1.0,9/22,24.09%,GTF2H5;UBB;UBC;RAD23B;GTF2H4;CHD1L;UBA52;CETN2;PARP1
prerank,mitochondrial genome maintenance (GO:0000002),0.35645277523498387,0.8253405490870369,0.6778169014084507,0.9825511974294491,1.0,4/11,13.99%,OPA1;SLC25A33;TOP3A;LONP1
prerank,oligodendrocyte development (GO:0014003),0.34515347528571305,0.8251369126516475,0.7097902097902098,0.9823092931400882,1.0,4/15,13.88%,EIF2B1;SOX10;PLP1;MYRF
prerank,mucosal immune response (GO:0002385),0.3466223003515822,0.8248001669329753,0.6916524701873935,0.9823730059081619,1.0,15/15,65.37%,IFNLR1;OTUD7B;PLA2G1B;DEFA6;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;RNASE3;RPL39
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.22919903078237885,-0.8244028105383404,0.7766323024054983,0.8900357156273984,1.0,11/46,20.68%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,skeletal muscle contraction (GO:0003009),-0.2832628192069002,-0.823507674037259,0.7290167865707434,0.891002412807066,1.0,14/19,54.12%,STAC;TNNT3;TNNI1;STAC2;TNNC1;TNNI3;CCDC78;TCAP;TNNI2;MYH14;TNNC2;JSRP1;TNNT1;CHRNA1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.28368481846298177,0.8233926868532131,0.7198142414860681,0.9845458701301804,1.0,10/36,17.82%,WNT5A;TCF7L2;AGO4;PPP3CB;AGO3;GNAO1;GNG2;TNRC6B;AGO1;CAMK2A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2786647482083564,0.8231943553406946,0.7136431784107946,0.9842969448935254,1.0,9/39,16.69%,UTRN;ANK3;SCN2B;NEDD4;FXYD4;FGF12;WNK2;FGF14;HECW1
prerank,tRNA processing (GO:0008033),0.25558287407230534,0.8230053074800902,0.7582872928176796,0.9840567902326234,1.0,19/61,23.78%,RPP40;CTU1;POP5;QTRT2;POP7;TSEN15;FAM98B;TRMT61A;WDR4;METTL1;PTCD1;SARS1;RPP21;DDX1;TRMT10A;LCMT2;AARS1;TRMT10C;SSB
prerank,Rac protein signal transduction (GO:0016601),0.3270529901699566,0.8229968807804824,0.6866883116883117,0.9834353183988448,1.0,5/18,17.41%,ELMO1;HACE1;CYFIP1;HACD3;RHOG
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3128648473729717,0.8219472719252109,0.6848673946957878,0.9848835577069134,1.0,6/22,17.33%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.23521372717677175,0.8217516834954774,0.7934918648310388,0.9846463001867793,1.0,17/121,12.94%,GHR;IL34;UNC119;CD40;ERBB4;TSLP;DLG3;DGKQ;IL5;RELN;TP53;GRM5;DLG4;IL12A;IGF2;CASS4;CD81
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.25657588565185435,-0.8215269132779425,0.7592592592592593,0.8938585226550976,1.0,6/29,12.98%,KANK2;RUNX1;VPS18;WBP2;KCTD6;VPS11
prerank,ventricular septum development (GO:0003281),0.28199047994184484,0.8206099578453097,0.7222222222222222,0.9862581773506585,1.0,8/37,15.15%,ROBO2;SALL1;MDM4;ZFPM2;TGFBR1;HECTD1;DAND5;GJA5
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2693253756748589,-0.8202433115463348,0.7473118279569892,0.8955185639785661,1.0,2/23,7.09%,NMT2;CALM1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.32289879164808094,0.8200968013292311,0.7162393162393162,0.9866541838049648,1.0,6/18,19.41%,SPTBN1;AR;LDLRAP1;ZDHHC2;CDK5;ABCA2
prerank,regulation of leukocyte migration (GO:0002685),-0.29584293713419646,-0.8199782262629206,0.6911392405063291,0.8953330322500889,1.0,2/16,5.15%,ANXA1;RAC1
prerank,negative regulation of telomere maintenance (GO:0032205),0.33484771953961323,0.8197862685329417,0.6839546191247974,0.9866210306648053,1.0,3/15,7.82%,ERCC1;ERCC4;TERF1
prerank,centromere complex assembly (GO:0034508),0.28530006447420814,0.8193431583687651,0.7186147186147186,0.9868267775633309,1.0,7/36,15.58%,MIS18A;CENPU;CENPE;CENPC;CENPW;MIS18BP1;CENPF
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.23756434298771226,-0.8191358653901097,0.7976539589442815,0.8961333061496664,1.0,6/38,10.98%,CACNA1C;CAV1;CAMK2D;ANK2;KCNJ2;KCNQ1
prerank,regulation of chromatin organization (GO:1902275),-0.30663144780200324,-0.8190424485642864,0.7262443438914027,0.8956516131438357,1.0,3/14,8.35%,MLLT3;TLK1;TLK2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.25856209556725734,0.818800346565937,0.7293640054127198,0.9872591962227978,1.0,10/63,11.51%,SH3RF1;TCF7L2;PHIP;ITGAV;FGFR1;NOL3;G0S2;SP100;PYCARD;TGFBR1
prerank,epithelial cell-cell adhesion (GO:0090136),0.3687409880159905,0.8186794690543119,0.7005444646098004,0.986872932563083,1.0,2/11,3.95%,ITGB5;JUP
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2931133978480427,0.818571030691461,0.7125,0.986451349901345,1.0,5/31,14.07%,GLMN;PDCD1LG2;TNFRSF21;CD86;LYN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3664600843132293,0.8183976204723231,0.6940559440559441,0.9861315343847508,1.0,2/10,8.21%,HRG;JAM3
prerank,iron-sulfur cluster assembly (GO:0016226),0.3055536479778263,0.8181265520866109,0.7162576687116564,0.9860396011334229,1.0,6/24,16.72%,NUBP2;FXN;CIAO1;ABCB7;MMS19;ISCA1
prerank,keratan sulfate catabolic process (GO:0042340),0.36241211376454796,0.8180536849685696,0.6799307958477508,0.9855596004691051,1.0,3/11,15.26%,LUM;GNS;HEXA
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.33409900461386705,-0.8175716095388424,0.7420924574209246,0.8976479149372905,1.0,6/12,28.65%,SERINC3;PSAT1;CBS;SEPHS2;CTH;GGT1
prerank,lysine catabolic process (GO:0006554),0.3565296753815675,0.8173797233751996,0.6980108499095841,0.9856032968374397,1.0,3/12,16.27%,SLC25A21;DLST;AASS
prerank,lysine metabolic process (GO:0006553),0.3565296753815675,0.8173797233751996,0.6980108499095841,0.9856032968374397,1.0,3/12,16.27%,SLC25A21;DLST;AASS
prerank,maintenance of protein location in nucleus (GO:0051457),0.3159032659940606,0.8169707865012729,0.7052980132450332,0.9857499757425308,1.0,7/20,20.71%,SUN2;TAF3;SP100;SYNE1;TAF8;SUPT7L;BBS4
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.25733861301634303,0.8163063040159794,0.7528089887640449,0.9863805961302686,1.0,17/67,18.81%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;PSMA7;CALR;PSMD14;PSMA2;PSMD11
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3310120267530773,-0.816238611497631,0.7111111111111111,0.8993484549284019,1.0,8/12,37.58%,SMO;SIX1;AGT;SIX4;SOX8;LHX1;PAX8;NOG
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.33636180189299714,0.816167668833013,0.6815834767641996,0.9860166033862775,1.0,6/15,21.14%,UNC119;SMAP1;NEU3;SCYL2;DGKD;SNAP91
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2786325087948147,0.8161330687838728,0.7518355359765051,0.985457779862666,1.0,5/39,7.53%,PIK3R1;PIP4K2A;PIK3R2;EFR3A;PI4KA
prerank,positive regulation of developmental growth (GO:0048639),0.2716292885813145,0.8159171438012274,0.7369942196531792,0.9852688828570269,1.0,12/49,20.03%,GHR;CDKL5;LIMK1;RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1;ZFYVE27;MAP3K13
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.26625279052336664,-0.8157536027058175,0.7479674796747967,0.899562665041459,1.0,7/25,16.04%,SLIT2;KANK1;CAPZB;TBC1D7;EVI5L;PRKCD;ARHGAP44
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32441140843432403,0.8155262723258607,0.7128874388254486,0.9853869670312156,1.0,2/18,8.27%,DCN;PINK1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.24101473229805537,-0.8154552191921821,0.7818696883852692,0.8994161515590449,1.0,12/37,25.89%,NFKB1;RIN3;APOE;OPTN;ITGB3;EDN1;SDCBP;SIRT5;MTMR2;ANKRD13D;MT3;BRCA1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3080441611912258,-0.8147813492954205,0.727735368956743,0.8999454719454193,1.0,5/15,17.19%,NUDT7;ACAT1;PMVK;ACACB;HMGCS2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.25888805243975865,-0.8146188332814241,0.739240506329114,0.8995738489848292,1.0,2/27,3.33%,CD200;SIRPA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.31540582613270857,0.8145126051954101,0.6839546191247974,0.986741074446692,1.0,4/22,8.98%,PDE4B;FMR1;GNB5;CACNB4
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3164039690310567,0.8137907527365685,0.7135593220338983,0.9869044785191571,1.0,7/20,22.29%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;BCKDK;HIBADH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3164039690310567,0.8137907527365685,0.7135593220338983,0.9869044785191571,1.0,7/20,22.29%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;BCKDK;HIBADH
prerank,neuron projection extension (GO:1990138),0.29039555941504563,0.8134632522410362,0.7229629629629629,0.9868992807028368,1.0,10/32,19.08%,AUTS2;SEMA5A;TMEM108;CDKL3;PPP3CB;IMPACT;ULK2;CYFIP1;CDK5;LLPH
prerank,ketone body metabolic process (GO:1902224),0.37286088491976366,0.8134004617254406,0.6996268656716418,0.9863767271880447,1.0,1/10,1.09%,ACSS3
prerank,regulation of mast cell degranulation (GO:0043304),0.33863971342486743,0.8133844506493785,0.6846689895470384,0.9857828741119956,1.0,4/14,17.29%,GAB2;FGR;LYN;LGALS9
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.272262420973899,0.8132936201244425,0.744776119402985,0.9853280799305875,1.0,8/43,15.28%,ZFYVE28;SPRY1;CBLB;EPS15;HGS;SH3KBP1;TSG101;AREG
prerank,negative regulation of autophagy (GO:0010507),0.26314233919542135,0.8130179880516829,0.7404255319148936,0.985199501349342,1.0,13/54,18.12%,EIF4G3;HTR2B;PTPN22;LRRK2;ZKSCAN3;GOLGA2;PINK1;MTOR;DAP;SNRNP70;TSC1;RRAGA;KLHL22
prerank,intracellular sterol transport (GO:0032366),0.34718472099937037,0.8128193991347205,0.6994906621392191,0.9849672130787976,1.0,5/13,19.36%,RELCH;SERAC1;ARV1;OSBP;NPC2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24571419808516948,0.812727108179187,0.7951807228915663,0.9845209794397267,1.0,21/78,19.81%,PRICKLE1;RNF180;LRRK2;SIRT6;PSMD10;HERPUD1;CBFA2T3;CDC20B;NKD2;ZYG11B;HECTD1;GSK3A;DDA1;CLU;CSNK1E;DET1;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,regulation of protein localization to nucleus (GO:1900180),-0.23020893807607515,-0.8127102191320158,0.8145896656534954,0.9023573590862259,1.0,14/43,26.33%,TFRC;GSK3B;LAMTOR5;PARP9;SUMO3;CTNNA1;AKT1;MFHAS1;ILRUN;WWTR1;GLUL;DTX3L;CARD10;PARK7
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.3304111445473652,0.812622443332133,0.705685618729097,0.9840995912266536,1.0,1/17,0.79%,XCL1
prerank,regulation of protein catabolic process (GO:0042176),-0.19701929778227031,-0.812499010742409,0.919047619047619,0.9020665727867351,1.0,24/99,20.49%,FOXO1;WWP1;EGFR;WWP2;GPC3;APC;GSK3B;VCP;AZIN1;SMURF2;EEF1A1;ASB5;RNF41;APC2;FLNA;FURIN;OAZ1;CYP51A1;OAZ2;TMEM9;SNX3;WDR91;FZR1;TNFAIP3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.3238155251142865,0.8122918355659973,0.7014925373134329,0.9841099827511973,1.0,1/19,0.79%,XCL1
prerank,regulation of DNA recombination (GO:0000018),0.2867695513637896,0.812103413818857,0.7525925925925926,0.9838640919770625,1.0,10/32,22.35%,MSH3;SIRT6;ZCWPW1;SPIDR;KPNA1;FIGNL1;MSH6;TERF2IP;PPP4R2;KPNA2
prerank,regulation of viral life cycle (GO:1903900),-0.2752515887430232,-0.8118579995221328,0.7468030690537084,0.9025951290599575,1.0,5/21,15.94%,TRIM25;TRIM5;TRIM14;PPIA;TRIM27
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3600454938554419,0.8112026484797997,0.6904761904761905,0.9849331951260013,1.0,2/11,7.82%,CCT5;TERF1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2306347071588364,-0.8110953367222409,0.7672955974842768,0.9032190934667476,1.0,27/43,38.41%,FOXN3;INTS3;BRCC3;ATM;NBN;CDKN1A;PABIR1;DONSON;HUS1;CHFR;ORC1;FZR1;TAOK2;TRIM39;BRSK1;BRCA1;CHEK1;UIMC1;NOP53;DTL;BABAM2;HUS1B;MRE11;PLK1;CDK1;CDC6;TICRR
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.34281439445047734,-0.811054066887919,0.7023060796645703,0.9026400133002319,1.0,2/10,9.33%,NFKBIZ;RC3H1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2545206728612901,0.8109752861825612,0.7584269662921348,0.9847619519308273,1.0,17/70,18.81%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;PSMA7;CALR;PSMD14;PSMA2;PSMD11
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.31524466684637364,-0.8109737601778563,0.7329974811083123,0.9021124495647481,1.0,6/13,25.75%,RPS15;NOP9;RAN;NPM1;LTV1;LSG1
prerank,negative regulation of organelle assembly (GO:1902116),0.27949825994714356,0.8109019632085959,0.7307110438729199,0.9842702331123769,1.0,6/35,11.18%,MDM1;LRRK2;TRIM37;PINK1;KAT2A;SCFD1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.30862977254720936,0.8106640631693455,0.7006688963210702,0.9841161164119538,1.0,8/22,20.43%,RPP40;NOL9;EXOSC9;RRS1;EXOSC10;EXOSC8;URB1;UTP20
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.29413963971635854,0.8106557534340089,0.7216174183514774,0.9835089574106854,1.0,5/29,11.37%,NCDN;GRIK2;SYP;SHISA6;DLG4
prerank,icosanoid metabolic process (GO:0006690),-0.23790137040210305,-0.810565132148291,0.804953560371517,0.9021507558707992,1.0,5/40,5.00%,PTGS1;PLA2G4A;CYP1B1;MGLL;PON3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.30219421209128544,0.810387011087849,0.7274193548387097,0.983383515661007,1.0,4/24,9.07%,CXCL10;DUSP1;PLA2G7;LGMN
prerank,artery morphogenesis (GO:0048844),-0.2554251278769207,-0.8101779543032595,0.736986301369863,0.9021969982550706,1.0,8/30,14.79%,NRP1;BMPR2;NOTCH1;TGFB2;TBX1;TBX2;HEY2;STRA6
prerank,copper ion homeostasis (GO:0055070),0.32419425674786573,0.809208439657415,0.7025210084033613,0.9849953704656284,1.0,4/17,14.03%,CCDC22;ABCB6;COMMD1;ATP7A
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2307505621051566,-0.809132355781042,0.8006042296072508,0.9034019415232365,1.0,11/42,20.69%,LBP;RPS19;DROSHA;SERPINE1;OPTN;RPL30;RNASE7;MPEG1;HMGB2;CHGA;ROMO1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.30636372900262543,0.809004726538576,0.724960254372019,0.9847589343275738,1.0,1/22,0.79%,XCL1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3331849599632211,0.8087318640726745,0.7245409015025042,0.9846521225889047,1.0,4/16,10.90%,HNRNPA2B1;ERCC4;TERF1;DHX36
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.2974435126273153,0.8087254669297091,0.7194928684627575,0.9840476310824674,1.0,5/27,10.84%,UTRN;SCN2B;COMMD1;FXYD4;FGF12
prerank,double-strand break repair (GO:0006302),0.22225192020012008,0.8086845976818774,0.8474374255065554,0.9834986300729612,1.0,37/158,20.20%,MORF4L1;ERCC1;LIG3;FAN1;FEN1;POLQ;ERCC5;POLA1;RPA1;ERCC4;POLL;MMS22L;RNF168;BRCA2;UBE2V2;ZFYVE26;REV3L;RECQL;SPIDR;POLN;XRCC1;POLB;CYREN;RAD52;EME2;PAXIP1;KDM2A;NHEJ1;PSMD14;SMARCAL1;HELQ;WRN;FBH1;RIF1;TRIP13;MTA1;DDX1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.33774553302798294,-0.8086411114439628,0.7016317016317016,0.9035695746606168,1.0,6/10,41.55%,TNFRSF1B;AGER;CCR2;TRPM4;ZBTB1;WAS
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2665167776367802,0.8083692489226944,0.7536023054755043,0.9834622754727528,1.0,5/50,7.12%,SH3RF1;NGFR;DHCR24;NOL3;CDKN2D
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.28233326564639344,-0.807738980378131,0.7292682926829268,0.9044749990608212,1.0,4/18,12.91%,ANXA1;KLF9;FAM107A;NR3C1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.2250836217445591,0.8072540570700704,0.833926453143535,0.9850062418794248,1.0,21/163,11.54%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;ICOSLG;PDPK1;PIK3R2;PTPN22;EIF2B1;CD276;PSMD10;PSMA5;PSMB5;PLEKHA1;PRKCB;PSMC4;TNFRSF21;PSMA4;FYN;PSMC5
prerank,negative regulation of histone modification (GO:0031057),0.33815515491774206,0.807006478817345,0.6730434782608695,0.9848553616771933,1.0,4/14,18.84%,TWIST1;NOC2L;AASS;THAP7
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.37048892236239245,0.8069252496370382,0.6987951807228916,0.9843863914200198,1.0,10/10,62.97%,SAG;PDE6A;GRK1;CNGA1;GNB1;CNGB1;GNAT1;RHO;PDE6B;PDE6G
prerank,ncRNA 3'-end processing (GO:0043628),0.34146870619127656,0.8069222183663269,0.6864406779661016,0.9837739726984588,1.0,3/14,15.80%,INTS8;INTS14;PTCD1
prerank,macrophage chemotaxis (GO:0048246),0.3708027364589218,0.8065179856643464,0.696588868940754,0.9839082227036848,1.0,10/10,62.94%,CCL2;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF
prerank,anterior/posterior pattern specification (GO:0009952),-0.21661625116796865,-0.8063965052660378,0.8621908127208481,0.9060803295489541,1.0,14/53,19.43%,BMPR2;SKI;WLS;TBX1;HOXC6;HEYL;HEY2;PCSK5;ATP6AP2;ACVR2B;HHEX;BHLHE40;HOXD3;HOXB6
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3439060621456191,0.8063516778520294,0.6976351351351351,0.9836129166931804,1.0,7/13,28.50%,RPP40;NOL9;RRS1;UTP20;ABT1;RCL1;TBL3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2447201943839848,-0.8060304282975563,0.7910447761194029,0.9060360058959722,1.0,10/33,25.15%,AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;EGF;AGT;DOK1;CNOT9
prerank,histone H2A monoubiquitination (GO:0035518),0.32455391915815807,0.8059062627056561,0.7185929648241206,0.9838374977653351,1.0,3/17,9.25%,BCOR;TRIM37;RNF168
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2902350422737199,0.8054668572687351,0.7312977099236642,0.9840351309643834,1.0,6/30,10.61%,NAT10;ERCC4;TERF1;PIF1;TENT4B;TP53
prerank,myofibril assembly (GO:0030239),0.270696290844854,0.8054094897405446,0.7595307917888563,0.9835232879041144,1.0,1/42,0.14%,PDGFRA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.3197141094617295,-0.8052308705002931,0.7321016166281755,0.906835168507484,1.0,5/12,36.86%,FDX1;FDXR;STAR;TSPO;FDX2
prerank,microtubule nucleation (GO:0007020),0.31418602851509275,0.8049443162119452,0.7157190635451505,0.9837985978772188,1.0,6/19,15.82%,CCDC57;GOLGA2;TUBGCP4;CLASP2;TUBGCP6;CLASP1
prerank,regulation of DNA replication (GO:0006275),-0.22052458063861924,-0.8048245432031491,0.8309859154929577,0.9069016845094524,1.0,10/49,12.73%,EGFR;S100A11;GLI2;PPP2R1A;ACVRL1;ESCO1;ATR;CCDC88A;PCNA;STN1
prerank,metal ion transport (GO:0030001),0.24110596385706998,0.804705289480209,0.8034300791556728,0.983619984868447,1.0,19/86,20.12%,CACNA1E;CALCRL;ITPR1;CACNG3;RYR2;SLC30A5;TRPC3;NDFIP2;FYN;TRPM2;TUSC3;RYR3;CACNA2D1;NDFIP1;GRIN3A;CAMK2A;ATP2C1;TRPC1;NIPA2
prerank,vesicle transport along actin filament (GO:0030050),0.3152129661752718,0.8046407758713672,0.7391304347826086,0.9831169581242261,1.0,4/19,11.64%,MYO7A;MYO1B;MYO6;MYO1G
prerank,regulation of Golgi organization (GO:1903358),-0.2944868523339411,-0.8045736721242611,0.7406542056074766,0.9066644126375897,1.0,4/17,18.35%,ARMH3;STX18;MAP2K2;CAMSAP2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3337145556907094,0.8045560953582422,0.7142857142857143,0.982657960770393,1.0,4/15,12.47%,SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.2723959705047641,0.8041895613291201,0.7782672540381792,0.9827189571175333,1.0,10/39,18.88%,ZFYVE28;SPRY1;EPS15;LGMN;HGS;SH3KBP1;TSG101;AREG;PTPN18;SPRY2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3359838475592152,0.8040516545853067,0.7365684575389948,0.9823360967819861,1.0,3/14,10.22%,SCRIB;FSCN1;OPHN1
prerank,membrane fusion (GO:0061025),0.2821458893162896,0.803628291336311,0.7462235649546828,0.9825293482792822,1.0,10/33,16.87%,VAMP2;SNAP23;OPA1;SNAP29;RIMS1;DNM1;RABIF;HACE1;VPS33B;UBXN2B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2835654971623575,0.8036231029676213,0.7362637362637363,0.9819289848033752,1.0,4/33,9.09%,PTEN;SUSD2;GLI1;APPL2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.26680191978712525,-0.8030010233467494,0.741514360313316,0.9086735553720905,1.0,14/23,34.97%,PRCC;INTS3;ZW10;WEE1;PLK5;PABIR1;SETMAR;CHFR;CHMP4C;CHEK1;PLK3;ZWILCH;VPS4A;PLK2
prerank,negative regulation of macroautophagy (GO:0016242),-0.25806640803310754,-0.8028406420821299,0.773224043715847,0.908313701683271,1.0,15/26,33.92%,MTM1;FEZ2;NRBP2;CLEC16A;TMEM39A;CHMP4B;CHMP4A;AKT1;NUPR1;SMG1;QSOX1;PHF23;LZTS1;FEZ1;PIK3CA
prerank,regulation of endocytic recycling (GO:2001135),-0.32723611302989564,-0.8027251921946251,0.7188940092165899,0.9078847666861679,1.0,2/11,5.18%,ACTN2;INPP5F
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.31546363390026405,-0.8026673854717471,0.7163461538461539,0.9073270367148799,1.0,8/12,30.16%,CD44;RPL26;SIRT1;CD74;MIF;KDM1A;TAF9;TRIAP1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.35763462197871954,0.8024703544791212,0.6991304347826087,0.9834646318270935,1.0,6/11,28.96%,JAK1;IL12A;CANX;STAT1;JAK2;STAT3
prerank,histone ubiquitination (GO:0016574),-0.26763282040460934,-0.8017386396331764,0.7447795823665894,0.9082013503051295,1.0,7/21,24.94%,RNF8;UBE2A;UBR2;UBE2N;LEO1;RNF20;DTX3L
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2393624423466381,0.8016159981253246,0.8114649681528663,0.9844616445104859,1.0,23/88,19.80%,EIF4A3;NANOS3;EPRS1;DNAJC1;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;EIF4ENIF1;PUS7;BAG6;CNOT7;TSC1;IGF2BP3;CALR;CDK5;ILF3;EIF2AK3;FXR1;PLAT
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.33470073248651744,-0.8013389964148935,0.7471526195899773,0.9082305219798028,1.0,2/10,3.59%,OSR1;CAMK2D
prerank,regulation of ion transport (GO:0043269),0.2450308933581513,0.8007780563728559,0.7986754966887417,0.9853677509622463,1.0,19/76,20.42%,NKAIN1;ANK3;NKAIN2;VAMP2;NEDD4;SYT3;HTR1A;SYT7;P2RX4;SYT5;KCNJ8;GDNF;STC1;KCNJ10;KCNJ3;SYT6;SYT1;KCNJ16;PXK
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.28059694399207835,0.8007572071358579,0.7391952309985097,0.9841850302313758,1.0,10/32,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,tRNA export from nucleus (GO:0006409),0.28059694399207835,0.8007572071358579,0.7391952309985097,0.9841850302313758,1.0,10/32,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,DNA duplex unwinding (GO:0032508),0.25588672494630393,0.800746473552021,0.7595870206489675,0.9835934204363158,1.0,16/50,20.55%,MCM7;RPA1;PIF1;XPC;MCM4;RECQL;GTF2H3;ERCC2;DHX9;GTF2H1;MCMDC2;WRN;SSBP1;CUL4A;DDX1;DDB1
prerank,positive regulation of JNK cascade (GO:0046330),0.2488507347974635,0.8005657210516063,0.793800539083558,0.9833280016444269,1.0,4/70,2.24%,SH3RF1;EDA2R;TRAF4;SH3RF3
prerank,cellular protein-containing complex assembly (GO:0034622),0.2224729101696163,0.8000598932032363,0.852112676056338,0.9836374968908984,1.0,28/159,15.58%,NRG1;STXBP6;TCF4;VAMP2;DNAJC28;CENPE;EPS15;DNAAF3;OMA1;IMMP2L;TTC12;DNAI4;CCDC65;CYBA;DNAJB12;VAMP4;TBCE;CENPC;CENPW;NUP107;AXIN1;LONP1;HSPA4;DHX9;CLU;COX7A2L;CCDC39;CENPF
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3029345715761682,0.7998257941204046,0.7347266881028939,0.9834606393185408,1.0,5/23,12.47%,SEC16A;SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,regulation of heart contraction (GO:0008016),0.23655628674798068,0.799620641645492,0.8073394495412844,0.9832345188859902,1.0,16/90,15.15%,ATP1A2;ITPR1;RYR2;TMEM65;ATP1A3;KCNIP2;ATP2A2;PRKACA;FXYD4;P2RX4;S100A1;GSK3A;RYR3;ASPH;STIM1;GJA5
prerank,regulation of primary metabolic process (GO:0080090),0.2287562951789524,0.7994362598977637,0.8406862745098039,0.9829646019070379,1.0,27/126,17.14%,PPARA;ODC1;NCOA2;PSMD1;PPARD;C1QTNF2;PSMD10;SC5D;IRS2;CHD9;PSMA5;PSMB5;EDF1;NCOA1;PSMC4;PSMA4;PSMC5;HMGCS1;PSMB9;CARM1;MED1;SREBF1;ELOVL6;IDI1;PSMA7;NR1D2;PSMD14
prerank,cellular response to zinc ion (GO:0071294),-0.3048342503170749,-0.7993843429117813,0.7244655581947743,0.910855430200887,1.0,11/15,30.92%,MT2A;MT3;HVCN1;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,photoperiodism (GO:0009648),0.29184050220790775,0.7993382781926126,0.7315541601255887,0.9825489057994442,1.0,12/28,25.73%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,regulation of sensory perception of pain (GO:0051930),-0.32872207742110027,-0.7984756962217746,0.7230769230769231,0.9116823621584377,1.0,2/11,4.87%,MGLL;CCN3
prerank,lipid phosphorylation (GO:0046834),-0.3306619856259121,-0.7984185710514329,0.7211981566820277,0.9111204073590984,1.0,3/10,12.53%,DGKH;DGKG;DGKZ
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2149032356246161,0.7983634606663076,0.89086859688196,0.9837684178911645,1.0,63/241,22.69%,TRA2B;EIF4A3;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNRPB2;SMU1;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;SRSF10;SYF2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;CTNNBL1;ZCRB1;RBM6;POLR2L;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,rRNA transcription (GO:0009303),-0.28982936143369287,-0.7983581972461069,0.7708830548926014,0.9105767809960305,1.0,6/17,22.51%,CAVIN1;TCOF1;NIFK;GTF3C6;POLR1G;GTF3A
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.24728959100982792,0.7983073861907591,0.7578347578347578,0.9832711884821976,1.0,9/65,8.14%,PPARA;SPRY1;PDPK1;SPRED1;HTRA3;MTMR4;IL17RD;CIDEA;SPRED2
prerank,negative regulation of cell cycle process (GO:0010948),-0.2136746537964716,-0.7979042665457123,0.847457627118644,0.9106821249503687,1.0,24/61,29.55%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;GPER1;RBBP7;PPP1R10;E2F1;PCGF2;TOM1L2;APAF1;CHMP4C;RNF2;RAD51;BRCA1;CHMP2A;CHEK1;YAF2;BMI1;E2F7
prerank,maturation of 5.8S rRNA (GO:0000460),0.3253963862068895,0.7976567758283458,0.7244367417677643,0.9838002927832071,1.0,4/17,15.30%,C1D;NOL9;MTREX;EXOSC10
prerank,protein alkylation (GO:0008213),0.3016457300659281,0.7975728271833442,0.729818780889621,0.9833481316782023,1.0,9/22,28.63%,PRMT3;VCPKMT;FAM98B;PRMT2;CAMKMT;ETF1;PCMT1;FAM98A;METTL22
prerank,cardiocyte differentiation (GO:0035051),0.3640664862459425,0.7974947554622394,0.7245283018867924,0.9828847451825067,1.0,1/10,0.84%,NRG1
prerank,regulation of interleukin-12 production (GO:0032655),-0.2198279168749757,-0.7973224412508059,0.8714285714285714,0.9110131536112301,1.0,3/47,2.21%,PLCB1;FOXP1;THBS1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2831759432623408,-0.7972167131918787,0.7563451776649747,0.9105739726321309,1.0,1/18,0.46%,PLCB1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.29373753546450476,-0.7969559804767203,0.7535211267605634,0.9103600532486472,1.0,8/15,26.33%,RPL5;RPS7;RPL11;RPL23;SMAD7;BAG2;DTX3L;PARK7
prerank,phosphatidylcholine catabolic process (GO:0034638),0.3546241166015277,0.79663223877924,0.7104795737122558,0.9838771263720423,1.0,2/10,8.19%,LIPC;PLA2G7
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3245199881029417,0.7966050120469521,0.7167530224525043,0.9833193126985436,1.0,4/15,18.56%,KCNIP2;KCNN2;KCNJ8;KCNJ3
prerank,ureteric bud morphogenesis (GO:0060675),0.3246644654615826,0.7965131985913989,0.7064846416382252,0.9828867314582964,1.0,6/16,24.19%,SALL1;GDNF;MYC;BMP2;PAX2;BMP4
prerank,regulation of chromatin binding (GO:0035561),0.3612939528631579,0.7963974937622827,0.6998158379373849,0.9825000889299785,1.0,4/10,14.17%,GMNN;CDT1;BTAF1;MED25
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.24523853498558776,-0.7963565047146888,0.8289085545722714,0.9107517505562394,1.0,11/30,21.55%,BCL2L1;ACKR3;THOC1;CD44;RTEL1;TPT1;SIRT1;SNAI1;CD74;MIF;CCAR2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3203875895072492,0.7963357464243779,0.7341337907375644,0.9820178214901756,1.0,2/16,12.11%,PTPN22;IL12A
prerank,mitotic nuclear division (GO:0140014),0.2440759660236999,0.7961629927428345,0.7981157469717362,0.9817404971494575,1.0,19/71,21.11%,CCDC61;LSM14A;AAAS;SGO1;GOLGA2;CEP192;NSL1;NUSAP1;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;KLHL22;RHOA;KPNB1;SMC3;KIF11
prerank,androgen receptor signaling pathway (GO:0030521),-0.33225688571699497,-0.7959519568648393,0.7181208053691275,0.9107824064965278,1.0,2/11,7.65%,DDX5;TMF1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3374568867451525,0.7958070158417255,0.7351973684210527,0.9817285275820269,1.0,5/13,21.92%,CISD3;CIAO1;MMS19;ISCA1;YAE1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.277234319922052,-0.795758206998868,0.7716535433070866,0.9104894193854932,1.0,7/18,23.26%,PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.1945618452744685,-0.7952902850260638,0.9345794392523364,0.910625683288992,1.0,24/104,21.77%,SLC8A3;ACTB;TRIB2;UVRAG;CCND2;CALM1;LRP6;CCNG1;CAB39;PPEF2;MAP2K2;RALB;ETAA1;CCND1;EZH2;CDKN1A;SERTAD1;SIRT1;CCNE2;AKT1;ADRB2;CIB1;DUSP19;CSF1R
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.315829730215393,0.7951382105844833,0.7287581699346405,0.9823437998376962,1.0,2/18,4.94%,FBXO5;CDC7
prerank,mRNA metabolic process (GO:0016071),0.23642141907554434,0.7948903814760376,0.8211488250652742,0.9821935383844244,1.0,19/90,16.75%,AGO4;GEMIN2;ZC3H12D;LSM11;ZFP36L2;PCBP3;HNRNPA2B1;SRSF11;PRKACA;NUDT21;TP53;AGO3;PRPF18;DIS3L2;SLBP;SNRPF;SRSF9;NONO;SF3A3
prerank,cardiac muscle cell contraction (GO:0086003),-0.2787552856201594,-0.7948270077093016,0.7610837438423645,0.910712978730665,1.0,3/19,3.69%,CACNA1C;CAMK2D;GSN
prerank,skin development (GO:0043588),0.251737739280963,0.7945861040445588,0.7986301369863014,0.9821621527805201,1.0,11/65,14.03%,KDF1;WNT5A;ITGA3;DHCR24;COL1A2;ABCB6;EVPL;FA2H;MED1;STMN1;ATP7A
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24500366290704795,0.7942216916686764,0.800818553888131,0.9822446378315229,1.0,6/66,5.48%,PIK3R1;NGFR;JUP;PIK3R2;ZIC1;CCT5
prerank,regulation of pH (GO:0006885),0.3518779516363247,0.7940165953638442,0.6837294332723949,0.9820271986745928,1.0,4/11,18.99%,SLC9A1;CLCN3;PDK2;ATP6AP1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2423476620686012,-0.7938284969237139,0.844776119402985,0.9117010088632022,1.0,8/32,13.64%,BCL2L1;VPS35;SOD2;HK2;BAD;BAX;BID;BOK
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3535154047080182,0.7936463148076137,0.7102473498233216,0.982109665411992,1.0,4/11,20.45%,NR1H4;DGKQ;BMP2;BMP5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2632054532088538,-0.7933060450770139,0.7894736842105263,0.911924850152406,1.0,9/22,30.22%,ROCK2;GSK3B;PPP4R4;PPP1R11;MGAT5;IKBKB;NCKAP1L;FKBP1A;PPP1R15A
prerank,cellular response to acid chemical (GO:0071229),0.2909019860258983,0.7929801242466895,0.7456828885400314,0.9826730755816024,1.0,7/27,18.69%,CPEB1;MTOR;GLRA1;GLRA2;RRAGA;RRAGD;CAPN2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.30969366253980446,-0.792924693562583,0.7597254004576659,0.9119319533666429,1.0,3/12,16.99%,ELAVL1;TERT;ESR1
prerank,positive regulation of intracellular transport (GO:0032388),-0.2304813580778501,-0.7922479500665353,0.8123167155425219,0.9123924343294911,1.0,11/38,19.79%,ACTN2;STX18;RUFY3;PRR5L;CEP290;DYNC1H1;OAZ1;BCAS3;OAZ2;NUMA1;PLA2G4E
prerank,action potential (GO:0001508),0.2652197275918828,0.7922371512342307,0.7496296296296296,0.9834358466278929,1.0,8/44,13.62%,ANK3;CACNA1G;GNA11;KCND2;KCNE4;AKAP6;SCN1A;SCN2A
prerank,actin filament-based transport (GO:0099515),0.30525813540125907,0.7919133123920109,0.7466887417218543,0.9834276829389109,1.0,5/21,11.64%,MYO7A;MYO1B;SUN2;MYO6;MYO1G
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.35250302379235476,0.7918916349574274,0.7174311926605504,0.982868875644489,1.0,2/11,7.25%,NOVA1;PCBP3
prerank,aminoglycan biosynthetic process (GO:0006023),0.2624764482525937,0.7918000315188898,0.773121387283237,0.9824346890221988,1.0,12/49,15.45%,HSPG2;GPC4;GCNT2;GPC5;B3GNT8;HS6ST2;B4GALT7;B3GALT5;HS3ST6;HS3ST5;HEXA;SDC2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.21681633745272477,-0.7914492919670636,0.8606271777003485,0.9129668378082564,1.0,22/54,29.73%,OTULIN;HIPK1;CASP8;MADD;PTPN2;CYLD;TNFRSF1A;LAPTM5;CCDC3;TRADD;TNFAIP3;CFLAR;TRAF1;RFFL;BIRC3;IKBKB;IKBKG;HSPA1A;PELI3;CASP1;HSPA1B;TRAF2
prerank,axonal fasciculation (GO:0007413),0.3402953204114939,0.7909262107632373,0.7277397260273972,0.9833661976384964,1.0,5/12,15.96%,SEMA5A;CNTN4;EPHA3;ARHGAP35;NRCAM
prerank,organelle disassembly (GO:1903008),0.27981309021689554,0.7907941034901662,0.7684210526315789,0.9830327499024155,1.0,10/33,19.54%,GBF1;GOLGA2;RB1CC1;TEX264;KIF9;GFM2;VRK1;ULK2;MTIF2;DDRGK1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.31601949408329366,0.7904527612147491,0.7265500794912559,0.9830629219277297,1.0,4/17,12.81%,PSMD10;TWIST1;ARMC10;PTTG1IP
prerank,long-chain fatty acid transport (GO:0015909),0.28427642714778645,0.7904356498784344,0.743202416918429,0.9824959922315714,1.0,7/30,12.17%,ABCD2;FABP5;FABP4;SPX;RPS6KB1;SLC25A20;FABP3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.25943039149088465,-0.7901751805922222,0.7936046511627907,0.9143088982081787,1.0,12/25,29.64%,PRKDC;MAPK14;ETS1;TAL1;HMGB2;ABCB10;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,regulation of DNA metabolic process (GO:0051052),0.2635454987635432,0.7899706765655315,0.7951635846372689,0.9826949029603305,1.0,15/44,22.35%,USP1;PIF1;UBE2V2;POLH;MPHOSPH8;KPNA1;CDT1;KDM1B;UBE2V1;HNRNPD;MYC;KAT7;TERF2IP;WDR18;KPNA2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.27642862383168393,-0.7897292925807832,0.7884130982367759,0.9143966491576343,1.0,11/19,30.46%,AMPD3;TERT;DCK;GMPR2;APRT;TYMS;CDA;POLD2;PNP;POLD1;ADA
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23082314161856132,-0.7891105460932802,0.834920634920635,0.914718996786995,1.0,18/40,28.73%,THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;DONSON;ALYREF;CDK9;SETMAR;MCM9;RFWD3;ZRANB3;RAD51;CENPX;GEN1;POLD1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3107077835834444,0.7888405324798413,0.734006734006734,0.9841991908135075,1.0,4/19,14.93%,TLR8;TLR4;DHX36;DHX9
prerank,mismatch repair (GO:0006298),0.2876328464276806,0.7884772811614281,0.7515723270440252,0.9842343848101871,1.0,9/27,23.03%,ERCC1;MSH3;RPA1;XPC;MUTYH;MSH6;MLH1;ABL1;TDG
prerank,negative regulation of protein depolymerization (GO:1901880),0.2890397546223551,0.7881854306411187,0.7237479806138933,0.9841714961872914,1.0,6/24,18.53%,PLEKHH2;STMN2;NAV3;CLASP2;CLASP1;SPEF1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.25958011725105357,-0.7881720823524294,0.8060109289617486,0.9155740518529812,1.0,11/23,32.74%,VCPIP1;MINDY1;OTUB1;USP25;TNFAIP3;BAP1;USP37;USP20;OTUB2;OTUD4;OTUD5
prerank,acylglycerol biosynthetic process (GO:0046463),0.30186687751697344,0.7881715751841689,0.7472178060413355,0.9836087713659531,1.0,5/23,15.44%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.24691733102066443,-0.7878681913204761,0.7921052631578948,0.9153865561282815,1.0,10/27,22.77%,CTPS1;CTPS2;DTYMK;AK2;RRM2B;GUK1;TYMS;AK6;AK5;TXNRD1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.31668913588697545,-0.7874455689899891,0.7275,0.9154145351248925,1.0,3/13,10.37%,ALG9;ALG12;MPDU1
prerank,prostanoid metabolic process (GO:0006692),0.3331582939152977,0.7871987265694572,0.7504159733777038,0.9847582467476261,1.0,3/13,12.63%,PTGES;PLAA;PTGR2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.24691373764601277,-0.7866658050778079,0.7942857142857143,0.9159546510141595,1.0,4/31,4.36%,RBPJ;TPM1;NOTCH1;TGFB2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.25550527142623974,-0.7865620848773872,0.7960893854748603,0.9154781437881667,1.0,7/24,24.20%,LEPR;COQ10A;COX15;SDHAF4;PID1;MRAP2;MT3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.23297542447155248,0.7863666807522863,0.8236040609137056,0.98559380505828,1.0,25/96,21.21%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3236678829550811,-0.7862184275964789,0.7444933920704846,0.9154180255266303,1.0,7/11,27.18%,SERTAD1;ARID1B;SMARCD1;ELOF1;PADI2;CDCA4;CHEK1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3278624548590776,-0.786141854841433,0.7325842696629213,0.9149020479756099,1.0,5/10,35.39%,CX3CR1;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,positive regulation of DNA recombination (GO:0045911),0.2823373030020344,0.7861303525839967,0.7460063897763578,0.985419824466346,1.0,8/27,18.77%,ZCWPW1;MRNIP;HMCES;ACTR2;ERCC2;PAXIP1;MMS19;RIF1
prerank,mitochondrial transcription (GO:0006390),0.35474509678519806,0.7860846083363824,0.7317073170731707,0.9849007962153413,1.0,5/10,27.93%,SLC25A33;TEFM;TFAM;FOXO3;MRPL12
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2328655228320083,0.7854165741787666,0.8199737187910644,0.985478989459206,1.0,23/85,19.81%,PRICKLE1;FMR1;RNF180;LRRK2;PSMD10;CBFA2T3;NKD2;PSMC5;ZYG11B;HECTD1;GSK3A;DDA1;ATXN3;BAG6;CLU;CSNK1E;DET1;USP13;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,regulation of sequestering of triglyceride (GO:0010889),0.32567597725055936,0.785345930977001,0.7200674536256324,0.9850035908269746,1.0,3/15,14.09%,PPARA;CIDEA;PLIN2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.31129445695353547,-0.7851632642134982,0.7494356659142212,0.9158492695937891,1.0,7/12,40.71%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3D;GCGR
prerank,macromolecule catabolic process (GO:0009057),0.28704082437038947,0.7849249557022655,0.7372488408037094,0.9851493154362682,1.0,5/26,9.11%,NEDD4;CAPN3;UCHL3;LGMN;MTOR
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3212258331397243,0.7848573820550842,0.7303754266211604,0.9846804543567304,1.0,6/15,24.27%,GRM5;GRM7;GRM1;HOMER3;HOMER2;GRM8
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.26120123804139095,-0.7848347802090219,0.783375314861461,0.915706391679305,1.0,3/21,10.66%,CCN3;DAB2;SH2B1
prerank,axonal transport of mitochondrion (GO:0019896),0.3514569963984109,0.7845856400160738,0.7222222222222222,0.9845631874926634,1.0,4/11,20.27%,OPA1;SYBU;HIF1A;ACTR10
prerank,BMP signaling pathway (GO:0030509),0.24821906950383477,0.7841193505861688,0.8058659217877095,0.9848199194335437,1.0,4/62,2.78%,RUNX2;RGMB;RGMA;SMAD5
prerank,pre-replicative complex assembly (GO:0036388),0.24491115675153483,0.7838480650060006,0.7997275204359673,0.9846969534498341,1.0,17/64,18.81%,PSMD1;MCM7;PSMD10;GMNN;PSMA5;PSMB5;PSMC4;MCM4;PSMA4;PSMC5;CDT1;PSMB9;ORC2;PSMA7;PSMD14;PSMA2;PSMD11
prerank,retrograde axonal transport (GO:0008090),0.31635153470645494,0.7838245170697902,0.7293103448275862,0.9841494743030103,1.0,2/16,6.30%,DLG2;TMEM108
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.311606762264761,0.7833256761758858,0.7425249169435216,0.9844483283323824,1.0,2/18,5.80%,TMEM102;NAIF1
prerank,cardiac muscle contraction (GO:0060048),0.2693559313669004,0.7826800043003592,0.7876923076923077,0.9850032995808196,1.0,3/34,4.25%,ATP1A2;RYR2;SCN2B
prerank,epidermal cell differentiation (GO:0009913),-0.2219780755865926,-0.7822742173016558,0.8567251461988304,0.9191812802754443,1.0,11/41,20.57%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;GATA6;BCR;WNT16;EPHA2;ADAM9;PIP5K1A
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.283086974676048,0.782002237032715,0.7667185069984448,0.9855957143710763,1.0,7/27,18.14%,MORF4L1;BRD8;KAT2A;NAA50;BAG6;PHF20L1;KAT7
prerank,myoblast fusion (GO:0007520),0.3398570443525607,0.7817953204751649,0.7307692307692307,0.9853583935187183,1.0,4/12,18.99%,ADGRB3;ADAM12;CD81;KCNH1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.28059255022611007,0.7817227958046734,0.7782805429864253,0.9848961053633972,1.0,1/29,0.79%,XCL1
prerank,regulation of autophagosome assembly (GO:2000785),0.27538181699370795,0.7816351530781322,0.7695852534562212,0.9844557357594395,1.0,6/33,12.23%,PIP4K2A;NPRL2;LRRK2;PINK1;SCFD1;IFT88
prerank,glial cell development (GO:0021782),0.28554444557262615,0.7815605610871579,0.7889060092449923,0.9839908949044998,1.0,5/25,13.88%,MXRA8;EIF2B1;NF1;SOX10;MYRF
prerank,thyroid hormone generation (GO:0006590),0.3549361496651546,0.7813007842160402,0.7269503546099291,0.98385763538278,1.0,1/10,4.90%,CPQ
prerank,mRNA catabolic process (GO:0006402),0.25952674879748516,0.7810113862610462,0.8017883755588674,0.9837682293216528,1.0,11/44,17.92%,AGO4;ZC3H12D;PDE12;ZFP36L2;AGO3;EXOSC9;DIS3L2;MRTO4;EXOSC10;AGO1;DXO
prerank,cellular component maintenance (GO:0043954),0.33769806649583545,0.7801186170327215,0.7338003502626971,0.9847046119989546,1.0,3/12,12.49%,ITGA3;FYN;LNPK
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3317783682355402,-0.7800310999055106,0.753880266075388,0.9219241999385446,1.0,2/10,7.95%,LBP;IFI35
prerank,respiratory tube development (GO:0030323),0.2817069935979923,0.7799633485888581,0.7897271268057785,0.9843903621417966,1.0,6/28,15.70%,ITGA3;NPHP3;LOXL3;BAG6;CCDC39;FGFR2
prerank,ceramide biosynthetic process (GO:0046513),0.26521185895924115,0.7797390304360559,0.7912408759124088,0.9841689116212227,1.0,9/40,12.53%,CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;ST6GALNAC6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2190228109540799,0.7794654811372119,0.8698795180722891,0.9840525488385528,1.0,20/148,11.13%,HDAC1;L3MBTL1;TAF9B;PIP4K2A;TAF12;PDPK1;PRR5;CHD4;MBD3;TAF15;RPA1;TAF3;MDM4;NOC2L;MTOR;DAXX;RFC3;TP53;TOP3A;RPL37
prerank,regulation of cell cycle process (GO:0010564),0.22631942424171902,0.7794239646256352,0.8479087452471483,0.9835286888792243,1.0,17/104,14.50%,ATF5;L3MBTL1;TIPIN;PKMYT1;FBXO5;CDK13;ZFYVE26;RCC1;MKI67;SOX9;USP19;RAB11FIP3;ENTR1;BUB1;MAP9;DBF4;CEP250
prerank,cellular response to arsenic-containing substance (GO:0071243),0.31915089752095693,0.7789821156089041,0.7495652173913043,0.9837088017981209,1.0,3/15,10.90%,GSTO2;DAXX;DHX36
prerank,heart contraction (GO:0060047),0.2605466980172647,0.7783445732423615,0.7868098159509203,0.9841974305432449,1.0,3/41,4.25%,ATP1A2;RYR2;SCN2B
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3177791301247265,-0.7779009126092339,0.7632183908045977,0.9244382751471939,1.0,4/10,12.00%,NCK1;CITED2;VHL;BAG3
prerank,positive regulation of neutrophil migration (GO:1902624),0.3117325912427493,0.7778084314414867,0.755,0.9845198156915635,1.0,1/18,0.79%,XCL1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24353873289108066,0.7772018947526281,0.7952973720608575,0.9849411562249715,1.0,10/63,12.54%,EIF4G3;GPLD1;HTR2B;PTPN22;SORL1;ZKSCAN3;GOLGA2;MTOR;DAP;GSK3A
prerank,histone H2A acetylation (GO:0043968),0.32009661066766176,0.7771241974175362,0.75,0.9844943348623707,1.0,8/16,26.17%,MORF4L1;BRD8;EPC1;DMAP1;ING3;ACTL6A;MORF4L2;YEATS4
prerank,membrane lipid metabolic process (GO:0006643),0.2960741417930684,0.7766120290180307,0.767515923566879,0.9847942653241861,1.0,5/22,12.15%,SERINC1;SPTLC1;AGMO;B4GALT4;AGK
prerank,cell junction maintenance (GO:0034331),0.3286472028675531,0.77644899483723,0.75,0.9844756285616509,1.0,5/14,27.43%,CBLN1;F2R;PRTN3;MYADM;DCTN1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.3087866201624201,-0.7762101804058488,0.7452380952380953,0.9263051297945076,1.0,7/12,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2893323880569615,0.7761947658425747,0.7592319054652881,0.9843261542731483,1.0,6/26,15.32%,POR;HTR2B;CDH3;S100A1;ATP7A;GDNF
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2636320648040915,-0.7761492458271996,0.7939560439560439,0.9257437911418639,1.0,9/21,26.33%,BCL2L1;TMBIM6;NCK1;BOK;CREB3;SELENOS;BCL2L11;HSPA1A;PARK7
prerank,protein neddylation (GO:0045116),-0.3059237885382421,-0.7758301706674664,0.7674418604651163,0.925581789341652,1.0,3/13,17.00%,UBE2F;NEDD8;DCUN1D3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.304255936575553,-0.7757237066197594,0.7611241217798594,0.9251082385647922,1.0,5/12,19.19%,RNF8;RECQL5;EAPP;NELFCD;HEXIM1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.2662745034070416,-0.7748001089605598,0.7855297157622739,0.9258490488382333,1.0,6/20,16.11%,ERLIN1;WNT4;SIK1;CEACAM1;ASXL3;GPER1
prerank,regulation of lipid storage (GO:0010883),-0.25746769507509587,-0.7747873487121736,0.8037135278514589,0.9252279955610966,1.0,5/22,15.99%,NFKB1;NFKBIA;PTPN2;ITGB3;SIRT1
prerank,spinal cord development (GO:0021510),0.33351069055348503,0.7736303000935235,0.7552083333333334,0.988052994833352,1.0,3/12,8.44%,LOXL3;NF1;RELN
prerank,actin polymerization or depolymerization (GO:0008154),0.25026862287475976,0.7732048055006913,0.7954866008462623,0.9881562612117967,1.0,4/50,6.98%,SVIL;MICALL2;ARHGAP6;WASF3
prerank,establishment of spindle orientation (GO:0051294),0.2813161584230814,0.7731894670584213,0.7805255023183926,0.9875962851228255,1.0,7/28,16.87%,GJA1;LLGL1;GPSM2;SPDL1;INSC;CLASP1;UBXN2B
prerank,negative regulation of DNA replication (GO:0008156),0.32985367715551855,0.7730469623099288,0.742320819112628,0.98725067154257,1.0,5/13,24.45%,GMNN;TERF1;TSPYL2;GMNC;GTPBP4
prerank,mitochondrial gene expression (GO:0140053),-0.22369672412369337,-0.7729494447868761,0.8454258675078864,0.9272891320205823,1.0,18/42,29.56%,IARS2;MRPS7;NOA1;MRPS17;MRPL16;MRPS18A;MRPL2;MRPS18B;POLRMT;GATC;TWNK;MRPL57;PTCD3;LARS2;MRPS34;MRPS12;FASTKD2;MRPS2
prerank,necroptotic process (GO:0070266),-0.2748918142918937,-0.7727823604399597,0.8150851581508516,0.9268942924489273,1.0,6/16,19.96%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2943285440926245,-0.7726563717478486,0.780373831775701,0.926441955949298,1.0,5/15,23.21%,SMO;SIX1;AGT;SIX4;SOX8
prerank,organonitrogen compound catabolic process (GO:1901565),0.2479213053775969,0.7721055364706352,0.8043478260869565,0.9882100685453213,1.0,9/57,12.20%,CPQ;LIPC;CAPN3;UCHL3;PLA2G7;MTOR;ADO;TXN2;SGPL1
prerank,snRNA metabolic process (GO:0016073),-0.2736183112327033,-0.7719320683180434,0.7979002624671916,0.9269140145981957,1.0,6/17,19.81%,INTS3;RBM7;INTS9;INTS10;INTS1;MEPCE
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.255432851270451,0.7717429273993408,0.8200899550224887,0.9882373913657594,1.0,11/42,20.57%,POLQ;SIRT6;MRNIP;SPIDR;FIGNL1;ACTR2;MMS19;FBH1;RIF1;TERF2IP;PPP4R2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2985379903206632,-0.7716698210809203,0.7756563245823389,0.9266770896080192,1.0,5/13,19.19%,RNF8;RECQL5;EAPP;NELFCD;HEXIM1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24674080053857123,0.77110856570951,0.8172942817294282,0.9886800168113496,1.0,14/62,15.09%,LRRK2;NOL3;HERPUD1;CDKN2D;PINK1;NOC2L;ARMC10;OPA1;RTKN2;BCL2L2;HTRA2;PTTG1IP;CREB3L1;CLU
prerank,actin filament polymerization (GO:0030041),-0.23833461406456607,-0.7710397564724452,0.8587896253602305,0.9269660507129617,1.0,6/29,10.35%,DIAPH1;GSN;RAC1;COBL;GAS7;FAM107A
prerank,sister chromatid segregation (GO:0000819),0.2777579883918157,0.7708073513912831,0.7830188679245284,0.9886012027745766,1.0,7/31,18.12%,TOP2B;SGO1;NSL1;NUSAP1;TOP2A;SMC1A;KLHL22
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.30882214228401755,0.7707696286717013,0.7680140597539543,0.9880891533794824,1.0,2/16,9.92%,NAA10;NAA50
prerank,negative regulation of protein ubiquitination (GO:0031397),0.25144071814675717,0.7699110339051273,0.819672131147541,0.9889369613039793,1.0,6/50,7.98%,OGT;PRMT3;FBXO5;ADGRB1;LIMK1;PER2
prerank,mRNA processing (GO:0006397),0.2043800773752711,0.7697902751664876,0.9302071973827699,0.9885689061689295,1.0,74/287,22.69%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;THOC7;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNRPB2;PRKACA;SMU1;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;GTF2H3;SRSF10;PRPF18;SYF2;ERCC2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;GTF2H1;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;THOC5;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;CTNNBL1;ZCRB1;RBM6;CHTOP;POLR2L;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CDK7;RNGTT;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,negative regulation of cell cycle (GO:0045786),0.23779857101351692,0.7697694262436813,0.8288770053475936,0.9880290790587865,1.0,14/73,16.23%,PTEN;NR2F2;CDKN2A;SIPA1;SCRIB;DUSP1;GMNN;BMP7;HTRA2;PDCD4;TSPYL2;TFAP4;RNF167;BRINP1
prerank,neuron projection fasciculation (GO:0106030),0.3434228894824647,0.7695095004334443,0.7365591397849462,0.9878832674708945,1.0,4/10,15.96%,SEMA5A;CNTN4;ARHGAP35;NRCAM
prerank,monoacylglycerol metabolic process (GO:0046462),-0.29877318018990806,-0.769224510574661,0.7821782178217822,0.9289604418931899,1.0,2/13,4.78%,PLA2G4A;MGLL
prerank,negative regulation of translational initiation (GO:0045947),-0.30631325182224983,-0.7690804818780754,0.7892271662763466,0.9285558750099251,1.0,5/13,17.68%,PAIP2;RBM4;EIF4EBP1;EIF3E;AGO2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.28182721282512274,-0.7689338567585255,0.7914572864321608,0.9281127627394629,1.0,5/16,21.55%,BCL2L1;ACKR3;TPT1;SNAI1;CCAR2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2211827455700745,0.7685633813272866,0.8717310087173101,0.9888791932667574,1.0,20/110,16.02%,NRG1;HRG;TRAF3IP1;SORL1;NAPB;MPP7;PINK1;SLF1;SAR1A;EIF2AK2;IAPP;SPIDR;CDT1;KIF9;HSPA5;BAK1;CLU;SLF2;TIRAP;IMPACT
prerank,regulation of protein modification process (GO:0031399),0.2502850365860637,0.768427901999182,0.8151862464183381,0.9885125486796235,1.0,12/50,16.19%,PHIP;RABL3;SPRED1;PTK2;SPRED2;GRM5;FKTN;PLXNB2;IGF2;LYN;ATG14;NDUFS4
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3121419554633931,-0.7681985838994104,0.7662037037037037,0.9279278356697213,1.0,3/12,11.96%,IGF1;LMCD1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3121419554633931,-0.7681985838994104,0.7662037037037037,0.9279278356697213,1.0,3/12,11.96%,IGF1;LMCD1;CAMTA1
prerank,positive regulation of dephosphorylation (GO:0035306),0.2799887044161927,0.7675211385625242,0.7729468599033816,0.9894977317365731,1.0,1/27,0.26%,DLC1
prerank,TOR signaling (GO:0031929),-0.247546969433221,-0.7673433866278945,0.8151260504201681,0.9285006222816834,1.0,15/26,35.05%,FNIP1;RICTOR;PRR5L;CCDC88A;MAPKAP1;EIF4EBP1;AKT1;NPRL3;RHEBL1;MLST8;EIF4EBP2;SMG1;SYAP1;RPS6KB2;CARD11
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3012282906084555,-0.7666964674269604,0.7611241217798594,0.9281927102680964,1.0,2/12,9.10%,GSK3B;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3012282906084555,-0.7666964674269604,0.7611241217798594,0.9281927102680964,1.0,2/12,9.10%,GSK3B;DYRK2
prerank,protein polyglutamylation (GO:0018095),0.333028640231285,0.7666911413360429,0.7831325301204819,0.9902492481414,1.0,2/11,13.44%,TTLL6;TPGS1
prerank,histone exchange (GO:0043486),0.26935858317004713,0.766634611778616,0.8053097345132744,0.9897562992591358,1.0,7/37,14.95%,MIS18A;CENPU;SPTY2D1;CENPC;CENPW;MIS18BP1;DMAP1
prerank,Golgi to endosome transport (GO:0006895),-0.28111544291892904,-0.7664234467302522,0.7885572139303483,0.9279455271160213,1.0,5/16,14.68%,DOP1B;AP2A1;KLHL20;MON2;VPS13A
prerank,L-serine metabolic process (GO:0006563),-0.31634529100167397,-0.7662128711365586,0.7614678899082569,0.9276157774732807,1.0,3/10,17.47%,SERINC3;PSAT1;CBS
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2393226122638619,0.7657773931046723,0.8416107382550335,0.9905818137320443,1.0,17/72,18.81%,MAP3K14;PSMD1;TLR6;PSMD10;PSMA5;PSMB5;BIRC2;IRAK1;PSMC4;PSMA4;PSMC5;PSMB9;TIRAP;PSMA7;PSMD14;PSMA2;PSMD11
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3427933573769046,0.7656740079758657,0.7633851468048359,0.9901632140640162,1.0,5/10,24.42%,DSE;CSGALNACT2;B3GAT3;DSEL;B3GAT2
prerank,nuclear envelope organization (GO:0006998),-0.2759242195022288,-0.7649965330173154,0.8167539267015707,0.9287743642376342,1.0,7/20,26.12%,LEMD3;REEP3;TOR1A;TMEM170A;TOR1AIP1;EMD;REEP4
prerank,embryonic hemopoiesis (GO:0035162),0.33104781366823993,0.7649668560660015,0.7165775401069518,0.9907127333806944,1.0,2/12,4.58%,FLT3LG;KMT2A
prerank,regulation of presynapse assembly (GO:1905606),0.3115000787703365,0.7649621503705474,0.7697368421052632,0.9895621525367502,1.0,5/18,18.74%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of presynapse organization (GO:0099174),0.3115000787703365,0.7649621503705474,0.7697368421052632,0.9895621525367502,1.0,5/18,18.74%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2683928943928523,0.764754011760707,0.796583850931677,0.9893054375632416,1.0,8/32,19.31%,CDK14;FBXO5;POLA1;CDT1;KLF11;CDK5;CCNE1;TFDP1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3108650629292398,0.7640611555100718,0.7571942446043165,0.9898953725231993,1.0,5/17,16.92%,NTRK2;SORL1;RTN2;CLU;RTN3
prerank,lung development (GO:0030324),0.2652938716892196,0.764051590442435,0.790519877675841,0.9893317333047555,1.0,7/33,15.70%,ITGA3;NPHP3;LOXL3;RCN3;BAG6;CCDC39;FGFR2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3537134530950333,0.7640178453214549,0.76,0.988807870109995,1.0,2/10,4.84%,PRKD3;HTR2B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3437542362368371,0.7636645834096569,0.759581881533101,0.9887740735037486,1.0,1/11,1.73%,TAF9B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.33046129592894685,0.7636003573535881,0.7338003502626971,0.9883084863669626,1.0,2/13,8.27%,PPARA;PINK1
prerank,response to alcohol (GO:0097305),0.27961171826017256,0.7635802393021889,0.7738998482549317,0.9877668630122906,1.0,6/27,19.41%,GRIN2B;GRIN2A;GLRA1;TGFBR1;GRIN3A;ABCA2
prerank,negative regulation of cell communication (GO:0010648),-0.26212190607446423,-0.7632337580269182,0.8147208121827412,0.9307128178221442,1.0,7/21,28.49%,IGFBP3;ACVR1;PTPN1;ERBB3;SOCS5;BRAP;KIF26A
prerank,lipid modification (GO:0030258),0.26451874602179626,0.763118744313508,0.8035450516986706,0.987933429271865,1.0,8/37,14.61%,PLPPR3;DGKQ;PLA2G7;PLPPR2;PLPP6;DGKI;MBOAT7;PLPP5
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.27074863317751974,-0.762837785452252,0.7832512315270936,0.9306638279859676,1.0,5/19,16.40%,CAT;MAOB;GPX1;PRDX1;PRDX3
prerank,alcohol catabolic process (GO:0046164),-0.3234249954214452,-0.7626871382154808,0.7790973871733967,0.9302361024939588,1.0,3/10,13.08%,SCARF1;APOE;SNX17
prerank,regulation of viral genome replication (GO:0045069),0.24139685543294248,0.7621370250231704,0.8371104815864022,0.9889528363709674,1.0,5/56,7.14%,PPARA;PPID;PPIH;PDE12;STAU1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.30708114750834803,-0.76190585448212,0.7748815165876777,0.9306798649858108,1.0,6/12,24.44%,CLN5;ATP6AP2;TMEM9;CLN6;CCDC115;TMEM199
prerank,calcium ion import (GO:0070509),0.27925294100346437,0.7617456285016165,0.801829268292683,0.9890349868387243,1.0,4/28,8.94%,CACNA1E;ATP2A2;CACNA1G;MICU3
prerank,negative regulation of secretion by cell (GO:1903531),0.2652604766944018,0.7616719658150564,0.8065015479876161,0.9885771782923144,1.0,6/38,16.33%,STXBP6;PNKD;TRH;IL12A;GRM7;IL1RAPL1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2976979898734995,-0.7615760645350574,0.7736720554272517,0.9305138891801815,1.0,4/13,17.56%,EPN2;NIBAN2;PTPN1;HHEX
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.34780772979044283,0.7614580920073356,0.7553571428571428,0.9883312715804469,1.0,2/10,8.32%,GFPT2;PFKM
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.30525313189718933,0.7610501531887753,0.7783171521035599,0.9884050483545268,1.0,8/17,25.82%,SEL1L;HERPUD1;SEC61B;HSP90B1;RHBDD1;UFD1;OS9;AUP1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19815960086961673,0.7610459760353023,0.9552401746724891,0.9878372834794582,1.0,92/314,24.57%,BUB1B;FBXO9;FBXO45;PSMD1;BFAR;FBXO5;FBXO31;SEL1L;ZSWIM8;NEDD4;DMAC2;CDC16;PSMD10;CRBN;HERPUD1;CDC20B;PSMA5;ECPAS;PSMB5;AMN1;UBE2G2;UBXN4;BIRC2;PLAA;DNAJB12;FBXO17;PSMC4;MAN1B1;SEC61B;PSMA4;TMEM67;PSMC5;DNAJC10;FBXW5;USP19;FBXL13;HSP90B1;CUL5;GSK3A;ANAPC5;PSMB9;AREL1;TRIM2;ATXN3;UBE2D1;HSPA5;RNF122;BAG6;TRIM3;HACE1;YOD1;PSMA7;HECW1;DNAJB14;UBXN2B;PSMD14;FEM1B;CDC26;KLHL22;RNF187;PSMA2;DCAF11;ZFAND2A;CUL4A;PSMD11;FBXO4;FBXW4;SPSB2;UBE2J1;MTA1;DDB1;UBE2K;FBXL22;DDIT3;BTRC;RNF216;RMND5B;UBR3;SPSB3;ANAPC4;FAF1;FBXL5;FBXL12;NHLRC3;KIF14;UBE2J2;UFD1;UBE4A;FBXO44;SPSB1;OS9;MAD2L1
prerank,pseudouridine synthesis (GO:0001522),-0.2902973946318237,-0.7609242847076043,0.7995169082125604,0.9308103613274121,1.0,6/13,33.68%,PUS10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,positive regulation of protein kinase activity (GO:0045860),0.21110228013229557,0.7607233745415013,0.9139650872817955,0.9877487184763003,1.0,26/148,17.33%,IL34;UNC119;TRAF4;MAP4K4;DLG3;CENPE;MTCP1;CALCA;MRNIP;PTK2;RELN;JTB;DAXX;CACUL1;MAP2K1;GRM5;DLG4;INCENP;CASS4;AXIN1;STRADB;CLU;TNIK;EFNA1;PAK5;ADRA2A
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.2991117027571722,0.760654845006472,0.7774140752864157,0.9872788554222225,1.0,5/18,17.83%,TLR4;LRRC17;FBN1;MAFB;GPR137B
prerank,negative regulation of cilium assembly (GO:1902018),-0.3042653088899851,-0.7603859948546191,0.785876993166287,0.9309188063384197,1.0,7/12,42.80%,TBC1D7;EVI5L;ODF2L;MAP4;TBC1D30;TCHP;CCP110
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.300809428471459,-0.760334652256841,0.7651331719128329,0.9303628807922734,1.0,6/13,22.16%,MTM1;FEZ2;TMEM39A;CHMP4B;CHMP4A;NUPR1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.23206986796383577,0.7602166062401511,0.8519515477792732,0.9873883651363055,1.0,7/73,9.15%,NTRK3;SH2D3C;MTCP1;DOCK7;PINK1;PRKD1;TENM1
prerank,protein depolymerization (GO:0051261),-0.23786758217295778,-0.7599811943176167,0.8771929824561403,0.9302337011364307,1.0,8/27,21.46%,MICAL2;GSN;KIF24;CFL1;DSTN;MICAL3;KATNB1;TWF2
prerank,histone deubiquitination (GO:0016578),0.3005955064833908,0.7599360605028772,0.7828947368421053,0.9872664514218956,1.0,6/18,18.17%,KAT2A;ENY2;USP21;USP16;USP49;TAF10
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2737169169675537,0.7599080134653534,0.8055555555555556,0.9867442985325117,1.0,6/31,17.29%,CD40;IL16;TLR4;TIRAP;MAPK11;LGALS9
prerank,lymphocyte proliferation (GO:0046651),-0.25429723834032886,-0.7596540121540606,0.8282548476454293,0.9300492803440498,1.0,3/22,6.09%,MEF2C;CTPS1;ELF4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2544227551122773,0.7595282571552596,0.8374455732946299,0.9867849708841834,1.0,6/45,10.91%,WNT5A;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.24604511590540018,0.7592697881156774,0.8492392807745505,0.9866515440559496,1.0,13/50,22.25%,CCNJ;PKMYT1;CDKN2D;CCNB2;CDKN2C;CCNA2;GTF2H1;CCNK;CCNE1;CDK5R1;CCND3;CDK7;CCNT2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2908459580217536,0.7590384867837988,0.7825370675453048,0.9864292844505189,1.0,6/22,18.28%,PSMA5;PSMB5;PSMA4;PSMB9;PSMA7;PSMA2
prerank,regulation of RNA splicing (GO:0043484),0.23138309626164955,0.7586063767870036,0.8579234972677595,0.9865474470787855,1.0,15/69,18.68%,PIK3R1;TRA2B;AFF2;PRX;KHDRBS3;CWC22;SRSF10;RBM20;ZNF326;SNRNP70;HNRNPLL;HNRNPL;HABP4;RRP1B;KHDRBS1
prerank,actin filament network formation (GO:0051639),0.33475905221787833,0.7570426942440796,0.7666666666666667,0.9884632444873298,1.0,7/11,29.22%,ACTN1;CARMIL2;SPIRE1;PLS3;CARMIL1;LCP1;FHOD3
prerank,cellular response to misfolded protein (GO:0071218),-0.2579002486850723,-0.7565127685622753,0.8155844155844156,0.9337458374869518,1.0,6/20,21.66%,RNF185;VCP;TOR1A;CUL3;RNF5;UGGT1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2692017829415054,-0.7562980048836905,0.8192488262910798,0.9333731356536579,1.0,3/16,11.42%,ST3GAL4;ETS1;MDK
prerank,DNA modification (GO:0006304),0.29184024227440486,0.756115306240417,0.7824620573355818,0.9893625314691228,1.0,6/22,19.03%,NEIL3;TERF1;MUTYH;MBD4;EXOSC5;TERF2IP
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.27503243883945505,0.7558130790238413,0.7917933130699089,0.9892801697486455,1.0,7/27,16.44%,PDE4B;RYR2;JUP;ATP2A2;CTNNA3;GJA5;STC1
prerank,positive regulation of viral transcription (GO:0050434),-0.25105870836971544,-0.7556972880804087,0.8230563002680965,0.9335925237548558,1.0,10/25,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;CDK9;NELFCD;GTF2F2;CTDP1;POLR2I;POLR2K
prerank,regulation of neuron apoptotic process (GO:0043523),0.22187207417520455,0.7553750431839816,0.8937823834196891,0.9894014320337624,1.0,9/96,9.07%,EPHA7;SLC30A10;NTRK2;GRID2;PRKCI;NF1;EGLN2;PINK1;LGMN
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.280116121878241,-0.7553165541598904,0.8038740920096852,0.9334942510550618,1.0,9/14,31.99%,WNT9A;PTHLH;RFLNA;EFEMP1;CHADL;RFLNB;GREM1;ADAMTS7;SNAI2
prerank,positive regulation of protein processing (GO:0010954),0.2914877224197259,0.7553052103945322,0.7785016286644951,0.9889534017979571,1.0,5/19,19.56%,KLKB1;CLEC3B;NKD2;ADAM8;RHBDD1
prerank,calcium ion homeostasis (GO:0055074),0.22192513647464146,0.7551120159341304,0.8830334190231363,0.988673129600376,1.0,9/95,9.09%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.28320803767127506,0.7550677057872534,0.7715736040609137,0.9876078978148632,1.0,7/22,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.28320803767127506,0.7550677057872534,0.7715736040609137,0.9876078978148632,1.0,7/22,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,positive regulation of cholesterol transport (GO:0032376),0.2786214492698794,0.7550503192684961,0.7953125,0.9870684512711595,1.0,2/27,4.06%,LRP1;NR1H2
prerank,neuron apoptotic process (GO:0051402),0.29447279716364566,0.7545777664570152,0.7828843106180665,0.9872385245066306,1.0,6/19,17.25%,NGFR;TNFRSF21;FAM162A;ATN1;SCN2A;CDK5
prerank,hexose biosynthetic process (GO:0019319),0.25578034399333005,0.7544371405612287,0.8154761904761905,0.9868771567919942,1.0,6/42,11.24%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3
prerank,synaptic vesicle localization (GO:0097479),0.3222740885699298,0.7544370480738734,0.7893835616438356,0.9863116111434027,1.0,4/13,17.25%,SYNDIG1;KIF5C;TMEM230;CDK5
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3289822924071194,0.7541364397793513,0.7996146435452793,0.9856729211205901,1.0,3/11,17.42%,AGO4;AGO3;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3289822924071194,0.7541364397793513,0.7996146435452793,0.9856729211205901,1.0,3/11,17.42%,AGO4;AGO3;AGO1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.29467952790621765,-0.7538666525179869,0.7798594847775175,0.9348663757794071,1.0,5/13,21.97%,PRPF3;LSM2;CD2BP2;PRPF19;DDX20
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.27001773090060205,-0.7534834647805706,0.7950617283950617,0.9347230535881942,1.0,5/17,17.86%,SOD2;HSPB1;PPIA;SIRT1;AKT1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.25872271573195105,-0.7534616970181516,0.8203883495145631,0.9341161271005187,1.0,4/20,19.11%,PLCB1;RGS10;LYPD1;AGRN
prerank,protein monoubiquitination (GO:0006513),-0.22384884394842314,-0.7533048378276975,0.8596491228070176,0.9336862284915367,1.0,8/36,24.94%,MGRN1;UBE2D3;TRIM25;UBE3D;CUL3;LEO1;RNF20;DTX3L
prerank,mitochondrial membrane organization (GO:0007006),-0.2280819641909725,-0.7531827068677672,0.8618618618618619,0.9332443922782737,1.0,10/32,25.67%,BCL2L1;APOOL;MICOS10;BAD;SLC25A5;GHITM;CHCHD3;PPIF;APOO;SLC25A4
prerank,neural crest cell development (GO:0014032),0.25243454028788204,0.7528908564853748,0.8397626112759644,0.9870358742889197,1.0,6/44,10.26%,NRG1;SEMA5A;ERBB4;HTR2B;TAPT1;SOX10
prerank,NAD biosynthetic process (GO:0009435),0.2943993207995441,0.7526919890381679,0.7911184210526315,0.9867821983865563,1.0,3/20,11.85%,NMNAT3;KYNU;PTGIS
prerank,mitochondrial translational termination (GO:0070126),0.22820469494921095,0.7526255872936463,0.8699731903485255,0.9863173411481833,1.0,24/88,23.64%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.32143356829919306,0.7525775866597698,0.7737104825291181,0.9858261609285255,1.0,4/15,18.75%,TLR6;TLR4;MYD88;HIF1A
prerank,body fluid secretion (GO:0007589),0.3137204667118938,0.7522220449276461,0.7593856655290102,0.9858121753512598,1.0,1/15,2.16%,ERBB4
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.31419706899879046,-0.7520666646919558,0.791578947368421,0.9340849805464514,1.0,4/10,24.67%,DCLRE1A;RTEL1;DCLRE1B;ACD
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.26722493378520457,-0.751940212123633,0.8534278959810875,0.9336259695358522,1.0,4/18,12.12%,PARN;CCT3;CCT4;CCT7
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.22976170036770197,0.7518896968122498,0.8824343015214384,0.9857450558468505,1.0,17/69,16.83%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;TMEM67;DNAJC10;USP19;HSP90B1;HSPA5;BAG6;YOD1;DNAJB14
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2684098518303735,-0.7514489038773078,0.8188775510204082,0.9336331440090672,1.0,6/18,23.90%,ASH1L;SMYD2;EEF1AKMT2;SETMAR;SETD1A;KMT2B
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2063839830032465,-0.7513184219634289,0.9439252336448598,0.9331825461244297,1.0,12/52,15.85%,TUT7;SAMD4A;CNOT10;PARN;PAN3;LSM6;CNOT8;RC3H1;EXOSC2;LSM2;NT5C3B;EXOSC3
prerank,protein localization to mitochondrion (GO:0070585),-0.3101041569155844,-0.7510286758301375,0.8037383177570093,0.9329388251553488,1.0,5/11,22.03%,HK1;HK2;ISG15;AKT1;COX18
prerank,postreplication repair (GO:0006301),0.25103156155749384,0.7508274005696296,0.8025210084033614,0.9868719623409637,1.0,11/45,14.56%,POLK;RPA1;RFC3;UBE2V2;POLH;FAAP20;POLN;SPRTN;REV1;POLI;UBE2V1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.269665496303308,0.7506940912669446,0.8009950248756219,0.9865205109036307,1.0,9/29,21.61%,ERCC5;RPA1;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1;CDK7
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.31234118934010646,0.7504334159983749,0.7649122807017544,0.9863697949726747,1.0,5/15,21.31%,REEP2;LNPK;RTN3;ZFYVE27;ATL1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3404890043759046,0.7503404609464058,0.7652027027027027,0.9859481590286073,1.0,1/11,1.25%,PTPRT
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3204780075957745,-0.7499523491262964,0.7624190064794817,0.9337460389329585,1.0,6/10,28.15%,RAPGEF3;SPHK2;BRCA1;SMAD4;CHEK1;HDAC5
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2821640180458217,-0.7495957512287127,0.7934508816120907,0.9336102471676185,1.0,4/16,13.27%,BMPR2;ACE;KLK2;DDAH1
prerank,DNA dealkylation (GO:0035510),-0.3111735572940771,-0.7493672893875609,0.7849223946784922,0.9326731196443173,1.0,6/10,31.64%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.3111735572940771,-0.7493672893875609,0.7849223946784922,0.9326731196443173,1.0,6/10,31.64%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2;ALKBH1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.25596779496819166,-0.7492445178388952,0.8226600985221675,0.9321901631560782,1.0,7/19,29.92%,PRKDC;MDK;PPP2R3C;RHOH;CD27;NCKAP1L;IL7
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24604468824189873,0.7487132459047192,0.8420289855072464,0.9878733104715911,1.0,11/48,18.75%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,macroautophagy (GO:0016236),0.21398599970558668,0.7484742727252739,0.9078282828282829,0.9876478274865238,1.0,25/118,17.76%,DYNLL1;PIP4K2A;VPS39;VIPAS39;PINK1;SNAP29;RB1CC1;PLAA;ARL8B;TMEM74;LIX1L;VAMP7;HGS;MFN1;HDAC10;TSG101;DYNLL2;ATG14;SNF8;YOD1;VPS33B;CSNK2A2;UBXN6;VPS4B;WIPI2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.20177608246494305,-0.7484098212911284,0.9071428571428571,0.932669615939833,1.0,19/48,32.92%,SLIT2;ROBO1;SAMHD1;PTPN2;NLRC5;ISG15;CCDC3;USP18;RFFL;SIGIRR;YTHDF2;PADI2;PELI3;TTLL12;PPARG;OTUD4;PYDC1;GPS2;TREM2
prerank,negative regulation of cellular component organization (GO:0051129),0.23009673744850584,0.7482859421294421,0.8599735799207398,0.9873785677810596,1.0,13/74,16.02%,TRAF3IP1;FAP;NR1H4;SORL1;CARMIL2;PRKD1;EPHA3;IAPP;HSPA5;CLU;PACSIN3;AR;IMPACT
prerank,programmed necrotic cell death (GO:0097300),-0.259245600618727,-0.748199880671242,0.8370927318295739,0.9323032058116005,1.0,7/18,22.66%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96;PPIF
prerank,mesonephros development (GO:0001823),-0.30050123153141284,-0.7480283590788502,0.8127659574468085,0.9319190859886947,1.0,2/11,7.93%,OSR1;FGF1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.22830949348042107,-0.7479083372380888,0.8774373259052924,0.9314238716756369,1.0,9/32,21.86%,CAVIN1;GTF2H5;UBTF;POLR2H;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,fatty acid oxidation (GO:0019395),0.2383876225980505,0.7478449602908074,0.8279266572637518,0.9874819507748436,1.0,5/57,6.34%,ABCD2;PEX2;PPARD;ACADL;ACADS
prerank,histone acetylation (GO:0016573),0.2304726563687751,0.7475335625784151,0.8601108033240997,0.9873880343404602,1.0,19/69,21.85%,TAF12;MORF4L1;BRD8;WDR5;BRCA2;KAT2A;NAA50;JADE1;EPC1;POLE3;DMAP1;ATF2;PHF20L1;KAT7;TAF10;MBIP;SUPT7L;ING3;CREBBP
prerank,regulation of cellular catabolic process (GO:0031329),0.23597917014440878,0.7475291644625655,0.8484848484848485,0.9868324182550625,1.0,13/62,18.15%,PIP4K2A;ITPR1;PIK3R2;MTMR4;LRRK2;RAB8A;WDR24;USP33;CISD2;USP13;RRAGA;GPR137B;RRAGD
prerank,positive regulation of DNA replication (GO:0045740),-0.27070406958700566,-0.7472158634493996,0.8010335917312662,0.9316737039784818,1.0,5/16,18.27%,EGFR;GLI2;PCNA;STN1;EGF
prerank,negative regulation of ion transport (GO:0043271),0.2789826107964605,0.747159891883856,0.8128,0.9868307917667867,1.0,6/24,17.33%,GPM6B;NEDD4;WNK2;PACSIN3;STC1;ADRA2A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2822313984858961,0.7467342800247814,0.784,0.9868937960625555,1.0,7/22,22.25%,CDK13;CCNK;THOC5;KAT7;CDC73;DDX39B;CCNT2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.32895997695849466,0.7465153071420766,0.7690972222222222,0.9866505317072948,1.0,3/11,14.60%,SIRT6;MPHOSPH8;RESF1
prerank,positive regulation of secretion by cell (GO:1903532),0.2293896039614993,0.7464004497248048,0.8630872483221477,0.9862606905913365,1.0,14/70,18.99%,CADPS2;EDN3;PPID;CADPS;IER3IP1;P2RX4;EXOC1;CLASP2;CLASP1;ADAM8;STXBP5;RAB2B;BMP2;ATP6AP1
prerank,regulation of activated T cell proliferation (GO:0046006),0.27126024586833963,0.7463667283065553,0.8233438485804416,0.9857525947038871,1.0,7/30,17.29%,SCRIB;ICOSLG;PDCD1LG2;PYCARD;IGF2;PRKAR1A;LGALS9
prerank,regulation of interleukin-8 production (GO:0032677),-0.19312787694198896,-0.7462059416830762,0.9291666666666667,0.9323095945826813,1.0,12/69,17.22%,AFAP1L2;KLF4;LBP;ANXA1;MAVS;LAMTOR5;SERPINE1;TMSB4X;MAP2K5;ANXA4;RAB1A;CD74
prerank,regulation of p38MAPK cascade (GO:1900744),-0.22008082840744705,-0.7461771798967171,0.8717948717948718,0.9317202279448347,1.0,10/35,20.30%,EZR;MINK1;XDH;GADD45B;CYLD;MAP3K4;PER1;DLG1;MFHAS1;GADD45G
prerank,negative regulation of phosphatase activity (GO:0010923),0.28110928642087213,0.746059671538406,0.8090614886731392,0.9856359079677994,1.0,6/25,15.54%,BOD1;GPATCH2;PTPA;PPP1R26;ZCCHC9;CRY2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.2891886151613148,0.7459549454119444,0.7890222984562607,0.9852340179929339,1.0,2/18,8.86%,XCL1;NAV3
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2743053347863855,-0.7458947141935902,0.8047619047619048,0.9314680528469321,1.0,5/15,19.75%,SMPD3;SDC4;SDC1;SDCBP;PDCD6IP
prerank,mitotic cytokinesis (GO:0000281),0.2430020235980287,0.7454285820008275,0.8430232558139535,0.9854629146907083,1.0,12/47,17.84%,UNC119;SPTBN1;ANK3;EFHC1;JTB;NUSAP1;INCENP;RTKN;STMN1;CEP55;STAMBP;CUL7
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.2775067348258635,0.7451476031980775,0.8009554140127388,0.9853200532850466,1.0,3/26,9.80%,TREML4;PTPN22;CYBA
prerank,piRNA metabolic process (GO:0034587),0.28614081562876137,0.7449380357601956,0.7810945273631841,0.9850697967367206,1.0,1/19,2.39%,TDRKH
prerank,negative regulation of signaling (GO:0023057),-0.24602802649893174,-0.7448857083973199,0.8523676880222841,0.932119288227707,1.0,4/25,10.53%,IGFBP3;ACVR1;PTPN1;OPTN
prerank,protein localization to vacuole (GO:0072665),0.3203702174033031,0.7444586928867123,0.8044596912521441,0.985249804988911,1.0,3/13,12.94%,SZT2;RNF128;CD81
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2581491205991331,0.7441926720173226,0.8375184638109305,0.9850499082642188,1.0,7/38,14.74%,MIS18A;CENPU;ASF1A;UBN1;CENPC;CENPW;MIS18BP1
prerank,post-translational protein modification (GO:0043687),0.1945362386649928,0.7440304845228284,0.9621212121212122,0.9847222696452136,1.0,86/332,23.17%,LAMC1;LAMB1;CCDC22;FBXO9;MXRA8;PRKCSH;COPS3;PSMD1;VCAN;FBXO31;ZBTB16;SPP1;RAB8A;EPAS1;PSMD10;UCHL3;AMELX;PSMA5;WDR5;PSMB5;APLP2;COMMD1;FBXO17;PSMC4;KCTD7;PSMA4;ASB1;PSMC5;RAB2A;FBXW5;FBXL13;HSP90B1;CUL5;COPS4;CAND1;PSMB9;LGALS1;SPARCL1;DDA1;ASB10;CHML;FBN1;SDC2;SERPINC1;PSMA7;DCAF4;IGFBP7;PSMD14;SOCS6;FEM1B;CUL7;WSB2;KLHL22;CALU;PSMA2;DCAF11;RCN1;HIF1A;CUL4A;PSMD11;ANO8;FBXO4;MIA3;DCAF10;RHBDD1;FBXW4;WSB1;SPSB2;MEN1;SCG2;DDB1;MBTPS1;FBXL22;CHGB;SENP8;WDTC1;RBBP5;BTRC;UBXN7;ASB13;KTN1;SPSB3;FBXO21;KLHL5;FBXL5;FBXL12
prerank,proton transmembrane transport (GO:1902600),0.25498018564112285,0.7439769979305905,0.8150375939849624,0.984244563911178,1.0,3/36,6.01%,ATP1A2;ATP1A3;SLC9A1
prerank,ncRNA export from nucleus (GO:0097064),0.25567697540742146,0.7432925435758161,0.8236173393124065,0.9846455056577527,1.0,11/36,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;TSC1;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,zymogen activation (GO:0031638),0.2497716110192158,0.7432667078821562,0.8671428571428571,0.9841370541569876,1.0,7/39,14.78%,KLKB1;GRIN2A;OMA1;PLAU;LGMN;ASPH;BAK1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.24382856580656398,-0.7432557515534272,0.8425,0.9335477914607136,1.0,7/25,21.22%,ATXN7;APC;APC2;TRPV4;CAMSAP2;CIB1;KATNB1
prerank,negative regulation of phagocytosis (GO:0050765),-0.262086698030098,-0.7427646492803924,0.8257756563245824,0.9335541091285227,1.0,5/17,31.67%,SIRPA;DYSF;SNX3;FCGR2B;CD300LF
prerank,telomere maintenance via telomerase (GO:0007004),0.27132000853762445,0.7427308854100515,0.8120915032679739,0.984368344943196,1.0,7/28,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,respiratory electron transport chain (GO:0022904),0.3146213795262794,0.742606034852542,0.7872696817420436,0.9839892056206551,1.0,2/14,8.61%,SDHB;SLC25A22
prerank,acyl-CoA metabolic process (GO:0006637),0.2583005966776837,0.7425674775278186,0.827433628318584,0.9834907739886374,1.0,7/35,17.51%,ACSF2;DLST;ACOT7;HMGCS1;ACSL6;ACOT2;MCEE
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.2955369959312443,0.7412784696861099,0.8136752136752137,0.984849684757184,1.0,6/19,20.26%,NR1H4;TLR4;IRAK1;TIRAP;LGALS9;RAB11FIP2
prerank,nucleotide biosynthetic process (GO:0009165),0.2944419331940722,0.7410780707339317,0.8123924268502581,0.9845919610984403,1.0,3/18,10.64%,NMNAT3;PRPS1L1;PRPS1
prerank,epithelial cell development (GO:0002064),-0.25511257683089944,-0.7410203669710232,0.8463414634146341,0.9351392885241452,1.0,13/20,44.96%,WNT5B;ACTA2;DACT2;SLC4A7;EXPH5;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.2871630794970894,0.7399732948717803,0.8,0.9856092075891282,1.0,7/20,18.37%,SPRY1;TBX3;TGFBR1;PDCD4;OLFM1;BMP2;HEY1
prerank,regulation of centrosome duplication (GO:0010824),0.27187581830422974,0.7394254484479553,0.8273716951788491,0.9858028184020012,1.0,7/29,19.18%,NAT10;CEP295;TMEM67;FBXW5;VPS4B;ALMS1;CENATAC
prerank,positive regulation of cellular senescence (GO:2000774),0.3294261832224063,0.7394029514341491,0.7886323268206039,0.985283326294568,1.0,1/10,2.62%,CDKN2A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.27279365491592705,0.7392235319751207,0.8210862619808307,0.9849660351213072,1.0,8/26,20.52%,C1QC;TLR4;LRRC17;FBN1;MYC;MAFB;GPR137B;INHBA
prerank,2-oxoglutarate metabolic process (GO:0006103),0.30864986848514775,0.7388671467634889,0.7743119266055046,0.98490658001606,1.0,2/13,10.06%,L2HGDH;DLST
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.2453691022009044,-0.7388393130215182,0.855191256830601,0.9372310426762839,1.0,8/23,23.87%,HOOK1;CCDC88A;CCDC186;CCDC88C;DYNC1I1;KIF1C;TUBA1C;KIF5B
prerank,regulation of chromosome organization (GO:0033044),-0.24335181985112586,-0.7387537609929671,0.8781725888324873,0.9367117734578466,1.0,9/22,26.33%,SMG6;MAPT;HDAC8;SMG5;SETMAR;SHCBP1L;RMI2;LIG4;RB1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.28066120439729714,0.7386060637139631,0.8196994991652755,0.9847163335145299,1.0,4/23,11.68%,SLC12A6;SLC9A1;CLCN3;PDK2
prerank,protein methylation (GO:0006479),0.24770990796417863,0.7379565585124518,0.8432267884322678,0.9851199358727204,1.0,17/40,28.63%,PRMT3;VCPKMT;NSD1;FAM98B;CARM1;PRMT2;N6AMT1;EHMT2;ATPSCKMT;CAMKMT;EHMT1;PRMT6;ETF1;PCMT1;FAM98A;NSD3;METTL22
prerank,heterocycle biosynthetic process (GO:0018130),-0.28441442854599813,-0.7376412949624357,0.8073394495412844,0.9373955048234377,1.0,7/14,27.94%,NFS1;GCH1;MOCS1;NOXRED1;PYCR2;MOCS3;PYCR3
prerank,RNA biosynthetic process (GO:0032774),0.2606892445234103,0.7373288061600702,0.8456692913385827,0.9854477705852615,1.0,3/31,10.17%,TAF12;POLA1;TBPL1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.32616991048670535,0.736778737425275,0.8061749571183533,0.9851510072336804,1.0,1/12,1.17%,SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.32616991048670535,0.736778737425275,0.8061749571183533,0.9851510072336804,1.0,1/12,1.17%,SPRY4
prerank,snRNA transcription (GO:0009301),0.22761069044842328,0.736700999921313,0.8820375335120644,0.9847205422770912,1.0,23/70,26.43%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;USPL1;SP1;TAF11;POLR2L;GTF2B;CDK7;GTF2A2;CCNT2;POLR2D;TAF5;GTF2E1;POU2F1;ELL;RPRD2
prerank,RNA export from nucleus (GO:0006405),0.2180003013956825,0.7365068317298379,0.9040404040404041,0.9844495826178615,1.0,25/100,21.21%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2827927348362982,0.7361469086720007,0.808641975308642,0.984413454168274,1.0,2/20,3.83%,MBTPS2;NGFR
prerank,rRNA methylation (GO:0031167),0.2845595667227141,0.7353416082766524,0.8305647840531561,0.9850035604672576,1.0,12/22,31.71%,MRM3;DIMT1;NSUN3;MTERF4;NSUN5;METTL15;METTL5;ZCCHC4;NSUN4;FTSJ3;EMG1;METTL16
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.26975282237194786,0.7351304379124025,0.8235294117647058,0.9847314432587558,1.0,6/26,13.75%,PDPK1;DUSP22;ZFP36L2;SOX9;GAREM1;MED1
prerank,pentose-phosphate shunt (GO:0006098),-0.30145423986730213,-0.734333422000606,0.8023529411764706,0.9408454997182712,1.0,5/11,24.52%,DERA;TALDO1;PGM2;SHPK;PGLS
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.29261670696435327,0.7341437498613202,0.8096774193548387,0.9855563072547661,1.0,3/17,8.14%,SPRED1;DGKQ;SPRED2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.24952216573734176,-0.7336830083203573,0.8578947368421053,0.9410116928505724,1.0,11/21,36.05%,NES;CX3CR1;MDK;FZD3;CX3CL1;SMARCD3;KDM1A;DLL4;DISP3;LRP2;FZD9
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3001418989124425,0.7336437273399198,0.7996515679442509,0.9857425330428911,1.0,2/15,7.17%,REST;ZFP36L2
prerank,lipid oxidation (GO:0034440),-0.2951811251986913,-0.7332013247546297,0.8271028037383178,0.940924576637001,1.0,1/12,2.57%,ADIPOR2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2634848086618425,0.7321066136921991,0.8244766505636071,0.9872922013886388,1.0,10/30,22.10%,ENTPD5;SELENOF;DNAJB12;HSPA13;HSPA5;DNAJB14;HSPE1;ST13;HSPA9;CHCHD4
prerank,DNA recombination (GO:0006310),0.2508920423702576,0.7318495118299619,0.8313253012048193,0.9871198727186455,1.0,10/37,22.28%,ERCC1;MSH3;RPA1;RECQL;RAD52;HDAC10;WRN;FBH1;RAD54L;HMGB1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.20687201599685553,-0.7311874753045087,0.8958990536277602,0.9426579555657725,1.0,15/45,24.00%,THAP4;GOT2;GPT2;RIMKLB;OAT;MTHFR;NOX4;ASS1;DDAH1;CBS;KYAT3;ASNS;DDAH2;GLUL;PYCR2
prerank,transition metal ion transport (GO:0000041),0.2548523882369451,0.730736674637862,0.8346456692913385,0.9880849412686707,1.0,8/35,19.44%,SLC30A10;SLC30A5;TRPC3;TRPC7;HEPH;ATP7A;ATP2C1;TRPC1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2169803820743102,-0.7307181085071726,0.8882175226586103,0.9425739550147411,1.0,14/33,29.64%,PRKDC;MAPK14;ETS1;TAL1;HMGB2;ABCB10;PITHD1;FES;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,tRNA transport (GO:0051031),0.2511802356164513,0.7304274486613127,0.8320950965824666,0.9879871390993687,1.0,10/35,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.28626741374015285,0.7304124187552429,0.8349514563106796,0.987461777659625,1.0,2/20,4.94%,PPID;PPIH
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2840812649401702,-0.7303180284684078,0.8255528255528255,0.9424034176368036,1.0,5/14,24.67%,TNKS2;ATR;TERT;TPP1;ACD
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22818041300559613,0.7301075936963523,0.8786610878661087,0.9873388887593972,1.0,17/62,23.31%,NUP214;AAAS;FMR1;DND1;POM121;NUP42;NUP107;DHX9;WTIP;NUP54;AGO1;NUP155;FXR1;POLR2L;RANBP2;IPO8;NUP35
prerank,transferrin transport (GO:0033572),0.25748219170776215,0.7300645481511638,0.8358895705521472,0.986858294186379,1.0,7/33,18.99%,STEAP3;ARHGAP1;ATP6V0E1;MCOLN1;ATP6V0D1;ATP6V1G2;ATP6AP1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3003276341643174,0.729479719478553,0.7982608695652174,0.987101220166801,1.0,4/15,19.66%,RYR2;SRPRA;ZFAND2A;RAB3GAP2
prerank,serine family amino acid metabolic process (GO:0009069),0.30297140268930234,0.7292663721425996,0.8091353996737357,0.9868469168437864,1.0,1/16,1.42%,THNSL2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.23221164952455553,0.7288042471052973,0.8801711840228246,0.9869775499025971,1.0,8/57,15.32%,CDC14B;TIPIN;FBXO31;MRNIP;TP53;RINT1;EME2;ATF2
prerank,pigment granule transport (GO:0051904),-0.25465208622867996,-0.728467090430943,0.8480392156862745,0.9433642862839254,1.0,6/18,28.53%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,melanosome transport (GO:0032402),-0.25465208622867996,-0.728467090430943,0.8480392156862745,0.9433642862839254,1.0,6/18,28.53%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.25679390898031673,0.7279901355507327,0.8289269051321928,0.9875626429256605,1.0,1/32,0.36%,CDC14B
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2799803556319838,0.727937790207551,0.8240131578947368,0.9870976590189304,1.0,3/21,8.79%,PTEN;CNKSR3;INPP5J
prerank,error-free translesion synthesis (GO:0070987),-0.2392571978761702,-0.7276052915917809,0.8394736842105263,0.9437222128614303,1.0,5/22,12.61%,NPLOC4;UBB;VCP;RCHY1;PCNA
prerank,negative regulation of histone methylation (GO:0031061),0.3314468668927771,0.7274428907854049,0.8140794223826715,0.9872034565738106,1.0,3/10,16.27%,BCOR;WDR5;AASS
prerank,spliceosomal snRNP assembly (GO:0000387),0.2480837481257907,0.7267126496055945,0.8599397590361446,0.9876382527471264,1.0,13/38,25.56%,GEMIN2;LSM4;SNUPN;SRSF10;CLNS1A;SNRPF;USP4;GEMIN8;PRPF8;SRSF12;GEMIN5;GEMIN7;SNRPG
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.23578487823828542,0.7267084226370422,0.8645066273932254,0.9870996735351161,1.0,14/49,23.38%,TRAF3IP1;THRA;SORL1;JAM3;IAPP;HSPA5;CLU;IMPACT;PTGER4;TFIP11;HMGB1;ANKRD27;NLRP2B;KIF14
prerank,phagosome maturation (GO:0090382),0.2486188535587213,0.7262388445837467,0.8441754916792739,0.9871760621688515,1.0,2/35,2.26%,RAB34;RAB20
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2229375743187738,-0.7261317554752036,0.8735632183908046,0.9448460272142788,1.0,8/31,15.33%,TMBIM6;HSPA8;HSPB8;BAX;PTPN1;OPTN;BAG3;ERN1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3067183123038366,-0.7257137029653025,0.8106235565819861,0.9447348448799825,1.0,5/10,24.32%,THOC1;ETAA1;CCAR2;RFWD3;RPA2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.25448076508531886,-0.7257092048906764,0.8507853403141361,0.944113304112128,1.0,2/18,2.06%,NPLOC4;DDX60
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2569877329295228,0.7255404066996686,0.8429237947122862,0.9875852495848133,1.0,10/31,20.39%,PTEN;CDKN2A;SUSD2;CDKN2D;JADE1;CDKN2C;PRMT2;BRD7;CDC73;CCL2
prerank,regulation of cell division (GO:0051302),0.22282519494807057,0.7255113150322217,0.8969210174029452,0.9870810971012922,1.0,12/72,15.70%,KDF1;SUSD2;EFHC1;NCOA3;HTR2B;ZFYVE26;INSC;RAB11FIP3;ENTR1;SMYD5;MYC;FGFR2
prerank,histone mRNA metabolic process (GO:0008334),0.26354061745327734,0.7249960023045188,0.8232558139534883,0.9872133477107037,1.0,6/27,15.30%,LSM11;TENT4B;TENT2;SLBP;SNRPF;EXOSC10
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2716675958299153,0.7249329026589361,0.8327814569536424,0.9867505983819359,1.0,5/24,15.36%,NCKAP5L;STMN2;STMN4;STMN1;KIF2A
prerank,membrane repolarization during action potential (GO:0086011),0.30135190697676295,0.7246852454327989,0.8154121863799283,0.986554556535779,1.0,2/13,10.97%,KCNIP2;KCNE4
prerank,negative regulation of bone remodeling (GO:0046851),-0.29122163049961597,-0.7246447361470042,0.8146453089244852,0.944698435319493,1.0,6/11,25.13%,SFRP1;TMEM119;P2RX7;GPR137;TNFAIP3;GREM1
prerank,tRNA modification (GO:0006400),0.22895518772160997,0.7245901581544777,0.89900426742532,0.9861504724461413,1.0,19/62,24.78%,CTU1;DUS2;QTRT2;TRMT13;OSGEP;TYW3;TRMT44;TRMT61A;PUS7;WDR4;METTL1;THUMPD3;TRMT10A;METTL2B;METTL2A;LCMT2;AARS1;SSB;NSUN6
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.20388990070888768,0.7245511763100746,0.9187192118226601,0.9856628103457549,1.0,20/136,15.42%,XCL1;TCF7L2;CDKN2A;FOXS1;PSMD10;BRMS1;TRIM37;TAF3;LRRC14;SP100;COMMD1;BMP7;IRAK1;PYCARD;DAP;PTGIS;PIM1;CTNNBIP1;PRMT2;PAXIP1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2794695791652319,-0.7240163747171665,0.8283752860411899,0.944781907857664,1.0,3/13,15.02%,TRIM5;TRIM11;TRIM35
prerank,regulation of striated muscle contraction (GO:0006942),0.2622788540449262,0.7236607294634653,0.8253968253968254,0.9863160256300043,1.0,5/27,15.15%,ATP1A2;RYR2;PRKACA;P2RX4;GJA5
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.31120605742643903,0.723002769508692,0.804159445407279,0.9866080120005283,1.0,3/14,12.41%,CD40;PRKCI;PDCD4
prerank,cellular response to BMP stimulus (GO:0071773),0.2274823618815462,0.7229864449218034,0.9,0.9860918271000368,1.0,8/66,12.41%,RUNX2;RGMB;RGMA;SMAD5;ADAMTS12;BMP7;SOX9;PDCD4
prerank,regulation of defense response to virus (GO:0050688),0.3030428117471638,0.7224491023141131,0.8131313131313131,0.9862449994162712,1.0,3/14,14.93%,TRAF3IP1;IFNLR1;DHX9
prerank,cellular response to radiation (GO:0071478),0.24524834570630674,0.7218525901408153,0.8498498498498499,0.986497506520019,1.0,5/40,12.58%,GPR88;GPR52;TP53;SPIDR;FIGNL1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.28613151405035975,-0.7217313260684323,0.8262806236080178,0.9467261166218244,1.0,5/12,25.16%,CRYAB;APOE;PFDN4;PFDN6;PFDN2
prerank,glycerol metabolic process (GO:0006071),0.33530306323809367,0.721421418608572,0.7967914438502673,0.9865327604066704,1.0,2/10,10.40%,COQ3;GK
prerank,positive regulation of T cell activation (GO:0050870),-0.18791044772588433,-0.7206598019803399,0.951310861423221,0.9473010692223387,1.0,6/62,6.18%,SIRPA;ANXA1;IL6ST;SLC7A1;TFRC;NCK1
prerank,negative regulation of calcium ion transport (GO:0051926),0.3025710260263461,0.7203179845909035,0.8196994991652755,0.9874349352220853,1.0,4/15,17.33%,ATP1A2;PACSIN3;STC1;ADRA2A
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.19946542341842993,-0.7200781923920087,0.9458483754512635,0.947333165156815,1.0,13/49,26.33%,AFAP1L2;LBP;MAVS;LAMTOR5;SERPINE1;RAB1A;CD74;TLR7;BCL10;HYAL2;NOD2;HSPA1A;PARK7
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.20673088626956357,-0.7195683619360389,0.9341317365269461,0.9472897962588442,1.0,6/40,10.69%,SLC13A3;SLC38A11;SLC16A1;SLC38A5;SLC38A10;SLC7A5
prerank,positive regulation of transporter activity (GO:0032411),0.3011258216273274,0.7195312909810063,0.8181818181818182,0.9879392430780936,1.0,3/13,15.57%,KMT2A;KCTD7;SGK1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2643710171470694,0.7187828079246291,0.8530805687203792,0.9883608172824007,1.0,5/23,20.55%,COPS3;XPC;COPS4;CUL4A;DDB1
prerank,mitochondrial translation (GO:0032543),0.21184676554618323,0.7184750008047606,0.9203655352480418,0.988187495278189,1.0,27/104,23.64%,MRPL44;EARS2;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;HARS1;MRPS23;MRPL3;MTIF2;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3076119896856963,0.7181245053823395,0.8170515097690941,0.988102624905342,1.0,5/14,21.79%,TLR6;IRAK1;TIRAP;TNFRSF10B;MALT1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2556596390699852,0.7166188919122987,0.8578052550231839,0.9894937824378395,1.0,11/29,23.83%,ELOVL2;HSD17B8;ACSL6;ACLY;ELOVL6;ELOVL1;ACSBG1;SCD5;ACACA;ELOVL5;TECR
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3077982947589718,0.7157541196289104,0.8107638888888888,0.9900799714050297,1.0,2/13,10.05%,UNC93B1;IRAK1
prerank,microtubule anchoring at centrosome (GO:0034454),0.32643483605784085,0.7147939597819666,0.8109540636042403,0.990798174265234,1.0,5/10,20.72%,PCM1;CEP19;KIF3A;BBS4;NIN
prerank,regulation of chromosome segregation (GO:0051983),0.3018938955823197,0.7146677285870525,0.8197573656845754,0.9904203937201506,1.0,3/16,15.91%,MKI67;BUB1;CSNK2A2
prerank,protein sumoylation (GO:0016925),0.23014463925669826,0.7146536236207658,0.8769898697539797,0.9898958457644904,1.0,18/49,26.97%,NUP214;AAAS;POM121;PIAS2;SAE1;NUP42;NUP107;NUP54;NUP155;SUMO2;RANBP2;NUP35;TRIM28;UBA2;NSMCE2;IFIH1;NUP210;NUP88
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.25695755756098,-0.7144928296835364,0.8681592039800995,0.9521149480926665,1.0,9/17,32.58%,MTBP;ZW10;BUB3;CTCF;RB1;IK;TTK;CENPA;ZWILCH
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.24068887213871543,0.7142916683793114,0.872992700729927,0.9898032292819801,1.0,12/42,23.52%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS1;SARS2;AIMP1;PPA2;MARS2;AARS1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.3275161336273272,0.7142748177645405,0.8214904679376083,0.9892857313762864,1.0,5/10,24.06%,EMC2;EMC9;EMC8;EMC10;EMC4
prerank,sulfur amino acid metabolic process (GO:0000096),0.2651074612520216,0.7141033083538953,0.8263565891472868,0.988959673319825,1.0,7/24,22.79%,MTRR;ADO;TXN2;DPEP1;MMUT;MSRA;MTHFD1
prerank,translational termination (GO:0006415),0.21361089208260392,0.7139350803236465,0.9213630406290957,0.9886273578991818,1.0,28/95,25.45%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;N6AMT1;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;ETF1;MRPL14;MRPL32
prerank,regulation of cellular amide metabolic process (GO:0034248),0.25321232145325656,0.7137388030183962,0.8406676783004552,0.9883496779734365,1.0,7/32,16.57%,NANOS3;NR1H4;MTPN;GRM5;RBM4B;TSC1;CYFIP1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.24799581643499122,0.7135909738352435,0.8700906344410876,0.9879888074388564,1.0,11/33,21.21%,NCOA2;DNAAF4;AXIN1;CARM1;SAFB2;PRMT2;AR;CALR;CBFB;DDRGK1;TRIM68
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.32067745029993905,0.7132914490734622,0.8058419243986255,0.9878385933603604,1.0,3/10,19.29%,PDE4B;CACNA2D1;NIPSNAP2
prerank,positive regulation of type I interferon production (GO:0032481),-0.18245191778893685,-0.7129308720187797,0.9675090252707581,0.9531886412099242,1.0,23/73,27.47%,NFKB1;PRKDC;POLR3E;MAVS;CRCP;IRF1;GAPDH;RIOK3;POLR2H;POLR3G;POLR3D;TBK1;NFKB2;ISG15;PQBP1;POLR1C;POLR3K;TLR7;HSPD1;IRF5;FLOT1;ZBP1;POLR2K
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.21862624104723477,0.7125870040348877,0.9171052631578948,0.9882393660330329,1.0,15/76,17.96%,C5AR1;P2RY1;HTR2B;CALCA;TRHR;CCKBR;HTR2C;GNA11;LPAR1;GRM5;F2R;LHCGR;ADRA2A;GPR35;GRM1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.21793408358356098,0.7123791514225664,0.9073305670816044,0.9879742701045674,1.0,3/72,4.21%,FLRT2;FGFR1;SPRED1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2569272920424282,-0.7122917164146279,0.8363636363636363,0.9532313666868132,1.0,4/18,13.03%,ADAM10;APOE;APH1A;APH1B
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.2652700141328183,-0.7121931765638785,0.868421052631579,0.9527110600250304,1.0,3/14,18.37%,MOXD1;NOS1;SLC22A2
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.2929384675821594,-0.7120040080418171,0.8325991189427313,0.9522932853987294,1.0,6/11,34.90%,ZC3H3;LEO1;NCBP2;AHCYL1;BARD1;PAPOLA
prerank,melanosome localization (GO:0032400),-0.23891251516306983,-0.7116315393177056,0.8989637305699482,0.9520796266463559,1.0,8/21,31.77%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A;VPS33A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.18614890243787785,-0.7111994256449541,0.9647887323943662,0.9519364811367138,1.0,14/63,15.10%,PRKDC;CNOT10;CRADD;SOX4;CASP2;PLAGL1;CNOT8;BTG2;BAX;RPL26;PCNA;ATM;CCND1;CDKN1A
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3020635284552668,0.7108438769220403,0.8166666666666667,0.9893474384077293,1.0,5/14,22.89%,NOL9;DDX18;URB1;RPL35;ZNHIT6
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2998338939029128,0.7106054841519164,0.8189509306260575,0.9891159011641683,1.0,4/14,14.65%,LRRK2;HERPUD1;OPA1;CREB3L1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23670281142911911,0.7102792915343913,0.8882521489971347,0.9889579612503863,1.0,6/45,9.77%,BUB1B;SCRIB;ZFP36L2;BCL6;BMP7;NME6
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2518972392103178,-0.7101882951386319,0.839622641509434,0.9524090818539184,1.0,4/16,16.16%,AMPD3;ADSS2;LHPP;PFAS
prerank,positive regulation of ruffle assembly (GO:1900029),0.29971663266145404,0.7096525404389018,0.8429319371727748,0.989242387651386,1.0,2/13,8.93%,CARMIL2;EPS8L1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2754174843123658,-0.7095257986675872,0.8586387434554974,0.9524956853526363,1.0,3/14,13.03%,ADAM10;APH1A;APH1B
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.2326996889939876,0.7093869720978851,0.8907801418439716,0.9890258414249471,1.0,7/45,15.28%,PIK3R1;SLC30A10;PDPK1;PTK2;SOX9;GAREM1;AREG
prerank,protein targeting to membrane (GO:0006612),0.21109537870559375,0.7088124290640874,0.9302631578947368,0.989193979181709,1.0,21/83,20.14%,RTP4;ABCD2;PEX2;PRKCI;SEC63;ZDHHC24;SRPRA;SLC25A17;GET3;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;PEX3;ZDHHC9;ALDH3A2;PEX14;SSR1;RABGEF1;MICALL1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.2508967040236022,0.7087212278152697,0.8637083993660856,0.9887740762393847,1.0,5/32,15.72%,DLC1;MTOR;PTPA;ANKLE2;SYMPK
prerank,regulation of programmed necrotic cell death (GO:0062098),0.2786195087114651,0.7087012226788283,0.828099173553719,0.9882660017377776,1.0,4/20,14.80%,OGT;FLOT2;BIRC2;RIPK1
prerank,positive regulation of viral life cycle (GO:1903902),0.26775029329788674,0.7084954464348207,0.84251968503937,0.9879885845350098,1.0,7/22,22.35%,FMR1;AXL;LGALS1;TSG101;LGALS9;DDB1;KPNA2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.26652855189340025,-0.7081851042812656,0.850632911392405,0.9532831437171779,1.0,1/14,2.21%,THBS1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.1817218616551126,-0.7071644110453952,0.971830985915493,0.9537418657022064,1.0,22/68,28.51%,CAVIN1;GTF2H5;WDR33;UBTF;SNRPE;POLR2H;TTF1;POLR1H;CLP1;TAF1C;GTF2H4;POLR1G;POLR1C;NCBP2;POLR3K;LSM10;SMN1;SSU72;CPSF7;POLR2K;MED18;MTERF2
prerank,negative regulation by host of viral process (GO:0044793),-0.2947422949730267,-0.7066541372219325,0.8478260869565217,0.9536407510064866,1.0,7/10,46.02%,VAPA;PSMC3;CRP;ZC3H12A;CCL8;PRKN;PTX3
prerank,regulation of biosynthetic process (GO:0009889),0.3170126244391115,0.704758539904477,0.8219424460431655,0.9920629436484919,1.0,2/11,18.50%,SLC25A33;ALOX5
prerank,RNA methylation (GO:0001510),-0.1890481089553915,-0.7047123238209494,0.9518518518518518,0.9549622870529738,1.0,17/60,26.01%,VIRMA;NSUN2;TRMT61B;CMTR1;FTSJ1;TRDMT1;TRMT5;THUMPD2;METTL6;GTPBP3;RBM15B;MEPCE;TRMT6;MRM2;TRMT12;TRMT112;NOP2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.21883595499886518,0.7046636432537219,0.9099462365591398,0.991650828017389,1.0,22/69,26.43%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;SP1;TAF11;POLR2L;GTF2B;CDK7;GTF2A2;CCNT2;POLR2D;TAF5;GTF2E1;POU2F1;ELL;RPRD2
prerank,CENP-A containing chromatin organization (GO:0061641),0.2574836410878294,0.7039137072843622,0.8532110091743119,0.9914695402938118,1.0,5/29,14.74%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.2574836410878294,0.7039137072843622,0.8532110091743119,0.9914695402938118,1.0,5/29,14.74%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,cellular response to chemical stress (GO:0062197),0.20629729093837904,0.7023489318584474,0.9371657754010695,0.9928032065590278,1.0,19/96,17.24%,ETV5;PRDX6;ALDH3B1;LRRK2;PRDX5;CCS;PYCR1;PINK1;PRKD1;CYBA;ERMP1;HTRA2;EIF2S1;RAD52;LONP1;VKORC1L1;TXNRD2;NOX1;NUDT2
prerank,potassium ion import across plasma membrane (GO:1990573),0.23734698654118458,0.7014694116228193,0.8935532233883059,0.9933155970138907,1.0,10/41,21.26%,ATP1A2;SLC12A6;ATP1A3;HCN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9;SLC12A9
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.2805858443505581,-0.7008430143112302,0.836104513064133,0.9582790869042522,1.0,3/12,13.82%,DIAPH1;ANK2;PTK2B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2561322443234394,-0.7007686609414595,0.8687350835322196,0.9577295048427329,1.0,10/15,43.15%,MAPK14;RAPGEF3;ADAM9;TYROBP;FLOT1;TREM2;EHD2;SCGB3A1;EHD1;IL4
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.23671420320341408,0.7004082510529243,0.9,0.9940370749992291,1.0,6/39,11.64%,MYO7A;MYO1B;MYO6;PPFIA2;TANC2;MYO1G
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2769653904676647,0.699801008767231,0.8341463414634146,0.9942514673093344,1.0,8/18,23.90%,LYAR;UTP15;EIF2AK3;POLR2L;HEATR1;DHX33;MAF1;ATF4
prerank,peptidyl-methionine modification (GO:0018206),0.30584872255621026,0.6993952314621495,0.8303249097472925,0.9941601396467923,1.0,1/12,6.11%,METAP1D
prerank,aspartate family amino acid catabolic process (GO:0009068),0.27517221146371496,0.6993006766965052,0.8545454545454545,0.9937505308598835,1.0,3/19,10.06%,SLC25A21;ASPA;DLST
prerank,maintenance of protein localization in organelle (GO:0072595),0.2748552881111507,0.6988824700238615,0.8658940397350994,0.9937136131561408,1.0,7/19,20.71%,TAF3;PINK1;TAPT1;HSPA5;TAF8;SUPT7L;BBS4
prerank,protein complex oligomerization (GO:0051259),0.20881382554641154,0.698817972260963,0.9321382842509603,0.9932590476175805,1.0,13/85,11.72%,POLQ;MPP2;NOL3;SLC9A1;ADCY8;KCNC2;OPA1;GLRA3;NUDT21;GSDMD;VSTM5;PYCARD;WDCP
prerank,positive regulation of protein maturation (GO:1903319),-0.28656203148393955,-0.6980611362513348,0.8463251670378619,0.9597625072999805,1.0,2/11,7.88%,SOX4;CCBE1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.30152007044738877,0.69796955179818,0.8125,0.9936887631701993,1.0,5/13,24.19%,CAMK4;ZC3H8;ADAM8;TOX;BMP4
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.2554281453167644,-0.6975948752256803,0.9027431421446384,0.9596096907063036,1.0,5/17,23.43%,CD55;TRIM5;CX3CL1;LY96;SIGIRR
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2527725376894594,0.6974442135506183,0.8677811550151976,0.9937733422178187,1.0,6/29,14.80%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,iron ion transport (GO:0006826),0.22920811007496833,0.6973532953910191,0.8940493468795355,0.9933441127488177,1.0,10/47,18.99%,STEAP3;ARHGAP1;HEPH;ATP6V0E1;ABCB7;MCOLN1;SLC39A14;ATP6V0D1;ATP6V1G2;ATP6AP1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2577993356428469,0.6968705816921726,0.8622848200312989,0.9933614104281334,1.0,4/26,9.56%,FLOT2;LRRC14;APPL2;BIRC2
prerank,translesion synthesis (GO:0019985),0.23908735361691813,0.6967297918192917,0.8731563421828908,0.9929881229878672,1.0,10/42,14.01%,POLK;RPA1;RFC3;REV3L;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.28764452499392157,0.6955792673625232,0.8506711409395973,0.9937812031823118,1.0,7/18,22.36%,NOL3;PINK1;HTRA2;NONO;HIF1A;BAG5;MAPK7
prerank,chromatin remodeling at centromere (GO:0031055),0.2497765276936733,0.6949853172419229,0.8577912254160364,0.9939606097631439,1.0,5/31,14.74%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,regulation of programmed cell death (GO:0043067),0.19431670039561694,0.6945818340306279,0.9715639810426541,0.9939121654784797,1.0,32/161,17.25%,CXCL10;STEAP3;HS1BP3;CASP6;LRRK2;TM7SF3;ACTN1;OMA1;BRMS1;BCL6;USP42;CIDEA;PINK1;BIRC2;DAXX;TMEM219;TP53;SLK;PSMC5;SOX9;RTKN;LGALS1;NME1;RIPK1;CLU;AIFM2;SGK1;ZBTB7A;SRA1;HAX1;CALR;CDK5
prerank,dicarboxylic acid metabolic process (GO:0043648),0.22616448590976324,0.6945621903116057,0.9143686502177069,0.9934128662389847,1.0,8/52,11.96%,MDH1;L2HGDH;MTRR;MTHFD1L;DLST;HOGA1;ALDH5A1;ACLY
prerank,cellular macromolecule catabolic process (GO:0044265),0.22914685485752664,0.6938487133245295,0.9185714285714286,0.9936797220265583,1.0,10/49,16.58%,RNASEH2C;UBE2G2;FBXO17;MTREX;RNASEH2B;HTRA2;RIPK1;HNRNPD;RNASEH1;PPP1R8
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2550855021337868,0.693538927065985,0.8578052550231839,0.9934889230986019,1.0,10/25,27.62%,CDK13;RNF168;NELFA;EAF2;LDB1;CDC73;NELFB;EAF1;ELL;WDR43
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.23113101721875554,-0.6929684043905574,0.9050279329608939,0.9633525081725608,1.0,3/22,9.87%,PPM1E;PPM1F;PPM1D
prerank,regulation of protein acetylation (GO:1901983),0.3021155653663339,0.6928959571663087,0.8472222222222222,0.9936892916295285,1.0,2/12,7.99%,CEP295;FAM161A
prerank,macrophage migration (GO:1905517),0.3016321406151913,0.6928766917007728,0.85451197053407,0.9931772983653524,1.0,13/13,69.86%,P2RX4;CCL2;P2RY12;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF;CCR2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.26151389878934167,-0.6926750596456928,0.8700980392156863,0.9630317538354832,1.0,6/14,32.75%,PTPN2;CCDC3;RFFL;PELI3;PYDC1;GPS2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.23414818801523662,0.6922698361718516,0.9090909090909091,0.9933295519462589,1.0,9/38,19.62%,DHX58;TLR8;AKIRIN2;PRKCA;CYBA;DHX9;ZCCHC3;ADAM8;CD180
prerank,regulation of interferon-alpha production (GO:0032647),0.26187706239928893,0.6919439275625927,0.8774509803921569,0.9931508922571317,1.0,4/23,14.93%,TLR8;TLR4;DHX36;DHX9
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.2665092868663389,0.6917787828585362,0.8541996830427893,0.9928112891383847,1.0,2/21,4.94%,FBXO5;CDC7
prerank,negative regulation of dephosphorylation (GO:0035305),0.272408748237221,0.6910875918989641,0.8564437194127243,0.9930548625474535,1.0,5/18,16.58%,GPATCH2;PTPA;PPP1R26;ZCCHC9;PPP1R8
prerank,snRNA processing (GO:0016180),0.2873364835701121,0.6905638199694621,0.86084142394822,0.9931127716211461,1.0,2/16,11.41%,INTS8;INTS14
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2062859729587359,-0.6903580077443673,0.9413489736070382,0.964529331769917,1.0,9/36,20.76%,ITGB1;SHANK3;NRP1;EPHB2;EDN1;HFE;EGF;ADRB2;HDAC6
prerank,protein insertion into membrane (GO:0051205),0.24203974855868632,0.6901882525444462,0.8930817610062893,0.9929889989453887,1.0,4/32,11.32%,RTP4;VAMP2;SEC61B;TRAM2
prerank,establishment of vesicle localization (GO:0051650),-0.24701884520595654,-0.6898719744695293,0.9026315789473685,0.9643634258372764,1.0,9/18,34.42%,CCDC186;TOR1A;SYNJ1;SPG11;KIF5B;IKBKG;RAB11A;F8A1;DNM2
prerank,synaptic vesicle membrane organization (GO:0048499),0.27903298264266574,0.689431068016979,0.8554421768707483,0.9932869175836193,1.0,4/17,13.40%,SNAP23;SYP;SNAP29;AP3D1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.214281086353047,0.6890462879684706,0.9203778677462888,0.9931871285811267,1.0,14/72,15.42%,ARID3A;CNOT11;E2F4;RPS6KA6;MYO6;MDM4;SP100;TP53;CNOT1;CARM1;FOXM1;TFAP4;CNOT7;PAXIP1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2487700849811192,0.6886826860942581,0.8740399385560675,0.9930819222479218,1.0,6/30,14.80%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,positive regulation of interferon-beta production (GO:0032728),0.24050830606316914,0.6885666246057729,0.9046898638426626,0.9927063520450651,1.0,6/33,16.13%,DHX58;TLR8;TRIM56;TLR4;DHX9;POLR3A
prerank,cellular response to inorganic substance (GO:0071241),0.272319976126446,0.688015761321077,0.872852233676976,0.9927573654463288,1.0,4/21,11.64%,ADCY10;FMR1;KCNC2;SPIDR
prerank,tRNA methylation (GO:0030488),0.24025993619140598,0.688006944830699,0.8990963855421686,0.9922435920648126,1.0,13/34,24.78%,PRORP;TRMT13;TYW3;TRMT44;TRMT61A;METTL1;THUMPD3;TRMT10A;METTL2B;METTL2A;LCMT2;TRMT10C;NSUN6
prerank,positive regulation of calcium ion import (GO:0090280),0.2914487479547049,0.6878001476450303,0.8421985815602837,0.9919429997316477,1.0,3/12,20.39%,STC1;PDGFRB;CCL2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.24914875314399526,0.6865739491476268,0.8829268292682927,0.9927728354921577,1.0,7/29,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,response to histamine (GO:0034776),-0.2904123632109805,-0.6853397935363177,0.88,0.9679168047490322,1.0,1/10,2.26%,DIAPH1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.20926401110958304,0.6850236628672435,0.9390243902439024,0.9939192724117325,1.0,15/76,18.45%,NTRK3;SEMA5A;FCHSD2;LIMK1;GPSM2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;HAX1;CDK5;VASP;CDC42EP3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.23556339466820553,0.6841930601958812,0.9013452914798207,0.9942194160813344,1.0,5/39,10.84%,UTRN;SCN2B;NEDD4;FXYD4;FGF12
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.23824478631614598,-0.6840920486316103,0.9104477611940298,0.9684424030125796,1.0,6/21,21.22%,ATXN7;APC;APC2;CAMSAP2;CIB1;KATNB1
prerank,non-motile cilium assembly (GO:1905515),0.24402328500969284,0.6829876780612192,0.8841463414634146,0.9949711244841182,1.0,11/30,25.20%,DISC1;RPGRIP1;IFT88;CEP250;BBS1;PCM1;BBS4;RPGRIP1L;IFT122;TOGARAM1;TMEM216
prerank,proteasomal protein catabolic process (GO:0010498),0.18506184558417965,0.6829587304190878,0.9907834101382489,0.9944825431783296,1.0,68/201,26.63%,FBXO45;PSMD1;BFAR;SEL1L;ZSWIM8;NEDD4;PSMD10;CRBN;PSMA5;PSMB5;BIRC2;PLAA;DNAJB12;PSMC4;PSMA4;RCN3;PSMC5;FBXW5;GSK3A;PSMB9;AREL1;TRIM2;ATXN3;RNF122;BAG6;TRIM3;HACE1;BRSK2;UBXN6;PSMA7;HECW1;UBXN2B;PSMD14;SOCS6;FEM1B;KLHL22;RNF187;PSMA2;DCAF11;ZFAND2A;CUL4A;PSMD11;RHBDD1;SPSB2;MTA1;DDB1;UBE2K;FBXL22;DDIT3;BTRC;RNF216;RMND5B;SPSB3;FAF1;NHLRC3;KIF14;CCDC47;FBXO44;SPSB1;CTNNB1;AGAP3;PSMB2;RMND5A;COP1;NR1D1;UBE4B;SKP2;KLHL42
prerank,intracellular cholesterol transport (GO:0032367),0.27888807570815555,0.6828240692206571,0.8547854785478548,0.994110302802379,1.0,5/15,19.36%,RELCH;SERAC1;LDLRAP1;OSBP;NPC2
prerank,protein acylation (GO:0043543),-0.19990246667506714,-0.6821964077347031,0.9369627507163324,0.9694527635784623,1.0,17/38,30.47%,FOXO1;ZDHHC21;ZDHHC16;ZDHHC14;ING4;ZDHHC18;ING5;CLOCK;NAA80;ZDHHC3;NAT9;GLUL;ZDHHC5;PORCN;KAT6A;ZDHHC23;ZDHHC12
prerank,polarized epithelial cell differentiation (GO:0030859),-0.26098858848134354,-0.6821327528248985,0.883177570093458,0.968884355769799,1.0,2/13,5.90%,EZR;CDC42
prerank,B cell activation involved in immune response (GO:0002312),0.28815225881594364,0.6817656074385748,0.8730964467005076,0.9946856325321431,1.0,4/13,19.62%,GPR183;RNF168;MSH6;CD180
prerank,monosaccharide transmembrane transport (GO:0015749),0.2690399949770829,0.6814726864463322,0.8506493506493507,0.9944769447459237,1.0,16/16,73.12%,SLC2A9;SLC45A3;SLC2A7;SLC2A8;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC2A6;SLC5A3;SLC50A1;SLC23A1;SLC23A2;SLC2A2;SLC2A12
prerank,histone H2A ubiquitination (GO:0033522),0.2700710212093423,0.6811637950442916,0.8661290322580645,0.9942748753698025,1.0,3/17,9.25%,BCOR;TRIM37;RNF168
prerank,positive regulation of isotype switching (GO:0045830),0.27376118503401387,0.6810061636360635,0.87,0.9939249972898575,1.0,4/15,18.77%,CD40;HMCES;PAXIP1;RIF1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.22456212642843876,-0.6808542824619785,0.9171270718232044,0.9693501028249286,1.0,3/23,5.15%,SLIT2;DPP4;RAC1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.20015057237578676,0.6803295206425383,0.9529262086513995,0.9935896160741058,1.0,14/104,14.07%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,cellular response to lectin (GO:1990858),0.20015057237578676,0.6803295206425383,0.9529262086513995,0.9935896160741058,1.0,14/104,14.07%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,glycine transport (GO:0015816),0.30938947286583124,0.6795070048983511,0.8434622467771639,0.9938924653987238,1.0,4/10,25.72%,SLC7A8;SLC25A38;SLC6A5;SLC36A1
prerank,positive regulation of rRNA processing (GO:2000234),0.30731906064573716,0.6792015560125269,0.8247787610619469,0.9936766422943273,1.0,5/10,27.62%,UTP15;DIMT1;HEATR1;RIOK2;WDR43
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.1998088966628459,-0.6791949309288707,0.9563953488372093,0.9700981413367303,1.0,14/35,29.64%,PRKDC;CDK6;MAPK14;ETS1;TAL1;HMGB2;ABCB10;ACVR2A;HSPA1A;SPI1;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.19941031968008377,0.6783468365734596,0.9569074778200254,0.9940041903598209,1.0,14/105,14.07%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.27977132415951855,-0.6783328508363244,0.8915094339622641,0.970185825236063,1.0,3/11,17.57%,RENBP;UAP1;UAP1L1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.1958662180764049,0.678077934462636,0.9734513274336283,0.99378079242993,1.0,9/112,10.91%,IL33;WNT5A;NR1H4;PTPN22;CIDEA;TWIST1;TLR4;CYBA;PYCARD
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.23948008436924342,-0.6779160490896204,0.9015151515151515,0.9698842242323995,1.0,4/17,15.56%,STX1A;KCNB1;SLC4A8;RAB3D
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.24977417264842167,0.6778438981719045,0.8843843843843844,0.9935139305450778,1.0,6/27,17.96%,CALCA;HTR2C;LPAR1;F2R;GPR35;GRM1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.20808698194117925,-0.6775731378150688,0.9348441926345609,0.969544835041285,1.0,14/29,40.06%,PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;DBI;PLA2G4C;LPCAT2;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4;PLBD1;PLB1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.24962260715999338,-0.6762544293821823,0.8995215311004785,0.9700499908860399,1.0,3/17,16.77%,SLC7A5;PRKCZ;HAVCR2
prerank,response to acidic pH (GO:0010447),0.2843043479936653,0.6751446260526603,0.8816,0.9957017736626075,1.0,3/13,16.02%,SLC9A1;LGMN;IMPACT
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.2693367602241036,-0.6749326075473555,0.880184331797235,0.9705362281092879,1.0,2/11,6.65%,ITPKB;IP6K2
prerank,protein targeting (GO:0006605),0.19273115372325933,0.673719648035964,0.9709962168978562,0.9966200633140869,1.0,28/118,21.73%,RTP4;TIMM10;DNAJC19;CACNG3;SORL1;PRKCI;SEC63;ZDHHC24;SRPRA;PITRM1;TIMM44;AKAP6;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;LTBP2;ZFAND2A;ZDHHC9;PEX6;KIF13B;HOMER3;RABGEF1;MICALL1;MFN2;FUT10;GDAP1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.23054341126796762,0.6737031142951484,0.9107142857142857,0.9961117229174602,1.0,13/35,25.53%,BOD1;PPP6R2;MTOR;PTPA;HSP90B1;CRY2;TSC1;PPP6R3;PDGFRB;BOD1L1;NUAK1;STYXL1;CALM2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23166751181084638,0.6725906953662667,0.8974739970282318,0.9966963423764377,1.0,14/38,26.70%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,histone H3 acetylation (GO:0043966),0.22738268144243529,0.6725714901897878,0.9149253731343283,0.9961998421785243,1.0,11/40,20.15%,TAF12;WDR5;BRCA2;KAT2A;JADE1;POLE3;LDB1;KAT7;TAF10;MBIP;SUPT7L
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.24328836052042502,-0.6725166291072706,0.9020618556701031,0.9718696278460948,1.0,5/17,21.03%,ALG9;ALG12;MPDU1;NUS1;DOLPP1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.28723475961423955,0.6722045881682251,0.871499176276771,0.9960310198477956,1.0,3/13,12.81%,PSMD10;TWIST1;PTTG1IP
prerank,cellular response to leucine starvation (GO:1990253),0.3118027303735553,0.6717820083528191,0.8315412186379928,0.9959322159009073,1.0,3/10,18.15%,MTOR;IMPACT;RRAGD
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2097623903247097,-0.6717727911196572,0.944,0.9718646076974273,1.0,9/27,30.15%,SIRPA;CD44;ETS1;MDK;SKAP1;HSPD1;ITGB2;HAS2;CCR2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2365140148563965,0.6717037670949767,0.9006309148264984,0.9954840306850755,1.0,7/32,18.53%,CLIP3;STMN2;NAV3;STMN1;CLASP2;CLASP1;SPEF1
prerank,insulin secretion (GO:0030073),0.2614041704978934,0.6713014464875106,0.8866666666666667,0.9953711165143697,1.0,2/19,6.62%,PTPRN2;RIMS2
prerank,lysosome localization (GO:0032418),0.23085594605223855,0.6712237197682114,0.9180327868852459,0.9949318398900027,1.0,7/37,19.53%,RAB34;KXD1;ARL8B;TFEB;VPS33B;PIK3CG;PLEKHM2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.24203161884242408,0.6707262774048596,0.917057902973396,0.994883143879255,1.0,6/30,19.54%,OGT;EIF3H;FHIT;BAG6;USP14;DDRGK1
prerank,regulation of JUN kinase activity (GO:0043506),-0.20457612815707085,-0.6692510282928639,0.9369369369369369,0.973273138178368,1.0,7/33,17.50%,MAP3K5;HIPK3;PPEF2;MAP3K4;MAPK8IP1;EDN1;MAP3K10
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2739703729486643,0.6691280279056788,0.8727272727272727,0.9959196739311387,1.0,2/15,10.61%,TCF7L2;TP53
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.2459450848393758,-0.6688595762419591,0.9040767386091128,0.9729336742311497,1.0,9/16,35.46%,TRIB2;TYROBP;JAK3;VSIR;FCGR2B;DLL1;AGER;LILRB1;CD274
prerank,mitochondrial translational elongation (GO:0070125),0.20198307808589439,0.6687408559687159,0.9566360052562418,0.9957859710120105,1.0,30/88,28.51%,MRPL44;MRPS31;MRPS24;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;MRPL14;MRPL32;GFM1;CHCHD1;MRPL12;MRPL1;MRPL47;MRPS11
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.296847132027583,0.6686366380015677,0.8791208791208791,0.9953681772080369,1.0,2/11,9.11%,PWP1;MTOR
prerank,ubiquinone metabolic process (GO:0006743),0.27667754454872406,0.6684303982490033,0.8735244519392917,0.9950628237845968,1.0,5/15,19.09%,COQ3;AIFM2;PDSS2;COQ8B;COQ7
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.28116512692635515,-0.6679713571216719,0.8923076923076924,0.9730309127116289,1.0,2/10,7.13%,PDGFA;TBX1
prerank,modulation by host of symbiont process (GO:0051851),0.23830893294300567,0.6679567566142375,0.9131782945736434,0.9950101234298235,1.0,8/31,20.00%,HDAC1;REST;SNW1;SAP30;TFAP4;RRP1B;SP1;TAF11
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.25011633836232716,-0.667579482574825,0.8791469194312796,0.9727268542455618,1.0,6/15,30.13%,CCT3;CCT4;CCT7;RUVBL2;NHP2;RUVBL1
prerank,secretory granule organization (GO:0033363),-0.2855835998887644,-0.6674582261662212,0.8691588785046729,0.9722065163648929,1.0,1/10,3.41%,SRGN
prerank,smoothened signaling pathway (GO:0007224),0.23918372715879757,0.6672131296960714,0.9251497005988024,0.9952155486683198,1.0,5/32,10.59%,PTCH2;PTCHD1;GLI1;GLI3;TCTN2
prerank,response to iron ion (GO:0010039),-0.26504739378124353,-0.6671970973238242,0.8795811518324608,0.971786416044767,1.0,4/12,24.08%,B2M;ACO1;HFE;SLC11A2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.24814063302281184,-0.6670667292505269,0.8942065491183879,0.9712554977965605,1.0,8/14,39.86%,DDX60;ANKRD17;ZDHHC5;PUM1;OASL;TLR5;TLR3;TLR2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.25671945300896704,-0.6665320764092904,0.9025522041763341,0.9710630549041277,1.0,5/13,24.35%,ECSIT;HDAC6;OXA1L;MT3;NOD2
prerank,regulation of gene silencing by RNA (GO:0060966),0.21557389335213195,0.6664221901669277,0.9324712643678161,0.9949095893578518,1.0,13/50,23.31%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;NUP54;AGO1;NUP155;POLR2L;RANBP2;IPO8;NUP35
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21557389335213195,0.6664221901669277,0.9324712643678161,0.9949095893578518,1.0,13/50,23.31%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;NUP54;AGO1;NUP155;POLR2L;RANBP2;IPO8;NUP35
prerank,regulation of vasculature development (GO:1901342),0.24444182064083303,0.6663842765001887,0.8944,0.9944273262522737,1.0,3/26,9.31%,ADGRA2;NF1;SP100
prerank,peptide hormone secretion (GO:0030072),0.24457421459202028,0.6663615344721079,0.905940594059406,0.9939379077892079,1.0,2/26,6.62%,EDN3;RIMS2
prerank,RNA 3'-end processing (GO:0031123),0.20821274255667657,0.6659850524186733,0.9507523939808481,0.9937779504648594,1.0,13/69,17.44%,EIF4A3;LIN28B;THOC7;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SYMPK;SRSF9;THOC5;SRSF6
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.22130521214291726,-0.66582180932483,0.9242424242424242,0.9709883802427662,1.0,5/23,15.12%,HACD1;FAR2;ACSL4;ELOVL7;ACSL5
prerank,intracellular pH reduction (GO:0051452),0.23081269293925055,0.6657961900674785,0.9052631578947369,0.9934252050046244,1.0,9/33,23.57%,RAB20;CLCN3;ATP6V0E1;ATP6V0D1;ATP6V1G2;GPR89A;GPR89B;ATP6V0B;DMXL1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.28844431264430986,0.6642287462712959,0.9097472924187726,0.9943922312328906,1.0,3/12,21.94%,ELOVL2;ELOVL1;ELOVL5
prerank,Golgi ribbon formation (GO:0090161),-0.25509622070865756,-0.6639474204834599,0.9017467248908297,0.9717966288848459,1.0,4/13,22.19%,VTI1A;OPTN;FHDC1;MYO18A
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.264752694567411,-0.6637060477646063,0.9024390243902439,0.9713741898730023,1.0,6/12,32.75%,ERLIN1;CEACAM1;SIRT1;BRCA1;TRIB3;APOC1
prerank,early endosome to Golgi transport (GO:0034498),-0.26959654282927004,-0.6636915094932544,0.8861047835990888,0.9707641397852165,1.0,5/11,28.34%,SURF4;LMAN1;RAB6A;SNX2;STX5
prerank,methylguanosine-cap decapping (GO:0110156),0.3004774824966597,0.6615707881642613,0.8629173989455184,0.9963566276893953,1.0,2/10,13.47%,EDC3;EDC4
prerank,myeloid dendritic cell activation (GO:0001773),0.2910404401394748,0.6613745885447324,0.8834459459459459,0.9960345336151735,1.0,2/12,10.91%,CAMK4;PYCARD
prerank,cholesterol efflux (GO:0033344),-0.22933299874956356,-0.6612006208188304,0.920844327176781,0.9720532557293075,1.0,3/20,12.84%,SCARB1;APOE;SOAT1
prerank,DNA replication checkpoint signaling (GO:0000076),0.2719773693705194,0.6605890352936196,0.8775510204081632,0.9962240087970698,1.0,2/16,12.29%,TIPIN;CDT1
prerank,negative regulation of cartilage development (GO:0061037),-0.25372889310777963,-0.6605757719572036,0.9115479115479116,0.9719231523294454,1.0,8/13,31.99%,WNT9A;PTHLH;EFEMP1;WNT11;CHADL;GREM1;ADAMTS7;SNAI2
prerank,response to interferon-alpha (GO:0035455),0.27316480119917064,0.6605439944402971,0.8752107925801011,0.9957439534263488,1.0,5/16,19.64%,PDE12;AXL;EIF2AK2;ADAR;RO60
prerank,regulation of trophoblast cell migration (GO:1901163),0.2782496275535142,0.660384811446534,0.8752079866888519,0.9953711081158964,1.0,3/14,18.21%,GJA1;CALR;SYDE1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2371210596427198,0.659217793167342,0.9152,0.9959021258349535,1.0,8/31,15.89%,LSM4;EDC3;EXOSC9;DIS3L2;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,positive regulation of myelination (GO:0031643),-0.2764348593060876,-0.6589962574643736,0.8888888888888888,0.9724972318406946,1.0,2/11,6.78%,PARD3;DICER1
prerank,response to UV-A (GO:0070141),0.2816504830491297,0.6589370354421733,0.8794567062818336,0.9956482825676418,1.0,1/14,1.67%,PPID
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.297992521033572,0.6587638851908921,0.8579136690647482,0.9952881492541782,1.0,2/11,13.23%,KCNIP2;AKAP6
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.24319324093869177,-0.6587151673234521,0.9122807017543859,0.9720733339433818,1.0,9/15,47.10%,SYN3;ZDHHC3;ZDHHC12;ADRA1A;HAP1;STXBP1;NPAS4;NPS;DRD2
prerank,protein tetramerization (GO:0051262),0.20254767324051653,0.6583883853720535,0.9569444444444445,0.995114978348032,1.0,13/67,18.60%,TRPA1;GRIN2B;GOLGA2;APPL2;HSD17B8;HCN1;NUDT21;TRPM2;RYR3;USP16;MCOLN1;ALDH9A1;SSBP1
prerank,RNA modification (GO:0009451),0.20863485184069258,0.6582628149562979,0.9613180515759312,0.9947138961496552,1.0,15/54,24.78%,NAT10;CTU1;QTRT2;TRMT61A;PUS7;WDR4;METTL1;ADAR;NSUN3;RBM15;LCMT2;NSUN5;AARS1;SSB;NSUN6
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2290990155953748,0.6565518763773727,0.9322289156626506,0.9957279936990168,1.0,6/37,15.91%,OGT;EIF3H;PDCL3;FHIT;BAG6;CSNK2A2
prerank,cellular response to interferon-beta (GO:0035458),-0.2502092796072495,-0.6564990765012259,0.9032258064516129,0.9730311097753901,1.0,7/14,29.08%,IRF1;CDC34;IFITM2;NDUFA13;PNPT1;TRIM6;IRGM
prerank,mRNA 3'-end processing (GO:0031124),0.20313352928390013,0.6555208515758026,0.9619047619047619,0.9960945675601061,1.0,18/78,20.65%,EIF4A3;THOC7;LSM11;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SLBP;SYMPK;SRSF9;THOC5;SRSF6;PAPOLB;CHTOP;CDC73;DDX39B
prerank,striated muscle contraction (GO:0006941),0.20960435360982355,0.6553946591495579,0.9534883720930233,0.9956909207840505,1.0,3/53,4.25%,ATP1A2;RYR2;SCN2B
prerank,mitotic metaphase plate congression (GO:0007080),0.2159781990507145,0.655268445602059,0.9433701657458563,0.9952876877924913,1.0,11/51,18.72%,BOD1;DCTN2;CENPE;SPDL1;RMDN1;CENPC;CDT1;RRS1;CEP55;VPS4B;KPNB1
prerank,regulation of T cell proliferation (GO:0042129),-0.17123941643261079,-0.6546847220399162,0.9824561403508771,0.9736857384796136,1.0,7/61,11.77%,ANXA1;IL6ST;SLC7A1;TFRC;NCK1;SDC4;DLG5
prerank,protein localization to centrosome (GO:0071539),0.26053120746318975,0.6546326995260721,0.8841059602649006,0.9953372012854084,1.0,7/17,25.80%,DCTN2;CEP192;PCM1;NUDCD3;BBS4;GOLGB1;CCDC14
prerank,calcium ion import across plasma membrane (GO:0098703),0.27960300673444644,0.6544783669662572,0.8715753424657534,0.994964434946116,1.0,3/14,15.77%,TRPV3;TRPM2;CACNA2D1
prerank,negative regulation of locomotion (GO:0040013),0.2828283885853901,0.6543185857655013,0.8776978417266187,0.994599625884342,1.0,3/12,18.40%,SPOCK3;CRK;FBLN1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.21916641395564357,-0.6538718080629538,0.9205479452054794,0.9736443588539118,1.0,4/22,11.42%,SLC16A2;NES;GATA2;MDK
prerank,positive regulation of cell aging (GO:0090343),0.2871318812213912,0.6538017308089037,0.8765432098765432,0.994532719612402,1.0,1/11,2.62%,CDKN2A
prerank,negative regulation of innate immune response (GO:0045824),0.22875890644172747,0.6537807779791404,0.9368575624082232,0.9940434098636074,1.0,6/34,17.52%,SUSD4;DHX58;LYAR;FAM3A;CNOT7;A2M
prerank,acute-phase response (GO:0006953),-0.25219807176900905,-0.6533383454527363,0.891156462585034,0.9734189692973529,1.0,3/12,23.43%,LBP;IL22;SIGIRR
prerank,relaxation of muscle (GO:0090075),0.2808307426759886,0.6517464561512559,0.8787878787878788,0.995258307515831,1.0,2/13,11.18%,ATP1A2;P2RX4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2529778076711532,0.6515956445459617,0.8916666666666667,0.994361343825453,1.0,2/20,7.45%,GSTO2;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.2529778076711532,0.6515956445459617,0.8916666666666667,0.994361343825453,1.0,2/20,7.45%,GSTO2;GSTA3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.22328778851888714,-0.650879028010518,0.9352331606217616,0.9744509587010911,1.0,5/19,16.30%,HIPK1;DYRK2;HIPK2;SIRT1;TMEM109
prerank,aspartate family amino acid metabolic process (GO:0009066),0.25739982921562127,0.6501602019942468,0.8888888888888888,0.9950668664329994,1.0,8/18,25.74%,ASPA;NAT8L;FOLH1;MSRA;ASPG;MTHFD1;NAALAD2;SMS
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23259055845285742,0.6500213324319666,0.9017160686427457,0.9946651198546551,1.0,6/33,17.00%,LSM11;NUDT21;SLBP;SNRPF;SYMPK;MAZ
prerank,B cell mediated immunity (GO:0019724),0.2946346299288904,0.6499673381042474,0.8558052434456929,0.994199429706805,1.0,1/10,6.38%,TLR8
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.26652089590777905,0.6496223367353472,0.8811881188118812,0.9940039157574947,1.0,3/15,15.04%,ADGRV1;SCN1A;PDZD7
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2512850262123634,-0.646983789676032,0.9078014184397163,0.9766073034346362,1.0,3/13,17.57%,RENBP;UAP1;UAP1L1
prerank,nuclear transport (GO:0051169),0.2620443136671558,0.6463070028269583,0.906896551724138,0.9962874407175499,1.0,2/16,5.60%,AAAS;NUTF2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.2468844167766875,-0.6462299882916345,0.8949880668257757,0.9764774054495275,1.0,2/14,15.22%,IL6ST;PTGS2
prerank,phosphatidylserine metabolic process (GO:0006658),0.23046759198113684,0.6458438715536812,0.9239766081871345,0.9961761454452318,1.0,6/32,14.68%,SERINC1;ABHD16A;ABHD12;PTDSS2;SERINC5;PLA2G12A
prerank,RNA destabilization (GO:0050779),0.260597806554148,0.6454319820363846,0.8914473684210527,0.9960007412278565,1.0,5/18,18.69%,RBM24;LIN28B;FTO;DXO;YTHDF1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.2592833661232024,0.6441670591354764,0.8954983922829582,0.9965227462991001,1.0,3/17,12.65%,RYR2;KCNE4;KCNJ8
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2890084212647914,0.6440357105078239,0.8891050583657587,0.9961309806098204,1.0,4/10,24.38%,UBE2G2;YOD1;UBE2J1;OS9
prerank,regulation of microglial cell activation (GO:1903978),-0.2363761928679056,-0.6440339302513323,0.9223300970873787,0.97727034419157,1.0,15/15,76.39%,CX3CL1;TTBK1;TREM2;STAP1;CST7;TAFA3;IL6;CCL3;GRN;SYT11;LDLR;MMP8;SPHK1;NR1D1;PTPRC
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.202111345404698,-0.6435807800128693,0.9708222811671088,0.9769442181436906,1.0,8/28,30.15%,SIRPA;PRKDC;TICAM1;TYROBP;HSPD1;NOD2;NCKAP1L;CCR2
prerank,negative regulation of cation channel activity (GO:2001258),0.23806289689132626,0.6434599080374178,0.9272445820433437,0.9960876531026283,1.0,3/26,8.56%,FMR1;KCNAB1;GNB5
prerank,regulation of actin filament-based movement (GO:1903115),0.29186130611468664,0.6431795116440711,0.8677536231884058,0.9958065670349787,1.0,1/10,2.74%,PDE4B
prerank,protein destabilization (GO:0031648),-0.1965542248612851,-0.6430868170946737,0.9567567567567568,0.9766700021743412,1.0,6/32,16.68%,GSN;SOX17;CTSH;CCDC88C;SIRT1;CUL3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.24772924697847593,0.6428997656506252,0.9406919275123559,0.9955063275209515,1.0,8/22,23.90%,PWP1;LYAR;MTOR;UTP15;EIF2AK3;HEATR1;DHX33;ATF4
prerank,negative regulation of protein metabolic process (GO:0051248),0.21060103464160282,0.6428219764314963,0.9518413597733711,0.9950637673754658,1.0,8/48,15.09%,ITGAV;ADGRB1;FLOT2;MDM4;EIF2AK1;IAPP;SNX12;CLU
prerank,positive regulation of cellular protein localization (GO:1903829),0.2003816222307028,0.6426142086678068,0.9671232876712329,0.9947147786031364,1.0,16/69,19.54%,GNL3;NGFR;NECAB2;FYN;GAS8;CDT1;ENTR1;MEAK7;CEP250;FERMT2;GPR137B;KAT7;ORMDL3;EIF2AK3;TRAPPC12;DDRGK1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.30046466606886263,0.64185176795855,0.8687392055267703,0.9948147588992909,1.0,2/10,12.41%,PTPN22;PDCD4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.22938569811980902,0.6413249298940645,0.915625,0.9947272583597931,1.0,5/28,16.75%,ABITRAM;FCHSD2;ARHGAP35;CTTN;HAX1
prerank,regulation of defense response to virus by host (GO:0050691),0.22808135002130375,0.6411746065361831,0.9385113268608414,0.9943459194746747,1.0,8/30,25.32%,PTPN22;IFNLR1;TRIM44;DHX9;RNF216;STAT1;TRAF3IP2;AIM2
prerank,positive regulation of protein acetylation (GO:1901985),0.28534537989353137,0.6410449259519511,0.8739054290718039,0.9939513125038267,1.0,2/12,7.99%,CEP295;FAM161A
prerank,axonal transport (GO:0098930),0.22228476001961825,0.6409902088700774,0.9414414414414415,0.9934932719826322,1.0,10/36,22.83%,TMEM108;AP3M1;OPA1;SYBU;AP3D1;HIF1A;KIF3A;KIF1B;AP3B2;BLOC1S6
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.27749036028406143,0.6404547835641125,0.8968692449355433,0.9934356561887099,1.0,1/12,6.06%,LIN28B
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.296990947006732,0.6403299838004666,0.8774422735346359,0.9930311123414969,1.0,3/10,17.15%,IGF2;KDM1B;DNMT3A
prerank,amino sugar biosynthetic process (GO:0046349),-0.25503500627654707,-0.639844657565699,0.9051094890510949,0.9781210167116939,1.0,3/12,17.57%,RENBP;UAP1;UAP1L1
prerank,cellular respiration (GO:0045333),0.21895358202504175,0.6395462586082402,0.9497041420118343,0.9931548858203467,1.0,7/41,16.19%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14;NDUFS4
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2244300581497674,0.6394718272389993,0.9453717754172989,0.9927069582498531,1.0,4/36,10.27%,OGT;EIF3H;OPHN1;FHIT
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2759289194146822,0.6392508717398482,0.8858695652173914,0.9923811171526358,1.0,2/12,12.02%,TLR4;SOX9
prerank,lung epithelium development (GO:0060428),-0.26470767417661517,-0.6389105454965534,0.9128440366972477,0.9781004541835429,1.0,2/10,14.79%,ERRFI1;STRA6
prerank,peptidyl-lysine methylation (GO:0018022),-0.20656486476531177,-0.6385887884046173,0.9656992084432717,0.977650018690072,1.0,3/26,11.45%,SMYD3;SMYD2;EEF2KMT
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.24209851432730414,0.638195323885998,0.919093851132686,0.9927200887277642,1.0,5/23,20.79%,ACOT7;ELOVL6;ALOX5;ACSBG1;GSTM1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.21214225796885555,-0.6376922872141775,0.9530864197530864,0.9775644004590194,1.0,9/21,30.22%,YWHAB;GSK3B;PPP1R16B;PPP4R4;PPP1R11;MFHAS1;ENSA;FKBP1A;PPP1R15A
prerank,anterograde synaptic vesicle transport (GO:0048490),0.262933569212845,0.6369480308968815,0.8963210702341137,0.9926832093289475,1.0,8/15,30.60%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1;SNAPIN;BLOC1S5;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.262933569212845,0.6369480308968815,0.8963210702341137,0.9926832093289475,1.0,8/15,30.60%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1;SNAPIN;BLOC1S5;AP3M2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.27140899526844564,-0.6363942227377714,0.9168591224018475,0.9777441273192131,1.0,2/10,17.54%,SMYD2;EEF1AKMT2
prerank,peptidyl-lysine acetylation (GO:0018394),0.28937482517043334,0.6359438219710499,0.8952042628774423,0.9929535913604475,1.0,4/10,21.85%,KAT2A;BAG6;KAT7;CREBBP
prerank,melanosome organization (GO:0032438),0.23929773858729947,0.6356587131097038,0.9173419773095624,0.9926718087169548,1.0,4/26,13.40%,HPS1;RAB29;ABCB6;AP3D1
prerank,regulation of protein neddylation (GO:2000434),-0.2713441868455059,-0.6352101053524405,0.9158653846153846,0.9778334574939497,1.0,4/10,20.00%,RPL5;RPL11;DCUN1D3;COPS9
prerank,response to UV-B (GO:0010224),-0.25130635162342785,-0.6351650628974235,0.90625,0.9772483745241445,1.0,8/12,36.07%,CRIP1;HYAL1;CDKN1A;MME;HYAL2;MSH2;HYAL3;RELA
prerank,glycoprotein catabolic process (GO:0006516),-0.23158591747380486,-0.6346950177426833,0.9244851258581236,0.9768922753441878,1.0,5/17,19.06%,OGA;MANBA;NGLY1;EDEM1;STT3B
prerank,nucleosome organization (GO:0034728),0.20227197788710596,0.6346556933301549,0.9550072568940493,0.9929270397486374,1.0,15/55,22.20%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;SOX9;POLE3;BPTF;DMAP1;SMARCD2;MCM3AP;LIN54;ATRX;ZNHIT1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.23786642117106324,0.6344179792933622,0.9205834683954619,0.9926210497354161,1.0,5/22,17.34%,NEDD4;PLAA;TSG101;SNF8;VPS4B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.23081440345109674,0.6312637091165252,0.9363057324840764,0.9944448245536427,1.0,5/28,15.82%,STMN2;STMN4;STMN1;CLASP2;CLASP1
prerank,calcium ion import into cytosol (GO:1902656),0.26398845311473473,0.6311866398900513,0.8993399339933993,0.9939936896203154,1.0,3/15,15.77%,TRPV3;TRPM2;CACNA2D1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.26568820889082007,0.631039469980012,0.9117647058823529,0.9935984951259369,1.0,3/14,9.24%,ERH;DHODH;DPYS
prerank,cellular response to hydroxyurea (GO:0072711),-0.26955501441272595,-0.6308143404310163,0.9015317286652079,0.9786625042357376,1.0,3/10,16.20%,DDI2;DDX11;NSMCE3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.23669387303969486,0.6305751517313608,0.9300155520995335,0.9934556683362571,1.0,4/23,11.85%,GJA1;GPSM2;SPDL1;INSC
prerank,detection of mechanical stimulus (GO:0050982),0.24678364389482954,0.6302716244209516,0.9263502454991817,0.9931711309507695,1.0,2/19,7.71%,JUP;PTK2
prerank,positive regulation of immune response (GO:0050778),0.19765401893299211,0.629826192040597,0.9719495091164095,0.9929736933177893,1.0,9/64,17.31%,HRG;TLR8;AKIRIN2;CYBA;PYCARD;CD81;DHX9;LGALS9;ADAM8
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2468409638012629,-0.6295076343583106,0.9076212471131639,0.9788262461747613,1.0,3/13,10.44%,NCK1;DNAJB9;PTPN1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2108600198179603,0.6293611490943973,0.9536231884057971,0.992794330896769,1.0,11/44,18.45%,FCHSD2;CARMIL2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;SPIRE1;VASP;CDC42EP3
prerank,negative regulation of T cell differentiation (GO:0045581),0.28467839415961704,0.6287589319934361,0.8932384341637011,0.992725409922587,1.0,2/10,10.74%,GLI3;ZC3H8
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.284546175022951,0.6286462609859187,0.8787878787878788,0.9923006728771271,1.0,4/11,22.52%,ASF1A;UBN1;ATRX;IPO4
prerank,nucleocytoplasmic transport (GO:0006913),0.21345003139336038,0.6282203588256018,0.9374045801526718,0.9921232221559227,1.0,12/40,25.56%,GEMIN2;AAAS;NUTF2;SNUPN;NXT2;SNRPF;GEMIN8;XPO1;MALT1;GEMIN5;GEMIN7;SNRPG
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.20821266202695302,-0.6280084295197278,0.952755905511811,0.9790897443914539,1.0,13/23,43.85%,MAP3K5;MAP3K4;EDN1;MAP3K10;DUSP19;TRAF2;FZD10;SASH1;RPS3;MAP3K7;DAB2IP;ARHGEF5;TAOK3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.24305344956758573,0.6279932011357602,0.9093904448105437,0.9917801511581404,1.0,8/20,27.04%,ATP2A2;HERPUD1;BAK1;PACS2;FIS1;CCDC47;SELENOK;BCAP31
prerank,vitamin D metabolic process (GO:0042359),0.26555867627935625,0.6279787628182588,0.8940397350993378,0.9912965000473488,1.0,2/13,16.48%,LGMN;CYP2R1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.26691727966874834,0.6277019930670208,0.912828947368421,0.9910046130162794,1.0,2/14,9.67%,DUSP1;PPP2R2A
prerank,erythrocyte development (GO:0048821),0.2879662938521324,0.6274954327060785,0.889090909090909,0.9906456677805066,1.0,3/10,16.25%,LYAR;MED1;ZBTB7A
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1983042407057517,-0.626349665726736,0.9558441558441558,0.9794380975730961,1.0,11/25,32.54%,PTGES3;HSPA8;GAK;DNAJB5;DNAJB1;HSPA14;HSPA1A;HSPA1B;DNAJB4;HSPA2;SDF2L1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.24160707266752762,-0.6260445655628066,0.9343065693430657,0.9790012538771853,1.0,2/13,7.77%,STX1A;KCNB1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2296923882501869,0.6253810956547906,0.93042071197411,0.9916147242231657,1.0,6/25,18.37%,PER2;TWIST1;NSD1;DOT1L;ZBTB7A;HEY1
prerank,negative regulation of DNA recombination (GO:0045910),0.20767626801005845,0.6252121503599282,0.9663608562691132,0.9912432444031253,1.0,10/43,22.12%,POLQ;MSH3;TERF1;DAXX;MSH6;FBH1;RIF1;TERF2IP;POLR2L;ATRX
prerank,DNA geometric change (GO:0032392),0.2344042876931247,0.6239648516907047,0.9185667752442996,0.9916049301611558,1.0,8/24,22.28%,HNRNPA2B1;PIF1;DHX36;RECQL;DHX9;WRN;DDX1;HMGB1
prerank,regulation of rRNA processing (GO:2000232),0.25212039656658497,0.6238667262107187,0.9071310116086235,0.9911813538832469,1.0,7/16,27.62%,UTP15;DIMT1;SHQ1;HEATR1;RIOK2;USP36;WDR43
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.203785140298548,-0.6231872583700773,0.9617486338797814,0.97999969062346,1.0,12/25,35.61%,TNFSF10;BAD;BAX;BID;GPER1;PPIF;BCL2L11;BIK;DNM1L;BMF;HRK;PMAIP1
prerank,relaxation of cardiac muscle (GO:0055119),0.2682670570964299,0.6225521510666657,0.9128113879003559,0.9915838863793204,1.0,2/13,11.18%,ATP1A2;P2RX4
prerank,transcription by RNA polymerase III (GO:0006383),-0.19849810059293094,-0.6219250401069848,0.9645776566757494,0.9800724211977315,1.0,10/27,32.21%,SNAPC3;CRCP;POLR3G;GTF3C6;POLR3K;GTF3A;ICE1;POLR2K;SNAPC2;GTF3C5
prerank,histone H2B ubiquitination (GO:0033523),0.2779993917183454,0.6217744744825452,0.9036608863198459,0.9916039219142657,1.0,1/10,4.62%,RNF40
prerank,regulation of histone methylation (GO:0031060),0.2631840680162789,0.6209426510831471,0.9029126213592233,0.991672000577143,1.0,3/13,19.19%,NSD1;AASS;CHTOP
prerank,steroid hormone biosynthetic process (GO:0120178),0.22252587441988403,0.6204189069241425,0.9389880952380952,0.9915192910764462,1.0,5/29,17.79%,HSD17B8;MED1;AKR1B1;HSD17B11;HSD17B2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.26004885028887026,0.6204154487529645,0.9173693086003373,0.9910293284797148,1.0,3/14,16.01%,MRNIP;ACTR2;MMS19
prerank,negative regulation of transmembrane transport (GO:0034763),0.28358525988626615,0.6202936826346048,0.9135593220338983,0.9906280529615872,1.0,2/10,9.17%,IRS2;PRKCB
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.2363395341924296,-0.6197316910946673,0.91324200913242,0.9806201327059618,1.0,2/13,10.66%,DAB2;SH2B1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.22352064252185738,0.618919258697052,0.9436392914653784,0.9910573184603467,1.0,7/29,15.89%,LSM4;EDC3;EXOSC9;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,regulation of interferon-beta production (GO:0032648),0.20414605236693756,0.6184960185594842,0.9542097488921714,0.99084906640173,1.0,18/46,28.85%,DHX58;TLR8;TRIM56;TLR4;PYCARD;DHX9;TIRAP;POLR3A;PTPN11;RNF216;CACTIN;PPM1B;POLR3F;IFIH1;POLR3B;RELB;PTPRS;POLR3C
prerank,purine-containing compound salvage (GO:0043101),0.2648146848537293,0.6182444561416083,0.9090909090909091,0.9905300707448346,1.0,3/12,12.96%,ADK;AMPD2;DGUOK
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.23290140364128523,0.6179086048409765,0.9226973684210527,0.9902575615779051,1.0,1/22,1.70%,WNT5A
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.21567878448267058,0.6178998244525217,0.9563758389261745,0.9897718363882859,1.0,5/29,13.43%,FBXO5;LIMK1;PINK1;DCUN1D5;AXIN1
prerank,natural killer cell mediated immunity (GO:0002228),0.25375119298066984,0.617113195445713,0.9244288224956063,0.9898047397875732,1.0,3/15,22.59%,ARL8B;PLEKHM2;ULBP1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2420907959874401,0.6169198553467913,0.9343434343434344,0.9894468224381836,1.0,4/20,14.07%,PTPN22;TLR4;IRAK1;LYN
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.20260029020640535,-0.6154651478955823,0.9788359788359788,0.9822842325034512,1.0,15/23,48.45%,PVR;PIK3R6;RAET1E;ARRB2;LAMP1;AP1G1;RASGRP1;LILRB1;SLAMF6;CD226;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26345982292657666,0.6148320560509278,0.892226148409894,0.9902911890115704,1.0,1/13,3.37%,JAK1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.21097294270686684,-0.6141796305512441,0.9353099730458221,0.9823438281696323,1.0,2/20,4.60%,GCLC;GATM
prerank,regulation of histone acetylation (GO:0035065),0.21282004382910716,0.6137801666490237,0.9539877300613497,0.9904585121151002,1.0,7/33,18.84%,KMT2A;SETD5;NOC2L;PAXIP1;IWS1;BRD7;THAP7
prerank,regulation of catecholamine secretion (GO:0050433),-0.19277115102792988,-0.6136750426783598,0.9805013927576601,0.9819777415448893,1.0,3/29,7.77%,SYT9;STX1A;KCNB1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2786868798442178,0.6126709856293068,0.9077490774907749,0.9906794472990642,1.0,3/10,23.58%,AREG;ADRA2A;ADAM17
prerank,acyl-CoA biosynthetic process (GO:0071616),0.25280317119786916,0.6122956693478104,0.9141914191419142,0.9904103864143424,1.0,7/16,28.19%,HSD17B8;ACLY;SCD5;ACACA;DIP2A;PPT1;SLC25A1
prerank,regulation of calcium ion transport (GO:0051924),0.1926350269967304,0.611401662201264,0.9845722300140253,0.990473822407832,1.0,12/54,19.26%,IL16;GRAMD2A;P2RX4;STIM1;F2R;PACSIN3;CACNA2D1;STC1;ADRA2A;CAMK2A;CRACR2A;HOMER3
prerank,lipoprotein biosynthetic process (GO:0042158),0.27511435758796365,0.6109637914804393,0.8931034482758621,0.9902412133833218,1.0,6/11,29.03%,WDR45B;WIPI2;ATG10;WIPI1;PIK3C3;ATG7
prerank,reticulophagy (GO:0061709),-0.2377329043791488,-0.6107890219078308,0.9401913875598086,0.9828411357308671,1.0,4/12,22.49%,RETREG1;ATG2B;ATG2A;UFM1
prerank,mitochondrial fusion (GO:0008053),-0.21617874573895215,-0.6101771919042942,0.9578163771712159,0.9825167791165025,1.0,6/18,25.58%,MIEF1;USP30;BAX;CHCHD3;MIGA1;MIEF2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2548891269379715,0.6101398510458752,0.9140893470790378,0.990259586301643,1.0,2/14,6.13%,ADK;GMPS
prerank,anterograde axonal transport (GO:0008089),-0.18078756720574668,-0.6100469124859681,0.9822485207100592,0.9819742632733096,1.0,6/37,13.35%,MAPK8IP3;RAB21;AP3B1;HSPB1;AP3S2;TRAK2
prerank,protein localization to chromosome (GO:0034502),0.2122541037880349,0.6098380377301688,0.9605055292259084,0.9899547842471688,1.0,4/34,10.29%,BOD1;RPA1;MRNIP;SLF1
prerank,histone mRNA catabolic process (GO:0071044),-0.23284464834108276,-0.608973144317935,0.9136690647482014,0.9818938884369688,1.0,3/15,13.13%,TUT7;ERI1;ATM
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.2421121698207253,-0.6085322737425672,0.9368932038834952,0.9814800275455062,1.0,5/12,26.57%,NINL;BICD2;CCDC68;CCDC120;BICD1
prerank,response to hydroxyurea (GO:0072710),0.2733792685845331,0.6068184974854345,0.9128014842300557,0.9912571208421486,1.0,4/11,22.12%,FMR1;SPIDR;KAT7;ATRX
prerank,tRNA wobble base modification (GO:0002097),-0.22998927837615413,-0.6067145097779233,0.942643391521197,0.9817818321660784,1.0,9/14,34.97%,TRMT9B;GTPBP3;ELP3;MOCS3;KTI12;URM1;ALKBH1;ADAT2;CTU2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.21546307732271672,-0.6065508664170433,0.9646464646464646,0.9812564742085174,1.0,2/18,5.51%,FER;IL6ST
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.2334142997092723,0.6064521688526744,0.9414634146341463,0.9909744220847313,1.0,4/22,15.74%,PTPN22;APPL2;LYN;TIRAP
prerank,peptidyl-proline modification (GO:0018208),0.2274883467070949,0.6053965887315587,0.9536741214057508,0.9910729608136445,1.0,2/25,4.94%,PPID;PPIH
prerank,regulation of B cell proliferation (GO:0030888),0.1996821094814515,0.6035553411457079,0.9703389830508474,0.9916228463961232,1.0,7/44,15.74%,CD40;IRS2;GPR183;TNFRSF21;CD81;LYN;TIRAP
prerank,regulation of actin nucleation (GO:0051125),-0.23761139051140429,-0.6029119678374188,0.9533799533799534,0.9823421213650312,1.0,5/12,29.88%,GSN;ARPIN;CORO1B;ARF1;WHAMM
prerank,spliceosomal complex assembly (GO:0000245),0.1989938392891437,0.6026713376855991,0.9672830725462305,0.9916447668902743,1.0,12/46,20.65%,ZRSR2;NOL3;CELF4;LUC7L2;SRSF10;SRSF9;RBM5;SF3A3;SRSF6;DDX1;LUC7L3;DDX39B
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.26065479561209814,0.6023355435243456,0.9264214046822743,0.9913350481105053,1.0,1/13,3.91%,DUSP1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.247626773174434,0.6018078358012817,0.9175257731958762,0.9911680522391767,1.0,3/15,15.32%,TIPIN;EME2;ATF2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2167655162916627,-0.6012723563080076,0.9285714285714286,0.982461882625118,1.0,7/18,38.71%,PRKDC;PRELID1;PRDM1;NCKAP1L;CCR2;IL4I1;IKZF3
prerank,mitochondrial transport (GO:0006839),0.19192085013538518,0.6011495427000718,0.9875518672199171,0.9910367006495147,1.0,13/53,24.01%,TIMM10;DNAJC19;BCS1L;PITRM1;TIMM44;BAK1;MFN2;SLC25A16;GDAP1;SLC25A24;FIS1;BNIP3;TOMM34
prerank,glucose transmembrane transport (GO:1904659),0.23520432747875306,0.6007764335555231,0.9378330373001776,0.9907687534910808,1.0,1/18,4.00%,PPARD
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.25503549390588687,0.6007260568111276,0.9191419141914191,0.9903076134994769,1.0,4/13,24.07%,SAE1;SENP6;ATG10;UBA2
prerank,folic acid metabolic process (GO:0046655),0.24132559518576266,0.6005583439656257,0.9372881355932203,0.9899083912983312,1.0,6/18,24.37%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2707113056578482,0.6002977191620825,0.9267399267399268,0.9895752622361927,1.0,4/10,21.51%,MAP2K1;LYN;RNF13;MAPK1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.23291544299452321,-0.600144509002148,0.9465116279069767,0.9823431920205228,1.0,6/12,30.20%,ADSS2;LHPP;PFAS;ATIC;PPAT;PAICS
prerank,translational elongation (GO:0006414),-0.14328722294137697,-0.6000255227030891,1.0,0.9817820311055081,1.0,37/101,33.21%,EEF1G;MRPL39;EEF1A1;EEF2K;EEFSEC;EEF1D;MRPS7;GTPBP1;MRPS17;MRPL15;MRPL20;MRPL16;MRPS18A;MRPL2;GADD45GIP1;MRPS18B;MRPL58;MRPL24;OXA1L;MRPL57;MRPL55;PTCD3;MRPS34;MRPL36;MRPL35;MRPS12;MRPL34;MRPL38;MRPS9;MRPS2;MRPL18;GTPBP2;TUFM;MRPL11;MRPS14;MRPL9;MRPS33
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.25409801712492447,0.5980727309515579,0.9195979899497487,0.9902466950847897,1.0,4/14,19.54%,BFAR;HSPA5;BAK1;DDRGK1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.23901443798336863,0.5969151666746575,0.9340277777777778,0.9903881075105032,1.0,7/18,23.83%,ELOVL2;ACSL6;ELOVL6;ELOVL1;ACSBG1;ELOVL5;TECR
prerank,negative regulation of cell division (GO:0051782),0.26818625912532607,0.5957099795486404,0.9312839059674503,0.9905174532942495,1.0,1/11,3.05%,SUSD2
prerank,microglial cell activation (GO:0001774),0.23141001488730856,0.5953675343535829,0.947986577181208,0.990212355094065,1.0,2/21,7.19%,C5AR1;C1QA
prerank,mesenchyme development (GO:0060485),0.24567955719958856,0.5950169846664924,0.9303571428571429,0.9899015968258138,1.0,4/15,18.02%,BMP7;TGFBR1;FGFR2;BMP2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.23637735946095126,0.5933571158726936,0.9565217391304348,0.990293453526295,1.0,6/19,24.37%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,purine nucleotide metabolic process (GO:0006163),0.2211212517197278,0.5931506782012934,0.9523809523809523,0.989922158719728,1.0,4/24,10.64%,ITPA;FHIT;PRPS1L1;PRPS1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21674760090206127,-0.59052228928188,0.9794520547945206,0.9853159193885695,1.0,6/15,27.04%,ERN1;CLP1;TSEN34;TRPT1;ZBTB8OS;TSEN54
prerank,Golgi to lysosome transport (GO:0090160),-0.23775223472028664,-0.5897357589038066,0.9266247379454927,0.9850197729679426,1.0,5/11,33.56%,GAK;LAPTM5;AP4M1;LAMP1;AP1G1
prerank,mitotic sister chromatid segregation (GO:0000070),0.17415267696865402,0.5889572899046949,0.9962779156327544,0.9915515611434587,1.0,18/98,18.72%,BOD1;DCTN2;SGO1;CENPE;TEX14;NAA50;NSL1;SPDL1;NUSAP1;DIS3L2;NCAPH;RRS1;CEP55;CSNK2A2;VPS4B;SMC1A;KLHL22;KPNB1
prerank,protein palmitoylation (GO:0018345),0.20900511916242448,0.587854205710652,0.9559055118110236,0.9916281397401739,1.0,8/30,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;HHAT;ZDHHC6;ZDHHC9;ZDHHC8
prerank,positive regulation of chromatin organization (GO:1905269),0.255338729143764,0.5868973507636815,0.9322033898305084,0.9916069958250975,1.0,4/12,22.12%,TERF1;DAXX;TERF2IP;ATRX
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24202885374110938,-0.5850929497127185,0.9426605504587156,0.9862825092059849,1.0,1/10,3.33%,SIRPA
prerank,regulation of interleukin-17 production (GO:0032660),0.2105989172485051,0.5827660152804799,0.9696969696969697,0.9930842485412403,1.0,3/31,12.11%,NR1H4;TLR4;IL12A
prerank,C4-dicarboxylate transport (GO:0015740),0.24275366934964782,0.5815778022203095,0.9379194630872483,0.9931599686756137,1.0,3/14,15.03%,SLC25A22;SLC25A30;SLC25A14
prerank,positive regulation of B cell proliferation (GO:0030890),0.20884232545444517,0.580758960222695,0.9637462235649547,0.993060529626746,1.0,5/29,15.74%,CD40;IRS2;GPR183;CD81;TIRAP
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2044616943947805,0.5804988863948166,0.9686520376175548,0.992704407321728,1.0,7/33,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,regulation of mitochondrial fusion (GO:0010635),-0.2319361955379198,-0.580402068472217,0.946067415730337,0.9874841018741272,1.0,3/11,18.65%,TFRC;ADCK1;PID1
prerank,regulation of spindle organization (GO:0090224),0.23123722298869953,0.5786594076690614,0.9394957983193277,0.9930516801747126,1.0,3/18,14.37%,GPSM2;MAP9;SENP6
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2529439599506803,0.57837443493292,0.945054945054945,0.9926976016956384,1.0,2/12,9.43%,SNAP23;SNAP29
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.22549305525870206,0.5774207134552445,0.9431438127090301,0.9926324295278491,1.0,6/20,19.39%,GMPS;AMPD2;AK4;AK3;ADSS1;IMPDH2
prerank,nuclear body organization (GO:0030575),0.24953991330139946,0.5758908070945143,0.9496402877697842,0.9928016107292036,1.0,3/12,19.34%,AFF2;HABP4;USPL1
prerank,V(D)J recombination (GO:0033151),0.25267012214299256,0.5756473394338657,0.9528795811518325,0.9924190029251466,1.0,1/11,3.44%,LIG3
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.19895804404127973,-0.5750072171884341,0.9760765550239234,0.9881883519569008,1.0,7/19,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;ACD;POLR2I;POLR2K
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.19895804404127973,-0.5750072171884341,0.9760765550239234,0.9881883519569008,1.0,7/19,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;ACD;POLR2I;POLR2K
prerank,positive regulation of interleukin-13 production (GO:0032736),0.26434626321816845,0.5744890775323365,0.9263351749539595,0.9924250401039124,1.0,1/10,3.59%,TSLP
prerank,microtubule anchoring (GO:0034453),0.25425666222817767,0.5732300327843923,0.9476351351351351,0.9924741451057624,1.0,4/12,18.83%,CLASP2;CLASP1;PCM1;PEX14
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.20492217336760382,-0.5712252274721686,0.9760191846522782,0.9889252524699127,1.0,11/16,48.45%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1
prerank,regulation of exosomal secretion (GO:1903541),0.2236232442278837,0.5705162871381304,0.9622950819672131,0.9931512668726916,1.0,5/19,17.34%,HGS;ATP9A;TSG101;SNF8;VPS4B
prerank,positive regulation of B cell activation (GO:0050871),0.18440544130892408,0.568735026003137,0.9971428571428571,0.9933796940727126,1.0,8/50,15.74%,CD40;IRS2;HMCES;GPR183;SH3KBP1;CD81;PAXIP1;TIRAP
prerank,phagosome acidification (GO:0090383),-0.17955919685808952,-0.5677261022825749,0.9813829787234043,0.9895164649041976,1.0,7/26,23.55%,ATP6V0A4;RAB38;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1;ATP6V1G1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.20703595662468277,-0.5657274593822808,0.9827586206896551,0.9895807332316313,1.0,5/16,21.44%,SIX1;PTGS2;SIRT1;ZBTB7B;SOX13
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.19783727975520154,-0.565707952723889,0.9896373056994818,0.9889797571348441,1.0,8/20,32.83%,MGRN1;YWHAB;MET;MRAP2;BICD1;ADA;PLEK;RGS2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.25179938485462217,0.5653707082390795,0.9533678756476683,0.9942433679833907,1.0,2/11,11.20%,GCK;ERFE
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.2243611423899682,-0.5653118253392247,0.9399038461538461,0.9884875245270152,1.0,1/13,1.78%,IL18
prerank,regulation of response to interferon-gamma (GO:0060330),0.23492567116663154,0.5645883605439701,0.9598603839441536,0.9940832899493959,1.0,1/14,3.37%,JAK1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.24513934863625747,0.5644656804001303,0.9508196721311475,0.9936491203854831,1.0,2/12,13.61%,FEN1;BUB1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.22890043419320483,-0.5640424621056481,0.9586056644880174,0.9883219899481762,1.0,4/11,26.35%,EGLN3;CRTAP;P4HA3;P4HB
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.18385087672477307,0.5638156261031159,0.9870875179340028,0.9934225350649669,1.0,8/54,15.37%,ARID3A;CNOT11;E2F4;MDM4;TP53;CNOT1;CARM1;CNOT7
prerank,protein localization to microtubule organizing center (GO:1905508),0.22779967266724016,0.5626262930836865,0.9393939393939394,0.9933998660977854,1.0,4/15,20.71%,DCTN2;CEP192;PCM1;BBS4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2142691938897427,0.558662441644318,0.9669811320754716,0.9944276043702804,1.0,2/22,6.01%,RYR2;SLC9A1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.22670994379121703,-0.5585461067078366,0.9563106796116505,0.9894480729725404,1.0,4/11,28.63%,RC3H1;ATM;TYROBP;FCGR2B
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.24283106323053877,0.558341690098416,0.9446366782006921,0.9940655846082813,1.0,2/12,10.61%,FBXO31;TP53
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2339129888881913,0.5564823912827626,0.9551495016611296,0.9942599088519954,1.0,14/14,76.63%,RAB29;CD81;NECTIN2;PRKD2;LCK;TESPA1;CD226;TRAT1;RELA;RPS3;CARD11;KCNN4;IKBKG;BCL10
prerank,response to peptide (GO:1901652),0.19423257057422702,0.5557893629444625,0.9857142857142858,0.9940041718960777,1.0,7/33,23.88%,EIF2B1;IRS1;FYN;KAT7;CACNA1A;EIF2B5;STAT1
prerank,hexose transmembrane transport (GO:0008645),0.2095018490156308,0.5550180510132011,0.9800995024875622,0.9938045212867013,1.0,1/21,4.00%,PPARD
prerank,membrane raft organization (GO:0031579),0.2326490082030166,0.5546246410228486,0.9578947368421052,0.9934653212301895,1.0,2/15,9.80%,FLOT2;FA2H
prerank,positive regulation of catalytic activity (GO:0043085),0.19223964981457142,0.5532974376481083,0.9811912225705329,0.9934640996904565,1.0,11/37,22.80%,MSH3;FXN;IGF2;ATP7A;NHEJ1;MSH6;WRN;SSBP1;CHTOP;B3GAT3;ABL1
prerank,negative regulation of histone acetylation (GO:0035067),-0.22768067224866212,-0.552700548037844,0.9527027027027027,0.9905158334466347,1.0,5/11,31.56%,SIRT1;BRCA1;SPI1;TAF7;SET
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.21722166408235755,0.5517977853423318,0.9670710571923743,0.9935064804119603,1.0,3/16,18.77%,POLQ;FBH1;RIF1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.23363084204752904,0.5498498905022426,0.9698046181172292,0.9936753702572968,1.0,3/13,21.56%,PER2;HEY1;DDIT3
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2500695704960954,0.5489753604032581,0.972027972027972,0.9934822216923409,1.0,2/10,18.84%,NOC2L;THAP7
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2462588652334421,0.548962256904231,0.9452830188679245,0.9930091910106313,1.0,3/11,15.89%,TENT4B;EXOSC10;EXOSC5
prerank,lipid biosynthetic process (GO:0008610),0.1682436764466318,0.5472464777232877,1.0,0.9930973183247268,1.0,8/77,14.56%,PAM;LIPC;LIPH;HSD17B8;ACSL6;ACLY;SREBF1;NDUFAB1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.18164857140835497,0.5465692389694058,0.9895209580838323,0.9928424087920458,1.0,10/47,20.76%,PPARD;ZBTB16;BMP7;WDFY2;CARM1;PIM1;FRZB;BMP2;CMKLR1;RARRES2
prerank,regulation of myoblast fusion (GO:1901739),0.2437772314145822,0.5464670394971946,0.953405017921147,0.9923933583905225,1.0,1/11,5.41%,ADGRB1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.24797391997885954,0.5436108349996466,0.95,0.9928083997544975,1.0,1/10,5.25%,SORL1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.20930214019635543,0.5435944668565788,0.9723127035830619,0.9923376618801253,1.0,1/22,2.85%,NR1H4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.19126059342529295,-0.541893577928968,0.9809523809523809,0.9928743877378788,1.0,12/17,50.62%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.21930906421047588,-0.541809404608144,0.9759615384615384,0.9922857352917113,1.0,5/12,32.75%,SOAT1;MFSD2A;P4HB;LPCAT3;APOC1
prerank,quinone biosynthetic process (GO:1901663),0.22767639961127817,0.5410624138945671,0.9759862778730704,0.9926321114841196,1.0,4/14,19.09%,COQ3;PDSS2;COQ8B;COQ7
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.20679024522847422,0.5398534538430769,0.975,0.9925194773430936,1.0,6/20,24.68%,GCK;ERFE;GSK3A;BCKDK;CRY1;CLK2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.21571953254768234,-0.5390400778066502,0.9767981438515081,0.9923532950341869,1.0,7/11,42.14%,PLCG2;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,regulation of mitochondrial translation (GO:0070129),0.20609757615061233,0.5369507290764579,0.9718543046357616,0.9929286588162063,1.0,7/21,23.65%,MALSU1;UQCC2;NSUN3;MRPS27;MTG1;RCC1L;TRMT10C
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.1824929229689139,-0.5341838771970238,0.9842931937172775,0.9929047045675026,1.0,3/20,12.17%,FAR2;CBR4;ACSL4
prerank,regulation of integrin activation (GO:0033623),-0.2003570487239587,-0.5327581240397596,0.9839080459770115,0.9925986684664851,1.0,7/15,33.06%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC;PLEK;SELP
prerank,negative regulation of double-strand break repair (GO:2000780),-0.16338140669795936,-0.5324453372310499,1.0,0.99206306103862,1.0,12/30,33.24%,TRIP12;SHLD2;OTUB1;RNF169;SMCHD1;OGG1;NUDT16L1;RMI2;PARPBP;OTUB2;SHLD3;HSF1
prerank,eosinophil chemotaxis (GO:0048245),-0.2031514847134158,-0.5253420155121983,0.9932279909706546,0.9924594345950845,1.0,14/14,79.71%,CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL13;CCL1;CCL3;LGALS3;CCL24;CCL26;CCL2;SCG2
prerank,eosinophil migration (GO:0072677),-0.2031514847134158,-0.5253420155121983,0.9932279909706546,0.9924594345950845,1.0,14/14,79.71%,CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL13;CCL1;CCL3;LGALS3;CCL24;CCL26;CCL2;SCG2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.20647571010205473,-0.5246358000159633,0.9716981132075472,0.991987560017655,1.0,6/13,31.80%,SIX1;PTGS2;ZBTB7B;SOX13;FNDC5;VSTM2A
prerank,ubiquinone biosynthetic process (GO:0006744),0.21696395959045708,0.5231414188389638,0.9742268041237113,0.9961777480776659,1.0,4/15,19.09%,COQ3;PDSS2;COQ8B;COQ7
prerank,T cell proliferation (GO:0042098),0.22161647769167853,0.5189924485439098,0.9756944444444444,0.9967118608326034,1.0,3/13,16.97%,PPP3CB;LMBR1L;PIK3CG
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.19919643417665894,-0.5185159349869868,0.9746543778801844,0.9926443196701283,1.0,14/14,80.10%,NGRN;MPV17L2;FASTKD2;RPUSD3;COA3;C1QBP;RMND1;FASTKD3;TRUB2;RPUSD4;TRMT10C;RCC1L;MRPS27;UQCC2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.17837936210965843,0.51757052405625,0.9955223880597015,0.9965737543054374,1.0,10/34,26.11%,TLR6;LRRC14;TLR4;LYN;NFKBIL1;CACTIN;NLRP2B;RAB7B;GRAMD4;NR1D1
prerank,negative regulation of receptor internalization (GO:0002091),0.2263877152752442,0.514066621699618,0.974025974025974,0.9968865625006024,1.0,2/12,11.37%,NECAB2;DLG4
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.21397070008343638,0.51046390657985,0.9726495726495726,0.9972373471264441,1.0,5/15,23.48%,GLI1;ATAD5;DDRGK1;CDC73;STXBP4
prerank,regulation of calcium ion import (GO:0090279),-0.17346288736913792,-0.5089520980796627,0.9924242424242424,0.9937316194002453,1.0,6/21,25.69%,TRIM27;EGF;SPHK2;PLN;PLPP4;PSEN2
prerank,synaptic vesicle transport (GO:0048489),0.22360390248464423,0.5081282927042967,0.9534482758620689,0.997268433422363,1.0,3/11,17.25%,KIF5C;TMEM230;CDK5
prerank,tetrahydrofolate metabolic process (GO:0046653),0.23417773994002736,0.5078070070415676,0.9714285714285714,0.9968584969253558,1.0,4/10,24.37%,MTHFD1L;MTHFD2L;MTHFD1;MTHFS
prerank,aminoglycan metabolic process (GO:0006022),0.23366597627565427,0.5070794612920302,0.9634146341463414,0.9965361941630642,1.0,10/10,76.65%,B4GALT7;B3GAT3;B3GAT2;CHST9;B3GAT1;XYLT1;GAL3ST3;B3GALT6;XYLT2;CLN6
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.21964846202134328,0.5060569972110357,0.9796954314720813,0.9962690108334686,1.0,13/13,78.05%,NUDT21;TUT1;CPSF2;CSTF2T;NCBP1;CPSF1;CSTF2;CPSF4;FIP1L1;CPSF4L;CPSF7;CPSF6;NCBP2
prerank,superoxide anion generation (GO:0042554),-0.19237513814579682,-0.5055758749778682,0.9882352941176471,0.9937097516078283,1.0,4/13,26.71%,NOX4;ALOX12;CYBB;NCF2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.22902152764702194,0.5015213463830848,0.9628975265017667,0.9962294907657271,1.0,10/10,77.11%,CEP250;RPE65;GRM6;CACNA1F;GNAT2;CNGB1;REEP6;GNAT1;CACNA2D4;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.22902152764702194,0.5015213463830848,0.9628975265017667,0.9962294907657271,1.0,10/10,77.11%,CEP250;RPE65;GRM6;CACNA1F;GNAT2;CNGB1;REEP6;GNAT1;CACNA2D4;TULP1
prerank,estrogen metabolic process (GO:0008210),0.20728364271090677,0.50064399773121,0.9847715736040609,0.9959342243594831,1.0,3/15,17.79%,HSD17B8;HSD17B11;HSD17B2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.2180251726242465,0.4965750605339584,0.9870848708487084,0.9962319056060539,1.0,1/11,5.86%,KCNIP2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.20610855125072308,0.4912684559631732,0.975177304964539,0.9967012194347216,1.0,3/14,20.20%,TSEN15;FAM98B;DDX1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.18405456376970858,-0.49058089937467153,0.9896373056994818,0.995408160917622,1.0,8/14,46.29%,ERN1;NCBP2;CPSF6;CPSF7;CPSF4L;FIP1L1;CPSF4;CSTF2
prerank,ether lipid biosynthetic process (GO:0008611),0.22151036413217898,0.4852128513091358,0.9763912310286678,0.9972537266516465,1.0,1/10,5.68%,PEX7
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.21265773521588993,0.48371257381879773,0.9841549295774648,0.996050621557367,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.21265773521588993,0.48371257381879773,0.9841549295774648,0.996050621557367,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.21265773521588993,0.48371257381879773,0.9841549295774648,0.996050621557367,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,sulfation (GO:0051923),0.21177220007645112,0.47792267594326215,0.9779005524861878,0.9964668354590879,1.0,2/11,15.14%,HS3ST5;SULT6B1
prerank,regulation of cilium movement (GO:0003352),0.21194996030131924,0.4743676449487561,0.9821428571428571,0.9965183215360083,1.0,2/10,15.25%,CCDC65;CCDC39
prerank,regulation of B cell activation (GO:0050864),0.1739540143234075,0.47217359251461277,0.9968203497615262,0.9963224436519008,1.0,25/25,82.63%,ZFP36L2;SH3KBP1;TNIP2;ZFP36L1;AHR;TLR9;MZB1;IGLL1;TNFSF4;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;FOXJ1;SAMSN1;BANK1;FCGR2B;NOD2;TNFAIP3;LAPTM5
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.18767593803357047,0.45322099643173086,0.9916387959866221,0.9980461463404835,1.0,5/14,25.35%,SRSF10;SRSF9;SRSF6;SRSF12;RNPS1
prerank,ovarian follicle development (GO:0001541),-0.1715042647612721,-0.4495558786261312,0.9930232558139535,0.999032959295374,1.0,5/13,37.95%,EIF2B4;INHBB;FOXL2;CEBPB;EIF2B2
prerank,regulation of neutrophil migration (GO:1902622),0.19715317338175414,0.4432192634233548,0.9895833333333334,0.9985150748156049,1.0,2/10,17.41%,JAM3;RHOG
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.20394322328990105,0.4426730344535602,0.9868913857677902,0.9980921805761572,1.0,2/10,19.85%,DLGAP3;NPTX2
prerank,negative regulation of mRNA processing (GO:0050686),-0.16620068302934193,-0.4413861412495286,0.9875,0.9989680351559027,1.0,3/15,16.15%,RBMX;SRSF4;SRSF7
prerank,DNA catabolic process (GO:0006308),-0.1821491338187296,-0.43860179536878985,0.9975845410628019,0.9985235309758529,1.0,11/11,81.80%,SETMAR;MUS81;DFFB;DNASE1L1;DNASE1;XRN2;DNASE1L3;ISG20;DNASE1L2;REXO4;FBH1
prerank,organophosphate catabolic process (GO:0046434),-0.17578385944989083,-0.43262997370068784,0.9977272727272727,0.9982358465757541,1.0,1/11,9.77%,ENPP2
prerank,exit from mitosis (GO:0010458),0.17023413470591936,0.3962746775493378,0.9982394366197183,1.0,1.0,12/12,82.99%,CLASP2;CLASP1;PPP2R2D;SIRT7;SPAST;EPS8;UBE2C;UBE2S;CHMP2A;CTDP1;CHMP7;CHMP4B
prerank,regulation of B cell differentiation (GO:0045577),0.1534849499379574,0.3912073938674243,0.9982758620689656,1.0,1.0,1/17,7.17%,ZFP36L2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.1356055355115287,0.36448146907665346,1.0,1.0,1.0,2/24,13.25%,PTPN22;TRIM44
prerank,megakaryocyte differentiation (GO:0030219),0.14718804920913894,0.32209859358315973,1.0,0.9999534988991996,1.0,11/11,85.29%,MED1;UBA5;SH2B3;KIT;MPIG6B;GATA1;ZFPM1;THPO;IL11;CDKN2B;TAL1
